Citrus Sinensis ID: 013122
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 449 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W4J2 | 567 | Mitogen-activated protein | yes | no | 0.988 | 0.783 | 0.784 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | yes | no | 0.984 | 0.815 | 0.761 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | yes | no | 0.890 | 0.803 | 0.790 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.908 | 0.717 | 0.625 | 1e-160 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | no | no | 0.857 | 0.630 | 0.713 | 1e-156 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 0.873 | 0.646 | 0.692 | 1e-156 | |
| Q9LV37 | 510 | Mitogen-activated protein | no | no | 0.766 | 0.674 | 0.773 | 1e-155 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.868 | 0.685 | 0.656 | 1e-155 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.688 | 0.536 | 0.789 | 1e-153 | |
| Q6L5F7 | 582 | Mitogen-activated protein | no | no | 0.681 | 0.525 | 0.790 | 1e-151 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/464 (78%), Positives = 397/464 (85%), Gaps = 20/464 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTD+LGTPS EAI RVRNEKARRYLSSMRKKKPIPFS KFP+ +PL
Sbjct: 229 PLFPGKNVVHQLDLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLE+ML+FEPKDRPTAEEALAD YFKGLAKVEREPSAQPVTK+EFEFERRRITKEDV
Sbjct: 289 ALRLLEKMLSFEPKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPER- 299
RELIYRE LEYHP+MLKE+L+GSEPT FMYPSAV+HFKKQFAYLEEHY GT+ PPER
Sbjct: 349 RELIYRESLEYHPKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQ 408
Query: 300 QHASLPRPCVLYSDKT----VQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVP 355
QHASLPR CVLYSD Q+SA VTD LSKCSI++ DR + +PM+R+PI VP
Sbjct: 409 QHASLPRACVLYSDNNHPVAQQSSAEVTDGLSKCSIRDERPRGADRNAQMPMSRIPINVP 468
Query: 356 Q-----GAARPGKVVSSVLRYNNCGAAAAAEALD--QRRVVRNPAVSTQYAASSYPRRSS 408
Q ARPGKVV SVLRYNNCGAA EAL+ QRR+VRNPA AAS YP+R+
Sbjct: 469 QTIQGAAVARPGKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPA-----AASQYPKRTQ 523
Query: 409 ACKNERVNDE---SVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
CK+ R +++ + EG + L+P QYI +KV+AAQ + S WY
Sbjct: 524 PCKSNRGDEDCATAAEGPSRLKPNTQYIPQKVSAAQDTAMSRWY 567
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 720 bits (1858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/452 (76%), Positives = 390/452 (86%), Gaps = 10/452 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 97 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 156
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAF+DTPTAIFWTDY+ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 157 DFGLARVAFSDTPTAIFWTDYIATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 216
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLDI+TDLLGTPSPE I+R+RNEKARRYL+SMR+KKPIPF+QKFPNA+PL
Sbjct: 217 PLFPGKNVVHQLDIITDLLGTPSPETISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPL 276
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+RLLERMLAF+PKDRP+AEEALADPYFK +A V+REPSAQP+TK+EFEFERRRITKED+
Sbjct: 277 AMRLLERMLAFDPKDRPSAEEALADPYFKNIANVDREPSAQPITKLEFEFERRRITKEDI 336
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+ML+EFLEG+E TGFMYPSAVDHFKKQFAYLEEHY KG+T APPERQ
Sbjct: 337 RELIYREILEYHPKMLREFLEGTESTGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQ 396
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQG-AA 359
H SLPRPCV+YSD Q++A+VT+DLS+C I++ D S + +R +PQG AA
Sbjct: 397 HNSLPRPCVVYSDNRPQSTASVTEDLSRCLIRDNNLKSQDSAS-VGASR----IPQGAAA 451
Query: 360 RPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYA---ASSYPRRSSACKNERVN 416
RPGK V SVLRY NC +AA + +QRRVVRNPA++ + SSYPRR+ CK+E +
Sbjct: 452 RPGKAVGSVLRYGNCSTSAAEQQYEQRRVVRNPAIAPNSSVPLGSSYPRRNQTCKSETGD 511
Query: 417 DESVEGSNGLQPKPQYIARKVAAAQGGSGSNW 448
E ++ S PKP Y+A K+ A G +W
Sbjct: 512 VERIDSSQTGPPKP-YVANKLPATVDGRSGHW 542
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 673 bits (1736), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/406 (79%), Positives = 355/406 (87%), Gaps = 6/406 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 97 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 156
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAF+DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 157 DFGLARVAFSDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 216
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLDI+TDLLGTPS EAI+R+RNEKARRYLSSMR+KKPIPF+QKFPNA+PL
Sbjct: 217 PLFPGKNVVHQLDIITDLLGTPSTEAISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPL 276
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERML+FEPKDRP AEEALADPYF+ +A V+REPSAQPVTK+EFEFERRRITKED+
Sbjct: 277 ALRLLERMLSFEPKDRPNAEEALADPYFRNIANVDREPSAQPVTKLEFEFERRRITKEDI 336
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYR+ILEYHP ML+E+LEG+E GFMYPSAVDHFKKQFAYLEEHY KG+T APPERQ
Sbjct: 337 RELIYRDILEYHPNMLREYLEGTESAGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQ 396
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGAAR 360
H SLPRP VLYSD QN+A + +DLSKC + + + ++ + R+P GAAR
Sbjct: 397 HNSLPRPSVLYSDDRPQNTANIAEDLSKCVLGDNTQKMHQGSASVCANRVP---QGGAAR 453
Query: 361 PGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAA--SSYP 404
PGKVV S LRY NC + + AE + RR RNPA++T + SYP
Sbjct: 454 PGKVVGSALRYGNC-STSTAEQYEHRRTDRNPALATNTVSPRGSYP 498
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 277/443 (62%), Positives = 338/443 (76%), Gaps = 35/443 (7%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M++DLHQVIKANDDLT EH+QFFLYQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKIC
Sbjct: 97 MDTDLHQVIKANDDLTKEHHQFFLYQMLRALKYIHTANVYHRDLKPKNILANANCKLKIC 156
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPT +FWTDYVATRWYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGK
Sbjct: 157 DFGLARVAFNDTPTTVFWTDYVATRWYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGK 216
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS + + R+RNEKARRYLSSMRKK+P+PFS++FP A+P
Sbjct: 217 PLFPGKNVVHQLDLMTDLLGTPSMDTVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPA 276
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL+LL+R+LAF+PKDRPTAEEALADPYFKGLAK EREPS QP+TKMEFEFERR++TKEDV
Sbjct: 277 ALKLLQRLLAFDPKDRPTAEEALADPYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDV 336
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
+ELI+REILEYHPQ+LK+++ G+E T F+YPSA+D+F++QFA LEE+ GK P +R+
Sbjct: 337 KELIFREILEYHPQLLKDYMNGTEKTNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRK 396
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGA-A 359
H SLPR T +SA + PP D + + QVPQ
Sbjct: 397 HVSLPR-------TTTVHSAPI--------------PPKDHQN------ITSQVPQRIPG 429
Query: 360 RPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAV---STQYAASSYPRRSSACKNERVN 416
R G+ V+ + N A +QRRVVRNP + +T +A +Y R+S + + E +
Sbjct: 430 RTGRGACPVIPFENLSAMG---PYNQRRVVRNPVLPPATTNLSAYAYHRKSDSSERE-LQ 485
Query: 417 DESVEGSNGLQPKPQYIARKVAA 439
E + QP ++ KV +
Sbjct: 486 QELEKDRMRYQPSEHFMDAKVVS 508
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 553 bits (1424), Expect = e-156, Method: Compositional matrix adjust.
Identities = 282/395 (71%), Positives = 325/395 (82%), Gaps = 10/395 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILAN++CKLKIC
Sbjct: 109 MESDLHQVIKANDDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGK
Sbjct: 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS + I+RVRN+KARRYLSSMRKK+PI FSQKFP+A+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL LL+++LAF+PKDRPTAEEALA PYFKGLAKVEREPS QP+TKMEFEFERRR+TKED+
Sbjct: 289 ALDLLQKLLAFDPKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDI 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELI+REILEYHPQ+LK+++ G+E T F+YPSAVD F+KQFA+LEE+ G G V P +R+
Sbjct: 349 RELIFREILEYHPQLLKDYINGTERTTFLYPSAVDQFRKQFAHLEENGGNG-PVIPMDRK 407
Query: 301 HASLPRPCVLYSDKT-VQNSAAVTDDLSKCSIKEVEKP-PMDRTSGIP--MARLPIQVPQ 356
H SLPR +++S + + K S + P DR SG ++ P +VP
Sbjct: 408 HTSLPRSTIVHSTPIPAKEQPRIGPSRDKPSDEPYSNPREFDRFSGNAPRTSQAPQRVP- 466
Query: 357 GAARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRN 391
ARPG+VV VL Y N A ++ D RR+ N
Sbjct: 467 -TARPGRVVGPVLPYEN---GATKDSYDARRLAMN 497
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 551 bits (1420), Expect = e-156, Method: Compositional matrix adjust.
Identities = 281/406 (69%), Positives = 322/406 (79%), Gaps = 14/406 (3%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKIC
Sbjct: 109 MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GK
Sbjct: 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS + I+RVRNEKARRYL+SMRKK PIPF+QKFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
+L+LLER+LAF+PKDRPTAEEALADPYFKGLAKVEREPS QP+TKMEFEFERR++TKED+
Sbjct: 289 SLKLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDI 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELI REILEYHPQ+LK+ + G++ F+YPSAVD F++QFA+LEE+ GK VAP ER+
Sbjct: 349 RELISREILEYHPQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERK 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---G 357
HASLPR V++ S AV + + T IP IQ Q
Sbjct: 409 HASLPRSTVIH-------STAVARGGQPKLMNNTNTLNPETTQNIPFNHATIQAQQRNLS 461
Query: 358 AARPGKVVSSVLRYNNCGAAAAAEALDQRRVVR--NPAVSTQYAAS 401
AA+P + V ++N + +A D R +R N S Q AA+
Sbjct: 462 AAKPSTFMGPVAPFDN--GRISRDAYDPRSFIRSTNLPFSQQSAAT 505
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 548 bits (1411), Expect = e-155, Method: Compositional matrix adjust.
Identities = 267/345 (77%), Positives = 299/345 (86%), Gaps = 1/345 (0%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKIC
Sbjct: 107 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKIC 166
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARV+FND P+AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGK
Sbjct: 167 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 226
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLDIMTDLLGTP PEAIAR+RNEKARRYL +MR+K P+PF+ KFP+ +PL
Sbjct: 227 PLFPGKNVVHQLDIMTDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPL 286
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLL R+LAF+PKDRP+AEEALADPYF GLA V+REPS QP+ K+EFEFERR+ITKEDV
Sbjct: 287 ALRLLHRLLAFDPKDRPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDV 346
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHPQML+E+L G E T FMYPS VD FK+QFA+LEE+YGKG +P +RQ
Sbjct: 347 RELIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQ 406
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCS-IKEVEKPPMDRTSG 344
HASLPR V K + ++ S S + +E PP + G
Sbjct: 407 HASLPRERVPAPKKENGSHNHDIENRSIASLVTTLESPPTSQHEG 451
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1408), Expect = e-155, Method: Compositional matrix adjust.
Identities = 277/422 (65%), Positives = 332/422 (78%), Gaps = 32/422 (7%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M++DLHQVIKANDDLT EH+QFFLYQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKIC
Sbjct: 97 MDTDLHQVIKANDDLTKEHHQFFLYQMLRALKYIHTANVYHRDLKPKNILANANCKLKIC 156
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPT +FWTDYVATRWYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGK
Sbjct: 157 DFGLARVAFNDTPTTVFWTDYVATRWYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGK 216
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS +AI+R+RN+KARRYLSSMR+K+P+PFS+KFPN +PL
Sbjct: 217 PLFPGKNVVHQLDLMTDLLGTPSMDAISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPL 276
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL+LL+R+LAF+PKDRPTAEEALADPYFKGLAKVEREPS QP++KMEFEFERR++TK+D+
Sbjct: 277 ALKLLQRLLAFDPKDRPTAEEALADPYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDI 336
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
+ELI+REILEYHPQ+LK+++ GSE T F+YPSAVD+F++QFA LEE+ GK + +R+
Sbjct: 337 KELIFREILEYHPQLLKDYMNGSENTSFLYPSAVDNFRRQFAILEENGGKSGAL---DRK 393
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQGAAR 360
H SLPR ++S N +D TS + R+P AR
Sbjct: 394 HVSLPRATTVHSTSIPPNEG------------------LDATSQV-TQRIP------TAR 428
Query: 361 PGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYA-ASSYPRRSSACKNERVNDES 419
PG+ V VL + N GAA A RRVVRNP V A S Y + ++R + E
Sbjct: 429 PGRTVGPVLPFENPGAADPHSA---RRVVRNPMVPPAAANKSGYSYNLKSDYSDRQHQEE 485
Query: 420 VE 421
+E
Sbjct: 486 LE 487
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 541 bits (1395), Expect = e-153, Method: Compositional matrix adjust.
Identities = 244/309 (78%), Positives = 278/309 (89%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEH+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKIC
Sbjct: 174 MESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKIC 233
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARV+FND PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GK
Sbjct: 234 DFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGK 293
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLDIMTD LGTP PEAI+++RN+KARRYL +MRKK+P+PFS+KFP A+P
Sbjct: 294 PLFPGKNVVHQLDIMTDFLGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPS 353
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLER++AF+PKDRP+AEEALADPYF GL+ REPS QP++K+EFEFER+++TK+D+
Sbjct: 354 ALRLLERLIAFDPKDRPSAEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDI 413
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHPQML+E+L G FMYPS VD F++QFA+LEE+ G G +RQ
Sbjct: 414 RELIYREILEYHPQMLEEYLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQ 473
Query: 301 HASLPRPCV 309
HASLPR V
Sbjct: 474 HASLPRERV 482
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5F7|MPK17_ORYSJ Mitogen-activated protein kinase 17 OS=Oryza sativa subsp. japonica GN=MPK17 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 535 bits (1379), Expect = e-151, Method: Compositional matrix adjust.
Identities = 242/306 (79%), Positives = 277/306 (90%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEH+QFFLYQLLRG+KYIH A+VFHRDLKPKNILANADCKLK+C
Sbjct: 189 MESDLHQVIKANDDLTPEHHQFFLYQLLRGMKYIHAASVFHRDLKPKNILANADCKLKVC 248
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARV+FNDTP+AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAELLTGK
Sbjct: 249 DFGLARVSFNDTPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGK 308
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS E++A++RNEKARRYLS+MRKK +PF++KFP +P+
Sbjct: 309 PLFPGKNVVHQLDLMTDLLGTPSAESLAKIRNEKARRYLSNMRKKPRVPFTKKFPGVDPM 368
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL LLER+LAF+PKDRP+AEEAL DPYF GLA EREP AQP++K+EFEFE+R++ K+DV
Sbjct: 369 ALHLLERLLAFDPKDRPSAEEALTDPYFNGLANSEREPIAQPISKLEFEFEKRKLAKDDV 428
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP ML+E+L G + FMYPS VD FK+QFA+LEE KG +P RQ
Sbjct: 429 RELIYREILEYHPHMLQEYLRGGDQMSFMYPSGVDRFKRQFAHLEEGVSKGEKSSPQLRQ 488
Query: 301 HASLPR 306
+ASLPR
Sbjct: 489 NASLPR 494
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 449 | ||||||
| 359477479 | 563 | PREDICTED: mitogen-activated protein kin | 1.0 | 0.797 | 0.896 | 0.0 | |
| 224107249 | 562 | predicted protein [Populus trichocarpa] | 0.997 | 0.797 | 0.898 | 0.0 | |
| 224102587 | 562 | predicted protein [Populus trichocarpa] | 0.997 | 0.797 | 0.894 | 0.0 | |
| 255551501 | 564 | big map kinase/bmk, putative [Ricinus co | 1.0 | 0.796 | 0.888 | 0.0 | |
| 356549019 | 563 | PREDICTED: mitogen-activated protein kin | 0.997 | 0.795 | 0.875 | 0.0 | |
| 449454432 | 565 | PREDICTED: mitogen-activated protein kin | 0.997 | 0.792 | 0.871 | 0.0 | |
| 449523117 | 565 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.997 | 0.792 | 0.868 | 0.0 | |
| 356555610 | 561 | PREDICTED: mitogen-activated protein kin | 0.993 | 0.795 | 0.868 | 0.0 | |
| 297748113 | 554 | mitogen-activated protein kinase 16 [Gos | 0.982 | 0.796 | 0.863 | 0.0 | |
| 357447643 | 564 | Mitogen activated protein kinase 16-2 [M | 0.997 | 0.794 | 0.875 | 0.0 |
| >gi|359477479|ref|XP_002279719.2| PREDICTED: mitogen-activated protein kinase 16-like [Vitis vinifera] gi|297736969|emb|CBI26170.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2204), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/455 (89%), Positives = 430/455 (94%), Gaps = 6/455 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKPIP SQKFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSAEAIARVRNEKARRYLSSMRKKKPIPLSQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERMLAFEPKDRP+AEEALADPYFKGLAKVEREPSAQPVTK+EFEFERRRITKEDV
Sbjct: 289 ALRLLERMLAFEPKDRPSAEEALADPYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
R+LIYREILEYHP+MLKE+LEG+EPT FMYPSAVD FKKQFAYLEEHYG G TVAPPERQ
Sbjct: 349 RDLIYREILEYHPKMLKEYLEGTEPTSFMYPSAVDQFKKQFAYLEEHYGNGATVAPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---- 356
HASLPRPCVLYSD ++ NSA V DDLSKC IKEVEKP MDR+ GIPMARLP+QVPQ
Sbjct: 409 HASLPRPCVLYSDNSLHNSAEVADDLSKCCIKEVEKPHMDRSCGIPMARLPLQVPQSTQG 468
Query: 357 GAARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNER 414
GAARPGKVV SVLRYNNCGAAAAAE L+QRR+VRNP V++QY AS SYPRR+S+CKNER
Sbjct: 469 GAARPGKVVGSVLRYNNCGAAAAAEVLEQRRMVRNPPVASQYNASSCSYPRRNSSCKNER 528
Query: 415 VNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
++E VEGSNGLQPKPQY+ARKVAAAQGGSGS+WY
Sbjct: 529 GDNEGVEGSNGLQPKPQYMARKVAAAQGGSGSHWY 563
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107249|ref|XP_002314421.1| predicted protein [Populus trichocarpa] gi|222863461|gb|EEF00592.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/455 (89%), Positives = 429/455 (94%), Gaps = 7/455 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP+AQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPTAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKEFL+GSEPTGFMYPSAVDHFKKQFAYLEEHYG G VAPPERQ
Sbjct: 349 RELIYREILEYHPKMLKEFLDGSEPTGFMYPSAVDHFKKQFAYLEEHYGNGAPVAPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---- 356
HASLPRPCVLYSD T+Q SA VT+DLSKCSIKE+EKP +DR+ G+PM RLP+QVPQ
Sbjct: 409 HASLPRPCVLYSDNTIQKSAEVTNDLSKCSIKEIEKPHVDRSDGMPMTRLPLQVPQSIQA 468
Query: 357 GAARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNER 414
GAAR GKV SSVLRYNNCG AAAAE LDQ+R+VRNPA+STQYA + SYPRR+ ACKNER
Sbjct: 469 GAARSGKVASSVLRYNNCG-AAAAENLDQQRMVRNPAISTQYATANCSYPRRNPACKNER 527
Query: 415 VNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
DE VEG NGLQPKPQY+ARKVAAAQGG G++WY
Sbjct: 528 GEDEGVEGPNGLQPKPQYMARKVAAAQGGPGNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102587|ref|XP_002312737.1| predicted protein [Populus trichocarpa] gi|222852557|gb|EEE90104.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/455 (89%), Positives = 429/455 (94%), Gaps = 7/455 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF+ELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFSELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTP+PEAIARVRNEKARRYLSSMRKKKP+PFSQKFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPTPEAIARVRNEKARRYLSSMRKKKPVPFSQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP+AQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPTAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKE L+GSEPTGFMYPSAVDHFKKQFAYLEEHYG G V PPERQ
Sbjct: 349 RELIYREILEYHPKMLKEHLDGSEPTGFMYPSAVDHFKKQFAYLEEHYGNGAPVTPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---- 356
HASLPR CVLYSD T+QNSA VT+DLSKCSIKE+EKP +DR+ GIPM RLP+QVPQ
Sbjct: 409 HASLPRACVLYSDNTIQNSAEVTNDLSKCSIKEIEKPHVDRSGGIPMTRLPLQVPQSIQA 468
Query: 357 GAARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQY--AASSYPRRSSACKNER 414
GAARPGKVVSSVLRYNNCG A +AE LDQRR+VRNPA+STQY A SS+PRR+ ACKNER
Sbjct: 469 GAARPGKVVSSVLRYNNCG-APSAENLDQRRMVRNPAISTQYTTANSSHPRRNPACKNER 527
Query: 415 VNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
DE VEGSNGLQPKPQY+ARKVAAAQGG G++WY
Sbjct: 528 GEDEGVEGSNGLQPKPQYMARKVAAAQGGPGNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551501|ref|XP_002516796.1| big map kinase/bmk, putative [Ricinus communis] gi|223543884|gb|EEF45410.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 847 bits (2187), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/456 (88%), Positives = 426/456 (93%), Gaps = 7/456 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL LLERMLAFEPK+RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALHLLERMLAFEPKNRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKE+LEGSEPT FMYPSAVDHFKKQFAYLEEHYG G TVAPPERQ
Sbjct: 349 RELIYREILEYHPKMLKEYLEGSEPTSFMYPSAVDHFKKQFAYLEEHYGNGATVAPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---- 356
HASLPRPCVLYSD TVQ+SA V +DLSKCSIKE+EKP +DR+ GIPM RLP+QVPQ
Sbjct: 409 HASLPRPCVLYSDNTVQSSAEVANDLSKCSIKEMEKPQVDRSGGIPMTRLPLQVPQSIQA 468
Query: 357 GAARPGKVVSSVLRYNNCGA-AAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNE 413
AARPGKVV SVLRYNNCGA A EAL+QRR+VRNPA+STQY A+ SYPRR+ CKNE
Sbjct: 469 SAARPGKVVGSVLRYNNCGATATTVEALEQRRMVRNPAISTQYTAANCSYPRRNPVCKNE 528
Query: 414 RVNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
R DE VEGS GLQPKPQY+ARKVAAAQGG G++WY
Sbjct: 529 RGEDEGVEGSGGLQPKPQYMARKVAAAQGGPGNHWY 564
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549019|ref|XP_003542896.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/456 (87%), Positives = 421/456 (92%), Gaps = 8/456 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKP+P SQKFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSLEAIARVRNEKARRYLSSMRKKKPVPLSQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLE+MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALRLLEKMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKG TV PPERQ
Sbjct: 349 RELIYREILEYHPKMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGGTVTPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQG--- 357
HASLPRPCVLYSD ++QN++ V DDLSKC IKEVEK P+D +S IPM+RLP+Q PQ
Sbjct: 409 HASLPRPCVLYSDHSMQNTSEVADDLSKCCIKEVEKQPIDSSSAIPMSRLPLQAPQNIQG 468
Query: 358 -AARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNER 414
AARPGKVV SV+RYNNCG A AEA +QRRVVRNP+VS QYAAS SYPRR+S K+ER
Sbjct: 469 VAARPGKVVGSVMRYNNCGVAGTAEA-EQRRVVRNPSVSAQYAASSCSYPRRNSGYKSER 527
Query: 415 VNDE-SVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
+E +EGSNGLQPKPQY+ARKVAAAQ G G WY
Sbjct: 528 GTEEGGIEGSNGLQPKPQYMARKVAAAQAGPGGQWY 563
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454432|ref|XP_004144959.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] gi|449471012|ref|XP_004153181.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 818 bits (2112), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/458 (87%), Positives = 424/458 (92%), Gaps = 10/458 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTD LGTP+ EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDFLGTPNAEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKEFL+GSEPTGFMYPSAVDHFKKQFA+LEEHYG G VAPPERQ
Sbjct: 349 RELIYREILEYHPKMLKEFLDGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGAPVAPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---- 356
HASLPRPCVLYSD VQN A V +DLSKCSIKEVE+PP+DRT IP+AR+PIQVPQ
Sbjct: 409 HASLPRPCVLYSDNMVQNPAQVANDLSKCSIKEVERPPVDRTCNIPLARVPIQVPQSIQG 468
Query: 357 GAARPGKVVSSVLRYNNCGAAAAA---EALDQRRVVRNPAVSTQYAAS--SYPRRSSACK 411
ARPGKVV SVLRY NCGAAAAA E L+QRR+ RNP++ QYA + SY RR+S+CK
Sbjct: 469 NGARPGKVVGSVLRY-NCGAAAAAVAPEVLEQRRMTRNPSIPPQYAGNNCSYTRRNSSCK 527
Query: 412 NERVNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
NER ++E++EG NGLQPKPQYIARKVAAAQGG G+NWY
Sbjct: 528 NERADEEAIEGPNGLQPKPQYIARKVAAAQGGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523117|ref|XP_004168571.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2108), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/458 (86%), Positives = 423/458 (92%), Gaps = 10/458 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP NILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPXNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTD LGTP+ EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDFLGTPNAEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKEFL+GSEPTGFMYPSAVDHFKKQFA+LEEHYG G VAPPERQ
Sbjct: 349 RELIYREILEYHPKMLKEFLDGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGAPVAPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---- 356
HASLPRPCVLYSD VQN A V +DLSKCSIKEVE+PP+DRT IP+AR+PIQVPQ
Sbjct: 409 HASLPRPCVLYSDNMVQNPAQVANDLSKCSIKEVERPPVDRTCNIPLARVPIQVPQSIQG 468
Query: 357 GAARPGKVVSSVLRYNNCGAAAAA---EALDQRRVVRNPAVSTQYAAS--SYPRRSSACK 411
ARPGKVV SVLRY NCGAAAAA E L+QRR+ RNP++ QYA + SY RR+S+CK
Sbjct: 469 NGARPGKVVGSVLRY-NCGAAAAAVAPEVLEQRRMTRNPSIPPQYAGNNCSYTRRNSSCK 527
Query: 412 NERVNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
NER ++E++EG NGLQPKPQYIARKVAAAQGG G+NWY
Sbjct: 528 NERADEEAIEGPNGLQPKPQYIARKVAAAQGGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555610|ref|XP_003546123.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/456 (86%), Positives = 418/456 (91%), Gaps = 10/456 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKP+PFSQKFP+A+P
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSLEAIARVRNEKARRYLSSMRKKKPVPFSQKFPHADPR 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYRE LEYHP+MLKEFLEG+EPTGFMYPSAVDHFKKQFAYLEEHYGKG TVAPPERQ
Sbjct: 349 RELIYRETLEYHPKMLKEFLEGAEPTGFMYPSAVDHFKKQFAYLEEHYGKGGTVAPPERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQG--- 357
HASLPRPCVLYSD ++QN++ V DDLSKC IKEVEK P++R+S IPM+RLP+Q PQ
Sbjct: 409 HASLPRPCVLYSDHSMQNTSEVADDLSKCCIKEVEKQPIERSSAIPMSRLPLQAPQNIQG 468
Query: 358 -AARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNER 414
AARP KVV SV+RYNNCG A AEA +QRRVVRNP+VS QYAAS SYPRR+ KNER
Sbjct: 469 VAARPRKVVGSVMRYNNCGVAVTAEA-EQRRVVRNPSVSAQYAASSCSYPRRNPGYKNER 527
Query: 415 -VNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
D+ +EGSNGLQPK Y+ARKVAAAQ G G WY
Sbjct: 528 GAEDDGIEGSNGLQPK--YMARKVAAAQAGPGGQWY 561
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297748113|gb|ADI52623.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] gi|297748125|gb|ADI52629.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 806 bits (2083), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/454 (86%), Positives = 413/454 (90%), Gaps = 13/454 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS EAIARVRNEKARRYLSSMRKKKPIP S KFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSAEAIARVRNEKARRYLSSMRKKKPIPLSHKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLERMLAFEPKDRP+AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV
Sbjct: 289 AVLLLERMLAFEPKDRPSAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKE+LEGSEPTGFMYPSAVDHFKKQFA+LEEHYG GTT AP ERQ
Sbjct: 349 RELIYREILEYHPKMLKEYLEGSEPTGFMYPSAVDHFKKQFAFLEEHYGNGTTAAPLERQ 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVP---QG 357
HASLPRPCVLYSD +VQNS VTD+LSKCSIKE EKP +R+ IPM+RLP QVP QG
Sbjct: 409 HASLPRPCVLYSDNSVQNSTDVTDNLSKCSIKETEKPQPERSFPIPMSRLPPQVPQSIQG 468
Query: 358 AARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKNERV 415
AARPGKVV SVLRYNNCGA AA EAL+QRR+ RNP+V TQY A+ SYPRR+ CK++
Sbjct: 469 AARPGKVVGSVLRYNNCGAVAAGEALEQRRMARNPSVPTQYTATNCSYPRRNPVCKDDEE 528
Query: 416 NDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
N+ LQPKPQY+ARKVAAAQGGS S WY
Sbjct: 529 NE--------LQPKPQYMARKVAAAQGGSRSQWY 554
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447643|ref|XP_003594097.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] gi|355483145|gb|AES64348.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2079), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/457 (87%), Positives = 420/457 (91%), Gaps = 9/457 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLDIMTD LGTPSP+AIARVRNEKARRYLSSMRKKKP+PFS KFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDIMTDFLGTPSPDAIARVRNEKARRYLSSMRKKKPVPFSHKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLERMLAFE KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV
Sbjct: 289 ALRLLERMLAFEAKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHP+MLKEFLEG+EPTGFMYPSAVD FKKQFAYLEEHYGKG TVAPPERQ
Sbjct: 349 RELIYREILEYHPKMLKEFLEGAEPTGFMYPSAVDLFKKQFAYLEEHYGKGGTVAPPERQ 408
Query: 301 HA-SLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGI-PMARLPIQVPQG- 357
HA SLPR CVLYSD T+QN+A V DDLSKC IKEVE+PP+DR+S I PM R+P+Q PQ
Sbjct: 409 HASSLPRACVLYSDNTMQNTAEVADDLSKCCIKEVERPPVDRSSDIHPMTRIPLQAPQNM 468
Query: 358 ---AARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAAS--SYPRRSSACKN 412
AARPGKVV S +RYNNCG A AE +QRRVVRNP VS+QYAAS SYPRR+ K+
Sbjct: 469 QGLAARPGKVVGSAMRYNNCGVAVTAET-EQRRVVRNPPVSSQYAASSCSYPRRNPNYKS 527
Query: 413 ERVNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
ERV D+ +EGSNGLQPKPQYIARKVAAAQGG+G WY
Sbjct: 528 ERVEDDVIEGSNGLQPKPQYIARKVAAAQGGAGGQWY 564
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 449 | ||||||
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.986 | 0.781 | 0.772 | 1.5e-186 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.815 | 0.603 | 0.726 | 1.1e-146 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.766 | 0.674 | 0.773 | 5.7e-146 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.962 | 0.722 | 0.630 | 5.3e-143 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.706 | 0.550 | 0.776 | 1.9e-138 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.766 | 0.584 | 0.722 | 4e-138 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.828 | 0.604 | 0.673 | 8.3e-138 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.815 | 0.753 | 0.631 | 3.2e-129 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.550 | 0.466 | 0.523 | 3.5e-68 | |
| UNIPROTKB|O42781 | 351 | MKP2 "Mitogen-activated protei | 0.550 | 0.703 | 0.513 | 4e-67 |
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1809 (641.9 bits), Expect = 1.5e-186, P = 1.5e-186
Identities = 359/465 (77%), Positives = 393/465 (84%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK
Sbjct: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTD+LGTPS EAI RVRNEKARRYLSSMRKKKPIPFS KFP+ +PL
Sbjct: 229 PLFPGKNVVHQLDLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLE+ML+FEPKDRPTAEEALAD YFKGLAKVEREPSAQPVTK+EFEFERRRITKEDV
Sbjct: 289 ALRLLEKMLSFEPKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDV 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYRE LEYHP+MLKE+L+GSEPT FMYPSAV+HFKKQFAYLEEHY GT+ PPERQ
Sbjct: 349 RELIYRESLEYHPKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQ 408
Query: 301 -HASLPRPCVLYSDKT----VQNSAAVTDDLSKCSIKEVEKPP-MDRTSGIPMARLPIQV 354
HASLPR CVLYSD Q+SA VTD LSKCSI++ E+P DR + +PM+R+PI V
Sbjct: 409 QHASLPRACVLYSDNNHPVAQQSSAEVTDGLSKCSIRD-ERPRGADRNAQMPMSRIPINV 467
Query: 355 PQ---GAA--RPGKVVSSVLRYNNCGXXXXXXXLDQ--RRVVRNPAVSTQXXXXXXXXXX 407
PQ GAA RPGKVV SVLRYNNCG L+Q RR+VRNPA ++Q
Sbjct: 468 PQTIQGAAVARPGKVVGSVLRYNNCGAATGVEALEQQQRRMVRNPAAASQYPKRTQP--- 524
Query: 408 XXCKNERVNDE---SVEGSNGLQPKPQYIARKVAAAQGGSGSNWY 449
CK+ R +++ + EG + L+P QYI +KV+AAQ + S WY
Sbjct: 525 --CKSNRGDEDCATAAEGPSRLKPNTQYIPQKVSAAQDTAMSRWY 567
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1416 (503.5 bits), Expect = 1.1e-146, Sum P(2) = 1.1e-146
Identities = 273/376 (72%), Positives = 310/376 (82%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKIC
Sbjct: 109 MESDLHQVIKANDDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKIC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GK
Sbjct: 169 DFGLARVAFNDTPTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTDLLGTPS + I+RVRNEKARRYL+SMRKK PIPF+QKFPNA+PL
Sbjct: 229 PLFPGKNVVHQLDLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
+L+LLER+LAF+PKDRPTAEEALADPYFKGLAKVEREPS QP+TKMEFEFERR++TKED+
Sbjct: 289 SLKLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDI 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELI REILEYHPQ+LK+ + G++ F+YPSAVD F++QFA+LEE+ GK VAP ER+
Sbjct: 349 RELISREILEYHPQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERK 408
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ---G 357
HASLPR V++S +A K P + T IP IQ Q
Sbjct: 409 HASLPRSTVIHS------TAVARGGQPKLMNNTNTLNP-ETTQNIPFNHATIQAQQRNLS 461
Query: 358 AARPGKVVSSVLRYNN 373
AA+P + V ++N
Sbjct: 462 AAKPSTFMGPVAPFDN 477
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1426 (507.0 bits), Expect = 5.7e-146, P = 5.7e-146
Identities = 267/345 (77%), Positives = 299/345 (86%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKIC
Sbjct: 107 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKIC 166
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARV+FND P+AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGK
Sbjct: 167 DFGLARVSFNDAPSAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGK 226
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLDIMTDLLGTP PEAIAR+RNEKARRYL +MR+K P+PF+ KFP+ +PL
Sbjct: 227 PLFPGKNVVHQLDIMTDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPL 286
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLL R+LAF+PKDRP+AEEALADPYF GLA V+REPS QP+ K+EFEFERR+ITKEDV
Sbjct: 287 ALRLLHRLLAFDPKDRPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDV 346
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHPQML+E+L G E T FMYPS VD FK+QFA+LEE+YGKG +P +RQ
Sbjct: 347 RELIYREILEYHPQMLQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQ 406
Query: 301 HASLPRPCVLYSDKTVQNSAAVTDDLSKCS-IKEVEKPPMDRTSG 344
HASLPR V K + ++ S S + +E PP + G
Sbjct: 407 HASLPRERVPAPKKENGSHNHDIENRSIASLVTTLESPPTSQHEG 451
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1398 (497.2 bits), Expect = 5.3e-143, P = 5.3e-143
Identities = 281/446 (63%), Positives = 332/446 (74%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+C
Sbjct: 109 MESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARV+FNDTPT +FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTGK
Sbjct: 169 DFGLARVSFNDTPTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGK+VVHQLD++TDLLGTP E IA VRNEKAR+YL+ MRKK +PFSQKFPNA+PL
Sbjct: 229 PLFPGKSVVHQLDLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLL+R+LAF+PKDRPTA EALADPYFK LAKVEREPS QP++KMEFEFERRR+TK+D+
Sbjct: 289 ALRLLQRLLAFDPKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDI 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHPQ+LK+++ SE + F+YPSA+ H +KQFAYLEE+ GK V PP+R+
Sbjct: 349 RELIYREILEYHPQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRK 407
Query: 301 HASLPRPCVLYS--DKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARL--PIQVPQ 356
HASLPR V S + Q S +D + SI+ + TS L P +VP
Sbjct: 408 HASLPRSAVHSSAVNSNAQPSLNASDS-RRVSIEPSRNGVVPSTSAYSTKPLGPPPRVPS 466
Query: 357 GAARPGKVVSSVLRYNNCGXXXXXXXLDQRRVVRNPAVSTQXXXXXXXXXXXXCKNERVN 416
G +PG+VV S + Y N D R ST N +N
Sbjct: 467 G--KPGRVVESSVTYEN-DRNLKESSYDARTSYYR---STVLPPQTVSPNCYFLPNT-MN 519
Query: 417 DESVEGSNGL-QPKPQYIARKVAAAQ 441
E G+ QPKPQ++ + +A+
Sbjct: 520 QEKRSGTEAASQPKPQFVPTQCNSAK 545
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1355 (482.0 bits), Expect = 1.9e-138, P = 1.9e-138
Identities = 247/318 (77%), Positives = 284/318 (89%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEH+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKIC
Sbjct: 174 MESDLHQVIKANDDLTPEHHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKIC 233
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARV+FND PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GK
Sbjct: 234 DFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGK 293
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLDIMTD LGTP PEAI+++RN+KARRYL +MRKK+P+PFS+KFP A+P
Sbjct: 294 PLFPGKNVVHQLDIMTDFLGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPS 353
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLER++AF+PKDRP+AEEALADPYF GL+ REPS QP++K+EFEFER+++TK+D+
Sbjct: 354 ALRLLERLIAFDPKDRPSAEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDI 413
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHPQML+E+L G FMYPS VD F++QFA+LEE+ G G +RQ
Sbjct: 414 RELIYREILEYHPQMLEEYLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQ 473
Query: 301 HASLPRPCVLYS-DKTVQ 317
HASLPR V S ++TV+
Sbjct: 474 HASLPRERVPASKNETVE 491
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1352 (481.0 bits), Expect = 4.0e-138, P = 4.0e-138
Identities = 253/350 (72%), Positives = 290/350 (82%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKIC
Sbjct: 188 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKIC 247
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARV+FND PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GK
Sbjct: 248 DFGLARVSFNDAPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGK 307
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD+MTD LGTP PE+I+R+RNEKARRYLSSMRKK+P+PFS KFP A+PL
Sbjct: 308 PLFPGKNVVHQLDLMTDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPL 367
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLER+LAF+PKDR +AE+ALADPYF GL+ EREP+ QP++K+EF+FER+++ K+DV
Sbjct: 368 ALRLLERLLAFDPKDRASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDV 427
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGK-----GTTVA 295
RELIYREILEYHPQML+E+L G + FMYPS VD FK+QFA+LEE+ GK G
Sbjct: 428 RELIYREILEYHPQMLEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRST 487
Query: 296 PPERQHASLPRPCV-LYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSG 344
R HASLPR V + +T + S+ V + +E D G
Sbjct: 488 ALHRHHASLPRERVPAPNGETAEESSDVERRAAAAVASTLESEEADNGGG 537
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 8.3e-138, P = 8.3e-138
Identities = 256/380 (67%), Positives = 308/380 (81%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLT EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILANA+CKLK+C
Sbjct: 109 MESDLHQVIKANDDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVC 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPT +FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTGK
Sbjct: 169 DFGLARVAFNDTPTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGK 228
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGK+VVHQL+++TDLLGTP E I+ VRN+KAR+YL+ MRKK P+ FSQKF A+PL
Sbjct: 229 PLFPGKSVVHQLELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPL 288
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLL+R+LAF+PKDRPT EALADPYFKGL+K+EREPS+Q ++KMEFEFERRR+TK+D+
Sbjct: 289 ALRLLQRLLAFDPKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDI 348
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQ 300
RELIYREILEYHPQ+LK+++ GSE + F+YPSA+ H ++QF YLEE+ + V P ER+
Sbjct: 349 RELIYREILEYHPQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERK 408
Query: 301 HASLPRPCVLYS--DKTVQNSAAVTDD--LS-KCSIKEVEKPPMDRTSGIPMARL--PIQ 353
HASLPR V + T Q + TD +S + S TS P + P +
Sbjct: 409 HASLPRSTVHSTVVHSTSQPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPR 468
Query: 354 VPQGAARPGKVVSSVLRYNN 373
VP + RPG+VV S + Y N
Sbjct: 469 VPP-SGRPGRVVESSVSYEN 487
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1268 (451.4 bits), Expect = 3.2e-129, P = 3.2e-129
Identities = 236/374 (63%), Positives = 302/374 (80%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLH V+K NDDLTP+H+QFFLYQLLRGLK++H+A+VFHRDLKPKNILANADCK+KIC
Sbjct: 100 MESDLHHVLKVNDDLTPQHHQFFLYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKIC 159
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
D GLARV+F D+P+A+FWTDYVATRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGK
Sbjct: 160 DLGLARVSFTDSPSAVFWTDYVATRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGK 219
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQL+++TDLLGTPSP ++R+RNEKAR+YL +MR+K P+PF+ KFPN +P+
Sbjct: 220 PLFPGKNVVHQLELVTDLLGTPSPITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPV 279
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL+LL+R++AF+PKDRP+AEEALADPYF+GLA V+ EPS QP++K+EFEFERR++T++DV
Sbjct: 280 ALKLLQRLIAFDPKDRPSAEEALADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDV 339
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTG--FMYPSAVDHFKKQFAYLEEHYG-KGTTVAPP 297
REL+YREILEYHPQML+E+L+G E F+YPS VD FK++FA LEEH + +PP
Sbjct: 340 RELMYREILEYHPQMLQEYLQGEENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPP 399
Query: 298 -ERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ 356
+R++ SLPR V S+ + S +V S S+ V PP + ++
Sbjct: 400 HQRKYTSLPRERVCSSED--EGSDSVHAQSSSASV--VFTPPQTPNTATGLSSQKASQVD 455
Query: 357 GAARPGKVVSSVLR 370
AA P K + ++R
Sbjct: 456 KAATPVKRSACLMR 469
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 3.5e-68, P = 3.5e-68
Identities = 134/256 (52%), Positives = 181/256 (70%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M++DLHQ+I + L+ +H Q+F+YQ+LRGLK+IH+ANV HRDLKP N+L N DC LKIC
Sbjct: 233 MDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIHSANVLHRDLKPSNLLINEDCLLKIC 292
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
D GLARV D F T+YVATRWYRAPE+ S+ +KYT AIDIWS+GCIFAELL K
Sbjct: 293 DLGLARV--EDATHQGFMTEYVATRWYRAPEVILSW-NKYTKAIDIWSVGCIFAELLGRK 349
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLF GK+ +HQ+ ++ + +G+PS E I + NE+AR+++ +M + + F+ FP ANP
Sbjct: 350 PLFQGKDYIHQITLIIETIGSPSEEDICNIANEQARQFIRNMGNQPKVNFANMFPKANPD 409
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVT--KMEFEFERRRITKE 238
A+ LLERML F+P R T EEALA PYF+ L +PS +P+ K FE + ++
Sbjct: 410 AIDLLERMLYFDPSKRLTVEEALAHPYFQSL----HDPSDEPICLHKFSLNFEAWDLNRD 465
Query: 239 DVRELIYREILEYHPQ 254
++ELIY E+L YHP+
Sbjct: 466 LLKELIYNEMLAYHPE 481
|
|
| UNIPROTKB|O42781 MKP2 "Mitogen-activated protein kinase 2" [Pneumocystis carinii (taxid:4754)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 4.0e-67, P = 4.0e-67
Identities = 129/251 (51%), Positives = 184/251 (73%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME+D+H+VI+ D L+ +H Q+F+YQ+LR LK +H+A++ HRDLKP N+L NA+C LK+C
Sbjct: 99 METDMHRVIRTQD-LSDDHCQYFIYQILRALKAMHSADILHRDLKPSNLLLNANCDLKVC 157
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A + ++ F T+YVATRWYRAPE+ +F +YT AIDIWS+GCI AE+L+G+
Sbjct: 158 DFGLARSAVSTEDSSSFMTEYVATRWYRAPEIMLTF-KEYTKAIDIWSVGCILAEMLSGR 216
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGK+ HQL ++ D+LGTP+ E +++ +AR Y+ S+ KK + F+ FP ANPL
Sbjct: 217 PLFPGKDYHHQLMLILDVLGTPTMEDYYGIKSRRAREYIRSLPFKKRVSFASIFPRANPL 276
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR--ITKE 238
AL LLE++LAF P R TAEEAL Y + + EP+A P++ F+F+R + +TK
Sbjct: 277 ALDLLEKLLAFNPAKRVTAEEALQHNYLEPYHDPDDEPTAPPISPSFFDFDRIKDSLTKN 336
Query: 239 DVRELIYREIL 249
D++ LIY+EI+
Sbjct: 337 DLKILIYKEIM 347
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q53N72 | MPK15_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7906 | 0.8908 | 0.8032 | yes | no |
| Q8W4J2 | MPK16_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7844 | 0.9888 | 0.7830 | yes | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7562 | 0.7104 | 0.6304 | N/A | no |
| Q75KK8 | MPK14_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7610 | 0.9844 | 0.8154 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.991 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00019886001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (567 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 449 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-139 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-118 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-109 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-100 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-100 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-94 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-92 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-83 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-80 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-78 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-75 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-72 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-72 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-70 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-70 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-67 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-66 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-64 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-62 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-61 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-60 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-59 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-57 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-57 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-56 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-54 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-53 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-51 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-51 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-51 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-51 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-50 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-50 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-50 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-48 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-46 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-46 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-46 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-46 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-45 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-45 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-44 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-44 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-43 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-42 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-42 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-42 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-39 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-37 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-35 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-34 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-34 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-32 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-31 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-30 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-29 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-16 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-13 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.004 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 569 bits (1469), Expect = 0.0
Identities = 238/253 (94%), Positives = 251/253 (99%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLHQVIKANDDLTPEH+QFFLYQLLR LKYIHTANVFHRDLKPKNILANADCKLKIC
Sbjct: 86 MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKIC 145
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGK
Sbjct: 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGKNVVHQLD++TDLLGTPSPE I+RVRNEKARRYLSSMRKK+P+PFSQKFPNA+PL
Sbjct: 206 PLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPL 265
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
ALRLLER+LAF+PKDRPTAEEALADPYFKGLAKVEREPSAQP+TK+EFEFERRR+TKEDV
Sbjct: 266 ALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDV 325
Query: 241 RELIYREILEYHP 253
RELIYREILEYHP
Sbjct: 326 RELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 403 bits (1037), Expect = e-139
Identities = 142/247 (57%), Positives = 181/247 (73%), Gaps = 2/247 (0%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME+DLH+VIK+ LT +H Q+FLYQ+LRGLKY+H+ANV HRDLKP NIL N++C LKIC
Sbjct: 86 METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKIC 145
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR D F T+YV TRWYRAPEL S S+YT AIDIWS+GCIFAELLT K
Sbjct: 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRK 204
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPG++ + QL+++ ++LGTPS E + + +EKAR YL S+ KK P S+ FP A+P
Sbjct: 205 PLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE 264
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML F+PK R TA+EALA PY L E EP A+P +F F+ +T+E++
Sbjct: 265 AIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDF-FDDDELTEEEL 323
Query: 241 RELIYRE 247
+ELIY E
Sbjct: 324 KELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 349 bits (897), Expect = e-118
Identities = 146/253 (57%), Positives = 185/253 (73%), Gaps = 6/253 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M++DLHQ+I+++ L+ +H Q+FLYQLLRGLKYIH+ANV HRDLKP N+L NA+C LKIC
Sbjct: 91 MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR + F T+YV TRWYRAPEL + S+YT AID+WS+GCIFAELL K
Sbjct: 151 DFGLARTT---SEKGDFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRK 206
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGK+ VHQL ++T+LLG+PS E + +RNEKARRY+ S+ F++ FP+ANPL
Sbjct: 207 PLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPL 266
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML F+P R T EEALA PY L EP Q T F+FE +T+ED+
Sbjct: 267 AIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQ--TPFSFDFEEDALTEEDI 324
Query: 241 RELIYREILEYHP 253
+ELIY E+L YHP
Sbjct: 325 KELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 326 bits (838), Expect = e-109
Identities = 129/254 (50%), Positives = 179/254 (70%), Gaps = 13/254 (5%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME+DL+++IK L+ +H Q+FLYQ+LRGLKYIH+ANV HRDLKP N+L N +C LKIC
Sbjct: 90 METDLYKLIKTQH-LSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKIC 148
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR+A + F T+YVATRWYRAPE+ + YT AIDIWS+GCI AE+L+ +
Sbjct: 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNR 207
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGK+ +HQL+++ +LGTPS E + + + +AR Y+ S+ K +P+++ FPNA+P
Sbjct: 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER--EPSAQPVTKMEFEFE---RRRI 235
AL LL++ML F P R T EEALA PY +E+ +PS +PV + F F+ +
Sbjct: 268 ALDLLDKMLTFNPHKRITVEEALAHPY------LEQYHDPSDEPVAEEPFPFDFELFDDL 321
Query: 236 TKEDVRELIYREIL 249
KE ++ELI+ EI+
Sbjct: 322 PKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 303 bits (778), Expect = e-100
Identities = 131/250 (52%), Positives = 170/250 (68%), Gaps = 7/250 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME+DLHQ+I++ LT H+Q F+YQ+L GLKYIH+ANV HRDLKP N+L NADC+LKIC
Sbjct: 88 MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKIC 147
Query: 61 DFGLARVAFNDTP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR F++ P A F T+YVATRWYRAPE+ SF YT AID+WS+GCI AELL
Sbjct: 148 DFGLAR-GFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLG 205
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
KP+F GK+ V QL+ + +LGTP E ++R+ + KA+ Y+ S+ PF FPNAN
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNAN 265
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
PLAL LLE++LAF+P R + EEAL PY + EP Q FE E + E
Sbjct: 266 PLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED---SME 322
Query: 239 DVRELIYREI 248
++R++I E+
Sbjct: 323 ELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 302 bits (775), Expect = e-100
Identities = 125/248 (50%), Positives = 179/248 (72%), Gaps = 4/248 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
MESDLH +I ++ LT EH ++FLYQLLRGLKYIH+ANV HRDLKP N+L N DC+L+I
Sbjct: 90 MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIG 149
Query: 61 DFGLAR-VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFG+AR ++ + T F T+YVATRWYRAPEL S +YT AID+WS+GCIFAE+L
Sbjct: 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGR 208
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+ LFPGKN VHQL ++ +LG+PS E + R+ +++ R+Y+ ++ +K+P+P+S+ FP A+P
Sbjct: 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASP 268
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKED 239
AL LL +ML F+P++R T E+AL P+ + EP+ P +F+FE +++E
Sbjct: 269 EALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP--PFDFDFEAIELSREQ 326
Query: 240 VRELIYRE 247
++E I +E
Sbjct: 327 LKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 288 bits (739), Expect = 1e-94
Identities = 119/253 (47%), Positives = 162/253 (64%), Gaps = 11/253 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL+ ++K L+ +H QF +YQ+LRGLKYIH+A + HRDLKP NI N DC+LKI
Sbjct: 102 MGADLNNIVKCQK-LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR ++ T YVATRWYRAPE+ ++ Y +DIWS+GCI AELLTGK
Sbjct: 161 DFGLARHTDDEM------TGYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGK 213
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LFPG + + QL + +L+GTP E + ++ +E AR Y+ S+ + F + F ANPL
Sbjct: 214 TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPL 273
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML +P R TA EALA PY E EP A P + FE R +T ++
Sbjct: 274 AIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPP---YDQSFESRDLTVDEW 330
Query: 241 RELIYREILEYHP 253
+EL+Y+EI+ + P
Sbjct: 331 KELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 282 bits (724), Expect = 2e-92
Identities = 110/251 (43%), Positives = 154/251 (61%), Gaps = 7/251 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME+DLH VI+AN L H ++ +YQLL+ LKYIH+ NV HRDLKP NIL N+DC++K+
Sbjct: 91 METDLHAVIRANI-LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLA 149
Query: 61 DFGLARVA--FNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELL 117
DFGLAR + P TDYVATRWYRAPE L GS ++YT +D+WS+GCI E+L
Sbjct: 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS--TRYTKGVDMWSVGCILGEML 207
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
GKPLFPG + ++QL+ + +++G PS E I +++ A L S+ + P + P A
Sbjct: 208 LGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA 267
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITK 237
+ AL LL+++L F P R TAEEAL PY EP + + + +++
Sbjct: 268 SDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD-DNVKLSV 326
Query: 238 EDVRELIYREI 248
+ R +Y EI
Sbjct: 327 AEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 4e-83
Identities = 117/249 (46%), Positives = 167/249 (67%), Gaps = 14/249 (5%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+ +DLH+++ + L + Q+FLYQ+LRGLKY+H+A V HRDLKP NIL N +C LKIC
Sbjct: 92 LGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKIC 150
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR+ T YV+TR+YRAPE+ ++ KY +DIWS GCIFAE+L GK
Sbjct: 151 DFGLARIQDPQM------TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGK 203
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPGK+ V+Q I+TDLLGTP + I + +E R++ S+ K++P+PFS+KF NA+P
Sbjct: 204 PLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPS 263
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE--FERRRITKE 238
A+ LLE+ML F+P+ R +A EALA PY +P+ +PV + +F+ F + +
Sbjct: 264 AIDLLEKMLVFDPQKRISAAEALAHPYLAPY----HDPTDEPVAEEKFDWSFNDADLPVD 319
Query: 239 DVRELIYRE 247
+ ++Y E
Sbjct: 320 TWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 2e-80
Identities = 100/210 (47%), Positives = 133/210 (63%), Gaps = 8/210 (3%)
Query: 1 MESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M++DL+++IK L + +LYQLL+GL + H+ + HRDLKP+N+L N + LK+
Sbjct: 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKL 139
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR +T YV TRWYRAPE L G Y+ +DIWS+GCIFAELL+
Sbjct: 140 ADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLGDKG--YSTPVDIWSVGCIFAELLS 194
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
+PLFPGK+ + QL + LGTP PE + + AR Y S KK +P + FPNA+
Sbjct: 195 RRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSFPKKAGMPLPKLFPNAS 253
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYF 208
P AL LL +ML ++P R TAE+ALA PYF
Sbjct: 254 PQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (624), Expect = 4e-78
Identities = 92/210 (43%), Positives = 122/210 (58%), Gaps = 9/210 (4%)
Query: 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
+ DL + + L+P + +YQLLRGL Y H+ + HRDLKP+NIL N D LK+
Sbjct: 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKL 139
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR T +T V T WYRAPE L GS Y+ A+DIWS+GCIFAE++T
Sbjct: 140 ADFGLARAFGIPLRT---YTHEVVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMIT 194
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
GKPLFPG + + QL + +LGTP+ E+ V K Y + K P + P +
Sbjct: 195 GKPLFPGDSEIDQLFKIFQILGTPTEESWPGV--TKLPDYKPTFPKFPPKDLEKVLPRLD 252
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYF 208
P + LL +ML + P R +A+EAL PYF
Sbjct: 253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 6e-75
Identities = 114/276 (41%), Positives = 159/276 (57%), Gaps = 32/276 (11%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+SDLH++I + L+ +H + FLYQ+LRGLKY+H+A + HRD+KP N+L N++C LKIC
Sbjct: 86 MQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKIC 145
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFGLARV D + T V T++YRAPE L GS YT A+DIWS+GCIFAELL
Sbjct: 146 DFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYTSAVDIWSVGCIFAELLGR 201
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+ LF ++ + QLD++TDLLGTPS EA+ E AR ++ KP + ++
Sbjct: 202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR-GPHKPPSLPVLYTLSSQ 259
Query: 180 L---ALRLLERMLAFEPKDRPTAEEALADPYFKG--------------------LAKVER 216
A+ LL RML F+P R +A +ALA PY + +
Sbjct: 260 ATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDF 319
Query: 217 EPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 252
EPSA P E+E+ + V+E +++ ILE
Sbjct: 320 EPSANPPFD--DEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 2e-72
Identities = 113/253 (44%), Positives = 158/253 (62%), Gaps = 11/253 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL+ ++K LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI
Sbjct: 104 MGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 162
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR T T YVATRWYRAPE+ ++ Y +DIWS+GCI AELLTG+
Sbjct: 163 DFGLAR------HTDDEMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGR 215
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LFPG + + QL ++ L+GTP E + ++ +E AR Y+ S+ + + F+ F ANPL
Sbjct: 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 275
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML + R TA +ALA YF + EP A P + FE R + ++
Sbjct: 276 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQ---SFESRDLLIDEW 332
Query: 241 RELIYREILEYHP 253
+ L Y E++ + P
Sbjct: 333 KSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 5e-72
Identities = 116/253 (45%), Positives = 159/253 (62%), Gaps = 11/253 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL+ ++K L+ EH QF +YQLLRGLKYIH+A + HRDLKP N+ N DC+L+I
Sbjct: 102 MGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A ++ T YVATRWYRAPE+ ++ Y +DIWS+GCI AELL GK
Sbjct: 161 DFGLARQADDEM------TGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLKGK 213
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LFPG + + QL + +++GTPSPE + ++ +E AR+Y+ S+ + F ANPL
Sbjct: 214 ALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPL 273
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML + R +A EALA PYF E EP A+P + E + T E+
Sbjct: 274 AIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDE---SPENKERTIEEW 330
Query: 241 RELIYREILEYHP 253
+EL Y E+ + P
Sbjct: 331 KELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 2e-70
Identities = 109/253 (43%), Positives = 158/253 (62%), Gaps = 11/253 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL +++K ++ L+ + QF +YQ+L+GLKYIH A + HRDLKP N+ N DC+LKI
Sbjct: 102 MGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR ++ T YV TRWYRAPE+ ++ YT +DIWS+GCI AE+LTGK
Sbjct: 161 DFGLARQTDSEM------TGYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGK 213
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLF G + + QL + + GTPS E + ++++E A+ Y+ + + + F PNANPL
Sbjct: 214 PLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPL 273
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ +LE+ML + + R TA EALA PYF+ E E A P + F+ + E+
Sbjct: 274 AVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDDSFDEVDQSLEEW 330
Query: 241 RELIYREILEYHP 253
+ L + EIL + P
Sbjct: 331 KRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 9e-70
Identities = 103/253 (40%), Positives = 152/253 (60%), Gaps = 12/253 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M++DL +++ L+ + Q+ +YQ+L GLKYIH+A + HRDLKP N+ N DC+LKI
Sbjct: 102 MQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKIL 159
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A + T YV TRWYRAPE+ ++ Y +DIWS+GCI AE+LTGK
Sbjct: 160 DFGLARHADAEM------TGYVVTRWYRAPEVILNWM-HYNQTVDIWSVGCIMAEMLTGK 212
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LF GK+ + QL + + G P PE + ++ ++ A+ Y+ S+ K FS FP A+P
Sbjct: 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQ 272
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML + R TA EAL PYF + E QP + E +++ ++
Sbjct: 273 AVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLENEKLSVDEW 329
Query: 241 RELIYREILEYHP 253
++ IY+E+ + P
Sbjct: 330 KKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 3e-67
Identities = 90/212 (42%), Positives = 118/212 (55%), Gaps = 12/212 (5%)
Query: 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
ME+DL +VIK LTP + ++ LRGL+Y+H+ + HRDLKP N+L +D LK+
Sbjct: 84 METDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKL 143
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELL 117
DFGLAR +F + T V TRWYRAPEL F Y +D+WS+GCIFAELL
Sbjct: 144 ADFGLAR-SFGSPNRKM--THQVVTRWYRAPEL---LFGARHYGVGVDMWSVGCIFAELL 197
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
P PG + + QL + + LGTP+ E V + + P P Q FP A
Sbjct: 198 LRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV---TSLPDYVEFKPFPPTPLKQIFPAA 254
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ AL LL+R+L P R TA +AL PYF
Sbjct: 255 SDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 2e-66
Identities = 89/217 (41%), Positives = 127/217 (58%), Gaps = 22/217 (10%)
Query: 1 MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
ME +L+Q++K + + +YQ+L+GL +IH FHRDLKP+N+L + +K
Sbjct: 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVK 139
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAE 115
I DFGLAR + P +TDYV+TRWYRAPE+ S Y+ +DIW++GCI AE
Sbjct: 140 IADFGLAREIRSRPP----YTDYVSTRWYRAPEILLRSTS----YSSPVDIWALGCIMAE 191
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPS----PEAIARVRNEKARRYLSSMRKKKPIPFS 171
L T +PLFPG + + QL + +LGTP+ PE + A + + P
Sbjct: 192 LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY-----KLASKLGFRFPQFAPTSLH 246
Query: 172 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
Q PNA+P A+ L++ ML ++PK RPTA +AL PYF
Sbjct: 247 QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 6e-64
Identities = 79/216 (36%), Positives = 120/216 (55%), Gaps = 18/216 (8%)
Query: 1 MESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M+ DL ++ T + ++ QLL GL+Y+H+ + HRD+K NIL N D LK+
Sbjct: 82 MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKL 141
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR + +A + T+ V T WYR PE L G+ ++Y P +D+WS+GCI AEL
Sbjct: 142 ADFGLAR-PYTKRNSADY-TNRVITLWYRPPELLLGA--TRYGPEVDMWSVGCILAELFL 197
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP------FSQ 172
GKP+F G + QL+ + +L G+P+ E V + +++ KKP F
Sbjct: 198 GKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP---WFENLKPKKPYKRRLREFFKH 254
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
+ AL LL+++L +PK R +A++AL YF
Sbjct: 255 LIDPS---ALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 2e-62
Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 33/205 (16%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL ++K L+ + +F+L Q+L L+Y+H+ + HRDLKP+NIL + D +K+ DFG
Sbjct: 83 DLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFG 142
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LAR T +V T Y APE+ Y A+DIWS+G I ELLTGKP F
Sbjct: 143 LARQLDPGEKL----TTFVGTPEYMAPEVLLG--KGYGKAVDIWSLGVILYELLTGKPPF 196
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
PG + QL + +G P PF + +P A
Sbjct: 197 PGDD---QLLELFKKIGKP------------------------KPPFPPPEWDISPEAKD 229
Query: 184 LLERMLAFEPKDRPTAEEALADPYF 208
L+ ++L +P+ R TAEEAL P+F
Sbjct: 230 LIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 1e-61
Identities = 94/214 (43%), Positives = 131/214 (61%), Gaps = 15/214 (7%)
Query: 1 MESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M SDL +V++ + L + ++ LL+G+ Y+H + HRDLKP N+L +AD LKI
Sbjct: 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR+ + P ++ VATRWYRAPEL G+ KY P +D+W++GCIFAELL
Sbjct: 141 ADFGLARLFSEEEPRL--YSHQVATRWYRAPELLYGA--RKYDPGVDLWAVGCIFAELLN 196
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN----EKARRYLSSMRKKKPIPFSQKF 174
G PLFPG+N + QL I+ LGTP+ E + + K + KPIP + F
Sbjct: 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT-----FPESKPIPLEEIF 251
Query: 175 PNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
P+A+P AL LL+ +L ++P R +A EAL PYF
Sbjct: 252 PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 1e-60
Identities = 97/261 (37%), Positives = 142/261 (54%), Gaps = 23/261 (8%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+++L QVI DL E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI
Sbjct: 103 MDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 160
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G
Sbjct: 161 DFGLARTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGT 214
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP----- 175
LFPG + + Q + + + LGTPS E ++R+ R Y+ + K F + FP
Sbjct: 215 VLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QPTVRNYVENRPKYAGYSFEELFPDVLFP 273
Query: 176 --NANPLALR------LLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 227
+ + L+ LL +ML +P+ R + ++AL PY E A P +
Sbjct: 274 PDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD-PSEVEAPPPAPYD 332
Query: 228 FEFERRRITKEDVRELIYREI 248
+ R T E+ +ELIY+E+
Sbjct: 333 HSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 1e-59
Identities = 98/235 (41%), Positives = 132/235 (56%), Gaps = 10/235 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKI 59
ME+DL V++ L+ EH + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI
Sbjct: 98 METDLANVLEQGP-LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFGLAR+ + ++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTG
Sbjct: 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTG 215
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPE---AIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176
KPLF G + + Q+ ++ + + E + V R R+ P P
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPG 271
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFE 231
NP AL LE++L F P DR TAEEAL PY + EP + +E E +
Sbjct: 272 VNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 4e-57
Identities = 85/211 (40%), Positives = 131/211 (62%), Gaps = 13/211 (6%)
Query: 1 MESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M+ +L+++IK PE + ++YQLL+ L ++H +FHRD+KP+NIL D LK+
Sbjct: 82 MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI-LKL 140
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELL 117
DFG R ++ P +T+Y++TRWYRAPE L + Y P +DIW++GC+F E+L
Sbjct: 141 ADFGSCRGIYSKPP----YTEYISTRWYRAPECLLTDGY---YGPKMDIWAVGCVFFEIL 193
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
+ PLFPG N + Q+ + D+LGTP E + + R K+R + KK + PNA
Sbjct: 194 SLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR--KSRHMNYNFPSKKGTGLRKLLPNA 251
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYF 208
+ L LL+++LA++P +R TA++AL PYF
Sbjct: 252 SAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 6e-57
Identities = 87/217 (40%), Positives = 120/217 (55%), Gaps = 20/217 (9%)
Query: 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
+E DL +++ + + QLL G+ ++H + HRDLK N+L N LKI
Sbjct: 88 VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKI 147
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
CDFGLAR + +T V T WYRAPE L G+ +Y+ AID+WS+GCIFAELLT
Sbjct: 148 CDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELLLGA--KEYSTAIDMWSVGCIFAELLT 202
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPI--PFSQ---K 173
KPLFPGK+ + QL+ + LLGTP+ + L +KK P++Q K
Sbjct: 203 KKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE------LPGAKKKTFTKYPYNQLRKK 256
Query: 174 FPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYF 208
FP + LL R+L ++P R +AE+AL PYF
Sbjct: 257 FPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-56
Identities = 80/210 (38%), Positives = 119/210 (56%), Gaps = 7/210 (3%)
Query: 2 ESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
E L ++++A+ L P+ + +++QLL+ + Y H+ N+ HRD+KP+NIL + LK+C
Sbjct: 83 ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLC 142
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFG AR A TDYVATRWYRAPE L G + Y +D+W+IGCI AELL G
Sbjct: 143 DFGFAR--ALRARPASPLTDYVATRWYRAPELLVGD--TNYGKPVDVWAIGCIMAELLDG 198
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA-N 178
+PLFPG + + QL ++ LG P + ++ +P +++P +
Sbjct: 199 EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVS 258
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYF 208
AL L+ L +PK+R T +E L PYF
Sbjct: 259 SPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 87/212 (41%), Positives = 122/212 (57%), Gaps = 11/212 (5%)
Query: 1 MESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 57
M+ DL + + + L P + F YQLL+G+ + H V HRDLKP+N+L N +L
Sbjct: 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL 139
Query: 58 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEL 116
K+ DFGLAR AF P F + V T WYRAP+ L GS Y+ +IDIWS+GCI AE+
Sbjct: 140 KLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDVLLGS--RTYSTSIDIWSVGCIMAEM 194
Query: 117 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176
+TG+PLFPG N QL + ++GTP+ + Y + + P Q FP+
Sbjct: 195 ITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPEYKPTFPRYPPQDLQQLFPH 252
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
A+PL + LL R+L P+ R +A +AL P+F
Sbjct: 253 ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL + L+ + + Q+LRGL+Y+H+ + HRDLKP+NIL + + +KI DFG
Sbjct: 84 DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFG 143
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA+ + + T +V T WY APE+ + Y P +D+WS+G I ELLTGKP F
Sbjct: 144 LAKKLLKSSSSL---TTFVGTPWYMAPEVL-LGGNGYGPKVDVWSLGVILYELLTGKPPF 199
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
G+N++ QL + I R+ + + + A
Sbjct: 200 SGENILDQL------------QLIRRI-----------LGPPLEFDEPKWSSG-SEEAKD 235
Query: 184 LLERMLAFEPKDRPTAEEALADPYF 208
L+++ L +P RPTAEE L P+F
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 84/215 (39%), Positives = 113/215 (52%), Gaps = 22/215 (10%)
Query: 1 MESDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
++ DL + L PE + + QLLRG+ ++H+ + HRDLKP+NIL +D ++K
Sbjct: 88 VDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELL 117
I DFGLAR+ + T V T WYRAPE L S Y +D+WS+GCIFAEL
Sbjct: 148 IADFGLARIYSFEMAL----TSVVVTLWYRAPEVLLQ---SSYATPVDMWSVGCIFAELF 200
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPS----PEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
+PLF G + QLD + D++G PS P ++ R SS P F
Sbjct: 201 RRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR--------SSFPSYTPRSFKSF 252
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
P L LL++ML F P R +A EAL PYF
Sbjct: 253 VPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 79/186 (42%), Positives = 110/186 (59%), Gaps = 6/186 (3%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83
++Q L+ + + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVA
Sbjct: 106 IWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVA 162
Query: 84 TRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142
TRWYRAPEL G ++Y P +D+W+IGC+FAELLTG+PL+PGK+ V QL ++ LG
Sbjct: 163 TRWYRAPELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL 220
Query: 143 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 202
P + + LS + P KFPN + AL L+ L +P +R + EE
Sbjct: 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280
Query: 203 LADPYF 208
L PYF
Sbjct: 281 LEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 84/198 (42%), Positives = 112/198 (56%), Gaps = 8/198 (4%)
Query: 12 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 71
L P + +LYQLL+G+ Y H+ V HRDLKP+N+L + + LK+ DFGLAR AF
Sbjct: 93 LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG- 150
Query: 72 TPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH 130
P + T V T WYRAPE L GS Y+ +DIWSIGCIFAE++ +PLFPG + +
Sbjct: 151 VPVRTY-THEVVTLWYRAPEILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
Query: 131 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 190
QL + LGTP + V Y + K S+ PN + L LL +ML
Sbjct: 208 QLFRIFRTLGTPDEDVWPGV--TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLV 265
Query: 191 FEPKDRPTAEEALADPYF 208
++P R +A+ AL PYF
Sbjct: 266 YDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-51
Identities = 80/222 (36%), Positives = 116/222 (52%), Gaps = 21/222 (9%)
Query: 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M+ DL +++ LT + ++ QLL G+ Y+H ++ HRD+K NIL + LKI
Sbjct: 97 MDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKI 156
Query: 60 CDFGLARVAFNDTPTAIF--------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIG 110
DFGLAR P +T+ V TRWYR PEL G +YT A+DIW IG
Sbjct: 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE--RRYTTAVDIWGIG 214
Query: 111 CIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN----EKARRYLSSMRKKK 166
C+FAE+ T +P+ GK+ + QL ++ L GTP+ E R+ E + + R
Sbjct: 215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT-- 272
Query: 167 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
++F P L LL ++L+ +P R TA +AL PYF
Sbjct: 273 ---LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 9e-51
Identities = 89/221 (40%), Positives = 117/221 (52%), Gaps = 17/221 (7%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M SDL +V+ LT + L Q+L GL +H HRDL P NI N+ KI
Sbjct: 102 MASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161
Query: 61 DFGLAR-----VAFNDTPTAIF------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWS 108
DFGLAR + T V T WYRAPEL G+ KY A+D+WS
Sbjct: 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWS 219
Query: 109 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPI 168
+GCIFAELLTGKPLFPG+N + QL + +LLGTP+ + + + + +KP
Sbjct: 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT---PRKPK 276
Query: 169 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
FPNA+ A+ LL+ +L P +R +A+EAL YFK
Sbjct: 277 DLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 84/214 (39%), Positives = 122/214 (57%), Gaps = 13/214 (6%)
Query: 1 MESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
+++DL Q + L+ + + FL+QLLRGL Y H V HRDLKP+N+L + +LK+
Sbjct: 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKL 144
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR + T +++ V T WYR P+ L GS ++Y+ ++D+W +GCIF E+ T
Sbjct: 145 ADFGLARAKSVPSKT---YSNEVVTLWYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMAT 199
Query: 119 GKPLFPG-KNVVHQLDIMTDLLGTPSPEAIARV-RNEKARRYLSSMRKKKPIPFSQKFP- 175
G+PLFPG +V QL + +LGTP+ E V N + + Y S P P P
Sbjct: 200 GRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY--SFPFYPPRPLINHAPR 257
Query: 176 -NANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
+ P L + L +EPK R +A EA+ PYF
Sbjct: 258 LDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 5e-50
Identities = 88/233 (37%), Positives = 120/233 (51%), Gaps = 29/233 (12%)
Query: 2 ESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 56
E DL Q+IK + P + L+Q+L G+ Y+H+ V HRDLKP NIL +
Sbjct: 87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGP 146
Query: 57 ----LKICDFGLARVAFNDTPTAIFWTD-YVATRWYRAPELC-GSFFSKYTPAIDIWSIG 110
+KI D GLAR+ FN + D V T WYRAPEL G+ YT AIDIW+IG
Sbjct: 147 ERGVVKIGDLGLARL-FNAPLKPLADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIG 203
Query: 111 CIFAELLTGKPLFPGKNV---------VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161
CIFAELLT +P+F G+ QL+ + ++LGTP+ + ++ L
Sbjct: 204 CIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMK 263
Query: 162 MRKKKPIPFS------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
K K P + +K + LL ++L ++P R TAEEAL PYF
Sbjct: 264 DFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 7e-50
Identities = 85/187 (45%), Positives = 112/187 (59%), Gaps = 11/187 (5%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
QLLRGL+Y+H + HRDLK N+L LKI DFGLAR + + T V T
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTL 172
Query: 86 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 144
WYRAPE L G + YT AID+W++GCI AELL KPL PGK+ + QLD++ LLGTP+
Sbjct: 173 WYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN- 229
Query: 145 EAIARVRNE--KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 202
E+I ++ ++ ++ K+ KFP + LRLL +L ++PK R TAEEA
Sbjct: 230 ESIWPGFSDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287
Query: 203 LADPYFK 209
L YFK
Sbjct: 288 LESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 96/262 (36%), Positives = 141/262 (53%), Gaps = 22/262 (8%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+++L QVI +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI
Sbjct: 108 MDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 165
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A T T YV TR+YRAPE+ Y +DIWS+GCI EL+ G
Sbjct: 166 DFGLARTA----CTNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGS 219
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN---- 176
+F G + + Q + + + LGTPS E + R++ R Y+ + + I F + FP+
Sbjct: 220 VIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFP 278
Query: 177 --------ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228
A LL +ML +P R + +EAL PY + E A P +
Sbjct: 279 SESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT-VWYDPAEAEAPPPQIYDA 337
Query: 229 EFERRRITKEDVRELIYREILE 250
+ E R E+ +ELIY+E+++
Sbjct: 338 QLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 77/191 (40%), Positives = 116/191 (60%), Gaps = 14/191 (7%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
+L+Q+LRG+++ H+ N+ HRD+KP+NIL + +K+CDFG AR P ++ TDYV
Sbjct: 105 YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYV 161
Query: 83 ATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 141
ATRWYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG + + QL + LG
Sbjct: 162 ATRWYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN 219
Query: 142 PSPEAIARVRNEKAR-RYLSSMR---KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197
P R + + + MR K+ P ++FP + L L L ++ L +P DRP
Sbjct: 220 LIP----RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275
Query: 198 TAEEALADPYF 208
++ + L +F
Sbjct: 276 SSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 85/215 (39%), Positives = 123/215 (57%), Gaps = 15/215 (6%)
Query: 1 MESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD- 54
++SDL + + +N L + + F+YQLL+G+ + H V HRDLKP+N+L +
Sbjct: 88 LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQK 147
Query: 55 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIF 113
LKI D GL R AF+ P + T + T WYRAPE L GS + Y+ +DIWS+GCIF
Sbjct: 148 GLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRAPEVLLGS--THYSTPVDIWSVGCIF 202
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
AE+ +PLFPG + + QL + LLGTP+ + V R + KP S+
Sbjct: 203 AEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK---LRDWHEFPQWKPQDLSRA 259
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
P+ +P L LL++ML ++P R +A+ AL PYF
Sbjct: 260 VPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-46
Identities = 87/206 (42%), Positives = 116/206 (56%), Gaps = 23/206 (11%)
Query: 12 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 71
N D+ PE + F++QLL+GL + H+ NV HRDLKP+N+L N + +LK+ DFGLAR AF
Sbjct: 93 NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG- 150
Query: 72 TPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 129
P + + V T WYR P+ L G+ Y+ +ID+WS GCIFAEL G+PLFPG +V
Sbjct: 151 IPVRCYSAE-VVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207
Query: 130 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP-------FSQKFPNANPLAL 182
QL + LLGTP E++ +S + KP P P N
Sbjct: 208 DQLKRIFRLLGTP---------TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGR 258
Query: 183 RLLERMLAFEPKDRPTAEEALADPYF 208
LL+ +L P R +AEEAL PYF
Sbjct: 259 DLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 7e-46
Identities = 98/261 (37%), Positives = 148/261 (56%), Gaps = 22/261 (8%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+++L QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI
Sbjct: 104 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K
Sbjct: 162 DFGLARTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHK 215
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA--- 177
LFPG++ + Q + + + LGTP PE + +++ R Y+ + K + F + FP++
Sbjct: 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFP 274
Query: 178 -----NPL----ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228
N L A LL +ML +P R + +EAL PY + E A P +
Sbjct: 275 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN-VWYDPAEVEAPPPQIYDK 333
Query: 229 EFERRRITKEDVRELIYREIL 249
+ + R T E+ +ELIY+E++
Sbjct: 334 QLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 97/263 (36%), Positives = 145/263 (55%), Gaps = 22/263 (8%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+++L QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI
Sbjct: 111 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G
Sbjct: 169 DFGLARTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 222
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA--- 177
LFPG + + Q + + + LGTP PE + +++ R Y+ + K F + FP+
Sbjct: 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFP 281
Query: 178 -----NPL----ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228
N L A LL +ML + R + +EAL PY + E A P +
Sbjct: 282 ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN-VWYDPSEAEAPPPKIPDK 340
Query: 229 EFERRRITKEDVRELIYREILEY 251
+ + R T E+ +ELIY+E+++
Sbjct: 341 QLDEREHTIEEWKELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 86/211 (40%), Positives = 119/211 (56%), Gaps = 14/211 (6%)
Query: 5 LHQVIKANDDLTPEH------YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
LHQ +K D +P + +L+QLL+GL + H+ V HRDLKP+N+L N + +K
Sbjct: 81 LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 140
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELL 117
+ DFGLAR AF P + T V T WYRAPE L G + Y+ A+DIWS+GCIFAE++
Sbjct: 141 LADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMV 195
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
T + LFPG + + QL + LGTP V + Y S K FS+ P
Sbjct: 196 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP--DYKPSFPKWARQDFSKVVPPL 253
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYF 208
+ LL +ML ++P R +A+ ALA P+F
Sbjct: 254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 87/215 (40%), Positives = 125/215 (58%), Gaps = 10/215 (4%)
Query: 1 MESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
++ DL Q + ++ H + FLYQ+LRGL Y H V HRDLKP+N+L N +LK+
Sbjct: 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKL 145
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR T T +++ V T WYR P+ L GS S+Y+ ID+W +GCIF E+ +
Sbjct: 146 ADFGLARAKSVPTKT---YSNEVVTLWYRPPDVLLGS--SEYSTQIDMWGVGCIFFEMAS 200
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV-RNEKARRYLSSMRKKKPIPFSQKFPNA 177
G+PLFPG V +L ++ LLGTP+ E + N++ + Y + K KP P P
Sbjct: 201 GRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY--NFPKYKPQPLINHAPRL 258
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212
+ + LL + L +E K R +AEEA+ YF+ L
Sbjct: 259 DTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 3e-44
Identities = 86/216 (39%), Positives = 121/216 (56%), Gaps = 10/216 (4%)
Query: 1 MESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
++ DL Q + + H + FL+QLLRGL Y H V HRDLKP+N+L N +LK+
Sbjct: 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKL 145
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR T T +++ V T WYR P+ L GS + Y+ ID+W +GCIF E+ T
Sbjct: 146 ADFGLARAKSIPTKT---YSNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMST 200
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV-RNEKARRYLSSMRKKKPIPFSQKFPNA 177
G+PLFPG V QL + +LGTP+ E + NE+ + Y + K + P
Sbjct: 201 GRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY--NYPKYRADCLHNHAPRL 258
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213
+ LL ++L FE + R +AEEA+ PYF L +
Sbjct: 259 DSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 80/201 (39%), Positives = 115/201 (57%), Gaps = 8/201 (3%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
+ + E + +LYQ+L+G+ + H+ V HRDLKP+N+L + +K+ DFGLAR A
Sbjct: 92 LPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-A 150
Query: 69 FNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
F P ++ T V T WYRAPE L GS +Y+ +DIWSIG IFAE+ T KPLF G +
Sbjct: 151 FG-IPVRVY-THEVVTLWYRAPEVLLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206
Query: 128 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 187
+ QL + +LGTP+ + V Y ++ K K N + L LLE+
Sbjct: 207 EIDQLFRIFRILGTPTEDVWPGV--TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEK 264
Query: 188 MLAFEPKDRPTAEEALADPYF 208
ML ++P R +A++AL PYF
Sbjct: 265 MLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-42
Identities = 85/194 (43%), Positives = 110/194 (56%), Gaps = 9/194 (4%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDY 81
+LYQ+LRG+ Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P F T
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THE 163
Query: 82 VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 140
V T WYRAPE L GS Y+ +DIWS+GCIFAE++ KPLFPG + + +L + +LG
Sbjct: 164 VVTLWYRAPEILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG 221
Query: 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 200
TP+ E V + Y S+ K P + P P + LL +ML +P R TA
Sbjct: 222 TPNEETWPGVTS--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITAR 279
Query: 201 EALADPYFKGLAKV 214
AL YFK L
Sbjct: 280 AALEHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 84/211 (39%), Positives = 121/211 (57%), Gaps = 10/211 (4%)
Query: 1 MESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
++SDL Q + +L H + F++QLLRGL Y H + HRDLKP+N+L N +LK+
Sbjct: 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKL 144
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR T T +++ V T WYR P+ L GS ++Y+ ID+W +GCI E+ T
Sbjct: 145 ADFGLARAKSVPTKT---YSNEVVTLWYRPPDVLLGS--TEYSTPIDMWGVGCILYEMAT 199
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV-RNEKARRYLSSMRKKKPIPFSQKFPNA 177
G+P+FPG V +L ++ LLGTP+ E + NE+ R YL + + P P
Sbjct: 200 GRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL--FPQYRAQPLINHAPRL 257
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYF 208
+ + LL +L +E K R +AE AL YF
Sbjct: 258 DTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 4e-42
Identities = 81/211 (38%), Positives = 116/211 (54%), Gaps = 11/211 (5%)
Query: 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M+ DL ++++ + +H + F+ QLL GL Y H N HRD+K NIL N ++K+
Sbjct: 98 MDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR+ ++ +T+ V T WYR PEL G +Y PAID+WS GCI EL T
Sbjct: 158 ADFGLARLYNSEESRP--YTNKVITLWYRPPELLLGE--ERYGPAIDVWSCGCILGELFT 213
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPI--PFSQKFPN 176
KP+F + QL++++ L G+P P V Y ++M+ KK ++F
Sbjct: 214 KKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLP---YFNTMKPKKQYRRRLREEFSF 270
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPY 207
AL LL+ ML +P R TAEEAL P+
Sbjct: 271 IPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 8e-39
Identities = 74/210 (35%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 11 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--- 67
N T + + LL GL YIH + HRD+K NIL D LK+ DFGLAR
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 68 AFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 126
+ N P +T+ V T WYR PE L G Y P ID+W GCI AE+ T P+ G
Sbjct: 172 SKNSKPNR--YTNRVVTLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227
Query: 127 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP--------NAN 178
HQL +++ L G+ +PE V + KK +P QK +
Sbjct: 228 TEQHQLTLISQLCGSITPEVWPGVDK-------LELFKKMELPQGQKRKVKERLKPYVKD 280
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYF 208
P AL L++++L +P R A+ AL +F
Sbjct: 281 PHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 85/225 (37%), Positives = 122/225 (54%), Gaps = 35/225 (15%)
Query: 1 MESDLHQ-VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M +DL Q +I+ L P + + F++QLLRGL YIH ++ HRDLKP+N+L + +LK+
Sbjct: 85 MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKL 144
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR P+ + ++ V T WYR P+ L G+ + Y+ A+DIW GCIF E+L
Sbjct: 145 ADFGLARA--KSIPSQTYSSE-VVTLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQ 199
Query: 119 GKPLFPG-KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
G+P FPG +V QL+ + +LG P+ + V S + KP + F
Sbjct: 200 GQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV---------SKLPNYKP----EWFLPC 246
Query: 178 NPLALR--------------LLERMLAFEPKDRPTAEEALADPYF 208
P LR L +ML PKDR +A++AL PYF
Sbjct: 247 KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-35
Identities = 74/197 (37%), Positives = 106/197 (53%), Gaps = 20/197 (10%)
Query: 17 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTA 75
E + ++QLLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ +F T+
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 168
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 135
+ V T WYRAPE+ S Y +D+WS+GCIFAE+ KPLF G + V QL +
Sbjct: 169 V-----VVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221
Query: 136 TDLLGTPSPE----AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 191
D++G P E +A R + P + + + L LL + L F
Sbjct: 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQ--------PIEKFVTDIDELGKDLLLKCLTF 273
Query: 192 EPKDRPTAEEALADPYF 208
P R +A AL+ PYF
Sbjct: 274 NPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 3e-35
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 1 MESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CK 56
L ++K L+ F L Q+L L+Y+H+ + HRD+KP+NIL + D
Sbjct: 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV 140
Query: 57 LKICDFGLARVAFNDT---PTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCI 112
+K+ DFGLA++ + + V T Y APE+ G + + + DIWS+G
Sbjct: 141 VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGIT 200
Query: 113 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172
ELLTG P F G+ + + + S + P
Sbjct: 201 LYELLTGLPPFEGEKNSSATS-----------QTLKIILELPTPSLASPLSPSNP----- 244
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ A LL+++LA +PK+R ++ L+
Sbjct: 245 --ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-35
Identities = 56/204 (27%), Positives = 84/204 (41%), Gaps = 31/204 (15%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L ++K L + + Q+L GL Y+H+ + HRD+K NIL ++D +K+ DFG
Sbjct: 88 LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124
A+ D T T ++ APE+ +Y A DIWS+GC E+ TGKP +
Sbjct: 148 AKR-LGDIETGEGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWS 204
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 184
+ P IP + + A
Sbjct: 205 ELGNPMAA-LYKIGSSGEPP----------------------EIP-----EHLSEEAKDF 236
Query: 185 LERMLAFEPKDRPTAEEALADPYF 208
L + L +PK RPTA+E L P+
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 66/193 (34%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 17 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76
PE + ++YQL++ + + H ++ HRD+KP+N+L + + LK+CDFG AR +
Sbjct: 99 PEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN- 157
Query: 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 136
+T+YVATRWYR+PEL + Y A+D+WS+GCI EL G+PLFPG++ + QL +
Sbjct: 158 -YTEYVATRWYRSPELL--LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214
Query: 137 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA-NPLALRLLERMLAFEPKD 195
+LG E + + L P +++ + + L L++ +L P D
Sbjct: 215 KVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTD 274
Query: 196 RPTAEEALADPYF 208
R E+ L P F
Sbjct: 275 RYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 76/226 (33%), Positives = 121/226 (53%), Gaps = 16/226 (7%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWT 79
+ + YQL R L YIH+ + HRDLKP+N+L + + LK+CDFG A+ +
Sbjct: 173 KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----V 228
Query: 80 DYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
Y+ +R+YRAPEL G+ + YT ID+WS+GCI AE++ G P+F G++ V QL + +
Sbjct: 229 SYICSRFYRAPELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP-LALRLLERMLAFEPKDRP 197
LGTP+ + + + A + KP + FP P A+ + + L +EP R
Sbjct: 287 LGTPTEDQLKEMNPNYADIKFPDV---KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343
Query: 198 TAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVREL 243
EALADP+F L R+P + ++ + +++E+
Sbjct: 344 NPIEALADPFFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 72/187 (38%), Positives = 98/187 (52%), Gaps = 12/187 (6%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
+ Q LRGL ++H + HRDLKP+NIL + ++K+ DFGLAR+ + T V
Sbjct: 113 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVV 168
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142
T WYRAPE+ S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P
Sbjct: 169 VTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226
Query: 143 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEE 201
+ R+ R S R +P+ Q P +LL ML F P R +A
Sbjct: 227 PEDDWP--RDVTLPRGAFSPRGPRPV---QSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281
Query: 202 ALADPYF 208
AL P+F
Sbjct: 282 ALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-31
Identities = 80/220 (36%), Positives = 125/220 (56%), Gaps = 19/220 (8%)
Query: 1 MESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
+ +DL Q + K L PE+ + FL+QLLRGL YIH + HRDLKP+N+L + +LK+
Sbjct: 85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKL 144
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR P+ + ++ V T WYR P+ L GS ++Y+ +D+W +GCIF E++
Sbjct: 145 ADFGLARA--KSVPSHTY-SNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQ 199
Query: 119 GKPLFPG-KNVVHQLDIMTDLLGTPSPE------AIARVRNEKARRYLSSMRKKKPIPFS 171
G FPG K++ QL+ + +LGTP+ + ++ + E+ Y ++ S
Sbjct: 200 GVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLS 259
Query: 172 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
+A LA +LL+ PK+R +A+ AL+ YF L
Sbjct: 260 Y-VNHAEDLASKLLQ----CFPKNRLSAQAALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 45/212 (21%)
Query: 4 DLHQVIKA---NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
DL Q IK PE Q + QL LKY+H+ + HRD+KP+NI ++ +K
Sbjct: 85 DLSQKIKKQKKEGKPFPEE-QILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVK 143
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ DFG+++V + A V T +Y +PELC + Y DIWS+GC+ EL T
Sbjct: 144 LGDFGISKVLSSTVDLA---KTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCT 198
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPN 176
K F G+N+ E ++ + PIP +S + N
Sbjct: 199 LKHPFEGENL---------------LELALKILKG----------QYPPIPSQYSSELRN 233
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
L+ +L +P++RP+ + L P+
Sbjct: 234 -------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 42/115 (36%), Positives = 64/115 (55%), Gaps = 6/115 (5%)
Query: 4 DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICD 61
L ++K N+ L+ + L Q+L GL+Y+H+ + HRDLKP+NIL + + K+K+ D
Sbjct: 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLAD 136
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
FGL+++ +D V T Y APE+ Y+ DIWS+G I EL
Sbjct: 137 FGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-29
Identities = 88/237 (37%), Positives = 121/237 (51%), Gaps = 44/237 (18%)
Query: 5 LHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KL 57
H+ KAN L + LYQ+L G+ Y+H V HRDLKP NIL + ++
Sbjct: 92 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151
Query: 58 KICDFGLARVAFNDTPTAIFWTD-YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAE 115
KI D G AR+ FN + D V T WYRAPEL G+ YT AIDIW+IGCIFAE
Sbjct: 152 KIADMGFARL-FNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAE 208
Query: 116 LLTGKPLFPGK-------NVVH--QLDIMTDLLGTPS----------PEAIARVRNEKAR 156
LLT +P+F + N H QLD + +++G P+ PE +++ +
Sbjct: 209 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN 268
Query: 157 RY-----LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
Y + M K K P S+ F LL+++L +P R T+E+A+ DPYF
Sbjct: 269 TYTNCSLIKYMEKHKVKPDSKAF--------HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 8e-29
Identities = 90/237 (37%), Positives = 120/237 (50%), Gaps = 44/237 (18%)
Query: 5 LHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KL 57
H+ KAN L + LYQ+L G+ Y+H V HRDLKP NIL + ++
Sbjct: 92 FHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151
Query: 58 KICDFGLARVAFNDTPTAIFWTD-YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAE 115
KI D G AR+ FN + D V T WYRAPEL G+ YT AIDIW+IGCIFAE
Sbjct: 152 KIADMGFARL-FNSPLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAE 208
Query: 116 LLTGKPLFPGK-------NVVH--QLDIMTDLLGTPS----------PEAIARVRNEKAR 156
LLT +P+F + N H QLD + ++G P+ PE ++ +
Sbjct: 209 LLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRT 268
Query: 157 RYLSS-----MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208
Y +S M K K P S+ F LL+++L +P R T+E+AL DPYF
Sbjct: 269 TYANSSLIKYMEKHKVKPDSKVF--------LLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 39/208 (18%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+L + + E +F+ +++ L+Y+H+ + +RDLKP+NIL +AD +K+ DFG
Sbjct: 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA+ ++ + T Y APE+ Y A+D WS+G + E+LTGKP F
Sbjct: 139 LAKELSSEGSRT---NTFCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPF 193
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
++ R+ + K P+ F + P A
Sbjct: 194 YAED----------------------------RKEIYEKILKDPLRFPEFLS---PEARD 222
Query: 184 LLERMLAFEPKDRPT---AEEALADPYF 208
L+ +L +P R AEE A P+F
Sbjct: 223 LISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 60/189 (31%), Positives = 85/189 (44%), Gaps = 29/189 (15%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWT 79
+ + QLL GL Y+H+ + HRD+KP NI + + +K+ DFG A ++ N T
Sbjct: 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 80 DYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T Y APE+ G + A DIWS+GC+ E+ TGK + +LD
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD----- 210
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 198
NE + K PIP S + +P L+R L +PK RPT
Sbjct: 211 -------------NEFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPT 254
Query: 199 AEEALADPY 207
A E L P+
Sbjct: 255 ASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 41/203 (20%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77
+ + ++ +++ L+Y+H+ + HRDLKP NIL +++ LK+ DFGL++V +
Sbjct: 93 DVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152
Query: 78 WTDY-----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 132
+ V T Y APE+ ++ +D WS+GCI E L G P F G+
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGET----- 205
Query: 133 DIMTDLLGTPSPEAI-ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 191
PE I + N K I + + + A+ L+ ++L
Sbjct: 206 -----------PEEIFQNILNGK-------------IEWPE-DVEVSDEAIDLISKLLVP 240
Query: 192 EPKDRPTA---EEALADPYFKGL 211
+P+ R A EE P+FKG+
Sbjct: 241 DPEKRLGAKSIEEIKNHPFFKGI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 46/214 (21%)
Query: 4 DLHQVI---KANDDLTPEHY--QFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANA 53
DL Q+I K E + + QLL L H + V HRDLKP NI +A
Sbjct: 87 DLAQLIQKCKKERKYIEEEFIWRILT-QLLLALYECHNRSDPGNTVLHRDLKPANIFLDA 145
Query: 54 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
+ +K+ DFGLA++ +D+ A YV T +Y +PE Y DIWS+GC+
Sbjct: 146 NNNVKLGDFGLAKILGHDSSFA---KTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLI 200
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
EL P F +N QL + ++++ K RR IP +
Sbjct: 201 YELCALSPPFTARN---QL------------QLASKIKEGKFRR----------IP-YRY 234
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEEALADPY 207
N +++ ML +P RP+ EE L P
Sbjct: 235 SSELN----EVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 35/204 (17%)
Query: 5 LHQVIKANDDLTPE-HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L ++K+ + E + +LL+GL+Y+H+ + HRD+K NIL +D ++K+ DFG
Sbjct: 84 LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFG 143
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
L+ +DT V T ++ APE+ Y DIWS+G EL GKP +
Sbjct: 144 LS-AQLSDTKARNTM---VGTPYWMAPEVI--NGKPYDYKADIWSLGITAIELAEGKPPY 197
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
+L M +A+ ++ + K F + F
Sbjct: 198 ------SELPPM---------KALFKIATNGPPGLRNPE--KWSDEF-KDF--------- 230
Query: 184 LLERMLAFEPKDRPTAEEALADPY 207
L++ L P+ RPTAE+ L P+
Sbjct: 231 -LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 54/226 (23%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+L Q I+ L + +F+ ++L L+Y+H+ + HRDLKP+NIL + D +KI DFG
Sbjct: 88 ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFG 147
Query: 64 LARV--------AFNDTPTAIFWTD---------YVATRWYRAPELCGSFFSKYTPAIDI 106
A+V + T I +V T Y +PEL + D+
Sbjct: 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDL 205
Query: 107 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKK 166
W++GCI ++LTGKP F G N ++ +
Sbjct: 206 WALGCIIYQMLTGKPPFRGSN---------------EYLTFQKILKLE------------ 238
Query: 167 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYF 208
F FP P A L+E++L +P+DR +E A P+F
Sbjct: 239 -YSFPPNFP---PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 63/195 (32%), Positives = 90/195 (46%), Gaps = 42/195 (21%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPT-- 74
+FF Q+L GL Y+H+ + HRDLK N+L +AD KI DFG+++ + ND
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 75 --AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 132
++FW APE+ S+ Y+ +DIWS+GC+ E+ G+ P +
Sbjct: 171 QGSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE---- 215
Query: 133 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 192
EAIA A L + R PIP N +P+AL L
Sbjct: 216 ------------EAIA------AMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTIN 256
Query: 193 PKDRPTAEEALADPY 207
P +RPTA E L P+
Sbjct: 257 PDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 32/207 (15%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFG 63
L ++K + + Q+L+GL Y+HT ++ HRD+KP N+L N+ ++KI DFG
Sbjct: 86 LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFG 145
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+++V + T +V T Y +PE Y+ A DIWS+G E GK F
Sbjct: 146 ISKVL--ENTLDQCNT-FVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPF 200
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
++M + P P FS +F +
Sbjct: 201 LPPGQPSFFELMQAICDGPPPSL-------------------PAEEFSPEFRD------- 234
Query: 184 LLERMLAFEPKDRPTAEEALADPYFKG 210
+ L +PK RP+A E L P+ K
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 5 LHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L Q+IK PE ++YQ+L+GL Y+H V HRD+K NIL D +K+ DFG
Sbjct: 86 LRQIIKKFGPF-PESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFG 144
Query: 64 LA-RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
+A ++ V T ++ APE+ S + A DIWS+GC ELLTG P
Sbjct: 145 VATKLNDVSKDD----ASVVGTPYWMAPEVIE--MSGASTASDIWSLGCTVIELLTGNPP 198
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
+ DL + I + P+P +P
Sbjct: 199 Y------------YDLNPMAALFRIVQ-------------DDHPPLP-----EGISPELK 228
Query: 183 RLLERMLAFEPKDRPTAEEALADPYF 208
L + +P RPTA++ L P+
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 57/208 (27%), Positives = 84/208 (40%), Gaps = 57/208 (27%)
Query: 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------- 65
+ + ++L+GL+Y+H+ NV HRD+K NIL + D +K+ DFG A
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171
Query: 66 -RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124
R + TP +W APE+ Y P +DIWS+G + E+ G+P P
Sbjct: 172 KRNSVVGTP---YWM---------APEVIKR--KDYGPKVDIWSLGIMCIEMAEGEP--P 215
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN---PLA 181
L P A+ + K IP N P
Sbjct: 216 -------------YLREPPLRALFLIT-------------TKGIP---PLKNPEKWSPEF 246
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFK 209
L + L +P+ RP+AEE L P+ K
Sbjct: 247 KDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 43/207 (20%)
Query: 5 LHQVIKANDD-LTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L+ I L E ++L+Q++ + YIH A + HRD+K NI +K+ DF
Sbjct: 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDF 145
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
G++++ ++ A V T +Y +PELC KY DIW++GC+ ELLT K
Sbjct: 146 GISKILGSEYSMA---ETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRT 200
Query: 123 FPGKNVVHQLDIMTDLLG---TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
F N L+++ ++ TP Y S +
Sbjct: 201 FDATN---PLNLVVKIVQGNYTPVVS-----------VYSSELIS--------------- 231
Query: 180 LALRLLERMLAFEPKDRPTAEEALADP 206
L+ +L +P+ RPTA+E L P
Sbjct: 232 ----LVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 4e-21
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 52/208 (25%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
DL ++ N L+ F Q+ RG++Y+ + N HRDL +N L + +KI DF
Sbjct: 87 DLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDF 146
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFA 114
GL+R ++D DY RW APE S K+T D+WS G +
Sbjct: 147 GLSRDLYDD--------DYYRKRGGKLPIRWM-APE---SLKEGKFTSKSDVWSFGVLLW 194
Query: 115 ELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
E+ T G+ +PG + E + ++N R +P
Sbjct: 195 EIFTLGEQPYPGMSNE---------------EVLEYLKNGY--------RLPQP------ 225
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEE 201
PN P L+ + A +P+DRPT E
Sbjct: 226 -PNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 36/204 (17%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L +++K + + Q+L GL+Y+H N HRD+K NIL + + +K+ DFG+
Sbjct: 89 LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGM 148
Query: 65 AR-VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
A+ V F + + ++ APE+ Y A DIWS+GC E+ TGKP +
Sbjct: 149 AKQVVEFS-----FAKSFKGSPYWMAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW 202
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
QL+ + A+ ++ K PIP A L+
Sbjct: 203 ------SQLEGV---------AAVFKIGRSKEL---------PPIPDHLS-DEAKDFILK 237
Query: 184 LLERMLAFEPKDRPTAEEALADPY 207
L+R +P RPTA E L P+
Sbjct: 238 CLQR----DPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 53/209 (25%)
Query: 4 DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 61
DL ++ N L+ F Q+ RG++Y+ + N HRDL +N L + +KI D
Sbjct: 87 DLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD 146
Query: 62 FGLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIF 113
FGL+R ++D DY RW APE S K+T D+WS G +
Sbjct: 147 FGLSRDLYDD--------DYYKVKGGKLPIRWM-APE---SLKEGKFTSKSDVWSFGVLL 194
Query: 114 AELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172
E+ T G+ +PG + E + ++ R KP
Sbjct: 195 WEIFTLGEEPYPGMSNA---------------EVLEYLKKGY--------RLPKP----- 226
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEE 201
PN P +L+ + A +P+DRPT E
Sbjct: 227 --PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 62/195 (31%), Positives = 86/195 (44%), Gaps = 49/195 (25%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDY 81
F+ Q+L+GL Y+H + HRD+K NIL + +KI DFG++ ++ N T
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST------- 163
Query: 82 VATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 132
T R P L GS F + YT DIWS+GC+ E+LTGK FP
Sbjct: 164 -KTNGAR-PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD------- 214
Query: 133 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 192
T L +AI ++ E A P S N + A+ LE+ +
Sbjct: 215 --CTQL------QAIFKI-GENAS----------PEIPS----NISSEAIDFLEKTFEID 251
Query: 193 PKDRPTAEEALADPY 207
RPTA E L P+
Sbjct: 252 HNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 67/213 (31%), Positives = 92/213 (43%), Gaps = 51/213 (23%)
Query: 3 SDLHQVI---KANDDLTPEH--YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 57
DL + I K L PE ++ F+ QLLRGL+ +H + HRDLK NIL A+ +
Sbjct: 84 GDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQALHEQKILHRDLKSANILLVANDLV 142
Query: 58 KICDFGLARVAFND-TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
KI D G+++V + T I T Y APE+ Y+ DIWS+GC+ E+
Sbjct: 143 KIGDLGISKVLKKNMAKTQI------GTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEM 194
Query: 117 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKK-KPIP--FSQK 173
T P F ++ M DL R K PIP +SQ
Sbjct: 195 ATFAPPFEARS-------MQDL-------------------RYKVQRGKYPPIPPIYSQD 228
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEEALADP 206
N + ML +PK RP ++ LA P
Sbjct: 229 LQN-------FIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 33/208 (15%)
Query: 5 LHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDF 62
L +++K PE +L+GL Y+H + HRD+KP NIL N+ ++K+CDF
Sbjct: 86 LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDF 145
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
G++ N +V T Y APE + Y+ DIWS+G EL TG+
Sbjct: 146 GVSGQLVNSLA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGR-- 196
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
FP E + + NE R S FS F +
Sbjct: 197 FPYPP--ENDPPDGIF------ELLQYIVNEPPPRLPSGK-------FSPDFQD------ 235
Query: 183 RLLERMLAFEPKDRPTAEEALADPYFKG 210
+ L +P++RP+ +E L P+ K
Sbjct: 236 -FVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 41/137 (29%), Positives = 76/137 (55%), Gaps = 9/137 (6%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+L +++ +F++ ++ +Y+H + +RDLKP+N+L +++ +K+ DFG
Sbjct: 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG 138
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPL 122
A+ + T WT + T Y APE+ +K Y ++D WS+G + ELLTG+P
Sbjct: 139 FAKKLKSGQKT---WT-FCGTPEYVAPEII---LNKGYDFSVDYWSLGILLYELLTGRPP 191
Query: 123 FPGKNVVHQLDIMTDLL 139
F G++ ++I D+L
Sbjct: 192 F-GEDDEDPMEIYNDIL 207
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 38/193 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLA-RVAFNDTPTAIFWTD 80
+ QLLRGL Y+H + HRD+K N+L ++ + L+I DFG A R+A T F
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL-- 138
+ T + APE+ +Y + D+WS+GC+ E+ T KP + + + L ++ +
Sbjct: 168 LLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS 225
Query: 139 -LGTPS-PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 196
PS PE ++ P + LR LE +P+DR
Sbjct: 226 ATTAPSIPEHLS--------------------------PGLRDVTLRCLEL----QPEDR 255
Query: 197 PTAEEALADPYFK 209
P + E L P F+
Sbjct: 256 PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 38/195 (19%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL + + E +F++ +++ L+Y+H+ + HRD+KP NIL + + I DF
Sbjct: 86 DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFN 145
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPL 122
+A DT T T T Y APE+ + Y+ A+D WS+G E L GK
Sbjct: 146 IATKVTPDTLT----TSTSGTPGYMAPEV---LCRQGYSVAVDWWSLGVTAYECLRGKRP 198
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
+ G T + I + +P
Sbjct: 199 YRGH------------SRTIR-DQIRAKQETA----------------DVLYPATWSTEA 229
Query: 183 R-LLERMLAFEPKDR 196
+ ++L +P+ R
Sbjct: 230 IDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 33/194 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L E +L+ L Y+H+ V HRD+K +IL D ++K+ DFG D P
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 134
V T ++ APE+ + Y +DIWS+G + E++ G+P + + V
Sbjct: 174 R---KSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----- 223
Query: 135 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 194
+A+ R+R+ P P + +P+ LERML EP+
Sbjct: 224 ----------QAMKRLRDS-------------PPPKLKNAHKISPVLRDFLERMLTREPQ 260
Query: 195 DRPTAEEALADPYF 208
+R TA+E L P+
Sbjct: 261 ERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 33/184 (17%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
+L+ L ++H V HRD+K +IL +D ++K+ DFG + P V T
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTP 179
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 145
++ APE+ Y +DIWS+G + E++ G+P + P +
Sbjct: 180 YWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLQ 222
Query: 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205
A+ R+R+ P + +P L+RML +P R TA E L
Sbjct: 223 AMKRIRDNLP-------------PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269
Query: 206 PYFK 209
P+
Sbjct: 270 PFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 62/189 (32%), Positives = 82/189 (43%), Gaps = 36/189 (19%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFWT 79
F+ Q+L GLKY+H + HRD+K N+L N +KI DFG + R+A + T F
Sbjct: 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-- 169
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
T Y APE+ Y DIWS+GC E+ TGKP F + L
Sbjct: 170 --TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------L 214
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLALRLLERMLAFEPKDRPT 198
G P +A + M K P IP S A LR E +P R +
Sbjct: 215 GEP-----------QAAMFKVGMFKIHPEIPESLS-AEAKNFILRCFEP----DPDKRAS 258
Query: 199 AEEALADPY 207
A + L DP+
Sbjct: 259 AHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 37/205 (18%)
Query: 4 DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 61
DLH+++K L + F Q+L GL ++H+ + HRD+K N+ +A +KI D
Sbjct: 85 DLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGD 144
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
G+A++ + F V T +Y +PELC Y D+W++G + E TGK
Sbjct: 145 LGVAKLL---SDNTNFANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGK- 198
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
H D N+ A L +R P P SQ + +
Sbjct: 199 --------HPFD----------------ANNQGA-LILKIIRGVFP-PVSQMY---SQQL 229
Query: 182 LRLLERMLAFEPKDRPTAEEALADP 206
+L+++ L + + RP + L +P
Sbjct: 230 AQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 6e-17
Identities = 54/186 (29%), Positives = 82/186 (44%), Gaps = 39/186 (20%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDY 81
F Q+L L ++HT + HRDLK +NIL + +KI DFG++++ + +
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV---- 161
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLG 140
V T Y +PELC Y DIW++GC+ EL + K F N+ L IM+ G
Sbjct: 162 VGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS---G 216
Query: 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 200
T +P + RY +R +L+ ML +P RP
Sbjct: 217 TFAP---------ISDRYSPDLR-------------------QLILSMLNLDPSKRPQLS 248
Query: 201 EALADP 206
+ +A P
Sbjct: 249 QIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 7e-17
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 35/206 (16%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
SD+ ++ N LT E LYQ L+GL+Y+H+ HRD+K NIL N + + K+ DF
Sbjct: 86 SDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADF 143
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
G V+ T T + T ++ APE+ Y DIWS+G E+ GKP
Sbjct: 144 G---VSGQLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKP- 197
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
P + +H + + + P P P +S +F +
Sbjct: 198 -PYSD-IHPMRAIFMIPNKPPPTL------------------SDPEKWSPEFND------ 231
Query: 183 RLLERMLAFEPKDRPTAEEALADPYF 208
+++ L +P++RP+A + L P+
Sbjct: 232 -FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L + F L ++L GL+Y+H HRD+K NIL + + +K+ DFG V+ T T
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTST 151
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
+V T ++ APE+ S Y DIWS+G EL G+P
Sbjct: 152 MSKRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 41/191 (21%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
++ +++ G++ +H + HRD+KP+N+L + LK+ DFGL+R + +V
Sbjct: 102 YIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFV 154
Query: 83 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 141
T Y APE + G D WS+GC+ E L G P F +
Sbjct: 155 GTPDYLAPETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHAE--------------- 196
Query: 142 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-- 199
+P+A+ N +RR K+ +P A+ L+ R+L +P R A
Sbjct: 197 -TPDAV--FDNILSRRINWPEEVKE---------FCSPEAVDLINRLLCMDPAKRLGANG 244
Query: 200 -EEALADPYFK 209
+E + P+FK
Sbjct: 245 YQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 36/185 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
+ QLL G+ Y+H + HRDLK KNI + LKI DFG++R+ A T +
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFT 166
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142
T +Y +PE Y DIWS+GCI E+ F G+N L ++ ++ P
Sbjct: 167 GTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGP 221
Query: 143 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 202
+P Y + N+ +++ ML +P RP+A E
Sbjct: 222 TPSL--------PETYSRQL-------------NS------IMQSMLNKDPSLRPSAAEI 254
Query: 203 LADPY 207
L +P+
Sbjct: 255 LRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 12/148 (8%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+F+ +LL L+ +H NV +RDLKP+NIL + + +CDFGL ++ D
Sbjct: 96 RFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NT 152
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLL 139
+ T Y APEL YT A+D W++G + E+LTG P F +NV I+ + L
Sbjct: 153 FCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL 210
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKP 167
P + A+ L + + P
Sbjct: 211 RFPDG------FDRDAKDLLIGLLSRDP 232
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 50/123 (40%), Positives = 67/123 (54%), Gaps = 9/123 (7%)
Query: 4 DLHQVIK-ANDDLTPEH--YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
DL Q IK L PE Q+F+ Q+ G+++IH V HRD+K KNI + K+K+
Sbjct: 84 DLMQKIKLQRGKLFPEDTILQWFV-QMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLG 142
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFG AR+ + P A + YV T +Y PE+ + Y DIWS+GCI EL T K
Sbjct: 143 DFGSARLLTS--PGA-YACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLK 197
Query: 121 PLF 123
F
Sbjct: 198 HPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 55/192 (28%), Positives = 77/192 (40%), Gaps = 35/192 (18%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTD 80
L ++L+GL+Y+H+ HRD+K NIL D +KI DFG+ A +A T
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP----LFPGKNVVHQLDIMT 136
+V T + APE+ Y DIWS G EL TG P K ++
Sbjct: 166 FVGTPCWMAPEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLM 217
Query: 137 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 196
L P L + K +S+ F ++ L +P R
Sbjct: 218 LTLQNDPPS-------------LETGADYK--KYSKSFRK-------MISLCLQKDPSKR 255
Query: 197 PTAEEALADPYF 208
PTAEE L +F
Sbjct: 256 PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 52/198 (26%), Positives = 75/198 (37%), Gaps = 50/198 (25%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72
L+ + F Q+ +G++Y+ + HRDL +N L D +KI DFGL+R ++D
Sbjct: 100 STLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD- 158
Query: 73 PTAIFWTDYVAT-------RWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFP 124
Y RW APE S +T D+WS G + E+ T
Sbjct: 159 ------DYYRKKTGGKLPIRWM-APE---SLKDGIFTSKSDVWSFGVLLWEIFT------ 202
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS-MRKKKPIPFSQKFPNANPLALR 183
L TP P + NE+ YL R KP +
Sbjct: 203 -------------LGATPYPG----LSNEEVLEYLRKGYRLPKPEYCPDEL-------YE 238
Query: 184 LLERMLAFEPKDRPTAEE 201
L+ +P+DRPT E
Sbjct: 239 LMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 50/189 (26%), Positives = 88/189 (46%), Gaps = 32/189 (16%)
Query: 28 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 87
L+GL Y+H+ + HRD+KP NIL ++K+CDFG++ N + T +Y
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-----LAGTFTGTSFY 169
Query: 88 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP--GKNVVHQLDIMTDLLGTPSP 144
APE + G Y+ D+WS+G E+ + FP G+ + +++++ ++ P+P
Sbjct: 170 MAPERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226
Query: 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204
E N I +S++F + +++ L +P RPT + L
Sbjct: 227 ELKDEPGNG--------------IKWSEEFKD-------FIKQCLEKDPTRRPTPWDMLE 265
Query: 205 DPYFKGLAK 213
P+ K K
Sbjct: 266 HPWIKAQMK 274
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 56/191 (29%), Positives = 85/191 (44%), Gaps = 42/191 (21%)
Query: 27 LLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFN---DTPTAIFWTDYV 82
++ GL Y++ + + HRD+KP NIL N+ ++K+CDFG++ N DT +V
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FV 163
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-----VHQLDIMTD 137
T Y +PE KYT D+WS+G EL GK F N+ + I+ D
Sbjct: 164 GTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-D 220
Query: 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197
LL ++ E R +P S FP ++ L +P +RP
Sbjct: 221 LL--------QQIVQEPPPR----------LP-SSDFP---EDLRDFVDACLLKDPTERP 258
Query: 198 TAEEALADPYF 208
T ++ A P F
Sbjct: 259 TPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 60/227 (26%), Positives = 87/227 (38%), Gaps = 59/227 (25%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA------- 65
D E +F++ +L+ L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 96 DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155
Query: 66 ---------RVAFNDTPTAIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAID 105
+ D+ V T Y APE L G + Y D
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECD 212
Query: 106 IWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKK 165
WS+G I E+L G P F + E ++ N K L
Sbjct: 213 WWSLGVILYEMLYGFPPFYSDTLQ---------------ETYNKIINWK--ESLR----- 250
Query: 166 KPIPFSQKFPNANPLALRLLERMLAFEPKDR-PTAEEALADPYFKGL 211
P P A+ L+ R+L +P+DR + EE + P+FKG+
Sbjct: 251 --FPPDPPVS---PEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 43/108 (39%), Positives = 61/108 (56%), Gaps = 7/108 (6%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKL-KICDFGLARVAFNDTPTAIFWTDYVAT 84
Q+ GLK+IH + HRD+K +NI + + + K+ DFG+AR ND+ V T
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSME--LAYTCVGT 165
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 132
+Y +PE+C + Y DIWS+GC+ EL T K F G N +HQL
Sbjct: 166 PYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 33/183 (18%)
Query: 27 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 86
+LR L Y+H V HRD+K +IL +D ++K+ DFG + P V T +
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPY 183
Query: 87 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 146
+ APE+ Y +DIWS+G + E++ G+P + P +A
Sbjct: 184 WMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPY---------------FNEPPLQA 226
Query: 147 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206
+ R+R+ R S + + + L+ ML EP R TA+E L P
Sbjct: 227 MRRIRDNLPPRVKDSHK-------------VSSVLRGFLDLMLVREPSQRATAQELLQHP 273
Query: 207 YFK 209
+ K
Sbjct: 274 FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 47/141 (33%), Positives = 75/141 (53%), Gaps = 9/141 (6%)
Query: 16 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75
T E +F+L +L L ++H+ + +RDLKP+NIL + + +K+ DFGL++ + + A
Sbjct: 96 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-I 134
+ T Y APE+ +T + D WS G + E+LTG F GK+ + I
Sbjct: 156 Y---SFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 135 MTDLLGTP---SPEAIARVRN 152
+ LG P SPEA + +R
Sbjct: 211 LKAKLGMPQFLSPEAQSLLRA 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 8/106 (7%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ +++ L+Y+H+ + +RDLKP+NIL + + +K+ DFG A+ + T WT
Sbjct: 105 FYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-L 158
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
T Y APE+ S + A+D W++G + E+L G P F N
Sbjct: 159 CGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 31/204 (15%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
+ +KA LT + + Q+L G++Y+H+ + HRD+K NIL ++ +K+ DFG
Sbjct: 91 VKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA 150
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124
++ + T ++ +PE+ Y D+WS+GC E+LT KP P
Sbjct: 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKP--P 206
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 184
EA+A + + + P Q + +P A
Sbjct: 207 WAEF----------------EAMAAIFK---------IATQPTNP--QLPSHVSPDARNF 239
Query: 185 LERMLAFEPKDRPTAEEALADPYF 208
L R K RP+AEE L +
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 40/118 (33%), Positives = 61/118 (51%), Gaps = 11/118 (9%)
Query: 4 DLHQVIK---ANDDLTPEH--YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
DL ++IK L PE +++F QL L+++H+ + HRD+KP N+ A +K
Sbjct: 88 DLSRMIKHFKKQKRLIPERTIWKYF-VQLCSALEHMHSKRIMHRDIKPANVFITATGVVK 146
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
+ D GL R F+ TA V T +Y +PE + Y DIWS+GC+ E+
Sbjct: 147 LGDLGLGRF-FSSKTTAAH--SLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 33/206 (16%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+L GL+Y+H + HRD+K +NI N ++ I D G A+ P + V T
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET- 222
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF---------PGKNV-VHQLDI 134
APE+ KY DIWS G + E+L +F K+ H L I
Sbjct: 223 --NAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
Query: 135 MTDLLGTPSPEAIARVRNEKARR----YLSSMRKKKPIPFSQKFPNANPLALR-----LL 185
++ L PE R + R Y S R+ P+++ +P + L L+
Sbjct: 279 ISTL--KVHPEEFPRDPGSRLVRGFIEYASLERQ----PYTR-YPCFQRVNLPIDGEFLV 331
Query: 186 ERMLAFEPKDRPTAEEALADPYFKGL 211
+ML F+ RP+AEE L P F L
Sbjct: 332 HKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 22/142 (15%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
DL ++ + + LT + Q+ +G++Y+ + N HRDL +N L + +KI DF
Sbjct: 87 DLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDF 146
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL+R + D Y +W APE K+T D+WS G + E
Sbjct: 147 GLSRDIYED-------DYYRKRGGGKLPIKWM-APESL--KDGKFTSKSDVWSFGVLLWE 196
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
+ T G+ +PG + V+ L+
Sbjct: 197 IFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 10/107 (9%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77
+F+ Q++ L+Y+H+ ++ +RDLKP+N+L ++D +KI DFG A+ T
Sbjct: 101 PVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT----- 155
Query: 78 WTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLF 123
+T T Y APE+ SK Y A+D W++G + E+L G P F
Sbjct: 156 YT-LCGTPEYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
D ++ L+ +H +F++ ++ + +H HRDLKP+N L +A +K+ DFG
Sbjct: 87 DFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFG 146
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
L++ + + DY+ APE+ Y +D WS+GC+ E L G P F
Sbjct: 147 LSKGIVTYANSVVGSPDYM------APEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPF 198
Query: 124 PGKNV 128
G
Sbjct: 199 SGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 33/182 (18%)
Query: 27 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 86
+L+ L +H V HRD+K +IL D ++K+ DFG + P V T +
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPY 181
Query: 87 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 146
+ APEL Y P +DIWS+G + E++ G+P +
Sbjct: 182 WMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPY----------------------- 216
Query: 147 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206
NE + + +R P P + +P L+R+L +P R TA E L P
Sbjct: 217 ----FNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP 271
Query: 207 YF 208
+
Sbjct: 272 FL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ LK++H + HRD+K +NI D +K+ DFG+ARV + A + T
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTP 165
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 128
+Y +PE+C + Y DIW++GC+ E+ T K F N+
Sbjct: 166 YYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 45/135 (33%), Positives = 72/135 (53%), Gaps = 11/135 (8%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTD 80
F+L ++ L+++H + +RDLKP+NIL +A +K+ DFGL + + T T F
Sbjct: 104 FYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF--- 160
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLL 139
T Y APE+ S + A+D WS+G + ++LTG P F +N +D I+ L
Sbjct: 161 -CGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL 217
Query: 140 GTP---SPEAIARVR 151
P +PEA ++
Sbjct: 218 NLPPYLTPEARDLLK 232
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 39/205 (19%)
Query: 25 YQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83
+LRGL Y+ + HRD+KP NIL N+ ++K+CDFG++ + + +V
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVG 160
Query: 84 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142
TR Y +PE L G + YT DIWS+G E+ G+ P + +L+ M G P
Sbjct: 161 TRSYMSPERLQG---THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAM---FGRP 213
Query: 143 SPEAIARVRNEKARRYLSSMRK------------KKPIP------FSQKFPNANPLALRL 184
E A+ + + + +P P FS +F +
Sbjct: 214 VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD-------F 266
Query: 185 LERMLAFEPKDRPTAEEALADPYFK 209
+++ L PK+R +E P+ K
Sbjct: 267 VDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 40/196 (20%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ Q++ GL+++H + +RDLKP+N+L + ++I D GLA
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KGR 154
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 141
T Y APE+ Y ++D +++GC E++ G+ F
Sbjct: 155 AGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPF------------------ 194
Query: 142 PSPEAIARVRNEKARRY-LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---- 196
R R EK + L + + + KF +P A L E +L +P+ R
Sbjct: 195 -------RQRKEKVEKEELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCR 244
Query: 197 -PTAEEALADPYFKGL 211
+A+E P FK L
Sbjct: 245 GGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 39/193 (20%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFW 78
F+ ++ GL+Y+H + +RDLK N+L + + +KI DFGL + + F D T+ F
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTF- 161
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T + APE+ + YT A+D W +G + E+L G+ FPG +
Sbjct: 162 ---CGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDD----------- 205
Query: 139 LGTPSPEAIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 196
E + N++ R R+LS ++ I ++ NP ER L KD
Sbjct: 206 ----EEEVFDSIVNDEVRYPRFLS----REAISIMRRLLRRNP------ERRLGSGEKD- 250
Query: 197 PTAEEALADPYFK 209
AE+ P+F+
Sbjct: 251 --AEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 43/194 (22%), Positives = 86/194 (44%), Gaps = 32/194 (16%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ ++ +++ L ++H + +RD+K +NIL +++ + + DFGL++ + +
Sbjct: 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--S 165
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 140
+ T Y APE+ + A+D WS+G + ELLTG
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA-------------------- 205
Query: 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---P 197
SP + +N ++ ++ K P P + A ++++L +PK R
Sbjct: 206 --SPFTVDGEQNSQSEISRRILKSKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGAN 258
Query: 198 TAEEALADPYFKGL 211
A+E P+F+G+
Sbjct: 259 GADEIKNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 25/166 (15%)
Query: 19 HYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD----------------CKLKICD 61
H ++Q L Y HT ++ H DLKP+NIL C+++ICD
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
G + TAI V+TR YR+PE+ Y+ D+WS+GCI EL TGK
Sbjct: 292 LG-GCCDERHSRTAI-----VSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKL 343
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 167
L+ + + L +M LG E R E+AR +S + +P
Sbjct: 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389
|
Length = 467 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 56/191 (29%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
++L LKYIH V HRD+K NIL +K+CDFG VA + + +V T
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTP 165
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 145
++ APE+ Y DIWS+G E+ TG P + V M L+ P
Sbjct: 166 YWMAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSD---VDAFRAM-MLIPKSKPP 220
Query: 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205
+ + Y +R+ F +A L E EPK+R +AEE L
Sbjct: 221 RL------EDNGYSKLLRE-----F---------VAACLDE-----EPKERLSAEELLKS 255
Query: 206 PYFKGLAKVER 216
+ K +K
Sbjct: 256 KWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 34/197 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT ++ Q+L L ++H+ V HRDLK NIL D +K+ DFG V+ + T
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFG---VSAKNKST 156
Query: 75 AIFWTDYVATRWYRAPEL--CGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 131
++ T ++ APE+ C +F Y DIWS+G EL +P P ++
Sbjct: 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNP 213
Query: 132 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 191
+ ++ +L + P P +S F + L+ L
Sbjct: 214 MRVLLKILKSEPPTLDQ------------------PSKWSSSFND-------FLKSCLVK 248
Query: 192 EPKDRPTAEEALADPYF 208
+P DRPTA E L P+
Sbjct: 249 DPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 27 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 86
+++GL Y+ + + HRD+KP N+L N ++K+CDFG++ N YV T
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNA 158
Query: 87 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124
Y APE +Y D+WS+G F EL G+ FP
Sbjct: 159 YMAPERISG--EQYGIHSDVWSLGISFMELALGR--FP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 42/121 (34%), Positives = 59/121 (48%), Gaps = 26/121 (21%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 78
Q+ G+ Y+ + N HRDL +NIL + KI DFGLAR+ +D TA I W
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170
Query: 79 TDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQL 132
T APE G F K D+WS G + E++T G+ +PG V+ Q+
Sbjct: 171 T---------APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
Query: 133 D 133
+
Sbjct: 218 E 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 38/117 (32%), Positives = 62/117 (52%), Gaps = 7/117 (5%)
Query: 5 LHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L + ++ +D + + L + G+KY+ N HRDL +NIL N++ + K+ DFG
Sbjct: 93 LDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFG 152
Query: 64 LARVAFNDTPTAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
L+RV D P + T + RW APE + K+T A D+WS G + E+++
Sbjct: 153 LSRV-LEDDPEGTYTTSGGKIPIRW-TAPEAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPTAIFWTDY 81
Q+L G+ Y+H V HRD+K N++ + +K+ DFG AR V + T + + + +
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
T ++ APE+ S Y DIWSIGC E+ TGKP
Sbjct: 170 -GTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 9e-13
Identities = 39/123 (31%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 26 QLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 84
Q++ L+Y+H + HRDL P NI+ D K+ I DFGLA+ P + T V T
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES-KLTSVVGT 176
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 144
Y PE+ + Y D+W+ GCI ++ T +P F N++ + + + P P
Sbjct: 177 ILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234
Query: 145 EAI 147
E +
Sbjct: 235 EGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 40/205 (19%)
Query: 6 HQVIKANDDLTPEH--YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
H++ + L PE+ ++F+ Q+ L+Y+H ++ HRDLK +N+ +K+ D G
Sbjct: 89 HKLKEQKGKLLPENQVVEWFV-QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLG 147
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPL 122
+ARV N A + + T +Y +PEL F +K Y D+W++GC E+ T K
Sbjct: 148 IARVLENQCDMA---STLIGTPYYMSPEL---FSNKPYNYKSDVWALGCCVYEMATLKHA 201
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
F K++ N R + K P+P + +P
Sbjct: 202 FNAKDM-----------------------NSLVYRIIEG--KLPPMP-----KDYSPELG 231
Query: 183 RLLERMLAFEPKDRPTAEEALADPY 207
L+ ML+ P+ RP+ + L PY
Sbjct: 232 ELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 44/145 (30%), Positives = 77/145 (53%), Gaps = 11/145 (7%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVAT 84
+ L+ L+++H+ V HRD+K NIL D +K+ DFG A++ TP + V T
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGT 179
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP-- 142
++ APE+ Y P +DIWS+G + E++ G+P + +N + L ++ GTP
Sbjct: 180 PYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL 236
Query: 143 -SPEAIARVRNEKARRYLSSMRKKK 166
+PE ++ + + R L +K+
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 34/202 (16%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
+ Q + +++ L+++H + +RD+K +NIL +++ + + DFGL++ D
Sbjct: 102 FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 134
+ + T Y AP++ + A+D WS+G + ELLTG F
Sbjct: 162 RAY--SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF----------- 208
Query: 135 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 194
+ + + E +RR L K +P P+ Q+ + LA +++R+L +PK
Sbjct: 209 --------TVDGEKNSQAEISRRIL----KSEP-PYPQEM---SALAKDIIQRLLMKDPK 252
Query: 195 DR----PT-AEEALADPYFKGL 211
R P+ A+E P+F+ +
Sbjct: 253 KRLGCGPSDADEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 4/104 (3%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F YQ+ RG++++ + N HRDL +N+L +KICDFGLAR +D+ + ++
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
+W APE F + YT D+WS G + E+ + G +PG
Sbjct: 302 PVKWM-APE--SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 42/201 (20%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAI 76
E F+ ++ GL+ +H + +RDLKP+NIL + ++I D GLA + +T
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG- 160
Query: 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 136
V T Y APE+ + +YT + D W +GC+ E++ GK F
Sbjct: 161 ----RVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPF------------- 201
Query: 137 DLLGTPSPEAIARVRNEKARRYLSSMR-KKKPIPFSQKFPNANPLALRLLERMLAFEPKD 195
R R EK +R R K+ +S+KF + A + ++L +P
Sbjct: 202 ------------RQRKEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGF 246
Query: 196 R-----PTAEEALADPYFKGL 211
R AEE A P+F+
Sbjct: 247 RLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+F++ +L+ L+++H ++ +RDLKP+NIL +A + +CDFGL++ D T
Sbjct: 99 KFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NT 155
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
+ T Y APE+ YT +D WS+G + E+ G
Sbjct: 156 FCGTTEYLAPEVLLD-EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 57/207 (27%), Positives = 86/207 (41%), Gaps = 37/207 (17%)
Query: 27 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATR 85
+LR ++Y+H + HRD+K +NI N + + DFG A + + W +AT
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT- 249
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV------VHQLDIMTDL 138
APEL Y PA+DIWS G + E+ T LF + Q+ ++
Sbjct: 250 --NAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE----------RM 188
GT E + Y+ +K S + P + PL L E +M
Sbjct: 306 SGTHPNEFPIDAQANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICKM 359
Query: 189 LAFEPKDRPTAE--------EALADPY 207
LAF+ RP+AE + + DPY
Sbjct: 360 LAFDAHHRPSAEALLDFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 5/106 (4%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ +++ GL+++H + +RDLK N+L + D +KI DFG+ + N A + +
Sbjct: 100 FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STF 156
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
T Y APE+ KY ++D WS G + E+L G+ F G++
Sbjct: 157 CGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 37/115 (32%), Positives = 57/115 (49%), Gaps = 4/115 (3%)
Query: 5 LHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L + ++ ND T L + G+KY+ N HRDL +NIL N++ K+ DFG
Sbjct: 92 LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
L+R + T + RW APE + K+T A D+WS G + E+++
Sbjct: 152 LSRRLEDSEATYTTKGGKIPIRW-TAPEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 10 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 69
+ LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 70 NDTPTAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GK 120
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 121 PLFPGKNV 128
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 55/249 (22%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAI 76
+F+ +++ GL+++H + +RDLK N+L +++ +KI DFG+ + T+
Sbjct: 96 PRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155
Query: 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 136
F T Y APE+ + Y PA+D W++G + E+L G+ F G +
Sbjct: 156 F----CGTPDYIAPEILS--YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------- 200
Query: 137 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 196
+ + + E RY + K+ A +L+ L P+ R
Sbjct: 201 -------EDELFQSILEDEVRYPRWLSKE---------------AKSILKSFLTKNPEKR 238
Query: 197 ----PTAEEALAD-PYFKGL--AKVER---EPSAQPVTKMEF-------EFERRRITKED 239
PT E+ + P+F+ + K+ER +P +P K F EF + +
Sbjct: 239 LGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTP 298
Query: 240 VRELIYREI 248
E I R I
Sbjct: 299 PDEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 53/186 (28%), Positives = 82/186 (44%), Gaps = 35/186 (18%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230
Query: 75 AIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 132
+ + +W APE S F K YT D+WS G + E+ + G +PG
Sbjct: 231 VRKGSARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG------- 279
Query: 133 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 192
++ E +R R + P NA P R++ +
Sbjct: 280 ---------------VQINEEFCQRLKDGTRMRAP-------ENATPEIYRIMLACWQGD 317
Query: 193 PKDRPT 198
PK+RPT
Sbjct: 318 PKERPT 323
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 6e-12
Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVAT 84
+ L+ L ++H+ V HRD+K NIL D +K+ DFG A++ TP + V T
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGT 178
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP-- 142
++ APE+ Y P +DIWS+G + E++ G+P + +N + L ++ GTP
Sbjct: 179 PYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL 235
Query: 143 -SPEAIARVRNEKARRYL 159
+PE ++ V + R L
Sbjct: 236 QNPERLSAVFRDFLNRCL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 2 ESDLHQVIKANDDLT--PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
+ D+ I D+L E F YQ+ +G+ ++ + N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 118
CDFGLAR ND+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 119 GKPLFPGKNV 128
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 35/204 (17%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72
D+ + + +F+ +++ L+++H + +RD+K +NIL +++ + + DFGL++ ++
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
Query: 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 132
+ + T Y APE+ + A+D WS+G + ELLTG
Sbjct: 160 KERTY--SFCGTIEYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGA------------ 204
Query: 133 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 192
SP + RN ++ ++ P P P A LL ++L +
Sbjct: 205 ----------SPFTLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKD 249
Query: 193 PKDR-----PTAEEALADPYFKGL 211
PK R A E P+FKGL
Sbjct: 250 PKKRLGAGPQGASEIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 5/102 (4%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
+ ++Y+ + HRDL +N L D +K+ DFGLAR +D T+ T + +
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVK 166
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 126
W PE+ +S+++ D+WS G + E+ + GK +
Sbjct: 167 W-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 44/208 (21%)
Query: 8 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR- 66
+ K L E + L + LRGL Y+H V HRD+K +NIL + ++K+ DFG++
Sbjct: 103 LRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162
Query: 67 ----VAFNDTPTAIFWTDYVATRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAELLTG 119
+ +T ++ T ++ APE C + Y D+WS+G EL G
Sbjct: 163 LDSTLGRRNT--------FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
KP +H + + + P P K P +S+KF +
Sbjct: 215 KPPLCD---MHPMRALFKIPRNPPP------------------TLKSPENWSKKFND--- 250
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPY 207
+ L + RP EE L P+
Sbjct: 251 ----FISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 40/110 (36%), Positives = 55/110 (50%), Gaps = 19/110 (17%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 78
Q+ G+ YI N HRDL+ NIL KI DFGLAR+ ++ TA I W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 127
T APE + + ++T D+WS G + EL+T G+ +PG N
Sbjct: 170 T---------APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 51/180 (28%), Positives = 78/180 (43%), Gaps = 35/180 (19%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83
L ++L+GL Y+H+ HRD+K N+L + +K+ DFG VA T T I +V
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVG 163
Query: 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 143
T ++ APE+ S Y DIWS+G EL G+P P + +H + ++ +
Sbjct: 164 TPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNP 218
Query: 144 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203
P FS+ F ++ L +P RPTA+E L
Sbjct: 219 PTLTGE--------------------FSKPFK-------EFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 41/107 (38%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 21 QFFLYQL---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73
QF + QL LRG +KY+ HRDL +NIL N++ K+ DFGL+RV D P
Sbjct: 102 QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDP 160
Query: 74 TAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
A + T + RW APE + K+T A D+WS G + E+++
Sbjct: 161 EAAYTTRGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 39/147 (26%), Positives = 56/147 (38%), Gaps = 39/147 (26%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL-------- 64
D T E +F++ + + + IH HRD+KP N+L +A +K+ DFGL
Sbjct: 96 DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155
Query: 65 ----ARVAFNDTPTAIFWTDY-----------------------VATRWYRAPELCGSFF 97
R+ + P+ V T Y APE+ F
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV---FL 212
Query: 98 SK-YTPAIDIWSIGCIFAELLTGKPLF 123
Y D WS+G I E+L G P F
Sbjct: 213 QTGYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 40/112 (35%), Positives = 58/112 (51%), Gaps = 4/112 (3%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT E F YQ+ +G+ ++ + N HRDL +N+L +KICDFGLAR ND+
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
+ + +W APE F YT D+WS G + E+ + G +PG
Sbjct: 198 VVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 36/189 (19%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVAT 84
+ L+ L+++H+ V HRD+K NIL D +K+ DFG A++ TP + V T
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGT 178
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 144
++ APE+ Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 179 PYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------------ 224
Query: 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204
YL + + +K + + L R L + + R +A+E L
Sbjct: 225 -------------YLIATNGTPELQNPEKL---SAIFRDFLNRCLEMDVEKRGSAKELLQ 268
Query: 205 DPYFKGLAK 213
P+ K +AK
Sbjct: 269 HPFLK-IAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72
LT E + +Q+ +G++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 73 PTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GKPLFPG 125
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 6/116 (5%)
Query: 11 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 70
N E F+ ++L GL+ +H N +RDLKP+NIL + ++I D GLA
Sbjct: 95 GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV---- 150
Query: 71 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 126
P V T Y APE+ + +YT + D W +GC+ E++ G+ F G+
Sbjct: 151 KIPEGESIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 38/195 (19%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ ++ GL+ +H + +RDLKP+NIL + ++I D GLA P
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGR 161
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 141
V T Y APE+ + +YT + D W++GC+ E++ G+ +
Sbjct: 162 VGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQ--------------------S 199
Query: 142 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR----- 196
P + +++ E+ R + K+ +S+KF +P A L + +L +PK+R
Sbjct: 200 PFQQRKKKIKREEVERLV----KEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQG 252
Query: 197 PTAEEALADPYFKGL 211
A E P FK +
Sbjct: 253 GGAREVKEHPLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-11
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 42/192 (21%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVAT 84
+ L+ L+++H V HRD+K N+L D +K+ DFG A++ TP + V T
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGT 178
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP-- 142
++ APE+ Y P +DIWS+G + E++ G+P + +N + L ++ GTP
Sbjct: 179 PYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL 235
Query: 143 -SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 201
+PE ++ P+ L R L + + R +A+E
Sbjct: 236 QNPEKLS------------------------------PIFRDFLNRCLEMDVEKRGSAKE 265
Query: 202 ALADPYFKGLAK 213
L P+ K LAK
Sbjct: 266 LLQHPFLK-LAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 44/124 (35%), Positives = 60/124 (48%), Gaps = 22/124 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------- 75
F Q+ G+ YI N HRDL+ N+L + KI DFGLARV ++ TA
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDI 134
I WT APE F +T D+WS G + E++T GK +PG + D+
Sbjct: 168 IKWT---------APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDV 213
Query: 135 MTDL 138
M+ L
Sbjct: 214 MSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 34/110 (30%), Positives = 59/110 (53%), Gaps = 7/110 (6%)
Query: 19 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIF 77
H F+ ++ GL ++H+ + +RDLK N++ +A+ +KI DFG+ + F T F
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF 161
Query: 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
T Y APE+ + Y ++D W+ G + E+L G+P F G++
Sbjct: 162 ----CGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+F+ ++ L ++H V +RDLK NIL +A+ K+ DFG+ + + T T
Sbjct: 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TT 155
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
+ T Y APE+ +Y P++D W++G + E++ G+P F N
Sbjct: 156 FCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 4e-11
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 34/200 (17%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
+KA LT + + Q+L G+ Y+H+ + HRD+K NIL ++ +K+ DFG ++
Sbjct: 97 LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156
Query: 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 128
+ T ++ +PE+ Y D+WS+GC E+LT KP +
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
Query: 129 VHQL-DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 187
+ + I T P I+ E AR +L
Sbjct: 215 MAAIFKIATQPTNPQLPSHIS----EHARDFL---------------------------G 243
Query: 188 MLAFEPKDRPTAEEALADPY 207
+ E + RP+AEE L P+
Sbjct: 244 CIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 38/119 (31%), Positives = 59/119 (49%), Gaps = 22/119 (18%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 78
Q+ G+ Y+ N HRDL +N+L + K+ DFGLARV D A I W
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW 170
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 133
T APE + +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 171 T---------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTD 80
F+ +++ GL+++H+ + +RDLK NIL + D +KI DFG+ + D T F
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF--- 156
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
T Y APE+ KY ++D WS G + E+L G+ F G +
Sbjct: 157 -CGTPDYIAPEIL--LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 42/124 (33%), Positives = 61/124 (49%), Gaps = 24/124 (19%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72
+ LT + F YQ+ RG++++ + HRDL +N+L D +KI DFGLAR
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR------ 180
Query: 73 PTAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKP 121
I DY + +W APE + F + YT D+WS G + E+ T G P
Sbjct: 181 --DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
Query: 122 LFPG 125
+PG
Sbjct: 235 -YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 22/123 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F YQ+ G++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 143 SPE 145
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 40/118 (33%), Positives = 61/118 (51%), Gaps = 11/118 (9%)
Query: 4 DLHQVI---KANDDLTPEH--YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
DL Q+I K L PE +++F+ QL ++++H+ V HRD+KP N+ A +K
Sbjct: 88 DLSQMIKYFKKQKRLIPERTVWKYFV-QLCSAVEHMHSRRVMHRDIKPANVFITATGVVK 146
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
+ D GL R + T A V T +Y +PE + Y DIWS+GC+ E+
Sbjct: 147 LGDLGLGRFFSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83
L ++L+GL Y+H+ HRD+K N+L + ++K+ DFG VA T T I +V
Sbjct: 107 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVG 163
Query: 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
T ++ APE+ S Y DIWS+G EL G+P
Sbjct: 164 TPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
T E +F+ +++ L+Y+H+ +V +RD+K +N++ + D +KI DFGL + +D T
Sbjct: 92 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH---- 130
+ T Y APE+ + Y A+D W +G + E++ G+ P N H
Sbjct: 152 M---KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHERLF 204
Query: 131 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 167
+L +M ++ R + +A+ L+ + KK P
Sbjct: 205 ELILMEEI-------RFPRTLSPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 53/184 (28%), Positives = 77/184 (41%), Gaps = 51/184 (27%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 78
Q+ G+ +I N HRDL+ NIL + KI DFGLAR+ ++ TA I W
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTD 137
T APE + +T D+WS G + E++T G+ +PG MT+
Sbjct: 170 T---------APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG---------MTN 209
Query: 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPKDR 196
PE I + E+ R P+ P L L+ +P++R
Sbjct: 210 ------PEVIQNL--ERGYRMPR--------------PDNCPEELYELMRLCWKEKPEER 247
Query: 197 PTAE 200
PT E
Sbjct: 248 PTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 9/115 (7%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFW 78
+F+ ++ L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + +A +DT T
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT--- 155
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133
+ T Y APE+ Y +D W +G + E+L G P F ++V D
Sbjct: 156 --FCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 55/199 (27%), Positives = 84/199 (42%), Gaps = 36/199 (18%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT Q Q+L L+Y+H+ + HRDLK N+L D +K+ DFG V+ + T
Sbjct: 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKT 163
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQ 131
++ T ++ APE+ K TP DIWS+G E+ +P H+
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH------HE 217
Query: 132 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERMLA 190
L+ M R L + K +P SQ P+ + R L+ L
Sbjct: 218 LNPM---------------------RVLLKIAKSEPPTLSQ--PSKWSMEFRDFLKTALD 254
Query: 191 FEPKDRPTAEEALADPYFK 209
P+ RP+A + L P+
Sbjct: 255 KHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DLH + + + + +F+ +++ GL+++H V +RDLKP NIL + ++I D G
Sbjct: 83 DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA P A V T Y APE+ + Y + D +S+GC+ +LL G F
Sbjct: 143 LACDFSKKKPHA-----SVGTHGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPF 196
Query: 124 PGKNV--VHQLDIMTDLLGTPSPEAIA 148
H++D MT + P++ +
Sbjct: 197 RQHKTKDKHEIDRMTLTVNVELPDSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 39/133 (29%), Positives = 58/133 (43%), Gaps = 10/133 (7%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L Q+ G+ Y+ N HRDL +NIL D K+ DFGLAR+ D
Sbjct: 101 LPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--- 157
Query: 75 AIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 131
++ + + +W APE ++ D+WS G + E+ T G+ +PG N
Sbjct: 158 -VYLSSDKKIPYKW-TAPEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213
Query: 132 LDIMTDLLGTPSP 144
D +T P P
Sbjct: 214 YDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 42/122 (34%), Positives = 64/122 (52%), Gaps = 10/122 (8%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFG 63
L QV+K + E +LRGL Y+ + + HRD+KP NIL N+ ++K+CDFG
Sbjct: 90 LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 149
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
++ + + +V TR Y +PE L G+ +S + DIWS+G EL G+
Sbjct: 150 VSGQLIDSMANS-----FVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVELAIGRYP 201
Query: 123 FP 124
P
Sbjct: 202 IP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 38/104 (36%), Positives = 52/104 (50%), Gaps = 18/104 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F Q+ +G+ Y+ + HRDL +NIL ++ +KI DFGLA+V D DY
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYY 166
Query: 83 ATR--------WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ WY APE C SK++ A D+WS G EL T
Sbjct: 167 YVKEPGESPIFWY-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F Q+ +G+ ++ + N HRD+ +N+L KICDFGLAR ND+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
+W APE F YT D+WS G + E+ + GK +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 7/107 (6%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTD 80
F+ +++ GL+++H+ + +RDLK N++ + D +KI DFG+ + F D + F
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF--- 156
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
T Y APE+ KYT ++D WS G + E+L G+ F G +
Sbjct: 157 -CGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 8/103 (7%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+F+ +L+ +Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ + T T
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------ 174
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
T Y APE+ S + A+D W++G + E + G P F
Sbjct: 175 LCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 43/123 (34%), Positives = 57/123 (46%), Gaps = 22/123 (17%)
Query: 31 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TR---- 85
LK H V HRD+KP NIL +A +K+CDFG++ D A TR
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTRSAGC 177
Query: 86 -WYRAPELCG--SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142
Y APE KY D+WS+G EL TG+ FP KN + +++T +L
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEE 235
Query: 143 SPE 145
P
Sbjct: 236 PPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 16 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75
+ + +F+ +++ L Y+H+ +V +RDLK +N++ + D +KI DFGL + +D T
Sbjct: 93 SEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLD 133
+ T Y APE+ + Y A+D W +G + E++ G+ F + + +L
Sbjct: 153 ---KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 167
+M ++ R + +A+ L+ + KK P
Sbjct: 208 LMEEI-------RFPRTLSPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F +Q+ RG++Y+ + HRDL +N+L K+KI DFGL+R + + +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191
Query: 83 ATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 125
+W A E S F YT D+WS G + E++T G P +PG
Sbjct: 192 PVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 39/219 (17%)
Query: 4 DLHQVIKA--NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
DL++ IK + L + Y+ YQ++ L +H+ + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFG ++ ++D+ + + + T +Y APEL +Y+ D+WS+G I ELLT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 120 KPLFPGKNVVHQLDIMTDLL-GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
F G + Q +IM +L G P P P S
Sbjct: 268 HRPFKGPS---QREIMQQVLYGKYDP---------------------FPCPVSSGMK--- 300
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217
LL+ +L+ P RPT ++ L + K +A + ++
Sbjct: 301 ----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
+ + +F+ +++ L Y+H+ + +RDLK +N++ + D +KI DFGL + D T
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT 151
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQL 132
+ T Y APE+ + Y A+D W +G + E++ G+ F ++ + +L
Sbjct: 152 M---KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 133 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 167
+M D+ R + A+ LS + K P
Sbjct: 207 ILMEDI-------KFPRTLSADAKSLLSGLLIKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 2/113 (1%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
+K+ LT + + Q+L G+ Y+H+ + HRD+K NIL ++ +K+ DFG ++
Sbjct: 97 LKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156
Query: 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
+ T ++ +PE+ Y DIWS+GC E+LT KP
Sbjct: 157 QTICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 5/113 (4%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+F+ ++ L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T +
Sbjct: 99 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---ST 155
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133
+ T Y APE+ Y +D W +G + E+L G P F +N D
Sbjct: 156 FCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DLH + + + +F+ +++ GL+++H V +RDLKP NIL + ++I D G
Sbjct: 83 DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA P A V T Y APE+ + Y + D +S+GC+ +LL G F
Sbjct: 143 LACDFSKKKPHA-----SVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPF 196
Query: 124 PGKNVV--HQLDIMT-----DLLGTPSPE 145
H++D MT +L + SPE
Sbjct: 197 RQHKTKDKHEIDRMTLTMAVELPDSFSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 39/112 (34%), Positives = 61/112 (54%), Gaps = 8/112 (7%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ G+ YI N HRDL+ NIL + KI DFGLAR+ ++ TA + +
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIK 168
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 133
W APE + + ++T D+WS G + EL+T G+ +PG + V+ Q++
Sbjct: 169 W-TAPE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 53/180 (29%), Positives = 83/180 (46%), Gaps = 35/180 (19%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83
L ++L+GL Y+H+ HRD+K N+L + +K+ DFG VA T T I +V
Sbjct: 107 LREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVG 163
Query: 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 143
T ++ APE+ S Y DIWS+G EL G+P P + +H + ++ L+ S
Sbjct: 164 TPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-LIPKNS 217
Query: 144 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203
P ++ + PF + +E L +P+ RPTA+E L
Sbjct: 218 P---------------PTLEGQYSKPFKE-----------FVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 39/108 (36%), Positives = 58/108 (53%), Gaps = 13/108 (12%)
Query: 21 QFFLYQL---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73
QF + QL LRG +KY+ N HRDL +NIL N++ K+ DFGL+R +DT
Sbjct: 102 QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
Query: 74 TAIFWTDY---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ + + RW APE + K+T A D+WS G + E+++
Sbjct: 162 DPTYTSSLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 35/186 (18%)
Query: 27 LLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
+++ L+Y+H+ +V HRD+KP N+L N + ++K+CDFG++ + + T +
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCK 167
Query: 86 WYRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 143
Y APE ++ Y D+WS+G EL TG+ FP + + ++ PS
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS 225
Query: 144 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203
P ++ EK FS +F + + + L K+RP E L
Sbjct: 226 P----QLPAEK---------------FSPEFQD-------FVNKCLKKNYKERPNYPELL 259
Query: 204 ADPYFK 209
P+F+
Sbjct: 260 QHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73
+ + +F+ +++ L Y+H+ NV +RDLK +N++ + D +KI DFGL + D
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151
Query: 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH--- 130
T + T Y APE+ + Y A+D W +G + E++ G+ P N H
Sbjct: 152 TM---KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKL 204
Query: 131 -QLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP 167
+L +M ++ R + +A+ LS + KK P
Sbjct: 205 FELILMEEI-------RFPRTLSPEAKSLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 52/207 (25%), Positives = 81/207 (39%), Gaps = 34/207 (16%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
D++QV L+ + + L+GL Y+H HRD+K NIL D +K+ DF
Sbjct: 88 QDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK- 120
G V+ T T ++ T ++ APE Y DIW++G EL +
Sbjct: 146 G---VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
P+F L M L +K + +S F +
Sbjct: 203 PMF-------DLHPMRALFLISKSNFPPPKLKDKEK-------------WSPVFHD---- 238
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPY 207
+++ L +PK RPTA + L P+
Sbjct: 239 ---FIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 42/127 (33%), Positives = 64/127 (50%), Gaps = 11/127 (8%)
Query: 4 DLHQVI---KANDDLTPEH--YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
DL ++I K L PE +++F+ QL L+++H+ V HRD+KP N+ A +K
Sbjct: 88 DLSRMIKHFKKQKRLIPEKTVWKYFV-QLCSALEHMHSRRVMHRDIKPANVFITATGVVK 146
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ D GL R + T A V T +Y +PE + Y DIWS+GC+ E+
Sbjct: 147 LGDLGLGRFFSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAA 201
Query: 119 GKPLFPG 125
+ F G
Sbjct: 202 LQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 51/220 (23%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
L+GL Y+H+ HRD+K NIL +K+ DFG A + +P F V T
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSF----VGTP 175
Query: 86 WYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPS 143
++ APE+ + +Y +D+WS+G EL K PLF ++ M+ L
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALY---- 224
Query: 144 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203
IA +N+ LS +S F N ++ L P+DRP++EE L
Sbjct: 225 --HIA--QNDSPT--LS------SNDWSDYFRN-------FVDSCLQKIPQDRPSSEELL 265
Query: 204 ADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVREL 243
+ V RE +P T + +R TK+ VREL
Sbjct: 266 KHRF------VLRE---RPPTVIIDLIQR---TKDAVREL 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 32/199 (16%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
+KA LT + + Q+L+G+ Y+H+ + HRD+K NIL ++ +K+ DFG ++
Sbjct: 97 LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156
Query: 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 128
+ T ++ +PE+ Y D+WS+ C E+LT KP
Sbjct: 157 QTICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKP------- 207
Query: 129 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 188
P E A ++++ K P P+ A R +
Sbjct: 208 -------------PWAEYEA----------MAAIFKIATQPTKPMLPDGVSDACRDFLKQ 244
Query: 189 LAFEPKDRPTAEEALADPY 207
+ E K RPTAE L P+
Sbjct: 245 IFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 21/171 (12%)
Query: 28 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 87
L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A + +P +V T ++
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYW 183
Query: 88 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 146
APE+ + +Y +D+WS+G EL KP N + L + SP
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNDSPTL 240
Query: 147 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197
+ + R ++ QK P P + LL F +DRP
Sbjct: 241 QSNEWTDSFRGFVDYCL--------QKIPQERPASAELLRH--DFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI-LANADCK--LKICD 61
L +V+ A+ L + Q+L L H + HRDLKP+NI ++ + K+ D
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125
Query: 62 FGLAR----VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEL 116
FG+ V D T T+ + T Y APE L G TP D+++ G IF E
Sbjct: 126 FGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDLYAWGLIFLEC 182
Query: 117 LTGKPLFPGKNV 128
LTG+ + G +V
Sbjct: 183 LTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 69/230 (30%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L+ E +F+ ++L L+Y+H + +RDLKP+NIL + + + DF L++ + + P
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPP 158
Query: 75 AIFWT---------------------------DYVATRWYRAPEL---CGSFFSKYTPAI 104
+ +V T Y APE+ G + A+
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAV 213
Query: 105 DIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 164
D W++G + E+L G F G N R+E L
Sbjct: 214 DWWTLGILLYEMLYGTTPFKGSN-----------------------RDETFSNIL----- 245
Query: 165 KKPIPFSQKFPNANPLALRLLERMLAFEPKDR----PTAEEALADPYFKG 210
KK + F P ++ A L+ ++L +P R A E P+F+G
Sbjct: 246 KKEVTFPGSPPVSS-SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 9/115 (7%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFW 78
+F+ ++ L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + + T +
Sbjct: 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST--- 155
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133
+ T Y APE+ Y +D W +G + E+L G P F ++ D
Sbjct: 156 --FCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 4e-10
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 28 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 87
L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A +A +P +V T ++
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFVGTPYW 187
Query: 88 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 146
APE+ + +Y +D+WS+G EL KP N + L + SP
Sbjct: 188 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNESPTL 244
Query: 147 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197
+ ++ R ++ S QK P P + LL+ M F ++RP
Sbjct: 245 QSNEWSDYFRNFVDSCL--------QKIPQDRPTSEELLKHM--FVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 35/114 (30%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWT 79
QF+L +L+ + +H HRD+KP+N+L + +K+ DFG AR+ N +
Sbjct: 105 QFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM---VNSK 161
Query: 80 DYVATRWYRAPELC----GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 129
V T Y APE+ G Y D WS+G I E++ G+ F
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 37/102 (36%), Positives = 51/102 (50%), Gaps = 4/102 (3%)
Query: 25 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 84
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR N +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
+W APE F YT D+WS G + E+ T G +PG
Sbjct: 201 KWM-APE--ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 31/109 (28%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 19 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78
H F+ ++ GL ++H+ + +RDLK N++ +++ +KI DFG+ + D T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT--- 158
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
+ T Y APE+ + Y ++D W+ G + E+L G+ F G++
Sbjct: 159 KTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 37/129 (28%), Positives = 64/129 (49%), Gaps = 6/129 (4%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+F+ ++ + Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T +
Sbjct: 99 RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---ST 155
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLL 139
+ T Y APE+ Y +D W +G + E+L G P F ++V D I+ L
Sbjct: 156 FCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
Query: 140 GTPSPEAIA 148
P + +A
Sbjct: 214 QLPGGKTVA 222
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 60/207 (28%), Positives = 85/207 (41%), Gaps = 32/207 (15%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFWTDYVAT 84
QLL ++YIH + HRD+K +NI N D K+ + DFG A + W VAT
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP----GKNVVHQLDIMTDLLG 140
+PE+ Y DIWS G I ++L+ P G QL + D L
Sbjct: 335 ---NSPEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKIIDSLS 388
Query: 141 T-----PSP-----EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 190
P P + I + A + + + +P ++P L +ML
Sbjct: 389 VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP---------LVKMLT 439
Query: 191 FEPKDRPTAEEALADPYFKGLAKVERE 217
F+ RP A E LA P F A+ E E
Sbjct: 440 FDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 19/111 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------- 75
Q+ G+ Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
I WT APE + + ++T D+WS G + EL T G+ +PG
Sbjct: 167 IKWT---------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 89
G++Y+ + HRDL +N L ++ +K+ DFG+ R +D T+ + +W
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SP 169
Query: 90 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 127
PE+ FSKY+ D+WS G + E+ T GK F K+
Sbjct: 170 PEVFN--FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 53/255 (20%)
Query: 4 DLHQVIKANDDLT---PEHYQFFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
DL Q IK+ EH L+ Q+L + ++H+ ++ HRD+K NIL ++ +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFG +++ + T + T +Y APE+ Y+ D++S+G + ELLT
Sbjct: 185 GDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTL 241
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
K F G+N+ ++M L A RY P+P P+ +P
Sbjct: 242 KRPFDGENME---EVMHKTL---------------AGRY-------DPLP-----PSISP 271
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE----------------PSAQPV 223
++ +L+ +PK RP++ + L P K E
Sbjct: 272 EMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQ 331
Query: 224 TKMEFEFERRRITKE 238
TK + ERRRI ++
Sbjct: 332 TKQLLQVERRRIVRQ 346
|
Length = 496 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 41/111 (36%), Positives = 55/111 (49%), Gaps = 19/111 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------- 75
F Q+ G+ +I N HRDL+ NIL +A KI DFGLARV ++ TA
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
I WT APE F +T D+WS G + E++T G+ +PG
Sbjct: 167 IKWT---------APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 39/196 (19%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ Q++ GL+++H + +RDLKP+N+L + D ++I D GLA V D + Y
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGY 157
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 141
T + APEL +Y ++D +++G E++ + F
Sbjct: 158 AGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPF------------------ 197
Query: 142 PSPEAIARVRNEKA-RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---- 196
R R EK + L + + KF +P + E +LA +P+ R
Sbjct: 198 -------RARGEKVENKELKQRILNDSVTYPDKF---SPASKSFCEALLAKDPEKRLGFR 247
Query: 197 -PTAEEALADPYFKGL 211
+ P F+ L
Sbjct: 248 DGNCDGLRTHPLFRDL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 43/204 (21%)
Query: 22 FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
Y +++GLK++ N+ HRD+KP N+L N + ++K+CDFG++ + ++ T+
Sbjct: 106 RITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN 161
Query: 81 YVATRWYRAPE----LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK---NVVHQLD 133
+ + Y APE + YT D+WS+G E+ G+ +P + N+ QL
Sbjct: 162 -IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS 220
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
+ D G P P +S +A + L ++ P
Sbjct: 221 AIVD--GDPP---------------------TLPSGYS---DDAQDFVAKCLNKI----P 250
Query: 194 KDRPTAEEALADPYFKGLAKVERE 217
RPT + L P+ + +
Sbjct: 251 NRRPTYAQLLEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 32/108 (29%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWT 79
+F+ ++ L ++H + +RDLK N+L + + K+ DFG+ + FN T+ F
Sbjct: 99 RFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-- 156
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
T Y APE+ Y P++D W++G + E+L G F +N
Sbjct: 157 --CGTPDYIAPEILQEML--YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
+ LY L GL+++H + HRD+K NIL + +K+ DFG V+ T T +
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTS 188
Query: 82 VATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 121
V T ++ APE+ + Y D+WS+G EL G P
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 89
G+ Y+ ++NV HRDL +N L + +K+ DFG+ R +D T+ T + +W +
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SS 169
Query: 90 PELCGSFFSKYTPAIDIWSIGCIFAELLT 118
PE+ FSKY+ D+WS G + E+ +
Sbjct: 170 PEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-10
Identities = 38/111 (34%), Positives = 57/111 (51%), Gaps = 20/111 (18%)
Query: 18 EHYQFFLY--QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75
+H + LY Q+ +G++Y+ + HRDL +NIL ++ ++KI DFGL +V D
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---- 161
Query: 76 IFWTDYVATR--------WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+Y R WY APE SK++ A D+WS G + EL T
Sbjct: 162 ---KEYYKVREPGESPIFWY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 49/192 (25%), Positives = 73/192 (38%), Gaps = 45/192 (23%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------RVAFN-D 71
F Q+ G+ Y+H+ + HRDL +N+L + D +KI DFGLA RV + D
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVV 129
+P +FW A E K++ A D+WS G ELLT P K
Sbjct: 172 SP--VFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218
Query: 130 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-LLERM 188
+ + R + + + +P P P + L++
Sbjct: 219 EMIGPKQGQM--------------TVVRLIELLERGMRLP----CPKNCPQEVYILMKNC 260
Query: 189 LAFEPKDRPTAE 200
E K RPT
Sbjct: 261 WETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 37/103 (35%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 25 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 84
YQ+ RG++Y+ + HRDL +N+L + +KI DFGLAR N +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPG 125
+W APE F YT D+WS G + E+ T G P +PG
Sbjct: 204 KWM-APE--ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 22/119 (18%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 78
Q+ ++Y+ N HRDL +N L + +K+ DFGL+R+ DT TA I W
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 171
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 133
T APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 172 T---------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 47/193 (24%), Positives = 86/193 (44%), Gaps = 29/193 (15%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL ++ L EH +F+ ++ L ++H + +RDLK N+L +AD +K+ D+G
Sbjct: 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYG 141
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+ + T + + T Y APE+ +Y ++D W++G + E++ G+ F
Sbjct: 142 MCKEGLGPGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
DI+TD + + + +V EK R + K A
Sbjct: 197 ---------DIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK---------------ASH 232
Query: 184 LLERMLAFEPKDR 196
+L+ L +PK+R
Sbjct: 233 VLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 49/187 (26%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
+ YQL L Y+ + HRD+ +N+L ++ +K+ DFGL+R +++ Y
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-------YK 164
Query: 83 ATR------WYRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTG-KPLFPGKNVVHQLDI 134
A++ W APE F ++T A D+W G C++ L+ G KP
Sbjct: 165 ASKGKLPIKWM-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------- 210
Query: 135 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 194
G + + I R+ E R P+P PN P L+ + A++P
Sbjct: 211 -----GVKNNDVIGRI--ENGERL--------PMP-----PNCPPTLYSLMTKCWAYDPS 250
Query: 195 DRPTAEE 201
RP E
Sbjct: 251 KRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ ++ GL ++H + +RDLK N++ +++ +KI DFG+ + D T +
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTF 161
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
T Y APE+ + Y ++D W+ G + E+L G+P F G++
Sbjct: 162 CGTPDYIAPEIIA--YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 41/128 (32%), Positives = 59/128 (46%), Gaps = 12/128 (9%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT + Q L L Y+H + HRDLK NIL D +K+ DFG V+ +T T
Sbjct: 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRT 156
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQ 131
++ T ++ APE+ SK P D+WS+G E+ +P H+
Sbjct: 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH------HE 210
Query: 132 LDIMTDLL 139
L+ M LL
Sbjct: 211 LNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 36/131 (27%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 4 DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
DL ++ +D PE +F++ +++ + IH + HRD+KP N+L + + +++ DF
Sbjct: 87 DLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADF 146
Query: 63 GLARVAFND----TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
G D + A+ DY++ +A E KY P D WS+G E+L
Sbjct: 147 GSCLKMNQDGTVQSSVAVGTPDYISPEILQAME---DGMGKYGPECDWWSLGVCMYEMLY 203
Query: 119 GKPLFPGKNVV 129
G+ F +++V
Sbjct: 204 GETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 40/112 (35%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 25 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 81
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR I DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 82 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 125
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 11/101 (10%)
Query: 27 LLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
+++GL Y+ + + HRD+KP NIL N+ ++K+CDFG++ + + +V TR
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTR 166
Query: 86 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFP 124
Y +PE L G+ +S + DIWS+G E+ G+ P+ P
Sbjct: 167 SYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 25 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 81
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR + DY
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVHDIDYYKK 192
Query: 82 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 125
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 193 TSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 43/191 (22%), Positives = 71/191 (37%), Gaps = 56/191 (29%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---- 81
++ G+ Y+ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETDYYRKG 178
Query: 82 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 136
+ RW APE +T D+WS G + E+ T + + G +
Sbjct: 179 GKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------- 226
Query: 137 DLLGTPSPEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
NE+ +++ + + P + L L L+ + P
Sbjct: 227 ---------------NEEVLKFVIDGGHLDLPENCP--------DKL-LELMRMCWQYNP 262
Query: 194 KDRPTAEEALA 204
K RPT E ++
Sbjct: 263 KMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 50/195 (25%), Positives = 76/195 (38%), Gaps = 23/195 (11%)
Query: 27 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWTDYVAT 84
LL L Y+H + HRD+K +NI + + DFG A A DTP W+ + T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTDLLGT 141
+PEL Y DIWS G + E+ GK V QL + +
Sbjct: 254 ---NSPEL--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308
Query: 142 PSPEAIARVRNEKAR------RYLSSMRKKKPIPFSQKFPNANPL--ALRLLERMLAFEP 193
E +N +Y ++ + P L+ +ML F+
Sbjct: 309 HPLEF---PQNGSTNLCKHFKQY--AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363
Query: 194 KDRPTAEEALADPYF 208
+ RP+A++ L+ P F
Sbjct: 364 EFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 7/111 (6%)
Query: 25 YQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83
++ L Y+ + HRD+KP NIL + + +K+CDFG++ + +I T
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAG 169
Query: 84 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQL 132
R Y APE + S Y D+WS+G E+ TGK +P +V QL
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 43/205 (20%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+L G+ Y+H ++ HRD+KP N+L N+ +KI DFG++R+ T V T
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPC--NSSVGTI 232
Query: 86 WYRAPE-----LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD---IMTD 137
Y +PE L + Y A DIWS+G E G+ F V Q D +M
Sbjct: 233 AYMSPERINTDLNHGAYDGY--AGDIWSLGVSILEFYLGRFPFG---VGRQGDWASLMCA 287
Query: 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197
+ + PEA P S++F + + L EP R
Sbjct: 288 ICMSQPPEA--------------------PATASREFRH-------FISCCLQREPAKRW 320
Query: 198 TAEEALADPYFKGLAKVEREPSAQP 222
+A + L P+ + +
Sbjct: 321 SAMQLLQHPFILRAQPGQGQGGPNL 345
|
Length = 353 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 10/105 (9%)
Query: 31 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATRWYRA 89
L+Y+H + HRDLKP N+L + +K+ DFGL+++ T ++ TR +
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 90 PELCGS---------FFSKYTPAIDIWSIGCIFAELLTGKPLFPG 125
++CG+ Y +D W++G I E L G F G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 4 DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
DL ++ +D PE +F+L +++ + +H + HRD+KP NIL + + +++ DF
Sbjct: 87 DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADF 146
Query: 63 GLARVAFND----TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
G D + A+ DY++ +A E KY P D WS+G E+L
Sbjct: 147 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLY 203
Query: 119 GKPLFPGKNVV 129
G+ F +++V
Sbjct: 204 GETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 8/102 (7%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ Q++ +Y+ + N+ +RDLKP+N+L + D +K+ DFG A+V T T
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------L 188
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
T Y APE+ + + A D W++G E+L G P F
Sbjct: 189 CGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 3/116 (2%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
S L V + D L P+ + Q+ +G+ Y+ + HR+L +NIL +D ++I DF
Sbjct: 94 SLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADF 153
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
G+A + + D + +W L F +YT D+WS G E+++
Sbjct: 154 GVADLLYPDDKKYFYSEHKTPIKWM---ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 31/120 (25%), Positives = 60/120 (50%), Gaps = 5/120 (4%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL ++ L EH +F+ ++ L Y+H + +RDLK N+L +++ +K+ D+G
Sbjct: 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+ + T + + T Y APE+ Y ++D W++G + E++ G+ F
Sbjct: 142 MCKEGLRPGDTT---STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 28 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 87
L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A + P +V T ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFVGTPYW 177
Query: 88 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 146
APE+ + +Y +D+WS+G EL KP N + L + SP
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNESPAL 234
Query: 147 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197
+ +E R ++ S QK P P + LL+ F ++RP
Sbjct: 235 QSGHWSEYFRNFVDSCL--------QKIPQDRPTSEVLLKHR--FVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 35/202 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L EH +F+ ++ L ++H + +RDLK N+L +A+ +K+ D+G+ + T
Sbjct: 93 LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 134
+ + T Y APE+ Y ++D W++G + E++ G+ F DI
Sbjct: 153 T---STFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPF---------DI 198
Query: 135 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL-ALRLLERMLAFEP 193
+ + +P+ + YL + +K I + P + + A +L+ L +P
Sbjct: 199 VGM---SDNPD-------QNTEDYLFQVILEKQI----RIPRSLSVKASSVLKGFLNKDP 244
Query: 194 KDR--PTAEEALAD----PYFK 209
K+R + D P+F+
Sbjct: 245 KERLGCHPQTGFRDIKSHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 25 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 84
+ G+ Y+ + HRDL +N L + +K+ DFGL+R +D T+ + +
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PV 165
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 120
RW PE+ +SK++ D+W+ G + E+ + GK
Sbjct: 166 RW-SPPEVL--LYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ +G+ Y+ + HRDL +N+L ++ ++KI DFGL + D D +
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
++ APE SK+ A D+WS G ELLT
Sbjct: 177 FWYAPECL--IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 16/138 (11%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L + +K ++ + +Q+ G+ Y+ + + HRDL +N+L + KI DFG+
Sbjct: 82 LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141
Query: 65 AR-VAFNDT----PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 118
+R + TA W +WY APE C ++ K++ D+WS G E +
Sbjct: 142 SRALGAGSDYYRATTAGRW----PLKWY-APE-CINYG-KFSSKSDVWSYGVTLWEAFSY 194
Query: 119 -GKPL--FPGKNVVHQLD 133
KP G V+ L+
Sbjct: 195 GAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 16/113 (14%)
Query: 16 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---AFNDT 72
+ QF L + G++Y+ + + HRDL +NIL + D K+ DFGLARV +++
Sbjct: 99 VIQLLQFSL-DVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157
Query: 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 124
+ WT APE K++ D+WS G + E+ + G+ +P
Sbjct: 158 KLPVKWT---------APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 3/97 (3%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F Q+ G+KY+ + N HRDL +N L + +KI DFG++R ++ I
Sbjct: 134 FMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAV 193
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ RW + K+T A D+W+ G E+LT
Sbjct: 194 LPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
+ L++ L GL+++H HRD+K NIL + +K+ DFG V+ T T +
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTS 184
Query: 82 VATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 121
V T ++ APE+ S Y D+WS+G EL G P
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 19/100 (19%)
Query: 25 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 81
Q+ G++Y+ + + HRDL +N L +KI DFGL+R I+ DY
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--------DIYSADYYRV 182
Query: 82 -----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
+ RW PE + K+T DIWS G + E+
Sbjct: 183 QSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
F+ +L GL+ + + +RDLKP+NIL + ++I D GLA P
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGR 161
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
V T Y APE+ + KYT + D W +GC+ E++ G+ F
Sbjct: 162 VGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+DL + K N L E + ++LRGL ++H V HRD+K +N+L + ++K+ DF
Sbjct: 97 TDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTG 119
G V+ T ++ T ++ APE+ + + Y D+WS+G E+ G
Sbjct: 156 G---VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161
P +H + + + P+P ++ ++K + ++ S
Sbjct: 213 APPLCD---MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIES 251
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 34/152 (22%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
D+ ++ D L+ E QF++ + + + IH HRD+KP N+L +A +K+ DFG
Sbjct: 87 DMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFG 146
Query: 64 LA-------RVAF-----------------NDTPTAIFWT--------DYVATRWYRAPE 91
L R F N A W V T Y APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206
Query: 92 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+ + Y D WS+G I E+L G P F
Sbjct: 207 VFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 12/116 (10%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L++ ++ N +T ++ ++Q+ G+KY+ N HRDL +N+L KI DFGL
Sbjct: 82 LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141
Query: 65 ARVAFND-----TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
++ D T W +WY APE C +++ K++ D+WS G + E
Sbjct: 142 SKALGADENYYKAKTHGKW----PVKWY-APE-CMNYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 34/152 (22%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
D+ ++ D LT E QF++ + + + IH HRD+KP N+L ++ +K+ DFG
Sbjct: 87 DMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFG 146
Query: 64 LA-------RVAF-----------------NDTPTAIFWT--------DYVATRWYRAPE 91
L R F N A W V T Y APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206
Query: 92 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+ + Y D WS+G I E+L G P F
Sbjct: 207 VFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 36/121 (29%), Positives = 52/121 (42%), Gaps = 4/121 (3%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ +G+ Y+ + HRDL +N+L +KI DFGLA++ D V +
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144
W A E YT D+WS G EL+T G + G V D++ P P
Sbjct: 177 WM-ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP 233
Query: 145 E 145
Sbjct: 234 P 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 52/203 (25%), Positives = 75/203 (36%), Gaps = 58/203 (28%)
Query: 26 QLLRGLKYIHT-------ANVFHRDLKPKNILANADCK-----------------LKICD 61
QLL L Y H V HRDLKP+NI + + KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
FGL++ + V T +Y +PEL Y D+W++GCI EL +GK
Sbjct: 186 FGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
F N QL +S +++ +P K N
Sbjct: 242 PFHKANNFSQL--------------------------ISELKRGPDLPIKGKSKELN--- 272
Query: 182 LRLLERMLAFEPKDRPTAEEALA 204
L++ +L K+RP+A + L
Sbjct: 273 -ILIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 36/122 (29%), Positives = 61/122 (50%), Gaps = 7/122 (5%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+DL + K N L + + ++LRGL ++H V HRD+K +N+L + ++K+ DF
Sbjct: 107 TDLVKNTKGNA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTG 119
G V+ T ++ T ++ APE+ + + Y DIWS+G E+ G
Sbjct: 166 G---VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
Query: 120 KP 121
P
Sbjct: 223 AP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 9e-08
Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 20/123 (16%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 62
DL ++K L+ + + QL+ L +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-----YTPAIDIWSIGCIFAELL 117
GL ++ TP+ Y T Y +PE K Y + D W++G + ELL
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPE-------KIKGHNYDVSFDWWAVGVLTYELL 200
Query: 118 TGK 120
TGK
Sbjct: 201 TGK 203
|
Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81
+ Q+ G+ ++H+ ++ +RD+KP+N+L + ++ D GLA + T
Sbjct: 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI----TQR 154
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
T Y APE+ Y+ +D +++GC E++ G+ F
Sbjct: 155 AGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 30/180 (16%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
+ L+GL Y+H+ HRD+K NIL + +K+ DFG VA T T ++ T
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTP 170
Query: 86 WYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 144
++ APE+ Y DIW++G EL +P + + L +M+ P
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP- 229
Query: 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204
+ K +S F N ++ L PK RPTAE L
Sbjct: 230 ------------------KLKDKTKWSSTFHNFVKIS-------LTKNPKKRPTAERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 51/204 (25%), Positives = 81/204 (39%), Gaps = 30/204 (14%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L + L+ + + L+GL Y+H+ HRD+K NIL + +K+ DFG
Sbjct: 93 LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG- 151
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
V+ T T ++ T ++ APE+ Y DIW++G EL +P
Sbjct: 152 --VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
+ + L +MT P + K + +S F + +A
Sbjct: 210 FDLHPMRALFLMTKSNFQPP-------------------KLKDKMKWSNSFHHFVKMA-- 248
Query: 184 LLERMLAFEPKDRPTAEEALADPY 207
L PK RPTAE+ L P+
Sbjct: 249 -----LTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 45/216 (20%), Positives = 80/216 (37%), Gaps = 37/216 (17%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF---------GLARVAFNDT 72
F L +L L YIH+ HR +K +IL + D K+ + G + +D
Sbjct: 105 FILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164
Query: 73 PTAI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 128
P + W +PE+ Y DI+S+G EL G P K++
Sbjct: 165 PKSSVKNLPWL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDM 213
Query: 129 VHQLDIMTDLLGTPS--------PEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANP 179
++ + GT P + ++ + R P+++ F + +
Sbjct: 214 PATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQ 273
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215
L+R +P+ RP+A + L +FK +
Sbjct: 274 FVELCLQR----DPESRPSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 34/114 (29%), Positives = 54/114 (47%), Gaps = 10/114 (8%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72
D++T + ++Q+ G+KY+ N HRDL +N+L KI DFGL++ D
Sbjct: 90 DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149
Query: 73 PTAIFWTDYVATRW---YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKP 121
++ A +W + APE F K++ D+WS G E + KP
Sbjct: 150 S---YYKARSAGKWPLKWYAPECIN--FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 3/90 (3%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 89
G++Y+ + N HRDL +N L + LKI DFG++R T + +W A
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TA 163
Query: 90 PELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
PE + +YT D+WS G + E +
Sbjct: 164 PEALN--YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 5/119 (4%)
Query: 7 QVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66
Q +A +L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
Query: 67 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK-PLF 123
++ + + RW PE + K+T D+WS G I E+ T GK P F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 3/93 (3%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ G+ Y+ HRDL +N L + +KI DFGL+R ++ D + R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
W PE F+++YT D+W+ G + E+ +
Sbjct: 198 WM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 39/152 (25%), Positives = 58/152 (38%), Gaps = 47/152 (30%)
Query: 17 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL----------- 64
PE +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL
Sbjct: 99 PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158
Query: 65 -----ARVAFNDTPTAIFWTD----------------------------YVATRWYRAPE 91
+ + + + W D V T Y APE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218
Query: 92 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+ YT D WS+G I E+L G+P F
Sbjct: 219 VL--LRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 18/104 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDY 81
+ Q+ G++Y+ + HRDL +NIL +D K+KI DFGL R + N+ D+
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DH 153
Query: 82 VATRWYR-------APELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ APE ++ A D+W G E+ T
Sbjct: 154 YVMEEHLKVPFAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 5/98 (5%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ +G+ Y+ + HRDL +N+L + +KI DFGLAR+ D + +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKP 121
W L + K+T D+WS G EL+T GKP
Sbjct: 177 WM---ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 6/102 (5%)
Query: 20 YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76
LY Q+ G+KY+ + N HRDL +N L +KI DFG++R ++ I
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ RW + K+T A D+W+ G E+ T
Sbjct: 188 QGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 3/105 (2%)
Query: 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73
+LT Q+ G+ Y+ + + HRDL +N L + +KI DFG++R ++
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175
Query: 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ + RW PE + K+T D+WS+G + E+ T
Sbjct: 176 YRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 19/101 (18%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---- 81
Q+ G+ Y+ + + HRDL +N L +KI DFG++R I+ TDY
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDYYRVG 181
Query: 82 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ RW PE + K+T DIWS G + E+ T
Sbjct: 182 GRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 42/181 (23%), Positives = 68/181 (37%), Gaps = 36/181 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F+ + G++Y+ + + HRDL +N + N + + + DFGL++ +N +
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 141
+W L YT D+WS G E+ T G+ +PG
Sbjct: 177 PVKWIAIESLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG---------------- 217
Query: 142 PSPEAIARVRNEKARRYL-SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 200
V N + YL R K+P P+ L+ PKDRP+ E
Sbjct: 218 --------VENSEIYDYLRQGNRLKQP-------PDCLDGLYSLMSSCWLLNPKDRPSFE 262
Query: 201 E 201
Sbjct: 263 T 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 33/97 (34%), Positives = 42/97 (43%), Gaps = 12/97 (12%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD---YVATRW 86
GL ++H A+ H DL +N AD +KI D+GL A P + T V RW
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRW 168
Query: 87 YRAPELCGSFFS-----KYTPAIDIWSIGCIFAELLT 118
APEL T +IWS+G EL T
Sbjct: 169 L-APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 39/156 (25%), Positives = 55/156 (35%), Gaps = 59/156 (37%)
Query: 17 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75
E +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL T
Sbjct: 99 EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC--------TG 150
Query: 76 IFWT------------------------------------------------DYVATRWY 87
WT V T Y
Sbjct: 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210
Query: 88 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
APE+ + YT D WS+G I E+L G+P F
Sbjct: 211 IAPEVLLR--TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F Q+ +G++Y+ + HRDL +N + + +K+ DFGLAR I+ +Y
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYY 154
Query: 83 ATRWYRAPELCGSFFS-------KYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDI 134
+ + +L + + K+T D+WS G + EL+T G P +P V DI
Sbjct: 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDI 211
Query: 135 MTDLL 139
LL
Sbjct: 212 TVYLL 216
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----L 64
+ +N D+ + +F+ +++ L IH+ + HRD+KP N+L + LK+ DFG +
Sbjct: 133 LMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPL 122
TA+ DY+ +PE+ S Y D WS+G E+L G
Sbjct: 193 DETGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
Query: 123 FPGKNVV 129
F ++V
Sbjct: 247 FYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 39/169 (23%), Positives = 69/169 (40%), Gaps = 32/169 (18%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 89
G++Y+ + + HRDL +N L LKI DFG++R + + + +W A
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TA 164
Query: 90 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 149
PE + +Y+ D+WS G + E + L P
Sbjct: 165 PEALN--YGRYSSESDVWSFGILLWEAFS-------------------LGAVPYAN---- 199
Query: 150 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 198
+ N++ R + + +P + P+A RL+ER ++P RP+
Sbjct: 200 LSNQQTREAI---EQGVRLPCPELCPDA---VYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 35/114 (30%), Positives = 53/114 (46%), Gaps = 18/114 (15%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WT 79
F + G++Y+ N HRDL +N+L + D K+ DFGLA+ A + WT
Sbjct: 107 FALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT 166
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVV 129
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 ---------APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 12/119 (10%)
Query: 11 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LAR 66
+N D+ + +F+ +++ L IH+ HRD+KP N+L + LK+ DFG +
Sbjct: 135 SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194
Query: 67 VAFNDTPTAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLF 123
TA+ DY+ +PE+ S Y D WS+G E+L G F
Sbjct: 195 NGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 60/240 (25%), Positives = 89/240 (37%), Gaps = 81/240 (33%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF--- 77
+F++ +L ++ +H HRD+KP NIL + D +K+ DFGL F T + +
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQS 162
Query: 78 --------------WTD----------------------------YVATRWYRAPELCGS 95
W D V T Y APE+
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-- 220
Query: 96 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155
+ YT D WS+G I E+L G+P F L TP + K
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPF--------------LAQTPLETQM------KV 260
Query: 156 RRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGL 211
+ +S+ IP K P A+ L ++L P+DR A+E A P+FK +
Sbjct: 261 INWQTSLH----IPPQAKLSPEASDLIIKLCR-----GPEDRLGKNGADEIKAHPFFKTI 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 11/109 (10%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVA 83
Q+ +G+ Y+ + HRDL +N+L + +KI DFGLAR+ D + D V
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVP 174
Query: 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPL--FPGKNV 128
+W + ++T D+WS G EL+T KP P + +
Sbjct: 175 IKWMALESI---LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 53/198 (26%), Positives = 80/198 (40%), Gaps = 20/198 (10%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
QLL + YIH + HRD+K +N+L N + + DFG A A T + T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY-GIAGTV 326
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTGKPLFPGKN-------------VVHQ 131
APE+ YTP++DIWS G IF + LF ++ Q
Sbjct: 327 DTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384
Query: 132 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 191
+ D A +R+ ++ R + R P ++ + L+ R L F
Sbjct: 385 AQVHVDEF---PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF 441
Query: 192 EPKDRPTAEEALADPYFK 209
+ RP+A E L P F+
Sbjct: 442 DGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 35/115 (30%), Positives = 52/115 (45%), Gaps = 20/115 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT Q+ G+ Y+ + + HRDL +N L D +KI DFG++R
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------- 170
Query: 75 AIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 120
++ TDY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 171 DVYTTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 33/124 (26%), Positives = 60/124 (48%), Gaps = 7/124 (5%)
Query: 10 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LA 65
K D L + +F+L +++ + +H HRD+KP N+L + + +++ DFG L
Sbjct: 94 KFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153
Query: 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 125
+ A+ DY++ +A E +Y P D WS+G E+L G+ F
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 126 KNVV 129
+++V
Sbjct: 211 ESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 6/101 (5%)
Query: 20 YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76
Y L+ Q+ G+KY+ + N HRDL +N L + +KI DFG++R + I
Sbjct: 137 YSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRI 196
Query: 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 117
+ RW A E K+T A D+W+ G E+L
Sbjct: 197 QGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 35/193 (18%)
Query: 10 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 69
K D+L + F G+ Y+ + N HRDL +N L + LKI DFG++R
Sbjct: 85 KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQE- 143
Query: 70 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 128
+D + + +W APE + +Y+ D+WS G + E + G +PG
Sbjct: 144 DDGIYSSSGLKQIPIKW-TAPEALN--YGRYSSESDVWSYGILLWETFSLGVCPYPG--- 197
Query: 129 VHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 188
MT N++AR + K + QK P+ ++++R
Sbjct: 198 ------MT---------------NQQARE---QVEKGYRMSCPQKCPDD---VYKVMQRC 230
Query: 189 LAFEPKDRPTAEE 201
++P++RP E
Sbjct: 231 WDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----L 64
+ +N D+ + +F+ +++ L IH+ HRD+KP N+L + LK+ DFG +
Sbjct: 133 LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPL 122
+ TA+ DY+ +PE+ S Y D WS+G E+L G
Sbjct: 193 NKEGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 123 FPGKNVV 129
F ++V
Sbjct: 247 FYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 32/124 (25%), Positives = 56/124 (45%), Gaps = 9/124 (7%)
Query: 1 MESDLHQVIKANDD------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 54
M S V +DD L P + + Q+ G++++ + +V H+DL +N+L
Sbjct: 101 MRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160
Query: 55 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 114
+KI D GL R + + + RW +PE + K++ DIWS G +
Sbjct: 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLW 217
Query: 115 ELLT 118
E+ +
Sbjct: 218 EVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 3/93 (3%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ G+ Y+H V H+D+ +N + + + ++KI D L+R F + + +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
W L +S A D+WS G + EL+T
Sbjct: 185 WMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 28/112 (25%), Positives = 51/112 (45%), Gaps = 20/112 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY- 81
F+ + G++Y+ + N HRDL +N + N + + + DFGL++ I+ DY
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYY 169
Query: 82 -------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 170 RQGCASKLPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 8/118 (6%)
Query: 7 QVIKANDDLTPE--HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
+ + + +TP+ Q ++ GL ++H N H DL +N L AD +KI D+GL
Sbjct: 87 RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-----TPAIDIWSIGCIFAELL 117
+ + + +V RW APEL T ++WS+G EL
Sbjct: 147 SHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 29/112 (25%), Positives = 48/112 (42%), Gaps = 20/112 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY- 81
F+ + G++Y+ N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYY 169
Query: 82 -------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 170 RQGRIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWTDYVAT 84
+++ L +H + RDL P NIL + +++ F + V + A+
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-------E 145
Query: 85 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
Y APE+ G S+ T A D WS+G I ELLTGK L
Sbjct: 146 NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 50/199 (25%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L+ + Q+ G+ ++ A HRDL +N L ++ ++K+ L++ +N
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--- 170
Query: 75 AIFWTDY-------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 126
+Y + RW APE ++ D+WS G + E+ T G+ F G
Sbjct: 171 -----EYYKLRNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG- 221
Query: 127 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLL 185
++D E + R++ K P P L +L+
Sbjct: 222 --------LSD------EEVLNRLQAGKLE---------------LPVPEGCPSRLYKLM 252
Query: 186 ERMLAFEPKDRPTAEEALA 204
R A PKDRP+ E ++
Sbjct: 253 TRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 18/118 (15%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA---IFWT 79
F + ++Y+ N HRDL +N+L + D K+ DFGL + A + T + WT
Sbjct: 107 FSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 166
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVVHQLD 133
APE K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 167 ---------APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 31/114 (27%), Positives = 51/114 (44%), Gaps = 3/114 (2%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L V + D++ ++ + Q+ +G+ Y+ + HRDL +N+L +KI DFGL
Sbjct: 96 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
A++ D V +W + YT D+WS G EL+T
Sbjct: 156 AKLLGADEKEYHAEGGKVPIKWMALESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 29/101 (28%), Positives = 45/101 (44%), Gaps = 19/101 (18%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---- 81
++ G+ Y++ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKG 178
Query: 82 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 35/112 (31%), Positives = 48/112 (42%), Gaps = 14/112 (12%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFND 71
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R V
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180
Query: 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 121
T + RW L +S YT D+WS G + E+ L G P
Sbjct: 181 T------MGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 3/93 (3%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
Q+ G++Y+ + H+DL +NIL +KI D GL+R ++ + + R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191
Query: 86 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
W PE + K++ DIWS G + E+ +
Sbjct: 192 WM-PPE--AIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65
+ Q+L GL+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 62/237 (26%), Positives = 89/237 (37%), Gaps = 76/237 (32%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVAFNDTPTAI 76
Q + Q+L L +H+ + HRD+KP+NI+ + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 77 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 114
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY-LSSMRKKKPIPFSQK 173
++ FP L + S I R K Y L + RK
Sbjct: 371 QM-----AFPN-------------LRSDS-NLIQFNRQLKRNDYDLVAWRKLVE------ 405
Query: 174 FPNANP--------------LALRLLERMLAFEPKDRPTAEEALADPYF--KGLAKV 214
P A+P LL+ M+ F+ + R +A+ ALA PYF +GL +
Sbjct: 406 -PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGLLGL 461
|
Length = 566 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 21/102 (20%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-ND-------TPTAIF 77
Q+ G++Y+ + N HRDL +N L + +KI DFG++R + +D P I
Sbjct: 138 QIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI- 196
Query: 78 WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLT 118
RW A E S K+T D+W+ G E+LT
Sbjct: 197 -------RWM-AWE---SVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 54/223 (24%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL------------ARVAFND 71
L+ LRGL Y+H HR++K +IL + D + + GL A+V + D
Sbjct: 107 LFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-D 163
Query: 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 131
P F T + W +PEL Y DI+S+G EL TG+ P ++++
Sbjct: 164 FPQ--FSTSVLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRT 216
Query: 132 LDIMTDLLGTPS--------PEAIARVRNEKA---------------RRYLSSMRKKKPI 168
++ L G P P +R++N ++ + ++S R + P
Sbjct: 217 QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276
Query: 169 P--FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
FS F N L+E L +P+ RP+A L+ +FK
Sbjct: 277 SKTFSPAFQN-------LVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 35/108 (32%), Positives = 45/108 (41%), Gaps = 21/108 (19%)
Query: 26 QLLR-------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTA 75
QLL G+ Y+ HRDL +NIL + KI DFGL+R V T
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT--- 169
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 121
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 170 ---MGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 34/112 (30%), Positives = 48/112 (42%), Gaps = 14/112 (12%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFND 71
LT + F + G++Y+ HRDL +N+L + KI DFGL+R V
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 121
T + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 T------MGRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 18/49 (36%), Positives = 31/49 (63%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 70
++ ++ L Y+H + HRDLKP N+L + + +K+ DFGL++V N
Sbjct: 108 KYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 27/97 (27%), Positives = 42/97 (43%), Gaps = 19/97 (19%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-------- 81
G+ Y++ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYYRKGGKGL 182
Query: 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ RW L F+ + D+WS G + E+ +
Sbjct: 183 LPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 25/93 (26%), Positives = 42/93 (45%), Gaps = 6/93 (6%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 89
G+ ++H N H DL +N +D +K+ D+G+ + + V RW A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169
Query: 90 PELCGSFF-----SKYTPAIDIWSIGCIFAELL 117
PEL G F ++ T ++W++G EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 40/115 (34%), Positives = 54/115 (46%), Gaps = 29/115 (25%)
Query: 29 RGLKYIHTANVFHRDLKPKNILA-----NADCKLKICDFGLARVAFNDTPTAIFWTDY-- 81
+G Y+ + HRDL +N L +AD +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 82 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 127
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 70/210 (33%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----------VAFNDT------ 72
++Y+H+ V HRDLKP NIL ++ I D+G A + ++
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 73 ---PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP---- 124
P I V T Y APE L G S+ T DI+++G I ++LT FP
Sbjct: 185 MTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FPYRRK 234
Query: 125 -GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
G+ + ++ I SP +A R IP P +
Sbjct: 235 KGRKISYRDVI-------LSPIEVAPYRE---------------IP---------PFLSQ 263
Query: 184 LLERMLAFEPKDRPTAEEALAD---PYFKG 210
+ + LA +P +R ++ + L P+ +G
Sbjct: 264 IAMKALAVDPAERYSSVQELKQDLEPHLQG 293
|
Length = 932 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 40/171 (23%), Positives = 66/171 (38%), Gaps = 52/171 (30%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL ++ D + + +F++ + + ++ +H HRD+KP NIL + +K+ DFG
Sbjct: 87 DLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFG 146
Query: 64 LARVAFNDTPTAIFWT------------------------------DYVATRW------- 86
L+ F+ + ++ D +AT W
Sbjct: 147 LS-TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIAT-WKKNRRLM 204
Query: 87 ---------YRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKN 127
Y APE+ F + Y D WS+G I E L G P F +N
Sbjct: 205 AYSTVGTPDYIAPEI---FLQQGYGQECDWWSLGAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 35/113 (30%), Positives = 49/113 (43%), Gaps = 31/113 (27%)
Query: 30 GLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPTAIFWTDY--- 81
G KY+ + HRD+ +N L CK KI DFG+AR I+ Y
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR--------DIYRASYYRK 177
Query: 82 -----VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 126
+ +W PE L G F SK D+WS G + E+ + G +PG+
Sbjct: 178 GGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 449 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.98 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.98 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.98 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.98 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.95 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.94 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.94 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.94 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.94 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.93 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.93 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.93 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.92 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.9 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.9 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.88 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.88 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.87 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.87 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.86 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.86 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.83 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.83 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.81 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.8 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.8 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.6 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.42 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.29 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.28 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.24 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.24 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.24 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.21 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.14 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.08 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 98.91 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.91 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.85 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.32 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.25 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.01 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.79 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 97.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.72 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.6 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.35 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.31 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.86 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 96.49 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.29 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.86 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.9 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 94.64 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 93.9 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 93.81 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.36 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 93.27 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.21 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 92.71 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.99 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 91.59 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 90.75 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 90.44 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.37 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 90.25 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.08 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 89.98 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 89.37 | |
| PLN02236 | 344 | choline kinase | 89.24 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 89.02 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 88.74 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 88.37 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 87.57 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 86.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 86.11 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 86.11 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 84.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 84.19 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 83.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 82.97 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 80.57 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-58 Score=444.26 Aligned_cols=250 Identities=62% Similarity=1.036 Sum_probs=236.7
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
||+||+++|+.++.|++++++.+++|||+||+|+|+.||+||||||.|+|++.+|.+||||||+|+..... ....+++.
T Consensus 108 MetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~~~~mTe 186 (359)
T KOG0660|consen 108 METDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FEDGFMTE 186 (359)
T ss_pred HhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-Ccccchhc
Confidence 79999999999988999999999999999999999999999999999999999999999999999988665 55567899
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
++.|+||+|||++... ..|+.++||||+||||+||++|+++|+|.+..+|+..|..++|+|+.+.+..+.++.++.++.
T Consensus 187 YVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~ 265 (359)
T KOG0660|consen 187 YVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIK 265 (359)
T ss_pred ceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHH
Confidence 9999999999999764 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
++....+.+|...|+++++.+.+||.+||.+||.+|+|++|+|+||||..++++++||.+++.... ++.. ++.+++
T Consensus 266 slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~~~~-~~~~~~ 341 (359)
T KOG0660|consen 266 SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---FEHE-LTEEEL 341 (359)
T ss_pred hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---cccc-ccHHHH
Confidence 999999999999999999999999999999999999999999999999999999999988876554 4445 999999
Q ss_pred HHHHHHHHHhhChhHH
Q 013122 241 RELIYREILEYHPQML 256 (449)
Q Consensus 241 ~e~i~~ei~~~~p~~~ 256 (449)
++++|+|++.|+|...
T Consensus 342 r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 342 RELIYKEILDFHPDVS 357 (359)
T ss_pred HHHHHHHHHhhCcccc
Confidence 9999999999998754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=353.02 Aligned_cols=253 Identities=94% Similarity=1.501 Sum_probs=230.6
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........+..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 165 (338)
T cd07859 86 MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165 (338)
T ss_pred CCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccC
Confidence 56899999999888999999999999999999999999999999999999999999999999999865443333333456
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||..|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+...+|.+..+.+..+.......++.
T Consensus 166 ~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (338)
T cd07859 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS 245 (338)
T ss_pred CCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence 78999999999987543578899999999999999999999999999999999999999999999999988888888888
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+....+.++...++..++.+.+||.+||..||++|||++|+|+||||+++......+..++...+++.++++.++.+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (338)
T cd07859 246 SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDV 325 (338)
T ss_pred hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhcCHHHH
Confidence 88887777888888889999999999999999999999999999999999999988899999999999999999999999
Q ss_pred HHHHHHHHHhhCh
Q 013122 241 RELIYREILEYHP 253 (449)
Q Consensus 241 ~e~i~~ei~~~~p 253 (449)
++.+++++++|||
T Consensus 326 ~~~~~~~~~~~~~ 338 (338)
T cd07859 326 RELIYREILEYHP 338 (338)
T ss_pred HHHHHHHHHhcCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.49 Aligned_cols=206 Identities=40% Similarity=0.740 Sum_probs=182.6
Q ss_pred CCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~~-Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+.+|+++++.+.+ |++..++.||+||++||+|+|.+|+.||||||+|||+..+..|||+|||+|+......+ ++
T Consensus 92 Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP----YT 167 (538)
T KOG0661|consen 92 MDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP----YT 167 (538)
T ss_pred hhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC----cc
Confidence 88999999998764 99999999999999999999999999999999999999988999999999998776654 58
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+|+.|+||+|||+|... ..|+.++|||++|||++|+.+-+++|+|.+..+++-+|++++|+|..+.|...... +...-
T Consensus 168 eYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L-a~~mn 245 (538)
T KOG0661|consen 168 EYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL-ASAMN 245 (538)
T ss_pred hhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH-HHHhc
Confidence 89999999999999764 78999999999999999999999999999999999999999999999888764211 11222
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
-.+....+.++...+++++.++.+||.+||.+||.+||||.++|+||||+.-.
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 23445556677788899999999999999999999999999999999998644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=322.70 Aligned_cols=205 Identities=42% Similarity=0.746 Sum_probs=180.1
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|++||..+|+.+. .|+..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+........ .+
T Consensus 83 m~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~---~~ 159 (318)
T KOG0659|consen 83 MPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI---QT 159 (318)
T ss_pred ccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc---cc
Confidence 7899999999876 4999999999999999999999999999999999999999999999999999987655432 34
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+.|+||+|||++.|. ..|+..+||||+|||++||+.|.+.|+|.++.+|+..|.+.+|+|.++.|..+..-.. |.
T Consensus 160 ~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd--Y~ 236 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD--YV 236 (318)
T ss_pred cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc--HH
Confidence 55899999999999886 7899999999999999999999999999999999999999999999999988754322 21
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.+......+....|+.++..+.||+.+||.+||.+|+|+.|+|+|+||+...
T Consensus 237 -~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 237 -KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred -HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 1122333344558899999999999999999999999999999999999743
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.45 Aligned_cols=246 Identities=40% Similarity=0.716 Sum_probs=211.1
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+.+|++++.. .++.+.+.++++|+++|++|||++||+||||||+||+++.+|.+||+|||+|+..... ...+.
T Consensus 103 m~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~----~~mtp 176 (369)
T KOG0665|consen 103 MDANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD----FMMTP 176 (369)
T ss_pred hhhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc----cccCc
Confidence 77899999984 5999999999999999999999999999999999999999999999999999865443 24588
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
++.|+.|+|||++.+ ..|...+||||+|||+.||++|+.+|+|.+..+++.+|.+.+|+|.+.++..+.. ..+.++.
T Consensus 177 yVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~-~~r~yv~ 253 (369)
T KOG0665|consen 177 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP-TVRNYVE 253 (369)
T ss_pred hhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH-HHHHHhh
Confidence 999999999999998 4699999999999999999999999999999999999999999999999988743 3455555
Q ss_pred hhccCCCCCCCCCCCC------------CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhh
Q 013122 161 SMRKKKPIPFSQKFPN------------ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~------------~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~ 228 (449)
...+.....+...||+ -+..+++|+.+||..||++|.+++++|+||||+ ++-...++..++....+.
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~-vw~~~~ev~ap~pe~~d~ 332 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK-VWYDPDEVEAPPPEIYDK 332 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee-eecccccccCCCCchhhh
Confidence 5555555555555554 246789999999999999999999999999999 445556666666556667
Q ss_pred HHHhhcCCHHHHHHHHHHHHHhhChhHH
Q 013122 229 EFERRRITKEDVRELIYREILEYHPQML 256 (449)
Q Consensus 229 ~~e~~~~~~e~~~e~i~~ei~~~~p~~~ 256 (449)
.++.+..+.++|+++||+|+.+|.+...
T Consensus 333 ~~d~~~~t~~e~ke~If~ev~~f~~~~~ 360 (369)
T KOG0665|consen 333 QLDEREHTIEEWKELIFKEVQRFEEFNK 360 (369)
T ss_pred hcccccCCHHHHHHHHHHHHHhhccccc
Confidence 7778888999999999999999887433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=327.42 Aligned_cols=204 Identities=38% Similarity=0.762 Sum_probs=172.2
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+.++.+-+.... .++.+.++.+++|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+..... ...+++
T Consensus 84 dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p---gd~YTD 160 (396)
T KOG0593|consen 84 DHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP---GDNYTD 160 (396)
T ss_pred chHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC---cchhhh
Confidence 344444454443 5999999999999999999999999999999999999999999999999999987642 235689
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
|+.|+||+|||++.+. ..|+..+||||+||++.||++|.++|+|.++.+|+-.|...+|...+....-.... .++.
T Consensus 161 YVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N---~~F~ 236 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN---PFFH 236 (396)
T ss_pred hhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC---Ccee
Confidence 9999999999999885 78999999999999999999999999999999999999999998877665443322 2222
Q ss_pred hhcc---CCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 161 SMRK---KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~---~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.++. ..+.++...+++++..+.||+.+||..||.+|++.+++|.|+||.++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 2222 234456778899999999999999999999999999999999997653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=340.44 Aligned_cols=202 Identities=36% Similarity=0.629 Sum_probs=175.6
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|++||..++...+ .|++.++++||+||+.||.|||++||+|||||.+|||||.+|.+||+|||||+.+...... .++
T Consensus 200 MdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~--~~T 277 (560)
T KOG0600|consen 200 MDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA--PYT 277 (560)
T ss_pred ccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc--ccc
Confidence 8999999999865 6999999999999999999999999999999999999999999999999999976554432 368
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+.|.||+|||+|.|. ..|+.++|+||+||||.||++|+++|+|.+.++|+..|.+++|.|.++.|....-. ..
T Consensus 278 ~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP----~~ 352 (560)
T KOG0600|consen 278 SRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP----HA 352 (560)
T ss_pred cceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC----cc
Confidence 88999999999999985 78999999999999999999999999999999999999999999999998722111 11
Q ss_pred hhhcc--CCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 160 SSMRK--KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 160 ~~~~~--~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
..+.. .....+.+.|..+++.+.+|+..||..||.+|.||.++|.|+||.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 11111 112234556778899999999999999999999999999999994
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=324.59 Aligned_cols=207 Identities=40% Similarity=0.651 Sum_probs=179.1
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
||+||..+|.+-. +|...+++.++.|+|+||+|||.+.|+|||||++|+|++..|.+||+|||+|+.+..... .++
T Consensus 159 ~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k---~~T 235 (419)
T KOG0663|consen 159 VEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK---PYT 235 (419)
T ss_pred HHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc---cCc
Confidence 5789999999876 799999999999999999999999999999999999999999999999999998765532 357
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+.|.||+|||++.+. ..|+.++||||+|||++||++++++|+|.+..+|++.|++++|+|+..+|..+..-.+...+
T Consensus 236 ~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred ceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 88999999999999886 78999999999999999999999999999999999999999999999999887554433321
Q ss_pred hhhccCCCCCCCCCCCC--CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPN--ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
. ........+...|+. ++....+|+.++|.+||.+|.||+|+|+|.||....
T Consensus 315 ~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 315 T-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred c-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 1 122222334445554 459999999999999999999999999999999743
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=326.34 Aligned_cols=207 Identities=42% Similarity=0.759 Sum_probs=180.8
Q ss_pred CCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-CCEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGlA~~~~~~~~~~ 75 (449)
|..+|+++++. +..++.-+++.+++||++||+|||+.||+||||||.|||+|.+ |.+||||||.|+....+.+.
T Consensus 104 mP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn- 182 (364)
T KOG0658|consen 104 MPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN- 182 (364)
T ss_pred chHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-
Confidence 45678888884 6789999999999999999999999999999999999999986 89999999999988766654
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
..|..|+.|+|||++.|. ..|+.++||||.|||++||+.|+++|+|.+..+|+..|.+++|+|+.+.+..+.....
T Consensus 183 ---iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 183 ---ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred ---eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 568999999999999985 7899999999999999999999999999999999999999999999999988765432
Q ss_pred HHHHhhhccCCCCCCCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccc
Q 013122 156 RRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~ 215 (449)
. .........++.. .+...++++.+|+.++|.++|.+|.++.|+|.||||..+....
T Consensus 259 ~---~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 259 E---FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred c---ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 1 1222333444444 5567899999999999999999999999999999999988763
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=319.46 Aligned_cols=207 Identities=38% Similarity=0.695 Sum_probs=177.7
Q ss_pred CCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcc
Q 013122 1 MESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 1 me~dL~~~i~~~~----~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
++.||.+++.... .++...++.+++||++||+|||++||+||||||.|||++.+|.+||+|||+|+...-...
T Consensus 99 ~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--- 175 (323)
T KOG0594|consen 99 LDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--- 175 (323)
T ss_pred ecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcc---
Confidence 4679999998866 588899999999999999999999999999999999999999999999999986542222
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
.++..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.+..+++..|.+++|+|+.+.|..+..-...
T Consensus 176 ~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~ 254 (323)
T KOG0594|consen 176 TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY 254 (323)
T ss_pred cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc
Confidence 25778899999999999885 57999999999999999999999999999999999999999999999998876432211
Q ss_pred HHHhhhccCC-CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 157 RYLSSMRKKK-PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.. ...... +..+....+..++.+.+|+.+||..+|.+|.|++.+|.||||..+..
T Consensus 255 k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 255 KA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 11 222222 45566667777889999999999999999999999999999997643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=320.19 Aligned_cols=180 Identities=34% Similarity=0.578 Sum_probs=150.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC---CCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+|+|++.+-.++.+.+...+.+++|||.||.|||++||+||||||+|||++.+ +.+||+|||+|+..... .++
T Consensus 260 GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~----sfm 335 (475)
T KOG0615|consen 260 GGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG----SFM 335 (475)
T ss_pred CccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccc----eeh
Confidence 58999999999999999999999999999999999999999999999999877 77999999999987543 356
Q ss_pred ccccccccccCcccccccCCC-CCCccchhhhHHHHHhhhhCCCCCCCCCchh-hHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~-~s~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
.+.|||+.|.|||++.+.... +..++||||+|||||-+|+|.+||.+..... ..+.|.+
T Consensus 336 ~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~------------------- 396 (475)
T KOG0615|consen 336 KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK------------------- 396 (475)
T ss_pred hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-------------------
Confidence 889999999999999653223 3448999999999999999999998765433 2222221
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
....-....+..++.++++||.+||..||++|||++|+|+||||+...
T Consensus 397 --------G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 397 --------GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred --------CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 111112345567899999999999999999999999999999998643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=325.08 Aligned_cols=206 Identities=33% Similarity=0.665 Sum_probs=169.6
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC--CCEEEeecCccccccCCCCCcc
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
|+.+|+++|+.+. .|+...++.|+.|||.||.+||+.||||+||||+|||+... ..|||+|||.++......
T Consensus 270 L~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v---- 345 (586)
T KOG0667|consen 270 LSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV---- 345 (586)
T ss_pred hhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc----
Confidence 4679999999987 48999999999999999999999999999999999999864 469999999998654332
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
..++.++.|+|||++.| ..|+.++||||||||++||++|.++|+|.+..+|+..|.+++|.|+...+....+. .
T Consensus 346 --ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~--~ 419 (586)
T KOG0667|consen 346 --YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA--H 419 (586)
T ss_pred --eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc--c
Confidence 37899999999999999 79999999999999999999999999999999999999999999999988765432 2
Q ss_pred HHHhh----------------------------hccCCCC-----CCCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 013122 157 RYLSS----------------------------MRKKKPI-----PFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEA 202 (449)
Q Consensus 157 ~~~~~----------------------------~~~~~~~-----~~~~~~~-~~s~~~~dLL~~~L~~DP~~RpTa~el 202 (449)
.++.+ ....... .+..... .....+.+||.+||.+||.+|+|+.++
T Consensus 420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa 499 (586)
T KOG0667|consen 420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA 499 (586)
T ss_pred eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence 22222 0111111 1122222 234568999999999999999999999
Q ss_pred HcCccccccccccC
Q 013122 203 LADPYFKGLAKVER 216 (449)
Q Consensus 203 L~hp~f~~~~~~~~ 216 (449)
|+||||.+......
T Consensus 500 l~Hpfl~~~~~~~~ 513 (586)
T KOG0667|consen 500 LNHPFLTGTSLERR 513 (586)
T ss_pred hcCccccccccccc
Confidence 99999997665433
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.27 Aligned_cols=247 Identities=59% Similarity=1.039 Sum_probs=211.4
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++..++.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... .....
T Consensus 91 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~ 167 (337)
T cd07858 91 MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTE 167 (337)
T ss_pred CCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc---ccccc
Confidence 467899999988899999999999999999999999999999999999999999999999999997653321 12245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+... ..++.++|||||||++|+|++|++||.+.+....+..+...+|.+..+.+..+.......++.
T Consensus 168 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (337)
T cd07858 168 YVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR 246 (337)
T ss_pred cccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHH
Confidence 6788999999988642 358899999999999999999999999998888889999999999888887766666666666
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+....+.+++.+.+||.+||+.||++|||++++|+||||..+.....++..+. .+.+.|+...++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 324 (337)
T cd07858 247 SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFEEDALTEEDI 324 (337)
T ss_pred hcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhhhhhcCHHHH
Confidence 55544444455556788999999999999999999999999999999999887777666543 5577888888999999
Q ss_pred HHHHHHHHHhhCh
Q 013122 241 RELIYREILEYHP 253 (449)
Q Consensus 241 ~e~i~~ei~~~~p 253 (449)
+++|+.|.+.|||
T Consensus 325 ~~~~~~~~~~~~~ 337 (337)
T cd07858 325 KELIYNEMLAYHP 337 (337)
T ss_pred HHHHHHHHhhcCC
Confidence 9999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=317.37 Aligned_cols=180 Identities=33% Similarity=0.537 Sum_probs=155.8
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|..++++++.|+|.++++|++||+.||.|||+++|+|||||..|||++++.+|||+|||||.....+... ..+.|
T Consensus 103 ~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er---k~TlC 179 (592)
T KOG0575|consen 103 GSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER---KKTLC 179 (592)
T ss_pred ccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc---cceec
Confidence 689999999999999999999999999999999999999999999999999999999999999887644332 36789
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||+.|.|||++.. ..++..+||||+|||||-||.|+|||..++..+.++.|... +
T Consensus 180 GTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------------~----- 234 (592)
T KOG0575|consen 180 GTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------------E----- 234 (592)
T ss_pred CCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------------C-----
Confidence 9999999999987 78999999999999999999999999998877777665431 0
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCC
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 218 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~ 218 (449)
......++.++++||.+||..||.+|||++++|.|+||+.-..+...+
T Consensus 235 --------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 235 --------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred --------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 011136789999999999999999999999999999996544444443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=301.61 Aligned_cols=178 Identities=27% Similarity=0.547 Sum_probs=149.9
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
|+|.++++..++++|.....++.+|++||.|||. .+||||||||+|||++..|.|||||||.+....+. ...++
T Consensus 163 GSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-----~a~tf 237 (364)
T KOG0581|consen 163 GSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-----IANTF 237 (364)
T ss_pred CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-----hcccc
Confidence 7999999999999999999999999999999995 99999999999999999999999999999876554 34678
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCC--CchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~--~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+||..|||||.+.+ ..|+.++||||||+.++||.+|+.||... .....++.+..++.
T Consensus 238 vGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~------------------- 296 (364)
T KOG0581|consen 238 VGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD------------------- 296 (364)
T ss_pred cccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-------------------
Confidence 99999999999998 79999999999999999999999999764 22233333322222
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
..+..+... .+++++++||..||++||.+|+|+.|+|+|||++....
T Consensus 297 -----~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 297 -----EPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred -----CCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 111111111 47899999999999999999999999999999997653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=312.03 Aligned_cols=179 Identities=31% Similarity=0.565 Sum_probs=156.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------- 74 (449)
.|||.++|++-+.|++..+++++.||+.||+|||++|||||||||+|||++.++++||+|||.|+.+......
T Consensus 158 nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~ 237 (604)
T KOG0592|consen 158 NGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDP 237 (604)
T ss_pred CCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCc
Confidence 4899999999999999999999999999999999999999999999999999999999999999876432211
Q ss_pred ---ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 75 ---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 75 ---~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
......++||-.|.+||+|.. ...++.+|||+||||||.|+.|.+||.+.+.....+.|+.+-
T Consensus 238 ~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~------------ 303 (604)
T KOG0592|consen 238 NQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD------------ 303 (604)
T ss_pred ccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc------------
Confidence 111256899999999999988 678899999999999999999999999999888777776531
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
..| .++.++.+++||.++|..||.+|+|+++|-+||||.++..
T Consensus 304 ----------------y~f---p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 304 ----------------YEF---PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred ----------------ccC---CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 112 2345689999999999999999999999999999997653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=288.44 Aligned_cols=206 Identities=46% Similarity=0.762 Sum_probs=174.6
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|.+||+.+|-..+.|+.++++-+++||++||+|||+.||.||||||.|+|+++++.+||||||+|+....+... .++.
T Consensus 139 mQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~--hMTq 216 (449)
T KOG0664|consen 139 MQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL--NMTH 216 (449)
T ss_pred HHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh--hhHH
Confidence 67899999999999999999999999999999999999999999999999999999999999999986544332 4567
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+.|.+|+|||++.|. ..|+.++||||+|||+.|||..+.+|...+..++++.|++++|+|+.|.+..-........+.
T Consensus 217 EVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 217 EVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 7889999999999885 789999999999999999999999999999999999999999999999887665544333333
Q ss_pred hhccCCCCCCCCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 161 SMRKKKPIPFSQKFP-----NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~-----~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.-.+.. .+...+. ....+..+++.+||.+||.+|++.++++.|+|....
T Consensus 296 ~~~k~P--s~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 296 AGLRAP--DTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred cCCCCC--CccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 222211 1222221 234578899999999999999999999999998754
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=301.08 Aligned_cols=240 Identities=48% Similarity=0.874 Sum_probs=193.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 102 ~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~ 174 (343)
T cd07878 102 MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTG 174 (343)
T ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC------cCC
Confidence 35788887764 47999999999999999999999999999999999999999999999999999765332 245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+.......++.
T Consensus 175 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (343)
T cd07878 175 YVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253 (343)
T ss_pred ccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhh
Confidence 6799999999998762 468899999999999999999999999999888999999999999998888877776666666
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+...+...++.+.+||.+||..||.+|||+.|+|+||||..+.....++...+ .....+....+.+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 330 (343)
T cd07878 254 SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP---YDESPENKERTIEEW 330 (343)
T ss_pred ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCc---cccchhhhhccHHHH
Confidence 55544444444555667889999999999999999999999999999998776654443332 222233445556777
Q ss_pred HHHHHHHHHhh
Q 013122 241 RELIYREILEY 251 (449)
Q Consensus 241 ~e~i~~ei~~~ 251 (449)
++..+.+...+
T Consensus 331 ~~~~~~~~~~~ 341 (343)
T cd07878 331 KELTYEEVSSF 341 (343)
T ss_pred HHHHHHHHHhc
Confidence 77766665433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=292.04 Aligned_cols=209 Identities=42% Similarity=0.670 Sum_probs=170.0
Q ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC----CCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~~-----~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~vKL~DFGlA~~~~~~~ 72 (449)
|+||.++|+-+. .++...++.|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||+++...+..
T Consensus 111 EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~pl 190 (438)
T KOG0666|consen 111 EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPL 190 (438)
T ss_pred hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccc
Confidence 689999997543 48999999999999999999999999999999999999988 899999999999876543
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC---------chhhHHHHHhhcCCCC
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---------VVHQLDIMTDLLGTPS 143 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~---------~~~~l~~i~~~lg~p~ 143 (449)
..-......+.|.||+|||++.|. ..|++++|||++|||++|||+-.++|.|.. ..+|++.|++++|.|.
T Consensus 191 kpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt 269 (438)
T KOG0666|consen 191 KPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPT 269 (438)
T ss_pred cccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCc
Confidence 332233456789999999999885 789999999999999999999999998753 3578999999999999
Q ss_pred HHHHHHHhhHHHH-HHHhhhccCCCCC-----CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 144 PEAIARVRNEKAR-RYLSSMRKKKPIP-----FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 144 ~e~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.+.|..+.+-... ..+..++...... +-.....-++.+.+||.+||..||.+|+|++++|+|+||..-
T Consensus 270 ~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 270 DKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred cccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 9999887653322 2233333221111 112223346669999999999999999999999999999854
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.61 Aligned_cols=246 Identities=52% Similarity=0.926 Sum_probs=202.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 90 ~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 168 (336)
T cd07849 90 METDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168 (336)
T ss_pred cccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCC
Confidence 45688888865 47999999999999999999999999999999999999999999999999998765433222222345
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+|+..|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+...++..+...++.+..+.+..+.......++.
T Consensus 169 ~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (336)
T cd07849 169 YVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIK 247 (336)
T ss_pred cCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHh
Confidence 6789999999987542 468889999999999999999999999999888999999999999998888777766666666
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
........++....+..++.+.+||.+||+.||++|||+.++++||||+.+.....++..+....++++.. ..+.++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 326 (336)
T cd07849 248 SLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF-DDLPKEKL 326 (336)
T ss_pred hcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc-cccCHHHH
Confidence 55555555555556778899999999999999999999999999999999988766666654445555443 55668999
Q ss_pred HHHHHHHHH
Q 013122 241 RELIYREIL 249 (449)
Q Consensus 241 ~e~i~~ei~ 249 (449)
+++|+.+|.
T Consensus 327 ~~~~~~~~~ 335 (336)
T cd07849 327 KELIFEEIM 335 (336)
T ss_pred HHHHHHHhc
Confidence 999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=292.61 Aligned_cols=175 Identities=31% Similarity=0.560 Sum_probs=152.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|+-.|.+++.++++.+++++..|+.||.|||++|||||||||+|||++.+|.|+|+|||+++........ ..++
T Consensus 109 GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~---t~tf 185 (357)
T KOG0598|consen 109 GGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA---TRTF 185 (357)
T ss_pred CccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc---cccc
Confidence 6899999999999999999999999999999999999999999999999999999999999999865443322 2458
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
|||+.|||||++.+ ..|+.++|.||||+++|||++|.+||.+.+.....+.|...
T Consensus 186 cGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~----------------------- 240 (357)
T KOG0598|consen 186 CGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG----------------------- 240 (357)
T ss_pred cCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-----------------------
Confidence 99999999999998 79999999999999999999999999998876665555321
Q ss_pred hccCCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCC----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRP----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~-~s~~~~dLL~~~L~~DP~~Rp----Ta~elL~hp~f~~~~ 212 (449)
+ ....+. ++.++++||+++|..||++|. .++++-+||||+++.
T Consensus 241 ----k----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 241 ----K----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred ----c----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 1 112233 789999999999999999995 689999999999764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=295.39 Aligned_cols=240 Identities=38% Similarity=0.679 Sum_probs=184.0
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 111 ~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~----~~~~ 184 (364)
T cd07875 111 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTP 184 (364)
T ss_pred CCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC----cccC
Confidence 35678887764 48999999999999999999999999999999999999999999999999997653321 2245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|.++.+..+... ...+..
T Consensus 185 ~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 261 (364)
T cd07875 185 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT-VRTYVE 261 (364)
T ss_pred CcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH-HHHHHh
Confidence 678999999999987 67899999999999999999999999999999999999999999988776655332 222222
Q ss_pred hhccCCCCCCCC------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhh
Q 013122 161 SMRKKKPIPFSQ------------KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228 (449)
Q Consensus 161 ~~~~~~~~~~~~------------~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~ 228 (449)
.........+.. .....+..+++||.+||+.||.+|||++++|+||||..+......+...+.. -+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~-~~~ 340 (364)
T cd07875 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKI-PDK 340 (364)
T ss_pred hCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCCCCC-CCc
Confidence 222111111111 1122456789999999999999999999999999998776655443322211 122
Q ss_pred HHHhhcCCHHHHHHHHHHHHHh
Q 013122 229 EFERRRITKEDVRELIYREILE 250 (449)
Q Consensus 229 ~~e~~~~~~e~~~e~i~~ei~~ 250 (449)
..+.+..+.+++++.++.++++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 341 QLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred cchhhhccHHHHHHHHHHHHHc
Confidence 3344567788899988887753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=296.37 Aligned_cols=244 Identities=45% Similarity=0.720 Sum_probs=187.0
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 86 ~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~--~~~~~ 163 (372)
T cd07853 86 MQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES--KHMTQ 163 (372)
T ss_pred cccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--ccCCC
Confidence 4578999998888899999999999999999999999999999999999999999999999999976533221 12344
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+++..|+|||++.+. ..++.++||||+||++|||++|+.||.+.+..+++..|.+.+|.+..+.+...... ....+.
T Consensus 164 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~-~~~~~~ 241 (372)
T cd07853 164 EVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG-ARAHIL 241 (372)
T ss_pred CCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH-HHHHHH
Confidence 5789999999998763 45789999999999999999999999999999999999999999998777655332 222222
Q ss_pred hhccCCCC--CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc--------------------cCCC
Q 013122 161 SMRKKKPI--PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV--------------------EREP 218 (449)
Q Consensus 161 ~~~~~~~~--~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~--------------------~~e~ 218 (449)
......+. .........++.+.+||.+||+.||.+|||+.|+|+||||.+.... ..++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (372)
T cd07853 242 RGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEP 321 (372)
T ss_pred hCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCcccCC
Confidence 21111110 0112234568899999999999999999999999999999874211 1111
Q ss_pred CCCCccchhhHHHhhcCCHHHHHHHHHHHHHh
Q 013122 219 SAQPVTKMEFEFERRRITKEDVRELIYREILE 250 (449)
Q Consensus 219 ~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~ 250 (449)
. ....++++++....+..++++.++.++.+
T Consensus 322 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (372)
T cd07853 322 S--ANPPFDDEYEKNLTSVRQVKEELHQFILE 351 (372)
T ss_pred C--CCCCCCcccccccCCHHHHHHHHHHHHHH
Confidence 1 11234455666667778888887776643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=292.39 Aligned_cols=244 Identities=57% Similarity=0.975 Sum_probs=207.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++................
T Consensus 87 ~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~ 166 (330)
T cd07834 87 ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166 (330)
T ss_pred hhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccccccc
Confidence 46799999888889999999999999999999999999999999999999999999999999998765443211223456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++.+|+|||++.+. ..++.++|+|||||++|+|++|++||.+.+..+.+..+...++.+..+.+..........++..
T Consensus 167 ~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
T cd07834 167 VVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS 245 (330)
T ss_pred ccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhh
Confidence 789999999999873 3788999999999999999999999999999999999999999999888776666666777766
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHHH
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVR 241 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~ 241 (449)
.......++...++..+..+.+||.+||++||.+|||++++|.||||+++.....+.......++. .|+...+++++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 324 (330)
T cd07834 246 LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDELTEEELK 324 (330)
T ss_pred cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhcCHHHHh
Confidence 666666667777788999999999999999999999999999999999998887776665544331 4677889999999
Q ss_pred HHHHHH
Q 013122 242 ELIYRE 247 (449)
Q Consensus 242 e~i~~e 247 (449)
++|+.|
T Consensus 325 ~~~~~~ 330 (330)
T cd07834 325 ELIYEE 330 (330)
T ss_pred HHhhcC
Confidence 998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.34 Aligned_cols=242 Identities=48% Similarity=0.894 Sum_probs=207.4
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ...
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~------~~~ 174 (343)
T cd07851 102 MGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------MTG 174 (343)
T ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc------ccC
Confidence 35689898876 47999999999999999999999999999999999999999999999999998765332 244
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+...++.+.+..+..+.......++.
T Consensus 175 ~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (343)
T cd07851 175 YVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ 253 (343)
T ss_pred CcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHH
Confidence 5788999999998652 367889999999999999999999999998888888999999999988888887777777776
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+...+...++.+.+||.+||..||.+|||+.++|+||||..+...+.++. ...++.+++...+..+.|
T Consensus 254 ~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 330 (343)
T cd07851 254 SLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV---APPYDQSFESRDLTVDEW 330 (343)
T ss_pred hccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc---ccccCcchhhhhcCHHHH
Confidence 66666555566666677999999999999999999999999999999999887766554 233456788899999999
Q ss_pred HHHHHHHHHhhCh
Q 013122 241 RELIYREILEYHP 253 (449)
Q Consensus 241 ~e~i~~ei~~~~p 253 (449)
+++++.++.+|.|
T Consensus 331 ~~~~~~~~~~~~~ 343 (343)
T cd07851 331 KELVYKEIMNFKP 343 (343)
T ss_pred HHHhHHHHHhccC
Confidence 9999999988765
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=281.18 Aligned_cols=180 Identities=31% Similarity=0.503 Sum_probs=153.4
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
|.|+|+|...-.|++...+.||+||+.|+.|||.++||||||||+|||++++.++||+|||+|+....+. .....|
T Consensus 108 GELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge----kLrelC 183 (411)
T KOG0599|consen 108 GELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE----KLRELC 183 (411)
T ss_pred chHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch----hHHHhc
Confidence 7899999998899999999999999999999999999999999999999999999999999998876554 357789
Q ss_pred ccccccCccccccc----CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 83 ATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 83 gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
||+.|+|||.+... ...|+..+|+|++|+|+|-||.|.+||......-.+..|++
T Consensus 184 GTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--------------------- 242 (411)
T KOG0599|consen 184 GTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--------------------- 242 (411)
T ss_pred CCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh---------------------
Confidence 99999999998542 25689999999999999999999999976554444444432
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.+..--+..+.+++...++||.+||+.||.+|+|++|+|+||||..+..
T Consensus 243 ------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 243 ------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred ------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 1111224456778899999999999999999999999999999977653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=291.29 Aligned_cols=237 Identities=39% Similarity=0.694 Sum_probs=176.8
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 108 ~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~ 181 (359)
T cd07876 108 MDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF----MMTP 181 (359)
T ss_pred CCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc----cCCC
Confidence 45677777754 48999999999999999999999999999999999999999999999999987543221 2245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.+.++.|..+.+..+.. ....+..
T Consensus 182 ~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 258 (359)
T cd07876 182 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP-TVRNYVE 258 (359)
T ss_pred CcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH-HHHHHHh
Confidence 678999999999987 6789999999999999999999999999998889999999999998877665432 2222332
Q ss_pred hhccCCCCCCCCCC------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhh
Q 013122 161 SMRKKKPIPFSQKF------------PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228 (449)
Q Consensus 161 ~~~~~~~~~~~~~~------------~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~ 228 (449)
.........+.+.+ ...++.+++||.+||..||++|||+.|+|+||||..+..+.......+. ....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~-~~~~ 337 (359)
T cd07876 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQ-IYDA 337 (359)
T ss_pred hCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcccccCCCcc-cccc
Confidence 22222222222211 1246789999999999999999999999999999876655433222221 1112
Q ss_pred HHHhhcCCHHHHHHHHHHH
Q 013122 229 EFERRRITKEDVRELIYRE 247 (449)
Q Consensus 229 ~~e~~~~~~e~~~e~i~~e 247 (449)
..+.+....+.+.+.|+..
T Consensus 338 ~~~~~~~~~~~~~~~~~~~ 356 (359)
T cd07876 338 QLEEREHAIEEWKELIYKE 356 (359)
T ss_pred ccccccccHHHHHHHHHHH
Confidence 2234444555566655543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=286.15 Aligned_cols=202 Identities=38% Similarity=0.729 Sum_probs=164.2
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 85 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~---~~~ 161 (288)
T cd07871 85 LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK---TYS 161 (288)
T ss_pred CCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc---ccc
Confidence 4578999887655 489999999999999999999999999999999999999999999999999875432221 124
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH-HHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK-ARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~-~~~~ 158 (449)
...++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+...++.|..+.+..+.... ...+
T Consensus 162 ~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 162 NEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred CceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 45789999999998652 468899999999999999999999999999999999999999999998887654321 1111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
. .......+.....+.++.++++||.+||.+||.+|+|++|+|+||||
T Consensus 241 ~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 L--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred c--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1 11111122233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=306.28 Aligned_cols=207 Identities=28% Similarity=0.431 Sum_probs=162.2
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCC----------------CEEEeecC
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC----------------KLKICDFG 63 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~----------------~vKL~DFG 63 (449)
++++|.+++.+.+.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++ .+||+|||
T Consensus 214 ~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG 293 (467)
T PTZ00284 214 YGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293 (467)
T ss_pred cCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCC
Confidence 357899999988899999999999999999999998 5999999999999998765 49999999
Q ss_pred ccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCC
Q 013122 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 143 (449)
Q Consensus 64 lA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~ 143 (449)
++..... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.+.+|.++
T Consensus 294 ~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p 365 (467)
T PTZ00284 294 GCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLP 365 (467)
T ss_pred ccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Confidence 8754321 1245689999999999987 6899999999999999999999999999999999999999999887
Q ss_pred HHHHHHHhhHHHHHHHhhhccCCCCCCC---------CCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 144 PEAIARVRNEKARRYLSSMRKKKPIPFS---------QKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 144 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.++...........++.......+.... ... ...++.+.+||.+||++||.+|||++|+|+||||..+.
T Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 366 SEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred HHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 6655433222223333221111100000 000 01256788999999999999999999999999999765
Q ss_pred ccc
Q 013122 213 KVE 215 (449)
Q Consensus 213 ~~~ 215 (449)
...
T Consensus 446 ~~~ 448 (467)
T PTZ00284 446 PEC 448 (467)
T ss_pred Ccc
Confidence 433
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.44 Aligned_cols=242 Identities=50% Similarity=0.950 Sum_probs=203.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-ccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-~~~~~ 79 (449)
|+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 90 ~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 169 (334)
T cd07855 90 MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169 (334)
T ss_pred hhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccc
Confidence 35789999988888999999999999999999999999999999999999999999999999998765432221 11223
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|..+.+..........++
T Consensus 170 ~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 248 (334)
T cd07855 170 EYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYI 248 (334)
T ss_pred cccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHH
Confidence 45789999999998653 45889999999999999999999999999999999999999999999988887777767666
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHH
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKED 239 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~ 239 (449)
.........++...++..+..+.+||.+||+.||.+|||++++|.||||.++...+.++.. ...++++++....+.|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 326 (334)
T cd07855 249 QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTC--PPPFDFDFEAIELSREQ 326 (334)
T ss_pred hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccC--CCCCCCChhhhhcChhh
Confidence 6666666666666677889999999999999999999999999999999998887776554 34566777777788888
Q ss_pred HHHHHH
Q 013122 240 VRELIY 245 (449)
Q Consensus 240 ~~e~i~ 245 (449)
+.+.|.
T Consensus 327 ~~~~~~ 332 (334)
T cd07855 327 LKEAIV 332 (334)
T ss_pred HHHHhh
Confidence 776664
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=296.77 Aligned_cols=174 Identities=30% Similarity=0.524 Sum_probs=147.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-CCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+|+|+++|.+.+++.+.+++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++.... .......+
T Consensus 104 gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~---~~~~~l~t 180 (370)
T KOG0583|consen 104 GGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP---GEDGLLKT 180 (370)
T ss_pred CccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC---CCCCcccC
Confidence 47999999998899999999999999999999999999999999999999999 999999999998763 12224578
Q ss_pred ccccccccCcccccccCCC-CC-CccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~-~s-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
.|||+.|+|||++.+ .. |+ .++||||+|++||.|++|..||...+.......|..
T Consensus 181 ~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~--------------------- 237 (370)
T KOG0583|consen 181 FCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK--------------------- 237 (370)
T ss_pred CCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc---------------------
Confidence 999999999999988 34 64 789999999999999999999988665444333211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
....+...+. ++.+++||.+||..||.+|+|+.++++||||+.
T Consensus 238 -------~~~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 -------GEFKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------CCccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1111222222 899999999999999999999999999999996
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=302.19 Aligned_cols=180 Identities=31% Similarity=0.488 Sum_probs=155.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|.|++++..+++|++.++.++++||+.||.|||..+|+||||||+|+|++..++|||+|||+|.....+. .+.+.
T Consensus 96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk----lLeTS 171 (786)
T KOG0588|consen 96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK----LLETS 171 (786)
T ss_pred CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc----ccccc
Confidence 58999999999999999999999999999999999999999999999999999999999999997654433 45788
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
||++.|.|||++.|. ...+.++||||+|||||.||+|+.||.+.+....+.++..
T Consensus 172 CGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~------------------------ 226 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR------------------------ 226 (786)
T ss_pred CCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc------------------------
Confidence 999999999999983 3346799999999999999999999997775554443322
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCC
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e 217 (449)
. ..+...++++++++||.+||..||++|+|.+|+++|||+.+.......
T Consensus 227 ---G----~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 227 ---G----VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ---C----cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 1 122235789999999999999999999999999999999988765543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=272.98 Aligned_cols=177 Identities=31% Similarity=0.487 Sum_probs=150.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++||+.-|-++.-+++..+..+++|||.||.|+|.+||||||+||+|+|+-+.. -+||+|||+|..... ...+
T Consensus 94 G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~----g~~~ 169 (355)
T KOG0033|consen 94 GGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND----GEAW 169 (355)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC----cccc
Confidence 357777777666789999999999999999999999999999999999986543 499999999987762 2346
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..++||+.|||||++.. ..|+..+|||+.|+|||-||.|.+||.+.+....++.|...
T Consensus 170 ~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-------------------- 227 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-------------------- 227 (355)
T ss_pred ccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------------
Confidence 78899999999999988 78999999999999999999999999997776666555431
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
..--....++++++++++||++||..||.+|+|+.|+|+|||+++-
T Consensus 228 -------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 228 -------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred -------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 1111233678899999999999999999999999999999999854
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=287.38 Aligned_cols=238 Identities=38% Similarity=0.689 Sum_probs=176.4
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 104 ~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~ 177 (355)
T cd07874 104 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTP 177 (355)
T ss_pred hcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc----ccCC
Confidence 35677777764 48999999999999999999999999999999999999999999999999997643321 2245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+.++.+..+... ...++.
T Consensus 178 ~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (355)
T cd07874 178 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRNYVE 254 (355)
T ss_pred ccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH-HHHHHh
Confidence 678999999999987 67899999999999999999999999999988888888888999888877665432 222322
Q ss_pred hhccCCCCCCC------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhh
Q 013122 161 SMRKKKPIPFS------------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228 (449)
Q Consensus 161 ~~~~~~~~~~~------------~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~ 228 (449)
.........+. ......+..+++||.+||..||++|||+.|+|+||||..+..........+ ..+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~-~~~~~ 333 (355)
T cd07874 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPP-QIYDK 333 (355)
T ss_pred cCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhccCCCc-ccccc
Confidence 21111111111 111224567899999999999999999999999999987654432211111 11111
Q ss_pred HHHhhcCCHHHHHHHHHHHH
Q 013122 229 EFERRRITKEDVRELIYREI 248 (449)
Q Consensus 229 ~~e~~~~~~e~~~e~i~~ei 248 (449)
.......+.+.+.+.++.++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~ 353 (355)
T cd07874 334 QLDEREHTIEEWKELIYKEV 353 (355)
T ss_pred chhhhhccHHHHHHHHHHHh
Confidence 22233445666776666654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=285.42 Aligned_cols=243 Identities=53% Similarity=0.898 Sum_probs=198.2
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-ccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-~~~~~ 79 (449)
|+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 167 (332)
T cd07857 88 MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167 (332)
T ss_pred ccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccccccc
Confidence 46789999988888999999999999999999999999999999999999999999999999999765432211 11123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|+..|+|||++.+. ..++.++||||+||++|+|++|.+||.+.+....+..+...+|.+..+.+..+.......+.
T Consensus 168 ~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (332)
T cd07857 168 EYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYI 246 (332)
T ss_pred CcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHH
Confidence 45789999999987652 46889999999999999999999999999999999999999999998887777666555555
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHH
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKED 239 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~ 239 (449)
..+.......+....+..+..+.+||.+||+.||++|||+.+++.||||+.++.+...+.+.....+.|+- .-+.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 323 (332)
T cd07857 247 RSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES---EDSMEE 323 (332)
T ss_pred HhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc---cccHHH
Confidence 55555555555566677889999999999999999999999999999999998876666665555444432 235667
Q ss_pred HHHHHHHH
Q 013122 240 VRELIYRE 247 (449)
Q Consensus 240 ~~e~i~~e 247 (449)
++..|..+
T Consensus 324 ~~~~~~~~ 331 (332)
T cd07857 324 LRDMIIEE 331 (332)
T ss_pred HHHHHhhc
Confidence 77776554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.36 Aligned_cols=182 Identities=30% Similarity=0.463 Sum_probs=144.6
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|+|.+++++.+ .|++..++.+.+||++||+|||++|||||||||+|||++. ++.+||+|||++..............
T Consensus 100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~ 179 (313)
T KOG0198|consen 100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSEL 179 (313)
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccc
Confidence 589999999987 7999999999999999999999999999999999999999 79999999999987654222222234
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...||+.|||||++... .....++|||||||++.||+||++||... ......+ +
T Consensus 180 ~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~-----------------------~ 233 (313)
T KOG0198|consen 180 SVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEAL-----------------------L 233 (313)
T ss_pred cccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHH-----------------------H
Confidence 67899999999999841 22335999999999999999999999763 1111111 1
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...... .. ......+++++++||.+||.+||++||||+++|.|||.+.-.
T Consensus 234 ~ig~~~-~~--P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 234 LIGRED-SL--PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHhccC-CC--CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 111111 11 144456899999999999999999999999999999997643
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=280.63 Aligned_cols=197 Identities=39% Similarity=0.685 Sum_probs=160.6
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 92 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~ 167 (290)
T cd07862 92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALT 167 (290)
T ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc----ccc
Confidence 568888887643 48999999999999999999999999999999999999999999999999997654321 224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...||..|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+.+..|.+..+.+.++.+....... ..
T Consensus 168 ~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~-- 242 (290)
T cd07862 168 SVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP-RQ-- 242 (290)
T ss_pred cccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhccc-ch--
Confidence 4578999999999976 578899999999999999999999999999989999998888887766554321100 00
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
........++....+.+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 243 -AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred -hccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 111122223334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=282.12 Aligned_cols=207 Identities=37% Similarity=0.627 Sum_probs=154.7
Q ss_pred CCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE----cCCCCEEEeecCcccc
Q 013122 1 MESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLARV 67 (449)
Q Consensus 1 me~dL~~~i~~~---------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGlA~~ 67 (449)
++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 356788887632 248999999999999999999999999999999999999 4567899999999976
Q ss_pred ccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc---------hhhHHHHHhh
Q 013122 68 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIMTDL 138 (449)
Q Consensus 68 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~~~ 138 (449)
..............+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+... ..++..+...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 54332222223456789999999998763 4588999999999999999999999976543 3567788889
Q ss_pred cCCCCHHHHHHHhhHHH-HHHHhhhccCCCC------CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 139 LGTPSPEAIARVRNEKA-RRYLSSMRKKKPI------PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 139 lg~p~~e~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
+|.|....+..+..... ............. .+.......+..+.+||.+||++||.+|+|++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99988887766532110 0111111110000 0011122346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=273.95 Aligned_cols=172 Identities=27% Similarity=0.507 Sum_probs=151.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|.|+.++++.++|++.++++++.||+.||+|||+++|++|||||+|||++.+|.+||+|||+|+.....+ .+.
T Consensus 128 GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT------~Tl 201 (355)
T KOG0616|consen 128 GGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRT------WTL 201 (355)
T ss_pred CccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcE------EEe
Confidence 68999999999999999999999999999999999999999999999999999999999999998765432 567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
|||+.|+|||++.. ..|+.++|.||||+++|||+.|.+||...+....++.|...
T Consensus 202 CGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~----------------------- 256 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG----------------------- 256 (355)
T ss_pred cCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-----------------------
Confidence 99999999999998 79999999999999999999999999998887666665431
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC-----CCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~R-----pTa~elL~hp~f~~~~ 212 (449)
... .....++.+++||.++|+.|-.+| ....++..||||+++.
T Consensus 257 -----~v~---fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 257 -----KVK---FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred -----ccc---CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 011 113468899999999999999999 3578999999999753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=292.65 Aligned_cols=174 Identities=28% Similarity=0.543 Sum_probs=148.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|-+++... .|+|.++..|++.+|.||+|||.+||+|||||.+|||++.+|.+||+|||++........ .....
T Consensus 354 ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---KR~Tm 429 (550)
T KOG0578|consen 354 GGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---KRSTM 429 (550)
T ss_pred CCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC---ccccc
Confidence 36788888876 599999999999999999999999999999999999999999999999999987765543 34678
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|||||++.. ..|++++||||||++++||+-|.+||-..+....+..|.. -|
T Consensus 430 VGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng--------------------- 485 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG--------------------- 485 (550)
T ss_pred cCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cC---------------------
Confidence 99999999999987 7899999999999999999999999977665544433322 11
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.+--.....+++.+++||.+||+.|+.+|++|.|||+||||+
T Consensus 486 ------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 486 ------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 112233456899999999999999999999999999999995
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.73 Aligned_cols=205 Identities=37% Similarity=0.683 Sum_probs=161.6
Q ss_pred CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 150 ~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--- 226 (440)
T PTZ00036 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR--- 226 (440)
T ss_pred CccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---
Confidence 456766664 345799999999999999999999999999999999999999765 699999999986543322
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
...++||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..+...+|.|..+.+.........
T Consensus 227 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 304 (440)
T PTZ00036 227 -SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304 (440)
T ss_pred -cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhc
Confidence 2346789999999998652 46899999999999999999999999999999999999999999988776544221100
Q ss_pred HHHhhhccCCCCCCCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~-~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
- .+.......+...++ ..++++++||.+||.+||.+|+|+.|+|+||||..+...
T Consensus 305 ~---~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 305 I---KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred c---cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 0 000111111122222 467899999999999999999999999999999987653
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=281.67 Aligned_cols=241 Identities=46% Similarity=0.860 Sum_probs=201.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 105 ~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~------~~~~ 177 (345)
T cd07877 105 GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGY 177 (345)
T ss_pred ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc------cccc
Confidence 56788877654 6999999999999999999999999999999999999999999999999998754321 2345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++.+|+|||++.+. ..++.++||||+||++|+|++|+.||.+.+....+..+....+.+..+.+..+.......++..
T Consensus 178 ~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (345)
T cd07877 178 VATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 256 (345)
T ss_pred ccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHH
Confidence 788999999988652 4678899999999999999999999998888888888888889888888877766666666665
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHHH
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVR 241 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~ 241 (449)
+.......+...+...++.+.+||.+||+.||.+|+|+.++|+||||+.+..++.++... .++..+....+..+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 333 (345)
T cd07877 257 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD---PYDQSFESRDLLIDEWK 333 (345)
T ss_pred hcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC---CccCcchhcccCHHHHH
Confidence 555544455555556789999999999999999999999999999999988877776543 35666666677789999
Q ss_pred HHHHHHHHhhCh
Q 013122 242 ELIYREILEYHP 253 (449)
Q Consensus 242 e~i~~ei~~~~p 253 (449)
...|+++..|-|
T Consensus 334 ~~~~~~~~~~~~ 345 (345)
T cd07877 334 SLTYDEVISFVP 345 (345)
T ss_pred HHHHHHHHhcCC
Confidence 999999877654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=266.50 Aligned_cols=209 Identities=32% Similarity=0.535 Sum_probs=174.9
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCC-CCCcccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFW 78 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~-~~~~~~~ 78 (449)
+++||..++... .+|+..+++.++.+++.||.|+|.+.|+|||+|+.|+||+.+|.+||+|||+++..... ......+
T Consensus 106 cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpry 185 (376)
T KOG0669|consen 106 CEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRY 185 (376)
T ss_pred hhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCc
Confidence 478999999876 57999999999999999999999999999999999999999999999999999765332 2222345
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
+..+.|.||++||++.|. ..|+++.|||..|||+.||++|.++|.|.+...++..|..++|.-..+.|..+.+-.+...
T Consensus 186 tnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~s 264 (376)
T KOG0669|consen 186 TNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQS 264 (376)
T ss_pred ccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHh
Confidence 778889999999999885 7899999999999999999999999999999999999999999999999988877655554
Q ss_pred Hhh--hccCCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSS--MRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~--~~~~~~~~~~~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
++. +.++......... -.-++++.+||.+||..||.+|+++.++|.|.||..
T Consensus 265 ie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 265 IELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred ccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 422 1222111111111 123678999999999999999999999999999974
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=280.62 Aligned_cols=239 Identities=43% Similarity=0.813 Sum_probs=190.9
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
.+|.+++. ..++++.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 104 ~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~------~~~~~ 175 (342)
T cd07879 104 TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYV 175 (342)
T ss_pred cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC------CCCce
Confidence 34555542 36999999999999999999999999999999999999999999999999998754221 23457
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....|.+.++.+..+.......+....
T Consensus 176 ~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (342)
T cd07879 176 VTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSL 254 (342)
T ss_pred eeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhc
Confidence 88999999998652 35788999999999999999999999998888888888888998888887776555444444444
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHHHH
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 242 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~e 242 (449)
.......+...++..+..+.+||.+||+.||++||+++++|.||||..+...+.++...+ +...-+...+..+++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 331 (342)
T cd07879 255 PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLENEKLSVDEWKK 331 (342)
T ss_pred CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccchhhhhhCCHHHHHH
Confidence 333334445556778899999999999999999999999999999999887655554333 34444555677788888
Q ss_pred HHHHHHHhhCh
Q 013122 243 LIYREILEYHP 253 (449)
Q Consensus 243 ~i~~ei~~~~p 253 (449)
.||.|+..+.|
T Consensus 332 ~~~~~~~~~~~ 342 (342)
T cd07879 332 HIYKEVKSFSP 342 (342)
T ss_pred HhhhhhhccCC
Confidence 99888765543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=281.68 Aligned_cols=237 Identities=39% Similarity=0.694 Sum_probs=183.3
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 103 ~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~----~~~ 176 (353)
T cd07850 103 MDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTP 176 (353)
T ss_pred cCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC----CCC
Confidence 356788888764 99999999999999999999999999999999999999999999999999976543221 234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...+|.|..+....+... ...+..
T Consensus 177 ~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 253 (353)
T cd07850 177 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT-VRNYVE 253 (353)
T ss_pred CcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh-hhHHhh
Confidence 568899999999987 67899999999999999999999999999888889999999999988776654322 122222
Q ss_pred hhccCCCCCCCCCC-------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchh
Q 013122 161 SMRKKKPIPFSQKF-------------PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 227 (449)
Q Consensus 161 ~~~~~~~~~~~~~~-------------~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~ 227 (449)
........++...+ ...+..+++||.+||+.||++|||+.|+|.||||+.+..........+. ..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~~~-~~~ 332 (353)
T cd07850 254 NRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPA-PYD 332 (353)
T ss_pred cCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCCCC-ccc
Confidence 21111111121111 1346678999999999999999999999999999987775444333222 234
Q ss_pred hHHHhhcCCHHHHHHHHHHH
Q 013122 228 FEFERRRITKEDVRELIYRE 247 (449)
Q Consensus 228 ~~~e~~~~~~e~~~e~i~~e 247 (449)
...+.+..+.++|++.++.+
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 333 HSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred cccccccccHHHHHHHHHhh
Confidence 44566677888888887765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=277.69 Aligned_cols=207 Identities=39% Similarity=0.732 Sum_probs=167.9
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 86 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~ 162 (309)
T cd07872 86 LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK---TYS 162 (309)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc---ccc
Confidence 3568888887654 489999999999999999999999999999999999999999999999999875432221 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+..+.+..+.........
T Consensus 163 ~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 163 NEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred cccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 45688999999998653 46889999999999999999999999999999999999999999998888765433211111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
......+.++....+.+++.+++||.+||..||.+|+|++|+|+||||+.+.
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 242 -NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred -hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 1122222333345567889999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=278.63 Aligned_cols=201 Identities=33% Similarity=0.587 Sum_probs=161.8
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC--------------------CCCEE
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--------------------DCKLK 58 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--------------------~~~vK 58 (449)
|+.+++++|+++. +++..+++.+.+||+.+++|||+.+++|.||||+|||+.+ +..||
T Consensus 173 lG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~ 252 (415)
T KOG0671|consen 173 LGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIK 252 (415)
T ss_pred cChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceE
Confidence 5668999999987 5899999999999999999999999999999999999742 23489
Q ss_pred EeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhh
Q 013122 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138 (449)
Q Consensus 59 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 138 (449)
|+|||.|+...... +..+.|+.|+|||++.+ -+++..+||||+||||+||.+|..+|++.+..+.+..|..+
T Consensus 253 vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 253 VIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred EEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 99999997654432 55789999999999999 58999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHhhHHHHHHHhhhccC---------------CCCCCCCCCCC---CCHHHHHHHHHhhhcCCCCCCCHH
Q 013122 139 LGTPSPEAIARVRNEKARRYLSSMRKK---------------KPIPFSQKFPN---ANPLALRLLERMLAFEPKDRPTAE 200 (449)
Q Consensus 139 lg~p~~e~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~---~s~~~~dLL~~~L~~DP~~RpTa~ 200 (449)
+|..+...+.+.. ..+++...+.. .+.++...... ....+.|||++||.+||.+|+|+.
T Consensus 325 lGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 325 LGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred hCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 9977777766553 23333322111 01111111111 123588999999999999999999
Q ss_pred HHHcCccccccc
Q 013122 201 EALADPYFKGLA 212 (449)
Q Consensus 201 elL~hp~f~~~~ 212 (449)
|+|.||||+.+.
T Consensus 402 EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 402 EALSHPFFARLT 413 (415)
T ss_pred HHhcCHHhhcCC
Confidence 999999999764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=256.44 Aligned_cols=205 Identities=40% Similarity=0.694 Sum_probs=169.5
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+.||..+... ++.++.+.++.++.|+++||.|+|++++.||||||.|+||+.+|.+||+|||+++...-.. ..++.
T Consensus 84 dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv---rcysa 160 (292)
T KOG0662|consen 84 DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---RCYSA 160 (292)
T ss_pred hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce---Eeeec
Confidence 4567777664 4579999999999999999999999999999999999999999999999999998764322 13456
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.+.|.||++|.++.+. ..|+..+|+||.|||++|+.. |+++|+|.+..+|+..|..++|+|..+.|..+..-. .|.
T Consensus 161 evvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp--dyk 237 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP--DYK 237 (292)
T ss_pred eeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC--CCc
Confidence 6789999999999885 679999999999999999986 899999999999999999999999999887653211 000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.--.......|++..|+.+...++|++++|.-+|.+|++++++|+||||.+..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 00000111235566677888899999999999999999999999999998654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=279.11 Aligned_cols=241 Identities=44% Similarity=0.813 Sum_probs=200.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...... ....
T Consensus 103 ~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~------~~~~ 175 (343)
T cd07880 103 GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE------MTGY 175 (343)
T ss_pred CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC------cccc
Confidence 5678888765 47999999999999999999999999999999999999999999999999998754322 1335
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.+....+..+....+.+..+....+.......+...
T Consensus 176 ~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07880 176 VVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK 254 (343)
T ss_pred ccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHh
Confidence 678899999998652 3578899999999999999999999998888888888888888888777777766666666665
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHHH
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVR 241 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~ 241 (449)
+.......+....+.+++.+.+||.+||+.||++|||+.+++.||||+.+...+.++... .+..++++...+.|+|+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 331 (343)
T cd07880 255 LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP---PYDDSFDEVDQSLEEWK 331 (343)
T ss_pred ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC---CccccHHhhccchHHHH
Confidence 555444444455677889999999999999999999999999999999987766554433 35566788888999999
Q ss_pred HHHHHHHHhhCh
Q 013122 242 ELIYREILEYHP 253 (449)
Q Consensus 242 e~i~~ei~~~~p 253 (449)
.+.+-||+.++|
T Consensus 332 ~~~~~~~~~~~~ 343 (343)
T cd07880 332 RLTFTEILSFQP 343 (343)
T ss_pred HHHHHHHHhcCC
Confidence 999999998875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=277.79 Aligned_cols=244 Identities=43% Similarity=0.780 Sum_probs=196.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC--ccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT--AIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~--~~~~~ 79 (449)
+++|.+++..+ .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......... .....
T Consensus 92 ~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 170 (337)
T cd07852 92 ETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170 (337)
T ss_pred ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchh
Confidence 56888988876 7899999999999999999999999999999999999999999999999998765433211 11234
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.++|+..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+....+....+....+.+..+.+..+........+
T Consensus 171 ~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (337)
T cd07852 171 DYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATML 249 (337)
T ss_pred cccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhh
Confidence 56789999999987652 46788999999999999999999999999888888899898898888887777655555555
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHH
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKED 239 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~ 239 (449)
...............+.++..+.+||.+||+.||.+|||+.++|+||||+.+.....++......+..+. ..+++...+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 328 (337)
T cd07852 250 DSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD-DNVKLSVAE 328 (337)
T ss_pred hhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc-ccceeeHHH
Confidence 5554444455566667789999999999999999999999999999999998777666544322222332 445667778
Q ss_pred HHHHHHHHH
Q 013122 240 VRELIYREI 248 (449)
Q Consensus 240 ~~e~i~~ei 248 (449)
.|..+|+||
T Consensus 329 ~~~~~~~~~ 337 (337)
T cd07852 329 YRNKLYEEI 337 (337)
T ss_pred HHhhhhhcC
Confidence 888887764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.90 Aligned_cols=207 Identities=35% Similarity=0.630 Sum_probs=155.1
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++..+ ..++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~ 161 (303)
T cd07869 85 VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH---TYS 161 (303)
T ss_pred CCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc---cCC
Confidence 467888888765 4699999999999999999999999999999999999999999999999999875432211 124
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc-hhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..++++.|+|||++.+. ..++.++|||||||++|+|++|..||.+... ...+..+...++.+....+..........
T Consensus 162 ~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (303)
T cd07869 162 NEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK- 239 (303)
T ss_pred CCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc-
Confidence 46789999999998652 4578899999999999999999999987543 46677777777877766554432110000
Q ss_pred HhhhccCCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........+..+...+ ...++.+.+||.+||+.||++|+|++|+|+||||+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000000011111111 12457899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=286.62 Aligned_cols=208 Identities=25% Similarity=0.367 Sum_probs=154.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 166 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~--~~~~~ 243 (391)
T PHA03212 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN--KYYGW 243 (391)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc--ccccc
Confidence 5789999988888999999999999999999999999999999999999999999999999999653222111 12346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC-------chhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-------VVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~-------~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ...++..+...+|.++.+.........
T Consensus 244 ~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 244 AGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 79999999999987 679999999999999999999997764432 234666777777765543221111000
Q ss_pred HHHHHhhhccCCC----CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 155 ARRYLSSMRKKKP----IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 155 ~~~~~~~~~~~~~----~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
...+......... .+.......++..+.+||.+||++||.+|||++|+|+||||+.+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 0111111111111 1111112235678999999999999999999999999999987643
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=273.35 Aligned_cols=197 Identities=37% Similarity=0.660 Sum_probs=158.1
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~----~~ 165 (288)
T cd07863 90 DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA----LT 165 (288)
T ss_pred ccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCccc----CC
Confidence 467888887643 489999999999999999999999999999999999999999999999999876543221 23
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...+|..|+|||++.+ ..++.++||||+||++|+|++|+++|.+......+..+...++.+....+....... .
T Consensus 166 ~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 239 (288)
T cd07863 166 PVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP----R 239 (288)
T ss_pred CccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc----c
Confidence 4578999999999977 678999999999999999999999999988888888888887777655443211100 0
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
...............+.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0011112223334456788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=272.54 Aligned_cols=203 Identities=33% Similarity=0.660 Sum_probs=152.7
Q ss_pred CCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~-~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++++.+.+. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......... ....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 160 (287)
T cd07848 83 EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--NYTE 160 (287)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc--cccc
Confidence 344444444 4456999999999999999999999999999999999999999999999999999765332211 1234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..|+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+.............
T Consensus 161 ~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 161 YVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 678999999999977 578999999999999999999999999988877777787777776665544322110000000
Q ss_pred hhccCCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 161 SMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 161 ~~~~~~~~~~-~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.......... ......++..+.+||.+||++||++|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000000000 01123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=265.70 Aligned_cols=188 Identities=29% Similarity=0.471 Sum_probs=151.7
Q ss_pred CCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+|+|+..|..++. +++.++..|++||..|+.|||+.+|.||||||+|+|... +..+||+|||+|+..... .
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----~ 218 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----G 218 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC----c
Confidence 4799999998876 999999999999999999999999999999999999875 456999999999865432 2
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
.+.+.|.|++|.|||+++. .+|+..+|+||+|||+|-||+|.+||........- +..-.+
T Consensus 219 ~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------pgMk~r------- 278 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKRR------- 278 (400)
T ss_pred cccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------hhHHhH-------
Confidence 3467789999999999987 68999999999999999999999999866542211 111111
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCC
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 218 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~ 218 (449)
++.....-....|..++..++++|++||..+|.+|.|+++++.|||+.+...+...+
T Consensus 279 -----I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tp 335 (400)
T KOG0604|consen 279 -----IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTP 335 (400)
T ss_pred -----hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCC
Confidence 111111112334566889999999999999999999999999999999876655443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=283.35 Aligned_cols=182 Identities=30% Similarity=0.494 Sum_probs=150.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCC----------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------- 71 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~---------- 71 (449)
+||+..+|.+.+.|+++++++++.+++.||..||..|+|||||||+|+||+..|++||+||||+......
T Consensus 225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~ 304 (550)
T KOG0605|consen 225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDE 304 (550)
T ss_pred CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchh
Confidence 6899999999999999999999999999999999999999999999999999999999999998532110
Q ss_pred -------------CC-----Cc----------------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhh
Q 013122 72 -------------TP-----TA----------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 117 (449)
Q Consensus 72 -------------~~-----~~----------------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl 117 (449)
.. .. ......+||+-|+|||++.+ ..|+..+|.||||||+||||
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDwWSLG~ImyEmL 382 (550)
T KOG0605|consen 305 QMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDWWSLGCIMYEML 382 (550)
T ss_pred hhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccHHHHHHHHHHHH
Confidence 00 00 01124589999999999998 78999999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 013122 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197 (449)
Q Consensus 118 tG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp 197 (449)
.|.+||.+.+..+.+..|...- ..+ .+. .-..++++++|||.+||. ||.+|.
T Consensus 383 vGyPPF~s~tp~~T~rkI~nwr-----------------~~l---------~fP-~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 383 VGYPPFCSETPQETYRKIVNWR-----------------ETL---------KFP-EEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred hCCCCCCCCCHHHHHHHHHHHh-----------------hhc---------cCC-CcCcccHHHHHHHHHHhc-CHHHhc
Confidence 9999999999887777665420 000 011 112356899999999999 999997
Q ss_pred C---HHHHHcCcccccccc
Q 013122 198 T---AEEALADPYFKGLAK 213 (449)
Q Consensus 198 T---a~elL~hp~f~~~~~ 213 (449)
. ++||-+||||+++..
T Consensus 435 G~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 435 GSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred CcccHHHHhcCCccccCCc
Confidence 5 999999999998653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=277.14 Aligned_cols=174 Identities=25% Similarity=0.479 Sum_probs=144.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~ 155 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTF 155 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cccce
Confidence 478999999888999999999999999999999999999999999999999999999999999875322211 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 156 ~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------------------------ 209 (323)
T cd05571 156 CGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------------------------ 209 (323)
T ss_pred ecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc------------------------
Confidence 79999999999987 6789999999999999999999999987654333222210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
. .. .....+++.+.+||.+||..||++|| ++.++++||||.++
T Consensus 210 --~--~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 --E--EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred --C--CC---CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0 00 11235688999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=272.50 Aligned_cols=207 Identities=37% Similarity=0.617 Sum_probs=152.3
Q ss_pred CCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE----cCCCCEEEeecCcccc
Q 013122 1 MESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLARV 67 (449)
Q Consensus 1 me~dL~~~i~~~---------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGlA~~ 67 (449)
++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 356788877532 248899999999999999999999999999999999999 4567899999999986
Q ss_pred ccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc---------hhhHHHHHhh
Q 013122 68 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIMTDL 138 (449)
Q Consensus 68 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~~~ 138 (449)
..............++|..|+|||++.+. ..++.++|||||||++|||++|++||.+... ..++..+...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 54432222223456789999999998652 4578999999999999999999999976432 3566778888
Q ss_pred cCCCCHHHHHHHhhHHHH-HHHhhhccCC--CC----CCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 139 LGTPSPEAIARVRNEKAR-RYLSSMRKKK--PI----PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 139 lg~p~~e~~~~~~~~~~~-~~~~~~~~~~--~~----~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
+|.+..+.|..+...... .......... .. .........+..+.+||.+||..||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888877777654321100 0000000000 00 0011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=268.24 Aligned_cols=172 Identities=24% Similarity=0.431 Sum_probs=144.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~------~~~ 158 (291)
T cd05612 85 GGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT------WTL 158 (291)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc------ccc
Confidence 47899999998899999999999999999999999999999999999999999999999999987653321 235
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~------------------------ 212 (291)
T cd05612 159 CGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA------------------------ 212 (291)
T ss_pred cCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------------
Confidence 78999999999987 6789999999999999999999999987665433322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
. ... .....++.+++||.+||+.||.+|++ ++++++||||+.+.
T Consensus 213 ---~-~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 213 ---G-KLE---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred ---C-CcC---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 0 001 11235788999999999999999995 99999999998643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=270.53 Aligned_cols=174 Identities=31% Similarity=0.514 Sum_probs=144.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 77 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 153 (312)
T cd05585 77 GGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTF 153 (312)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---ccccc
Confidence 478999999888999999999999999999999999999999999999999999999999999875432221 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 154 ~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~------------------------ 207 (312)
T cd05585 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ------------------------ 207 (312)
T ss_pred cCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc------------------------
Confidence 79999999999987 6789999999999999999999999987654332221110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp---Ta~elL~hp~f~~~ 211 (449)
. +. .....+++.+.+||.+||..||.+|+ ++.++|.||||...
T Consensus 208 ---~-~~---~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ---E-PL---RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---C-CC---CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0 11 11235788999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=278.30 Aligned_cols=177 Identities=33% Similarity=0.619 Sum_probs=151.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
.|||+.+|..++.|+++.++.|++|++.||.|||+++|+|||+||.|||+...+.+|+||||+|+...... ...+..
T Consensus 84 ~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t---~vltsi 160 (808)
T KOG0597|consen 84 VGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT---SVLTSI 160 (808)
T ss_pred hhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc---eeeeec
Confidence 47999999999999999999999999999999999999999999999999999999999999999875533 234667
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
-||+.|||||++.+ ..|+..+|+||||||+|||+.|++||...+..+....|.
T Consensus 161 kGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~------------------------- 213 (808)
T KOG0597|consen 161 KGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL------------------------- 213 (808)
T ss_pred cCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh-------------------------
Confidence 89999999999998 799999999999999999999999997655443333221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.. +..+ ...++..+..||..+|.+||.+|+|..+++.|||+++-...
T Consensus 214 --~d-~v~~---p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 214 --KD-PVKP---PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI 260 (808)
T ss_pred --cC-CCCC---cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence 11 1111 23678999999999999999999999999999999875443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=257.99 Aligned_cols=172 Identities=30% Similarity=0.476 Sum_probs=143.8
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--cccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT--AN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs--~g--IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
.|||.+.|+. +..+++..++.++.||++||..+|+ .. |+||||||.||+++.+|.+||+|||+++.......
T Consensus 104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t 183 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT 183 (375)
T ss_pred ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence 3799998863 3359999999999999999999999 44 99999999999999999999999999998765543
Q ss_pred CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
+...++||+.||+||++.+ ..|+.++||||+||++|||+.-++||.|++......+|...-
T Consensus 184 ---fA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-------------- 244 (375)
T KOG0591|consen 184 ---FAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-------------- 244 (375)
T ss_pred ---HHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC--------------
Confidence 4578999999999999998 799999999999999999999999999998766665554321
Q ss_pred HHHHHHhhhccCCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 154 KARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
++... ...+..+..||..|+..||..||+. +|++.++..
T Consensus 245 ----------------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 245 ----------------YPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred ----------------CCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 11111 2356788999999999999999987 666665543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=267.20 Aligned_cols=207 Identities=38% Similarity=0.697 Sum_probs=162.0
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ ...
T Consensus 86 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~ 162 (301)
T cd07873 86 LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYS 162 (301)
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC---ccc
Confidence 356888888764 4689999999999999999999999999999999999999999999999999875432221 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+....|..+........
T Consensus 163 ~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (301)
T cd07873 163 NEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS- 240 (301)
T ss_pred ccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc-
Confidence 44678899999998652 4578899999999999999999999999998888889999999888776655422110000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...............+.+++.+.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00000011111122346788999999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=268.51 Aligned_cols=236 Identities=49% Similarity=0.923 Sum_probs=196.3
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.++++.. .+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++...... ...
T Consensus 92 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~------~~~ 164 (328)
T cd07856 92 LGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ------MTG 164 (328)
T ss_pred hccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC------cCC
Confidence 457888888754 6899999999999999999999999999999999999999999999999998754221 134
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.........+.+.+|.+..+.+..+.......++.
T Consensus 165 ~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 165 YVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 5678899999987542 468899999999999999999999999988888888888999999988887766666566666
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+....+.+....++..+..+.+||.+||+.+|++|||++++|.||||..+..+..++.. -.++++.+....+..+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 321 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA--EEKFDWSFNDADLPVDTW 321 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc--hhhcCCchhcccCCHHHH
Confidence 666555666666677889999999999999999999999999999999988776555443 237778888888888888
Q ss_pred HHHHHH
Q 013122 241 RELIYR 246 (449)
Q Consensus 241 ~e~i~~ 246 (449)
+-+.|.
T Consensus 322 ~~~~~~ 327 (328)
T cd07856 322 KVMMYS 327 (328)
T ss_pred HHHhcC
Confidence 766553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=270.61 Aligned_cols=175 Identities=23% Similarity=0.433 Sum_probs=145.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 156 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---TTSTF 156 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---ccccc
Confidence 479999999888999999999999999999999999999999999999999999999999999875322211 12446
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~------------------------ 210 (320)
T cd05590 157 CGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------------------------ 210 (320)
T ss_pred ccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc------------------------
Confidence 79999999999987 6789999999999999999999999987765444333211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa------~elL~hp~f~~~~ 212 (449)
.. . .....++..+.+||.+||+.||.+|+++ ++++.||||+.+.
T Consensus 211 ---~~-~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 211 ---DE-V---VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred ---CC-C---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 00 0 1123468899999999999999999998 9999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=271.27 Aligned_cols=170 Identities=24% Similarity=0.422 Sum_probs=142.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 102 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------~~~ 175 (329)
T PTZ00263 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT------FTL 175 (329)
T ss_pred CChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc------cee
Confidence 47999999998899999999999999999999999999999999999999999999999999997653321 235
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 176 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~------------------------ 229 (329)
T PTZ00263 176 CGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA------------------------ 229 (329)
T ss_pred cCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc------------------------
Confidence 79999999999987 6788999999999999999999999987654333222211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKG 210 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~ 210 (449)
. ... ....++..+.+||.+||+.||.+|++ +++++.||||++
T Consensus 230 ---~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 230 ---G-RLK---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ---C-CcC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 0 011 11236788999999999999999997 799999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=269.19 Aligned_cols=191 Identities=25% Similarity=0.409 Sum_probs=149.2
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc-
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW- 78 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~- 78 (449)
.|++.++|+..- .|.|..|..|++++|+||.|||.+|.||||||+.||||+.+|.|||+|||....+..........
T Consensus 108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf 187 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF 187 (516)
T ss_pred CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee
Confidence 478999998754 49999999999999999999999999999999999999999999999999876655433322222
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..++||++|||||++...-..|+.|+||||||+...||.+|..||...-.... .+.++-|.|+.-.......+
T Consensus 188 ~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn~pp~~~t~~~~~d----- 260 (516)
T KOG0582|consen 188 NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQNDPPTLLTSGLDKD----- 260 (516)
T ss_pred ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcCCCCCcccccCChH-----
Confidence 77899999999999655457899999999999999999999999976544332 23333343331111111111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.....+..++.+|..||+.||.+||||+++|+|+||+....
T Consensus 261 --------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 261 --------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred --------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 11223557899999999999999999999999999997553
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=262.20 Aligned_cols=202 Identities=39% Similarity=0.655 Sum_probs=157.1
Q ss_pred CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~ 157 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---CYS 157 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC---CcC
Confidence 35688888865 45799999999999999999999999999999999999999999999999999875432211 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCC-CCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.+. ..++.++|||||||++|+|++|..| |.+.+....+..+.+.++.+....+..+........
T Consensus 158 ~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 158 AEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 45678899999998662 4578899999999999999998765 677777788888888888887766654322111000
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... ......+.+..+.+++.+.+||.+||..||.+|||++++|.||||
T Consensus 237 ~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPM--YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCC--CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000 001112233456688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=275.97 Aligned_cols=205 Identities=23% Similarity=0.293 Sum_probs=152.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
.++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......
T Consensus 169 ~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~-~~~~~~ 247 (392)
T PHA03207 169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQCYGW 247 (392)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc-cccccc
Confidence 5789999987788999999999999999999999999999999999999999999999999999765433221 122346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc---hhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~---~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
+||..|+|||++.+ ..|+.++|||||||++|||++|+.||.+... ..++..+.+.++....+..... .......
T Consensus 248 ~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~-~~~~~~~ 324 (392)
T PHA03207 248 SGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG-STNLCKH 324 (392)
T ss_pred ccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc-chhHHHH
Confidence 79999999999987 6789999999999999999999999977643 3455556655554333221110 0011111
Q ss_pred HhhhccCC--CCCCCCC--CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSSMRKKK--PIPFSQK--FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~--~~~~~~~--~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
+....... +...... ....+..+.+||.+||..||++|||+.|+|.||||..
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 11111111 1111111 1235678999999999999999999999999999975
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=269.71 Aligned_cols=180 Identities=26% Similarity=0.413 Sum_probs=142.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 89 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~--~~~~~ 166 (332)
T cd05614 89 GGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE--RTYSF 166 (332)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC--ccccc
Confidence 4689999998888999999999999999999999999999999999999999999999999998764332221 12346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+. ..++.++|||||||++|+|++|+.||...........+. ..
T Consensus 167 ~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-----------------------~~ 222 (332)
T cd05614 167 CGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-----------------------RR 222 (332)
T ss_pred cCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH-----------------------HH
Confidence 799999999998762 357889999999999999999999997543221111110 00
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
+.... ......+++.+.+||.+||+.||++|+ +++++++||||++.
T Consensus 223 ~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 223 ILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00110 111235788999999999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=268.01 Aligned_cols=174 Identities=24% Similarity=0.440 Sum_probs=145.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 156 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTF 156 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---ccccc
Confidence 468999999888899999999999999999999999999999999999999999999999999875432221 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~------------------------ 210 (321)
T cd05591 157 CGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH------------------------ 210 (321)
T ss_pred ccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc------------------------
Confidence 79999999999987 6789999999999999999999999988765544433221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-------CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-------TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-------Ta~elL~hp~f~~~ 211 (449)
.. . .....++..+.+||.+||+.||++|+ +++++++||||..+
T Consensus 211 ---~~-~---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 211 ---DD-V---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred ---CC-C---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 00 0 01123678999999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=271.65 Aligned_cols=172 Identities=23% Similarity=0.370 Sum_probs=144.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 115 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~------~~~~ 188 (340)
T PTZ00426 115 GGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTL 188 (340)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC------ccee
Confidence 5799999999889999999999999999999999999999999999999999999999999999765322 1346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 189 ~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~------------------------ 242 (340)
T PTZ00426 189 CGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE------------------------ 242 (340)
T ss_pred cCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc------------------------
Confidence 79999999999987 5788999999999999999999999987664433322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
. .. .....+++.+.+||.+||+.||.+|+ +++++++||||+++.
T Consensus 243 ---~-~~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 243 ---G-II---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred ---C-CC---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0 00 11234678899999999999999995 899999999998753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=269.36 Aligned_cols=174 Identities=24% Similarity=0.472 Sum_probs=143.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 155 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTF 155 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---ccccc
Confidence 468999998888899999999999999999999999999999999999999999999999999875332211 12446
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------------------------ 209 (328)
T cd05593 156 CGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------------------------ 209 (328)
T ss_pred cCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------------------------
Confidence 79999999999977 6789999999999999999999999977654332221110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
... .....+++.+.+||.+||..||.+|+ ++.++++||||.+.
T Consensus 210 ----~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 ----EDI---KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ----CCc---cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 11234688999999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=267.53 Aligned_cols=174 Identities=24% Similarity=0.429 Sum_probs=143.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTF 156 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---ceecc
Confidence 478999999888899999999999999999999999999999999999999999999999999864322111 22456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~------------------------ 210 (316)
T cd05620 157 CGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV------------------------ 210 (316)
T ss_pred CCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------------
Confidence 79999999999987 6789999999999999999999999987664333222210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-HHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-EEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa-~elL~hp~f~~~ 211 (449)
.. ......++..+.+||.+||..||++|+++ +++++||||+..
T Consensus 211 ---~~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 ---DT----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred ---CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 00 01112367899999999999999999998 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=268.44 Aligned_cols=174 Identities=26% Similarity=0.477 Sum_probs=144.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|..++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---TTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---ccccc
Confidence 468999999888899999999999999999999999999999999999999999999999999875322221 22456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~------------------------ 210 (323)
T cd05575 157 CGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN------------------------ 210 (323)
T ss_pred cCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc------------------------
Confidence 79999999999987 6789999999999999999999999987664433322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa----~elL~hp~f~~~ 211 (449)
. . ....+..+..+.+||.+||+.||.+|+++ .++++||||..+
T Consensus 211 ---~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 ---K-P---LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred ---C-C---CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 0 11234568899999999999999999987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=262.55 Aligned_cols=178 Identities=25% Similarity=0.378 Sum_probs=142.3
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 84 ~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~ 159 (285)
T cd05631 84 GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVR 159 (285)
T ss_pred CCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----eec
Confidence 46888887643 359999999999999999999999999999999999999999999999999997643222 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---------------------- 215 (285)
T cd05631 160 GRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---------------------- 215 (285)
T ss_pred CCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH----------------------
Confidence 4578999999999987 6889999999999999999999999987654322211111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
.+.. ........++..+.+||.+||+.||.+|++ ++++++||||.++.
T Consensus 216 -~~~~----~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 216 -RVKE----DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred -Hhhc----ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0000 011122356889999999999999999997 89999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=266.35 Aligned_cols=174 Identities=28% Similarity=0.486 Sum_probs=144.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 160 (323)
T cd05584 84 GGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---VTHTF 160 (323)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC---ccccc
Confidence 468999999888899999999999999999999999999999999999999999999999999875432221 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 161 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~------------------------ 214 (323)
T cd05584 161 CGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK------------------------ 214 (323)
T ss_pred CCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc------------------------
Confidence 79999999999987 5788999999999999999999999987664333322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
. . ....+.+++.+.+||.+||+.||++|+ +++++++||||...
T Consensus 215 ---~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ---G-K---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ---C-C---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0 112245688999999999999999999 89999999999853
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=258.73 Aligned_cols=202 Identities=38% Similarity=0.640 Sum_probs=157.0
Q ss_pred CCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 1 MESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 1 me~dL~~~i~~~---~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~ 157 (285)
T cd07861 81 LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR---V 157 (285)
T ss_pred CCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc---c
Confidence 346788887643 4599999999999999999999999999999999999999999999999999875432211 1
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....++..|+|||++.+. ..++.++|||||||++|+|++|++||.+......+..+...++.+....+....... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP--D 234 (285)
T ss_pred ccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH--H
Confidence 2344678899999988653 457889999999999999999999999988877777777777777666655433211 1
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
+..................+++++.+||.+||..||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 111111111112223345578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=268.57 Aligned_cols=175 Identities=26% Similarity=0.488 Sum_probs=143.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++........ ....
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~ 155 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKT 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---cccc
Confidence 46899999888889999999999999999999997 7999999999999999999999999999875332211 1234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 156 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~----------------------- 210 (325)
T cd05594 156 FCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----------------------- 210 (325)
T ss_pred ccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-----------------------
Confidence 679999999999977 6789999999999999999999999987654333222210
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
.... ....+++.+.+||.+||+.||++|+ ++.++|+||||.+..
T Consensus 211 -----~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 211 -----EEIR---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred -----CCCC---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 0001 1134688999999999999999997 999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=266.68 Aligned_cols=174 Identities=22% Similarity=0.432 Sum_probs=144.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 161 (324)
T cd05587 85 GGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTF 161 (324)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC---ceeee
Confidence 479999999888899999999999999999999999999999999999999999999999999864322211 12346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 162 ~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~----------------------- 216 (324)
T cd05587 162 CGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH----------------------- 216 (324)
T ss_pred cCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence 79999999999987 67899999999999999999999999876654433322210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa-----~elL~hp~f~~~ 211 (449)
.. .....++..+.+||.+||..||.+|+++ +++++||||+..
T Consensus 217 -----~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 217 -----NV---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -----CC---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 1123468899999999999999999986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=266.98 Aligned_cols=179 Identities=24% Similarity=0.471 Sum_probs=147.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 85 g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------~~~~~ 158 (333)
T cd05600 85 GGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSV 158 (333)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc------ccCCc
Confidence 479999999888899999999999999999999999999999999999999999999999999976533 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+..... .
T Consensus 159 ~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------~ 216 (333)
T cd05600 159 VGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE--------------------T 216 (333)
T ss_pred ccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--------------------c
Confidence 79999999999987 5889999999999999999999999988765544433321100 0
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
+ ...........++..+.+||.+||..+|.+|++++++++||||+++
T Consensus 217 ~---~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 217 L---QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred c---cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 0 0000111113568899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=265.70 Aligned_cols=174 Identities=25% Similarity=0.488 Sum_probs=143.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~~~~~ 156 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---KASTF 156 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---ccccc
Confidence 479999999888999999999999999999999999999999999999999999999999999875433221 22456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------------------------ 210 (316)
T cd05592 157 CGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------------------------ 210 (316)
T ss_pred cCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------------------------
Confidence 79999999999987 5789999999999999999999999988765433322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-HHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-EEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa-~elL~hp~f~~~ 211 (449)
.. ......++..+.+||.+||..||.+|+++ .+++.||||..+
T Consensus 211 ---~~----~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 ---DR----PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred ---CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 00 01113467889999999999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=281.23 Aligned_cols=173 Identities=27% Similarity=0.559 Sum_probs=147.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|||..+++ .+.|++..+++|+..|+.||.|||++|||+||||.+|||+|.+|.+||+|||+++..-.... ..+++
T Consensus 453 Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~---~TsTf 528 (694)
T KOG0694|consen 453 GGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD---RTSTF 528 (694)
T ss_pred CCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC---ccccc
Confidence 567555444 35799999999999999999999999999999999999999999999999999986432222 34789
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
|||+.|+|||++.+ ..|+.++|.|||||+|||||.|..||+|.+..+..+.|..
T Consensus 529 CGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------------------------ 582 (694)
T KOG0694|consen 529 CGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------------------------ 582 (694)
T ss_pred cCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------------------------
Confidence 99999999999998 7999999999999999999999999999998766655532
Q ss_pred hccCCCCCCCCCCC-CCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~-~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
. ...+| .++.++.++|+++|..||++|.. ++++..||||+.+.
T Consensus 583 ---d-----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 583 ---D-----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred ---C-----CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 0 11222 47889999999999999999976 58999999999764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=266.79 Aligned_cols=174 Identities=26% Similarity=0.484 Sum_probs=143.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|..++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 155 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTF 155 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---ccccc
Confidence 478999998888899999999999999999999999999999999999999999999999999875322211 12346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~------------------------ 209 (323)
T cd05595 156 CGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------------------ 209 (323)
T ss_pred cCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------------
Confidence 79999999999977 6789999999999999999999999987654333222210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
.. . .....+++.+.+||.+||..||.+|+ ++.++++|+||.+.
T Consensus 210 --~~--~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 --EE--I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred --CC--C---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 00 0 11234688999999999999999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=268.47 Aligned_cols=176 Identities=24% Similarity=0.451 Sum_probs=142.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~~~~ 156 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNTF 156 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---CccCc
Confidence 468999999888999999999999999999999999999999999999999999999999999875432221 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 157 ~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~------------------------ 211 (330)
T cd05586 157 CGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF------------------------ 211 (330)
T ss_pred cCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc------------------------
Confidence 799999999998652 4578999999999999999999999987654333222210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp----Ta~elL~hp~f~~~ 211 (449)
.. ..+. ...+++.+.+||.+||..||.+|+ +++++++||||...
T Consensus 212 ---~~-~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 ---GK-VRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred ---CC-CCCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 00 0011 123678899999999999999998 79999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=261.93 Aligned_cols=208 Identities=41% Similarity=0.647 Sum_probs=163.0
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ....
T Consensus 91 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~---~~~~ 167 (309)
T cd07845 91 EQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTP 167 (309)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC---CCCc
Confidence 46788888763 5699999999999999999999999999999999999999999999999999976543221 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.+....+..+........+.
T Consensus 168 ~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (309)
T cd07845 168 KVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFT 246 (309)
T ss_pred ccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccccc
Confidence 4567889999998652 467899999999999999999999999999999999999999888777665442211100000
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
+.......+...+...++.+.+||.+||++||++|||++++|+||||++..-+
T Consensus 247 -~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 247 -LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred -ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 00111111222344568899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=269.40 Aligned_cols=180 Identities=28% Similarity=0.447 Sum_probs=141.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------- 74 (449)
+++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 164 (363)
T cd05628 85 GGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLN 164 (363)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccc
Confidence 4799999999889999999999999999999999999999999999999999999999999998754321100
Q ss_pred -------------------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCch
Q 013122 75 -------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 129 (449)
Q Consensus 75 -------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~ 129 (449)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~ 242 (363)
T cd05628 165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242 (363)
T ss_pred ccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 001124579999999999987 67899999999999999999999999877654
Q ss_pred hhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCC---CCCCHHHHHcCc
Q 013122 130 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK---DRPTAEEALADP 206 (449)
Q Consensus 130 ~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~---~RpTa~elL~hp 206 (449)
..+..+... .....+.. ...+++.+++||.+|+. +|. .||+++|+++||
T Consensus 243 ~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 243 ETYKKVMNW--------------------------KETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred HHHHHHHcC--------------------------cCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCC
Confidence 444333211 00111111 12368899999999875 455 458999999999
Q ss_pred ccccc
Q 013122 207 YFKGL 211 (449)
Q Consensus 207 ~f~~~ 211 (449)
||+++
T Consensus 295 ~f~~~ 299 (363)
T cd05628 295 FFEGV 299 (363)
T ss_pred CCCCC
Confidence 99875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=261.84 Aligned_cols=176 Identities=27% Similarity=0.439 Sum_probs=152.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc-CCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|||++||-++. .|.++.++.++.||+.|+.|+|...+|||||||+||++. .-|-|||+|||++..+..+. .++
T Consensus 101 ~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~----kL~ 176 (864)
T KOG4717|consen 101 GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK----KLT 176 (864)
T ss_pred CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc----hhh
Confidence 479999998876 599999999999999999999999999999999999755 56889999999987655443 457
Q ss_pred cccccccccCcccccccCCCCC-CccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s-~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
+.||+..|-|||++.| ..|+ +++||||||||||.|++|++||...++.+.+..|++.--
T Consensus 177 TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------------------ 236 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------------------ 236 (864)
T ss_pred cccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------------------
Confidence 8899999999999998 4554 789999999999999999999999999888877765311
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.....++.++++||..||+.||++|.+.+++..|+|++.....
T Consensus 237 -------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 237 -------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred -------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 1223568899999999999999999999999999999976543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=265.12 Aligned_cols=174 Identities=21% Similarity=0.412 Sum_probs=144.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 85 ~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 161 (323)
T cd05616 85 GGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---TTKTF 161 (323)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC---ccccC
Confidence 479999999888899999999999999999999999999999999999999999999999999875432211 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 162 ~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~----------------------- 216 (323)
T cd05616 162 CGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------------------- 216 (323)
T ss_pred CCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 79999999999987 67999999999999999999999999877654443333210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~ 211 (449)
.. .....++..+.+||.+||+.||.+|++ ..++++||||+.+
T Consensus 217 -----~~---~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 217 -----NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred -----CC---CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 00 111346889999999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=256.75 Aligned_cols=204 Identities=45% Similarity=0.831 Sum_probs=163.1
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........ .....
T Consensus 82 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 159 (286)
T cd07832 82 PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--RLYSH 159 (286)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--Ccccc
Confidence 57899988653 4699999999999999999999999999999999999999999999999999876544322 11244
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++.+|+|||.+.+. ..++.++||||+||++|+|++|.++|.+.+....+..+...++.+....+...........+
T Consensus 160 ~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (286)
T cd07832 160 QVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI- 237 (286)
T ss_pred ccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc-
Confidence 5789999999998652 45688999999999999999999999998888888888888888887766654321111000
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.........+...+++.+..+.+||.+||..||.+|||++++|+||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1111222233445567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=266.84 Aligned_cols=180 Identities=31% Similarity=0.530 Sum_probs=145.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC--------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-------- 73 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~-------- 73 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 164 (350)
T cd05573 85 GGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164 (350)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccc
Confidence 479999999888899999999999999999999999999999999999999999999999999876543320
Q ss_pred ------------------CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHH
Q 013122 74 ------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 135 (449)
Q Consensus 74 ------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i 135 (449)
........+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i 242 (350)
T cd05573 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI 242 (350)
T ss_pred ccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHH
Confidence 0011234679999999999987 58899999999999999999999999877644333322
Q ss_pred HhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHcCcccccc
Q 013122 136 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFKGL 211 (449)
Q Consensus 136 ~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-a~elL~hp~f~~~ 211 (449)
.... .... + .....+++.+.+||.+||. ||.+|++ ++++|+||||+++
T Consensus 243 ~~~~------------------------~~~~--~-p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 243 INWK------------------------ESLR--F-PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred hccC------------------------Cccc--C-CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 2110 0001 1 1112368999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=263.95 Aligned_cols=175 Identities=31% Similarity=0.482 Sum_probs=145.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC------CCEEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~------~~vKL~DFGlA~~~~~~~~~~ 75 (449)
+|||.++|++.+.+++..++.|+.||+.||++||+++||||||||.|||++.+ -.+||+|||+|+......
T Consensus 93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~--- 169 (429)
T KOG0595|consen 93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS--- 169 (429)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh---
Confidence 48999999999999999999999999999999999999999999999999875 458999999999876443
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
...+.||++.|||||++.. ..|+.|+|+||+|+|+|+|++|++||...+..+.+..+.+-
T Consensus 170 -~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~----------------- 229 (429)
T KOG0595|consen 170 -MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG----------------- 229 (429)
T ss_pred -HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc-----------------
Confidence 3467899999999999976 79999999999999999999999999887765554322110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.... .......+....+|+..+|..++.+|.+..+-+.|+++..
T Consensus 230 -------~~~~----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 230 -------NEIV----PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred -------cccc----CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 0000 0111124555678999999999999999999999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=267.91 Aligned_cols=203 Identities=27% Similarity=0.379 Sum_probs=142.5
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~ 215 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP----AFLG 215 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc----cccc
Confidence 57888888754 469999999999999999999999999999999999999999999999999987533221 1234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCC-CCCCCCCc---------hhhHHHHHhhcCCCCHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV---------VHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~-~pF~~~~~---------~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
..||..|+|||++.+ ..++.++|||||||++|||+++. ++|..... ...+..+...++..+.+.....
T Consensus 216 ~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 216 LAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred ccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 578999999999987 67899999999999999999854 45543221 1222333333333222211000
Q ss_pred hhHHHHHHHhhhccCCCCCCCC----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQ----KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.......++.... ....++.. ...+++..+.+||.+||++||.+|||+.|+|+||||+.+
T Consensus 294 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 294 GSRLVRGFIEYAS-LERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred ccHHHHHHHhhcc-cCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 0111111111100 00111111 112457788899999999999999999999999999853
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=263.58 Aligned_cols=174 Identities=24% Similarity=0.465 Sum_probs=144.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTF 156 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---cccce
Confidence 478999999888999999999999999999999999999999999999999999999999999865322211 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~------------------------ 210 (318)
T cd05570 157 CGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE------------------------ 210 (318)
T ss_pred ecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc------------------------
Confidence 78999999999987 6789999999999999999999999987664333222211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa-----~elL~hp~f~~~ 211 (449)
... .....++..+.+||.+||..||.+|||+ .++++||||+..
T Consensus 211 ---~~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 ---DEV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred ---CCC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 000 1113467899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=267.71 Aligned_cols=180 Identities=29% Similarity=0.483 Sum_probs=143.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------ 75 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~------ 75 (449)
+++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 85 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 164 (364)
T cd05599 85 GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164 (364)
T ss_pred CcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccc
Confidence 47999999988889999999999999999999999999999999999999999999999999986542211000
Q ss_pred -----------------------------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCC
Q 013122 76 -----------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 126 (449)
Q Consensus 76 -----------------------------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~ 126 (449)
......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~G~~Pf~~~ 242 (364)
T cd05599 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLVGYPPFCSD 242 (364)
T ss_pred ccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhhcCCCCCCCC
Confidence 00113469999999999977 67899999999999999999999999877
Q ss_pred CchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 013122 127 NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEAL 203 (449)
Q Consensus 127 ~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT---a~elL 203 (449)
+.......+... .....+.. ...+++.+.+||.+||. +|.+|++ ++++|
T Consensus 243 ~~~~~~~~i~~~--------------------------~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 243 NPQETYRKIINW--------------------------KETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred CHHHHHHHHHcC--------------------------CCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 654333222110 00111111 12468899999999997 9999998 99999
Q ss_pred cCcccccc
Q 013122 204 ADPYFKGL 211 (449)
Q Consensus 204 ~hp~f~~~ 211 (449)
+||||++.
T Consensus 295 ~h~~~~~~ 302 (364)
T cd05599 295 SHPFFKGV 302 (364)
T ss_pred cCCCcCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=259.17 Aligned_cols=182 Identities=29% Similarity=0.497 Sum_probs=150.0
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccC--------
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN-------- 70 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~-------- 70 (449)
++|||+.+++++. .|+++.+++++..|+.||+|||-.|||.|||||+||||.++|.|.|+||.|+.....
T Consensus 160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~ 239 (459)
T KOG0610|consen 160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS 239 (459)
T ss_pred CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence 5799999998765 499999999999999999999999999999999999999999999999998743210
Q ss_pred -------------------------C-C-------------------CCccccccccccccccCcccccccCCCCCCccc
Q 013122 71 -------------------------D-T-------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAID 105 (449)
Q Consensus 71 -------------------------~-~-------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~D 105 (449)
. . +.......++||-.|+|||++.| ...+.++|
T Consensus 240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G--~GHgsAVD 317 (459)
T KOG0610|consen 240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG--EGHGSAVD 317 (459)
T ss_pred CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec--CCCCchhh
Confidence 0 0 00111235789999999999999 68999999
Q ss_pred hhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHH
Q 013122 106 IWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 185 (449)
Q Consensus 106 IWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL 185 (449)
.|+||+++||||.|..||.|.+..+.+..|.. .+..|.. .+.++..++|||
T Consensus 318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----------------------------~~l~Fp~-~~~vs~~akDLI 368 (459)
T KOG0610|consen 318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----------------------------QPLKFPE-EPEVSSAAKDLI 368 (459)
T ss_pred HHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----------------------------CCCcCCC-CCcchhHHHHHH
Confidence 99999999999999999999987666544421 1111221 235678999999
Q ss_pred HHhhhcCCCCCCC----HHHHHcCcccccccc
Q 013122 186 ERMLAFEPKDRPT----AEEALADPYFKGLAK 213 (449)
Q Consensus 186 ~~~L~~DP~~RpT----a~elL~hp~f~~~~~ 213 (449)
+++|.+||.+|.. |.||-+||||+++..
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 9999999999998 999999999998754
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=257.54 Aligned_cols=205 Identities=43% Similarity=0.720 Sum_probs=163.6
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ ....
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~ 161 (298)
T cd07841 85 ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR---KMTH 161 (298)
T ss_pred CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc---cccc
Confidence 678999998876 799999999999999999999999999999999999999999999999999976543321 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+..+.+..+...++.+....+....... .+ .
T Consensus 162 ~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~ 237 (298)
T cd07841 162 QVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP--DY-V 237 (298)
T ss_pred cccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc--cc-c
Confidence 4567889999988542 467889999999999999999999999988888888888878777766554332111 01 1
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
........+....+...+..+.+||.+||..||++|||+.|+|.|+||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 11112223334455667889999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=264.53 Aligned_cols=174 Identities=28% Similarity=0.497 Sum_probs=143.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---Ccccc
Confidence 468999999888999999999999999999999999999999999999999999999999999875322221 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~------------------------ 210 (325)
T cd05604 157 CGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH------------------------ 210 (325)
T ss_pred cCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc------------------------
Confidence 79999999999987 6789999999999999999999999987664333222211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa----~elL~hp~f~~~ 211 (449)
. . ....+..+..+.+||.+||..||.+||++ .++++||||...
T Consensus 211 ---~-~---~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 ---K-P---LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ---C-C---ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 0 0 11224578889999999999999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=262.62 Aligned_cols=175 Identities=25% Similarity=0.450 Sum_probs=143.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---KTCTF 156 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---ceeee
Confidence 479999999888899999999999999999999999999999999999999999999999999875322211 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+....+..+.
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~------------------------- 209 (316)
T cd05619 157 CGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR------------------------- 209 (316)
T ss_pred cCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------------------
Confidence 78999999999987 678999999999999999999999998765433322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-HHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~-elL~hp~f~~~~ 212 (449)
...+ .....++..+.+||.+||..||.+|+++. ++++||||+.+.
T Consensus 210 --~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 210 --MDNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred --hCCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 0000 01123678899999999999999999996 999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=264.82 Aligned_cols=180 Identities=25% Similarity=0.422 Sum_probs=143.6
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......... ....
T Consensus 85 ~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~ 162 (330)
T cd05601 85 GGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV--NSKL 162 (330)
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--eeec
Confidence 47899999886 57999999999999999999999999999999999999999999999999999765433221 1234
Q ss_pred ccccccccCccccccc----CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 81 YVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
.+||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------------------ 224 (330)
T cd05601 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF------------------ 224 (330)
T ss_pred ccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC------------------
Confidence 5789999999998631 145788999999999999999999999876654333222110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.....+ ...+.+++.+.+||.+||. ||.+|+|++++++||||..+
T Consensus 225 --------~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 --------QRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred --------CCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 000111 1224578899999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=264.08 Aligned_cols=174 Identities=28% Similarity=0.471 Sum_probs=144.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---Ccccc
Confidence 468999999888899999999999999999999999999999999999999999999999999875432221 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~------------------------ 210 (325)
T cd05602 157 CGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------------------------ 210 (325)
T ss_pred cCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh------------------------
Confidence 79999999999987 6789999999999999999999999987665433322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH----HHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE----EALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~----elL~hp~f~~~ 211 (449)
. + ....+.++..+.+||.+||+.||.+|+++. ++++|+||..+
T Consensus 211 ---~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 211 ---K-P---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred ---C-C---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0 0 112346788999999999999999999875 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=265.21 Aligned_cols=177 Identities=31% Similarity=0.500 Sum_probs=151.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC----CCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+|+|++.|... .+++..+..++.||+.|++|||+.||+||||||+|+|+... +.+|++|||++...... ..
T Consensus 120 GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~----~~ 194 (382)
T KOG0032|consen 120 GGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG----ER 194 (382)
T ss_pred CchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC----ce
Confidence 58999999887 59999999999999999999999999999999999998653 47999999999877552 23
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+.......|..
T Consensus 195 ~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-------------------- 252 (382)
T KOG0032|consen 195 LHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-------------------- 252 (382)
T ss_pred EeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc--------------------
Confidence 477899999999999987 6899999999999999999999999998876544432221
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
....-....|+.++..+++||.+||..||.+|+|+.++|+|||+++..
T Consensus 253 -------~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 253 -------GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred -------CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 112223456788899999999999999999999999999999998753
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=254.26 Aligned_cols=200 Identities=41% Similarity=0.795 Sum_probs=155.2
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+.+... ..+++..+..++.||+.||.|||+.||+||||+|+||+++. +.+||+|||++........ ..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~----~~ 156 (282)
T cd07831 82 MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP----YT 156 (282)
T ss_pred CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC----cC
Confidence 357888888764 46899999999999999999999999999999999999999 9999999999976543322 23
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||.+... ..++.++||||+||++|+|++|.+||.+.+..+.+..+...++.+...............+
T Consensus 157 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (282)
T cd07831 157 EYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY- 234 (282)
T ss_pred CCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc-
Confidence 45688999999976542 4578899999999999999999999999998888888888888877755322211100000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.........+....+..+..+.+||.+||..||++|||++++|+||||
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 -NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred -cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000000011112234568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=255.71 Aligned_cols=203 Identities=40% Similarity=0.689 Sum_probs=160.6
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........ ...
T Consensus 88 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~ 164 (293)
T cd07843 88 VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK---PYT 164 (293)
T ss_pred cCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc---ccc
Confidence 3568888887654 499999999999999999999999999999999999999999999999999876544321 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||.+.+. ..++.++||||+||++|+|++|.+||.+......+..+...++.|....+..+..-.....
T Consensus 165 ~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (293)
T cd07843 165 QLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK- 242 (293)
T ss_pred cccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc-
Confidence 45678899999998652 3468899999999999999999999999998888888999999888877765432111100
Q ss_pred hhhccCCCCCCCCCCCC--CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPN--ANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..........+...++. +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00111111122334444 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=261.78 Aligned_cols=173 Identities=27% Similarity=0.494 Sum_probs=141.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 86 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 161 (324)
T cd05589 86 GGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTF 161 (324)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---ccccc
Confidence 3688888765 4799999999999999999999999999999999999999999999999999865332221 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 162 ~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~------------------------ 215 (324)
T cd05589 162 CGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN------------------------ 215 (324)
T ss_pred ccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------------
Confidence 79999999999987 6789999999999999999999999987765443322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
... .....+++.+.+||.+||+.||.+|| ++.++++||||+++
T Consensus 216 ---~~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 216 ---DEV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 000 11234688899999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=252.95 Aligned_cols=201 Identities=39% Similarity=0.659 Sum_probs=157.7
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++........ ...
T Consensus 82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~ 158 (284)
T cd07860 82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYT 158 (284)
T ss_pred ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---ccc
Confidence 35677877653 4689999999999999999999999999999999999999999999999999875432211 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+.++.+....+...... ..+.
T Consensus 159 ~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (284)
T cd07860 159 HEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL--PDYK 235 (284)
T ss_pred cccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH--HHHH
Confidence 34578899999988652 34688899999999999999999999998888888888888888876655543221 1111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..........+....+.+++.+++||.+||+.||.+|||++++|.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 2222222222333345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=267.88 Aligned_cols=180 Identities=27% Similarity=0.434 Sum_probs=141.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC--------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-------- 73 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~-------- 73 (449)
+++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~ 164 (382)
T cd05625 85 GGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD 164 (382)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccc
Confidence 468999999888899999999999999999999999999999999999999999999999999753210000
Q ss_pred ------------------------------------CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhh
Q 013122 74 ------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 117 (449)
Q Consensus 74 ------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl 117 (449)
........+||+.|+|||++.+ ..|+.++|||||||++|||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvil~ell 242 (382)
T cd05625 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVILYEML 242 (382)
T ss_pred ccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEechHHHHHHH
Confidence 0000123579999999999987 67999999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 013122 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 197 (449)
Q Consensus 118 tG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp 197 (449)
+|++||.+.+.......+... .. ...+ .....+++.+.+||.+|+ .||.+|+
T Consensus 243 tG~~Pf~~~~~~~~~~~i~~~------------------------~~--~~~~-p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 243 VGQPPFLAQTPLETQMKVINW------------------------QT--SLHI-PPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred hCCCCCCCCCHHHHHHHHHcc------------------------CC--CcCC-CCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 999999876643332222110 00 0001 112357899999999987 5999999
Q ss_pred C---HHHHHcCcccccc
Q 013122 198 T---AEEALADPYFKGL 211 (449)
Q Consensus 198 T---a~elL~hp~f~~~ 211 (449)
+ ++++++||||+.+
T Consensus 295 ~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 295 GKNGADEIKAHPFFKTI 311 (382)
T ss_pred CCCCHHHHhcCCCcCCc
Confidence 7 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.96 Aligned_cols=206 Identities=27% Similarity=0.342 Sum_probs=143.6
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~ 321 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST-PFHYG 321 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-ccccc
Confidence 56888888765 36999999999999999999999999999999999999999999999999999765332211 11234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCC-CCCCCCc------hhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP-LFPGKNV------VHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~-pF~~~~~------~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.+||..|+|||++.+ ..++.++|||||||++|||++|.. +|..... ..++..+....+....+........
T Consensus 322 ~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 322 IAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 579999999999987 678999999999999999999774 4443211 2233333333222111110000000
Q ss_pred HHHHHHhh----hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 154 KARRYLSS----MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 154 ~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
....+... .......+....+..++..+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00111111 0111111111223356778999999999999999999999999999974
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=262.76 Aligned_cols=174 Identities=29% Similarity=0.463 Sum_probs=144.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.++..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 158 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSF 158 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---ceecc
Confidence 478999998888899999999999999999999999999999999999999999999999999876433221 12346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 159 ~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------------- 213 (318)
T cd05582 159 CGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------------- 213 (318)
T ss_pred cCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence 78999999999987 57889999999999999999999999876644333222110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~ 211 (449)
. ......+++.+.+||.+||+.||++||+ +++++.||||..+
T Consensus 214 ---~-----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 ---K-----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ---C-----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0 0112346788999999999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=262.16 Aligned_cols=183 Identities=22% Similarity=0.437 Sum_probs=141.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 156 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTF 156 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---ccccc
Confidence 468999998888999999999999999999999999999999999999999999999999999864322111 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..... . .....
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------~~~~~~-----~---~~~~~ 216 (329)
T cd05588 157 CGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN----------PDQNTE-----D---YLFQV 216 (329)
T ss_pred cCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCccccccccc----------ccccch-----H---HHHHH
Confidence 79999999999987 6789999999999999999999999964321110 000000 0 00000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT------a~elL~hp~f~~~ 211 (449)
+... ... ....++..+.+||.+||+.||.+|+| ++++++||||..+
T Consensus 217 ~~~~-~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 217 ILEK-QIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHcC-CCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 1111 111 12346888999999999999999987 7899999999754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=266.97 Aligned_cols=181 Identities=30% Similarity=0.459 Sum_probs=137.9
Q ss_pred CCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~-Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+.||.++|++... +..-.++++.+|||.|++++|.+||||.||||.|+|+- .|.+||+|||.|.....++ +.+....
T Consensus 443 d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT-TsI~kds 520 (677)
T KOG0596|consen 443 DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT-TSIVKDS 520 (677)
T ss_pred cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc-cceeecc
Confidence 4699999998765 33359999999999999999999999999999999986 5789999999998876554 3455667
Q ss_pred ccccccccCcccccccCC---------CCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~---------~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
.+||..||+||.+..... +.++++||||||||||+|+.|++||..-. .++.++..+
T Consensus 521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI------------- 585 (677)
T KOG0596|consen 521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI------------- 585 (677)
T ss_pred ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh-------------
Confidence 899999999999854211 25678999999999999999999995311 111111110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
+.....+.|....++ .++.++++.||.+||++|||+.++|+|||+...
T Consensus 586 ----------~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 586 ----------TDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred ----------cCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 001111222222221 238999999999999999999999999999853
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=255.69 Aligned_cols=179 Identities=23% Similarity=0.397 Sum_probs=141.0
Q ss_pred CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++. .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--- 153 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--- 153 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc---
Confidence 468887774 3346999999999999999999999999999999999999999999999999998765433221
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 154 ~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~--------------------- 210 (280)
T cd05608 154 TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------------------- 210 (280)
T ss_pred ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---------------------
Confidence 234578999999999987 678899999999999999999999997654321111100
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
..... .. ......++..+.+|+.+||+.||++|+ |++++++||||+++.
T Consensus 211 --~~~~~-~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 211 --QRILN-DS---VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred --Hhhcc-cC---CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 00000 01 112235788999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=260.47 Aligned_cols=174 Identities=21% Similarity=0.422 Sum_probs=143.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 85 ~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---~~~~~ 161 (323)
T cd05615 85 GGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---TTRTF 161 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc---cccCc
Confidence 479999999888999999999999999999999999999999999999999999999999999875432211 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+...
T Consensus 162 ~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~----------------------- 216 (323)
T cd05615 162 CGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH----------------------- 216 (323)
T ss_pred cCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 79999999999987 67899999999999999999999999877654333322210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~ 211 (449)
. . .....++..+.+|+.+||..||.+|++ .+++++||||..+
T Consensus 217 ---~--~---~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 217 ---N--V---SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred ---C--C---CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0 0 112346788999999999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=267.65 Aligned_cols=180 Identities=27% Similarity=0.414 Sum_probs=141.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC--------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-------- 73 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~-------- 73 (449)
+++|.++|...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 85 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~ 164 (376)
T cd05598 85 GGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164 (376)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccc
Confidence 479999999988899999999999999999999999999999999999999999999999999753210000
Q ss_pred --------------------------------CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCC
Q 013122 74 --------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121 (449)
Q Consensus 74 --------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~ 121 (449)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyell~G~~ 242 (376)
T cd05598 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVILYEMLVGQP 242 (376)
T ss_pred ccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccceeeehhhCCC
Confidence 0000123579999999999987 678999999999999999999999
Q ss_pred CCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC---C
Q 013122 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---T 198 (449)
Q Consensus 122 pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp---T 198 (449)
||.+.+..+....+... ... .. ......+++.+.+||.+|+ .+|.+|+ |
T Consensus 243 Pf~~~~~~~~~~~i~~~------------------------~~~--~~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 243 PFLADTPAETQLKVINW------------------------ETT--LH-IPSQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred CCCCCCHHHHHHHHhcc------------------------Ccc--cc-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 99877654332222110 000 00 1112357889999999977 5999999 9
Q ss_pred HHHHHcCcccccc
Q 013122 199 AEEALADPYFKGL 211 (449)
Q Consensus 199 a~elL~hp~f~~~ 211 (449)
+.++++||||+++
T Consensus 295 ~~ell~h~~~~~~ 307 (376)
T cd05598 295 ADEIKAHPFFKGI 307 (376)
T ss_pred HHHHhCCCCcCCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.92 Aligned_cols=180 Identities=26% Similarity=0.453 Sum_probs=141.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------- 74 (449)
+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 164 (377)
T cd05629 85 GGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164 (377)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccc
Confidence 5799999998888999999999999999999999999999999999999999999999999998632110000
Q ss_pred -----c--------------------------------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhh
Q 013122 75 -----A--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 117 (449)
Q Consensus 75 -----~--------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl 117 (449)
. ......+||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell 242 (377)
T cd05629 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWSLGAIMFECL 242 (377)
T ss_pred cccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEecchhhhhhh
Confidence 0 00012479999999999977 67899999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC-
Q 013122 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR- 196 (449)
Q Consensus 118 tG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~R- 196 (449)
+|.+||.+.+..+.+..+... .. ...+ .....++..+.+||.+||. +|.+|
T Consensus 243 tG~~Pf~~~~~~~~~~~i~~~------------------------~~--~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 243 IGWPPFCSENSHETYRKIINW------------------------RE--TLYF-PDDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred cCCCCCCCCCHHHHHHHHHcc------------------------CC--ccCC-CCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999876654443332210 00 0111 1112468899999999997 77775
Q ss_pred --CCHHHHHcCcccccc
Q 013122 197 --PTAEEALADPYFKGL 211 (449)
Q Consensus 197 --pTa~elL~hp~f~~~ 211 (449)
+|+.++|.||||++.
T Consensus 295 ~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 295 GRGGAHEIKSHPFFRGV 311 (377)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=260.46 Aligned_cols=201 Identities=24% Similarity=0.381 Sum_probs=145.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~ 161 (331)
T cd06649 87 GGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANS 161 (331)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-----ccc
Confidence 369999999888899999999999999999999986 69999999999999999999999999987553321 234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHH--------------
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA-------------- 146 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~-------------- 146 (449)
..|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+...........
T Consensus 162 ~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 162 FVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred CCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 578999999999987 6789999999999999999999999987654433222211000000000
Q ss_pred -----HHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 147 -----IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 147 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
............+..+....... ......++.+++||.+||.+||++|||++++|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00000000011111111111111 1112467899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=250.58 Aligned_cols=201 Identities=43% Similarity=0.763 Sum_probs=163.9
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~ 157 (282)
T cd07829 81 DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---TYTH 157 (282)
T ss_pred CcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc---ccCc
Confidence 56899999886 5799999999999999999999999999999999999999999999999999876543221 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+....+..+...++.+....+..+.... .+..
T Consensus 158 ~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 234 (282)
T cd07829 158 EVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYKP 234 (282)
T ss_pred cccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--cccc
Confidence 4567889999998762 378899999999999999999999999999888899999999988887776553322 1111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.............++..+..+.+||.+||..||++||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 112222223334556678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=254.68 Aligned_cols=202 Identities=39% Similarity=0.705 Sum_probs=156.9
Q ss_pred CCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~-----~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~ 74 (449)
|+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 88 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~- 166 (295)
T cd07837 88 LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK- 166 (295)
T ss_pred cCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCcc-
Confidence 457888888653 35899999999999999999999999999999999999998 88999999999875432211
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+....+..+...++.+....+.......
T Consensus 167 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T cd07837 167 --SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243 (295)
T ss_pred --ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhcc
Confidence 11334578899999988652 457899999999999999999999999988888887888877877766554332211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
... ......+.......+.++..+.+||.+||..||.+|||++|+|.||||+
T Consensus 244 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 244 DWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 100 0111111222233456789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=250.88 Aligned_cols=202 Identities=40% Similarity=0.704 Sum_probs=160.6
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~ 156 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---TY 156 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc---cc
Confidence 3567889988776 699999999999999999999999999999999999999999999999999875432211 11
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+.++.+..+.+..+... ..+
T Consensus 157 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 233 (283)
T cd07835 157 THEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL--PDY 233 (283)
T ss_pred CccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc--hhh
Confidence 334568899999987652 35788999999999999999999999998888777788888888877766543221 122
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
................+.++..+.+||.+||+.||.+|||++|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 22222222223334456778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.27 Aligned_cols=174 Identities=25% Similarity=0.436 Sum_probs=142.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---TTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---ccccc
Confidence 468999998888899999999999999999999999999999999999999999999999999875322211 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~------------------------ 210 (321)
T cd05603 157 CGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH------------------------ 210 (321)
T ss_pred cCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc------------------------
Confidence 79999999999977 6789999999999999999999999987654333222110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa----~elL~hp~f~~~ 211 (449)
. +. ...+..+..+.+||.+||+.||.+|+++ .++++|+||..+
T Consensus 211 ---~-~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 ---K-PL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred ---C-CC---CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 0 11 1223567889999999999999999875 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=260.89 Aligned_cols=183 Identities=22% Similarity=0.448 Sum_probs=140.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 156 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 156 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---ccccc
Confidence 478999998888899999999999999999999999999999999999999999999999999875322211 12446
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.... .. .....
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~~~-----~~---~~~~~ 216 (329)
T cd05618 157 CGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNT-----ED---YLFQV 216 (329)
T ss_pred cCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCC----------ccccc-----HH---HHHHH
Confidence 79999999999987 6789999999999999999999999953211000 00000 00 00000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT------a~elL~hp~f~~~ 211 (449)
+.. ... ......+..+.+||.+||+.||.+|+| ++++++||||+.+
T Consensus 217 i~~-~~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 217 ILE-KQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred Hhc-CCC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 101 111 122356888999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=265.26 Aligned_cols=181 Identities=25% Similarity=0.394 Sum_probs=139.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------- 74 (449)
+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 85 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~ 164 (381)
T cd05626 85 GGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGS 164 (381)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccc
Confidence 4799999999888999999999999999999999999999999999999999999999999997532110000
Q ss_pred -------------------------------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhh
Q 013122 75 -------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 117 (449)
Q Consensus 75 -------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl 117 (449)
.......+||..|+|||++.+ ..++.++|||||||++|||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlG~il~ell 242 (381)
T cd05626 165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSVGVILFEML 242 (381)
T ss_pred cccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeehhhHHHHHH
Confidence 000123579999999999987 67899999999999999999
Q ss_pred hCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhh--cCCCC
Q 013122 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA--FEPKD 195 (449)
Q Consensus 118 tG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~--~DP~~ 195 (449)
+|..||.+.+.......+... .. ... ......+++++.+||.+||. .++..
T Consensus 243 tG~~Pf~~~~~~~~~~~i~~~------------------------~~--~~~-~~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 243 VGQPPFLAPTPTETQLKVINW------------------------EN--TLH-IPPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred hCCCCCcCCCHHHHHHHHHcc------------------------cc--ccC-CCCCCCCCHHHHHHHHHHccCcccccC
Confidence 999999876643332222110 00 000 11123468999999999664 45556
Q ss_pred CCCHHHHHcCcccccc
Q 013122 196 RPTAEEALADPYFKGL 211 (449)
Q Consensus 196 RpTa~elL~hp~f~~~ 211 (449)
|++++++++||||+++
T Consensus 296 R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 296 RNGADDIKAHPFFSEV 311 (381)
T ss_pred CCCHHHHhcCcccCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=264.96 Aligned_cols=180 Identities=28% Similarity=0.446 Sum_probs=142.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------- 74 (449)
+++|.+++.++..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~ 164 (360)
T cd05627 85 GGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164 (360)
T ss_pred CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccc
Confidence 4799999998889999999999999999999999999999999999999999999999999998654221100
Q ss_pred -------------------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCch
Q 013122 75 -------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 129 (449)
Q Consensus 75 -------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~ 129 (449)
.......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~ 242 (360)
T cd05627 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242 (360)
T ss_pred cCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCCCCCCCCCHH
Confidence 001124579999999999987 67999999999999999999999999877654
Q ss_pred hhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCc
Q 013122 130 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADP 206 (449)
Q Consensus 130 ~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp---Ta~elL~hp 206 (449)
..+..+... .....+.. ...+++.+++||.+|+. ||.+|+ +++++++||
T Consensus 243 ~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 243 ETYRKVMNW--------------------------KETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHP 294 (360)
T ss_pred HHHHHHHcC--------------------------CCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence 433322210 00111111 12368899999999874 999998 489999999
Q ss_pred ccccc
Q 013122 207 YFKGL 211 (449)
Q Consensus 207 ~f~~~ 211 (449)
||+++
T Consensus 295 ~f~~~ 299 (360)
T cd05627 295 FFEGV 299 (360)
T ss_pred CCCCC
Confidence 99975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=264.58 Aligned_cols=174 Identities=29% Similarity=0.475 Sum_probs=147.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|++.++++....+.+.++..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+......... ..++
T Consensus 95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r---r~tf 171 (467)
T KOG0201|consen 95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR---RKTF 171 (467)
T ss_pred CcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc---cccc
Confidence 4788888888877899999999999999999999999999999999999999999999999999876554332 3678
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|||||++.+ ..|+.++||||||++.+||++|.+|+........ +-.
T Consensus 172 vGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------------------------lfl 222 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------------------------LFL 222 (467)
T ss_pred cccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---------------------------EEe
Confidence 99999999999997 7999999999999999999999999976554221 111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
+.+..+..+.. .+++.+++||..||..||+.||+|.++|+|+|++.
T Consensus 223 Ipk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 223 IPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 22222222222 67889999999999999999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=258.67 Aligned_cols=211 Identities=43% Similarity=0.726 Sum_probs=156.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++...............
T Consensus 99 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 177 (342)
T cd07854 99 ETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177 (342)
T ss_pred cccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccc
Confidence 5678888765 46999999999999999999999999999999999999985 557899999998765332221112233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+......+..+........... ...
T Consensus 178 ~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 255 (342)
T cd07854 178 GLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPS-FVR 255 (342)
T ss_pred ccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhh-hhh
Confidence 4678899999987542 46788999999999999999999999988877766666655544444333322211111 111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~ 215 (449)
........++....+..+..+.+||.+||+.||.+|||++++|.||||+.+..+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 256 NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred hcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 1111112223334566889999999999999999999999999999999775543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=263.69 Aligned_cols=179 Identities=26% Similarity=0.391 Sum_probs=142.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 127 gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~--~~~~~ 203 (370)
T cd05596 127 GGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV--RCDTA 203 (370)
T ss_pred CCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc--cCCCC
Confidence 47899988764 6999999999999999999999999999999999999999999999999998765332111 12346
Q ss_pred cccccccCccccccc--CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~--~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..|..
T Consensus 204 ~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~---------------------- 261 (370)
T cd05596 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD---------------------- 261 (370)
T ss_pred CCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc----------------------
Confidence 799999999998652 12478899999999999999999999988765443333221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~ 210 (449)
......+. ....++..+.+||.+||..+|.+ |+|++++++||||+.
T Consensus 262 ----~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 262 ----HKNSLTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred ----CCCcCCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 00111111 12357899999999999999988 999999999999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=259.11 Aligned_cols=182 Identities=25% Similarity=0.469 Sum_probs=143.3
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.+ ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......... ....
T Consensus 85 ~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~--~~~~ 162 (332)
T cd05623 85 GGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSV 162 (332)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc--eecc
Confidence 5799999987 457999999999999999999999999999999999999999999999999998754322211 1234
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-------------------- 222 (332)
T cd05623 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------------------- 222 (332)
T ss_pred cccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC--------------------
Confidence 5799999999998531 14678899999999999999999999987765444333221
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~~ 211 (449)
......+......+++.+++||.+||..++.+ |++++++++||||.++
T Consensus 223 ------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 223 ------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 11112233344567899999999999765544 6899999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=251.16 Aligned_cols=199 Identities=39% Similarity=0.740 Sum_probs=147.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
+.|..++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........ ......
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~ 161 (286)
T cd07847 85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---DYTDYV 161 (286)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc---cccCcc
Confidence 34555666666799999999999999999999999999999999999999999999999999976543321 123456
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
++..|+|||.+.+. ..++.++||||+||++|+|++|.+||.+.+..+.+..+...++............. .+...+
T Consensus 162 ~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 237 (286)
T cd07847 162 ATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN---QFFKGL 237 (286)
T ss_pred cccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc---cccccc
Confidence 78899999998652 45788999999999999999999999988776666655554443322211110000 000000
Q ss_pred ccCC---CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 163 RKKK---PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 163 ~~~~---~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.... ..+....++.++..+.+||.+||..||++|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 011122345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=250.13 Aligned_cols=202 Identities=48% Similarity=0.824 Sum_probs=162.7
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... .....
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---~~~~~ 157 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---RPYTH 157 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---ccccC
Confidence 56788888764 579999999999999999999999999999999999999999999999999987664432 11234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+. ..++.++|+|||||++|+|++|+.+|.+.+..+++..+...++.+..+.+....... .....
T Consensus 158 ~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 235 (283)
T cd05118 158 YVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA-RNYKF 235 (283)
T ss_pred ccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh-hhhhh
Confidence 5688899999998762 368899999999999999999999999999888888888888888777666543311 11111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..............+.++..+.+||.+||..||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 122222222333445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=261.66 Aligned_cols=182 Identities=23% Similarity=0.427 Sum_probs=141.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTF 156 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---ceecc
Confidence 478999998888899999999999999999999999999999999999999999999999999875322111 12456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..+. ....
T Consensus 157 ~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---------~~~~-----------~~~~ 214 (327)
T cd05617 157 CGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---------TEDY-----------LFQV 214 (327)
T ss_pred cCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------cHHH-----------HHHH
Confidence 79999999999987 678999999999999999999999996433211100 0000 0000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT------a~elL~hp~f~~~~ 212 (449)
+ ...+.. ....++..+.+||.+||+.||.+|++ +++++.||||+.+.
T Consensus 215 ~-~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 215 I-LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred H-HhCCCC---CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 0 011111 12346788999999999999999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=254.74 Aligned_cols=205 Identities=38% Similarity=0.679 Sum_probs=156.4
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC------
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------ 74 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------ 74 (449)
+++|...+... ..+++..++.++.||++||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 98 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 177 (311)
T cd07866 98 DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177 (311)
T ss_pred CcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCc
Confidence 45677777653 46999999999999999999999999999999999999999999999999999765332211
Q ss_pred --ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 75 --AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 75 --~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
....+...++..|+|||++.+. ..++.++|||||||++|+|++|+++|.+.+.......+....+.+.+..+.....
T Consensus 178 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T cd07866 178 GGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS 256 (311)
T ss_pred ccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhh
Confidence 1112345678899999988652 4578899999999999999999999999998888888888888776655443211
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
...... .......+......+....+.+.+||.+||..||.+|||+.++|.||||
T Consensus 257 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 257 LPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred cccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 100000 0001111112223345566889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=253.33 Aligned_cols=205 Identities=34% Similarity=0.578 Sum_probs=154.6
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-ccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-~~~~~ 79 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......... .....
T Consensus 102 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 181 (310)
T cd07865 102 EHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181 (310)
T ss_pred CcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCcc
Confidence 567888877654 6999999999999999999999999999999999999999999999999998765332211 11123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||.+.+. ..++.++||||+||++|+|++|.++|.+.+....+..+..+.|..+.+.+...........+
T Consensus 182 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (310)
T cd07865 182 NRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKM 260 (310)
T ss_pred CcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhc
Confidence 45678899999988652 34788999999999999999999999998888888888888887776655443221111110
Q ss_pred hhhccCCCCCCC--CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFS--QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~--~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
. .......... ......+..+.+||.+||..||.+|||++++|+||||
T Consensus 261 ~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 261 E-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred c-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 0000000000 0011246778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=251.20 Aligned_cols=202 Identities=40% Similarity=0.745 Sum_probs=158.7
Q ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 1 MESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 1 me~dL~~~i~~~~---~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~---~ 156 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN---T 156 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc---c
Confidence 3568888887643 589999999999999999999999999999999999999999999999999875432211 1
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....++..|++||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.|....+..+... ..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 233 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL--PE 233 (284)
T ss_pred cccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC--ch
Confidence 2345678899999988652 45788999999999999999999999999888888888888888877766554311 11
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
+................+..+..+.++|.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111111111111122334568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=251.63 Aligned_cols=203 Identities=38% Similarity=0.715 Sum_probs=153.9
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~ 161 (291)
T cd07844 85 LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---TYS 161 (291)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc---ccc
Confidence 3568999887653 689999999999999999999999999999999999999999999999999865422111 112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC-chhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.+. ..++.++||||+||++|+|++|+.||.+.. ..+++..+.+.++.+..+.+..+........
T Consensus 162 ~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 162 NEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred ccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 33567889999998652 457889999999999999999999998766 5567777888888887776654432100000
Q ss_pred HhhhccCCCCCCCCCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNAN--PLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s--~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
...............+.++ ..+.+||.+||..||.+|||+.++|+||||
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 -YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred -ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000111111222233444 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=245.57 Aligned_cols=176 Identities=26% Similarity=0.434 Sum_probs=140.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++................
T Consensus 88 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 167 (263)
T cd06625 88 GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167 (263)
T ss_pred CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCC
Confidence 46899999988889999999999999999999999999999999999999999999999999987653322211111345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.
T Consensus 168 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------------------------- 220 (263)
T cd06625 168 TGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA------------------------- 220 (263)
T ss_pred CcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh-------------------------
Confidence 68889999999987 568899999999999999999999997644322211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.... .......++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 221 -~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 221 -TQPT---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -ccCC---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0000 111223568889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=263.08 Aligned_cols=175 Identities=32% Similarity=0.483 Sum_probs=153.9
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|||.+.|+... .++++.++.|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+....... ...
T Consensus 88 Gg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~---~a~ 164 (426)
T KOG0589|consen 88 GGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS---LAS 164 (426)
T ss_pred CCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh---hhh
Confidence 589999998765 489999999999999999999999999999999999999999999999999998876542 336
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|++||++.+ ..|+.++|||||||++|||++-++.|.+.+.......|......|.
T Consensus 165 tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl---------------- 226 (426)
T KOG0589|consen 165 TVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL---------------- 226 (426)
T ss_pred eecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC----------------
Confidence 7899999999999999 7999999999999999999999999999998777766665433222
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
....+.+++.||..||..+|..||++.++|.+|.+...
T Consensus 227 --------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 227 --------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred --------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 23457789999999999999999999999999887644
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=256.13 Aligned_cols=210 Identities=42% Similarity=0.662 Sum_probs=164.1
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC--------
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-------- 72 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~-------- 72 (449)
|+++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 102 ~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 181 (335)
T PTZ00024 102 MASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181 (335)
T ss_pred cccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccc
Confidence 467899999988889999999999999999999999999999999999999999999999999987654111
Q ss_pred ---CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHH
Q 013122 73 ---PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 149 (449)
Q Consensus 73 ---~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~ 149 (449)
..........++..|+|||.+.+. ..++.++|+|||||++|+|++|.+||.+.+..+.+..+...++.|....|..
T Consensus 182 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (335)
T PTZ00024 182 ETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQ 260 (335)
T ss_pred ccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcc
Confidence 001112334568889999998763 4578899999999999999999999999998888888888888887655443
Q ss_pred HhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 150 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
..... .+ .......+..+...++..+..+.+||.+||+.||++|||++|+|.||||+.....
T Consensus 261 ~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 261 AKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred hhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 21100 00 0011111222233445678899999999999999999999999999999976544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=259.38 Aligned_cols=169 Identities=29% Similarity=0.479 Sum_probs=138.1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC--CCccccccccccccccCccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT--PTAIFWTDYVATRWYRAPEL 92 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~--~~~~~~~~~~gt~~Y~APE~ 92 (449)
|++.+++.|+++++.||.|||.+|||||||||+|+|++.+|.+||+|||.+....... .....+...+||+.|+|||+
T Consensus 207 ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 207 LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 8999999999999999999999999999999999999999999999999987653221 11223445789999999999
Q ss_pred cccc--CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCC
Q 013122 93 CGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 170 (449)
Q Consensus 93 l~~~--~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (449)
+.+. ....+.+.||||+||+||.|+.|+.||-+....+..++|.. .+..+
T Consensus 287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn----------------------------~pL~f 338 (576)
T KOG0585|consen 287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN----------------------------DPLEF 338 (576)
T ss_pred hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc----------------------------CcccC
Confidence 8662 12346789999999999999999999988776666555532 11111
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 171 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 171 ~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...+.+.+.+++||.+||.+||++|++..++..|||...-.
T Consensus 339 -P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 339 -PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred -CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 12346788999999999999999999999999999997653
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=261.13 Aligned_cols=179 Identities=26% Similarity=0.391 Sum_probs=140.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ......
T Consensus 127 gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~--~~~~~~ 203 (370)
T cd05621 127 GGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM--VRCDTA 203 (370)
T ss_pred CCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc--eecccC
Confidence 47999999765 699999999999999999999999999999999999999999999999999976532221 112456
Q ss_pred cccccccCcccccccC--CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 204 ~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--------------------- 262 (370)
T cd05621 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--------------------- 262 (370)
T ss_pred CCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------------------
Confidence 7999999999986521 23788999999999999999999999877654443332211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~ 210 (449)
.....+. ....++..+++||.+||..++.+ |+|++|+++||||+.
T Consensus 263 -----~~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 263 -----KNSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred -----CcccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 0011111 11346889999999999855543 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=255.48 Aligned_cols=182 Identities=24% Similarity=0.462 Sum_probs=141.8
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 162 (331)
T cd05597 85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QSNV 162 (331)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--cccc
Confidence 5799999976 457999999999999999999999999999999999999999999999999998764332211 1123
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.+||+.|+|||++... ...++.++||||+||++|+|++|+.||.+.+..+.+..+..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 222 (331)
T cd05597 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------------------- 222 (331)
T ss_pred eeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 5699999999998631 13578899999999999999999999987665443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~~ 211 (449)
......+....+.++..+++||.+||..++++ |++++++|+||||.++
T Consensus 223 ------~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 223 ------HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ------CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 11111223334457899999999999765444 7899999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=247.66 Aligned_cols=202 Identities=37% Similarity=0.702 Sum_probs=150.4
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
+.|..++.....+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++........ ......
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~ 161 (286)
T cd07846 85 TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYV 161 (286)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc---ccCccc
Confidence 45666666666799999999999999999999999999999999999999999999999999876543321 234567
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
++.+|+|||++.+. ..++.++|||||||++|+|++|+++|.+....+.+..+....+......................
T Consensus 162 ~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 162 ATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred ceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 89999999998652 45778999999999999999999999888777766666665554433221111100000000000
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
...........++.++..+.+||.+||..||.+||++.++|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000111122356778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=251.87 Aligned_cols=206 Identities=41% Similarity=0.666 Sum_probs=149.9
Q ss_pred CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC----CCCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~-----~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~----~~~vKL~DFGlA~~~~~~~ 72 (449)
+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.......
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~ 166 (316)
T cd07842 87 EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166 (316)
T ss_pred CcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCc
Confidence 56777776532 26899999999999999999999999999999999999999 8999999999987654332
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCch---------hhHHHHHhhcCCCC
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---------HQLDIMTDLLGTPS 143 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~---------~~l~~i~~~lg~p~ 143 (449)
.........+++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..+...++.+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 245 (316)
T cd07842 167 KPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPT 245 (316)
T ss_pred ccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCc
Confidence 211122345788999999987652 45788999999999999999999999876543 24556667777766
Q ss_pred HHHHHHHhhHHHHHHHhhhccCCCCC------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 144 PEAIARVRNEKARRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 144 ~e~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
...+.....................+ +.......+..+.+||.+||+.||++|||+.|+++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 246 EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 65554332211100000000000000 001112567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=270.16 Aligned_cols=178 Identities=26% Similarity=0.446 Sum_probs=144.6
Q ss_pred CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~----~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.++|+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 123 ~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~-~~ 201 (496)
T PTZ00283 123 AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD-DV 201 (496)
T ss_pred CCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccc-cc
Confidence 47899988753 36999999999999999999999999999999999999999999999999998765432211 12
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-------------------- 259 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-------------------- 259 (496)
T ss_pred cccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999987 6799999999999999999999999987654333222110
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. .....+.+++.+.+||.+||..||.+||++.++|+|||++.+.
T Consensus 260 -------~~---~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 260 -------GR---YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred -------CC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 00 1112345788999999999999999999999999999998654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=252.76 Aligned_cols=170 Identities=26% Similarity=0.495 Sum_probs=148.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|+|||...+.|++.+++.|++||..|+.|+|.++++|||||.+|||++.++++||+|||++..+... .++.++
T Consensus 137 ~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~----kfLqTF 212 (668)
T KOG0611|consen 137 GGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK----KFLQTF 212 (668)
T ss_pred CccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc----cHHHHh
Confidence 5899999999999999999999999999999999999999999999999999999999999999766443 367889
Q ss_pred cccccccCcccccccCCCC-CCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
||++.|.+||++.| ..| ++.+|.||||++||-|+.|..||.|.+....+..|...-
T Consensus 213 CGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga--------------------- 269 (668)
T KOG0611|consen 213 CGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA--------------------- 269 (668)
T ss_pred cCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc---------------------
Confidence 99999999999988 444 689999999999999999999999988766555543210
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
-.-|..+..+.-||+.||..||++|.|++++-.|=|++
T Consensus 270 -----------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 -----------YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -----------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 01134456788999999999999999999999997775
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=249.77 Aligned_cols=207 Identities=40% Similarity=0.703 Sum_probs=157.6
Q ss_pred CCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCccc
Q 013122 1 MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 1 me~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
|+++|.+++..... +++..++.++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~---~ 159 (294)
T PLN00009 83 LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR---T 159 (294)
T ss_pred ccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc---c
Confidence 35678888876553 588899999999999999999999999999999999985 55799999999975433211 1
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....++..|+|||.+.+. ..++.++||||+||++|+|++|.+||.+....+.+..+...++.+....+...... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 236 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL--PD 236 (294)
T ss_pred cccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc--hh
Confidence 2345678899999988652 45788999999999999999999999988877777777777787776655432211 11
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
+................+..++.+.+||.+||+.||++||++.++|+||||.++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 11111111111222234567889999999999999999999999999999997654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=270.05 Aligned_cols=204 Identities=26% Similarity=0.287 Sum_probs=142.7
Q ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~-----~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.+++.... ......++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++.........
T Consensus 246 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-- 323 (501)
T PHA03210 246 DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-- 323 (501)
T ss_pred ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccc--
Confidence 456777765432 2446778899999999999999999999999999999999999999999999765432211
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCC-CCCC--CchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGK--NVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~p-F~~~--~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.....+||..|+|||++.+ ..++.++|||||||++|||++|..+ |.+. +...++..+...++....++.. . ..
T Consensus 324 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~-~~ 399 (501)
T PHA03210 324 FDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD-P-PC 399 (501)
T ss_pred ccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCC-c-HH
Confidence 1234679999999999987 6799999999999999999998754 4322 2334455555544433222110 0 01
Q ss_pred HHHHHHhhhcc-CCCCCCCCC--CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 154 KARRYLSSMRK-KKPIPFSQK--FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 154 ~~~~~~~~~~~-~~~~~~~~~--~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
....++..... ..+..+... ...++..+.++|.+||++||.+|||+.|+|.||||...
T Consensus 400 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 400 KLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11222211110 000111111 12356778999999999999999999999999999753
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=247.96 Aligned_cols=202 Identities=38% Similarity=0.699 Sum_probs=150.9
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~g 83 (449)
.|..++.+...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........ ......++
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~ 163 (288)
T cd07833 86 LLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA--SPLTDYVA 163 (288)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--ccccCccc
Confidence 4445555556799999999999999999999999999999999999999999999999999877544332 12245678
Q ss_pred cccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhc
Q 013122 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMR 163 (449)
Q Consensus 84 t~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~ 163 (449)
+.+|+|||++.+. ..++.++|||||||++|+|++|+++|.+.+..+.+..+...++...+...................
T Consensus 164 ~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07833 164 TRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242 (288)
T ss_pred ccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCC
Confidence 8999999999772 378899999999999999999999999888777777777766665554333221110000000000
Q ss_pred cCCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 164 KKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 164 ~~~~~~~~~~~~~-~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
......+...++. ++..+.+||.+||..||++|||++++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000011112233 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=246.11 Aligned_cols=197 Identities=42% Similarity=0.721 Sum_probs=153.6
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........ ..
T Consensus 89 ~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~----~~ 164 (287)
T cd07838 89 DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA----LT 164 (287)
T ss_pred ccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc----cc
Confidence 457888887644 499999999999999999999999999999999999999999999999999876543321 13
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++.+ ..++.++|+||+||++|+|++|.++|.+.+..+.+..+.+..+.+....+........
T Consensus 165 ~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 238 (287)
T cd07838 165 SVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR---- 238 (287)
T ss_pred cccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch----
Confidence 3457889999999987 5788999999999999999999999999888888877777666554433221110000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..........+....+..++.+.+||.+||+.||.+||+++++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0011111222233345667889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=246.60 Aligned_cols=177 Identities=36% Similarity=0.582 Sum_probs=140.5
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....+++..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+...... ........
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~ 159 (260)
T PF00069_consen 83 GSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---NENFNPFV 159 (260)
T ss_dssp EBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST---TSEBSSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccc
Confidence 389999997778999999999999999999999999999999999999999999999999998754111 11235667
Q ss_pred ccccccCccccc-ccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 83 ATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 83 gt~~Y~APE~l~-~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
++..|+|||++. + ..++.++||||||+++|+|++|..||......+....+...... .....
T Consensus 160 ~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~ 222 (260)
T PF00069_consen 160 GTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR---------------PLPSS 222 (260)
T ss_dssp SSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT---------------HHHHH
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhcccc---------------ccccc
Confidence 899999999987 4 57889999999999999999999999877443433333221110 00000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. ........+.+||.+||+.||++|||+.++++||||
T Consensus 223 ~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 SQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 001112789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=243.95 Aligned_cols=201 Identities=42% Similarity=0.748 Sum_probs=159.1
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~ 156 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YT 156 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC----cC
Confidence 678999888765 789999999999999999999999999999999999999999999999999876543221 24
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++... ..++.++|+||||+++++|++|+++|++.+..+.+..+...++.+....+....... ...-
T Consensus 157 ~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 234 (283)
T cd07830 157 DYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA-SKLG 234 (283)
T ss_pred CCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh-cccc
Confidence 46788999999988542 457899999999999999999999999999888888888888888776554321110 0000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..+...........++..+..+.+||.+||..||++|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011111111222334557889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=259.39 Aligned_cols=202 Identities=33% Similarity=0.578 Sum_probs=160.0
Q ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~---~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
.-+|.++|++-+ .|....+..+++||+.||..|-..||+|.||||+|||++... .+||||||.|.......
T Consensus 517 slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene----- 591 (752)
T KOG0670|consen 517 SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE----- 591 (752)
T ss_pred hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc-----
Confidence 357899998766 499999999999999999999999999999999999999865 58999999997765443
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh--hHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR--NEKA 155 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~--~~~~ 155 (449)
.+.|..++.|+|||++.| -.|+...|+||+||.||||.||+.+|+|....+.+..++++-|..+..++..-. +..+
T Consensus 592 itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHF 669 (752)
T KOG0670|consen 592 ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHF 669 (752)
T ss_pred ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhc
Confidence 367888999999999999 689999999999999999999999999999999999999999988877665421 1111
Q ss_pred HHHHhhh----------------ccCCC-CCCC------CCCC----CCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 156 RRYLSSM----------------RKKKP-IPFS------QKFP----NANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 156 ~~~~~~~----------------~~~~~-~~~~------~~~~----~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..-+..+ ....| ..+. +.++ .+-..+++||.+||..||++|.|+.++|.||||
T Consensus 670 D~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 670 DQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred ccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcc
Confidence 1101000 00011 0000 0011 122468999999999999999999999999999
Q ss_pred cc
Q 013122 209 KG 210 (449)
Q Consensus 209 ~~ 210 (449)
.+
T Consensus 750 ~~ 751 (752)
T KOG0670|consen 750 TE 751 (752)
T ss_pred cC
Confidence 74
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=246.81 Aligned_cols=179 Identities=22% Similarity=0.349 Sum_probs=139.4
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........ ..
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~~ 152 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----IT 152 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----ee
Confidence 468888886544 489999999999999999999999999999999999999999999999999876543221 23
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+ .
T Consensus 153 ~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~-----------------------~ 207 (277)
T cd05607 153 QRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL-----------------------K 207 (277)
T ss_pred ccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH-----------------------H
Confidence 4568999999999987 56899999999999999999999999764321110000 0
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa----~elL~hp~f~~~~ 212 (449)
...... . .......+++.+.+||.+||+.||++||++ ++++.||||+.+.
T Consensus 208 ~~~~~~-~--~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 208 RRTLED-E--VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred HHhhcc-c--cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 000000 0 111123568899999999999999999999 7788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=248.36 Aligned_cols=177 Identities=27% Similarity=0.400 Sum_probs=141.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~ 155 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHAS 155 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-----ccCc
Confidence 47899999988889999999999999999999999999999999999999999999999999986543221 1234
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|+|||.+... ..++.++||||+||++|+|++|..||.+....... .+. ...
T Consensus 156 ~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~--------------------~~~-- 211 (279)
T cd05633 156 VGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EID--------------------RMT-- 211 (279)
T ss_pred CCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHH--------------------HHh--
Confidence 689999999998631 46789999999999999999999999754321110 000 000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
.... ....+..+..+.+||.+||..||.+|+ |+.++++||||+++.
T Consensus 212 --~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 212 --LTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred --hcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0000 112345688999999999999999999 699999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=257.23 Aligned_cols=179 Identities=25% Similarity=0.369 Sum_probs=140.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 127 gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~--~~~~~ 203 (371)
T cd05622 127 GGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--RCDTA 203 (371)
T ss_pred CCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc--cccCc
Confidence 47899998765 6999999999999999999999999999999999999999999999999999765432211 12356
Q ss_pred cccccccCcccccccC--CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+||+.|+|||++.+.. ..++.++|||||||++|||++|..||.+.+.......|...
T Consensus 204 ~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------------- 262 (371)
T cd05622 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--------------------- 262 (371)
T ss_pred ccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------------
Confidence 7999999999986521 23788999999999999999999999877654333332211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~ 210 (449)
.....+. ....++..+++||.+||..++.+ |++++++++|+||++
T Consensus 263 -----~~~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 263 -----KNSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred -----CCcccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 1111111 22467899999999999844433 789999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=245.41 Aligned_cols=204 Identities=38% Similarity=0.685 Sum_probs=157.1
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++......... ..+
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~ 159 (287)
T cd07840 82 MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA--DYT 159 (287)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--ccc
Confidence 356788888765 47999999999999999999999999999999999999999999999999999766443211 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+....+..+.........
T Consensus 160 ~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 160 NRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred ccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 44678889999987652 46789999999999999999999999998888888888888887776655443221000000
Q ss_pred hhhccCCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~-~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. .......+...+.. .+..+.++|.+||..||.+||+++++++||||
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 00000011122333 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=238.77 Aligned_cols=172 Identities=27% Similarity=0.486 Sum_probs=139.3
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ ...
T Consensus 84 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~ 160 (257)
T cd08223 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MAS 160 (257)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC---ccc
Confidence 36899988763 3589999999999999999999999999999999999999999999999999876543221 223
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++.+ ..++.++|+||+||++++|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---------------------- 216 (257)
T cd08223 161 TLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE---------------------- 216 (257)
T ss_pred cccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh----------------------
Confidence 4568899999999987 6788999999999999999999999976553322211110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. ........++.+.+||.+||+.||.+|||+.++++||||
T Consensus 217 ----~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 ----GK----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----cC----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 011123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=254.25 Aligned_cols=201 Identities=22% Similarity=0.390 Sum_probs=144.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-----~~~ 161 (333)
T cd06650 87 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANS 161 (333)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-----ccc
Confidence 479999999888899999999999999999999985 79999999999999999999999999987543321 134
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHh-hcCCCCHHHHH-----------
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD-LLGTPSPEAIA----------- 148 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~-~lg~p~~e~~~----------- 148 (449)
..|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.. ..+.+......
T Consensus 162 ~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 162 FVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred CCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 578999999999987 5788999999999999999999999987654333222111 11111100000
Q ss_pred HHhh-----HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 149 RVRN-----EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 149 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.... .........+.......+ .....+.++.+||.+||++||++|||++|+|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000 000001111111111111 112357889999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=246.18 Aligned_cols=177 Identities=27% Similarity=0.414 Sum_probs=141.2
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~~ 159 (285)
T cd05605 84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET----IR 159 (285)
T ss_pred CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc----cc
Confidence 46888887654 3599999999999999999999999999999999999999999999999999876532221 13
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+..
T Consensus 160 ~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~---------------------- 215 (285)
T cd05605 160 GRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER---------------------- 215 (285)
T ss_pred cccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH----------------------
Confidence 4578999999999976 6788999999999999999999999987654322221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
.+... . ......++..+.+||.+||+.||.+|| +++++++||||...
T Consensus 216 -~~~~~-~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 216 -RVKED-Q---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -Hhhhc-c---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 00000 0 111234688899999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=252.24 Aligned_cols=182 Identities=23% Similarity=0.462 Sum_probs=142.8
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 85 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~ 162 (331)
T cd05624 85 GGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSV 162 (331)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--eecc
Confidence 5799999987 457999999999999999999999999999999999999999999999999998765432211 1133
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.+||+.|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+..+.+..+..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~-------------------- 222 (331)
T cd05624 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-------------------- 222 (331)
T ss_pred ccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc--------------------
Confidence 5799999999998642 13577899999999999999999999987664433322211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~~ 211 (449)
.....++......++..+++||.+||..++.+ |++++++++||||++.
T Consensus 223 ------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 223 ------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 11112233444567899999999999876654 5799999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=254.03 Aligned_cols=171 Identities=28% Similarity=0.381 Sum_probs=139.2
Q ss_pred CCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccCCcEEEcCCC-CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~g-IvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+|+|.+++.. +..|+...+..|+.||++||.|||+++ |||||||++|||++.++ .+||||||+++...... ..
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~~ 200 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---TS 200 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---cc
Confidence 5899999988 567999999999999999999999999 99999999999999998 99999999998765432 12
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.+...||+.|||||++.+....|+.++||||||+++|||+||+.||.+.........+..
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~-------------------- 260 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV-------------------- 260 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 244689999999999984115799999999999999999999999998776332222111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... .....+++.+..||.+||..||++||++.+++.
T Consensus 261 ------~~~Rp---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 261 ------GGLRP---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ------cCCCC---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 01111 111227888999999999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=242.64 Aligned_cols=203 Identities=24% Similarity=0.351 Sum_probs=157.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC---EEEeecCccccccCCCCC----
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPT---- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGlA~~~~~~~~~---- 74 (449)
+|.|...|.++..|++.++..+++.|+.||+|||.+||.||||||+|||...... ||||||.++.........
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 5788899999989999999999999999999999999999999999999876544 899999987654322221
Q ss_pred ccccccccccccccCccccc---ccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 75 AIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~---~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
...+.+.+|+-.|||||+.. +....|+..+|.||||+|+|-||+|.+||.|....+- |...- ...
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrG----e~C 307 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRG----EVC 307 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCC----Ccc
Confidence 22345678999999999863 3235689999999999999999999999988654221 10000 011
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccC
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 216 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~ 216 (449)
..--...++++......-....|..++.++++||..+|..|+..|.++.++|+|||+++......
T Consensus 308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka 372 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA 372 (463)
T ss_pred HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence 12223456666666555556677889999999999999999999999999999999998765433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=262.62 Aligned_cols=165 Identities=30% Similarity=0.470 Sum_probs=134.5
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE-cCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl-~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+.|.+.|.....+. ..+..|+.+|+.||.|||++|||||||||+|||+ +..+.++|+|||.++..... +...
T Consensus 401 ~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------~~tp 473 (612)
T KOG0603|consen 401 GELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------CDTP 473 (612)
T ss_pred cHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh------hccc
Confidence 34555566655455 7888899999999999999999999999999999 68999999999999876544 2345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+-|..|.|||++.. ..|+.++||||||++||+||+|+.||...... . .|...++.
T Consensus 474 ~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~-ei~~~i~~-------------------- 528 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I-EIHTRIQM-------------------- 528 (612)
T ss_pred chhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch--H-HHHHhhcC--------------------
Confidence 67889999999986 79999999999999999999999999765433 1 11111111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..++ ..+|..+++||++||++||.+|+++.+++.||||
T Consensus 529 ------~~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 529 ------PKFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------Cccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1111 5689999999999999999999999999999999
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=256.19 Aligned_cols=177 Identities=24% Similarity=0.462 Sum_probs=156.8
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+|+|+.+++.++.|.+..+++++..+++|++|||++|||.|||||+|++++.+|-+||.|||+|+....+..+ .+
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT----wT 578 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT----WT 578 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce----ee
Confidence 78999999999999999999999999999999999999999999999999999999999999999988766543 57
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
+|||+.|.|||++.+ ...+.++|.||||+++||||+|.+||.+.+....++.|.+.+..
T Consensus 579 FcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~------------------- 637 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK------------------- 637 (732)
T ss_pred ecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-------------------
Confidence 899999999999988 78999999999999999999999999999988887777543210
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
+ .....++..+.+||+++...+|.+|.. +.++-.|.||.++.
T Consensus 638 -------i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 638 -------I---EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred -------h---hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 0 111245677999999999999999976 89999999998764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=254.18 Aligned_cols=169 Identities=25% Similarity=0.307 Sum_probs=129.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+||..|+|||++
T Consensus 164 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~ 240 (353)
T PLN00034 164 IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---PCNSSVGTIAYMSPERI 240 (353)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc---cccccccCccccCcccc
Confidence 467888999999999999999999999999999999999999999999999876543221 12346799999999987
Q ss_pred ccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCC
Q 013122 94 GSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 170 (449)
Q Consensus 94 ~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (449)
... ....+.++|||||||++|||++|+.||......+....+.. ..... .
T Consensus 241 ~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------------------~~~~~---~ 293 (353)
T PLN00034 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------------------ICMSQ---P 293 (353)
T ss_pred ccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------------------HhccC---C
Confidence 431 02345689999999999999999999974332211111100 00000 1
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 171 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 171 ~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
......++..+++||.+||..||++|||+.|+|+||||.+..
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 122345688999999999999999999999999999998753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=235.00 Aligned_cols=172 Identities=25% Similarity=0.393 Sum_probs=149.2
Q ss_pred CCcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~--~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|+|+..|. ....+++.....+++|++.||.|+|..+|+||||||+|+|++..+.+||+|||.+...... ...
T Consensus 106 ~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-----kR~ 180 (281)
T KOG0580|consen 106 RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-----KRK 180 (281)
T ss_pred CchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC-----Cce
Confidence 478999999 6667999999999999999999999999999999999999999999999999998765422 236
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+.|||.-|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+.+..|.++
T Consensus 181 tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------------------- 237 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------------------- 237 (281)
T ss_pred eeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------------------
Confidence 7899999999999988 68999999999999999999999999887766665555432
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... ....++..+.|||.+||..+|.+|.+..|++.|||+...
T Consensus 238 ---~~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 ---DLK-------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ---ccc-------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 111 115688999999999999999999999999999998753
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=243.16 Aligned_cols=202 Identities=39% Similarity=0.688 Sum_probs=148.0
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++..+ ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++....... ...
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~ 161 (291)
T cd07870 85 MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ---TYS 161 (291)
T ss_pred ccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC---CCC
Confidence 356777776653 4688999999999999999999999999999999999999999999999999875432211 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc-hhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+. .+.+..+...+|.|....+..+.... .+
T Consensus 162 ~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 238 (291)
T cd07870 162 SEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP--NY 238 (291)
T ss_pred CccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc--cc
Confidence 34578899999998652 4578899999999999999999999986553 35555666667777666544432110 00
Q ss_pred Hhhh-ccCCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSM-RKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~-~~~~~~~~~~~~~--~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.... ....+......+. ..+..+.+||.+||..||++|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 0000111111111 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=264.36 Aligned_cols=177 Identities=27% Similarity=0.405 Sum_probs=142.6
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.++|.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~-~~ 227 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL-DV 227 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc-cc
Confidence 4788887753 346999999999999999999999999999999999999999999999999999865432211 12
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 228 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-------------------- 285 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-------------------- 285 (478)
T ss_pred ccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999987 6789999999999999999999999987654333222211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... ......++..+.+||.+||..||++||+++++|.|+|++.+
T Consensus 286 -------~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 286 -------GKY---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -------CCC---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 000 01123467889999999999999999999999999999754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=247.35 Aligned_cols=177 Identities=27% Similarity=0.443 Sum_probs=139.7
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........ ..
T Consensus 84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~~ 159 (285)
T cd05630 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IK 159 (285)
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc----cc
Confidence 468988886543 599999999999999999999999999999999999999999999999999875432221 13
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+. ..+
T Consensus 160 ~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------------~~~ 217 (285)
T cd05630 160 GRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------------RLV 217 (285)
T ss_pred CCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH--------------------hhh
Confidence 3478999999999977 678999999999999999999999997643211111110 011
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 211 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~ 211 (449)
.... .......++.+.+||.+||+.||++|+| ++|+++||||+++
T Consensus 218 ~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 218 KEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 1000 0112346788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=240.99 Aligned_cols=176 Identities=26% Similarity=0.432 Sum_probs=137.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++................
T Consensus 90 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 169 (266)
T cd06651 90 GGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169 (266)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccC
Confidence 36899999888889999999999999999999999999999999999999999999999999987543221111112334
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...........+.
T Consensus 170 ~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~------------------------- 222 (266)
T cd06651 170 TGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA------------------------- 222 (266)
T ss_pred CccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-------------------------
Confidence 58889999999977 578899999999999999999999997543222111110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.... .......+++.+.+|| +||..||++||+++|+++||||+
T Consensus 223 --~~~~--~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 223 --TQPT--NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred --cCCC--CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0000 0111224577888898 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=240.37 Aligned_cols=175 Identities=24% Similarity=0.414 Sum_probs=136.5
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++........ ...
T Consensus 93 ~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 169 (272)
T cd06637 93 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRN 169 (272)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc---cCC
Confidence 35889988864 3589999999999999999999999999999999999999999999999999876433221 124
Q ss_pred cccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 80 DYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
...|+..|+|||++.+. ...++.++||||+||++|+|++|..||...........+
T Consensus 170 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~--------------------- 228 (272)
T cd06637 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------------------- 228 (272)
T ss_pred cccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---------------------
Confidence 46789999999998531 135788999999999999999999999654322111000
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.... . .......++..+.+||.+||..||.+|||+.+++.||||
T Consensus 229 -----~~~~-~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 229 -----PRNP-A--PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -----hcCC-C--CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0000 0 011123467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=245.62 Aligned_cols=204 Identities=38% Similarity=0.652 Sum_probs=155.9
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||++......... ...
T Consensus 98 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~ 175 (302)
T cd07864 98 MDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR--PYT 175 (302)
T ss_pred cCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCccc--ccc
Confidence 3567777777643 6999999999999999999999999999999999999999999999999998765433221 122
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||.+.+. ..++.++|||||||++|+|++|+++|...+....+..+.+..+.+....+..+.........
T Consensus 176 ~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T cd07864 176 NKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTM 254 (302)
T ss_pred cceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccc
Confidence 33567789999988652 45788999999999999999999999988888888888888887776655433211100000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... ..........+..++..+.+||.+||..||.+|||++++|.||||
T Consensus 255 ~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 255 KPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000 000011222344568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=239.21 Aligned_cols=177 Identities=25% Similarity=0.423 Sum_probs=137.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ .....
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 166 (267)
T cd06645 90 GGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA---KRKSF 166 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc---ccccc
Confidence 368999999888999999999999999999999999999999999999999999999999999875533221 12345
Q ss_pred cccccccCcccccc-cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.|+..|+|||++.. ....++.++|+|||||++|+|++|..||........+..+..
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~----------------------- 223 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK----------------------- 223 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-----------------------
Confidence 78999999998742 114578899999999999999999999865432211111000
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 207 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~ 207 (449)
....+ +.......++..+.+||.+||..||++|||++++++|||
T Consensus 224 --~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 --SNFQP-PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --cCCCC-CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00000 111112245778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=239.02 Aligned_cols=174 Identities=28% Similarity=0.475 Sum_probs=141.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..... ....
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------~~~~ 153 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------NKKF 153 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------cccC
Confidence 468999999888899999999999999999999999999999999999999999999999999875432 1234
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 154 ~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------------ 207 (260)
T cd05611 154 VGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS------------------------ 207 (260)
T ss_pred CCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------------------------
Confidence 67889999999887 4588999999999999999999999977654332221110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT---a~elL~hp~f~~~ 211 (449)
............+++.+.+||.+||+.||++||+ ++|+|.||||+.+
T Consensus 208 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 ---RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ---cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 0000111222357889999999999999999995 5899999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=232.07 Aligned_cols=195 Identities=30% Similarity=0.612 Sum_probs=153.3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCccccccccccccccCccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 92 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~ 92 (449)
.|+.-.++.++++||.||.|||+.||+|||+||.|++++... +++|+|+|+|......... .-.+.++.|.-||+
T Consensus 128 tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPEL 203 (338)
T KOG0668|consen 128 TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPEL 203 (338)
T ss_pred hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee----eeeeehhhcCCchh
Confidence 588999999999999999999999999999999999999754 5999999999887665433 44678899999999
Q ss_pred ccccCCCCCCccchhhhHHHHHhhhhCC-CCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH-HHHHhhhccCCCCCC
Q 013122 93 CGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA-RRYLSSMRKKKPIPF 170 (449)
Q Consensus 93 l~~~~~~~s~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~-~~~~~~~~~~~~~~~ 170 (449)
+... ..|+.+-|+|||||+|+.|+..+ +.|.|.+..+|+-.|.+++|+......-.-..-.+ .++-.-+......+|
T Consensus 204 LVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w 282 (338)
T KOG0668|consen 204 LVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPW 282 (338)
T ss_pred eeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccH
Confidence 9874 78999999999999999999877 55689999999999999999754332221111111 112122233333344
Q ss_pred CCCCC-----CCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 171 SQKFP-----NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 171 ~~~~~-----~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
..... -.++++.|||.++|..|-.+|+||.|++.||||..+..
T Consensus 283 ~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 283 SRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 33222 25799999999999999999999999999999986553
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=242.71 Aligned_cols=177 Identities=28% Similarity=0.424 Sum_probs=141.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-----~~~~ 155 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHAS 155 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-----CcCc
Confidence 57899999888889999999999999999999999999999999999999999999999999987543221 1345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+......... ...
T Consensus 156 ~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---------------------~~~--- 210 (278)
T cd05606 156 VGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---------------------DRM--- 210 (278)
T ss_pred CCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---------------------HHH---
Confidence 789999999998752 4688999999999999999999999976532211100 000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
...... ......+..+.+||.+||..||.+|+ ++.++++||||+...
T Consensus 211 -~~~~~~---~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 211 -TLTMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred -hhccCC---CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 000011 11224578999999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=238.06 Aligned_cols=175 Identities=27% Similarity=0.522 Sum_probs=140.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc---ccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA---IFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~---~~~ 78 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||+|+||+++.++.+||+|||+++......... ...
T Consensus 90 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 169 (267)
T cd06628 90 GGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169 (267)
T ss_pred CCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccc
Confidence 46899999988889999999999999999999999999999999999999999999999999987664321111 111
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+....+..+.
T Consensus 170 ~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------------- 225 (267)
T cd06628 170 PSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---------------------- 225 (267)
T ss_pred cccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh----------------------
Confidence 23457889999999877 578889999999999999999999997654322211110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. .........+..+.+||.+||+.||.+||++.++++||||
T Consensus 226 -----~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 226 -----EN---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----cc---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 0111223467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=241.31 Aligned_cols=172 Identities=26% Similarity=0.416 Sum_probs=139.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++...... ..
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-------~~ 165 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-------SC 165 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-------cc
Confidence 479999999888899999999999999999999999999999999999999998 9999999998755322 23
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||++.+ ..++.++|+||+||++|+|++|..||......... . .....
T Consensus 166 ~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-----------~-----------~~~~~ 221 (267)
T PHA03390 166 YDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-----------L-----------ESLLK 221 (267)
T ss_pred CCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-----------H-----------HHHHH
Confidence 458889999999977 57889999999999999999999999754322100 0 00000
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHcCcccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFK 209 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-a~elL~hp~f~ 209 (449)
.. . .........++.+.+||.+||+.||.+|++ ++++|+||||+
T Consensus 222 ~~--~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 222 RQ--Q---KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hh--c---ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 11 0 011223367899999999999999999996 59999999996
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=237.89 Aligned_cols=177 Identities=24% Similarity=0.393 Sum_probs=140.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC---CCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT---PTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~---~~~~~~ 78 (449)
+++|.+++.+...+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++....... ......
T Consensus 86 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (265)
T cd06631 86 GGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165 (265)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccc
Confidence 46899999988889999999999999999999999999999999999999999999999999987542211 111122
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 166 ~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 222 (265)
T cd06631 166 KSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA--------------------- 222 (265)
T ss_pred cccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh---------------------
Confidence 34568999999999987 5788999999999999999999999976543221111100
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
. ...........+..+.+||.+||..||.+||++.++|+||||
T Consensus 223 -----~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 223 -----H--RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -----c--cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 001112234568889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=252.54 Aligned_cols=179 Identities=28% Similarity=0.458 Sum_probs=146.5
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|||+=.|.+.+ .|+++.+.+++.+|+.||.+||..+||.|||||+|||+|+.|+|+|+|+|+|..+....+. .
T Consensus 269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~----~ 344 (591)
T KOG0986|consen 269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI----R 344 (591)
T ss_pred CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc----c
Confidence 578888887776 7999999999999999999999999999999999999999999999999999877655443 4
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||..|||||++.+ ..|+...|.|||||++|||+.|+.||........ .+...+
T Consensus 345 ~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------------------~eEvdr-- 400 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------------------REEVDR-- 400 (591)
T ss_pred cccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------------HHHHHH--
Confidence 5699999999999998 6799999999999999999999999965432111 111111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLAK 213 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~~ 213 (449)
+....+..++ ...++++++|.+.+|..||++|.. ++++-+||||+.+..
T Consensus 401 --r~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 401 --RTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred --HHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 1112222222 356899999999999999999965 679999999998654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=239.93 Aligned_cols=179 Identities=23% Similarity=0.342 Sum_probs=138.7
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ ....
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~ 162 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---RRDS 162 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc---cccc
Confidence 4677777754 45699999999999999999999999999999999999999999999999999865432211 1234
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
..++..|+|||++... ...++.++||||+||++|+|++|++||...+.......+..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------------- 222 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------------------- 222 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh--------------------
Confidence 5688999999998421 14577899999999999999999999976554332221111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... +.......++..+.+||.+||+.||.+|||++++++||||+..
T Consensus 223 -------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 223 -------SEP-PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------cCC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 000 0011123467889999999999999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=241.01 Aligned_cols=178 Identities=26% Similarity=0.523 Sum_probs=143.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......... ....
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~---~~~~ 175 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---RKSL 175 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc---cccc
Confidence 4689999887 57999999999999999999999999999999999999999999999999988654332221 1335
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+....+..+..
T Consensus 176 ~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~------------------------ 229 (285)
T cd06648 176 VGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD------------------------ 229 (285)
T ss_pred cCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh------------------------
Confidence 68899999999877 5688999999999999999999999976554333222111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
. ..+.......++..+.+||.+||..||++|||+.++|+||||+....
T Consensus 230 ---~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 230 ---N-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ---c-CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 0 00111112336788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=236.95 Aligned_cols=176 Identities=23% Similarity=0.438 Sum_probs=142.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 77 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~----~~~~ 152 (262)
T cd05572 77 GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWTF 152 (262)
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc----cccc
Confidence 478999999888899999999999999999999999999999999999999999999999999976644321 1335
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc--hhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.++..|++||.+.+ ..++.++|+||+||++|+|++|..||..... ...+..+.
T Consensus 153 ~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------------- 207 (262)
T cd05572 153 CGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL----------------------- 207 (262)
T ss_pred cCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh-----------------------
Confidence 68889999999876 5788999999999999999999999976552 11111110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
....... .....++.+.+||.+||..||.+|++ ++|+++||||+++.
T Consensus 208 ---~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 208 ---KGNGKLE---FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ---ccCCCCC---CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 0000111 11234788999999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=239.84 Aligned_cols=174 Identities=24% Similarity=0.424 Sum_probs=135.9
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~ 180 (282)
T cd06636 104 GSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNT 180 (282)
T ss_pred CcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc---CCCc
Confidence 5888988764 3589999999999999999999999999999999999999999999999999875432211 1234
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
..|+..|+|||.+... ...++.++|+|||||++|+|++|..||...........+
T Consensus 181 ~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~---------------------- 238 (282)
T cd06636 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI---------------------- 238 (282)
T ss_pred ccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH----------------------
Confidence 5689999999987521 146788999999999999999999999654322111100
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... .........++..+.+||.+||..||.+|||+.|+|+||||
T Consensus 239 -----~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 239 -----PRN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -----hhC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000 01111223467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=244.49 Aligned_cols=203 Identities=24% Similarity=0.395 Sum_probs=145.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.+...+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++....... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~ 157 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANS 157 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-----ccc
Confidence 46999999988889999999999999999999998 599999999999999999999999999986543221 234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHH---------HHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI---------ARVR 151 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~---------~~~~ 151 (449)
.+++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+............ ....
T Consensus 158 ~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 158 FVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence 678999999999876 56889999999999999999999999876543322222111100000000 0000
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
..........+..... ........+..+.+||.+||..||++|||+.++++||||.+...
T Consensus 236 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 236 PMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred hhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 0000011111111111 01111236788999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=243.46 Aligned_cols=179 Identities=27% Similarity=0.523 Sum_probs=141.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ .....
T Consensus 103 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~ 178 (292)
T cd06658 103 GGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---KRKSL 178 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---cCcee
Confidence 3578887754 4699999999999999999999999999999999999999999999999999875433221 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|+|||.+.+ ..++.++|+||+||++|||++|+.||.+.+....+..+...
T Consensus 179 ~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----------------------- 233 (292)
T cd06658 179 VGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN----------------------- 233 (292)
T ss_pred ecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------------
Confidence 78999999999876 57889999999999999999999999765543322211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
+ . .........+..+.+||.+||..||.+|||++++|+||||.....+
T Consensus 234 ~----~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 234 L----P-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred C----C-CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 0 0 0011122467889999999999999999999999999999866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=247.04 Aligned_cols=208 Identities=22% Similarity=0.270 Sum_probs=139.5
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC----cc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT----AI 76 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~----~~ 76 (449)
++|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+......... ..
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 163 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHD 163 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccccc
Confidence 6899998753 35999999999999999999999999999999999999999999999999875433211110 00
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHH-HHHHHhhHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE-AIARVRNEKA 155 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e-~~~~~~~~~~ 155 (449)
......++..|+|||++.+....++.++|||||||++|+|++|+.||............ ..+..... ....+..+..
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 164 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCccccccccchhhhhc
Confidence 11223567889999998753246889999999999999999999999765443222111 11111000 0000000000
Q ss_pred HHHH------hhhccC----------CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 156 RRYL------SSMRKK----------KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 156 ~~~~------~~~~~~----------~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.... ...... ...........+++.+.+||.+||+.||++|||++|+|+||||+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0000 000000 00000111223578899999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=233.92 Aligned_cols=172 Identities=28% Similarity=0.487 Sum_probs=139.6
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........ ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---~~~ 159 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---FAN 159 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---hhh
Confidence 46899999875 4699999999999999999999999999999999999999999999999999876543322 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------------- 215 (256)
T cd08529 160 TIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR---------------------- 215 (256)
T ss_pred ccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----------------------
Confidence 4568899999999987 5788999999999999999999999976653322221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. .......++..+.++|.+||+.+|++||++.++++|||+
T Consensus 216 -----~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 -----GV---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----CC---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 111112467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=234.45 Aligned_cols=174 Identities=29% Similarity=0.529 Sum_probs=138.2
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......... ...
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~---~~~ 158 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---RNT 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc---ccc
Confidence 3688999875 446899999999999999999999999999999999999999999999999998765433211 133
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||++.+ ..++.++||||+||++|+|++|+.||...........+
T Consensus 159 ~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------------------- 211 (256)
T cd06612 159 VIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------------------- 211 (256)
T ss_pred ccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------------------
Confidence 457889999999877 57889999999999999999999999765432211110
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... ..........++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 212 --~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 212 --PNK-PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --ccC-CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000 001111123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=243.06 Aligned_cols=181 Identities=27% Similarity=0.498 Sum_probs=142.8
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-----
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT----- 74 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~----- 74 (449)
+++|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (316)
T cd05574 85 GGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164 (316)
T ss_pred CCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccc
Confidence 46899998764 46999999999999999999999999999999999999999999999999998654322110
Q ss_pred ---------------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHH
Q 013122 75 ---------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133 (449)
Q Consensus 75 ---------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~ 133 (449)
.......+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~ 242 (316)
T cd05574 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242 (316)
T ss_pred ccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHH
Confidence 001123578899999999987 578899999999999999999999998766433322
Q ss_pred HHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC----HHHHHcCcccc
Q 013122 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT----AEEALADPYFK 209 (449)
Q Consensus 134 ~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT----a~elL~hp~f~ 209 (449)
.+.. . ...+. .....+..+.+||.+||..||++||| ++++|.||||+
T Consensus 243 ~~~~--------------------------~--~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 243 NILK--------------------------K--EVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HHhc--------------------------C--CccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 1110 0 01111 11226889999999999999999999 99999999998
Q ss_pred cccc
Q 013122 210 GLAK 213 (449)
Q Consensus 210 ~~~~ 213 (449)
+...
T Consensus 294 ~~~~ 297 (316)
T cd05574 294 GVNW 297 (316)
T ss_pred cCCh
Confidence 7643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=240.86 Aligned_cols=178 Identities=27% Similarity=0.415 Sum_probs=141.3
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~ 159 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----SIR 159 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----ccc
Confidence 36788887653 369999999999999999999999999999999999999999999999999986543221 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...|+..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+... +
T Consensus 160 ~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~--------------------~ 217 (285)
T cd05632 160 GRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR--------------------V 217 (285)
T ss_pred CCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--------------------h
Confidence 4578999999999977 67899999999999999999999999876543222221110 0
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
... .......++..+.+|+.+||+.||++||| +.+++.|+||+...
T Consensus 218 ---~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 218 ---LET----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ---hcc----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 000 00112346788999999999999999999 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=241.40 Aligned_cols=177 Identities=26% Similarity=0.490 Sum_probs=142.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......... ....
T Consensus 100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~ 175 (296)
T cd06655 100 GGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTM 175 (296)
T ss_pred CCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc---CCCc
Confidence 46888888764 6999999999999999999999999999999999999999999999999998764332211 1335
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 176 ~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~------------------------ 229 (296)
T cd06655 176 VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------------------ 229 (296)
T ss_pred CCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------------
Confidence 68889999999877 5788999999999999999999999977654332211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
. ..+.......+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 230 ---~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 230 ---N-GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ---c-CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 0 0111122345788899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=260.51 Aligned_cols=179 Identities=31% Similarity=0.531 Sum_probs=145.3
Q ss_pred CCcHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~-~~L--s~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+|+|..+++.. ++| .+..+.++.+|||+||+|||++.|||||||-+|||++. .|.+||.|||-++....-++..
T Consensus 656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T-- 733 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT-- 733 (1226)
T ss_pred CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc--
Confidence 68999999864 567 89999999999999999999999999999999999986 7889999999998776555543
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.++.||..|||||++.....+|+.++|||||||.+.||.||++||..... |.. ..
T Consensus 734 -ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-------------pqA-----------AM 788 (1226)
T KOG4279|consen 734 -ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-------------PQA-----------AM 788 (1226)
T ss_pred -cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-------------hhH-----------hh
Confidence 56789999999999966557899999999999999999999999964322 111 11
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
+--.|-+.. ......++.+++.||.+|+..||.+||+|.++|.+||++.-
T Consensus 789 FkVGmyKvH----P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 789 FKVGMYKVH----PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhcceecC----CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 111111111 12223467889999999999999999999999999999854
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=239.65 Aligned_cols=177 Identities=24% Similarity=0.391 Sum_probs=136.4
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.++++. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.........
T Consensus 108 ~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--- 184 (291)
T cd06639 108 GGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--- 184 (291)
T ss_pred CCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc---
Confidence 3588888753 456999999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccccccccCcccccccC---CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 78 WTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~---~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
.....|+..|+|||.+.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 185 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~----------------- 247 (291)
T cd06639 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR----------------- 247 (291)
T ss_pred ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-----------------
Confidence 13356888999999875421 2367899999999999999999999976543322211110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
... +........+..+.+||.+||+.||++||++.++|+||||+
T Consensus 248 ----------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 ----------NPP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ----------CCC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 000 00111223567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=241.54 Aligned_cols=174 Identities=26% Similarity=0.466 Sum_probs=149.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|+-.|.....++++..+++-..|+.||.|||+++||.||||.+|+|++.+|.+||+|||+++...... ....++
T Consensus 252 GGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g---~t~kTF 328 (516)
T KOG0690|consen 252 GGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG---DTTKTF 328 (516)
T ss_pred CceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc---ceeccc
Confidence 57777778877789999999999999999999999999999999999999999999999999997543332 234789
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
|||+.|+|||++.. ..|+.++|.|.+|+++|||++|+.||...+.......|..-
T Consensus 329 CGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------------------- 383 (516)
T KOG0690|consen 329 CGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------------------- 383 (516)
T ss_pred cCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------------------
Confidence 99999999999988 68999999999999999999999999988876665554320
Q ss_pred hccCCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~-~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
...| ..++++++.||..+|..||.+|.. +.|+.+|+||.++.
T Consensus 384 ---------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 384 ---------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred ---------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 1122 357899999999999999999964 88999999999764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=232.82 Aligned_cols=176 Identities=24% Similarity=0.437 Sum_probs=138.6
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccc
Q 013122 6 HQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83 (449)
Q Consensus 6 ~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~g 83 (449)
..+++. .++++|..+-++...++.||.||.+ +||+|||+||+|||++..|++||||||.+........ .+...|
T Consensus 178 ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA----htrsAG 253 (391)
T KOG0983|consen 178 EKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA----HTRSAG 253 (391)
T ss_pred HHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc----cccccC
Confidence 344433 3469999999999999999999986 5899999999999999999999999999876654432 245678
Q ss_pred cccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCch-hhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 84 TRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 84 t~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
-+.|||||.+.-. ...|+..+||||||+.++||.||+.||.+.+.. +.+.+|.
T Consensus 254 C~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl------------------------- 308 (391)
T KOG0983|consen 254 CAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL------------------------- 308 (391)
T ss_pred CccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-------------------------
Confidence 8999999998532 367999999999999999999999999986532 2222221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
...+ +....-...++.+++|+..||.+|+.+||...++|+|||+..+..
T Consensus 309 --n~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 309 --NEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred --hcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 1112 111111237899999999999999999999999999999987653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=244.43 Aligned_cols=159 Identities=28% Similarity=0.493 Sum_probs=123.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++
T Consensus 170 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 170 PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLPLKWMAPESI 248 (338)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCCccccCcHHh
Confidence 4888999999999999999999999999999999999999999999999999765332211 111233456789999999
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|||++ |..||.+......+... +...... .
T Consensus 249 ~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~--------------------------~~~~~~~---~ 297 (338)
T cd05102 249 FD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--------------------------LKDGTRM---R 297 (338)
T ss_pred hc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--------------------------HhcCCCC---C
Confidence 77 678999999999999999997 99999875432211100 0011110 1
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.....++.+.+||.+||..||.+|||+.++++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=240.68 Aligned_cols=168 Identities=22% Similarity=0.281 Sum_probs=137.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.++..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...... ..
T Consensus 106 ~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------~~ 179 (283)
T PHA02988 106 RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------FK 179 (283)
T ss_pred CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------cc
Confidence 36899999998889999999999999999999998 499999999999999999999999999987653321 23
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+|+..|+|||++.+.+..++.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~----------------------- 236 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN----------------------- 236 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----------------------
Confidence 468899999999976446789999999999999999999999987654433322211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...... .....++.+.+||.+||+.||++|||+.|+++
T Consensus 237 ---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 237 ---KNNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ---cCCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 011111 11256889999999999999999999999985
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=239.28 Aligned_cols=172 Identities=26% Similarity=0.460 Sum_probs=142.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++...... ....
T Consensus 85 ~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------~~~~ 158 (290)
T cd05580 85 GGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TYTL 158 (290)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------CCCC
Confidence 5789999999889999999999999999999999999999999999999999999999999998765433 1345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+..
T Consensus 159 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------------ 212 (290)
T cd05580 159 CGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE------------------------ 212 (290)
T ss_pred CCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------------
Confidence 68899999999876 5678899999999999999999999976653222221110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
. ... .....+..+.++|.+||..||.+|+ +++|+++||||+.+.
T Consensus 213 --~--~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 --G--KVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred --C--Ccc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 0 011 1123578899999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=238.11 Aligned_cols=180 Identities=24% Similarity=0.402 Sum_probs=138.3
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|..++.+ ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~ 169 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ---RRDS 169 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc---ccce
Confidence 3567777654 44699999999999999999999999999999999999999999999999999865432211 1234
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
..++..|+|||++.+. ...++.++|+|||||++|+|++|.+||...+.......+.
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--------------------- 228 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--------------------- 228 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---------------------
Confidence 5688899999998531 1356789999999999999999999997654322211110
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. ..+.......++..+.+||.+||..||++||+++++|+||||..+.
T Consensus 229 ------~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 229 ------KS-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred ------cC-CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 0011112235678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=234.72 Aligned_cols=181 Identities=27% Similarity=0.437 Sum_probs=140.6
Q ss_pred CCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-cc
Q 013122 2 ESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IF 77 (449)
Q Consensus 2 e~dL~~~i~~~---~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~-~~ 77 (449)
+++|.+++... ..+++..++.++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence 46889998764 358999999999999999999999999999999999999999999999999987655432221 11
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+|+..|++||.+... ..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 163 ~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 221 (267)
T cd06610 163 RKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------------- 221 (267)
T ss_pred cccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc--------------------
Confidence 2345688999999998762 3688899999999999999999999976543222111110
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
. ..........+..+++.+.+||.+||..||.+|||++++++||||
T Consensus 222 ---~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 222 ---N--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---C--CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 000111111234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=240.63 Aligned_cols=176 Identities=26% Similarity=0.461 Sum_probs=140.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........ .....
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~ 176 (296)
T cd06654 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 176 (296)
T ss_pred CCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc---ccCcc
Confidence 46899988754 689999999999999999999999999999999999999999999999999876433221 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+.
T Consensus 177 ~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~------------------------- 229 (296)
T cd06654 177 VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------------------- 229 (296)
T ss_pred cCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh-------------------------
Confidence 68899999999877 578899999999999999999999997654322211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.. ..+.......++..+.+||.+||..||.+|||+.++++||||...
T Consensus 230 -~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 230 -TN--GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred -cC--CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00 011111223567889999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=240.26 Aligned_cols=181 Identities=26% Similarity=0.418 Sum_probs=141.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------- 74 (449)
+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 164 (305)
T cd05609 85 GGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164 (305)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccccc
Confidence 3689999998888999999999999999999999999999999999999999999999999998642111000
Q ss_pred -----ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHH
Q 013122 75 -----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 149 (449)
Q Consensus 75 -----~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~ 149 (449)
........++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+......+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~------------ 230 (305)
T cd05609 165 EKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS------------ 230 (305)
T ss_pred ccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence 001122457888999999876 5788999999999999999999999987654322221110
Q ss_pred HhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccc
Q 013122 150 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLA 212 (449)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT---a~elL~hp~f~~~~ 212 (449)
. ...+.......+..+.+||.+||+.||++||+ +.++|+||||....
T Consensus 231 ---------------~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 231 ---------------D-DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ---------------c-ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 0 00111112256888999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=234.75 Aligned_cols=176 Identities=25% Similarity=0.433 Sum_probs=138.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++................
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 169 (265)
T cd06652 90 GGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169 (265)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccC
Confidence 46899999888789999999999999999999999999999999999999999999999999987543221111112345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+.
T Consensus 170 ~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~------------------------- 222 (265)
T cd06652 170 TGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA------------------------- 222 (265)
T ss_pred CCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-------------------------
Confidence 68889999999877 578899999999999999999999996543222111110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.... ........+..+.++|.+||. +|++||+++++++|||+.
T Consensus 223 --~~~~--~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 223 --TQPT--NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred --cCCC--CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0000 011123457789999999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=235.90 Aligned_cols=176 Identities=27% Similarity=0.465 Sum_probs=141.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+ .+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......... ....
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~---~~~~ 158 (274)
T cd06609 83 GGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK---RNTF 158 (274)
T ss_pred CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc---cccc
Confidence 36899998876 8999999999999999999999999999999999999999999999999999776543211 2345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 159 ~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------------------------- 211 (274)
T cd06609 159 VGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------------------------- 211 (274)
T ss_pred cCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------------------------
Confidence 68889999999987 568999999999999999999999997654322211111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........ ...++..+.+||.+||..||++|||++++++||||....
T Consensus 212 --~~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 212 --KNNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred --hcCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 00000000 112678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=240.05 Aligned_cols=177 Identities=30% Similarity=0.559 Sum_probs=142.0
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|..++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......... ....+
T Consensus 103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~ 178 (297)
T cd06659 103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLV 178 (297)
T ss_pred CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc---cccee
Confidence 578887765 46999999999999999999999999999999999999999999999999998754332211 23457
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 179 ~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------------------- 231 (297)
T cd06659 179 GTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD------------------------- 231 (297)
T ss_pred cCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------------
Confidence 8999999999977 5788999999999999999999999976554333222110
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
. ...........+..+.+||.+||+.||.+||+++++++||||.....
T Consensus 232 --~-~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 232 --S-PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred --c-CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 0 11112223456788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=234.39 Aligned_cols=180 Identities=27% Similarity=0.482 Sum_probs=140.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCc-cccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTA-IFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~-~~~~ 79 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++ .+||+|||++.......... ....
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 166 (268)
T cd06630 87 GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166 (268)
T ss_pred CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccc
Confidence 368999999888899999999999999999999999999999999999998776 59999999987654332111 1112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+.+.
T Consensus 167 ~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 223 (268)
T cd06630 167 QLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI--------------------- 223 (268)
T ss_pred ccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH---------------------
Confidence 3468889999999876 57889999999999999999999999754433222221110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
... ..........++.+.++|.+||..||.+|||+.++|+||||+
T Consensus 224 ---~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 224 ---ASA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---hcc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000 001122234678899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=243.28 Aligned_cols=204 Identities=22% Similarity=0.314 Sum_probs=140.9
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC----cc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT----AI 76 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~----~~ 76 (449)
++|.+++... ..+++..+..+++||+.||+|||++||+||||||+||+++.++.+||+|||.+......... ..
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 6788888764 35899999999999999999999999999999999999999999999999988654322111 11
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
......++..|+|||++.+....++.++||||+||++|+|++|..||........+ +....+..... +... ...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~-~~~~---~~~ 237 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCL-LDKS---TYP 237 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccc-cccC---chh
Confidence 11334577889999998763346889999999999999999999999865433221 11111111100 0000 000
Q ss_pred HHHhhhcc--------CCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 157 RYLSSMRK--------KKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 157 ~~~~~~~~--------~~~~~~-~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.....+.. ...... .......+..+.+||.+||..||++|||++++|+||||+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000000 000000 001112456789999999999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=236.05 Aligned_cols=176 Identities=29% Similarity=0.524 Sum_probs=139.7
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++... ..+++..+..++.||+.||+|||+ .||+|+||||+||+++.++.++|+|||.+........ ..
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-----~~ 158 (265)
T cd06605 84 GSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----KT 158 (265)
T ss_pred CcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-----hc
Confidence 6899999876 679999999999999999999999 9999999999999999999999999999865532211 12
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc--hhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+. ....+ .
T Consensus 159 ~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------------------~ 212 (265)
T cd06605 159 FVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE------------------------L 212 (265)
T ss_pred ccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHH------------------------H
Confidence 568889999999987 5789999999999999999999999965431 00010 1
Q ss_pred HhhhccCCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~-~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
+......... ..... ++..+.+||.+||..||++|||+.+++.||||+.+.
T Consensus 213 ~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 213 LQYIVNEPPP---RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred HHHHhcCCCC---CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 1111111111 11111 688899999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=237.88 Aligned_cols=172 Identities=26% Similarity=0.457 Sum_probs=132.0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCc
Q 013122 12 NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 90 (449)
Q Consensus 12 ~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~AP 90 (449)
...+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++......... ....|+..|+||
T Consensus 101 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aP 176 (288)
T cd06616 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAP 176 (288)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc----ccccCccCccCH
Confidence 35699999999999999999999985 9999999999999999999999999998765432211 334678899999
Q ss_pred ccccccC-CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCC
Q 013122 91 ELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP 169 (449)
Q Consensus 91 E~l~~~~-~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~ 169 (449)
|++.+.. ..++.++||||+||++|+|++|+.||.... .....+.+.. ....+..
T Consensus 177 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~-----------------------~~~~~~~ 231 (288)
T cd06616 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVV-----------------------KGDPPIL 231 (288)
T ss_pred HHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhc-----------------------CCCCCcC
Confidence 9987621 258899999999999999999999996543 1111111110 0111111
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 170 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 170 ~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.......++..+.+||.+||+.||++|||++++++||||+...
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 1112235788999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=234.18 Aligned_cols=175 Identities=27% Similarity=0.455 Sum_probs=135.1
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++.. +..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........ ..
T Consensus 94 ~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~ 170 (275)
T cd06608 94 GSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG---RR 170 (275)
T ss_pred CcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchh---hh
Confidence 577777764 34799999999999999999999999999999999999999999999999999876433221 12
Q ss_pred ccccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 79 TDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
....++..|+|||++... ...++.++|||||||++|+|++|+.||........+..+.
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------------- 231 (275)
T cd06608 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP------------------- 231 (275)
T ss_pred cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh-------------------
Confidence 345688999999987531 1346788999999999999999999997544322221111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.... .........+..+.+||.+||..||++|||+.++++|||+
T Consensus 232 --------~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 232 --------RNPP-PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------ccCC-CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0000 0001112357789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=232.00 Aligned_cols=179 Identities=30% Similarity=0.538 Sum_probs=142.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-----cc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-----AI 76 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-----~~ 76 (449)
+++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 77 GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 3689999998778999999999999999999999999999999999999999999999999998765433211 01
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
......++..|++||.+.. ..++.++|+|||||++|+|++|..||...........+..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------- 215 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------- 215 (265)
T ss_pred cccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------
Confidence 1234567889999999877 5688899999999999999999999976654332222111
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---HHHHcCcccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYFKGL 211 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa---~elL~hp~f~~~ 211 (449)
....+.. ....+..+.+||.+||+.+|.+|||+ .++|+||||+++
T Consensus 216 ---------~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ---------GKIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ---------CCcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0011111 11247889999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=235.42 Aligned_cols=179 Identities=28% Similarity=0.436 Sum_probs=139.4
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ ....
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~ 162 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDT 162 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc---ccce
Confidence 35888888764 4699999999999999999999999999999999999999999999999998865433221 1234
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
..++..|++||++... ...++.++|+|||||++|+|++|+.||.+.+....+..+.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------------- 221 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL--------------------- 221 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh---------------------
Confidence 5688999999997521 1346789999999999999999999997654332221111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.... +.......++..+.+||.+||..||.+||+++++|+||||...
T Consensus 222 ------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 222 ------KSEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ------cCCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0000 1111123467889999999999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=233.05 Aligned_cols=176 Identities=25% Similarity=0.447 Sum_probs=137.3
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++........ .....
T Consensus 85 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~ 161 (262)
T cd06613 85 GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA---KRKSF 161 (262)
T ss_pred CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh---ccccc
Confidence 5888888876 6899999999999999999999999999999999999999999999999999876543221 12345
Q ss_pred cccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.++..|+|||.+.+. ...++.++|+|||||++|+|++|++||.+.+.......+...
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~---------------------- 219 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS---------------------- 219 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------------
Confidence 688899999998651 126788999999999999999999999775543322111100
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 207 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~ 207 (449)
...+ .........+..+.+||.+||..||.+|||+.+++.|+|
T Consensus 220 ---~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 220 ---NFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---cCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0000 001111234677899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=239.54 Aligned_cols=179 Identities=26% Similarity=0.462 Sum_probs=141.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.+. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........ .....
T Consensus 100 ~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~ 175 (297)
T cd06656 100 GGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 175 (297)
T ss_pred CCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---CcCcc
Confidence 46888888764 689999999999999999999999999999999999999999999999999876433221 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.
T Consensus 176 ~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~------------------------- 228 (297)
T cd06656 176 VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------------------- 228 (297)
T ss_pred cCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-------------------------
Confidence 68889999999977 678899999999999999999999997654322211100
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.. ..+........+..+.+||.+||..||.+||+++++|.||||+.....
T Consensus 229 --~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 229 --TN-GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred --cC-CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 00 011111223467889999999999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=270.66 Aligned_cols=178 Identities=17% Similarity=0.222 Sum_probs=128.7
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-------------------CCEEEe
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------------------CKLKIC 60 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-------------------~~vKL~ 60 (449)
++++|+++|... ..+++.+++.+++||+.||.|||++||+||||||+|||++.. +.+||+
T Consensus 62 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~ 141 (793)
T PLN00181 62 EDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSR 141 (793)
T ss_pred CCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccc
Confidence 468999999764 459999999999999999999999999999999999999654 445666
Q ss_pred ecCccccccCCC-------------CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC
Q 013122 61 DFGLARVAFNDT-------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127 (449)
Q Consensus 61 DFGlA~~~~~~~-------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~ 127 (449)
|||+++...... .........+||++|+|||++.+ ..|+.++|||||||+||||++|.++|....
T Consensus 142 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~ 219 (793)
T PLN00181 142 EIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG--SSSNCASDVYRLGVLLFELFCPVSSREEKS 219 (793)
T ss_pred ccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc--CCCCchhhhhhHHHHHHHHhhCCCchhhHH
Confidence 666654321100 00000122468999999999987 678999999999999999999887764321
Q ss_pred chhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 013122 128 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 207 (449)
Q Consensus 128 ~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~ 207 (449)
. .+..+.. .. .+ .......+...+++.+||..||.+||++.|+|+|||
T Consensus 220 ~--~~~~~~~-------------------~~-------~~----~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 220 R--TMSSLRH-------------------RV-------LP----PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred H--HHHHHHH-------------------hh-------cC----hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchh
Confidence 0 1000000 00 00 000112345678999999999999999999999999
Q ss_pred ccccc
Q 013122 208 FKGLA 212 (449)
Q Consensus 208 f~~~~ 212 (449)
|....
T Consensus 268 ~~~~~ 272 (793)
T PLN00181 268 INEPR 272 (793)
T ss_pred hhhhh
Confidence 98643
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=235.18 Aligned_cols=181 Identities=23% Similarity=0.419 Sum_probs=140.4
Q ss_pred CCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~---~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|..++... ..+++..++.++.||+.||.|||+ .||+|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----- 157 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----- 157 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-----
Confidence 35888888764 369999999999999999999997 599999999999999999999999999987543221
Q ss_pred cccccccccccCcccccccC----CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 78 WTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~----~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...........+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----------------- 220 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----------------- 220 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----------------
Confidence 13346788999999985421 235789999999999999999999997644322221111
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.+.... .....+.++..+.+||.+||..+|.+||++++++.||||......
T Consensus 221 -------~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 221 -------AIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred -------HHhhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 111111 112334578899999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=249.91 Aligned_cols=169 Identities=27% Similarity=0.438 Sum_probs=135.8
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCccc
Q 013122 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 92 (449)
Q Consensus 13 ~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~ 92 (449)
..|++.+++.+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+....... .....++||++|||||+
T Consensus 125 r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~---qkRDsFIGTPYWMAPEV 201 (1187)
T KOG0579|consen 125 RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR---QKRDSFIGTPYWMAPEV 201 (1187)
T ss_pred cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH---hhhccccCCcccccchh
Confidence 469999999999999999999999999999999999999999999999999875432221 22357899999999998
Q ss_pred cccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCC
Q 013122 93 CGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP 169 (449)
Q Consensus 93 l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~ 169 (449)
..+. ...|++++||||||+.|.||..+.+|-..-+....+-.|. +..+..
T Consensus 202 vmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia---------------------------KSePPT 254 (1187)
T KOG0579|consen 202 VMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---------------------------KSEPPT 254 (1187)
T ss_pred eeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh---------------------------hcCCCc
Confidence 7431 2579999999999999999999999987666543332221 111111
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 170 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 170 ~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
......++..+.|||.+||..||..||++.++|+||||....
T Consensus 255 -LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 255 -LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 112235677899999999999999999999999999998643
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=236.22 Aligned_cols=177 Identities=25% Similarity=0.398 Sum_probs=140.8
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~ 153 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KIKG 153 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cccc
Confidence 68999998766 69999999999999999999999999999999999999999999999999987653321 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|++||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 154 ~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------------------- 208 (277)
T cd05577 154 RAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----------------------- 208 (277)
T ss_pred ccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh-----------------------
Confidence 567889999999877 5688999999999999999999999976543211111110
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
.. .... .......++.+.+||.+||+.||.+|| ++.+++.||||..+.
T Consensus 209 ~~-~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 209 RT-LEMA---VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred cc-cccc---ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 00 0001 112234688999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=233.62 Aligned_cols=176 Identities=24% Similarity=0.394 Sum_probs=136.0
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++..+..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........ ......
T Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~ 167 (267)
T cd06646 91 GSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA---KRKSFI 167 (267)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc---ccCccc
Confidence 68999998888899999999999999999999999999999999999999999999999999876532221 113456
Q ss_pred ccccccCcccccc-cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 83 ATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 83 gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
++..|+|||.+.. ....++.++|+||+||++|+|++|+.||...........+..
T Consensus 168 ~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------------------------ 223 (267)
T cd06646 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------------------------ 223 (267)
T ss_pred cCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------------------------
Confidence 8889999998743 114577899999999999999999999864432111100000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 207 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~ 207 (449)
.... .+.......++..+.+||.+||..||++|||++++|+|+|
T Consensus 224 -~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 -SNFQ-PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -CCCC-CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000 0111112346789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=231.89 Aligned_cols=164 Identities=27% Similarity=0.395 Sum_probs=133.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.+...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 69 ~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~ 142 (237)
T cd05576 69 GGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGE 142 (237)
T ss_pred CCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccC
Confidence 37899999888889999999999999999999999999999999999999999999999999876543321 233
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+||+||++|+|++|..+|...... .
T Consensus 143 ~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------------------~-- 189 (237)
T cd05576 143 AVENMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------------------I-- 189 (237)
T ss_pred CcCccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------------------c--
Confidence 45778999999876 57889999999999999999999877432100 0
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa-----~elL~hp~f 208 (449)
...... .....+++.+.+||.+||+.||++|+++ ++++.||||
T Consensus 190 -~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 190 -NTHTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -cccccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 000000 1113467889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=234.62 Aligned_cols=171 Identities=22% Similarity=0.366 Sum_probs=135.4
Q ss_pred CCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~----------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~ 171 (283)
T cd05048 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171 (283)
T ss_pred CCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcce
Confidence 36899998765 45889999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
......... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 172 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~------- 241 (283)
T cd05048 172 RDIYSADYY-RVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS------- 241 (283)
T ss_pred eeccccccc-cccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-------
Confidence 764332211 11234467888999999876 578999999999999999998 9999987654333222111
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......+++.+.+|+.+||+.||.+||++.+++++
T Consensus 242 --------------------~~~---~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 --------------------RQL---LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred --------------------CCc---CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111 11124568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=256.30 Aligned_cols=181 Identities=22% Similarity=0.279 Sum_probs=123.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCccccccccccccccCcccccc
Q 013122 17 PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 95 (449)
Q Consensus 17 ~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~ 95 (449)
...+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+........ ....+++++.|+|||.+..
T Consensus 254 ~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~--~~~~~~~t~~Y~APE~~~~ 331 (566)
T PLN03225 254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIM 331 (566)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc--CCcccccCCCccChHHhhc
Confidence 4457789999999999999999999999999999986 578999999999754332211 2245688999999997633
Q ss_pred cC--------------------CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 96 FF--------------------SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 96 ~~--------------------~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
.. ..++.++||||||||||||+++.. ...+...++..+....+..... |...
T Consensus 332 ~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~~-~~~~----- 403 (566)
T PLN03225 332 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLVA-WRKL----- 403 (566)
T ss_pred cCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHHH-HHHh-----
Confidence 10 123456799999999999998654 3333333333333332222111 1110
Q ss_pred HHHHhhhccCCCCCC---CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 156 RRYLSSMRKKKPIPF---SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~---~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
+. ....... ...+...+..+++||.+||++||++|||+.++|+||||++...
T Consensus 404 ---~~---~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 404 ---VE---PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ---hc---cccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 00 0000000 1111223456779999999999999999999999999987554
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=229.55 Aligned_cols=180 Identities=31% Similarity=0.451 Sum_probs=139.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc-ccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~-~~~ 80 (449)
+++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++............ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 162 (264)
T cd06626 83 GGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162 (264)
T ss_pred CCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccC
Confidence 3689999998878999999999999999999999999999999999999999999999999998775443322111 223
Q ss_pred ccccccccCcccccccC-CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|++||++.+.. ..++.++||||+||++|+|++|+.||.+.......... +
T Consensus 163 ~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-----------------------~ 219 (264)
T cd06626 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-----------------------V 219 (264)
T ss_pred CcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-----------------------H
Confidence 56788999999987631 23788999999999999999999999754321111000 0
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
. .. ..+.......+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 220 ~---~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 220 G---AG-HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred h---cC-CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 00 011111223457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=270.20 Aligned_cols=181 Identities=29% Similarity=0.366 Sum_probs=147.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC-CCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-PTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~-~~~~~~~~ 80 (449)
+|.|.+++.....+++...+.+..|++.||+|||++|||||||||.|||++.+|.+|++|||.|....+.. ........
T Consensus 1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~ 1397 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQS 1397 (1509)
T ss_pred cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHh
Confidence 58899999988778899999999999999999999999999999999999999999999999998776553 22233457
Q ss_pred ccccccccCcccccccC-CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||+.|||||++.+.. .+...+.|||||||++.||+||+.||...+...+ .|..
T Consensus 1398 ~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IMy~---------------------- 1453 (1509)
T KOG4645|consen 1398 MMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IMYH---------------------- 1453 (1509)
T ss_pred hcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HHhH----------------------
Confidence 89999999999997642 3466799999999999999999999976554322 2221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
-.+..+..+ ...++++.++||.+||..||++|+++.|+|+|-|-+.-
T Consensus 1454 V~~gh~Pq~-----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1454 VAAGHKPQI-----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HhccCCCCC-----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 122222222 22378999999999999999999999999999987643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=236.18 Aligned_cols=177 Identities=18% Similarity=0.227 Sum_probs=134.1
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc----ccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA----IFW 78 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~----~~~ 78 (449)
.++.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+|+......... ...
T Consensus 111 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~ 190 (294)
T PHA02882 111 ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190 (294)
T ss_pred cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccc
Confidence 3566677665567899999999999999999999999999999999999999999999999997653221110 111
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..... ..+
T Consensus 191 ~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~------------------~~~ 250 (294)
T PHA02882 191 DLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK------------------CDF 250 (294)
T ss_pred cccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH------------------HHH
Confidence 23469999999999887 6799999999999999999999999987643222111100 111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
+..+.... ...+..+..+.+++..||..+|++||+++++++
T Consensus 251 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 251 IKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111111 123456788999999999999999999999975
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=231.09 Aligned_cols=181 Identities=28% Similarity=0.534 Sum_probs=140.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ .......
T Consensus 92 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 170 (272)
T cd06629 92 GGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD-NDQNMSM 170 (272)
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccc-ccccccc
Confidence 578999999888899999999999999999999999999999999999999999999999999876432211 1112345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+......++.++|+||||+++|+|++|..||........+ .+. ..
T Consensus 171 ~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~--------------------~~- 226 (272)
T cd06629 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM---FKL--------------------GN- 226 (272)
T ss_pred cCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH---HHh--------------------hc-
Confidence 688899999998763224788999999999999999999999644322111 100 00
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.... ........+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 227 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 KRSA-PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccC-CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 111112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=230.34 Aligned_cols=171 Identities=22% Similarity=0.316 Sum_probs=135.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++................
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 36899999888889999999999999999999999999999999999999999999999999987654332211111223
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.++..|+|||.+.. ..++.++|||||||++|||++ |..||.+.+.......+.
T Consensus 159 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~------------------------ 212 (257)
T cd05116 159 KWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE------------------------ 212 (257)
T ss_pred CCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------------------------
Confidence 34578999999876 578889999999999999997 999997765433322221
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... .....+++.+.+||.+||+.||.+||++.++..
T Consensus 213 ---~~~~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 213 ---SGERM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---CCCCC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 11111 122357889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=229.32 Aligned_cols=172 Identities=34% Similarity=0.534 Sum_probs=139.5
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcccccccCCcEEEcCCCCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLH-----s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~ 72 (449)
+++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 164 (265)
T cd08217 85 GGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164 (265)
T ss_pred CCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence 3688888875 357999999999999999999999 9999999999999999999999999999988764432
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......+.
T Consensus 165 ~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------- 223 (265)
T cd08217 165 S---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK---------------- 223 (265)
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh----------------
Confidence 2 1234578999999999977 568899999999999999999999998765322211111
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... +.......+..+.+|+.+||..+|.+|||++++|+|||+
T Consensus 224 -----------~~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 224 -----------EGK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -----------cCC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 111 111223567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=228.44 Aligned_cols=173 Identities=28% Similarity=0.494 Sum_probs=139.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++....... .....
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----~~~~~ 161 (258)
T cd06632 86 GGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----FAKSF 161 (258)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----ccccc
Confidence 36899999988889999999999999999999999999999999999999999999999999987654332 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+... ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 162 ~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------------------------- 215 (258)
T cd06632 162 KGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG------------------------- 215 (258)
T ss_pred CCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH-------------------------
Confidence 688999999998762 238899999999999999999999997644221111110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. .........+++.+.+||.+||..||.+||++.++|.|||+
T Consensus 216 --~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 216 --RS--KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred --hc--ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00 01112234568899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=229.38 Aligned_cols=177 Identities=30% Similarity=0.509 Sum_probs=142.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 84 ~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---~~~~ 160 (264)
T cd06623 84 GSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ---CNTF 160 (264)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc---ccce
Confidence 7899999988889999999999999999999999 99999999999999999999999999998765443322 1345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........+.+ ..
T Consensus 161 ~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~------------------------~~ 214 (264)
T cd06623 161 VGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM------------------------QA 214 (264)
T ss_pred eecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH------------------------HH
Confidence 68889999999877 57889999999999999999999999765421111111 11
Q ss_pred hccCCCCCCCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~-~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
+..... ...... ++..+.+||.+||..+|++|||+.++|+||||+..
T Consensus 215 ~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 215 ICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 111111 111223 67889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=261.76 Aligned_cols=182 Identities=25% Similarity=0.415 Sum_probs=153.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
||||..++.+.++++++.+++++..|+.||.-||+.|+|||||||+|||++..|+|||+|||.+-.+..+.. ......
T Consensus 159 GGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~--V~s~~a 236 (1317)
T KOG0612|consen 159 GGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT--VRSSVA 236 (1317)
T ss_pred CchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc--EEeccc
Confidence 799999999998999999999999999999999999999999999999999999999999999876653322 234668
Q ss_pred cccccccCccccccc--C-CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 82 VATRWYRAPELCGSF--F-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~--~-~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
+|||-|.+||++... . +.|+..+|.||+||++||||.|..||...+.++.+..|+..
T Consensus 237 VGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-------------------- 296 (1317)
T KOG0612|consen 237 VGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-------------------- 296 (1317)
T ss_pred cCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--------------------
Confidence 999999999998431 2 56999999999999999999999999988887777766542
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT---a~elL~hp~f~~~~~ 213 (449)
+....|+ .-..+|..+++||+++| -+|+.|.. ++++-.||||.++..
T Consensus 297 ------k~~l~FP-~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 ------KESLSFP-DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ------hhhcCCC-cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCCh
Confidence 1122333 22348999999999987 47888988 999999999998654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=232.41 Aligned_cols=176 Identities=22% Similarity=0.353 Sum_probs=135.0
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||++........ .
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~ 180 (286)
T cd06638 104 GGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---R 180 (286)
T ss_pred CCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC---c
Confidence 4678887753 34689999999999999999999999999999999999999999999999999876533221 1
Q ss_pred cccccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 78 WTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
.....|+..|+|||++... ...++.++||||+||++|+|++|+.||...+....+..+
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~------------------- 241 (286)
T cd06638 181 RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI------------------- 241 (286)
T ss_pred cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc-------------------
Confidence 2345689999999987531 135788999999999999999999999765432211110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
....... .......+..+.+||.+||+.||.+|||+.|+|+|+||
T Consensus 242 --------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 242 --------PRNPPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred --------cccCCCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000000 00112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=218.34 Aligned_cols=165 Identities=22% Similarity=0.273 Sum_probs=127.0
Q ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
|+|.+++..++ .|++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 68999998744 5999999999999999999999998 999999999999999 9998765332 22
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchh-hHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .+..+..
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------------------- 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN----------------------- 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH-----------------------
Confidence 68899999999987 678999999999999999999999996543221 1111111
Q ss_pred hhccCCCCCCCCCCCCCCH--HHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 161 SMRKKKPIPFSQKFPNANP--LALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~--~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.+....+.. .......+. .+.+||.+||..||.+|||+.++++|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111000000 000011222 589999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=227.49 Aligned_cols=171 Identities=29% Similarity=0.484 Sum_probs=136.8
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.... .+++..+..++.||+.||+|||++||+|+||+|+||+++.++ .+||+|||++........ .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~----~ 158 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----A 158 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc----c
Confidence 358999998643 489999999999999999999999999999999999998654 589999999976543322 1
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....++..|+|||.+.+ ..++.++|+||+||++|+|++|..+|.+.+.......+..
T Consensus 159 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~--------------------- 215 (256)
T cd08220 159 YTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--------------------- 215 (256)
T ss_pred cccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh---------------------
Confidence 23568889999999987 5688999999999999999999999977654332211110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 216 ------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 ------GT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------cC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 111123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=233.66 Aligned_cols=169 Identities=25% Similarity=0.484 Sum_probs=130.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ....+++..|+|||.+
T Consensus 91 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~ 165 (279)
T cd06619 91 KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-----AKTYVGTNAYMAPERI 165 (279)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----ccCCCCChhhcCceee
Confidence 57899999999999999999999999999999999999999999999999987653321 2346789999999999
Q ss_pred cccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (449)
.+ ..++.++|+|||||++|+|++|+.||......... .... .....+..... ....
T Consensus 166 ~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~~-----------~~~~~~~~~~~--~~~~ 221 (279)
T cd06619 166 SG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMPL-----------QLLQCIVDEDP--PVLP 221 (279)
T ss_pred cC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cchH-----------HHHHHHhccCC--CCCC
Confidence 87 57899999999999999999999999653211100 0000 00000000000 0111
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 174 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 174 ~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
....++.+.+||.+||..||.+||++++++.||||...
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 23467889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=250.73 Aligned_cols=172 Identities=27% Similarity=0.444 Sum_probs=143.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcC-CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
.|.|..|+++.++++...++.|++|||+||.|||++. |||||||.+||+|+. .|.|||+|+|||....... .
T Consensus 127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-----a 201 (632)
T KOG0584|consen 127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-----A 201 (632)
T ss_pred CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-----c
Confidence 4799999999999999999999999999999999996 999999999999987 5789999999998765443 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhH-HHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
...+||+.|||||+... .|+..+||||||++++||+|+..||.......++ .+++ .
T Consensus 202 ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~---S----------------- 258 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT---S----------------- 258 (632)
T ss_pred ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH---c-----------------
Confidence 44789999999999974 7999999999999999999999999765544332 2221 1
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
..+|..+.. --++++++||.+||.. .++|+|+.|+|.||||..-
T Consensus 259 ------GiKP~sl~k---V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 259 ------GIKPAALSK---VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------CCCHHHhhc---cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 111111111 1278899999999999 9999999999999999864
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=227.00 Aligned_cols=172 Identities=29% Similarity=0.546 Sum_probs=140.4
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~~~ 159 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---MAE 159 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---ccc
Confidence 36899999875 4589999999999999999999999999999999999999999999999999876543321 224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+..
T Consensus 160 ~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---------------------- 215 (256)
T cd08221 160 TVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---------------------- 215 (256)
T ss_pred ccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----------------------
Confidence 4578999999999877 5678899999999999999999999977554333222211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. +......++..+.+||.+||..||.+||+++++|+|+|+
T Consensus 216 -----~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 -----GN---YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----CC---CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 00 111124567889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=231.50 Aligned_cols=178 Identities=25% Similarity=0.422 Sum_probs=135.9
Q ss_pred CCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
|+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (283)
T cd06617 82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-- 159 (283)
T ss_pred hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc--
Confidence 45677777754 23689999999999999999999998 999999999999999999999999999876533211
Q ss_pred cccccccccccccCccccccc--CCCCCCccchhhhHHHHHhhhhCCCCCCCCCc-hhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 76 IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~--~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
.+...++..|+|||.+.+. ...++.++|+|||||++|+|++|+.||..... ...+..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------------ 219 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ------------------ 219 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH------------------
Confidence 1334688899999988541 13468899999999999999999999864221 111110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... .... ......++..+.+||.+||..||.+|||++++++||||...
T Consensus 220 -----~~~----~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 220 -----VVE----EPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -----HHh----cCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 000 0000 00112367889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=232.91 Aligned_cols=182 Identities=24% Similarity=0.395 Sum_probs=142.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++......... .....
T Consensus 89 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~ 166 (290)
T cd05613 89 GGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE--RAYSF 166 (290)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc--ccccc
Confidence 3689999998888999999999999999999999999999999999999999999999999998765332211 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+. ..
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-----------------------~~ 223 (290)
T cd05613 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-----------------------RR 223 (290)
T ss_pred cCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH-----------------------HH
Confidence 6889999999987533457789999999999999999999996433221111111 01
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
+.... .+ ....+++.+.+||.+||..||.+|+ ++++++.||||+.+.
T Consensus 224 ~~~~~-~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 224 ILKSE-PP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred hhccC-CC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 10110 01 1234678899999999999999997 899999999998654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=230.53 Aligned_cols=176 Identities=29% Similarity=0.487 Sum_probs=134.5
Q ss_pred CCcHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~-~~L--s~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++........ .
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~---~ 165 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---C 165 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC---c
Confidence 36899999865 446 88999999999999999999999999999999999986 67899999999875533222 1
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....++..|+|||.+.+....++.++|+||+|+++|+|++|..||..........
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~------------------------ 221 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM------------------------ 221 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH------------------------
Confidence 23345788999999986532357889999999999999999999996533211100
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
+...... ........+++.+.+|+.+||..+|.+|||+.+++.||||
T Consensus 222 ~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 222 FKVGMFK----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhhhhhc----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0000000 0011123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=230.35 Aligned_cols=177 Identities=29% Similarity=0.503 Sum_probs=140.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .....
T Consensus 86 ~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 161 (277)
T cd06917 86 GGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS---KRSTF 161 (277)
T ss_pred CCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc---ccccc
Confidence 46899988764 799999999999999999999999999999999999999999999999999876544332 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.........+
T Consensus 162 ~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------------------------- 214 (277)
T cd06917 162 VGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------------------------- 214 (277)
T ss_pred cCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc--------------------------
Confidence 688999999988652 45788999999999999999999999765432211100
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
....+..+. ....+..+.+||.+||..||.+||++.+++.|+||+...
T Consensus 215 -~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 215 -PKSKPPRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -ccCCCCCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 000010110 112678899999999999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=227.91 Aligned_cols=172 Identities=26% Similarity=0.467 Sum_probs=138.0
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++......... ..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~ 159 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---AR 159 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh---hh
Confidence 368888887643 5899999999999999999999999999999999999999999999999998765332211 12
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...|+..|+|||++.+ ..++.++|+|||||++++|++|+.||...+..+....+..
T Consensus 160 ~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---------------------- 215 (256)
T cd08218 160 TCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR---------------------- 215 (256)
T ss_pred hccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc----------------------
Confidence 3457888999999877 5788899999999999999999999976543332221110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. ........+..+.+||.+||+.+|.+||++.++|+||||
T Consensus 216 -----~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 -----GS---YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----CC---CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 111223467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=230.19 Aligned_cols=174 Identities=34% Similarity=0.595 Sum_probs=141.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------- 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------- 74 (449)
+++|.+++.+...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (280)
T cd05581 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165 (280)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCC
Confidence 5799999999889999999999999999999999999999999999999999999999999998765433211
Q ss_pred ----------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 75 ----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 75 ----------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
........++..|+|||.+.+ ..++.++|||||||++++|++|..||...+.......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------- 236 (280)
T cd05581 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK------- 236 (280)
T ss_pred ccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------
Confidence 011233467889999999876 5688899999999999999999999987653222211110
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCccc
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYF 208 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa----~elL~hp~f 208 (449)
. .......+++.+.+||.+||..||.+|||+ +++|+||||
T Consensus 237 -------------------~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 -------------------L-----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred -------------------c-----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 0 011123457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=229.80 Aligned_cols=173 Identities=26% Similarity=0.424 Sum_probs=140.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 84 ~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~ 159 (258)
T cd05578 84 GGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTST 159 (258)
T ss_pred CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc----cccc
Confidence 578999998888899999999999999999999999999999999999999999999999999876543321 2345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..... . +...
T Consensus 160 ~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~-----------------------~~~~ 213 (258)
T cd05578 160 SGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD-Q-----------------------IRAK 213 (258)
T ss_pred CCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH-H-----------------------HHHH
Confidence 68889999999977 56889999999999999999999999866532110 0 0111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH--HHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA--EEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa--~elL~hp~f 208 (449)
... ......+..+..+.++|.+||..||.+|+++ .|+++||||
T Consensus 214 ~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 214 QET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 110 0111223467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=264.42 Aligned_cols=176 Identities=30% Similarity=0.430 Sum_probs=137.1
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcccccccCCcEEEcC-----------------
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-------NVFHRDLKPKNILANA----------------- 53 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~-------gIvHrDLKP~NILl~~----------------- 53 (449)
+++|.++|.. ...|++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 98 gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng 177 (1021)
T PTZ00266 98 AGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177 (1021)
T ss_pred CCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence 3689998875 34699999999999999999999985 4999999999999964
Q ss_pred CCCEEEeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHH
Q 013122 54 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133 (449)
Q Consensus 54 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~ 133 (449)
.+.+||+|||++....... .....+||+.|+|||++.+....++.++||||||||||+|++|..||...+....+.
T Consensus 178 ~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli 253 (1021)
T PTZ00266 178 RPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253 (1021)
T ss_pred CCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHH
Confidence 2348999999997653322 123457999999999986533468899999999999999999999997654332211
Q ss_pred HHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 134 ~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.+ +..... ......+..+.+||.+||..+|.+||++.|+|.|+||+.+
T Consensus 254 ~~--------------------------lk~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 254 SE--------------------------LKRGPD----LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HH--------------------------HhcCCC----CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 10 111111 1123457889999999999999999999999999999754
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=225.82 Aligned_cols=171 Identities=26% Similarity=0.413 Sum_probs=137.8
Q ss_pred CCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~---------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~ 72 (449)
+++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 57899999886 679999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
. ........++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------- 222 (262)
T cd00192 160 Y-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-------------- 222 (262)
T ss_pred c-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------
Confidence 1 111234567888999999877 578899999999999999999 6999987654333222211
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......++..+.++|.+||..||.+|||+.+++++
T Consensus 223 -------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 -------------GYR---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------CCC---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111 11223458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=226.92 Aligned_cols=171 Identities=20% Similarity=0.292 Sum_probs=134.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++|..+..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||+++...............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 36899999988889999999999999999999999999999999999999999999999999997654332211111112
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 159 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~----------------------- 213 (257)
T cd05060 159 RWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES----------------------- 213 (257)
T ss_pred cccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-----------------------
Confidence 23457999999876 678999999999999999997 9999976554322221111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......++..+++||.+||..||++||++.++++
T Consensus 214 ----~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 ----GER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----CCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011 1122356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=243.22 Aligned_cols=167 Identities=29% Similarity=0.446 Sum_probs=137.3
Q ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+|.++|+. ...+...+...|+.||++|++||+++++|||||...||||+++..+||+|||+|+...++.... ...
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~--~~~ 363 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA--SEG 363 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceee--cCC
Confidence 789999997 4469999999999999999999999999999999999999999999999999999544332211 111
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.--...|.|||.+.- ..++.++||||||++||||+| |+.||++.+..+.++.+.+....|
T Consensus 364 ~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp----------------- 424 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP----------------- 424 (468)
T ss_pred CCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-----------------
Confidence 122345889999976 789999999999999999998 899999988777666554432221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL 203 (449)
..+.+++.+.+|+..||+.+|++|||++.+.
T Consensus 425 -------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 -------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 1245788999999999999999999999664
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=223.15 Aligned_cols=171 Identities=30% Similarity=0.508 Sum_probs=137.4
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~ 157 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----RNTM 157 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----ccce
Confidence 7899999876 5799999999999999999999999999999999999999999999999999876644332 2345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+....+..+..
T Consensus 158 ~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------------ 211 (253)
T cd05122 158 VGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT------------------------ 211 (253)
T ss_pred ecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh------------------------
Confidence 68889999999877 4688999999999999999999999976543222211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 207 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~ 207 (449)
. ..+.......++..+.+||.+||..||++|||+.++|+|||
T Consensus 212 ---~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ---N-GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---c-CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 00000111123788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=230.88 Aligned_cols=176 Identities=31% Similarity=0.549 Sum_probs=141.3
Q ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++.... .++...+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ .....
T Consensus 100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~ 176 (286)
T cd06614 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---KRNSV 176 (286)
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh---hhccc
Confidence 78999999887 899999999999999999999999999999999999999999999999998865433221 11234
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus 177 ~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~------------------------ 230 (286)
T cd06614 177 VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT------------------------ 230 (286)
T ss_pred cCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------------
Confidence 57888999999877 5788999999999999999999999976543322211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... ........++..+.+||.+||+.+|.+|||+.++|+|+||+..
T Consensus 231 ---~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 ---KGI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ---cCC-CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 000 1111123367889999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=232.26 Aligned_cols=177 Identities=27% Similarity=0.539 Sum_probs=141.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.. ..+++..+..++.||+.||+|||++||+|+||+|+||+++.++.++|+|||++......... ....
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~---~~~~ 176 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSL 176 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc---cccc
Confidence 3578887754 46999999999999999999999999999999999999999999999999998654332211 2335
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+.+ ..++.++|+||+||++|+|++|..||.+.........+..
T Consensus 177 ~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~------------------------ 230 (292)
T cd06657 177 VGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------------------ 230 (292)
T ss_pred ccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------------
Confidence 68899999999876 5788999999999999999999999987654333222111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..+.. ......+++.+.+||.+||..||.+||++.++|+||||....
T Consensus 231 ---~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 231 ---NLPPK-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ---hCCcc-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 00111 112245678899999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=231.19 Aligned_cols=175 Identities=26% Similarity=0.404 Sum_probs=138.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........ .....
T Consensus 86 ~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 161 (277)
T cd06642 86 GGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTF 161 (277)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch---hhhcc
Confidence 3688888865 4799999999999999999999999999999999999999999999999999876543221 11234
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+
T Consensus 162 ~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------------------------- 213 (277)
T cd06642 162 VGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-------------------------- 213 (277)
T ss_pred cCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh--------------------------
Confidence 67889999999987 57889999999999999999999998654322211100
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.... ........+..+.+||.+||..+|.+|||+.++|+||||..+.
T Consensus 214 -~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 214 -PKNS---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred -hcCC---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 0000 0111234577899999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=238.36 Aligned_cols=211 Identities=20% Similarity=0.260 Sum_probs=139.2
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-cc--
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IF-- 77 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~-~~-- 77 (449)
++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.+.......... ..
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 58888888643 58999999999999999999999999999999999999999999999998654322211110 00
Q ss_pred -cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHH-H-----HHHH
Q 013122 78 -WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE-A-----IARV 150 (449)
Q Consensus 78 -~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e-~-----~~~~ 150 (449)
.....++..|+|||++.+....++.++||||+||++|+|++|+.||.+......+..+.......... . ....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 01123456799999987643457899999999999999999999998765443332222111000000 0 0000
Q ss_pred hhH--HHH-HHHhhhcc-----CCC-CCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 151 RNE--KAR-RYLSSMRK-----KKP-IPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 151 ~~~--~~~-~~~~~~~~-----~~~-~~~-~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
... ... ........ ... ..+ .......++.+.+||.+||..||++|||++|+|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000 000 00000000 000 000 0011235678999999999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=226.36 Aligned_cols=175 Identities=25% Similarity=0.424 Sum_probs=138.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++...............
T Consensus 90 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 169 (264)
T cd06653 90 GGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCcccccc
Confidence 46899999887789999999999999999999999999999999999999999999999999997653321111112345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......... .....
T Consensus 170 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~--------------------- 223 (264)
T cd06653 170 TGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIAT--------------------- 223 (264)
T ss_pred CCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHHc---------------------
Confidence 68899999999977 57889999999999999999999999754322211 11100
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. ........+++.+.++|.+||. +|..|||+.++|.|||.
T Consensus 224 --~~---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 224 --QP---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --CC---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 00 0112234578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=246.03 Aligned_cols=176 Identities=28% Similarity=0.547 Sum_probs=145.2
Q ss_pred CCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~~~~~ 75 (449)
|.||+.+.|.. .++|++...++++.|||.||.|||-+||+|+||||+|||+.+.. .+||||||+|+.+....
T Consensus 645 l~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 645 LHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred hcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 45788777754 45799999999999999999999999999999999999998754 59999999999876543
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
+....+||+.|+|||++.. ..|...-||||+|+|+|.-|.|..||....+. -+.|..
T Consensus 722 -FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN------------------ 778 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN------------------ 778 (888)
T ss_pred -hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccch--hHHhhc------------------
Confidence 4567899999999999998 79999999999999999999999999754432 111111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.--...+. -|.++++.+.|||..+|+..-.+|.|.+..|.|||++++
T Consensus 779 -----AaFMyPp~----PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 779 -----AAFMYPPN----PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred -----cccccCCC----chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 00112222 344678999999999999999999999999999999874
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-26 Score=235.16 Aligned_cols=169 Identities=28% Similarity=0.428 Sum_probs=138.3
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~g 83 (449)
||.++.++ +|.+.+|..|+.+.|.||+|||+.+.||||||..|||++..|.|||+|||.|.....- ..++|
T Consensus 114 DlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-------nsFvG 184 (948)
T KOG0577|consen 114 DLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-------NSFVG 184 (948)
T ss_pred HHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-------hcccC
Confidence 45555443 5999999999999999999999999999999999999999999999999999765432 56899
Q ss_pred cccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 84 TRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 84 t~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
|++|||||++... .+.|+-++||||||++..||.-.+||+-..+....+-.|..
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ------------------------- 239 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------------------- 239 (948)
T ss_pred CccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-------------------------
Confidence 9999999998532 25799999999999999999999998877665544433321
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
+.+..+ .-+.++..++.|+..||++-|.+|||.+++|.|+|...
T Consensus 240 --NesPtL--qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 --NESPTL--QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred --cCCCCC--CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 111111 12456788999999999999999999999999999864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=222.32 Aligned_cols=176 Identities=29% Similarity=0.459 Sum_probs=141.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ......
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~ 163 (260)
T cd06606 85 GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTGSV 163 (260)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-ccccCC
Confidence 5689999998888999999999999999999999999999999999999999999999999998876544321 012345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+.+ ..++.++|||||||++|+|++|..||..... ....+..
T Consensus 164 ~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~------------------------ 215 (260)
T cd06606 164 RGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYK------------------------ 215 (260)
T ss_pred CCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHh------------------------
Confidence 68889999999877 4688999999999999999999999976651 1111111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... ...........+..+.+||.+||..||.+||++.++|.||||
T Consensus 216 ~~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 216 IGS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ccc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000 001112223457889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=223.39 Aligned_cols=171 Identities=31% Similarity=0.560 Sum_probs=139.0
Q ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~~----~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~ 160 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---LA 160 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc---ee
Confidence 5888888764 6799999999999999999999999999999999999999999999999999876544321 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....|+..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+.
T Consensus 161 ~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---------------------- 216 (258)
T cd08215 161 KTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---------------------- 216 (258)
T ss_pred cceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh----------------------
Confidence 34578889999999876 568899999999999999999999997655322211110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... ........+..+.++|.+||..+|.+|||+.++|+||||
T Consensus 217 -----~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 217 -----KGQ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----cCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 110 111122567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=222.76 Aligned_cols=171 Identities=32% Similarity=0.513 Sum_probs=139.8
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......... .....
T Consensus 84 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~ 160 (254)
T cd06627 84 GSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---DASVV 160 (254)
T ss_pred CcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc---ccccc
Confidence 589999998888999999999999999999999999999999999999999999999999999876543321 23356
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+
T Consensus 161 ~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~--------------------------- 211 (254)
T cd06627 161 GTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--------------------------- 211 (254)
T ss_pred cchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------------------
Confidence 7889999999877 45889999999999999999999999754422111110
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
... ........++..+.++|.+||..+|++|||+.+++.||||
T Consensus 212 ~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 212 VQD---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred hcc---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 000 1111223567899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=226.02 Aligned_cols=169 Identities=23% Similarity=0.434 Sum_probs=133.2
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~--~~ 163 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HA 163 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec--cC
Confidence 468999987643 58999999999999999999999999999999999999999999999999987654332111 11
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 164 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--------------------- 220 (263)
T cd05052 164 GAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------------------- 220 (263)
T ss_pred CCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---------------------
Confidence 2233567999999876 678899999999999999998 9999987654333222211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......++..+.+||.+||..||++|||+.++++
T Consensus 221 ------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 ------GYR---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ------CCC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 0112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=227.53 Aligned_cols=170 Identities=22% Similarity=0.362 Sum_probs=133.4
Q ss_pred CCcHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 2 ESDLHQVIKAND--------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 2 e~dL~~~i~~~~--------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
+++|.++|..++ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~ 171 (280)
T cd05049 92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171 (280)
T ss_pred CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCccccee
Confidence 468888887653 488999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHH
Q 013122 68 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 146 (449)
Q Consensus 68 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~ 146 (449)
....... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 172 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~---------- 238 (280)
T cd05049 172 VYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT---------- 238 (280)
T ss_pred cccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----------
Confidence 4332211 11123346788999999987 678999999999999999998 999997655433322221
Q ss_pred HHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 147 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ........+..+.+||.+||..||.+|||+.|+++
T Consensus 239 -----------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 -----------------QGR---LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred -----------------cCC---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 110 11112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=222.51 Aligned_cols=171 Identities=31% Similarity=0.529 Sum_probs=140.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 77 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~ 153 (250)
T cd05123 77 GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTF 153 (250)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccCC
Confidence 578999999888899999999999999999999999999999999999999999999999999876544321 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 154 ~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------------------------- 206 (250)
T cd05123 154 CGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL------------------------- 206 (250)
T ss_pred cCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-------------------------
Confidence 68889999999877 567889999999999999999999997655322111111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---HHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA---EEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa---~elL~hp~f 208 (449)
. .... .....+..+.+||.+||..||++|||+ +++++||||
T Consensus 207 --~-~~~~---~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 207 --K-DPLR---FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --c-CCCC---CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0 0111 112347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-27 Score=230.67 Aligned_cols=173 Identities=24% Similarity=0.397 Sum_probs=135.8
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...... ..
T Consensus 98 ~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-------~~ 170 (307)
T cd06607 98 LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-------NS 170 (307)
T ss_pred CCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-------CC
Confidence 4677777754 446999999999999999999999999999999999999999999999999998654322 23
Q ss_pred ccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~----------------------- 227 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------------------- 227 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-----------------------
Confidence 5678899999987421 1457889999999999999999999997655332211110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.... ........+..+.+||.+||..||.+||++.+++.||||..
T Consensus 228 ----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 228 ----QNDS--PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred ----cCCC--CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0000 00111235678999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=224.04 Aligned_cols=172 Identities=30% Similarity=0.519 Sum_probs=137.2
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC-EEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+||+++.++. +||+|||.+......... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---~ 159 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL---A 159 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc---c
Confidence 358888887654 4899999999999999999999999999999999999998864 699999998765433211 1
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 160 ~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------------- 215 (257)
T cd08225 160 YTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC---------------------- 215 (257)
T ss_pred cccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh----------------------
Confidence 33468889999999876 578899999999999999999999997654322221110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. .+....+..+..+.++|.+||..+|++|||+.++++||||
T Consensus 216 -----~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 216 -----QG---YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----cc---cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00 1122234567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=232.37 Aligned_cols=177 Identities=26% Similarity=0.472 Sum_probs=140.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.+. .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ .....
T Consensus 100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---~~~~~ 175 (293)
T cd06647 100 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 175 (293)
T ss_pred CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---ccccc
Confidence 46899988764 689999999999999999999999999999999999999999999999998865433221 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|++||.+.. ..++.++|+|||||++|+|++|+.||...+....+..+.
T Consensus 176 ~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------------------------- 228 (293)
T cd06647 176 VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------------------- 228 (293)
T ss_pred cCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------------------------
Confidence 68889999999876 578899999999999999999999997655432211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
... .+.......++..+.+||.+||..+|.+||++.+++.|+||+...
T Consensus 229 --~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 229 --TNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred --cCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 000 011111224577899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=229.00 Aligned_cols=174 Identities=25% Similarity=0.406 Sum_probs=139.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 86 ~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 161 (277)
T cd06640 86 GGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTF 161 (277)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc---ccccc
Confidence 3588998876 4799999999999999999999999999999999999999999999999999876543221 11334
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+
T Consensus 162 ~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------------------------- 213 (277)
T cd06640 162 VGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------------------------- 213 (277)
T ss_pred cCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh--------------------------
Confidence 67889999999876 57889999999999999999999999765432221111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.... ........+..+.+||.+||..+|.+||++++++.|+||...
T Consensus 214 -~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 214 -PKNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -hcCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0000 111223456789999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=229.32 Aligned_cols=170 Identities=23% Similarity=0.348 Sum_probs=133.1
Q ss_pred CCcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 2 ESDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 2 e~dL~~~i~~~~-------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
+++|.++|.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 170 (288)
T cd05093 91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 170 (288)
T ss_pred CCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccc
Confidence 368889887543 3899999999999999999999999999999999999999999999999998755
Q ss_pred cCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHH
Q 013122 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 69 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~ 147 (449)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+....+..+..
T Consensus 171 ~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~---------- 237 (288)
T cd05093 171 YSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---------- 237 (288)
T ss_pred cCCcee-ecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------
Confidence 332211 11233445778999999877 678899999999999999998 8999976654332222211
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... .......+..+.+|+.+||+.||.+|||+.+++.
T Consensus 238 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 -----------------GRV---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -----------------CCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 1112346788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=229.70 Aligned_cols=170 Identities=22% Similarity=0.349 Sum_probs=133.2
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.+++..+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a 170 (291)
T cd05094 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170 (291)
T ss_pred CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcc
Confidence 468889887543 3899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+....++.+.
T Consensus 171 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------- 239 (291)
T cd05094 171 RDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-------- 239 (291)
T ss_pred cccCCCcee-ecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------
Confidence 755332211 11234456788999999877 678899999999999999998 999987655433222111
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ........+..+.+|+.+||+.||++|||+.++++
T Consensus 240 -------------------~~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 -------------------QGR---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred -------------------CCC---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 100 11122345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=233.30 Aligned_cols=171 Identities=22% Similarity=0.339 Sum_probs=133.6
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++..+. .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ....
T Consensus 92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~ 170 (316)
T cd05108 92 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY-HAEG 170 (316)
T ss_pred CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcce-eccC
Confidence 478999998754 58999999999999999999999999999999999999999999999999998654332211 1122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+.
T Consensus 171 ~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~----------------------- 225 (316)
T cd05108 171 GKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------------------- 225 (316)
T ss_pred CccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------------
Confidence 334667999999877 678999999999999999997 999997654322211110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.....+ ..+.++..+.+|+.+||..||.+|||+.+++.+
T Consensus 226 ----~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 ----KGERLP---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ----CCCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111111 123456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=230.76 Aligned_cols=177 Identities=20% Similarity=0.325 Sum_probs=131.0
Q ss_pred CCcHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeec
Q 013122 2 ESDLHQVIKAND-------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62 (449)
Q Consensus 2 e~dL~~~i~~~~-------------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DF 62 (449)
+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Df 182 (304)
T cd05096 103 NGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF 182 (304)
T ss_pred CCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCC
Confidence 468888886532 3677889999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh--CCCCCCCCCchhhHHHHHhhcC
Q 013122 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLG 140 (449)
Q Consensus 63 GlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg 140 (449)
|+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ +..||.+.+....+..+..
T Consensus 183 G~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~--- 256 (304)
T cd05096 183 GMSRNLYAGDYYR-IQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGE--- 256 (304)
T ss_pred ccceecccCceeE-ecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHH---
Confidence 9987653322111 1123455778999999876 578999999999999999986 5567766554333222211
Q ss_pred CCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 141 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+.. .....+....+.++..+.+||.+||..||++|||++++.+
T Consensus 257 -----------------~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 257 -----------------FFRD---QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred -----------------Hhhh---ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 1110 0001111223456788999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=227.53 Aligned_cols=170 Identities=22% Similarity=0.338 Sum_probs=132.0
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~-~~~~~ 170 (279)
T cd05109 92 YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE-YHADG 170 (279)
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce-eecCC
Confidence 47899999874 46999999999999999999999999999999999999999999999999999765432211 11122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+
T Consensus 171 ~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------------------------ 224 (279)
T cd05109 171 GKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL------------------------ 224 (279)
T ss_pred CccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------------------------
Confidence 234677999999876 578999999999999999998 88998654432221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. .... ......+..+.+||.+||..||++||++.+++.
T Consensus 225 ~~---~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 225 EK---GERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HC---CCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1111 112346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=228.71 Aligned_cols=174 Identities=25% Similarity=0.403 Sum_probs=135.9
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+|||++.++.+||+|||++...... ..
T Consensus 98 ~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-------~~ 170 (308)
T cd06634 98 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NX 170 (308)
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-------cc
Confidence 4577777754 446999999999999999999999999999999999999999999999999998754322 23
Q ss_pred ccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+. ...++.++|||||||++|+|++|..||...+.......+.
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----------------------- 227 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------------------- 227 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-----------------------
Confidence 4688899999997531 1357889999999999999999999986543322211110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.... + .......+..+.+||.+||..+|.+||+++++++|||+...
T Consensus 228 ----~~~~-~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 228 ----QNES-P-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ----hcCC-C-CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0000 0 11123467789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=230.35 Aligned_cols=179 Identities=25% Similarity=0.424 Sum_probs=135.5
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.. ...+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++........ ..
T Consensus 97 ~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~----~~ 172 (296)
T cd06618 97 STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA----KT 172 (296)
T ss_pred CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc----cc
Confidence 4566666665 3469999999999999999999997 5999999999999999999999999999876533221 12
Q ss_pred cccccccccCcccccccC--CCCCCccchhhhHHHHHhhhhCCCCCCCCCch-hhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 80 DYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
...++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...... +.+..+
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--------------------- 231 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI--------------------- 231 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH---------------------
Confidence 335778899999986521 24788999999999999999999999653221 111100
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
+. .. ...+ ......+..+.+||.+||..||.+||++++++.||||..+.
T Consensus 232 --~~---~~-~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 232 --LQ---EE-PPSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred --hc---CC-CCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 00 00 0000 11114578899999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=235.04 Aligned_cols=160 Identities=29% Similarity=0.474 Sum_probs=124.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... .......++..|+|||++
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPESI 247 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCccccCcHHh
Confidence 6899999999999999999999999999999999999999999999999999865332211 112234566789999998
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|+|++ |..||.+....+.+... + ...... .
T Consensus 248 ~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~-----------------------~---~~~~~~---~ 296 (337)
T cd05054 248 FD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR-----------------------L---KEGTRM---R 296 (337)
T ss_pred cC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH-----------------------H---hccCCC---C
Confidence 77 689999999999999999997 99999764432211110 0 000000 1
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.....++.+.+|+.+||+.+|++||+++|+++|
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=227.53 Aligned_cols=158 Identities=20% Similarity=0.373 Sum_probs=125.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++..|+|||.+
T Consensus 120 ~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05091 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAI 198 (283)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchhe-eeccCccCCccccCHHHH
Confidence 4888999999999999999999999999999999999999999999999998765332211 112334567789999998
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|||++ |..||.+....+.+..+.. .... .
T Consensus 199 ~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~---------------------------~~~~---~ 246 (283)
T cd05091 199 MY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN---------------------------RQVL---P 246 (283)
T ss_pred hc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---------------------------CCcC---C
Confidence 76 578899999999999999998 8888877654433322221 1111 1
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....++..+.+|+.+||+.||.+||++.+++.
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 247 CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 12356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=227.87 Aligned_cols=182 Identities=24% Similarity=0.461 Sum_probs=135.9
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----- 160 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----- 160 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc-----
Confidence 577776643 34589999999999999999999999999999999999999999999999999865433221
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc--hhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~--~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+..
T Consensus 161 ~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 217 (287)
T cd06621 161 GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL--------------------- 217 (287)
T ss_pred ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH---------------------
Confidence 23457888999999877 6788999999999999999999999976532 0001000
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..+..............-...++.+.+||.+||..||.+|||+.|++.||||+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 218 SYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 11111000000000000012467899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-27 Score=226.16 Aligned_cols=171 Identities=23% Similarity=0.389 Sum_probs=131.7
Q ss_pred CCcHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~~------~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 169 (272)
T cd05075 90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR 169 (272)
T ss_pred CCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCccccee
Confidence 3688888742 2248999999999999999999999999999999999999999999999999998654322111
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
......++..|++||.+.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 170 -~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~------------------ 228 (272)
T cd05075 170 -QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR------------------ 228 (272)
T ss_pred -cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------------------
Confidence 0122345678999999887 678999999999999999999 889997754432221111
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
..... ...+..+..+.+||.+||+.||.+|||+.+++++
T Consensus 229 ---------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 229 ---------QGNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---------cCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11111 1123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=227.07 Aligned_cols=178 Identities=22% Similarity=0.343 Sum_probs=136.4
Q ss_pred CCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~~----------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~ 71 (449)
+++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~ 172 (288)
T cd05061 93 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172 (288)
T ss_pred CCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcccccccc
Confidence 478999997532 3567789999999999999999999999999999999999999999999998754332
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 173 ~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------------- 235 (288)
T cd05061 173 DYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-------------- 235 (288)
T ss_pred cccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------
Confidence 2111 1122345677999999876 578899999999999999998 788887654332221111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc------Cccccccc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA------DPYFKGLA 212 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~------hp~f~~~~ 212 (449)
.... .......++.+.+||.+||+.||++|||+.++++ ||||.++.
T Consensus 236 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 -------------DGGY---LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred -------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 0000 1112245688999999999999999999999987 99998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=229.12 Aligned_cols=167 Identities=23% Similarity=0.341 Sum_probs=129.9
Q ss_pred CcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 3 SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 3 ~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 167 (297)
T cd05089 88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167 (297)
T ss_pred CcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCc
Confidence 68888887643 48899999999999999999999999999999999999999999999999986
Q ss_pred cccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHH
Q 013122 67 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 67 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e 145 (449)
....... ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 168 ~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~--------- 232 (297)
T cd05089 168 GEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP--------- 232 (297)
T ss_pred cccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---------
Confidence 4321111 111223456999999876 578899999999999999997 999997765433322111
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... ......++..+.+||.+||..||.+|||++++++.
T Consensus 233 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 233 ------------------QGYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 01123467889999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=227.02 Aligned_cols=171 Identities=23% Similarity=0.395 Sum_probs=132.1
Q ss_pred CCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~~-------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~ 71 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 93 g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~ 172 (277)
T cd05036 93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172 (277)
T ss_pred CCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCc
Confidence 478999997654 489999999999999999999999999999999999998765 5899999999765322
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.... .......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~------------- 236 (277)
T cd05036 173 SYYR-KGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG------------- 236 (277)
T ss_pred ccee-cCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-------------
Confidence 1110 0112233567999999976 579999999999999999996 9999987654333222111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... .....++..+.+|+.+||+.||++|||+.++|+|
T Consensus 237 --------------~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 --------------GGRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --------------CCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0000 1123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=225.93 Aligned_cols=171 Identities=20% Similarity=0.351 Sum_probs=131.8
Q ss_pred CCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~~----------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~ 71 (449)
+++|.+++.... .++...+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++......
T Consensus 93 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 172 (277)
T cd05062 93 RGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172 (277)
T ss_pred CCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCc
Confidence 468999987532 3577889999999999999999999999999999999999999999999998754332
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+....+..+..
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~------------- 236 (277)
T cd05062 173 DYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME------------- 236 (277)
T ss_pred ceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-------------
Confidence 2111 1122345778999999876 578999999999999999998 7889877654333221111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. ........+..+.+||.+||+.||++|||+.|++++
T Consensus 237 --------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 --------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred --------------CC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 011123457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=229.28 Aligned_cols=173 Identities=24% Similarity=0.384 Sum_probs=136.6
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..... ...
T Consensus 104 ~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------~~~ 176 (313)
T cd06633 104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANS 176 (313)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-------CCC
Confidence 4677777765 34699999999999999999999999999999999999999999999999999854321 134
Q ss_pred ccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..|+..|+|||++... ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---------------------- 234 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------------------- 234 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----------------------
Confidence 5688899999998421 14578899999999999999999999977654333222110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.. . ........+..+.+||.+||+.+|.+||++.++|.||||..
T Consensus 235 ----~~-~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ----ND-S--PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ----cC-C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 00 0 01112345678999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=226.33 Aligned_cols=185 Identities=26% Similarity=0.405 Sum_probs=140.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++...+.+++..++.++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++....... ...
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-----~~~ 161 (284)
T cd06620 87 CGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----ADT 161 (284)
T ss_pred CCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-----cCc
Confidence 36899999888889999999999999999999997 699999999999999999999999999986542221 123
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+|+..|+|||++.+ ..++.++||||+||++|+|++|..||........... . .......+.
T Consensus 162 ~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~--------~~~~~~~~~ 223 (284)
T cd06620 162 FVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------D--------PMGILDLLQ 223 (284)
T ss_pred cccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------h--------hhHHHHHHH
Confidence 578999999999876 5788999999999999999999999976543211000 0 000011111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.+.......+. ...++..+.+||.+||+.||.+|||++|+++|+||..-
T Consensus 224 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 224 QIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 11111111111 11256789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=223.43 Aligned_cols=171 Identities=22% Similarity=0.320 Sum_probs=132.3
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 4689999875 446999999999999999999999999999999999999999999999999998754333221111112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 158 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----------------------- 212 (257)
T cd05115 158 GKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE----------------------- 212 (257)
T ss_pred CCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----------------------
Confidence 223567999999876 578899999999999999996 999997665433222111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... ......++.+.+||.+||..||++||++.++++
T Consensus 213 ----~~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 213 ----QGKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ----CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 122356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.76 Aligned_cols=170 Identities=21% Similarity=0.352 Sum_probs=132.5
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+. .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~--~~~ 160 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS--SQG 160 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc--cCC
Confidence 468999997643 68999999999999999999999999999999999999999999999999987654322111 112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------------------- 216 (256)
T cd05059 161 TKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA---------------------- 216 (256)
T ss_pred CCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc----------------------
Confidence 223457999999887 678899999999999999998 8899976554332221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... ......+..+.+|+.+||..+|++|||+.++++.
T Consensus 217 -----~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 -----GYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -----CCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1000 1123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=222.81 Aligned_cols=169 Identities=28% Similarity=0.381 Sum_probs=132.8
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~ 161 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA--RQ 161 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc--cc
Confidence 36899999764 358999999999999999999999999999999999999999999999999997653322111 12
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 162 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--------------------- 218 (260)
T cd05070 162 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER--------------------- 218 (260)
T ss_pred CCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 2345667999999876 578899999999999999999 8899987654433322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......+..+.+||.+||..||.+|||+.++++
T Consensus 219 ------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 219 ------GYRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ------CCCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1111 112346788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=226.36 Aligned_cols=177 Identities=22% Similarity=0.329 Sum_probs=134.4
Q ss_pred CCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccC
Q 013122 2 ESDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 70 (449)
Q Consensus 2 e~dL~~~i~~~~-----------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~ 70 (449)
+++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||+++....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05051 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred CCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeeccc
Confidence 368999988765 689999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh--CCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 71 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 71 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
.... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+....+..+...+
T Consensus 183 ~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~--------- 250 (296)
T cd05051 183 SDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFF--------- 250 (296)
T ss_pred Ccce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcc---------
Confidence 2211 11233456778999999876 578999999999999999998 667776554433322221110
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
............+..+..+.+||.+||+.||.+|||+.++++
T Consensus 251 --------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 251 --------------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred --------------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 000111111122356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=223.39 Aligned_cols=171 Identities=22% Similarity=0.340 Sum_probs=132.0
Q ss_pred CCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~~~------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
.++|..++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 91 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 170 (273)
T cd05035 91 HGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170 (273)
T ss_pred CCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecccccccc
Confidence 36788887432 358999999999999999999999999999999999999999999999999997654332111
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+......++.+.
T Consensus 171 -~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~------------------ 229 (273)
T cd05035 171 -QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR------------------ 229 (273)
T ss_pred -ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------------------
Confidence 1112234667999999876 578899999999999999999 889997655432221111
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... .......+..+.+||.+||+.||.+|||+.|++++
T Consensus 230 ---------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 230 ---------HGNR---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ---------cCCC---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 11223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=254.66 Aligned_cols=176 Identities=34% Similarity=0.496 Sum_probs=133.2
Q ss_pred cHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccccc-------------
Q 013122 4 DLHQVIKANDDL-TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF------------- 69 (449)
Q Consensus 4 dL~~~i~~~~~L-s~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~------------- 69 (449)
.|.++|..+... ....+++++++|++||+|+|++|||||||||.||+++.++.|||+|||+|....
T Consensus 682 ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~ 761 (1351)
T KOG1035|consen 682 LLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFS 761 (1351)
T ss_pred HHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCcc
Confidence 355666666444 588999999999999999999999999999999999999999999999997621
Q ss_pred -CC-CCCccccccccccccccCcccccccCC-CCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHH
Q 013122 70 -ND-TPTAIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 146 (449)
Q Consensus 70 -~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~ 146 (449)
.. .......+..+||..|+|||++.+... .|+.++||||||+||+||+. ||...- +-
T Consensus 762 ~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER--------------- 821 (1351)
T KOG1035|consen 762 TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER--------------- 821 (1351)
T ss_pred ccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HH---------------
Confidence 00 011123467899999999999987421 69999999999999999986 364321 11
Q ss_pred HHHHhhHHHHHHHhhhccCCCCCCC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 147 IARVRNEKARRYLSSMRKKKPIPFS-QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
...+..++ ...++.. ..+.+.-+.-..+|+.||+.||.+||||.|+|++.||-
T Consensus 822 ---------a~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 822 ---------ASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ---------HHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 12233344 2223332 23344456678899999999999999999999999986
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.45 Aligned_cols=164 Identities=20% Similarity=0.362 Sum_probs=131.1
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++.++. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~------~~ 158 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DT 158 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC------CC
Confidence 68999998754 38999999999999999999999999999999999999999999999999987543322 12
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+.......+.
T Consensus 159 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~----------------------- 213 (256)
T cd05082 159 GKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------------------- 213 (256)
T ss_pred CccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----------------------
Confidence 334567999999876 678899999999999999997 999987654322221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......+++.+.+||.+||..||++|||+.++++
T Consensus 214 ----~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 214 ----KGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----cCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1101 1122456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=227.90 Aligned_cols=171 Identities=28% Similarity=0.442 Sum_probs=132.6
Q ss_pred CCcHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKA----------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~----------------~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~ 179 (293)
T cd05053 100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179 (293)
T ss_pred CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccc
Confidence 3688888864 235899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 180 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------- 248 (293)
T cd05053 180 RDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-------- 248 (293)
T ss_pred ccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH--------
Confidence 8654322111 1122234567999999876 678899999999999999997 899998765433322211
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... .......+..+.+|+.+||..||++|||+.+++++
T Consensus 249 -------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 249 -------------------EGYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -------------------cCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1100 01123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=222.91 Aligned_cols=169 Identities=25% Similarity=0.384 Sum_probs=133.4
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~ 162 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT--ARE 162 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee--ccC
Confidence 46899999763 45899999999999999999999999999999999999999999999999999765432211 112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 163 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~--------------------- 219 (261)
T cd05072 163 GAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR--------------------- 219 (261)
T ss_pred CCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc---------------------
Confidence 3345678999999876 578889999999999999998 9999987554333222211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....++..+.+|+.+||..||++|||++++++
T Consensus 220 ------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 220 ------GYRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ------CCCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 122356788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=226.76 Aligned_cols=182 Identities=24% Similarity=0.403 Sum_probs=139.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~ 166 (288)
T cd05583 89 GGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE--RAYSF 166 (288)
T ss_pred CCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc--ccccc
Confidence 3689999988778999999999999999999999999999999999999999999999999998765433211 11234
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|++||.+.+....++.++|+||||+++|+|++|..||...........+. .....
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------------------~~~~~- 226 (288)
T cd05583 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS-------------------RRILK- 226 (288)
T ss_pred cCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH-------------------HHHHc-
Confidence 6888999999987632247789999999999999999999996433211111110 00010
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT---a~elL~hp~f~~~~ 212 (449)
.. ......++..+.+||.+||+.||++||| +.++|+||||+.+.
T Consensus 227 --~~-----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 227 --SK-----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred --cC-----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 00 1112336788999999999999999998 56789999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=222.26 Aligned_cols=169 Identities=30% Similarity=0.448 Sum_probs=134.3
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..++++.+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ ...
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~ 158 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA---YAC 158 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---ccc
Confidence 36788888653 3589999999999999999999999999999999999999999999999999876533221 223
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 159 ~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----------------------- 213 (255)
T cd08219 159 TYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC----------------------- 213 (255)
T ss_pred cccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-----------------------
Confidence 4578899999999977 578899999999999999999999997655332221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... ......++..+.+||.+||..||.+|||+.++|.-
T Consensus 214 ----~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 214 ----QGSY---KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----cCCC---CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1101 11123467789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=225.26 Aligned_cols=170 Identities=22% Similarity=0.390 Sum_probs=133.2
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 92 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 170 (279)
T cd05111 92 LGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSE 170 (279)
T ss_pred CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc-ccccCC
Confidence 47999999764 4699999999999999999999999999999999999999999999999999976543221 112234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|++||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+.
T Consensus 171 ~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~----------------------- 225 (279)
T cd05111 171 HKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE----------------------- 225 (279)
T ss_pred CCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----------------------
Confidence 456778999999876 578999999999999999998 999997765322211111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...... .....+..+.+++.+||..||.+|||+.|+++
T Consensus 226 ----~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 226 ----KGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----CCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111 11124567899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=221.88 Aligned_cols=169 Identities=25% Similarity=0.386 Sum_probs=133.4
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......... ..
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~ 162 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA--RE 162 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc--cC
Confidence 578999998754 69999999999999999999999999999999999999999999999999998764322111 11
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....+..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+..
T Consensus 163 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------------------- 219 (261)
T cd05068 163 GAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ--------------------- 219 (261)
T ss_pred CCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 1223457999999877 678899999999999999999 9999987654333222211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+ .....+..+.+|+.+||+.||.+||++.++++
T Consensus 220 ------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 220 ------GYRMP---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------CCCCC---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11111 12346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=220.69 Aligned_cols=172 Identities=22% Similarity=0.346 Sum_probs=135.3
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.++|.+++..+. .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 468999998765 689999999999999999999999999999999999999999999999999987644222111112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 159 ~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------------------- 215 (257)
T cd05040 159 HLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK--------------------- 215 (257)
T ss_pred CCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------------------
Confidence 3456778999999877 578999999999999999998 9999976654433322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .......+..+.+|+.+||..+|++|||+.++++
T Consensus 216 -----~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 216 -----EGER---LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----cCCc---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0000 0111245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=219.74 Aligned_cols=170 Identities=29% Similarity=0.461 Sum_probs=137.6
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----- 157 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----- 157 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-----
Confidence 3578888866 3569999999999999999999999999999999999999999999999999997765431
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--------------------- 214 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ--------------------- 214 (256)
T ss_pred cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------------------
Confidence 123567889999999977 678889999999999999999999997665322211110
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. .+.......+..++++|.+||..+|.+|||+.++|+||++
T Consensus 215 ------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 215 ------RG---KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------cC---CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 00 0111123467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=224.45 Aligned_cols=169 Identities=20% Similarity=0.283 Sum_probs=132.1
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+......... ....
T Consensus 90 ~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 167 (266)
T cd05064 90 NGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY--TTMS 167 (266)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh--cccC
Confidence 36899999874 46999999999999999999999999999999999999999999999999987543221111 0112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+....+..+.+
T Consensus 168 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---------------------- 223 (266)
T cd05064 168 GKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED---------------------- 223 (266)
T ss_pred CCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC----------------------
Confidence 234678999999877 678999999999999999775 9999987654433322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+ ....++..+.+|+.+||+.+|.+|||++++++
T Consensus 224 -----~~~~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 224 -----GFRLP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----CCCCC---CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11111 12456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=236.54 Aligned_cols=159 Identities=28% Similarity=0.445 Sum_probs=122.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 286 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESI 286 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-eeccCCCCccceeCHHHh
Confidence 4788999999999999999999999999999999999999999999999998765332211 111223356679999998
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|+|++ |+.||........+..+ .. ......
T Consensus 287 ~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~-----------------------~~---~~~~~~--- 335 (374)
T cd05106 287 FD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-----------------------VK---RGYQMS--- 335 (374)
T ss_pred cC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH-----------------------HH---cccCcc---
Confidence 76 679999999999999999997 99999764432211111 00 000000
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.....++.+.+||.+||+.||.+|||+.++++
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11235789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=220.54 Aligned_cols=169 Identities=23% Similarity=0.353 Sum_probs=132.8
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........ ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~--~~~~ 160 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT--SSSG 160 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee--ccCC
Confidence 47899998754 46899999999999999999999999999999999999999999999999998764332211 1122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+.+..+...
T Consensus 161 ~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~--------------------- 217 (256)
T cd05114 161 AKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG--------------------- 217 (256)
T ss_pred CCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---------------------
Confidence 335567999999876 578899999999999999999 89999776654433332210
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... ....+..+.+|+.+||..||.+||+++++++
T Consensus 218 ------~~~~~---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 218 ------FRLYR---PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------CCCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00001 1224678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-27 Score=229.77 Aligned_cols=175 Identities=22% Similarity=0.416 Sum_probs=151.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|||.-.|+.-+++.+.++.+++..|+-||-|||++|||.||||.+|||++.+|.|||+|||+++....+.. ...++
T Consensus 434 GGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~---TTkTF 510 (683)
T KOG0696|consen 434 GGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV---TTKTF 510 (683)
T ss_pred CchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc---ceeee
Confidence 589999999999999999999999999999999999999999999999999999999999999875433322 23678
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
|||+.|+|||++.- ..|+.++|.||+|++|||||.|++||.|.+..+..+.|++.--
T Consensus 511 CGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------------------- 567 (683)
T KOG0696|consen 511 CGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------------------- 567 (683)
T ss_pred cCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------------------
Confidence 99999999999975 7999999999999999999999999999998877776654210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa-----~elL~hp~f~~~~ 212 (449)
.....++.++.++...+|...|.+|..+ .++-.||||+.+.
T Consensus 568 ----------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 568 ----------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred ----------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 1123468899999999999999999654 5899999998754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=221.53 Aligned_cols=170 Identities=20% Similarity=0.348 Sum_probs=132.8
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||+++......... ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~--~~~ 160 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS--SVG 160 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee--cCC
Confidence 468999998754 68999999999999999999999999999999999999999999999999987653322111 112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|++||.+.+ ..++.++|||||||++|+|++ |..||...+.......+..
T Consensus 161 ~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---------------------- 216 (256)
T cd05113 161 SKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ---------------------- 216 (256)
T ss_pred CccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc----------------------
Confidence 335677999999976 578899999999999999998 9999876554332222211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
..... .....+..+.+|+.+||+.||.+|||+.+++.+
T Consensus 217 -----~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 217 -----GLRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----CCCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 11111 112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=224.70 Aligned_cols=170 Identities=22% Similarity=0.370 Sum_probs=132.0
Q ss_pred CCcHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 2 ESDLHQVIKAND---------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 2 e~dL~~~i~~~~---------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 170 (280)
T cd05092 91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170 (280)
T ss_pred CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCcee
Confidence 468888887653 48999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHH
Q 013122 67 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 67 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e 145 (449)
......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.+..+.
T Consensus 171 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--------- 238 (280)
T cd05092 171 DIYSTDYYR-VGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--------- 238 (280)
T ss_pred EcCCCceee-cCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---------
Confidence 543322111 1123345678999999877 578999999999999999998 899997654433221111
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... .....+++.+.+||.+||+.||.+||+++++++
T Consensus 239 ------------------~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 239 ------------------QGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ------------------cCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11010 112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=223.68 Aligned_cols=171 Identities=21% Similarity=0.382 Sum_probs=132.8
Q ss_pred CCcHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCc
Q 013122 2 ESDLHQVIKAN-----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64 (449)
Q Consensus 2 e~dL~~~i~~~-----------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 64 (449)
+++|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (283)
T cd05090 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170 (283)
T ss_pred CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccc
Confidence 36888888532 2478999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCC
Q 013122 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPS 143 (449)
Q Consensus 65 A~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~ 143 (449)
++......... ......++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+.+.......+.
T Consensus 171 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~------- 240 (283)
T cd05090 171 SREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR------- 240 (283)
T ss_pred cccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------
Confidence 97654322111 1133445678999999876 578999999999999999998 999997765433222211
Q ss_pred HHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 144 PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 144 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... ......+++.+.+|+.+||+.||.+||++.+++++
T Consensus 241 --------------------~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 --------------------KRQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred --------------------cCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1111 11223467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=221.14 Aligned_cols=171 Identities=23% Similarity=0.368 Sum_probs=132.3
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+ ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++...............
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 169 (268)
T cd05063 90 NGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG 169 (268)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccC
Confidence 36899998764 46999999999999999999999999999999999999999999999999998765432221111111
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 170 ~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~--------------------- 226 (268)
T cd05063 170 GKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG--------------------- 226 (268)
T ss_pred CCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC---------------------
Confidence 223456999999876 578899999999999999997 99999766543333222111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...+. ....+..+.+|+.+||..||.+||++.++++
T Consensus 227 ------~~~~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 227 ------FRLPA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------CCCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11111 1245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=238.71 Aligned_cols=167 Identities=27% Similarity=0.415 Sum_probs=138.5
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
|-|+.+|+....++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++...... ..-.++
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S----TkMSFa 272 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS----TKMSFA 272 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh----hhhhhh
Confidence 6799999999999999999999999999999999999999999999999999999999999987664432 124689
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||..|||||++.. ...+.++|||||||||||||||..||..-+. ..+| +|.-+
T Consensus 273 GTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVds---sAII---wGVGs------------------- 325 (904)
T KOG4721|consen 273 GTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS---SAII---WGVGS------------------- 325 (904)
T ss_pred hhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccch---heeE---EeccC-------------------
Confidence 9999999999998 7899999999999999999999999965332 1111 11100
Q ss_pred ccCCCCCCCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 163 RKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 163 ~~~~~~~~~~-~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
..+.. ....++..++-||+.||+-.|..||++.++|.|
T Consensus 326 -----NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 326 -----NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred -----CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 00111 113466778889999999999999999999987
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=223.74 Aligned_cols=173 Identities=27% Similarity=0.434 Sum_probs=138.6
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........ ......
T Consensus 87 ~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~ 162 (277)
T cd06641 87 GSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFV 162 (277)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh---hhcccc
Confidence 578888875 4699999999999999999999999999999999999999999999999999875533221 123356
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...........+.
T Consensus 163 ~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------------------------- 214 (277)
T cd06641 163 GTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-------------------------- 214 (277)
T ss_pred CCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh--------------------------
Confidence 8889999999876 577889999999999999999999997544322211110
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... .......++..+.++|.+||..+|.+||++.++++||||...
T Consensus 215 -~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 215 -KNN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred -cCC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 000 111223467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=241.48 Aligned_cols=176 Identities=25% Similarity=0.324 Sum_probs=135.7
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+.+|+.+|+-.. +|.....+.|++||++|+.|||.++|||||||..||++.++++|||+|||++....-.. .......
T Consensus 471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~-g~~q~~q 549 (678)
T KOG0193|consen 471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS-GEQQLEQ 549 (678)
T ss_pred CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec-cccccCC
Confidence 357888887554 59999999999999999999999999999999999999999999999999997643221 1112345
Q ss_pred ccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..|...|||||++... ...|+..+|||||||++|||++|..||...+....+=.+-+.++
T Consensus 550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l------------------- 610 (678)
T KOG0193|consen 550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL------------------- 610 (678)
T ss_pred CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-------------------
Confidence 5688899999998531 24689999999999999999999999984433222111111111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.........+++.++++|+..||.+++++||.+.+||.
T Consensus 611 -------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 611 -------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 12223334456778999999999999999999999986
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=220.19 Aligned_cols=168 Identities=26% Similarity=0.411 Sum_probs=133.7
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......... ..
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~---~~ 162 (261)
T cd05148 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL---SS 162 (261)
T ss_pred cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc---cc
Confidence 36899999864 35899999999999999999999999999999999999999999999999998765332211 12
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|++||.+.. ..++.++|||||||++|+|++ |+.||.+.+..+.+..+..
T Consensus 163 ~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--------------------- 219 (261)
T cd05148 163 DKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA--------------------- 219 (261)
T ss_pred CCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh---------------------
Confidence 3345678999999876 578899999999999999998 8999987664333322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......++.+.++|.+||..||.+|||+.++++
T Consensus 220 ------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 220 ------GYRM---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------CCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0001 112456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=228.28 Aligned_cols=168 Identities=24% Similarity=0.369 Sum_probs=129.6
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~ 171 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccC
Confidence 368899887543 4789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 172 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--------- 236 (303)
T cd05088 172 RGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--------- 236 (303)
T ss_pred cccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH---------
Confidence 64221111 111223567999999876 568899999999999999998 99999765543222111
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
...... ......++.+.+||.+||+.+|.+||+++++|.+
T Consensus 237 ------------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 ------------------PQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ------------------hcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 010000 1112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=220.71 Aligned_cols=168 Identities=29% Similarity=0.402 Sum_probs=132.2
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.......... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~--~~~ 162 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQG 162 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc--ccC
Confidence 6899999864 358999999999999999999999999999999999999999999999999997654322111 123
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 163 ~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~---------------------- 218 (262)
T cd05071 163 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---------------------- 218 (262)
T ss_pred CcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc----------------------
Confidence 346678999999876 578999999999999999999 8888976654332222111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+ .....+..+.+||.+||+.||.+||++.++++
T Consensus 219 -----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 -----GYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----CCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00111 12346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=231.34 Aligned_cols=148 Identities=31% Similarity=0.530 Sum_probs=106.9
Q ss_pred EEEeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCC------Cchh
Q 013122 57 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK------NVVH 130 (449)
Q Consensus 57 vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~------~~~~ 130 (449)
|||+|||.|+-... .++.-+.|+.|+|||++.+ ..|++.+||||++|++|||+||..+|... .+.+
T Consensus 393 vKIaDlGNACW~~k------hFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 393 VKIADLGNACWVHK------HFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred EEEeeccchhhhhh------hhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 45556655543221 2345578999999999999 79999999999999999999999999643 3567
Q ss_pred hHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh------ccCCCCCCCCC------CC-CCCHHHHHHHHHhhhcCCCCCC
Q 013122 131 QLDIMTDLLGTPSPEAIARVRNEKARRYLSSM------RKKKPIPFSQK------FP-NANPLALRLLERMLAFEPKDRP 197 (449)
Q Consensus 131 ~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~------~~~~~~~~~~~------~~-~~s~~~~dLL~~~L~~DP~~Rp 197 (449)
.+..|++++|..+..+...- ...+.||..- .+-++.++... |+ ....++.+||.-||.++|++|+
T Consensus 465 HiA~i~ELLG~iPr~ia~~G--k~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGG--KYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHhhccHHHHhcC--cchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 88999999998887766433 2234444332 22222222111 11 1235688999999999999999
Q ss_pred CHHHHHcCccccccccc
Q 013122 198 TAEEALADPYFKGLAKV 214 (449)
Q Consensus 198 Ta~elL~hp~f~~~~~~ 214 (449)
||.++|+|||++.+...
T Consensus 543 tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHhcCccccCCCCC
Confidence 99999999999977654
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=221.48 Aligned_cols=170 Identities=22% Similarity=0.360 Sum_probs=132.2
Q ss_pred CCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~~----------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~ 71 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~ 172 (277)
T cd05032 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172 (277)
T ss_pred CCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccC
Confidence 368898886532 3688899999999999999999999999999999999999999999999998765433
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------------- 235 (277)
T cd05032 173 DYYR-KGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-------------- 235 (277)
T ss_pred cccc-cCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh--------------
Confidence 2111 1123456788999999876 578899999999999999998 999997765433222111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... ......+..+.+||.+||+.+|++|||+.++++
T Consensus 236 -------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 -------------DGGHL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111 112235788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=220.41 Aligned_cols=168 Identities=28% Similarity=0.381 Sum_probs=132.5
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......... ...
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~--~~~ 162 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA--RQG 162 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc--cCC
Confidence 58999997643 48999999999999999999999999999999999999999999999999997653322111 122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 163 ~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------------------- 218 (260)
T cd05069 163 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER---------------------- 218 (260)
T ss_pred CccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------------------
Confidence 345678999998876 578899999999999999999 8999987654333222211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......+..+.+|+.+||..||.+||+++++++
T Consensus 219 -----~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 219 -----GYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----CCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=226.30 Aligned_cols=173 Identities=26% Similarity=0.419 Sum_probs=135.8
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++...... ..
T Consensus 108 ~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-------~~ 180 (317)
T cd06635 108 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-------NS 180 (317)
T ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-------cc
Confidence 4677777754 446999999999999999999999999999999999999999999999999988653221 23
Q ss_pred ccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+... ...++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---------------------- 238 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------------------- 238 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----------------------
Confidence 4688899999997421 14578899999999999999999999876543322221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.... .......+..+.+||.+||+.+|.+||++.++++|+|+..
T Consensus 239 -----~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 239 -----NESP--TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----ccCC--CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 0112345778999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=219.50 Aligned_cols=170 Identities=30% Similarity=0.514 Sum_probs=133.8
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++. +.+||+|||++......... .
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~---~ 162 (260)
T cd08222 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL---A 162 (260)
T ss_pred CCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCccc---c
Confidence 577777753 346999999999999999999999999999999999999975 56999999998765433221 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..+|.+.+.......+.
T Consensus 163 ~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~---------------------- 218 (260)
T cd08222 163 TTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV---------------------- 218 (260)
T ss_pred cCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----------------------
Confidence 33557889999999876 568889999999999999999999997654322221111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. .........+..+.+||.+||..||++||++.++++||||
T Consensus 219 -----~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 219 -----EG---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----cC---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00 0111123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=218.72 Aligned_cols=170 Identities=21% Similarity=0.357 Sum_probs=129.1
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ....
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~ 155 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TGGM 155 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cCCC
Confidence 468999997654 58999999999999999999999999999999999999999999999999987543221110 0111
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...+..|+|||.+.+ ..++.++|||||||++|+|++ |..||........... +
T Consensus 156 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~------------------------~ 209 (252)
T cd05084 156 KQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA------------------------I 209 (252)
T ss_pred CCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH------------------------H
Confidence 123456999999877 578899999999999999997 8888865432211111 1
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. ...... .....+..+.+|+.+||+.||++|||+.++++
T Consensus 210 ~---~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 210 E---QGVRLP---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred H---cCCCCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 111111 12345788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=222.45 Aligned_cols=167 Identities=24% Similarity=0.370 Sum_probs=129.1
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.++|..+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 368999987643 4789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
........ ......+..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+.......+
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~--------- 224 (270)
T cd05047 160 RGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--------- 224 (270)
T ss_pred cccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH---------
Confidence 53221110 111223567999999876 678899999999999999997 99999765533222111
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...... ......+..+.+|+.+||..||.+|||+.+++.
T Consensus 225 ------------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 225 ------------------PQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ------------------hCCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 011000 112346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=233.00 Aligned_cols=159 Identities=28% Similarity=0.427 Sum_probs=122.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.++++.+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......... ......++..|+|||++
T Consensus 210 ~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-VKGNARLPVKWMAPESI 288 (375)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc-ccCCCCCCcceeChhHh
Confidence 47889999999999999999999999999999999999999999999999997654322111 11223355679999999
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|+|++ |..||.+......+. ..+.. .... .
T Consensus 289 ~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~-----------------------~~~~~---~~~~---~ 337 (375)
T cd05104 289 FN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-----------------------KMIKE---GYRM---L 337 (375)
T ss_pred cC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH-----------------------HHHHh---CccC---C
Confidence 77 678999999999999999998 888887654322111 01110 0000 0
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.....+..+.+||.+||+.||++|||+.++++
T Consensus 338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=241.83 Aligned_cols=178 Identities=26% Similarity=0.456 Sum_probs=150.3
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|+|+++|.+++++.+..+..++.|+++|++|||+++|||||||.+|||++.+.++||+|||++..+.... ...+
T Consensus 138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~----~lqt 213 (596)
T KOG0586|consen 138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL----MLQT 213 (596)
T ss_pred cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc----cccc
Confidence 578999999999999999999999999999999999999999999999999999999999999998765433 3467
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
+||++.|.|||++.+. ..-++.+|+||+|+++|-|+.|..||.|.+....-..
T Consensus 214 ~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-------------------------- 266 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-------------------------- 266 (596)
T ss_pred cCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccch--------------------------
Confidence 8999999999999884 4457899999999999999999999998774332111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.++.+..+++ -++.++.+||+++|..+|.+|++++++..|.|.......
T Consensus 267 vl~gk~rIp~-----~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 267 VLRGKYRIPF-----YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred heeeeecccc-----eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 1112222222 356789999999999999999999999999999876554
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=225.16 Aligned_cols=171 Identities=27% Similarity=0.419 Sum_probs=133.1
Q ss_pred CCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~----------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.++|... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~ 184 (304)
T cd05101 105 KGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184 (304)
T ss_pred CCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccc
Confidence 36888888764 24788899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 185 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------- 254 (304)
T cd05101 185 RDVNNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE------- 254 (304)
T ss_pred eecccccccc-cccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-------
Confidence 7654322111 1122345678999999877 578999999999999999998 7888877654333222211
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......++..+.+||.+||..+|.+|||+.++++.
T Consensus 255 --------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 255 --------------------GHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred --------------------CCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 100 01123567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=218.81 Aligned_cols=171 Identities=23% Similarity=0.370 Sum_probs=129.2
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-cccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~-~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 478999997643 47888899999999999999999999999999999999999999999999987543321110 0112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++|||||||++|||++ |.++|...+..+....+
T Consensus 161 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~----------------------- 215 (262)
T cd05058 161 GAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL----------------------- 215 (262)
T ss_pred cCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----------------------
Confidence 3345678999999876 578899999999999999999 46777654432221111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
......... ...+..+.+|+.+||..+|++||++.+++.
T Consensus 216 ----~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 216 ----LQGRRLLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ----hcCCCCCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011111111 234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=219.57 Aligned_cols=171 Identities=25% Similarity=0.382 Sum_probs=132.8
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......... ....
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~ 167 (266)
T cd05033 89 NGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY-TTKG 167 (266)
T ss_pred CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce-eccC
Confidence 358999987644 69999999999999999999999999999999999999999999999999998764221111 1112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+..
T Consensus 168 ~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---------------------- 223 (266)
T cd05033 168 GKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---------------------- 223 (266)
T ss_pred CCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc----------------------
Confidence 234578999999876 578899999999999999997 9989865543322222211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
....+ .....+..+.+|+.+||+.||++||++.+++++
T Consensus 224 -----~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 224 -----GYRLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----CCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10111 113467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=225.57 Aligned_cols=170 Identities=26% Similarity=0.421 Sum_probs=131.8
Q ss_pred CCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~----------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.++|... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~ 181 (314)
T cd05099 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181 (314)
T ss_pred CCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccc
Confidence 36899998763 24889999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 182 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-------- 250 (314)
T cd05099 182 RGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR-------- 250 (314)
T ss_pred cccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------
Confidence 7654322111 0111234467999999877 678999999999999999998 888997765433322211
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......++..+.+||.+||..||++|||+.++++
T Consensus 251 -------------------~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 251 -------------------EGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1110 1112356778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=218.46 Aligned_cols=169 Identities=27% Similarity=0.388 Sum_probs=133.3
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.......... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~--~~ 161 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA--RE 161 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc--cc
Confidence 468999987643 58999999999999999999999999999999999999999999999999987654222111 12
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 162 ~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------------------- 218 (260)
T cd05067 162 GAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER--------------------- 218 (260)
T ss_pred CCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc---------------------
Confidence 2345678999999876 578899999999999999998 9999987664433322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......+..+.+||.+||..||++|||+++++.
T Consensus 219 ------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 219 ------GYRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ------CCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111 112345778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=218.62 Aligned_cols=169 Identities=28% Similarity=0.437 Sum_probs=133.1
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......... ..
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~~ 162 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA--RE 162 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh--hh
Confidence 368999998754 69999999999999999999999999999999999999999999999999987654321110 11
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++||||+||++|+|++ |+.||.+.+....+..+...+
T Consensus 163 ~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------------- 221 (261)
T cd05034 163 GAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY------------------- 221 (261)
T ss_pred ccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 2234567999999887 578899999999999999998 999998766544433322111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. ......+..+.+++.+||..||.+||+++++++
T Consensus 222 --------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 222 --------RM---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------CC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00 111234778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=220.02 Aligned_cols=163 Identities=20% Similarity=0.301 Sum_probs=125.3
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC-------EEEeecCccccccCCCCC
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------LKICDFGLARVAFNDTPT 74 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-------vKL~DFGlA~~~~~~~~~ 74 (449)
++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 89 ~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--- 165 (262)
T cd05077 89 GPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--- 165 (262)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---
Confidence 5677777654 46999999999999999999999999999999999999987654 899999998654321
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhh-hCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
....++..|+|||.+... ..++.++|||||||++|+|+ .|..||.+....+...
T Consensus 166 ----~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------------------- 220 (262)
T cd05077 166 ----QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------------------- 220 (262)
T ss_pred ----ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--------------------
Confidence 234678889999988642 56889999999999999998 5888886544221110
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
+.... .......+..+.+||.+||+.||.+||++.++|++
T Consensus 221 ----~~~~~--------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 221 ----FYEGQ--------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----HHhcC--------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00000 00112235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=225.78 Aligned_cols=170 Identities=26% Similarity=0.411 Sum_probs=131.2
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.++|.... .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a 187 (307)
T cd05098 108 KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 187 (307)
T ss_pred CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCccc
Confidence 368999997642 4889999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-------- 256 (307)
T cd05098 188 RDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-------- 256 (307)
T ss_pred ccccccchhh-ccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH--------
Confidence 7553221111 0112234567999999877 578899999999999999998 888887654322221111
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .......+..+.+||.+||..+|.+|||+.++++
T Consensus 257 -------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 257 -------------------EGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred -------------------cCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1111 1122356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=222.05 Aligned_cols=184 Identities=24% Similarity=0.315 Sum_probs=131.9
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++..+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.................
T Consensus 93 ~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 171 (283)
T cd05080 93 GSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171 (283)
T ss_pred CCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCC
Confidence 6888888765 699999999999999999999999999999999999999999999999999876543322111112234
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ....+....+.... ......+
T Consensus 172 ~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~~~~~--- 237 (283)
T cd05080 172 SPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTV--------VRLIELL--- 237 (283)
T ss_pred CCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccch--------hhhhhhh---
Confidence 5667999999876 57889999999999999999999888543211 00000000000000 0000111
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
......+ .....+..+.+|+.+||..||++|||++++++
T Consensus 238 ~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111111 12346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-27 Score=225.78 Aligned_cols=176 Identities=26% Similarity=0.431 Sum_probs=144.0
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
|+..++++.+ ..|+++++..+++.-|+||.|||...-+|||||..|||++.+|..||+|||.|......... ..+.
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK---RNTV 189 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK---RNTV 189 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh---hCcc
Confidence 6778888754 46999999999999999999999999999999999999999999999999999766443322 3567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|||||++.. -.|+.++||||||+...||..|++||..-.. +..|+-+
T Consensus 190 IGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMI----------------------- 241 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMI----------------------- 241 (502)
T ss_pred ccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEec-----------------------
Confidence 89999999999988 6899999999999999999999999965432 2222211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
...+.+-.......+.++-|||++||..+|++|.||-++++|||++.-
T Consensus 242 --PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 242 --PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred --cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 111222222233467889999999999999999999999999999863
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=218.60 Aligned_cols=169 Identities=25% Similarity=0.412 Sum_probs=133.8
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||+|||+.|++|+||||+|||++.++.+||+|||++.......... .+.
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~~~ 167 (270)
T cd05056 90 LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK--ASK 167 (270)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee--cCC
Confidence 468999998754 58999999999999999999999999999999999999999999999999987654332111 122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 168 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~----------------------- 222 (270)
T cd05056 168 GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE----------------------- 222 (270)
T ss_pred CCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----------------------
Confidence 234567999999876 578899999999999999986 999998766443322221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... ...+.++..+.+||.+||..+|.+|||+.+++.
T Consensus 223 ----~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 223 ----NGERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ----cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 123456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=221.66 Aligned_cols=158 Identities=26% Similarity=0.414 Sum_probs=123.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ......++..|+|||.+
T Consensus 123 ~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESL 201 (290)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHH
Confidence 47899999999999999999999999999999999999999999999999987653322111 11223456789999998
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|+|++ |..||.+.......+.+.. .... .
T Consensus 202 ~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------------------------~~~~---~ 249 (290)
T cd05045 202 FD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT---------------------------GYRM---E 249 (290)
T ss_pred cc--CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---------------------------CCCC---C
Confidence 76 578899999999999999998 9999977654332221111 0000 1
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.....+..+.+|+.+||+.||++||++.++++
T Consensus 250 ~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 250 RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 12346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=222.83 Aligned_cols=171 Identities=27% Similarity=0.443 Sum_probs=132.4
Q ss_pred CCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++..... +++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... ....
T Consensus 123 ~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 201 (302)
T cd05055 123 YGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY-VVKG 201 (302)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCce-eecC
Confidence 3789999976443 899999999999999999999999999999999999999999999999998765432211 1112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+......... .
T Consensus 202 ~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-----------------------~ 256 (302)
T cd05055 202 NARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-----------------------L 256 (302)
T ss_pred CCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH-----------------------H
Confidence 3346778999999877 578899999999999999998 9999976543221111 1
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
+. ..... ......++.+.+|+.+||..+|++|||+.++++
T Consensus 257 ~~---~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 257 IK---EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HH---cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 10 00000 112345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=218.15 Aligned_cols=176 Identities=24% Similarity=0.313 Sum_probs=127.9
Q ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~-----~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.++|.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 368999997753 24678889999999999999999999999999999999999999999999986533221111
Q ss_pred ccccccccccccCccccccc-----CCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+..+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~------------- 224 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR------------- 224 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh-------------
Confidence 11223456779999987431 1356789999999999999999 7788876543322221111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. .....+........+..+.+++..|| .||++|||++++++
T Consensus 225 ----------~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 225 ----------E--QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ----------c--cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0 01111112223456788899999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-26 Score=220.29 Aligned_cols=169 Identities=20% Similarity=0.342 Sum_probs=131.6
Q ss_pred CcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC
Q 013122 3 SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 3 ~dL~~~i~~~--------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++........
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~ 173 (280)
T cd05043 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173 (280)
T ss_pred CcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE
Confidence 6888888753 35899999999999999999999999999999999999999999999999999765432211
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
. ......++..|+|||.+.+ ..++.++|||||||++|++++ |+.||...+.......+.
T Consensus 174 ~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----------------- 233 (280)
T cd05043 174 C-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK----------------- 233 (280)
T ss_pred E-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----------------
Confidence 1 1122345677999999876 578899999999999999998 999997654322211111
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... .....+++.+.+++.+||..||++|||+.++++
T Consensus 234 ----------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 234 ----------DGYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ----------cCCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111 112345788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=214.98 Aligned_cols=169 Identities=30% Similarity=0.486 Sum_probs=133.7
Q ss_pred CCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++..... +++..+..++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++........... .
T Consensus 85 ~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--~ 162 (258)
T smart00219 85 GGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK--K 162 (258)
T ss_pred CCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc--c
Confidence 3689999987654 99999999999999999999999999999999999999999999999999976654322111 1
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+.+.......+.
T Consensus 163 ~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---------------------- 218 (258)
T smart00219 163 GGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK---------------------- 218 (258)
T ss_pred cCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----------------------
Confidence 2236788999999865 678999999999999999998 788887654433322221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .......+..+.+++.+||..||++|||+.++++
T Consensus 219 -----~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 219 -----KGYR---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----cCCC---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 1111 1112336888999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=217.30 Aligned_cols=171 Identities=24% Similarity=0.366 Sum_probs=131.7
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ .
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---~ 162 (267)
T cd08229 86 AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---A 162 (267)
T ss_pred CCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc---c
Confidence 3688888863 34689999999999999999999999999999999999999999999999999876543322 1
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... .
T Consensus 163 ~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------------------------~ 215 (267)
T cd08229 163 AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-------------------------S 215 (267)
T ss_pred cccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchHH-------------------------H
Confidence 234568889999999977 5788999999999999999999999975432110 0
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+..... ........+..+.+||.+||..||.+|||+.++++
T Consensus 216 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 216 LCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhhhhhcCCC--CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0001111000 01112246788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=236.47 Aligned_cols=181 Identities=28% Similarity=0.451 Sum_probs=141.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccC---------CC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN---------DT 72 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~---------~~ 72 (449)
+|||..+|-+.+-|.|+.+++++..|.+|+++.|..|+|||||||+|||||.+|.|||+||||+..+.. +.
T Consensus 713 GGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gd 792 (1034)
T KOG0608|consen 713 GGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGD 792 (1034)
T ss_pred CccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCC
Confidence 689999999999999999999999999999999999999999999999999999999999999864311 00
Q ss_pred CC------------------------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCC
Q 013122 73 PT------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122 (449)
Q Consensus 73 ~~------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~p 122 (449)
.. .+.....+||+.|+|||++.. ..|+..+|.||.|||||||+.|++|
T Consensus 793 H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 793 HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHHHHHhhCCCC
Confidence 00 011124689999999999988 7899999999999999999999999
Q ss_pred CCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC---H
Q 013122 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---A 199 (449)
Q Consensus 123 F~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT---a 199 (449)
|......+...+|..+ +.++ . .....+++.++.+||.++. .++++|.. +
T Consensus 871 f~~~tp~~tq~kv~nw-----------------~~~l-------~---~~~~~~ls~e~~~li~kLc-~sad~RLGkng~ 922 (1034)
T KOG0608|consen 871 FLADTPGETQYKVINW-----------------RNFL-------H---IPYQGNLSKEALDLIQKLC-CSADSRLGKNGA 922 (1034)
T ss_pred ccCCCCCcceeeeeeh-----------------hhcc-------c---cccccccCHHHHHHHHHHh-cChhhhhcccch
Confidence 9876543322111110 0000 0 1122467899999998864 57778864 7
Q ss_pred HHHHcCccccccc
Q 013122 200 EEALADPYFKGLA 212 (449)
Q Consensus 200 ~elL~hp~f~~~~ 212 (449)
+++-.||||+++.
T Consensus 923 d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 923 DQVKAHPFFKGID 935 (1034)
T ss_pred hhhhcCccccccc
Confidence 7899999999864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=246.40 Aligned_cols=170 Identities=26% Similarity=0.425 Sum_probs=132.4
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc-
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF- 77 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~- 77 (449)
+.|-|++.++ .+|++.++..|++|+++||++||... |||||||-+||||+.++.+||||||.|.-..........
T Consensus 127 g~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~ 206 (738)
T KOG1989|consen 127 GSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEV 206 (738)
T ss_pred CcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHH
Confidence 6888998743 35999999999999999999999998 999999999999999999999999998654332211100
Q ss_pred -----cccccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 78 -----WTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 78 -----~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
--....|+.|||||++.-. ....+.|+|||+|||+||-|+....||.+.....++.
T Consensus 207 ~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln------------------ 268 (738)
T KOG1989|consen 207 NYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN------------------ 268 (738)
T ss_pred HHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe------------------
Confidence 0123568999999987321 0457899999999999999999999997653221110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.+..+ ..++..+..+.+||..||+.||.+||++-+++.+
T Consensus 269 ------------g~Y~~---P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 ------------GNYSF---PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ------------ccccC---CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 01111 1236778999999999999999999999999874
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=226.13 Aligned_cols=171 Identities=28% Similarity=0.431 Sum_probs=132.5
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.++|.... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~ 181 (334)
T cd05100 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181 (334)
T ss_pred CCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccc
Confidence 468999887532 4788899999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 182 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 251 (334)
T cd05100 182 RDVHNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE------- 251 (334)
T ss_pred eecccccccc-cccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------
Confidence 7654322111 1122334567999999977 678899999999999999998 8889977654333222211
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... .......+..+.+||.+||+.+|.+|||+.+++++
T Consensus 252 --------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 252 --------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred --------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 000 11123457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=219.66 Aligned_cols=187 Identities=23% Similarity=0.387 Sum_probs=134.3
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.++. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...............
T Consensus 92 g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 171 (284)
T cd05079 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171 (284)
T ss_pred CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCC
Confidence 478999997654 5899999999999999999999999999999999999999999999999999865433221111234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|+++..++.... ....+..+....+... .....
T Consensus 172 ~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~-----~~~~~~~~~~~~~~~~-------~~~~~ 237 (284)
T cd05079 172 LDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM-----TLFLKMIGPTHGQMTV-------TRLVR 237 (284)
T ss_pred CCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc-----chhhhhcccccccccH-------HHHHH
Confidence 556778999999876 578899999999999999999876543211 1111122211111000 00111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.+..... ......++..+.+||.+||+.||.+|||+++++++
T Consensus 238 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111111 11234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=214.51 Aligned_cols=170 Identities=24% Similarity=0.384 Sum_probs=130.8
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......... ....
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SDGL 154 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cccc
Confidence 46899998764 468999999999999999999999999999999999999999999999999987653221110 0011
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.........+..
T Consensus 155 ~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~---------------------- 210 (251)
T cd05041 155 KQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES---------------------- 210 (251)
T ss_pred CcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc----------------------
Confidence 233567999999876 578899999999999999998 8888876553222211110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... .....+..+.+||.+||..+|.+|||+.|+|+
T Consensus 211 -----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 211 -----GYRMP---APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -----CCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00001 11245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=217.82 Aligned_cols=171 Identities=24% Similarity=0.375 Sum_probs=132.9
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...............
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (267)
T cd05066 89 NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168 (267)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCC
Confidence 468999998753 5899999999999999999999999999999999999999999999999999765433221111112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|++||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+
T Consensus 169 ~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---------------------- 224 (267)
T cd05066 169 GKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE---------------------- 224 (267)
T ss_pred CccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC----------------------
Confidence 223567999999976 578999999999999999886 9999976554333222211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+ .....++.+.+|+.+||+.+|.+||++.++++
T Consensus 225 -----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 225 -----GYRLP---APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----CCcCC---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 11111 12346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=215.54 Aligned_cols=165 Identities=23% Similarity=0.403 Sum_probs=130.9
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------~ 155 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------D 155 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC------C
Confidence 368999998654 48999999999999999999999999999999999999999999999999987543221 1
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+.......+.
T Consensus 156 ~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------------------- 211 (254)
T cd05083 156 NSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE---------------------- 211 (254)
T ss_pred CCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh----------------------
Confidence 2234567999999876 578899999999999999997 999997665432221111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... .....++..+.+|+.+||+.+|.+||++++++.
T Consensus 212 -----~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 212 -----KGYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -----CCCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 112356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=215.12 Aligned_cols=164 Identities=23% Similarity=0.398 Sum_probs=131.3
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||.++...... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------~~ 158 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------DS 158 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc------cc
Confidence 68999998776 69999999999999999999999999999999999999999999999999997653221 12
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...+..|+|||.+.. ..++.++|||||||++|+|++ |..||......+....+.
T Consensus 159 ~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----------------------- 213 (256)
T cd05039 159 GKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE----------------------- 213 (256)
T ss_pred CCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-----------------------
Confidence 234567999999876 578889999999999999997 999987654332211111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .......++.+.+||.+||..+|++|||++++++
T Consensus 214 ----~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 214 ----KGYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ----cCCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 1112346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=247.73 Aligned_cols=65 Identities=28% Similarity=0.573 Sum_probs=62.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
+++|.++|...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 88 g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 57999999988889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=216.24 Aligned_cols=164 Identities=18% Similarity=0.264 Sum_probs=126.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC--------EEEeecCccccccCCC
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--------vKL~DFGlA~~~~~~~ 72 (449)
.++|.+++..+. .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++......
T Consensus 83 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~- 161 (258)
T cd05078 83 FGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK- 161 (258)
T ss_pred CCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-
Confidence 368999998755 5899999999999999999999999999999999999987654 699999988654321
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCC-CCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
....++..|+|||++.+. ..++.++|||||||++|+|++|. .||...+......
T Consensus 162 ------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~------------------ 216 (258)
T cd05078 162 ------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ------------------ 216 (258)
T ss_pred ------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH------------------
Confidence 234678889999998752 45788999999999999999985 5554433221110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ... ......+..+.+||.+||+.||++|||++++++.
T Consensus 217 ------~~~---~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 217 ------FYE---DRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ------HHH---ccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 000 000 1112345778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=215.38 Aligned_cols=169 Identities=27% Similarity=0.384 Sum_probs=132.4
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++......... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~ 161 (260)
T cd05073 84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT--ARE 161 (260)
T ss_pred CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc--ccc
Confidence 36899999764 35788999999999999999999999999999999999999999999999998765332211 112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.. ..++.++|+|||||++|+|++ |..||.+.+.......+..
T Consensus 162 ~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~--------------------- 218 (260)
T cd05073 162 GAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER--------------------- 218 (260)
T ss_pred CCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---------------------
Confidence 2345677999999876 578889999999999999998 8999987654333222211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... .......+..+.+++.+||+.||++||++.++++
T Consensus 219 ------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 ------GYR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ------CCC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 000 1122456788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=213.30 Aligned_cols=169 Identities=22% Similarity=0.385 Sum_probs=131.3
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......... ...
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~~~ 153 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--SGL 153 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--CCC
Confidence 46888888754 358999999999999999999999999999999999999999999999999987543222111 112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 154 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~----------------------- 208 (250)
T cd05085 154 KQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE----------------------- 208 (250)
T ss_pred CCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-----------------------
Confidence 234567999999876 578899999999999999998 999997765432221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......++..+.+|+.+||..+|++||++.++++
T Consensus 209 ----~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 209 ----KGYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ----cCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0001 1122346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=221.89 Aligned_cols=170 Identities=24% Similarity=0.353 Sum_probs=132.2
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++........ .....
T Consensus 92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~ 170 (303)
T cd05110 92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE-YNADG 170 (303)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc-cccCC
Confidence 368999988755 5899999999999999999999999999999999999999999999999999765432211 11123
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+
T Consensus 171 ~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~------------------------ 224 (303)
T cd05110 171 GKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL------------------------ 224 (303)
T ss_pred CccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------------------
Confidence 345678999999876 678899999999999999997 88999765432221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. .....+ ..+..+..+.+++.+||..||++||++.++++
T Consensus 225 ~---~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 225 E---KGERLP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred H---CCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1 111111 12345678999999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=216.74 Aligned_cols=170 Identities=24% Similarity=0.364 Sum_probs=130.1
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ ..
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~~ 163 (267)
T cd08228 87 GDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AA 163 (267)
T ss_pred CcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH---HH
Confidence 578877753 34589999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... ... .
T Consensus 164 ~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~------------------------~ 216 (267)
T cd08228 164 HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFS------------------------L 216 (267)
T ss_pred hcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHH------------------------H
Confidence 34568889999999876 57888999999999999999999998654321 000 0
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...+...... .......+..+.+||.+||..+|.+||++.++|+
T Consensus 217 ~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 217 CQKIEQCDYP--PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHhcCCCC--CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 0001110000 0111235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=212.53 Aligned_cols=177 Identities=26% Similarity=0.394 Sum_probs=129.5
Q ss_pred CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~~~----~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
.|+|.+.|... ..+++.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.|||.+....-.....
T Consensus 107 ~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~ 186 (302)
T KOG2345|consen 107 RGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGS 186 (302)
T ss_pred cccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeech
Confidence 46777777643 25999999999999999999999999 9999999999999999999999999987543211110
Q ss_pred ------cccccccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 76 ------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 76 ------~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
..+..-..|..|+|||++... ....+.++|||||||+||.|+.|..||.-. ...-|...-
T Consensus 187 ~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~GgSlaL---- 253 (302)
T KOG2345|consen 187 RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGGSLAL---- 253 (302)
T ss_pred HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCCeEEE----
Confidence 123344578899999998431 135678999999999999999999999411 000000000
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
. -......+... ...+..+.+||+.||+.||.+||++.+++.+
T Consensus 254 ------------A-v~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 ------------A-VQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ------------e-eeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 00001112222 2278899999999999999999999999864
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=214.40 Aligned_cols=170 Identities=24% Similarity=0.413 Sum_probs=131.9
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..++++.++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.......... ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~--~~~ 160 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS--STG 160 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc--cCC
Confidence 36788888765 458999999999999999999999999999999999999999999999999987653322111 122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.
T Consensus 161 ~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----------------------- 215 (256)
T cd05112 161 TKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN----------------------- 215 (256)
T ss_pred CccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-----------------------
Confidence 335568999999876 578899999999999999998 899997655433322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
...... .....+..+.+|+.+||+.+|++|||+.+++++
T Consensus 216 ----~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 216 ----AGFRLY---KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----CCCCCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 110000 012246889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=219.07 Aligned_cols=177 Identities=22% Similarity=0.352 Sum_probs=131.3
Q ss_pred CCcHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccccc
Q 013122 2 ESDLHQVIKAND------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 69 (449)
Q Consensus 2 e~dL~~~i~~~~------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~ 69 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 101 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred CCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccc
Confidence 368888886542 37889999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh--CCCCCCCCCchhhHHHHHhhcCCCCHHHH
Q 013122 70 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 70 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~p~~e~~ 147 (449)
..... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+....+..+..
T Consensus 181 ~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~---------- 247 (295)
T cd05097 181 SGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE---------- 247 (295)
T ss_pred cCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHH----------
Confidence 32211 11123345678999999876 578999999999999999988 5677776554333222211
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
+..... ...+....+..++.+.+||.+||..||++|||++++++
T Consensus 248 ----------~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 248 ----------FFRNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ----------hhhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111000 00111223346789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=215.04 Aligned_cols=164 Identities=19% Similarity=0.273 Sum_probs=127.3
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-------CEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-------~vKL~DFGlA~~~~~~~~ 73 (449)
+++|.+++.... .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 84 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~-- 161 (259)
T cd05037 84 FGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR-- 161 (259)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc--
Confidence 368999998766 699999999999999999999999999999999999999887 7999999998765331
Q ss_pred CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
....++..|+|||.+.+....++.++|||||||++|+|++ |..||...+......
T Consensus 162 -----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~------------------- 217 (259)
T cd05037 162 -----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER------------------- 217 (259)
T ss_pred -----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH-------------------
Confidence 2345667899999987622368899999999999999999 567775543211110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... .....+ ......+.+||.+||..||.+|||+.++++
T Consensus 218 -----~~~---~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 218 -----FYQ---DQHRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----HHh---cCCCCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000 000000 111267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=217.78 Aligned_cols=187 Identities=21% Similarity=0.366 Sum_probs=131.5
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 91 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 170 (284)
T cd05081 91 YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREP 170 (284)
T ss_pred CCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCC
Confidence 47899999764 45999999999999999999999999999999999999999999999999999865433221111112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||.+.+ ..++.++|||||||++|||++|..++..... ... ...+...... .. ......
T Consensus 171 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~----~~~~~~~~~~---~~---~~~~~~ 237 (284)
T cd05081 171 GESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFM----RMMGNDKQGQ---MI---VYHLIE 237 (284)
T ss_pred CCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhh----hhcccccccc---cc---hHHHHH
Confidence 233456999999876 5788999999999999999998766543221 111 1111100000 00 000111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+...... .....++..+.+||.+||..+|++|||+.++++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 LLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11111111 123456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=220.41 Aligned_cols=170 Identities=25% Similarity=0.414 Sum_probs=130.8
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.++|.++|... ..+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++......... ....
T Consensus 85 ~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~-~~~~ 163 (259)
T PF07714_consen 85 GGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY-KNDS 163 (259)
T ss_dssp TEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE-EEST
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence 36899999987 67999999999999999999999999999999999999999999999999999776322211 1223
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
.......|+|||.+.. ..++.++||||||+++|||++ |+.||...+..+....+.+
T Consensus 164 ~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~--------------------- 220 (259)
T PF07714_consen 164 SQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ--------------------- 220 (259)
T ss_dssp TSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT---------------------
T ss_pred cccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc---------------------
Confidence 3456778999999977 568999999999999999999 6788877654333322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....++..+.+||.+||..||.+|||+.++++
T Consensus 221 ------~~~~---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 221 ------GQRL---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ------TEET---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ------cccc---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 112346888999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=215.02 Aligned_cols=170 Identities=26% Similarity=0.413 Sum_probs=130.7
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......... .
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---~ 163 (267)
T cd08224 87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---A 163 (267)
T ss_pred CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc---c
Confidence 688888864 235899999999999999999999999999999999999999999999999998754332211 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .. ..
T Consensus 164 ~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~------------------------~~ 216 (267)
T cd08224 164 HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LY------------------------SL 216 (267)
T ss_pred ceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HH------------------------HH
Confidence 34568889999999876 67889999999999999999999998654311 00 00
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...+......+ ......+..+.++|.+||..+|.+|||+.++++
T Consensus 217 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 217 CKKIEKCDYPP--LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HhhhhcCCCCC--CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00011100000 011245778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=215.45 Aligned_cols=171 Identities=23% Similarity=0.374 Sum_probs=133.0
Q ss_pred CCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKAND---------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~~---------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~ 72 (449)
+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~ 171 (275)
T cd05046 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171 (275)
T ss_pred CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc
Confidence 378999998766 69999999999999999999999999999999999999999999999999986543222
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+
T Consensus 172 ~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~---------------- 231 (275)
T cd05046 172 YY--KLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL---------------- 231 (275)
T ss_pred cc--ccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH----------------
Confidence 11 1233456778999999876 567889999999999999998 77888654432221111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ...+ .....++..+.++|.+||..||.+|||+.+++.+
T Consensus 232 -----------~~~-~~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 232 -----------QAG-KLEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -----------HcC-CcCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000 0111 1123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-25 Score=218.25 Aligned_cols=177 Identities=22% Similarity=0.350 Sum_probs=130.5
Q ss_pred CCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccC
Q 013122 2 ESDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 70 (449)
Q Consensus 2 e~dL~~~i~~~~-----------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~ 70 (449)
+++|.+++.... .+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 182 (296)
T cd05095 103 NGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182 (296)
T ss_pred CCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccC
Confidence 468999887643 367789999999999999999999999999999999999999999999999876533
Q ss_pred CCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh--CCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 71 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 71 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
..... ......++..|++||.+.+ ..++.++|||||||++|||++ |..||...+..+.+...
T Consensus 183 ~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~------------- 246 (296)
T cd05095 183 GDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENT------------- 246 (296)
T ss_pred Cccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHH-------------
Confidence 22111 1122344678999998766 578999999999999999998 66788655443322111
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..++....... .......+++.+.+|+.+||+.||.+||++.++++
T Consensus 247 -------~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 247 -------GEFFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred -------HHHHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01111110000 11112346688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=214.81 Aligned_cols=170 Identities=27% Similarity=0.368 Sum_probs=130.9
Q ss_pred CCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-----CEEEeecCcccccc
Q 013122 2 ESDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVAF 69 (449)
Q Consensus 2 e~dL~~~i~~~-------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-----~vKL~DFGlA~~~~ 69 (449)
+++|.++|... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++.++ .++|+|||++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~ 162 (269)
T cd05044 83 GGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162 (269)
T ss_pred CCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccc
Confidence 36888888742 3488999999999999999999999999999999999999877 89999999987553
Q ss_pred CCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 70 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 70 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
...... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 163 ~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~------------ 227 (269)
T cd05044 163 KSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT------------ 227 (269)
T ss_pred cccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh------------
Confidence 322111 1122345678999999977 578999999999999999998 999997655433222111
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .......+..+.+||.+||..+|.+||+++++++
T Consensus 228 ---------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 228 ---------------AGGR---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------cCCc---cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 0112346788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=208.52 Aligned_cols=172 Identities=40% Similarity=0.689 Sum_probs=138.1
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....++...+..++.+|+.+|.|||+.||+|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 72 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~ 147 (244)
T smart00220 72 GDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFV 147 (244)
T ss_pred CCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----cccccc
Confidence 3899999887679999999999999999999999999999999999999999999999999998765432 123456
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC-chhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
++..|++||.+.+ ..++.++||||+|+++++|++|..||.... .....+.+.
T Consensus 148 ~~~~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~------------------------- 200 (244)
T smart00220 148 GTPEYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG------------------------- 200 (244)
T ss_pred CCcCCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-------------------------
Confidence 7889999999876 578889999999999999999999997632 211111111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
. ...........++..+.+++.+||..||++||++.++++||||
T Consensus 201 --~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 201 --K-PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred --c-cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 0 0111111111267889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=217.52 Aligned_cols=158 Identities=21% Similarity=0.300 Sum_probs=121.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... .......+..|+|||.+
T Consensus 126 ~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 204 (288)
T cd05050 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESI 204 (288)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHH
Confidence 37888999999999999999999999999999999999999999999999987543322111 01223345679999998
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|+|++ |..||.+.+..+....+. ..... .
T Consensus 205 ~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~---------------------------~~~~~---~ 252 (288)
T cd05050 205 FY--NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR---------------------------DGNVL---S 252 (288)
T ss_pred hc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---------------------------cCCCC---C
Confidence 76 678999999999999999997 878887655433221111 11111 1
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.....+..+.+||.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 253 CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 12346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=215.17 Aligned_cols=171 Identities=23% Similarity=0.381 Sum_probs=131.1
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 168 (269)
T cd05065 89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168 (269)
T ss_pred CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccc
Confidence 35899998764 45899999999999999999999999999999999999999999999999998765432221111111
Q ss_pred c--cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~--~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
. ..+..|+|||.+.+ ..++.++||||+||++|||++ |..||.+.+..+....+..
T Consensus 169 ~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~-------------------- 226 (269)
T cd05065 169 LGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------------- 226 (269)
T ss_pred cCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 1 12457999999876 678999999999999999886 9999976554332222211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+. ...++..+.+++.+||..+|.+||++++++.
T Consensus 227 -------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 227 -------DYRLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------CCcCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111111 2345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=213.84 Aligned_cols=175 Identities=20% Similarity=0.290 Sum_probs=127.1
Q ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~~~----~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++.+.. .+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++......... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 158 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI-ETE 158 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh-hcc
Confidence 68999997642 3677788999999999999999999999999999999999999999999997643221110 011
Q ss_pred ccccccccccCccccccc-----CCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 79 TDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
...+++..|+|||++... ...++.++|||||||++|||++ |..||...+..+.+..+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~--------------- 223 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK--------------- 223 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------------
Confidence 345678899999997531 1245789999999999999997 5678866554333222110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. ..............++.+.+||..|| .+|.+||+++++++
T Consensus 224 --------~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 224 --------D--QQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred --------h--cccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0 00001111222346788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=215.93 Aligned_cols=170 Identities=24% Similarity=0.341 Sum_probs=132.1
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+. .+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++......... ....
T Consensus 92 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~ 170 (279)
T cd05057 92 LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY-HAEG 170 (279)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccce-ecCC
Confidence 478999998753 69999999999999999999999999999999999999999999999999997654322111 1111
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.. ..++.++|+|||||++|||++ |+.||.+....+....+.
T Consensus 171 ~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----------------------- 225 (279)
T cd05057 171 GKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE----------------------- 225 (279)
T ss_pred CcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-----------------------
Confidence 223567999999876 578899999999999999998 999997765433222111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... ......+..+.+++.+||..||.+|||+.++++
T Consensus 226 ----~~~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 226 ----KGERL---PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ----CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111 112335678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-26 Score=240.39 Aligned_cols=179 Identities=31% Similarity=0.456 Sum_probs=134.8
Q ss_pred CCCcHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CC--CEEEeecCccccccCC
Q 013122 1 MESDLHQVIKAND-D---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DC--KLKICDFGLARVAFND 71 (449)
Q Consensus 1 me~dL~~~i~~~~-~---Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~--~vKL~DFGlA~~~~~~ 71 (449)
|..+|.++|.... . ......+.++.|++.||++||+.+||||||||.||||+. ++ +++|+|||+++....+
T Consensus 585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 3568999998841 1 222566889999999999999999999999999999986 34 5899999999987665
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhC-CCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
...-.......||-.|+|||++.. ..-+.++||||+|||+|+.++| ..||...- ..+.+.+..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~-~R~~NIl~~------------- 728 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-ERQANILTG------------- 728 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchH-HhhhhhhcC-------------
Confidence 544333556789999999999987 4566799999999999999996 78885322 111111100
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.......-+..+.++.+||.+||++||..||+|.++|.||+|-..
T Consensus 729 ----------------~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 729 ----------------NYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ----------------ccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 001111112222389999999999999999999999999999654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=215.10 Aligned_cols=170 Identities=21% Similarity=0.358 Sum_probs=130.1
Q ss_pred CCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~~~------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
+++|.+++... ..++...++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 91 ~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 170 (273)
T cd05074 91 HGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170 (273)
T ss_pred CCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCccee
Confidence 36788777532 148999999999999999999999999999999999999999999999999988653322111
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
......++..|++||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+..
T Consensus 171 -~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~----------------- 230 (273)
T cd05074 171 -QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK----------------- 230 (273)
T ss_pred -cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-----------------
Confidence 1122345677999999876 578899999999999999999 8899876554322211110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ...+..+..+.+|+.+||+.+|.+|||+.+++.
T Consensus 231 ----------~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 231 ----------GNRL---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ----------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 111346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=215.38 Aligned_cols=164 Identities=22% Similarity=0.297 Sum_probs=125.6
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-------CEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-------~vKL~DFGlA~~~~~~~~ 73 (449)
+++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+ .+||+|||++......
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-- 177 (274)
T cd05076 100 HGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-- 177 (274)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--
Confidence 3678888875 45699999999999999999999999999999999999997643 3899999987543221
Q ss_pred CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhh-hCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
....++..|+|||.+.+. ..++.++|||||||++|||+ +|..||.+........
T Consensus 178 -----~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~------------------- 232 (274)
T cd05076 178 -----EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER------------------- 232 (274)
T ss_pred -----cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-------------------
Confidence 223567889999988653 56889999999999999985 6889887654322111
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
++. .... .....++.+.+||.+||+.+|++|||+.++|++
T Consensus 233 -----~~~---~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -----FYE---KKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -----HHH---hccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 110 0000 011235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-25 Score=212.37 Aligned_cols=176 Identities=22% Similarity=0.325 Sum_probs=127.1
Q ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~-----~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.++|.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-~ 157 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-V 157 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee-e
Confidence 378999987532 3567888999999999999999999999999999999999999999999998654322111 1
Q ss_pred ccccccccccccCcccccccC-----CCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~-----~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
......++..|+|||++.+.. ..++.++|||||||++|||++ |..||......+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~--------------- 222 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT--------------- 222 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---------------
Confidence 112345678899999986421 135789999999999999996 99999765432221110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ..............+..+.+|+.+|| .+|.+|||+++++.
T Consensus 223 --------~~~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 223 --------VRE--QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------hhc--ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00011111112245678999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-26 Score=213.32 Aligned_cols=174 Identities=22% Similarity=0.395 Sum_probs=138.0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCc
Q 013122 12 NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 90 (449)
Q Consensus 12 ~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~AP 90 (449)
+..++|+.+-.|....+.||.||-+ .+||||||||+|||++..|.|||||||.+....+... .+.-.|-+.||||
T Consensus 161 ~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA----kT~daGCrpYmAP 236 (361)
T KOG1006|consen 161 KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA----KTVDAGCRPYMAP 236 (361)
T ss_pred hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH----hhhccCCccccCh
Confidence 4469999999999999999999986 5899999999999999999999999999866543322 2445788899999
Q ss_pred ccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhc-CCCCHHHHHHHhhHHHHHHHhhhccCCCCC
Q 013122 91 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL-GTPSPEAIARVRNEKARRYLSSMRKKKPIP 169 (449)
Q Consensus 91 E~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l-g~p~~e~~~~~~~~~~~~~~~~~~~~~~~~ 169 (449)
|.+......|+-++|+||||+.|||+.||+.||.+.+. +++.+..+. |.|+ ...
T Consensus 237 ERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp-----------------------~l~ 291 (361)
T KOG1006|consen 237 ERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPP-----------------------ILL 291 (361)
T ss_pred hccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCC-----------------------eec
Confidence 99976545699999999999999999999999987553 222222211 1111 112
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 170 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 170 ~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
+....-+.+..++.||.-||.+|-++||...+++++||++.+...
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 223334578899999999999999999999999999999876543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=219.75 Aligned_cols=160 Identities=28% Similarity=0.451 Sum_probs=121.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... .......++..|+|||.+
T Consensus 175 ~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 253 (343)
T cd05103 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETI 253 (343)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcCCCCCCcceECcHHh
Confidence 3788889999999999999999999999999999999999999999999998764322111 111223456779999998
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|+|++ |..||.+......... .+ .......
T Consensus 254 ~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-----------------------~~---~~~~~~~--- 302 (343)
T cd05103 254 FD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-----------------------RL---KEGTRMR--- 302 (343)
T ss_pred cC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH-----------------------HH---hccCCCC---
Confidence 76 678999999999999999996 8899876432211100 00 0000001
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.....++.+.+++.+||+.||.+|||+.++++|
T Consensus 303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=211.44 Aligned_cols=186 Identities=25% Similarity=0.418 Sum_probs=133.2
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...............
T Consensus 92 ~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 171 (284)
T cd05038 92 SGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP 171 (284)
T ss_pred CCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCC
Confidence 468999998765 5999999999999999999999999999999999999999999999999999876532221111122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|++||.+.+ ..++.++|||||||++|+|++|..||....... ....+....... . .....
T Consensus 172 ~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~----~---~~~~~ 237 (284)
T cd05038 172 GESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQMI----V---TRLLE 237 (284)
T ss_pred CCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccccc----H---HHHHH
Confidence 345567999999876 578899999999999999999998875432211 111111100000 0 01111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+......+ ....++..+.+|+.+||..+|.+|||+.|+++
T Consensus 238 ~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111111 12345678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=210.66 Aligned_cols=168 Identities=26% Similarity=0.412 Sum_probs=131.6
Q ss_pred CcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 3 SDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 3 ~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
++|.+++. ....+++..++.++.||+.||.|||+ .||+|+||+|+|||++.++.+||+|||++....... .
T Consensus 94 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~ 169 (269)
T cd08528 94 APLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----K 169 (269)
T ss_pred CcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc----c
Confidence 47777763 33469999999999999999999996 789999999999999999999999999997654332 2
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 170 ~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 227 (269)
T cd08528 170 LTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE-------------------- 227 (269)
T ss_pred cccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--------------------
Confidence 245678899999999987 5788999999999999999999999975543322211111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
....+ ......++.+.+||.+||+.||++||++.|+.++
T Consensus 228 -------~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 228 -------AVYEP--LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------ccCCc--CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 00001 0112457889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=224.34 Aligned_cols=170 Identities=26% Similarity=0.429 Sum_probs=129.8
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++..+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~-~~~~~ 298 (400)
T cd05105 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY-VSKGS 298 (400)
T ss_pred hhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccc-cccCC
Confidence 45667776543 5999999999999999999999999999999999999999999999999999765332211 11123
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..
T Consensus 299 ~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~------------------------- 351 (400)
T cd05105 299 TFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN------------------------- 351 (400)
T ss_pred cCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-------------------------
Confidence 456778999999877 578999999999999999997 8889876432211100
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+...... .....++..+.+||.+||+.||++|||+.++.+
T Consensus 352 -~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 -KIKSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred -HHhcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 00111111 112356788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=211.78 Aligned_cols=179 Identities=24% Similarity=0.482 Sum_probs=139.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|||.=.+....+|++++++++...|+.||.|||++|||.||||.+|||++..|.+||+|+|+++....... ..+++
T Consensus 335 ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd---~tstf 411 (593)
T KOG0695|consen 335 GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD---TTSTF 411 (593)
T ss_pred CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCc---ccccc
Confidence 467776777778899999999999999999999999999999999999999999999999999875433322 33679
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCC--CCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP--GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~--~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
|||+.|.|||++.+ ..|+..+|.|+||++++||+.|+.||. |.+..++ ..+.|+
T Consensus 412 cgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~----------------------ntedyl 467 (593)
T KOG0695|consen 412 CGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM----------------------NTEDYL 467 (593)
T ss_pred cCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceecCCCccc----------------------chhHHH
Confidence 99999999999999 799999999999999999999999995 2111110 001111
Q ss_pred hh--hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHcCccccccc
Q 013122 160 SS--MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT------AEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~--~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT------a~elL~hp~f~~~~ 212 (449)
-. +.+...++ ..++-.+..+|+..|++||.+|.. +.++-.|+||+.+.
T Consensus 468 fqvilekqirip-----rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 468 FQVILEKQIRIP-----RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred HHHHhhhccccc-----ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 11 11111111 234556778999999999999954 67999999998643
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=239.49 Aligned_cols=174 Identities=23% Similarity=0.324 Sum_probs=129.8
Q ss_pred CCcHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccC
Q 013122 2 ESDLHQVIKAN-----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 70 (449)
Q Consensus 2 e~dL~~~i~~~-----------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~ 70 (449)
+++|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~ 165 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKL 165 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccc
Confidence 46888888642 2356678899999999999999999999999999999999999999999999976521
Q ss_pred CCCC---------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHH
Q 013122 71 DTPT---------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 135 (449)
Q Consensus 71 ~~~~---------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i 135 (449)
.... .......+||+.|+|||++.+ ..++.++||||+||++|||++|..||.+.........
T Consensus 166 ~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~- 242 (932)
T PRK13184 166 EEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR- 242 (932)
T ss_pred ccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh-
Confidence 1100 001123579999999999987 6789999999999999999999999976443211100
Q ss_pred HhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 136 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 136 ~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. + ..+... ..+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 243 -~~-----------------------i--~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 243 -DV-----------------------I--LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred -hh-----------------------c--cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 0 000000 1123567889999999999999999887766654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=216.34 Aligned_cols=197 Identities=30% Similarity=0.444 Sum_probs=140.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCC--------------CC-----
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFND--------------TP----- 73 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~--------------~~----- 73 (449)
.++..+++.+++.++.||+++|.+|||||||||.|+|.+. .++-.|+|||+|...... ..
T Consensus 128 ~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~ 207 (418)
T KOG1167|consen 128 SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKD 207 (418)
T ss_pred cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCc
Confidence 3789999999999999999999999999999999999986 567899999999721000 00
Q ss_pred ------------Cc----------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCC-CCCCCchh
Q 013122 74 ------------TA----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVH 130 (449)
Q Consensus 74 ------------~~----------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~p-F~~~~~~~ 130 (449)
.. ...-...||+.|+|||++... ..-++++||||.|+|+..+++++.| |...++.+
T Consensus 208 ~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~ 286 (418)
T KOG1167|consen 208 VHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDAD 286 (418)
T ss_pred ccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccceeehhhccccccccCccccc
Confidence 00 001135689999999999875 6778999999999999999999866 56777777
Q ss_pred hHHHHHhhcCCCCHHHHHHHhhH-------------HHHHHH-----hhhccCCC--CCCCCCCCCCCHHHHHHHHHhhh
Q 013122 131 QLDIMTDLLGTPSPEAIARVRNE-------------KARRYL-----SSMRKKKP--IPFSQKFPNANPLALRLLERMLA 190 (449)
Q Consensus 131 ~l~~i~~~lg~p~~e~~~~~~~~-------------~~~~~~-----~~~~~~~~--~~~~~~~~~~s~~~~dLL~~~L~ 190 (449)
.+..|..++|.-........... ....-+ ..+.+... ..........+..+.+|+.+||.
T Consensus 287 al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le 366 (418)
T KOG1167|consen 287 ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLE 366 (418)
T ss_pred hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHcc
Confidence 78777777775443332221111 000111 11111111 11112223346689999999999
Q ss_pred cCCCCCCCHHHHHcCcccccc
Q 013122 191 FEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 191 ~DP~~RpTa~elL~hp~f~~~ 211 (449)
.||.+|+||+++|.||||...
T Consensus 367 ~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 367 LNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred CChhhcccHHHHhcCcCCcch
Confidence 999999999999999999844
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.9e-24 Score=218.69 Aligned_cols=160 Identities=25% Similarity=0.358 Sum_probs=123.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... ......++..|+|||.+
T Consensus 235 ~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 313 (401)
T cd05107 235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESI 313 (401)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHh
Confidence 47788899999999999999999999999999999999999999999999997643222111 11234567889999999
Q ss_pred cccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..++.++|||||||++|||++ |..||......+.+.. .+. ..... .
T Consensus 314 ~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~-----------------------~~~---~~~~~---~ 362 (401)
T cd05107 314 FN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN-----------------------AIK---RGYRM---A 362 (401)
T ss_pred cC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH-----------------------HHH---cCCCC---C
Confidence 77 578899999999999999998 8888876443222111 000 00000 1
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
....++..+.+||.+||..||.+||++.+++..
T Consensus 363 ~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 363 KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 123467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=221.44 Aligned_cols=175 Identities=20% Similarity=0.271 Sum_probs=120.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCccccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 94 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 94 (449)
+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.......... .....+++.|+|||.+.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPEELV 383 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChhhhc
Confidence 4677899999999999999999999999999999999999999999999997543322111 11223478999999875
Q ss_pred ccCC------------------CCC--CccchhhhHHHHHhhhhCCC-CCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 95 SFFS------------------KYT--PAIDIWSIGCIFAELLTGKP-LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 95 ~~~~------------------~~s--~~~DIWSlG~il~eLltG~~-pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.... .|+ ...||||+|||+|+|++|.. +|.+....... + + .. ..
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~-~-----------~~-~~ 448 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--L-R-----------QY-DN 448 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--H-h-----------hc-cc
Confidence 3110 011 24799999999999999874 66432211100 0 0 00 00
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCC---CCCCCHHHHHcCcccc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP---KDRPTAEEALADPYFK 209 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP---~~RpTa~elL~hp~f~ 209 (449)
.... +... ......+. .+...++.+++||.+||..+| .+|+|++|+|+||||.
T Consensus 449 ~~~~-~r~~-~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 449 DLNR-WRMY-KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred hHHH-HHhh-cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 0000 0001 11122222 355678999999999999876 6899999999999996
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-24 Score=210.40 Aligned_cols=183 Identities=27% Similarity=0.477 Sum_probs=141.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcC---CCCEEEeecCccccccCCCCCc-
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTA- 75 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~- 75 (449)
+.||.=||+.+.-+++.+++.|+.||+.||.||.+.. |||-||||.|||+-. -|.+||+|||+++.+..+....
T Consensus 552 GNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~v 631 (775)
T KOG1151|consen 552 GNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSV 631 (775)
T ss_pred CCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcc
Confidence 4588889999989999999999999999999999875 999999999999854 4679999999999876554331
Q ss_pred ---cccccccccccccCccccccc--CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 76 ---IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 76 ---~~~~~~~gt~~Y~APE~l~~~--~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.......||.||++||.+.-. ..+.+.++||||+|||||.++.|+.||........ .+..
T Consensus 632 dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILqe------------- 696 (775)
T KOG1151|consen 632 DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQE------------- 696 (775)
T ss_pred cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHhh-------------
Confidence 123456799999999987432 35678899999999999999999999964332111 1100
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
..+.+.....|. .-|-+++++++||++||++.-++|....++-.||||.
T Consensus 697 ---------NTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 697 ---------NTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred ---------hchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 001111111121 2256899999999999999999999999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=231.71 Aligned_cols=170 Identities=21% Similarity=0.387 Sum_probs=137.4
Q ss_pred CCcHHHHHHhC------C-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC
Q 013122 2 ESDLHQVIKAN------D-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 2 e~dL~~~i~~~------~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
+|||..+|++. . .|+..+...|+.||++|+.||+++++|||||..+|+|++....+||+|||+|+........
T Consensus 779 gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yy 858 (1025)
T KOG1095|consen 779 GGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYY 858 (1025)
T ss_pred cCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchhe
Confidence 48999999987 3 4999999999999999999999999999999999999999999999999999955443322
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
... ....-...|||||.+.. ..++.++|||||||++||+++ |..||++.+..+.+....+
T Consensus 859 r~~-~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~---------------- 919 (1025)
T KOG1095|consen 859 RKH-GEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE---------------- 919 (1025)
T ss_pred ecc-CccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh----------------
Confidence 111 11123457999999987 689999999999999999998 8899998876554432211
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... -...+.++..+.+||..||+.+|++||++..+++
T Consensus 920 -----------ggR---L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 920 -----------GGR---LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------CCc---cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 111 1122456778899999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=223.31 Aligned_cols=167 Identities=25% Similarity=0.437 Sum_probs=138.1
Q ss_pred CcHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 3 SDLHQVIKAND----------D----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 3 ~dL~~~i~~~~----------~----Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
|||+++|+.+. . |+..+...|+.||+.|+.||-++.+|||||-.+|+||+++..|||+|||+++..
T Consensus 574 GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 574 GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDI 653 (774)
T ss_pred ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhh
Confidence 79999998643 2 889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHH
Q 013122 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 69 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~ 147 (449)
...+.... .....-...||+||.+.- .+|+.++||||+||+|||+++ |+.||.|.+..+.++.|..
T Consensus 654 YssDYYk~-~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~---------- 720 (774)
T KOG1026|consen 654 YSSDYYKV-RGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA---------- 720 (774)
T ss_pred hhhhhhcc-cCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc----------
Confidence 65443321 112233567999999876 799999999999999999998 8899988887666655532
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 202 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~el 202 (449)
.. .-....+++..+.+|+..||+.+|++||++.||
T Consensus 721 -----------------g~---lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 721 -----------------GQ---LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred -----------------CC---cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 11 122335678999999999999999999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=212.68 Aligned_cols=180 Identities=27% Similarity=0.422 Sum_probs=129.1
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
|+|.+.|.... .|+|.....|+.++++||+|||+.. |||||||++|||+|.++..||+|||+|+..... ...
T Consensus 157 GsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~-- 233 (361)
T KOG1187|consen 157 GSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTS-- 233 (361)
T ss_pred CCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccc--
Confidence 69999998766 7999999999999999999999965 999999999999999999999999999654431 111
Q ss_pred cccc-cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC---chhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 78 WTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---VVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 78 ~~~~-~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~---~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.... .||..|+|||.+.. ...+.++||||||+++.||++|+.+..... ......+.. ..+...
T Consensus 234 ~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~-----------~~~~~~ 300 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK-----------PLLEEG 300 (361)
T ss_pred eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH-----------HHHHCc
Confidence 1122 79999999999976 678999999999999999999998776432 111111111 111111
Q ss_pred HHHHHHhhhccCCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...++++..... ..++ ..-..+..+..+|++.+|.+||++.|++.
T Consensus 301 ~~~eiiD~~l~~------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 KLREIVDPRLKE------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred chhheeCCCccC------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111111111000 1111 11223567889999999999999999754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=214.70 Aligned_cols=169 Identities=24% Similarity=0.406 Sum_probs=135.8
Q ss_pred CCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~-Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+|+|.++|++++. ++..+...++++.++||+|||+++++||||-.+|+|++.++.+||+|||+++......... ..
T Consensus 245 gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~---~~ 321 (474)
T KOG0194|consen 245 GGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKK---FL 321 (474)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeecc---cc
Confidence 5799999999985 9999999999999999999999999999999999999999999999999987653111110 11
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.--...|+|||.+.. ..|+.++||||+||++||+++ |..||+|....+....|..
T Consensus 322 ~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~---------------------- 377 (474)
T KOG0194|consen 322 KKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK---------------------- 377 (474)
T ss_pred ccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh----------------------
Confidence 124567999999987 589999999999999999998 8889999887655444411
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...+.+.+ ...+..+..++.+||..||++|+|+.++.+
T Consensus 378 ----~~~r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 378 ----NGYRMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----cCccCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 01111111 245677888999999999999999999965
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-23 Score=218.65 Aligned_cols=177 Identities=23% Similarity=0.418 Sum_probs=140.6
Q ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+.-|+++. ..+|.|+.+.+|++.+|+||.+||.+.++|||||-.|||++.++.|||+|||.+....... ....+
T Consensus 106 GSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~---grRnT 182 (953)
T KOG0587|consen 106 GSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV---GRRNT 182 (953)
T ss_pred ccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc---ccccC
Confidence 455566553 4479999999999999999999999999999999999999999999999999987664432 23467
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.+||+.|||||++... ...|+..+|+||||++..||.-|.+|+......- .++.+-..|+
T Consensus 183 ~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---aLF~IpRNPP-------------- 245 (953)
T KOG0587|consen 183 FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---ALFLIPRNPP-------------- 245 (953)
T ss_pred cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---hhccCCCCCC--------------
Confidence 8999999999998542 2357788999999999999999999996554322 1222111111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
+-.......+..+.+||..||..|-.+||+..++|+|||++.
T Consensus 246 -----------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 246 -----------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -----------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 112223456788999999999999999999999999999983
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=212.26 Aligned_cols=168 Identities=27% Similarity=0.465 Sum_probs=135.4
Q ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
|.|..|++.+. .|+......+++||+.||+|||+.++|||||...|||+.+...|||+|||+++....+..... +..
T Consensus 475 GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka--S~~ 552 (974)
T KOG4257|consen 475 GELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA--SRG 552 (974)
T ss_pred hhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc--ccc
Confidence 68999998876 599999999999999999999999999999999999999999999999999998765543221 111
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.-..-|||||-+.- ..++.++|||.||+.+||++. |..||.|-...+.+-.|
T Consensus 553 kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i------------------------- 605 (974)
T KOG4257|consen 553 KLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI------------------------- 605 (974)
T ss_pred ccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------------------------
Confidence 12345999998864 789999999999999999986 89999886544332221
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+....+ ..+++++.+..|+.+||++||.+||++.++..
T Consensus 606 --EnGeRlP---~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 606 --ENGERLP---CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred --cCCCCCC---CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 2222222 33678899999999999999999999998854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-23 Score=221.29 Aligned_cols=187 Identities=29% Similarity=0.398 Sum_probs=146.0
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-ccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-~~~~~~~ 81 (449)
+||+.++.....++..++..++.||+.||+|||+.||.|||||++|+++..+|.+||+|||.+......... .......
T Consensus 405 ~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~ 484 (601)
T KOG0590|consen 405 YDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGI 484 (601)
T ss_pred HHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCc
Confidence 489999999889999999999999999999999999999999999999999999999999998765433222 1344678
Q ss_pred cccccccCcccccccCCCCCC-ccchhhhHHHHHhhhhCCCCCCCCCchhhHH-HHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~-~~DIWSlG~il~eLltG~~pF~~~~~~~~l~-~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+|+..|+|||++.+ ..|.+ .+||||.|+++..|++|+.||.-....++.. .+.
T Consensus 485 ~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~----------------------- 539 (601)
T KOG0590|consen 485 VGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN----------------------- 539 (601)
T ss_pred ccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-----------------------
Confidence 89999999999987 56665 6899999999999999999996544332210 000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.................++...+.+|.+||++||.+|.|+++|++++||+.+...
T Consensus 540 ~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 540 YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 0000111111222233456778899999999999999999999999999987644
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=209.95 Aligned_cols=175 Identities=22% Similarity=0.342 Sum_probs=141.6
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+|.+.|++. ..|-....+.|+.||+.|+.||.++++|||||-..|||+-..-.||||||||.+.+......-.+...
T Consensus 195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~ 274 (1039)
T KOG0199|consen 195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQ 274 (1039)
T ss_pred chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCC
Confidence 7888888872 35889999999999999999999999999999999999999889999999999987665543322223
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.--...|+|||.|.. ..++.++|+|++||.+|||++ |..||.|......++.|-+
T Consensus 275 rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~---------------------- 330 (1039)
T KOG0199|consen 275 RKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA---------------------- 330 (1039)
T ss_pred CcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc----------------------
Confidence 334567999999987 789999999999999999998 7899999887766654421
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
+. .....+.++..+.+++..||..+|.+|||+..|.+.-+..
T Consensus 331 -----~e---rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 331 -----GE---RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred -----cc---cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 00 0112345788999999999999999999999987654443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=199.43 Aligned_cols=187 Identities=25% Similarity=0.303 Sum_probs=136.9
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
|+|.++|+.+ .+++....+++..|++||+|||+. .|+|||||.+||||..|+.+.|+|||+|........
T Consensus 293 GsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~ 371 (534)
T KOG3653|consen 293 GSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKP 371 (534)
T ss_pred CcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCC
Confidence 7899999987 799999999999999999999974 599999999999999999999999999998776555
Q ss_pred CccccccccccccccCcccccccCCCCC-----CccchhhhHHHHHhhhhCCCCCC-CCCchhhHHHHHhhcCCCCHHHH
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAELLTGKPLFP-GKNVVHQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s-----~~~DIWSlG~il~eLltG~~pF~-~~~~~~~l~~i~~~lg~p~~e~~ 147 (449)
.... ...+||..|||||+|.+. ..+. .++||||+|.|+|||+++...+. +.-..-++---.++-..|.-+.+
T Consensus 372 ~~d~-~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 372 QGDT-HGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred Ccch-hhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 4432 347999999999999763 2222 36899999999999999876554 33333333333334445555443
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEA 202 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLL~~~L~~DP~~RpTa~el 202 (449)
... +-. ++....+...+. ..-..+++.+..||..|++-|.||.=+
T Consensus 450 q~~--------VV~--kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 450 QEL--------VVR--KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHH--------HHh--hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 322 111 111111211111 234568899999999999999998755
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-21 Score=197.48 Aligned_cols=167 Identities=23% Similarity=0.420 Sum_probs=137.0
Q ss_pred CCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
-|+|.+||+...+ ++.-...+++.||..|+.||..+++|||||...|+|+..+..||++|||+++.+..++.+.. .
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH--A 424 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH--A 424 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc--c
Confidence 4899999997664 78888899999999999999999999999999999999999999999999999877654321 1
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..--..-|.|||-|.- ..++.++|||+|||+|||+.| |..||+|-+....+..+.+-+
T Consensus 425 GAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------------------- 483 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------------------- 483 (1157)
T ss_pred CccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-------------------
Confidence 1112445899998865 688999999999999999998 889999988666554443221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 202 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~el 202 (449)
+.. ....+++...+|++.||++.|.+||++.|+
T Consensus 484 ----RM~-------~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 484 ----RMD-------GPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ----ccc-------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 111 123578899999999999999999999998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=182.76 Aligned_cols=125 Identities=27% Similarity=0.465 Sum_probs=101.9
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccc
Q 013122 7 QVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85 (449)
Q Consensus 7 ~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~ 85 (449)
++++.++.++|..+-+|+..|+.||.|||++ .|+|||+||+|||++.+|++|+||||.+....+.... +-..|-.
T Consensus 137 ~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk----t~daGCk 212 (282)
T KOG0984|consen 137 KVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK----TMDAGCK 212 (282)
T ss_pred HHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH----HHhcCCC
Confidence 4566777899999999999999999999986 7999999999999999999999999998765443322 3345777
Q ss_pred cccCcccccc--cCCCCCCccchhhhHHHHHhhhhCCCCCCCC-CchhhHHHH
Q 013122 86 WYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIM 135 (449)
Q Consensus 86 ~Y~APE~l~~--~~~~~s~~~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i 135 (449)
.|+|||.+.. ....|+-++||||||+.+.||.+++.||... +..+|+..+
T Consensus 213 pYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 213 PYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred ccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 8999999843 1247999999999999999999999999643 444444433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=212.79 Aligned_cols=168 Identities=26% Similarity=0.429 Sum_probs=143.5
Q ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
|.|..+|+.++ .|+..++.-+++.|+.|++||-+.|+|||||...|||++.+-.+|++|||+++...++.... .+..
T Consensus 715 GsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~--ytt~ 792 (996)
T KOG0196|consen 715 GSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTL 792 (996)
T ss_pred CcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc--cccc
Confidence 78999999876 49999999999999999999999999999999999999999999999999999876655322 2222
Q ss_pred cc--cccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 82 VA--TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 82 ~g--t~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
-| ...|.|||.+.- .+++.++||||+|+++||.++ |..||...+..+.+..|.+-+..|++
T Consensus 793 GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-------------- 856 (996)
T KOG0196|consen 793 GGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-------------- 856 (996)
T ss_pred CCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--------------
Confidence 22 356999999976 799999999999999999886 89999988887777777665554433
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+++..+..|+..||++|-.+||++.+|+.
T Consensus 857 ----------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 ----------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ----------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 357788999999999999999999999987
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=210.43 Aligned_cols=169 Identities=27% Similarity=0.487 Sum_probs=131.9
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
.|+|.++++.+. .|+..+...+++||+.|++||++..+|||||-.+|||+..+..+||+|||+|
T Consensus 386 ~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGla 465 (609)
T KOG0200|consen 386 HGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLA 465 (609)
T ss_pred CCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccce
Confidence 478888888775 3999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccc--ccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCC-chhhHHHHHhhcCC
Q 013122 66 RVAFNDTPTAIFWTDYV--ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN-VVHQLDIMTDLLGT 141 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~--gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~-~~~~l~~i~~~lg~ 141 (449)
+.......... .... -...|||||.+.. ..|+.++||||+|++||||++ |..||++-. ..+.++
T Consensus 466 r~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-------- 533 (609)
T KOG0200|consen 466 RDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-------- 533 (609)
T ss_pred eccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH--------
Confidence 86544332211 1111 2344999999987 689999999999999999998 789998733 111111
Q ss_pred CCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 142 PSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 142 p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
++ +..... .....+++++.+|++.||+.+|++||++.++.+
T Consensus 534 ----------------~l---~~G~r~---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 ----------------FL---KEGNRM---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred ----------------HH---hcCCCC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 11 111111 122346889999999999999999999999965
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-22 Score=208.92 Aligned_cols=181 Identities=28% Similarity=0.470 Sum_probs=129.9
Q ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc--CCCC--EEEeecCccccccCCCCC
Q 013122 2 ESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCK--LKICDFGLARVAFNDTPT 74 (449)
Q Consensus 2 e~dL~~~i~~~~---~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~--vKL~DFGlA~~~~~~~~~ 74 (449)
+|||..++.+-. .|++.++..++..+..||.|||++|||||||||.||++- .+|+ .||+|||.|+....+.
T Consensus 101 gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s-- 178 (732)
T KOG4250|consen 101 GGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS-- 178 (732)
T ss_pred CCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC--
Confidence 589999998644 599999999999999999999999999999999999964 3444 6999999999876554
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchh-hHHHHHhhc-CCCCHHHHHHHhh
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLL-GTPSPEAIARVRN 152 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~l-g~p~~e~~~~~~~ 152 (449)
.+...+||..|++||++... ..|+..+|.|||||++|+++||..||-...... ....+.... +.|+.-
T Consensus 179 --~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v------- 248 (732)
T KOG4250|consen 179 --LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV------- 248 (732)
T ss_pred --eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce-------
Confidence 45788999999999999842 678999999999999999999999985432221 111111111 111110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCC---CCH----HHHHHHHHhhhcCCCCCCC
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPN---ANP----LALRLLERMLAFEPKDRPT 198 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~---~s~----~~~dLL~~~L~~DP~~RpT 198 (449)
..........+..|+..+|- .++ .+-.+|..||..+|.+|..
T Consensus 249 ----~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 249 ----AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred ----eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 01111223345555554443 222 2345778899999999984
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-21 Score=195.97 Aligned_cols=179 Identities=21% Similarity=0.312 Sum_probs=138.2
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|||.+++.++. .+..+....|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++....+..... -..
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v-qgr 698 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV-QGR 698 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee-ecc
Confidence 79999999884 345667778999999999999999999999999999999999999999999997665544321 133
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh--CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt--G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
.+-...|||+|.+.. .+++.++|+|++|+.+||+++ ...||....+.+..+....++..+
T Consensus 699 ~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~---------------- 760 (807)
T KOG1094|consen 699 AVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ---------------- 760 (807)
T ss_pred eeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC----------------
Confidence 455678999998876 689999999999999999865 667887665544443333322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.........+-++..+.+||.+||..|-++||+++++ |-+|+
T Consensus 761 -------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l--h~~lq 802 (807)
T KOG1094|consen 761 -------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL--HLFLQ 802 (807)
T ss_pred -------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence 1111222334567889999999999999999999999 44454
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=214.85 Aligned_cols=176 Identities=21% Similarity=0.294 Sum_probs=121.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLH---s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..+++ ||.+......
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------- 835 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------- 835 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-------
Confidence 4789999963 899999999999999999999 6699999999999999998887775 6655432211
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCch--hhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV--HQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~--~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...... .........+. .....
T Consensus 836 ~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~ 902 (968)
T PLN00113 836 TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS-----------DCHLD 902 (968)
T ss_pred CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC-----------ccchh
Confidence 23468899999999887 67999999999999999999999998532211 11100000000 00000
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.++...... . ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 903 ~~~~~~~~~---~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 903 MWIDPSIRG---D-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred heeCccccC---C-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000000 0 00001112356789999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=167.70 Aligned_cols=138 Identities=38% Similarity=0.662 Sum_probs=118.3
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.+|.+++... ..++...+..++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKT 152 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhc
Confidence 6899998876 47999999999999999999999999999999999999999 89999999999876544321 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 5577889999998762 2778899999999999998
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
..+.+++.+||..||.+||++.++++|+
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1356799999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-20 Score=184.21 Aligned_cols=180 Identities=27% Similarity=0.339 Sum_probs=124.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccccCCcEEEcCCCCEEEeecCccccccCCC-
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 72 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~- 72 (449)
.|+|+|+|..+ .++.+...+++..++.||++||.. .|.|||||.+|||+..++.+.|+|+|||.......
T Consensus 293 ~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~ 371 (513)
T KOG2052|consen 293 HGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTD 371 (513)
T ss_pred CCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCC
Confidence 37999999984 899999999999999999999964 49999999999999999999999999998765543
Q ss_pred CCccccccccccccccCccccccc-----CCCCCCccchhhhHHHHHhhhhC----------CCCCCCCCchhhHHHHHh
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLTG----------KPLFPGKNVVHQLDIMTD 137 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLltG----------~~pF~~~~~~~~l~~i~~ 137 (449)
.-.......+||..|||||+|... |..| ..+||||||.|+||+..+ ++||.+....
T Consensus 372 ~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~-------- 442 (513)
T KOG2052|consen 372 TIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS-------- 442 (513)
T ss_pred cccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC--------
Confidence 223344678999999999998542 1222 358999999999999763 3555443221
Q ss_pred hcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 013122 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 202 (449)
Q Consensus 138 ~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~el 202 (449)
.|+.+.+..+ -.+..++...+..|... ..-..+..|++.||..+|.-|.||--+
T Consensus 443 ---DPs~eeMrkV------VCv~~~RP~ipnrW~s~--~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 443 ---DPSFEEMRKV------VCVQKLRPNIPNRWKSD--PALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ---CCCHHHHhcc------eeecccCCCCCcccccC--HHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 1111111110 00111111111111110 011235668999999999999998665
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=178.61 Aligned_cols=169 Identities=20% Similarity=0.321 Sum_probs=132.5
Q ss_pred CcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC
Q 013122 3 SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 3 ~dL~~~i~~~--------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
++|..++... +.++..+...++.||..|++|||+.||||.||..+|++|++.-++||+|=.+++..+.....
T Consensus 373 gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYh 452 (563)
T KOG1024|consen 373 GNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYH 452 (563)
T ss_pred chHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCccccc
Confidence 6788888721 24788899999999999999999999999999999999999999999999999887665432
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
..- ..-.....||++|.+.. ..|+.++|+||||+++|||+| |+.|+-.-+..+...
T Consensus 453 cLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-------------------- 509 (563)
T KOG1024|consen 453 CLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-------------------- 509 (563)
T ss_pred ccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--------------------
Confidence 211 11123456999999988 789999999999999999998 888887665543322
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
|+.. ... + ...-++++++..++.-||+.+|++||+++|+..
T Consensus 510 ----ylkd---GyR--l-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 510 ----YLKD---GYR--L-AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ----HHhc---cce--e-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 2221 111 1 112367889999999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=189.00 Aligned_cols=169 Identities=24% Similarity=0.373 Sum_probs=134.0
Q ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
|.|.++++.+. .+-.+....|.+||++|+.|||.+++|||||-.+||||..-..+||.|||+|+....+...-. ...-
T Consensus 782 G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~-~~~g 860 (1177)
T KOG1025|consen 782 GCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS-APGG 860 (1177)
T ss_pred chHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc-cccc
Confidence 68889988765 599999999999999999999999999999999999999999999999999988765433211 1111
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
-...-|||=|.+.. ..|+.++||||+||.+||++| |..|+.+....+.-+.+
T Consensus 861 K~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll------------------------- 913 (1177)
T KOG1025|consen 861 KVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL------------------------- 913 (1177)
T ss_pred ccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------------------------
Confidence 12345788888776 789999999999999999998 88999887654332221
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
++... ....+..+-++.-++.+||..|+..||+++++..
T Consensus 914 --e~geR---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 914 --EKGER---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --hcccc---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11111 2234667888999999999999999999999865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.5e-20 Score=172.31 Aligned_cols=177 Identities=30% Similarity=0.446 Sum_probs=125.2
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC--CCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|||..-+..+ .+.+.-.+.++.||+.||.|+|++++||||||.+||||-. ..+|||||||+.+..+.... .
T Consensus 107 gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~------~ 179 (378)
T KOG1345|consen 107 GDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK------Y 179 (378)
T ss_pred chhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh------h
Confidence 5666665554 5889999999999999999999999999999999999754 23699999999875433221 1
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.--+..|.+||++... .-...+..|||.||+|+|.+|+|++||+.....++ ...+
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~----------------------~Y~~ 237 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK----------------------PYWE 237 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc----------------------hHHH
Confidence 1234568899987431 11346789999999999999999999974332211 1111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHHcCcccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFK 209 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~R---pTa~elL~hp~f~ 209 (449)
+..-..++ .......|...++.+..+.++-|..++++| .++......-|..
T Consensus 238 ~~~w~~rk-~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 238 WEQWLKRK-NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HHHHhccc-CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 21111111 224456677789999999999999999999 4455554444543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.3e-20 Score=189.19 Aligned_cols=115 Identities=24% Similarity=0.462 Sum_probs=104.8
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~g 83 (449)
||+++|.-+..++|.+++.|++||..|+++||+.||||||||-+||.++.+|.+||+|||.|....++. +..++|
T Consensus 656 DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp-----fd~f~g 730 (772)
T KOG1152|consen 656 DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP-----FDVFVG 730 (772)
T ss_pred chhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCCC-----cceeee
Confidence 899999999999999999999999999999999999999999999999999999999999997765543 456899
Q ss_pred cccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCC
Q 013122 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124 (449)
Q Consensus 84 t~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~ 124 (449)
|..|.|||++.|. ...+..-|||+||++||-++....||.
T Consensus 731 tv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 731 TVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999984 344678899999999999999988875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=188.42 Aligned_cols=180 Identities=25% Similarity=0.401 Sum_probs=138.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|.++-.-.+.|++.++.++++..++||+|||+.|-+|||||-.|||+++.|.+||+|||.+..+..... ....+
T Consensus 96 ggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~---Krksf 172 (829)
T KOG0576|consen 96 GGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA---KRKSF 172 (829)
T ss_pred CCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh---hhhcc
Confidence 467777777778899999999999999999999999999999999999999999999999999866543332 23678
Q ss_pred cccccccCccccc-ccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~-~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
+||+.|||||+.. +....|...+|||++|+...|+---++|.-.......+-.|.+..
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~--------------------- 231 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG--------------------- 231 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC---------------------
Confidence 9999999999852 222578999999999999999877666543332222222222211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
..+. -.......++.+-+|++.+|..+|++|||++.+|.|||...
T Consensus 232 ----~qpp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 232 ----FQPP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ----CCCC-cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1111 11222345788999999999999999999999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-19 Score=193.52 Aligned_cols=173 Identities=29% Similarity=0.446 Sum_probs=125.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccccc--CCCCC--cccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF--NDTPT--AIFW 78 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~--~~~~~--~~~~ 78 (449)
++|+|.|..+..|..-+.+.|+.||+.||..+|..||+|||||.+||||+.-..+.|+||...+... .+++. ..++
T Consensus 105 hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFF 184 (1431)
T KOG1240|consen 105 HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFF 184 (1431)
T ss_pred hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEE
Confidence 6899999999889999999999999999999999999999999999999999899999998765432 22221 1222
Q ss_pred ccccccccccCcccccccC---------CCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~---------~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
.+...-.+|.|||.+.... ...+++.||||+||+++||++ |+++|.- .|+-..... +....
T Consensus 185 DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~-~~~~~---- 255 (1431)
T KOG1240|consen 185 DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSG-NADDP---- 255 (1431)
T ss_pred ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhcc-CccCH----
Confidence 2333445799999874310 125788999999999999988 7999941 111000000 00000
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
...++.+ -+..++.||..|++.||++|.+|++.|+.
T Consensus 256 -------e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 -------EQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -------HHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111 13357889999999999999999999984
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-18 Score=188.82 Aligned_cols=157 Identities=27% Similarity=0.400 Sum_probs=125.6
Q ss_pred HHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc------------cccccccccccccCcccccc
Q 013122 28 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------------IFWTDYVATRWYRAPELCGS 95 (449)
Q Consensus 28 l~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~------------~~~~~~~gt~~Y~APE~l~~ 95 (449)
+.+++|||+-||+|||+||+|+||+.-|.+|++|||+.+......... ......|||+.|+|||++..
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 789999999999999999999999999999999999987532211111 11234589999999999987
Q ss_pred cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCC
Q 013122 96 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175 (449)
Q Consensus 96 ~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (449)
..|+..+|.|++|+|+||.+.|..||.|....+.+...... .+.|.+.-.
T Consensus 233 --qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd----------------------------~i~wpE~de 282 (1205)
T KOG0606|consen 233 --QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD----------------------------DIEWPEEDE 282 (1205)
T ss_pred --hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----------------------------hccccccCc
Confidence 68999999999999999999999999988766554333211 122334445
Q ss_pred CCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCccccccccc
Q 013122 176 NANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGLAKV 214 (449)
Q Consensus 176 ~~s~~~~dLL~~~L~~DP~~Rp---Ta~elL~hp~f~~~~~~ 214 (449)
...++++++|.++|+.+|..|. .+-++-+|+||+.+...
T Consensus 283 a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 283 ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 6789999999999999999994 56788899999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.75 E-value=6e-18 Score=157.86 Aligned_cols=120 Identities=40% Similarity=0.684 Sum_probs=103.4
Q ss_pred CcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~-Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++..... +++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+......... .....
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~--~~~~~ 159 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA--LLKTV 159 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--cccce
Confidence 489999988777 999999999999999999999999999999999999999999999999998876543211 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCC
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 125 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~ 125 (449)
.++..|++||.+.+ ...++.++|+|+||+++++|++|+.||.+
T Consensus 160 ~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 67888999999832 26778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-17 Score=156.96 Aligned_cols=189 Identities=32% Similarity=0.469 Sum_probs=138.7
Q ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCc--
Q 013122 2 ESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTA-- 75 (449)
Q Consensus 2 e~dL~~~i~~~~---~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~-- 75 (449)
+++|.+++.... .+....+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||.+..........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccc
Confidence 457777777765 799999999999999999999999999999999999999988 69999999997544333221
Q ss_pred -cccccccccccccCcccccccC-CCCCCccchhhhHHHHHhhhhCCCCCCCCCch---hhHHHHHhhcCCCCHHHHHHH
Q 013122 76 -IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---HQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 76 -~~~~~~~gt~~Y~APE~l~~~~-~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~---~~l~~i~~~lg~p~~e~~~~~ 150 (449)
......+|+..|++||.+.+.. ..++...|+||+|++++++++|..||...... ............+
T Consensus 162 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 233 (384)
T COG0515 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-------- 233 (384)
T ss_pred cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--------
Confidence 1246678999999999987621 36788999999999999999999998766531 1111111111110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.......... ......+.+++.+|+..+|..|.+..+...++|.....
T Consensus 234 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 234 --------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred --------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 0000000000 11235788999999999999999999999987665443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-18 Score=177.12 Aligned_cols=166 Identities=26% Similarity=0.377 Sum_probs=136.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|...+.....+++.....+...++.+++++|+.||+|||+|++||+++.+|.+++.|||+.+...... ..
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------IA 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh-------hc
Confidence 35777777777789999999999999999999999999999999999999999999999999988654432 22
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHh-hcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD-LLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~-~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
|||..|||||++.+ +..++|.||+|++.++|++|..||.+ +.+..|.+ -++
T Consensus 154 cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~-------------------- 205 (612)
T KOG0603|consen 154 CGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE-------------------- 205 (612)
T ss_pred ccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC--------------------
Confidence 89999999999874 66899999999999999999999977 33333322 111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLAKV 214 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~~~ 214 (449)
....++..+.+++..|+..+|..|.- +.|+++|+||..+...
T Consensus 206 ------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 206 ------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 11235677899999999999999965 4799999999876544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-17 Score=171.20 Aligned_cols=169 Identities=30% Similarity=0.496 Sum_probs=125.4
Q ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC---CCcc
Q 013122 3 SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT---PTAI 76 (449)
Q Consensus 3 ~dL~~~i~~~~---~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~---~~~~ 76 (449)
..|.++|..+. ..+....+.++.|+..|++| +|.+|+|+||.||++..++.+||+|||+........ ....
T Consensus 341 ~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a 417 (516)
T KOG1033|consen 341 ETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAA 417 (516)
T ss_pred hhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhh
Confidence 57889997554 37788999999999999999 999999999999999999999999999987654443 1112
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
..+..+||.+||+||.+.+ ..|+.++||||||+||+||+.- |.. +.+.+
T Consensus 418 ~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~---f~T-----~~er~--------------------- 466 (516)
T KOG1033|consen 418 SHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQ---FST-----QFERI--------------------- 466 (516)
T ss_pred hhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHH---hcc-----HHHHH---------------------
Confidence 3467789999999999998 7899999999999999999972 110 00000
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
..+..++.. .+...+-.-.+.-..|+.+||...|.+||++.+.--|.|.
T Consensus 467 ~t~~d~r~g---~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 467 ATLTDIRDG---IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HhhhhhhcC---CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111111111 1111112223556789999999999999988877777764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=165.21 Aligned_cols=278 Identities=23% Similarity=0.261 Sum_probs=181.5
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCc-ccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANV-FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gI-vHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.|+|.|+|... ..++.-....+++.|+.||.|||..-| +|+.|+..|++++..+.+||+|||+...... ........
T Consensus 31 rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~-~~~~~~~~ 109 (484)
T KOG1023|consen 31 RGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEE-TAEPEAHH 109 (484)
T ss_pred CccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccc-cccccccc
Confidence 47899999884 368999999999999999999999876 9999999999999999999999999876532 11100111
Q ss_pred cccccccccCccccccc--CCC---CCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 80 DYVATRWYRAPELCGSF--FSK---YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~--~~~---~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
...-...|.|||++.+. ... .+.+.||||+|++++|+++...||........-..+ +..
T Consensus 110 ~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~ei-----------i~~----- 173 (484)
T KOG1023|consen 110 PIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEI-----------ILR----- 173 (484)
T ss_pred hhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHH-----------HHH-----
Confidence 22234568999998762 111 467799999999999999999999764332111111 110
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCC-C-CCCccchhhHHHh
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP-S-AQPVTKMEFEFER 232 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~-~-~~~~~~~~~~~e~ 232 (449)
+.........+.-.......+.+..++..||..+|.+||+++++-.. +....... . ...+..+....+.
T Consensus 174 ----~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~-----~~~~~~~~~~~~nl~D~m~~~le~ 244 (484)
T KOG1023|consen 174 ----VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK-----LLTINKGGSSKGNLMDSLFRMLES 244 (484)
T ss_pred ----HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh-----hhhhcccccccchhHHHHHHHHHH
Confidence 11101111111111111455678999999999999999999988431 11111111 0 0122223333444
Q ss_pred hcCCHHHHHHHHHHHHHhhChhHHHhhhcCCCCCCCCCChhhHHHHHHHHHHhhhcCCCCcCCCCCCCCCCCCCCccccC
Q 013122 233 RRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYS 312 (449)
Q Consensus 233 ~~~~~e~~~e~i~~ei~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (449)
.....|+..+....++ ..+..+.....+-|.|..|+ +..++|..+.|.....+.+.++.++++
T Consensus 245 Y~~nLe~~v~eRt~~l-------~~e~~k~d~LL~~mLP~~VA----------~~lk~G~~v~pe~~~~vti~fsDiv~f 307 (484)
T KOG1023|consen 245 YADNLEKLVDERTAEL-------EEEKKKTDTLLGQMLPKSVA----------ESLKLGKTVDPESFDSVTIYFSDIVGF 307 (484)
T ss_pred HHhhhHHHHHHHHHHH-------HHHHHHHHHHHHHhcCHHHh----------hHhhcCCcCCccccCceeeeeHHHHHH
Confidence 5555555444433333 22223333344457787666 677889999999999999999999998
Q ss_pred CCCCCCCccc
Q 013122 313 DKTVQNSAAV 322 (449)
Q Consensus 313 ~~~~~~~~~~ 322 (449)
++...++++.
T Consensus 308 T~l~~~~~P~ 317 (484)
T KOG1023|consen 308 TVLSSNSTPI 317 (484)
T ss_pred HHHHhcCCCc
Confidence 8876666554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=156.36 Aligned_cols=169 Identities=22% Similarity=0.272 Sum_probs=119.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc--CCC--CEEEeecCccccccCCCC---C
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADC--KLKICDFGLARVAFNDTP---T 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~--~vKL~DFGlA~~~~~~~~---~ 74 (449)
..+|++++-.+ ..+......++.|+|+|+.|||.+||.|||||.+|||+. +++ .+.|+|||++-......- .
T Consensus 326 ~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy 404 (598)
T KOG4158|consen 326 RQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY 404 (598)
T ss_pred hhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc
Confidence 35788888876 588889999999999999999999999999999999974 333 389999998754322111 1
Q ss_pred ccccccccccccccCcccccccCCC----CCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~----~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
....-+.-|.-..||||+.....+. --.++|.|+.|.+.||+++...||.+......-
T Consensus 405 ~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------------ 466 (598)
T KOG4158|consen 405 ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------------ 466 (598)
T ss_pred ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------------
Confidence 1111234467778999997542111 113789999999999999999999764321110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE 200 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~ 200 (449)
.+.| ....+......+++.+++|+..+|+.||++|++..
T Consensus 467 ----~r~Y-------qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 467 ----TRTY-------QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ----hhhh-------hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 0011 11112223345789999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.7e-17 Score=162.45 Aligned_cols=155 Identities=23% Similarity=0.285 Sum_probs=101.7
Q ss_pred CCCcHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 1 MESDLHQVIKA---NDD----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 1 me~dL~~~i~~---~~~----Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
|.+||.+++.. ... +.......+..|+++.+++||+.||+|+||+|+|+|++.+|.++|+||+.....+...
T Consensus 121 ~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~- 199 (288)
T PF14531_consen 121 AQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY- 199 (288)
T ss_dssp -SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-
T ss_pred hhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCcee-
Confidence 35677777542 222 2233335566899999999999999999999999999999999999999876543321
Q ss_pred CccccccccccccccCccccccc------CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHH
Q 013122 74 TAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~------~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~ 147 (449)
.....+..|.+||+.... ...++.+.|.|+||+++|.|++|..||..........
T Consensus 200 -----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~-------------- 260 (288)
T PF14531_consen 200 -----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE-------------- 260 (288)
T ss_dssp -----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG--------------
T ss_pred -----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc--------------
Confidence 112345678999976431 1347889999999999999999999997654321100
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 196 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~R 196 (449)
..|.... ++++.+++||.+||++||.+|
T Consensus 261 --------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 --------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred --------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 0233333 788999999999999999988
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=146.16 Aligned_cols=176 Identities=19% Similarity=0.199 Sum_probs=127.2
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-----CCEEEeecCccc--cccCC
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFGLAR--VAFND 71 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-----~~vKL~DFGlA~--~~~~~ 71 (449)
++.+|.++.+... .++...+..++.|++.+|.+||+.|++||||||.|+++... ..+.|.|||+++ .....
T Consensus 103 ~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~ 182 (322)
T KOG1164|consen 103 LGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGD 182 (322)
T ss_pred cCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCC
Confidence 3678999886554 69999999999999999999999999999999999999865 359999999998 32222
Q ss_pred CCC-----ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHH
Q 013122 72 TPT-----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 146 (449)
Q Consensus 72 ~~~-----~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~ 146 (449)
... ......+.||..|.++....+ ...+...|+||++.++.+++.|..||.+.........+...
T Consensus 183 ~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~-------- 252 (322)
T KOG1164|consen 183 SGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD-------- 252 (322)
T ss_pred CCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH--------
Confidence 111 111234569999999999887 67889999999999999999999999765533222111110
Q ss_pred HHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 147 IARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...... .......+..+..++..+-..+...+|....+..
T Consensus 253 ------------~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 253 ------------PRKLLT------DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred ------------hhhhcc------ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 000000 0022234456677777777788888888877755
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.6e-14 Score=136.74 Aligned_cols=127 Identities=19% Similarity=0.316 Sum_probs=104.2
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-----CEEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-----~vKL~DFGlA~~~~~~~~~ 74 (449)
++.+|.|++.-.+ +|+...+..++.|++.-++|+|++.+|.|||||+|+||...+ .|.|+|||+|+........
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 3556777666554 599999999999999999999999999999999999998654 4899999999876543322
Q ss_pred c-cc---cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCch
Q 013122 75 A-IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 129 (449)
Q Consensus 75 ~-~~---~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~ 129 (449)
. +. .....||-.||+-....| ..-+...|+=|||-+|+..|.|..||.|....
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 1 11 235679999999888777 67788999999999999999999999986543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-14 Score=155.63 Aligned_cols=182 Identities=29% Similarity=0.394 Sum_probs=140.9
Q ss_pred CCcHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVI-KAND-DLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i-~~~~-~Ls~~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++++..+ .... ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++.++ .+++.|||+|............
T Consensus 105 g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~ 184 (601)
T KOG0590|consen 105 GGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERS 184 (601)
T ss_pred ccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCccee
Confidence 35666666 4444 5788899999999999999999 99999999999999999999 9999999999877652333334
Q ss_pred cccccc-cccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 78 WTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 78 ~~~~~g-t~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....+| ++.|.|||...+. ....+..|+||+|+++.-+++|..++......+.
T Consensus 185 ~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~------------------------- 238 (601)
T KOG0590|consen 185 LKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG------------------------- 238 (601)
T ss_pred eecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc-------------------------
Confidence 566788 9999999998773 3456789999999999999999988864432211
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.+...+.. ....-...+..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 RYSSWKSN-KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cceeeccc-ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 01111111 111112334567888999999999999999999999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.4e-13 Score=124.46 Aligned_cols=172 Identities=20% Similarity=0.242 Sum_probs=121.0
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC---CCEEEeecCccccccCCCCCc-c
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTA-I 76 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGlA~~~~~~~~~~-~ 76 (449)
+-+|.+++.-. ..++...+..++-|++.-|+|+|.+++|||||||+|+|..-+ .++.|+|||+|+...+..... +
T Consensus 94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI 173 (341)
T KOG1163|consen 94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI 173 (341)
T ss_pred CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence 44566655432 359999999999999999999999999999999999997543 358999999998764432211 1
Q ss_pred ---ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 77 ---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 77 ---~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
......||..|.+-....+ ..-+...|+-|+|.+|..+..|..||+|.......++..++
T Consensus 174 pyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI--------------- 236 (341)
T KOG1163|consen 174 PYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI--------------- 236 (341)
T ss_pred ccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---------------
Confidence 1134578999988877666 45678899999999999999999999987654443332221
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 198 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT 198 (449)
..++...+....+...+.++.-.|.-|-..--++-|.
T Consensus 237 --------~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 237 --------SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred --------HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 1122233444445556666666676665555555554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1e-11 Score=137.83 Aligned_cols=115 Identities=23% Similarity=0.306 Sum_probs=98.9
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-------CCCEEEeecCccccccCCCCCc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-------~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
|+|.+++..++.+++..+.+|..|+|.-|++||..+|||+||||+|+||.. ..-++|+|||.+..+.--...
T Consensus 779 Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~- 857 (974)
T KOG1166|consen 779 GTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG- 857 (974)
T ss_pred ccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC-
Confidence 789999998888999999999999999999999999999999999999853 234899999998654322221
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCC
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~ 120 (449)
..+...++|-.+-.+|+..| ..++..+|.|.|+.+++.||.|+
T Consensus 858 ~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 858 TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 23456778888999999998 78999999999999999999997
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.7e-12 Score=128.82 Aligned_cols=75 Identities=25% Similarity=0.305 Sum_probs=61.1
Q ss_pred HHHHHHHHHHHHHHHHCCcccccc-cCCcEEEcCCCCEEEeecCccccccCCCCCcc-----ccccccccccccCccccc
Q 013122 21 QFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVAFNDTPTAI-----FWTDYVATRWYRAPELCG 94 (449)
Q Consensus 21 ~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~-----~~~~~~gt~~Y~APE~l~ 94 (449)
..++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.......... ..+..++++.|.|||.+.
T Consensus 114 ~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 114 PAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred HHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 568899999999999999999999 99999999999999999999987644322111 124567888899999885
Q ss_pred c
Q 013122 95 S 95 (449)
Q Consensus 95 ~ 95 (449)
.
T Consensus 194 ~ 194 (365)
T PRK09188 194 P 194 (365)
T ss_pred h
Confidence 4
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-11 Score=115.70 Aligned_cols=162 Identities=17% Similarity=0.238 Sum_probs=117.2
Q ss_pred CcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCCEEE--eecCccccccCCCCCcc
Q 013122 3 SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKI--CDFGLARVAFNDTPTAI 76 (449)
Q Consensus 3 ~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL--~DFGlA~~~~~~~~~~~ 76 (449)
++|+.++..... .+..++.+++.+|++|++|||+.. |.---|....|+++++...+| +|--++...
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-------- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------- 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec--------
Confidence 689999987654 678899999999999999999975 455568889999999876554 443333211
Q ss_pred ccccccccccccCcccccccCC-CCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~-~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
....-.+.|++||.+..... .--.++|+|||++++|||.|...||...+..+.--+|
T Consensus 344 --~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------------------- 401 (448)
T KOG0195|consen 344 --VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------------------- 401 (448)
T ss_pred --cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--------------------
Confidence 12234678999999865211 1235789999999999999999999766543321111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL 203 (449)
.++.++- ...|.++.....|+.-|++.||.+||.++.++
T Consensus 402 --aleglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 402 --ALEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred --hhccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1112221 23467888899999999999999999988764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.7e-12 Score=136.13 Aligned_cols=180 Identities=27% Similarity=0.378 Sum_probs=142.8
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC---------
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--------- 73 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~--------- 73 (449)
++|...+.+-+.++.+-++.++..+..++.|||+..++|+|++|.|+|+..++..++.|||..........
T Consensus 889 ~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~ 968 (1205)
T KOG0606|consen 889 GDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSS 968 (1205)
T ss_pred CCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccc
Confidence 67778888877889999999999999999999999999999999999999999999999984322110000
Q ss_pred -----------------C--ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHH
Q 013122 74 -----------------T--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 134 (449)
Q Consensus 74 -----------------~--~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~ 134 (449)
. .......+||+.|.+||.+.+ .....++|.|++|++++|.++|.++|.........+
T Consensus 969 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~- 1045 (1205)
T KOG0606|consen 969 SGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFE- 1045 (1205)
T ss_pred cCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhh-
Confidence 0 011234578999999999988 678889999999999999999999997765433322
Q ss_pred HHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH---HHHcCcccccc
Q 013122 135 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE---EALADPYFKGL 211 (449)
Q Consensus 135 i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~---elL~hp~f~~~ 211 (449)
++ .....+|..-....+..+.+++.++|..+|.+|..+. ++-.|+||+..
T Consensus 1046 --------------------------ni-~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1046 --------------------------NI-LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred --------------------------cc-ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 21 1223455666666789999999999999999999887 88889999975
Q ss_pred c
Q 013122 212 A 212 (449)
Q Consensus 212 ~ 212 (449)
.
T Consensus 1099 ~ 1099 (1205)
T KOG0606|consen 1099 D 1099 (1205)
T ss_pred C
Confidence 4
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.6e-12 Score=116.65 Aligned_cols=106 Identities=20% Similarity=0.092 Sum_probs=76.1
Q ss_pred HHHHHHHHHHHHHHHHCCcccccc-cCCcEEEcCCCCEEEeecCccccccCCCCC----c-cc-----cccccccccccC
Q 013122 21 QFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVAFNDTPT----A-IF-----WTDYVATRWYRA 89 (449)
Q Consensus 21 ~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~vKL~DFGlA~~~~~~~~~----~-~~-----~~~~~gt~~Y~A 89 (449)
..++.|++.+|.+||++||+|||| ||.|||++.++.++|+|||+|......... . .. ..-...++.|++
T Consensus 94 ~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~ 173 (218)
T PRK12274 94 LAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALT 173 (218)
T ss_pred HHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 457889999999999999999999 799999999999999999999854332210 0 00 000124566777
Q ss_pred cccccccCCCCC-CccchhhhHHHHHhhhhCCCCCCCCC
Q 013122 90 PELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKN 127 (449)
Q Consensus 90 PE~l~~~~~~~s-~~~DIWSlG~il~eLltG~~pF~~~~ 127 (449)
|+..... ...+ ...+.++.|+.+|.++|+..++.+.+
T Consensus 174 ~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 174 PVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 7653321 1223 45677899999999999998775543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.9e-11 Score=113.67 Aligned_cols=64 Identities=19% Similarity=0.230 Sum_probs=55.1
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
+|...+.....++.+.+..++.||+.+|.+| |+.||+||||||+|||++ ++.++|+|||+|...
T Consensus 103 ~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 103 GWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 4444444456799999999999999999999 799999999999999998 578999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.1e-11 Score=109.21 Aligned_cols=58 Identities=26% Similarity=0.220 Sum_probs=52.9
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCcccccc
Q 013122 11 ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 69 (449)
Q Consensus 11 ~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~ 69 (449)
....++...+..++.||+.+|.+||+ .||+||||||+|||++ ++.++|+|||++....
T Consensus 110 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 110 KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 34568899999999999999999999 9999999999999999 8899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-11 Score=113.51 Aligned_cols=77 Identities=13% Similarity=0.171 Sum_probs=59.3
Q ss_pred HHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccccccCCCCCC
Q 013122 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 102 (449)
Q Consensus 23 i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~ 102 (449)
.+.+|+.+|..||..||+||||||.||+++.++ ++|+|||............ .++.. ..|..
T Consensus 140 ~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d---------------~~vle--r~y~~ 201 (232)
T PRK10359 140 VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD---------------RIDLE--RHYGI 201 (232)
T ss_pred HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH---------------HHHHH--hHhcc
Confidence 466999999999999999999999999999988 9999999876542221110 02222 34667
Q ss_pred ccchhhhHHHHHhhh
Q 013122 103 AIDIWSIGCIFAELL 117 (449)
Q Consensus 103 ~~DIWSlG~il~eLl 117 (449)
++|+|+||+.+..+.
T Consensus 202 ~~di~~lg~~~~~~~ 216 (232)
T PRK10359 202 KNEIKDLGYYLLIYK 216 (232)
T ss_pred cccccceeEeehHHH
Confidence 899999999877654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-10 Score=122.37 Aligned_cols=161 Identities=23% Similarity=0.314 Sum_probs=115.9
Q ss_pred HHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcc-ccc-----cccccccccCcccc
Q 013122 21 QFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI-FWT-----DYVATRWYRAPELC 93 (449)
Q Consensus 21 ~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~-~~~-----~~~gt~~Y~APE~l 93 (449)
-.=+.++..||.|+|. .++||++|.|++|.++.++..||+.|+++........... .++ -......|.|||++
T Consensus 102 f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3334556699999996 5899999999999999999999999998866544221100 000 11235579999999
Q ss_pred cccCCCCCCccchhhhHHHHHhhh-hCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLl-tG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ...+.++|+||+||++|.+. .|+.+|.+.+.......-...++ .....
T Consensus 182 ~~--~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~---------------------------~~~~~ 232 (700)
T KOG2137|consen 182 LG--TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN---------------------------AGAFG 232 (700)
T ss_pred cc--ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc---------------------------ccccc
Confidence 87 67789999999999999999 67777766543222111000000 00011
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.-.++++++++=|.++|..+...||++.+++..|||.+
T Consensus 233 ~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 233 YSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred ccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 11467899999999999999999999999999999985
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-10 Score=119.76 Aligned_cols=175 Identities=25% Similarity=0.230 Sum_probs=131.5
Q ss_pred CcHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCcccccccCCcEEEcCC-CCEEEeecCccccccCCCCCcc
Q 013122 3 SDLHQVIKANDD-LTPEHYQFFLYQLLR----GLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 3 ~dL~~~i~~~~~-Ls~~~i~~i~~QIl~----aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
.+|..+...... +++..++..+.+.+. ||.++|+.+|+|-|+||.||++..+ ..++++|||+...+........
T Consensus 202 ~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~ 281 (524)
T KOG0601|consen 202 ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSV 281 (524)
T ss_pred chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccc
Confidence 456666665554 889999999999999 9999999999999999999999999 7899999999987765442221
Q ss_pred cc--ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCC--CchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 77 FW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 77 ~~--~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~--~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
.. ....|...|++||++.+ .++.+.||+++|.++.+..++..++... +...+++.+.
T Consensus 282 ~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---------------- 342 (524)
T KOG0601|consen 282 FKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---------------- 342 (524)
T ss_pred eeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc----------------
Confidence 11 12246677999999986 6889999999999999999987665443 2111111100
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
-..+.+...+..+...+..|+..+|..|++++.+++|+++....
T Consensus 343 ----------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 343 ----------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred ----------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence 01122334455566689999999999999999999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-09 Score=101.92 Aligned_cols=60 Identities=25% Similarity=0.320 Sum_probs=49.6
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCcccccccCCcEEEcCC----CCEEEeecCcc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGL-KYIHTANVFHRDLKPKNILANAD----CKLKICDFGLA 65 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL-~yLHs~gIvHrDLKP~NILl~~~----~~vKL~DFGlA 65 (449)
++|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 92 ~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 92 ITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred hhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 6999999774 57666 46788888888 99999999999999999999743 37999995543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.3e-09 Score=104.93 Aligned_cols=64 Identities=20% Similarity=0.188 Sum_probs=53.6
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-cccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~g-IvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
+|...+..+..+....+..++.||+.+|.+||+.| |+||||||+||+++ ++.++|+|||++...
T Consensus 134 ~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 134 GLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred cccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 34444334445677778899999999999999999 99999999999999 889999999998643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.3e-09 Score=100.79 Aligned_cols=60 Identities=28% Similarity=0.447 Sum_probs=51.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
.+|.+++... .+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.+..
T Consensus 132 ~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 132 RDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 4788887653 566543 67899999999999999999999999999989999999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=9.1e-09 Score=100.75 Aligned_cols=174 Identities=21% Similarity=0.249 Sum_probs=114.0
Q ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCCEEEeecCccc--cccCCCCC
Q 013122 3 SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPT 74 (449)
Q Consensus 3 ~dL~~~i~~~----~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGlA~--~~~~~~~~ 74 (449)
+.|.++|++. ..+.....++|+-||+.||.|||+.. |+|+++..+.|++..+|-||++--.-.. ........
T Consensus 157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH
Confidence 4677777643 35889999999999999999999986 9999999999999999988876322111 00000000
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCC-CCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.......+-+.|.+||.=.. ...+.++|||++|....+|..+..- -.+.+....-..|.
T Consensus 237 -~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia----------------- 296 (458)
T KOG1266|consen 237 -AEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIA----------------- 296 (458)
T ss_pred -hhhhccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhh-----------------
Confidence 00112234567888886443 4566789999999999999877632 11111111100000
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
..+ +.--...-++++.+||.-.|..||++.++|.||.+-.++.
T Consensus 297 ---~~i--------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 297 ---NVI--------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHS 339 (458)
T ss_pred ---hhe--------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeeecch
Confidence 000 0001222356899999999999999999999998776553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.7e-09 Score=96.07 Aligned_cols=61 Identities=26% Similarity=0.389 Sum_probs=53.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
+.+|.+++..... ....++.+|+.+|.+||+.||+|+|++|.|||++ ++.++|+|||++..
T Consensus 83 G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 83 GEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 3578888765432 7889999999999999999999999999999999 78899999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.4e-08 Score=93.02 Aligned_cols=51 Identities=25% Similarity=0.277 Sum_probs=46.9
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 18 ~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
.....++.+|+.++.++|+.||+|+||||.||+++.++.++|+|||++...
T Consensus 125 ~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 125 EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 456789999999999999999999999999999999999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-08 Score=94.50 Aligned_cols=57 Identities=35% Similarity=0.543 Sum_probs=48.5
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
++|.+++..... .++.||+.+|.+||+.||+|+|++|.||+++ ++.++|+|||++..
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 456666544321 8899999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.1e-08 Score=90.03 Aligned_cols=51 Identities=29% Similarity=0.266 Sum_probs=47.3
Q ss_pred HHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCcccccc
Q 013122 18 EHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 69 (449)
Q Consensus 18 ~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~ 69 (449)
..+..++.+++.++.++|. .||+|+||||+||+++ ++.++|+|||.+....
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 6788999999999999999 9999999999999999 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.6e-07 Score=91.70 Aligned_cols=173 Identities=21% Similarity=0.248 Sum_probs=117.1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
...+....+..+.|+.+.+-||..|.+-+|++++|+|+++++.|.|.|=..-....++. .....+|...|.+||+-
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~----~~~cpVg~~eftPPElQ 188 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGT----LHLCPVGVSEFTPPELQ 188 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCc----eEecccCccccCCHHHh
Confidence 36789999999999999999999999999999999999999999999865433322222 23456789999999975
Q ss_pred c-ccCC--CCCCccchhhhHHHHHhhhhC-CCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH-hhhccCCCC
Q 013122 94 G-SFFS--KYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL-SSMRKKKPI 168 (449)
Q Consensus 94 ~-~~~~--~~s~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~-~~~~~~~~~ 168 (449)
. +.+. .-+...|.|.||+++++||.| +.||.|-..... -+.|-...|.... ..+- +.-...++.
T Consensus 189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------ap~p~E~~Ia~g~----f~ya~~~~~g~~p~ 257 (637)
T COG4248 189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------APNPLETDIAHGR----FAYASDQRRGLKPP 257 (637)
T ss_pred ccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-------CCCcchhhhhcce----eeechhccCCCCCC
Confidence 3 2112 345678999999999999986 899987431100 0011111111110 0011 111222333
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhc--CCCCCCCHHH
Q 013122 169 PFSQKFPNANPLALRLLERMLAF--EPKDRPTAEE 201 (449)
Q Consensus 169 ~~~~~~~~~s~~~~dLL~~~L~~--DP~~RpTa~e 201 (449)
+.+--+.-+++.+..|..+|+.. ++.-|||++.
T Consensus 258 P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 258 PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 44444556788999999999974 3678999865
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.9e-08 Score=104.85 Aligned_cols=56 Identities=27% Similarity=0.448 Sum_probs=48.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
++|.+++. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 421 ~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 421 KDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 46666654 357799999999999999999999999999999 677899999999865
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.9e-06 Score=91.71 Aligned_cols=98 Identities=23% Similarity=0.417 Sum_probs=74.9
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
++...+..-++||+.||.||| ..+++|++|.-..|+|+..|..||++|.++.....-... .....---.|..|+.+
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~---~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP---AKSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc---cccchhhhcccChhhc
Confidence 447889999999999999997 678999999999999999999999999988654332211 0111222336677655
Q ss_pred cccCCCCCCccchhhhHHHHHhhhhC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLTG 119 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLltG 119 (449)
.. .. ...|.|-|||+++|++.|
T Consensus 178 ~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cc--cc--cchhhhhHHHHHHHHhCc
Confidence 43 12 457999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.7e-07 Score=98.23 Aligned_cols=156 Identities=24% Similarity=0.232 Sum_probs=110.7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-CCEEEeecCccccccCCCCCcccccccccccccc-Cc
Q 013122 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR-AP 90 (449)
Q Consensus 13 ~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~-AP 90 (449)
..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+....-.. ......-++. ..
T Consensus 361 ~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~------~~~~~~~r~~p~~ 434 (524)
T KOG0601|consen 361 QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS------GVFHHIDRLYPIA 434 (524)
T ss_pred HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec------ccccccccccccc
Confidence 358889999999999999999999999999999999999986 778999999886421111 1122333344 24
Q ss_pred ccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCC
Q 013122 91 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 170 (449)
Q Consensus 91 E~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (449)
|++... ..+..+.|++|||.-+.+.+++.++-...+.... |. . ..
T Consensus 435 ~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~---------------------------~----~~ 479 (524)
T KOG0601|consen 435 EILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IR---------------------------S----GD 479 (524)
T ss_pred hhhccc-cccccccccccccccccccccCcccCccccccee---ee---------------------------c----cc
Confidence 544432 5677899999999999999998865433221100 00 0 00
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 171 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 171 ~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
....+.....+..+.+.++..|+..|+.+.++..|.-|.
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 011122335677889999999999999999998887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.2e-07 Score=82.56 Aligned_cols=54 Identities=28% Similarity=0.343 Sum_probs=47.8
Q ss_pred CCCHHHHHHHHHHHHHHHHHH-HHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
.++.+.+..++.+++.+|..| |..||||+||++.|||+. ++.+.|+|||.+...
T Consensus 120 ~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 120 KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 466677888899999999999 899999999999999997 568999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.25 E-value=2e-06 Score=80.86 Aligned_cols=64 Identities=30% Similarity=0.538 Sum_probs=58.1
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCcccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 67 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~ 67 (449)
+|.+++.....++......++.+|...++-||.+||+|+|+++.|||++.+. .+.|+||+.++.
T Consensus 104 ~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 104 DLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 6888888765688888999999999999999999999999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-06 Score=74.33 Aligned_cols=52 Identities=31% Similarity=0.322 Sum_probs=46.7
Q ss_pred CHHHHHHHHHHHHHHHHHHHHC---CcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 16 TPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 16 s~~~i~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
+......++.+++.+|++||.. +++|+||+|.||+++..+.++|+|||.+..
T Consensus 84 ~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 84 SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 4467788999999999999985 799999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.7e-06 Score=82.45 Aligned_cols=63 Identities=21% Similarity=0.294 Sum_probs=54.2
Q ss_pred cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-------CCCEEEeecCccc
Q 013122 4 DLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDFGLAR 66 (449)
Q Consensus 4 dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-------~~~vKL~DFGlA~ 66 (449)
+|.+++.. ....+......++.+|...+.-||.+||+|+||++.|||++. +..+.|+||+.+.
T Consensus 122 sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 122 SLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred cHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 68888764 235677788899999999999999999999999999999975 4679999999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.2e-05 Score=73.82 Aligned_cols=46 Identities=28% Similarity=0.429 Sum_probs=40.5
Q ss_pred HHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 21 ~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
..+++.|=.-+.-||.+||+|+||.++||++.... +.++|||++..
T Consensus 95 ~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 95 PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 55777777888899999999999999999998765 99999999864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.7e-06 Score=73.41 Aligned_cols=45 Identities=31% Similarity=0.429 Sum_probs=40.3
Q ss_pred HHHHHHHHHHHHHHHHCCc-----ccccccCCcEEEcCCCCEEEeecCccc
Q 013122 21 QFFLYQLLRGLKYIHTANV-----FHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 21 ~~i~~QIl~aL~yLHs~gI-----vHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
..++.+|+.+|+.||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 4567899999999999985 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=6e-05 Score=69.12 Aligned_cols=65 Identities=23% Similarity=0.338 Sum_probs=51.4
Q ss_pred cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC---EEEeecCccccc
Q 013122 4 DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVA 68 (449)
Q Consensus 4 dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGlA~~~ 68 (449)
.+.+++..... ...+....+++.|-+.|.-||.++|||+||..+||++..++. +.|+|||++...
T Consensus 97 ~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 97 TVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred HHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 66777765432 333344789999999999999999999999999999987653 589999998653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.3e-05 Score=80.19 Aligned_cols=48 Identities=31% Similarity=0.422 Sum_probs=41.0
Q ss_pred HHHHHHHHH-HHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 21 QFFLYQLLR-GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 21 ~~i~~QIl~-aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
..++.+++. .+..+|..|++|+|+||.||+++.++.++|+|||++...
T Consensus 259 ~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 259 KALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 345666665 478899999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=8.6e-05 Score=69.95 Aligned_cols=65 Identities=17% Similarity=0.146 Sum_probs=56.2
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC--EEEeecCcccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 67 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--vKL~DFGlA~~ 67 (449)
-||.+++.... +.+......++.+|...|+-||..|+.|+|+-+.|||++.++. ++++||..++.
T Consensus 111 ~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 111 ISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred ccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 47888876642 4688888999999999999999999999999999999987677 99999987654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.60 E-value=5.6e-05 Score=70.18 Aligned_cols=52 Identities=35% Similarity=0.478 Sum_probs=40.8
Q ss_pred HHHHHHHHHHHHHHHHH-HHHCCcccccccCCcEEEcCCCCEEEeecCcccccc
Q 013122 17 PEHYQFFLYQLLRGLKY-IHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 69 (449)
Q Consensus 17 ~~~i~~i~~QIl~aL~y-LHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~ 69 (449)
.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.+....
T Consensus 105 ~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 105 PEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp GSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred chhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 45677888889886555 579999999999999999987 89999999986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0002 Score=80.91 Aligned_cols=163 Identities=18% Similarity=0.280 Sum_probs=109.0
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCC---cEEEcCCCCEEEe--ecCccccccCCCCCcccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK---NILANADCKLKIC--DFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~---NILl~~~~~vKL~--DFGlA~~~~~~~~~~~~~ 78 (449)
+|...+..-..++.+..+.+..++++||+|+|+....|.-|..+ +-..+..+.+.++ ||+...........
T Consensus 272 ~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---- 347 (1351)
T KOG1035|consen 272 ELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---- 347 (1351)
T ss_pred chHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc----
Confidence 56667777778999999999999999999999997666655544 3334445556666 88877654332221
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
.....+..+.++|.............|+|.+|..+..+..|..+-.-.. .+.
T Consensus 348 ~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------~~~---------------------- 399 (1351)
T KOG1035|consen 348 FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA------VPV---------------------- 399 (1351)
T ss_pred hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc------chh----------------------
Confidence 2223445567888776532233345799999999999988764321100 000
Q ss_pred HhhhccCCCCCCCCCCCCCC-HHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNAN-PLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s-~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
...+..+ ....+++.+|+.-|.++|+++.++|.|+|.+--
T Consensus 400 -------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 400 -------------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred -------------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 0001111 156788999999999999999999999998743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00017 Score=77.30 Aligned_cols=47 Identities=28% Similarity=0.504 Sum_probs=39.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC----CEEEeecCccccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVA 68 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGlA~~~ 68 (449)
+.+..+..++.||+ ..|++|+|+||.||+++.++ .++++|||++...
T Consensus 264 la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 264 LAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 55556666666665 58999999999999999988 8999999998655
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0014 Score=68.59 Aligned_cols=133 Identities=19% Similarity=0.214 Sum_probs=95.0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcc
Q 013122 12 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 91 (449)
Q Consensus 12 ~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE 91 (449)
+..++++.+|.++.||..||.+||+.|+.-+-|.+.+||++.+.+++|...|.......+.. |
T Consensus 387 ~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~-----------------~ 449 (655)
T KOG3741|consen 387 NLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT-----------------E 449 (655)
T ss_pred CCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC-----------------c
Confidence 34588999999999999999999999999999999999999998899987776654433320 1
Q ss_pred cccccCCCCCCccchhhhHHHHHhhhhCCCC-CCCCCchhh-HHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCC
Q 013122 92 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQ-LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP 169 (449)
Q Consensus 92 ~l~~~~~~~s~~~DIWSlG~il~eLltG~~p-F~~~~~~~~-l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~ 169 (449)
.+.+ -.+-|.=.||.+++.|.+|..- +........ +..
T Consensus 450 ~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~----------------------------------- 489 (655)
T KOG3741|consen 450 PLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR----------------------------------- 489 (655)
T ss_pred chhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-----------------------------------
Confidence 2222 1356899999999999999632 111111000 111
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 170 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 170 ~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
..+..+.+++++|.-+...++++ -++.++|.+
T Consensus 490 ---I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 490 ---ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 11334667788888888888886 688888875
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0017 Score=61.70 Aligned_cols=43 Identities=23% Similarity=0.444 Sum_probs=37.2
Q ss_pred HHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 23 i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
+...|..++.-||..|++|+|+.|.|++++.++ ++++||+..+
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 446677889999999999999999999998554 9999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0048 Score=57.38 Aligned_cols=31 Identities=23% Similarity=0.384 Sum_probs=26.5
Q ss_pred CCcccccccCCcEEEcC--CCCEEEeecCcccc
Q 013122 37 ANVFHRDLKPKNILANA--DCKLKICDFGLARV 67 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~--~~~vKL~DFGlA~~ 67 (449)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 174 ~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 174 PGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 35799999999999998 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0051 Score=71.63 Aligned_cols=117 Identities=15% Similarity=0.091 Sum_probs=89.9
Q ss_pred CCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccCCcEEEcCCCCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~~----~Ls~~~i~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~ 72 (449)
.|+++++|-+.- .+...-+-....+.+.+..-+|+.. .+|++||+-|.+|..+..+|++++|+.+.....
T Consensus 1315 ~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~- 1393 (2724)
T KOG1826|consen 1315 FGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV- 1393 (2724)
T ss_pred HhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-
Confidence 467888876543 3555555555556578888888642 699999999999999999999999999843222
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCC
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF 123 (449)
..+....++++.|+.+++... -.++.++|+|..||.+|++..|..+|
T Consensus 1394 --~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1394 --LSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred --HhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 223456678889999998876 56777799999999999998888766
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0074 Score=58.83 Aligned_cols=53 Identities=25% Similarity=0.288 Sum_probs=46.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
++.+....++..|++-+.-+-..||||+|+.+-||+++.+|.+.++||-.+..
T Consensus 199 ~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 199 LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 34677778888888888888899999999999999999999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.017 Score=55.69 Aligned_cols=54 Identities=24% Similarity=0.215 Sum_probs=47.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCcccccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 69 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~ 69 (449)
+..+++..+..++++.+.-|-. .|+||+||+.-|||+. ++.+.|+|||.|....
T Consensus 163 ~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 163 LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 4455788899999999999877 9999999999999999 8889999999986543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.025 Score=59.66 Aligned_cols=92 Identities=25% Similarity=0.305 Sum_probs=68.7
Q ss_pred CCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHH
Q 013122 101 TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180 (449)
Q Consensus 101 s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 180 (449)
.+++||||+|.++.++..|..++......+++..|.++.-.+.....-.... .+ .-.++..
T Consensus 109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----~~--------------~~~~d~~ 169 (725)
T KOG1093|consen 109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEH-----LI--------------QLLADKK 169 (725)
T ss_pred CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----HH--------------HHhhhHh
Confidence 3699999999999999999999988888888877777654443322211111 00 0124566
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 181 ~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
...++.+|+-..|..||...++++++-|...
T Consensus 170 ~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 170 RLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7889999999999999999999999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.051 Score=50.40 Aligned_cols=54 Identities=26% Similarity=0.242 Sum_probs=48.6
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs---~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
-++..+..|+.++++.+.+|+. ..+.-.|++++|+-+++++++|++|...+...
T Consensus 56 ~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 56 SPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5799999999999999999997 45888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.096 Score=51.80 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.4
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.93 E-value=0.086 Score=52.42 Aligned_cols=30 Identities=37% Similarity=0.514 Sum_probs=26.8
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988767899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.034 Score=59.93 Aligned_cols=154 Identities=19% Similarity=0.193 Sum_probs=101.4
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccccccC
Q 013122 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 97 (449)
Q Consensus 18 ~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 97 (449)
-+...+++.-+++|++||+.-=+|+| ||+..+ +..|+.||+....+.... ......+++.++|||+...
T Consensus 336 ~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~-- 404 (829)
T KOG0576|consen 336 YQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQE-- 404 (829)
T ss_pred hhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc----ccccCCCCCCCCCchhhcc--
Confidence 34455666677899999998778998 777655 679999999886654432 2255779999999998877
Q ss_pred CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCC-HHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCC
Q 013122 98 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS-PEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176 (449)
Q Consensus 98 ~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~-~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (449)
..+....|.|++|.--.+|.-|-+|-...- ..+. ..|... ... +.. ...|...+.
T Consensus 405 ~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~~p~s~~---L~~--------------~~aw~~~~~- 460 (829)
T KOG0576|consen 405 NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGNGPNSPM---LTD--------------KSAWSPVFH- 460 (829)
T ss_pred cccccCCCccCCCcchhhcCCCCCCCCCCc--cccC----CCCCCCCccc---cch--------------hhhcCcccc-
Confidence 678889999999987667766665543210 0000 000000 000 000 001111111
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 177 ~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.++...|+..-|..|+....++-|.+|.+.
T Consensus 461 -----~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 461 -----RDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred -----cCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 146778999999999999999999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=93.81 E-value=0.048 Score=51.99 Aligned_cols=31 Identities=32% Similarity=0.468 Sum_probs=25.7
Q ss_pred HCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 36 TANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 36 s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
..+++|+|+.+.|||++.+...-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3468999999999999876555799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.12 Score=51.54 Aligned_cols=30 Identities=33% Similarity=0.352 Sum_probs=25.8
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.|+||+|+.+.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999866556899999874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.096 Score=48.70 Aligned_cols=30 Identities=40% Similarity=0.614 Sum_probs=21.2
Q ss_pred CCcccccccCCcEEEc-CCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILAN-ADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~-~~~~vKL~DFGlA~ 66 (449)
..++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 4699999999999999 66667899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.084 Score=50.00 Aligned_cols=30 Identities=30% Similarity=0.388 Sum_probs=26.4
Q ss_pred CCcccccccCCcEEEcC-CCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANA-DCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~ 66 (449)
.+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 36899999999999998 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.27 E-value=0.18 Score=49.84 Aligned_cols=29 Identities=38% Similarity=0.416 Sum_probs=26.0
Q ss_pred CcccccccCCcEEEcCC----CCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANAD----CKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~----~~vKL~DFGlA~ 66 (449)
+++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.21 E-value=0.13 Score=50.66 Aligned_cols=30 Identities=33% Similarity=0.381 Sum_probs=26.6
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.71 E-value=0.11 Score=55.71 Aligned_cols=35 Identities=31% Similarity=0.511 Sum_probs=31.2
Q ss_pred HHCCcccccccCCcEEEcCCCCEEEeecCcccccc
Q 013122 35 HTANVFHRDLKPKNILANADCKLKICDFGLARVAF 69 (449)
Q Consensus 35 Hs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~ 69 (449)
-..|++|.|.+|-||+++.+|++.+.|||+.....
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 34899999999999999999999999999986543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.99 E-value=0.21 Score=49.04 Aligned_cols=51 Identities=25% Similarity=0.296 Sum_probs=39.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHC--CcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 17 PEHYQFFLYQLLRGLKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 17 ~~~i~~i~~QIl~aL~yLHs~--gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
...+...+..+-.++.-++.. -++|+|+.|.|+|.+..+.++|+||..|..
T Consensus 131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344455666666666666655 589999999999999989999999988753
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.59 E-value=0.14 Score=47.53 Aligned_cols=28 Identities=25% Similarity=0.413 Sum_probs=24.9
Q ss_pred cccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 39 VFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 39 IvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
.+|+|+.|.||+++.++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 59999999999998877 99999998743
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.41 E-value=0.27 Score=48.99 Aligned_cols=30 Identities=17% Similarity=0.135 Sum_probs=27.5
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=90.75 E-value=0.16 Score=48.45 Aligned_cols=28 Identities=18% Similarity=0.259 Sum_probs=25.3
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 478999999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.45 E-value=0.17 Score=47.41 Aligned_cols=30 Identities=43% Similarity=0.618 Sum_probs=21.2
Q ss_pred CcccccccCCcEEE-cCCCCEEEeecCcccc
Q 013122 38 NVFHRDLKPKNILA-NADCKLKICDFGLARV 67 (449)
Q Consensus 38 gIvHrDLKP~NILl-~~~~~vKL~DFGlA~~ 67 (449)
.++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 7889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=90.44 E-value=0.19 Score=47.91 Aligned_cols=30 Identities=23% Similarity=0.151 Sum_probs=26.3
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
..++|+|+.|.|||++.+..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 358999999999999987778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.37 E-value=0.24 Score=50.12 Aligned_cols=52 Identities=33% Similarity=0.411 Sum_probs=33.9
Q ss_pred HHHHHHHHHHHHHHHHHHH----HCCcccccccCCcEEEcCC------------------CCEEEeecCccccc
Q 013122 17 PEHYQFFLYQLLRGLKYIH----TANVFHRDLKPKNILANAD------------------CKLKICDFGLARVA 68 (449)
Q Consensus 17 ~~~i~~i~~QIl~aL~yLH----s~gIvHrDLKP~NILl~~~------------------~~vKL~DFGlA~~~ 68 (449)
.+-++.++.||+.-.--+- -.+.+|-||||+|||+-+. -.++|.||.+++..
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3456667777754321122 2468999999999997432 23577888887654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=90.25 E-value=0.19 Score=48.52 Aligned_cols=28 Identities=25% Similarity=0.433 Sum_probs=25.1
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++|+|+.|.||+++.++ +.|+||..|.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 589999999999999877 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.08 E-value=0.47 Score=44.07 Aligned_cols=30 Identities=30% Similarity=0.400 Sum_probs=25.2
Q ss_pred CCcccccccCCcEEEcCCC-----CEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADC-----KLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~-----~vKL~DFGlA~ 66 (449)
..++|||+.+.||++..++ .+.|+||..+.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 4689999999999998643 58999999864
|
subfamily of choline kinases |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.98 E-value=0.35 Score=48.98 Aligned_cols=28 Identities=36% Similarity=0.567 Sum_probs=25.4
Q ss_pred cccccccCCcEEEcCCCC-EEEeecCccc
Q 013122 39 VFHRDLKPKNILANADCK-LKICDFGLAR 66 (449)
Q Consensus 39 IvHrDLKP~NILl~~~~~-vKL~DFGlA~ 66 (449)
|||+|+.|.|||++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998875 8999999763
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=89.37 E-value=0.95 Score=42.38 Aligned_cols=54 Identities=26% Similarity=0.380 Sum_probs=38.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC----CEEEee
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICD 61 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~D 61 (449)
-+|.++++.. .++. . +...|-.-..||-+++|+.+||+|.||++.... .+.|+|
T Consensus 108 ~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 108 PTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 4688888654 4666 3 333344556688899999999999999986532 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=89.24 E-value=0.37 Score=48.96 Aligned_cols=29 Identities=28% Similarity=0.442 Sum_probs=25.5
Q ss_pred CcccccccCCcEEEcC-CCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANA-DCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~-~~~vKL~DFGlA~ 66 (449)
.++|+|+++.|||++. ++.+.|+||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4679999998874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=89.02 E-value=0.64 Score=46.90 Aligned_cols=48 Identities=19% Similarity=0.238 Sum_probs=40.1
Q ss_pred HHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 19 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 19 ~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.+..+...|+.-+.-|-.+|+||+|..-=||++..++.++++||-...
T Consensus 203 d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 203 DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence 344556666667778889999999999999999999999999997654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=88.74 E-value=0.28 Score=48.25 Aligned_cols=30 Identities=33% Similarity=0.570 Sum_probs=25.3
Q ss_pred CcccccccCCcEEEcCCCC-EEEeecCcccc
Q 013122 38 NVFHRDLKPKNILANADCK-LKICDFGLARV 67 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~-vKL~DFGlA~~ 67 (449)
.++|+|+++.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.37 E-value=0.87 Score=45.81 Aligned_cols=28 Identities=36% Similarity=0.387 Sum_probs=23.7
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4689999999999995 4 57899999763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=87.57 E-value=1.1 Score=45.93 Aligned_cols=53 Identities=25% Similarity=0.390 Sum_probs=43.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
-..+++..|+.+.+.-++-+..+ ..-|||+.-.||||+ .|+|.|+||-+++..
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 34677888888877776666654 579999999999999 999999999999843
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=86.27 E-value=0.84 Score=53.14 Aligned_cols=31 Identities=42% Similarity=0.574 Sum_probs=26.3
Q ss_pred CCcccccccCCcEEEcCCC--CEE-EeecCcccc
Q 013122 37 ANVFHRDLKPKNILANADC--KLK-ICDFGLARV 67 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~--~vK-L~DFGlA~~ 67 (449)
.++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=86.11 E-value=0.61 Score=44.59 Aligned_cols=38 Identities=26% Similarity=0.380 Sum_probs=32.5
Q ss_pred HHHHHHHHH--CCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 28 LRGLKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 28 l~aL~yLHs--~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+.+|.-.|+ .+.+|+|-.|+||+.+..|.+||.|-+..
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 566777884 36899999999999999999999998753
|
The function of this family is unknown. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.11 E-value=1.4 Score=44.56 Aligned_cols=38 Identities=34% Similarity=0.381 Sum_probs=27.4
Q ss_pred HHHHHHHHHHHHHHHHHHHH----CCcccccccCCcEEEcCC
Q 013122 17 PEHYQFFLYQLLRGLKYIHT----ANVFHRDLKPKNILANAD 54 (449)
Q Consensus 17 ~~~i~~i~~QIl~aL~yLHs----~gIvHrDLKP~NILl~~~ 54 (449)
.+-+++++.||+.-.-.+-+ .+.+|-||||+|||+-+.
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 35677888888765534433 368999999999997543
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=84.78 E-value=1 Score=52.22 Aligned_cols=32 Identities=22% Similarity=0.360 Sum_probs=25.9
Q ss_pred HCCcccccccCCcEEEcCCC--C---EEEeecCcccc
Q 013122 36 TANVFHRDLKPKNILANADC--K---LKICDFGLARV 67 (449)
Q Consensus 36 s~gIvHrDLKP~NILl~~~~--~---vKL~DFGlA~~ 67 (449)
..|+||+|+.+.|||++.+. . .-|+|||.+..
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 46899999999999998653 3 37999998743
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=84.19 E-value=1.5 Score=44.29 Aligned_cols=28 Identities=32% Similarity=0.464 Sum_probs=24.7
Q ss_pred cccccccCCcEEEcC-CCCEEEeecCccc
Q 013122 39 VFHRDLKPKNILANA-DCKLKICDFGLAR 66 (449)
Q Consensus 39 IvHrDLKP~NILl~~-~~~vKL~DFGlA~ 66 (449)
++|+||.+.|||++. ++.++|+||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 4689999999873
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=83.91 E-value=1.2 Score=41.93 Aligned_cols=41 Identities=34% Similarity=0.461 Sum_probs=35.6
Q ss_pred HHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 20 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 20 i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
...-+.+|++-|..+|..||+-+|+++.|.. .=||+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 4556889999999999999999999999986 2489999965
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.97 E-value=3.1 Score=44.85 Aligned_cols=62 Identities=29% Similarity=0.409 Sum_probs=41.4
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC----CCCEEEeecCcccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFGLARVAF 69 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~----~~~vKL~DFGlA~~~~ 69 (449)
|| +.|.++ .++...+..-+.+... ..|-..|++|+|-+|-||++.. ++.+.|.|||+.....
T Consensus 291 Dl-~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 291 DL-DAIDKR-GISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CH-HHHHHc-CCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 44 445554 3666544444433322 2234578999999999999994 6679999999986553
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=80.57 E-value=2.3 Score=41.72 Aligned_cols=48 Identities=25% Similarity=0.369 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHHHHHHHH------CCcccccccCCcEEEcCC--C---CEEEeecCccc
Q 013122 19 HYQFFLYQLLRGLKYIHT------ANVFHRDLKPKNILANAD--C---KLKICDFGLAR 66 (449)
Q Consensus 19 ~i~~i~~QIl~aL~yLHs------~gIvHrDLKP~NILl~~~--~---~vKL~DFGlA~ 66 (449)
.+..+...++..+..+.. +=|+|||++..|||+..+ | .+++.||-+++
T Consensus 191 ~l~~~~~~~~~~~~~~~~~~~~~~~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 191 KLEALLDKFFERMQELVDPSKEPFNVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred HHHHHHHHHHHHHHHHhccccCCceEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 344444455555555542 138999999999999765 3 58999998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 449 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-67 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-67 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-64 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-64 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-64 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-64 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-64 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-64 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-64 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-64 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-64 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-64 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-64 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-64 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-64 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-64 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-63 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-63 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-63 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-63 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-63 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-63 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-63 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-62 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-62 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-62 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-60 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-59 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-59 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-59 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-59 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-59 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-59 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-59 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-59 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-59 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-59 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-59 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-59 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-59 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-59 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-59 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-59 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-59 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-59 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-59 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-59 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-59 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-59 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-59 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-59 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-59 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-59 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-59 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-59 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-59 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-59 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-59 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-59 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-58 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-58 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-58 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-58 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-58 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-58 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-58 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-58 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-58 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-58 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-58 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-58 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-58 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-58 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-58 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-58 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-58 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-58 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-58 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-58 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-58 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-57 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-57 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-57 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-57 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-57 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-57 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-57 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-57 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-56 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-55 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-55 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-52 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-51 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-51 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-47 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-45 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-43 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-41 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-41 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-41 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-40 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-40 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-40 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-40 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-40 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-40 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-40 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-40 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-40 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-40 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-40 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-40 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-40 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-40 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-40 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-40 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-40 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-40 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-40 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-40 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-39 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-39 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-39 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-39 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-39 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-39 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-39 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-39 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-39 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-39 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-39 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-38 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-38 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-37 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-37 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-35 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-34 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-34 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-34 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-34 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-34 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-33 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-32 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-32 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-31 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-31 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-31 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-31 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-31 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-31 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-31 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-31 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-31 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-31 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-31 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-31 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-31 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-31 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-31 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-31 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-31 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-31 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-31 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-31 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-31 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-31 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-31 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-31 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-31 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-31 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-31 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-31 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-30 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-30 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-30 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-30 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-30 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-30 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-30 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-30 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-30 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-30 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-30 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-30 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-30 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-30 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-30 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-30 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-30 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-30 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-30 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-30 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-30 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-30 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-30 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-30 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-30 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-30 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-30 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-30 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-30 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-30 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-30 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-30 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-30 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-29 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-26 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-26 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-26 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-26 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-26 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-26 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-25 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-25 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-25 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-24 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-21 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-21 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-21 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-21 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-21 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-21 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-21 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-21 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-21 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-21 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-21 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-20 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-20 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-20 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-20 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-19 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-16 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-16 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-16 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-16 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-16 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-16 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-15 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-06 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-06 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-06 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 447 bits (1151), Expect = e-157
Identities = 123/254 (48%), Positives = 169/254 (66%), Gaps = 4/254 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME+DL++++K L+ +H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKIC
Sbjct: 112 METDLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVA D F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNR 229
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
P+FPGK+ + QL+ + +LG+PS E + + N KAR YL S+ K +P+++ FPNA+
Sbjct: 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL LL++ML F P R E+ALA PY + EP A+ +F+ E + KE +
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKL 347
Query: 241 RELIYREILEYHPQ 254
+ELI+ E + P
Sbjct: 348 KELIFEETARFQPG 361
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 434 bits (1119), Expect = e-152
Identities = 106/259 (40%), Positives = 159/259 (61%), Gaps = 12/259 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M++DLH+VI L+ +H Q+F+YQ LR +K +H +NV HRDLKP N+L N++C LK+C
Sbjct: 96 MQTDLHRVISTQM-LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVC 154
Query: 61 DFGLARVAFND-------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
DFGLAR+ T ++VATRWYRAPE+ + +KY+ A+D+WS GCI
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCIL 213
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA-IARVRNEKARRYLSSMRKKKPIPFSQ 172
AEL +P+FPG++ HQL ++ ++GTP + + + + +AR Y+ S+ P +
Sbjct: 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK 273
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF-- 230
FP NP + LL+RML F+P R TA+EAL PY + EP +P+ FEF
Sbjct: 274 MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDH 333
Query: 231 ERRRITKEDVRELIYREIL 249
+ +T +D+++LI+ EI
Sbjct: 334 YKEALTTKDLKKLIWNEIF 352
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-149
Identities = 106/265 (40%), Positives = 159/265 (60%), Gaps = 11/265 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL +++K L + QF +YQ+L+GL+YIH A + HRDLKP N+ N DC+LKI
Sbjct: 112 MGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A ++ T YV TRWYRAPE+ ++ +YT +DIWS+GCI AE++TGK
Sbjct: 171 DFGLARQADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGK 223
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LF G + + QL + + GTP E + R+++++A+ Y+ + + + F+ NA+PL
Sbjct: 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 283
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML + + R TA EALA PYF+ L E EP Q + F+ T ++
Sbjct: 284 AVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDDSFDDVDRTLDEW 340
Query: 241 RELIYREILEYHPQMLKEFLEGSEP 265
+ + Y+E+L + P E
Sbjct: 341 KRVTYKEVLSFKPPRQLGARVSKET 365
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-148
Identities = 104/253 (41%), Positives = 153/253 (60%), Gaps = 11/253 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M++DL +++ + E Q+ +YQ+L+GLKYIH+A V HRDLKP N+ N DC+LKI
Sbjct: 111 MQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A + T YV TRWYRAPE+ S+ Y +DIWS+GCI AE+LTGK
Sbjct: 169 DFGLARHADAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGK 221
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LF GK+ + QL + + G P E + ++ ++ A+ Y+ S+ + F+Q FP A+P
Sbjct: 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ 281
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A LLE+ML + R TA +AL P+F+ E E AQ + E ++T ++
Sbjct: 282 AADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEW 339
Query: 241 RELIYREILEYHP 253
++ IY+EI+ + P
Sbjct: 340 KQHIYKEIVNFSP 352
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-148
Identities = 112/258 (43%), Positives = 159/258 (61%), Gaps = 11/258 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL+ ++K LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI
Sbjct: 116 MGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR + T YVATRWYRAPE+ ++ Y +DIWS+GCI AELLTG+
Sbjct: 175 DFGLARHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGR 227
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LFPG + + QL ++ L+GTP E + ++ +E AR Y+ S+ + + F+ F ANPL
Sbjct: 228 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 287
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML + R TA +ALA YF + EP A P + E R + ++
Sbjct: 288 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEW 344
Query: 241 RELIYREILEYHPQMLKE 258
+ L Y E++ + P L +
Sbjct: 345 KSLTYDEVISFVPPPLDQ 362
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 423 bits (1090), Expect = e-147
Identities = 90/254 (35%), Positives = 132/254 (51%), Gaps = 10/254 (3%)
Query: 1 MESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
M +DL QVI ++P+H Q+F+Y +L GL +H A V HRDL P NIL + + I
Sbjct: 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
CDF LAR D T YV RWYRAPEL F +T +D+WS GC+ AE+
Sbjct: 176 CDFNLAREDTADA----NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNR 230
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL-SSMRKKKPIPFSQKFPNAN 178
K LF G +QL+ + +++GTP E + + AR YL +S+ ++ P A+
Sbjct: 231 KALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
P+AL L+ +ML F P+ R + E+AL PYF+ L F F+
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLS---ERFHFDESVTDVY 347
Query: 239 DVRELIYREILEYH 252
D+ ++ E+ ++
Sbjct: 348 DMHKIFTAEVERFN 361
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 424 bits (1093), Expect = e-147
Identities = 103/315 (32%), Positives = 154/315 (48%), Gaps = 49/315 (15%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+SDL ++ K LT EH + LY LL G +IH + + HRDLKP N L N DC +K+C
Sbjct: 112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVC 171
Query: 61 DFGLARVAFNDTPTAI-------------------FWTDYVATRWYRAPELCGSFFSKYT 101
DFGLAR ++ T I T +V TRWYRAPEL YT
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYT 230
Query: 102 PAIDIWSIGCIFAELLTG-----------KPLFPG-----------------KNVVHQLD 133
+IDIWS GCIFAELL PLFPG K+ QL+
Sbjct: 231 KSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLN 290
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
I+ +++GTP+ + + + + +Y+ +KPI QK+P+ + + LLE ML F P
Sbjct: 291 IIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNP 350
Query: 194 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 253
R T ++AL PY K + K + E + + F+ + +++ +R + +E+ +HP
Sbjct: 351 NKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHP 409
Query: 254 QMLKEFLEGSEPTGF 268
+++ + F
Sbjct: 410 ELVIPSVFTIHENNF 424
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-145
Identities = 103/299 (34%), Positives = 159/299 (53%), Gaps = 39/299 (13%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME+DLH VI+AN L P H Q+ +YQL++ +KY+H+ + HRD+KP NIL NA+C +K+
Sbjct: 93 METDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVA 151
Query: 61 DFGLARV------------------AFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYT 101
DFGL+R N TDYVATRWYRAPE L GS +KYT
Sbjct: 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS--TKYT 209
Query: 102 PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161
ID+WS+GCI E+L GKP+FPG + ++QL+ + ++ PS E + +++ A+ + S
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
Query: 162 MRKKKPIPFSQKF----------------PNANPLALRLLERMLAFEPKDRPTAEEALAD 205
+++K I S K + N AL LL+++L F P R +A +AL
Sbjct: 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329
Query: 206 PYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSE 264
P+ EP+ + + + + + +D R L+Y EI +++ + +
Sbjct: 330 PFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISNKHQNVQ 387
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 403 bits (1037), Expect = e-139
Identities = 93/266 (34%), Positives = 140/266 (52%), Gaps = 22/266 (8%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+++L QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI
Sbjct: 112 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G
Sbjct: 170 DFGLARTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 223
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA--- 177
LFPG + + Q + + + LGTP PE + ++ R Y+ + K F + FP+
Sbjct: 224 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFP 282
Query: 178 ---------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228
A LL +ML + R + +EAL PY + P +
Sbjct: 283 ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPP-KIPDK 341
Query: 229 EFERRRITKEDVRELIYREILEYHPQ 254
+ + R T E+ +ELIY+E+++
Sbjct: 342 QLDEREHTIEEWKELIYKEVMDLEHH 367
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 402 bits (1034), Expect = e-137
Identities = 95/285 (33%), Positives = 149/285 (52%), Gaps = 22/285 (7%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+++L QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI
Sbjct: 149 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K
Sbjct: 207 DFGLARTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHK 260
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA--- 177
LFPG++ + Q + + + LGTP PE + ++ R Y+ + K + F + FP++
Sbjct: 261 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFP 319
Query: 178 ---------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228
A LL +ML +P R + ++AL PY A P +
Sbjct: 320 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDK 378
Query: 229 EFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSA 273
+ + R T E+ +ELIY+E++ + ++G ++
Sbjct: 379 QLDEREHTIEEWKELIYKEVMNSEEKTKNGVVKGQPSPSGAAVNS 423
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-137
Identities = 107/310 (34%), Positives = 151/310 (48%), Gaps = 57/310 (18%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+SD ++ + LT H + LY LL G+KY+H+A + HRDLKP N L N DC +K+C
Sbjct: 139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198
Query: 61 DFGLARVA------------------------FNDTPTAIFWTDYVATRWYRAPELCGSF 96
DFGLAR + T +V TRWYRAPEL
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL- 257
Query: 97 FSKYTPAIDIWSIGCIFAELLT-----------GKPLFPGKNVV---------------- 129
YT AID+WSIGCIFAELL PLFPG +
Sbjct: 258 QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHT 317
Query: 130 ----HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 185
QL+++ ++LGTPS E I + E A+RY+ K++ +++FP ++ A+ LL
Sbjct: 318 RGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLL 377
Query: 186 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIY 245
+RML F P R T E LA P+FK + E E +A ++ F + + + +R
Sbjct: 378 KRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFV 436
Query: 246 REILEYHPQM 255
+EI YHP++
Sbjct: 437 KEIQRYHPEI 446
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 388 bits (1000), Expect = e-134
Identities = 91/219 (41%), Positives = 127/219 (57%), Gaps = 4/219 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKI 59
ME+DL V++ L EH + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI
Sbjct: 104 METDLANVLEQGP-LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFGLAR+ ++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTG
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTG 221
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
K LF G + + Q+ ++ + + E + + Y+ + + P +Q P +
Sbjct: 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 218
A+ LE++L F P DR TAEEAL+ PY + EP
Sbjct: 281 EAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 354 bits (910), Expect = e-120
Identities = 86/261 (32%), Positives = 127/261 (48%), Gaps = 22/261 (8%)
Query: 1 MESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN-A 53
+ LH+ + P + FL+QL+R + +H + NV HRD+KP N+L N A
Sbjct: 108 VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167
Query: 54 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
D LK+CDFG A+ P Y+ +R+YRAPEL YT A+DIWS+GCIF
Sbjct: 168 DGTLKLCDFGSAKKLSPSEPN----VAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIF 222
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
AE++ G+P+F G N QL + +LG PS E + ++ L K IP+S
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDL---YNSKGIPWSNV 279
Query: 174 F----PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE-PSAQPVTKMEF 228
F A LL +L + P++R EAL PYF L + P+ + + + F
Sbjct: 280 FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLF 339
Query: 229 EFERR--RITKEDVRELIYRE 247
F + E + + R+
Sbjct: 340 RFLPNEIEVMSEAQKAKLVRK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 337 bits (865), Expect = e-113
Identities = 83/263 (31%), Positives = 131/263 (49%), Gaps = 28/263 (10%)
Query: 1 MESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DC 55
+ LH+V+ ++ + ++YQL R + +IH+ + HRD+KP+N+L N+ D
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 56 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 114
LK+CDFG A+ P+ Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF 174
EL+ GKPLF G+ + QL + ++GTP+ E + R+ K + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP---TLKAKDWRKIL 290
Query: 175 PNANP-LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME------ 227
P P LA+ LLE++L +EP R EA+A P+F L
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 228 ---FEF---ERRRITKEDVRELI 244
F F E I + ++
Sbjct: 351 PQLFNFSPYELSIIPGNVLNRIL 373
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 335 bits (860), Expect = e-112
Identities = 91/290 (31%), Positives = 144/290 (49%), Gaps = 25/290 (8%)
Query: 1 MESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC- 55
+ +++ K + + ++YQLLR L YIH+ + HRD+KP+N+L +
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179
Query: 56 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFA 114
LK+ DFG A++ P Y+ +R+YRAPEL G+ + YT IDIWS GC+ A
Sbjct: 180 VLKLIDFGSAKILIAGEPN----VSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMA 233
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF 174
EL+ G+PLFPG++ + QL + +LGTPS E I + + +P PFS+ F
Sbjct: 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP---QIRPHPFSKVF 290
Query: 175 -PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE-REPSAQPVTKM-EFEFE 231
P P A+ L+ R+L + P R TA EAL P+F L E R P+ + + + + E
Sbjct: 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKE 350
Query: 232 RRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQF 281
+ + + L+ H + + G + F P ++ K
Sbjct: 351 ELSVRPDLISRLVP-----QHAEA-ELLSRGIDVHNFQ-PIPLESLKVTL 393
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-105
Identities = 84/253 (33%), Positives = 126/253 (49%), Gaps = 18/253 (7%)
Query: 1 MESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC- 55
+ +++V + A L + + ++YQL R L YIH+ + HRD+KP+N+L + D
Sbjct: 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194
Query: 56 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFA 114
LK+CDFG A+ P Y+ +R+YRAPEL G+ + YT +ID+WS GC+ A
Sbjct: 195 VLKLCDFGSAKQLVRGEPN----VSYICSRYYRAPELIFGA--TDYTSSIDVWSAGCVLA 248
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF 174
ELL G+P+FPG + V QL + +LGTP+ E I + + K P+++ F
Sbjct: 249 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP---QIKAHPWTKVF 305
Query: 175 -PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 233
P P A+ L R+L + P R T EA A +F L + T F F +
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 365
Query: 234 --RITKEDVRELI 244
LI
Sbjct: 366 ELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 4e-99
Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 16/223 (7%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKI 59
+D Q+ + LT +F++Y++L+ L Y H+ + HRD+KP N++ + KL++
Sbjct: 116 NNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 172
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
D+GLA + VA+R+++ PEL + Y ++D+WS+GC+ A ++
Sbjct: 173 IDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFR 227
Query: 120 K-PLFPGKNVVHQLDIMTDLLGTPSPEA-IARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
K P F G + QL + +LGT I + E R+ + + + + +
Sbjct: 228 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE 287
Query: 178 N-----PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215
N P AL L+++L ++ + R TA EA+ PYF + K +
Sbjct: 288 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 3e-91
Identities = 75/224 (33%), Positives = 114/224 (50%), Gaps = 7/224 (3%)
Query: 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
+ + + + + +Q L+ + + H N HRD+KP+NIL +K+
Sbjct: 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKL 143
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
CDFG AR P+ + D VATRWYR+PE L G ++Y P +D+W+IGC+FAELL+
Sbjct: 144 CDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLVGD--TQYGPPVDVWAIGCVFAELLS 198
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
G PL+PGK+ V QL ++ LG P + + + P KFPN +
Sbjct: 199 GVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNIS 258
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 222
AL LL+ L +P +R T E+ L PYF+ + ++E
Sbjct: 259 YPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 7e-85
Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 7/211 (3%)
Query: 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
++ + ++ + L + Q +L+Q++ G+ + H+ N+ HRD+KP+NIL + +K+
Sbjct: 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKL 165
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLT 118
CDFG AR P ++ D VATRWYRAPEL G KY A+D+W+IGC+ E+
Sbjct: 166 CDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLVGD--VKYGKAVDVWAIGCLVTEMFM 220
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
G+PLFPG + + QL + LG P + K+ P +++P +
Sbjct: 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ + L ++ L +P RP E L +F+
Sbjct: 281 EVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-79
Identities = 85/211 (40%), Positives = 120/211 (56%), Gaps = 9/211 (4%)
Query: 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
++ DL +++ L + FL QLL G+ Y H V HRDLKP+N+L N + +LKI
Sbjct: 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKI 141
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR AF P + T + T WYRAP+ L GS KY+ IDIWS+GCIFAE++
Sbjct: 142 ADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDVLMGS--KKYSTTIDIWSVGCIFAEMVN 196
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
G PLFPG + QL + +LGTP+ + V + +Y + +P+P+ +
Sbjct: 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--ELPKYDPNFTVYEPLPWESFLKGLD 254
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ LL +ML +P R TA++AL YFK
Sbjct: 255 ESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 6e-79
Identities = 93/218 (42%), Positives = 125/218 (57%), Gaps = 14/218 (6%)
Query: 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
ME DL +V+ L + +LYQLLRG+ + H + HRDLKP+N+L N+D LK+
Sbjct: 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR AF P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++T
Sbjct: 161 ADFGLAR-AFGI-PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMIT 215
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEA---IARVRNEKARRYLSSMRKKKPIPFSQKFP 175
GKPLFPG QL + +LGTP+P + + K R + + + P+S P
Sbjct: 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIP 271
Query: 176 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213
+ LL ML F+P R +A +A+ PYFK L
Sbjct: 272 GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 9e-79
Identities = 87/243 (35%), Positives = 128/243 (52%), Gaps = 18/243 (7%)
Query: 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
++ DL Q + + + + + FL+QLLRGL Y H V HRDLKP+N+L N +LK+
Sbjct: 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKL 141
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLAR A + PT + + V T WYR P+ L GS + Y+ ID+W +GCIF E+ T
Sbjct: 142 ADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILLGS--TDYSTQIDMWGVGCIFYEMAT 196
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEA---IARVRNEKARRYLSSMRKKKPIPFSQKFP 175
G+PLFPG V QL + +LGTP+ E I K Y K + P
Sbjct: 197 GRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY----PKYRAEALLSHAP 252
Query: 176 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL----AKVEREPSAQPVTKMEFEFE 231
+ LL ++L FE ++R +AE+A+ P+F L K+ S + +++ + E
Sbjct: 253 RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKE 312
Query: 232 RRR 234
Sbjct: 313 ASL 315
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 8e-78
Identities = 72/215 (33%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 1 MESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
++ DL + L E + + Q LRGL ++H + HRDLKP+NIL + +K
Sbjct: 101 VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELL 117
+ DFGLAR ++ T V T WYRAPE L S Y +D+WS+GCIFAE+
Sbjct: 161 LADFGLAR-IYSYQMA---LTPVVVTLWYRAPEVLLQS---TYATPVDMWSVGCIFAEMF 213
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPE---AIARVRNEKARRYLSSMRKKKPIPFSQKF 174
KPLF G + QL + DL+G P + + + + P P
Sbjct: 214 RRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR-------GAFPPRGPRPVQSVV 266
Query: 175 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
P +LL ML F P R +A AL Y
Sbjct: 267 PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-77
Identities = 81/234 (34%), Positives = 117/234 (50%), Gaps = 15/234 (6%)
Query: 1 MESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
++ DL + + E + ++QLLRGL ++H+ V HRDLKP+NIL + ++K
Sbjct: 101 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 160
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELL 117
+ DFGLAR ++ T V T WYRAPE L S Y +D+WS+GCIFAE+
Sbjct: 161 LADFGLAR-IYSFQMA---LTSVVVTLWYRAPEVLLQS---SYATPVDLWSVGCIFAEMF 213
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
KPLF G + V QL + D++G P E R + K P + +
Sbjct: 214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP----RQAFHSKSAQPIEKFVTDI 269
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK-VEREPSAQPVTKMEFEF 230
+ L LL + L F P R +A AL+ PYF+ L + E S P ++ E
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSEL 323
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-77
Identities = 80/214 (37%), Positives = 115/214 (53%), Gaps = 16/214 (7%)
Query: 1 MESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
ME+DL +IK N LTP H + ++ L+GL+Y+H + HRDLKP N+L + + LK+
Sbjct: 94 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL 153
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFGLA+ +F P + T V TRWYRAPE L G+ Y +D+W++GCI AELL
Sbjct: 154 ADFGLAK-SFGS-PNRAY-THQVVTRWYRAPELLFGA--RMYGVGVDMWAVGCILAELLL 208
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEA---IARVRNEKARRYLSSMRKKKPIPFSQKFP 175
P PG + + QL + + LGTP+ E + + + + + IP F
Sbjct: 209 RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV------TFKSFPGIPLHHIFS 262
Query: 176 NANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
A L L++ + F P R TA +AL YF
Sbjct: 263 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 5e-77
Identities = 88/214 (41%), Positives = 117/214 (54%), Gaps = 10/214 (4%)
Query: 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
+ DL + + N DL PE + FL+QLL+GL + H+ NV HRDLKP+N+L N + +LK+
Sbjct: 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 118
+FGLAR AF P + + V T WYR P+ L G+ Y+ +ID+WS GCIFAEL
Sbjct: 143 ANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDVLFGA--KLYSTSIDMWSAGCIFAELAN 197
Query: 119 -GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA 177
G+PLFPG +V QL + LLGTP+ E + K Y P
Sbjct: 198 AGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--KLPDYKPYPMYPATTSLVNVVPKL 255
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
N LL+ +L P R +AEEAL PYF
Sbjct: 256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-75
Identities = 80/218 (36%), Positives = 111/218 (50%), Gaps = 14/218 (6%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---- 56
E+DL + + N D++ + FLYQL+ G+ + H+ HRDLKP+N+L +
Sbjct: 115 AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETP 174
Query: 57 -LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFA 114
LKI DFGLAR AF P F T + T WYR PE L GS Y+ ++DIWSI CI+A
Sbjct: 175 VLKIGDFGLAR-AFGI-PIRQF-THEIITLWYRPPEILLGS--RHYSTSVDIWSIACIWA 229
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF 174
E+L PLFPG + + QL + ++LG P V + S K + +
Sbjct: 230 EMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV--TALPDWKQSFPKFRGKTLKRVL 287
Query: 175 PNA-NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
+ L LL ML +P R +A+ AL PYF
Sbjct: 288 GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 8e-75
Identities = 82/223 (36%), Positives = 121/223 (54%), Gaps = 19/223 (8%)
Query: 1 MESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 54
M++DL + + + L ++F +QLL+GL + H + HRDLKP+N+L N
Sbjct: 85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR 144
Query: 55 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIF 113
+LK+ DFGLAR AF P F + V T WYRAP+ L GS Y+ +IDIWS GCI
Sbjct: 145 GQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLWYRAPDVLMGS--RTYSTSIDIWSCGCIL 199
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
AE++TGKPLFPG N QL ++ D++GTP+ V K +Y +++++ P Q
Sbjct: 200 AEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV--TKLPKYNPNIQQRPPRDLRQV 257
Query: 174 FPNA-----NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
+ + L +L P R +A++AL P+F
Sbjct: 258 LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-73
Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 21/247 (8%)
Query: 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
E DL ++ T + + LL GL YIH + HRD+K N+L D LK+
Sbjct: 106 CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 165
Query: 60 CDFGLARVAFNDTPTAIFWTDY---VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAE 115
DFGLAR AF+ Y V T WYR PE L G Y P ID+W GCI AE
Sbjct: 166 ADFGLAR-AFSL-AKNSQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAE 221
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA---IARVRNEKARRYLSSMRKKKPIPFSQ 172
+ T P+ G HQL +++ L G+ +PE + + K +
Sbjct: 222 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL----VKGQKRKVKD 277
Query: 173 KFPN--ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL---AKVEREPSAQPVTKME 227
+ +P AL L++++L +P R +++AL +F + ++ S + E
Sbjct: 278 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFE 337
Query: 228 FEFERRR 234
+ RR
Sbjct: 338 YLAPPRR 344
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-65
Identities = 86/277 (31%), Positives = 125/277 (45%), Gaps = 46/277 (16%)
Query: 1 MESDLHQVIKANDD---------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 51
E DL +IK + L + LYQ+L G+ Y+H V HRDLKP NIL
Sbjct: 102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 161
Query: 52 NADCK----LKICDFGLARVAFNDTPTAIF--WTDYVATRWYRAPE-LCGSFFSKYTPAI 104
+ +KI D G AR FN P V T WYRAPE L G+ YT AI
Sbjct: 162 MGEGPERGRVKIADMGFAR-LFNS-PLKPLADLDPVVVTFWYRAPELLLGA--RHYTKAI 217
Query: 105 DIWSIGCIFAELLTGKPLFPGKN---------VVHQLDIMTDLLGTPS----------PE 145
DIW+IGCIFAELLT +P+F + QLD + +++G P+ PE
Sbjct: 218 DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPE 277
Query: 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205
+++ + Y + K + + A LL+++L +P R T+E+A+ D
Sbjct: 278 HSTLMKDFRRNTYTNCSLIK---YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334
Query: 206 PYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 242
PYF P++ + + +R E+ +
Sbjct: 335 PYFLEDPL----PTSDVFAGCQIPYPKREFLTEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 69/313 (22%), Positives = 117/313 (37%), Gaps = 53/313 (16%)
Query: 1 MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-----ANAD 54
+ L + ++ D L Q GL ++H+ N+ HRDLKP NIL A+
Sbjct: 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGK 159
Query: 55 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIF 113
K I DFGL + + + T + APE L T +DI+S GC+F
Sbjct: 160 IKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
+++ GK++ Q +I+ +
Sbjct: 220 YYVISEGSHPFGKSLQRQANIL---------------------------LGACSLDCLHP 252
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK-----------VEREPSAQP 222
+ + +A L+E+M+A +P+ RP+A+ L P+F L K +E+E P
Sbjct: 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGP 312
Query: 223 VTKMEFEFERRRITKEDVRELIYREILE-------YHPQMLKEFLEGSEPTGFMYPSAVD 275
+ K + E R + K D RE I + Y +++ L Y
Sbjct: 313 IVK-QLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPA 371
Query: 276 HFKKQFAYLEEHY 288
++ L + +
Sbjct: 372 EVRETLGTLPDDF 384
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 69/243 (28%), Positives = 112/243 (46%), Gaps = 42/243 (17%)
Query: 1 MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCK 56
+ +L+++IK N + + F + +L+ L +H + H DLKP+NIL
Sbjct: 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAE 115
+K+ DFG + T Y+ +R+YRAPE + G+ +Y ID+WS+GCI AE
Sbjct: 241 IKVIDFGSSCYEHQRVYT------YIQSRFYRAPEVILGA---RYGMPIDMWSLGCILAE 291
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN-------------------EKAR 156
LLTG PL PG++ QL M +LLG PS + + +
Sbjct: 292 LLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGS 351
Query: 157 RYLSSMRKK----KPIPFSQKFPNANPLALR-----LLERMLAFEPKDRPTAEEALADPY 207
L+ R + + P S+++ NA L++ L ++P R T +AL P+
Sbjct: 352 VVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411
Query: 208 FKG 210
+
Sbjct: 412 LRR 414
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 55/252 (21%), Positives = 92/252 (36%), Gaps = 60/252 (23%)
Query: 5 LHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL------------ 50
L+++I N+ E + + ++L+ L Y+ ++ H DLKP+NIL
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181
Query: 51 -------------ANADCKLKICDFGLARVAFNDTPTAIFWTD----YVATRWYRAPE-L 92
+K+ DFG A F +D + TR YRAPE +
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFG----------CATFKSDYHGSIINTRQYRAPEVI 231
Query: 93 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152
+ + D+WS GC+ AEL TG LF + L +M ++ +
Sbjct: 232 LNL---GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATK 288
Query: 153 EKARRYL-------------SSMRKKKPIPFSQKFPNA--NPLALRLLERMLAFEPKDRP 197
+Y+ SS+ K + + L L +L +P RP
Sbjct: 289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348
Query: 198 TAEEALADPYFK 209
+ E L + +
Sbjct: 349 SPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-46
Identities = 68/259 (26%), Positives = 98/259 (37%), Gaps = 54/259 (20%)
Query: 5 LHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL------------ 50
+ +K N+ H + YQL L+++H + H DLKP+NIL
Sbjct: 108 TFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167
Query: 51 -------ANADCKLKICDFGLARVAFNDTPTAIFWTD----YVATRWYRAPE-LCGSFFS 98
+ + +++ DFG +A F + VATR YR PE +
Sbjct: 168 HKSCEEKSVKNTSIRVADFG----------SATFDHEHHTTIVATRHYRPPEVILEL--- 214
Query: 99 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK---- 154
+ D+WSIGCI E G LF L +M +LG I R R +K
Sbjct: 215 GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYK 274
Query: 155 --ARRYLSSMRKKKPIPFSQKFPNA-------NPLALRLLERMLAFEPKDRPTAEEALAD 205
+S + + + + L+ RML F+P R T EAL
Sbjct: 275 GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334
Query: 206 PYFKGLAKVER--EPSAQP 222
P+F GL ER S P
Sbjct: 335 PFFAGLTPEERSFHTSRNP 353
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 5e-46
Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 47/251 (18%)
Query: 1 MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHT--ANVFHRDLKPKNIL--ANAD 54
+ +L+ +++ + ++ + F Q+ L ++ T ++ H DLKP+NIL
Sbjct: 138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 55 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 114
+KI DFG + Y+ +R+YR+PE+ Y AID+WS+GCI
Sbjct: 198 SAIKIVDFGSSCQLGQRIYQ------YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILV 249
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK-----------ARRYLSSMR 163
E+ TG+PLF G N V Q++ + ++LG P + + + + +
Sbjct: 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGK 309
Query: 164 KKKPIPFSQKFPNANPLALR----------------------LLERMLAFEPKDRPTAEE 201
++ P ++K N + L+ RML ++PK R
Sbjct: 310 REYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369
Query: 202 ALADPYFKGLA 212
AL +FK A
Sbjct: 370 ALQHSFFKKTA 380
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 63/252 (25%), Positives = 100/252 (39%), Gaps = 60/252 (23%)
Query: 5 LHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL------------ 50
+ IK N +H + YQ+ + + ++H+ + H DLKP+NIL
Sbjct: 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162
Query: 51 -------ANADCKLKICDFGLARVAFNDTPTAIFWTD----YVATRWYRAPE-LCGSFFS 98
+ +K+ DFG +A + + V+TR YRAPE +
Sbjct: 163 KIKRDERTLINPDIKVVDFG----------SATYDDEHHSTLVSTRHYRAPEVILAL--- 209
Query: 99 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK---- 154
++ D+WSIGCI E G +FP + L +M +LG I + R K
Sbjct: 210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHH 269
Query: 155 ----------ARRYLSSMRKKKPIPFSQKFPNANP---LALRLLERMLAFEPKDRPTAEE 201
A RY + P + + + L+++ML ++P R T E
Sbjct: 270 DRLDWDEHSSAGRY----VSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
Query: 202 ALADPYFKGLAK 213
AL P+F L K
Sbjct: 326 ALKHPFFDLLKK 337
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-45
Identities = 60/251 (23%), Positives = 95/251 (37%), Gaps = 37/251 (14%)
Query: 1 MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN----- 52
+ +L +IK + + + + QLL GL Y+H + H D+KP+N+L
Sbjct: 112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171
Query: 53 -ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIG 110
++KI D G A T+ + TR YR+PE L G+ + DIWS
Sbjct: 172 ENLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGA---PWGCGADIWSTA 222
Query: 111 CIFAELLTGKPLFPGKNV------VHQLDIMTDLLGTPSPEAIARVR------NEKARRY 158
C+ EL+TG LF + + +LLG + + N +
Sbjct: 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282
Query: 159 LSSMRKKKP----IPFSQKFPNANPLALR-LLERMLAFEPKDRPTAEEALADPYFKG-LA 212
S K P + KF + L ML +P+ R A + P+ K L
Sbjct: 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342
Query: 213 KVEREPSAQPV 223
E + +
Sbjct: 343 MEEIRVPDREL 353
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 159 bits (402), Expect = 1e-44
Identities = 35/227 (15%), Positives = 65/227 (28%), Gaps = 38/227 (16%)
Query: 1 MESDLHQVIKANDDLTPEHY-------QFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 53
DL + D + QL+R + + + H P N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP 229
Query: 54 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
D +L + D P Y E + + +T A++ W +G
Sbjct: 230 DGRLMLGDVSALWKVGTRGPA------SSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
+ F + L P +++ + P+P
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL-------------AFGSCTPLP---- 326
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 220
L+ R L F+ + R EA+ P F +++ E S+
Sbjct: 327 -----DFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEISS 365
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-44
Identities = 59/233 (25%), Positives = 86/233 (36%), Gaps = 43/233 (18%)
Query: 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 61
DL+ +K + P + + +L + IH + H DLKP N L D LK+ D
Sbjct: 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 169
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCI 112
FG+A DT T++ V T Y PE G SK +P D+WS+GCI
Sbjct: 170 FGIANQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 113 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172
+ GK F +Q+ + AI + I F
Sbjct: 229 LYYMTYGKTPFQQII--NQISKL---------HAI--------------IDPNHEIEFP- 262
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 225
+L+ L +PK R + E LA PY +++ P Q
Sbjct: 263 --DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-42
Identities = 60/246 (24%), Positives = 91/246 (36%), Gaps = 42/246 (17%)
Query: 1 ME---SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 57
ME DL+ +K + P + + +L + IH + H DLKP N L D L
Sbjct: 88 MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGML 146
Query: 58 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWS 108
K+ DFG+A DT T++ V T Y PE G SK +P D+WS
Sbjct: 147 KLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 205
Query: 109 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPI 168
+GCI + GK F +Q+ + AI + I
Sbjct: 206 LGCILYYMTYGKTPFQQII--NQISKL---------HAI--------------IDPNHEI 240
Query: 169 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228
F +L+ L +PK R + E LA PY + + + +M++
Sbjct: 241 EFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKY 297
Query: 229 EFERRR 234
+
Sbjct: 298 VLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 57/242 (23%), Positives = 89/242 (36%), Gaps = 39/242 (16%)
Query: 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 61
DL+ +K + P + + +L + IH + H DLKP N L D LK+ D
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 197
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCI 112
FG+A DT T++ V Y PE G SK +P D+WS+GCI
Sbjct: 198 FGIANQMQPDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
Query: 113 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172
+ GK F ++ ++ L AI + I F
Sbjct: 257 LYYMTYGKTPFQ-----QIINQISKL------HAI--------------IDPNHEIEFP- 290
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFER 232
+L+ L +PK R + E LA PY + + + +M++ +
Sbjct: 291 --DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 348
Query: 233 RR 234
Sbjct: 349 LV 350
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 50/227 (22%)
Query: 1 ME----SDLHQVIKANDDLTPEHYQ---FFLYQLLRGLKYIHTANVFHRDLKPKNILANA 53
M+ +L + L + Q+ ++++H+ + HRDLKP NI
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199
Query: 54 DCKLKICDFGLARVAFND---------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAI 104
D +K+ DFGL D P T V T+ Y +PE + Y+ +
Sbjct: 200 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--NNYSHKV 257
Query: 105 DIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 164
DI+S+G I ELL E+ R
Sbjct: 258 DIFSLGLILFELLY--SFSTQ--------------------------MERVRIITDVRNL 289
Query: 165 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
K P+ F+QK+P + +++ ML+ P +RP A + + + F+ L
Sbjct: 290 KFPLLFTQKYPQEH----MMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 51/219 (23%), Positives = 78/219 (35%), Gaps = 49/219 (22%)
Query: 4 DLHQVIK-ANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 61
L Q I+ + + Q+ +G+ YIH+ + +RDLKP NI ++KI D
Sbjct: 106 TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 120
FGL ND T Y +PE S Y +D++++G I AELL
Sbjct: 166 FGLVTSLKNDGKRTRS----KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCD 219
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNAN 178
F L + I F +K
Sbjct: 220 TAFETSKFFTDL-------------------------------RDGIISDIFDKKEKT-- 246
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217
LL+++L+ +P+DRP E L + + E
Sbjct: 247 -----LLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 53/230 (23%), Positives = 84/230 (36%), Gaps = 46/230 (20%)
Query: 4 DLHQVIKANDDLTPEHYQF---FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+L + + Q+ ++++H+ + HRDLKP NI D +K+
Sbjct: 101 NLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160
Query: 61 DFGLARVAFNDTPTA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 111
DFGL D T V T+ Y +PE + Y+ +DI+S+G
Sbjct: 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGL 218
Query: 112 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS 171
I ELL P V + VRN K P F+
Sbjct: 219 ILFELLY--PFSTQMERV---------------RTLTDVRNLKF-----------PPLFT 250
Query: 172 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 221
QK+P +++ ML+ P +RP A + + F+ L + Q
Sbjct: 251 QKYPCEY----VMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 49/243 (20%), Positives = 88/243 (36%), Gaps = 41/243 (16%)
Query: 4 DLHQVIK-ANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 61
DL + I L E + Q+ LK++H + HRD+K +NI D +++ D
Sbjct: 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD 168
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
FG+ARV + A + T +Y +PE+C + Y DIW++GC+ EL T K
Sbjct: 169 FGIARVLNSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKH 223
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNANP 179
F ++ + ++ + P+ +S +
Sbjct: 224 AFEAGSM---------------KNLVLKIISGSF----------PPVSLHYSYDLRS--- 255
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKED 239
L+ ++ P+DRP+ L + + P F +
Sbjct: 256 ----LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIP 311
Query: 240 VRE 242
+
Sbjct: 312 AKR 314
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 54/232 (23%), Positives = 83/232 (35%), Gaps = 48/232 (20%)
Query: 1 ME----SDLHQVIKANDDLTPE-HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 55
ME L+ +I + + Y Q+L L YIH+ + HRDLKP NI +
Sbjct: 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153
Query: 56 KLKICDFGLARVAFNDTPTAIFW-----------TDYVATRWYRAPELCGSFFSKYTPAI 104
+KI DFGLA+ T + T Y A E+ Y I
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-TGHYNEKI 212
Query: 105 DIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRK 164
D++S+G IF E++ P G V+ I+ L +
Sbjct: 213 DMYSLGIIFFEMIY--PFSTGMERVN---ILKKL-------------------------R 242
Query: 165 KKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215
I F F N + +++ ++ +P RP A L + + E
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 49/207 (23%), Positives = 69/207 (33%), Gaps = 40/207 (19%)
Query: 4 DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L Q +A PE +L L L ++H+ + H D+KP NI + K+ DF
Sbjct: 142 SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDF 201
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
GL + Y APEL Y A D++S+G E+ L
Sbjct: 202 GLLVELGTAGAGEVQ----EGDPRYMAPELLQ---GSYGTAADVFSLGLTILEVACNMEL 254
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
G QL + P F+ +
Sbjct: 255 PHGGEGWQQL-----------------------------RQGYLPPEFTAGLSSE---LR 282
Query: 183 RLLERMLAFEPKDRPTAEEALADPYFK 209
+L ML +PK R TAE LA P +
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 59/217 (27%), Positives = 84/217 (38%), Gaps = 48/217 (22%)
Query: 4 DLHQVIKA---NDDLTPEHY-QFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANAD 54
DL VI E + + QL LK H + V HRDLKP N+ +
Sbjct: 93 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152
Query: 55 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 114
+K+ DFGLAR+ +DT A +V T +Y +PE Y DIWS+GC+
Sbjct: 153 QNVKLGDFGLARILNHDTSFA---KTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLY 207
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQ 172
EL P F + E ++R K + IP +S
Sbjct: 208 ELCALMPPFTAFSQ---------------KELAGKIREGKF----------RRIPYRYSD 242
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ ++ RML + RP+ EE L +P
Sbjct: 243 ELNE-------IITRMLNLKDYHRPSVEEILENPLIL 272
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 49/195 (25%), Positives = 76/195 (38%), Gaps = 32/195 (16%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR-VAFNDTPTAIFWT 79
+ Q+ L Y+H + HRD+KP+N L N ++K+ DFGL++ + T
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
T ++ APE+ + Y P D WS G + LL G FPG N D +
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN---DADTI---- 285
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
+ K + F + + +PLA LL +L +R
Sbjct: 286 -----SQV----------------LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 199 AEEALADPYFKGLAK 213
A AL P+ +
Sbjct: 325 AMRALQHPWISQFSD 339
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-35
Identities = 48/226 (21%), Positives = 77/226 (34%), Gaps = 42/226 (18%)
Query: 4 DLHQVIKA---NDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
DL ++IK L PE + QL L+++H+ V HRD+KP N+ A +K+
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKL 177
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
D GL R + T A V T +Y +PE + Y DIWS+GC+ E+
Sbjct: 178 GDLGLGRFFSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAAL 232
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP---FSQKFPN 176
+ F G ++ P+P +S++
Sbjct: 233 QSPFYGDK-------------MNLYSLCKKIEQCDY----------PPLPSDHYSEELRQ 269
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 222
L+ + +P+ RP
Sbjct: 270 -------LVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 21/225 (9%)
Query: 4 DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCK 56
L+ V++ L + L ++ G+ ++ + HR++KP NI+ +
Sbjct: 95 SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL------CGSFFSKYTPAIDIWSIG 110
K+ DFG AR +D T Y P++ KY +D+WSIG
Sbjct: 155 YKLTDFGAARELEDDEQF----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210
Query: 111 CIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP 169
F TG F P + ++M ++ AI+ V+ + S
Sbjct: 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270
Query: 170 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214
S L +L +L + + ++ A+
Sbjct: 271 LS---RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 36/199 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
+ YQ+L ++Y+H + HRDLKP+N+L DC +KI DFG +++ +
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMR 299
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T Y APE L + Y A+D WS+G I L+G P F Q+ +
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR--TQVSLK--- 354
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
+ I F + + + AL L++++L +PK R
Sbjct: 355 ------DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 392
Query: 198 TAEEALADPYFKGLAKVER 216
T EEAL P+ + +
Sbjct: 393 TTEEALRHPWLQDEDMKRK 411
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 53/272 (19%), Positives = 99/272 (36%), Gaps = 24/272 (8%)
Query: 4 DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCK 56
L+ V++ L + L ++ G+ ++ + HR++KP NI+ +
Sbjct: 95 SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL------CGSFFSKYTPAIDIWSIG 110
K+ DFG AR +D + T Y P++ KY +D+WSIG
Sbjct: 155 YKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG 210
Query: 111 CIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP 169
F TG F P + ++M ++ AI+ V+ + S
Sbjct: 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270
Query: 170 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 229
S L +L +L + + ++ A+ V S Q +T +
Sbjct: 271 LS---RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIY 327
Query: 230 FERRRITKEDVRELIYRE--ILEYHPQMLKEF 259
T EL+Y++ I+ + +++ E
Sbjct: 328 IHSYN-TATIFHELVYKQTKIISSNQELIYEG 358
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 54/270 (20%), Positives = 95/270 (35%), Gaps = 56/270 (20%)
Query: 1 MESDLHQVIKANDDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNIL--- 50
+L ++++ + L Q+ G+ ++H+ + HRDLKP+NIL
Sbjct: 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
Query: 51 ----------ANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPEL-----CG 94
+ ++ I DFGL + + + + T +RAPEL
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 95 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153
+ T +IDI+S+GC+F +L+ GK F K + +
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY-----------------SRESNIIRG 253
Query: 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213
+ A L+ +M+ +P RPTA + L P F +K
Sbjct: 254 I---------FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304
Query: 214 VEREPSAQPVTKMEFEFERRRITKEDVREL 243
+ V+ E E R + +
Sbjct: 305 --KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 41/201 (20%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
Q+L G+ Y+H N+ HRD+KP+NIL N+ +KI DFGL+ F+ D +
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDYK---LRDRL 209
Query: 83 ATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 141
T +Y APE L KY D+WS G I LL G P F G+N DI+
Sbjct: 210 GTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDII------ 256
Query: 142 PSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAE 200
+ + +K F + N + A L++ ML ++ R TAE
Sbjct: 257 ---KKV----------------EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAE 297
Query: 201 EALADPYFKGLAKVEREPSAQ 221
EAL + K A + +
Sbjct: 298 EALNSRWIKKYANNINKSDQK 318
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 39/201 (19%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
Q+L G+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V F + + +
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKK---MKERL 199
Query: 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142
T +Y APE+ KY D+WSIG I LL G P F G+ +I+
Sbjct: 200 GTAYYIAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEIL------- 246
Query: 143 SPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEE 201
+ +K F S ++ N + A L+++ML F+ + R +A++
Sbjct: 247 --RKV----------------EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQ 288
Query: 202 ALADPYFKGLAKVEREPSAQP 222
AL P+ K + + P
Sbjct: 289 ALEHPWIKEMCSKKESGIELP 309
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 61/205 (29%), Positives = 87/205 (42%), Gaps = 41/205 (20%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ F D
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTK---MKD 182
Query: 81 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
+ T +Y APE L G Y D+WS G I LL+G P F GKN + DI+
Sbjct: 183 RIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL---- 231
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
+ + + F ++ + A L+ +ML F P R T
Sbjct: 232 -----KRV----------------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 199 AEEALADPYFKGLAKVEREPSAQPV 223
A + L P+ + + S P
Sbjct: 271 ATQCLEHPWIQKYSSETPTISDLPS 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 39/202 (19%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ Q+L G+ Y+H + HRDLKP+N+L + D ++I DFGL+ F + D
Sbjct: 132 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEASKK---MKD 187
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 140
+ T +Y APE+ Y D+WS G I LL+G P F G N + DI+
Sbjct: 188 KIGTAYYIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDIL----- 236
Query: 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTA 199
+ + +K F ++ + A L+ +ML + P R +A
Sbjct: 237 ----KKV----------------EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISA 276
Query: 200 EEALADPYFKGLAKVEREPSAQ 221
+AL + + K +
Sbjct: 277 RDALDHEWIQTYTKEQISVDVP 298
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-32
Identities = 53/202 (26%), Positives = 84/202 (41%), Gaps = 36/202 (17%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
+ YQ+L ++Y+H + HRDLKP+N+L DC +KI DFG +++ +
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMR 174
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T Y APE L + Y A+D WS+G I L+G P F Q+ +
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR--TQVSLK--- 229
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
+ I F + + + AL L++++L +PK R
Sbjct: 230 ------DQI----------------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 267
Query: 198 TAEEALADPYFKGLAKVEREPS 219
T EEAL P+ + +
Sbjct: 268 TTEEALRHPWLQDEDMKRKFQD 289
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 68/248 (27%), Positives = 100/248 (40%), Gaps = 54/248 (21%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L ++ K LT +++L Q++ G +Y+H V HRDLK N+ N D ++KI DFGL
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
Query: 65 ARVAFND---------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
A D TP +Y+ APE+ ++ +D+WSIGCI
Sbjct: 188 ATKVEYDGERKKVLCGTP------NYI------APEVLSK--KGHSFEVDVWSIGCIMYT 233
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175
LL GKP F + E R++ Y IP
Sbjct: 234 LLVGKPPFETSCL---------------KETYLRIKK---NEY--------SIP-----K 262
Query: 176 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRI 235
+ NP+A L+++ML +P RPT E L D +F R P F +
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSL 322
Query: 236 TKEDVREL 243
+ + L
Sbjct: 323 DPSNRKPL 330
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 54/201 (26%), Positives = 80/201 (39%), Gaps = 37/201 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
+ LL + +H N+ HRDLKP+NIL + D +K+ DFG + +
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVC 184
Query: 83 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T Y APE + S Y +D+WS G I LL G P F + Q+ ++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML--- 238
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I F S ++ + + L+ R L +P+ R
Sbjct: 239 ------RMI----------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY 276
Query: 198 TAEEALADPYFKGLAKVEREP 218
TAEEALA P+F+ E
Sbjct: 277 TAEEALAHPFFQQYVVEEVRH 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-31
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 54/214 (25%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L ++ K LT +++L Q++ G +Y+H V HRDLK N+ N D ++KI DFGL
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
Query: 65 ARVAFND---------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
A D TP +Y+ APE+ ++ +D+WSIGCI
Sbjct: 162 ATKVEYDGERKKVLCGTP------NYI------APEVLSK--KGHSFEVDVWSIGCIMYT 207
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175
LL GKP F + E R++ Y IP
Sbjct: 208 LLVGKPPFETSCL---------------KETYLRIKK---NEY--------SIP-----K 236
Query: 176 NANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ NP+A L+++ML +P RPT E L D +F
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 48/214 (22%), Positives = 76/214 (35%), Gaps = 39/214 (18%)
Query: 4 DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 59
L I+ + LT + + L + RGL+ IH HRDLKP NIL + + +
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175
Query: 60 CDFGLARVAFNDTPTA------IFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCI 112
D G A + W T YRAPEL D+WS+GC+
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 113 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172
++ G+ + +K +++ + IP S
Sbjct: 236 LYAMMFGEGPYDMV-------------------------FQKGDSVALAVQNQLSIPQSP 270
Query: 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206
+ +A +LL M+ +P RP L+
Sbjct: 271 RHSSA---LWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-30
Identities = 60/197 (30%), Positives = 87/197 (44%), Gaps = 41/197 (20%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ +T D
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKD 182
Query: 81 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
+ T +Y APE L G Y D+WS G I LL+G P F GKN + DI+
Sbjct: 183 RIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL---- 231
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
+ + + F ++ + A L+ +ML F P R T
Sbjct: 232 -----KRV----------------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 199 AEEALADPYFKGLAKVE 215
A + L P+ + + E
Sbjct: 271 ATQCLEHPWIQKYSSEE 287
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 53/238 (22%), Positives = 83/238 (34%), Gaps = 30/238 (12%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
L + L+Y+H + HRDLKP+NI+ KI D G A+ T
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCT 181
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
++V T Y APEL KYT +D WS G + E +TG F Q
Sbjct: 182 EFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---- 235
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL-------ALRLLERMLAFE 192
VR + + + FS P N L R L+ ML +
Sbjct: 236 ----------VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285
Query: 193 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 250
+ R T + F+ L + + + +T+ + + + + +
Sbjct: 286 QRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 40/191 (20%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
+ Q++ L Y H+ +V H+DLKP+NIL + +KI DFGLA + +D T
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HST 184
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
+ T Y APE T DIWS G + LLTG F G + ++
Sbjct: 185 NAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQ--- 234
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 198
+ K ++ + P A+ LL++ML +P+ RP+
Sbjct: 235 ------QKA----------------TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
Query: 199 AEEALADPYFK 209
A + L +FK
Sbjct: 273 AAQVLHHEWFK 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 54/193 (27%), Positives = 77/193 (39%), Gaps = 41/193 (21%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
+ +L + Y H NV HRDLKP+N L + D LK+ DFGLA
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMR 166
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
V T +Y +P+ L G Y P D WS G + LL G P F ++M
Sbjct: 167 TKVGTPYYVSPQVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM--- 216
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I ++ F + + N +P A L+ R+L PK R
Sbjct: 217 ------LKI----------------REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI 254
Query: 198 TAEEALADPYFKG 210
T+ +AL +F+
Sbjct: 255 TSLQALEHEWFEK 267
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 40/233 (17%), Positives = 72/233 (30%), Gaps = 64/233 (27%)
Query: 4 DLHQVIKANDDLT---PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNIL--------- 50
L I N + E + L Q+ RGL+YIH+ ++ H D+KP NI
Sbjct: 97 SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 156
Query: 51 ----------ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 100
A+ KI D G + + A E+ ++ +
Sbjct: 157 ASEEGDEDDWASNKVMFKIGDLGHVTR-ISSPQV------EEGDSRFLANEVLQENYT-H 208
Query: 101 TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160
P DI+++ +PL + H++
Sbjct: 209 LPKADIFALALTVVCAAGAEPLPRNGDQWHEI---------------------------- 240
Query: 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213
R+ + Q LL+ M+ +P+ RP+A + ++
Sbjct: 241 --RQGRLPRIPQVLS---QEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 46/197 (23%), Positives = 75/197 (38%), Gaps = 54/197 (27%)
Query: 22 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------T 72
F++Q++ G+ Y+H+ + HRDL N+L + +KI DFGLA T
Sbjct: 116 HFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGT 175
Query: 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 132
P +Y+ +PE+ S + D+WS+GC+F LL G+P F V
Sbjct: 176 P------NYI------SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV---- 217
Query: 133 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 192
+ +V +P + A L+ ++L
Sbjct: 218 -----------KNTLNKVVLADYE-----------MP-----SFLSIEAKDLIHQLLRRN 250
Query: 193 PKDRPTAEEALADPYFK 209
P DR + L P+
Sbjct: 251 PADRLSLSSVLDHPFMS 267
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 34/217 (15%), Positives = 61/217 (28%), Gaps = 51/217 (23%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L + L Q++R L +H + H L+P +I+ + + + F
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFA 114
+ +R + PEL + T + D W++G +
Sbjct: 252 HLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF 174
+ + E I R K IP
Sbjct: 305 WIWCADLPITKDAALG------------GSEWI--------------FRSCKNIP----- 333
Query: 175 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
LLE L + +DR +A+ P ++ L
Sbjct: 334 ----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 32/220 (14%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ +L+ + ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP---LKT 168
Query: 81 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
T Y APE L + Y + D+WS+G I +L+G+ F + +++
Sbjct: 169 PCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
+ I KK F + + N + A L++ +L +P R
Sbjct: 226 -----KKI----------------KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264
Query: 199 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
+ + + +++ P P K
Sbjct: 265 MSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 33/223 (14%), Positives = 56/223 (25%), Gaps = 40/223 (17%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L + L Q++R L +H + H L+P +I+ + + + F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAELLTG 119
A A + + T A D W++G +
Sbjct: 256 EHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+ E I R K IP
Sbjct: 314 DLPNTDDAALG------------GSEWI--------------FRSCKNIP---------Q 338
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 222
LLE L + +DR +A+ P ++ L
Sbjct: 339 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLY 381
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 39/210 (18%), Positives = 71/210 (33%), Gaps = 27/210 (12%)
Query: 22 FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT- 79
+ +L YIH N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES----EYMVDKKIKGS 210
Query: 80 ----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 135
+++ PE + S +DIWS+G + F K + +L
Sbjct: 211 RGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL--- 261
Query: 136 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 195
I E + + + + L+ L P +
Sbjct: 262 --------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 196 RPTAEEALADPYFKGLAKVEREPSAQPVTK 225
R T+E+AL + + ++ + K
Sbjct: 314 RITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 49/213 (23%), Positives = 79/213 (37%), Gaps = 54/213 (25%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
+++ ++ + ++ +L L Y H+ V HRD+KP+N+L + +LKI DFG
Sbjct: 96 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155
Query: 65 ARVAFND-------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 117
+ A + T DY+ PE+ + +D+WS+G + E L
Sbjct: 156 SVHAPSSRRTDLCGTL------DYL------PPEMIEG--RMHDEKVDLWSLGVLCYEFL 201
Query: 118 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN- 176
GKP F + I+RV FP+
Sbjct: 202 VGKPPFEANTYQETY------------KRISRVE--------------------FTFPDF 229
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
A L+ R+L P RP E L P+
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 39/210 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFW 78
FL Q+L G+ Y+H+ + H DLKP+NI+ ++KI DFGLA +
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----F 174
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
+ T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 175 KNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL--- 226
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
++ V F + F N + LA + R+L +PK R
Sbjct: 227 ------ANVSAVN----------------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264
Query: 198 TAEEALADPYFKGLAKVEREPSAQPVTKME 227
T +++L P+ K + ME
Sbjct: 265 TIQDSLQHPWIKPKDTQQALSRKASAVNME 294
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 58/217 (26%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
+ Q+L + Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWH 188
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
+ T Y +PE L Y+ +DIW+ G I LL G P F ++ Q +
Sbjct: 189 GFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY--- 239
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I K + S ++ P A L++ ML PK R
Sbjct: 240 ------AQI----------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 277
Query: 198 TAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 234
TA++AL P+ +V Q +F RR
Sbjct: 278 TADQALKVPWICNRERVASAIHRQDTVDCLKKFNARR 314
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
+ Q+L + Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWH 165
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
+ T Y +PE L Y+ +DIW+ G I LL G P F ++ Q +
Sbjct: 166 GFAGTPGYLSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLY--- 216
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I K + S ++ P A L++ ML PK R
Sbjct: 217 ------AQI----------------KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254
Query: 198 TAEEALADPYFKGLAKVEREPSAQ 221
TA++AL P+ +V Q
Sbjct: 255 TADQALKVPWICNRERVASAIHRQ 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 37/192 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
+ LL + ++H N+ HRDLKP+NIL + + ++++ DFG + +
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLRELC 260
Query: 83 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T Y APE L S Y +D+W+ G I LL G P F + Q+ ++
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILML--- 314
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I + F S ++ + + L+ R+L +P+ R
Sbjct: 315 ------RMI----------------MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL 352
Query: 198 TAEEALADPYFK 209
TAE+AL P+F+
Sbjct: 353 TAEQALQHPFFE 364
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 39/202 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFW 78
FL Q+L G+ Y+H+ + H DLKP+NI+ + ++K+ DFG+A +
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----F 168
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
+ T + APE+ + D+WSIG I LL+G F G+ + + +
Sbjct: 169 KNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL--- 220
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I+ V F + F N + LA + R+L +PK R
Sbjct: 221 ------TNISAVN----------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRM 258
Query: 198 TAEEALADPYFKGLAKVEREPS 219
T ++L + K + +
Sbjct: 259 TIAQSLEHSWIKAIRRRNVRGE 280
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 39/210 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFW 78
F+ Q+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----F 175
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
+ T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 176 KNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL--- 227
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I V F + F + LA + ++L E + R
Sbjct: 228 ------ANITAVS----------------YDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265
Query: 198 TAEEALADPYFKGLAKVEREPSAQPVTKME 227
T +EAL P+ + + + V +E
Sbjct: 266 TIQEALRHPWITPVDTQQAMVRRESVVNLE 295
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 39/210 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFW 78
F+ Q+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + +
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----F 175
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
+ T + APE+ + D+WSIG I LL+G F G + + +
Sbjct: 176 KNIFGTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL--- 227
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I V F + F + + LA + ++L E + R
Sbjct: 228 ------ANITSVS----------------YDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265
Query: 198 TAEEALADPYFKGLAKVEREPSAQPVTKME 227
T +EAL P+ + + + V +E
Sbjct: 266 TIQEALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 47/225 (20%), Positives = 81/225 (36%), Gaps = 48/225 (21%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L++ ++ + + F+ +L L Y H V HRD+KP+N+L +LKI DFG
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW 160
Query: 65 ARVAFNDTPTAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
+ P+ T DY+ PE+ + +D+W G + E L G
Sbjct: 161 S----VHAPSLRRRTMCGTLDYL------PPEMIEG--KTHDEKVDLWCAGVLCYEFLVG 208
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
P F + E R+ N + P P +
Sbjct: 209 MPPFDSPSH---------------TETHRRIVNVDLK-----------FP-----PFLSD 237
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVT 224
+ L+ ++L + P R + + P+ K ++ P Q
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 56/280 (20%), Positives = 93/280 (33%), Gaps = 81/280 (28%)
Query: 1 MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANAD--- 54
+ L + I ++ L + + Q+L+GL Y+HT + H D+KP+NIL + +
Sbjct: 127 LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186
Query: 55 ----------------------------------------------CKLKICDFGLARVA 68
K+KI D G A
Sbjct: 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246
Query: 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 128
+T+ + TR YR+ E+ S Y DIWS C+ EL TG LF +
Sbjct: 247 HKH------FTEDIQTRQYRSLEVL--IGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298
Query: 129 VHQLDI------MTDLLGTPSPEAIARVRNEKARRYLSS---MRKKKPIPFSQ------- 172
+ +LLG + I + ++ + + ++ +
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIV--AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 173 --KFPNAN-PLALRLLERMLAFEPKDRPTAEEALADPYFK 209
++ L ML P+ R TA E L P+
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 35/219 (15%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ + ++++H+ N+ HRD+KP+N+L D LK+ DFG A+ +
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-----LQT 188
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 140
T +Y APE+ G KY + D+WS+G I LL G P F I +
Sbjct: 189 PCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNT---GQAISPGMK- 242
Query: 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTA 199
R+R + F + ++ + A +L+ +L +P +R T
Sbjct: 243 -------RRIRLGQ-------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTI 282
Query: 200 EEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
+ + P+ V + P E + + +E
Sbjct: 283 TQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEE 321
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 39/208 (18%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICD 61
L +K + + + + Q+L+GL+++HT + HRDLK NI +KI D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
GLA + A+ T + APE+ KY ++D+++ G E+ T +
Sbjct: 176 LGLATLKRASFAKAVIGTPE----FM-APEMYEE---KYDESVDVYAFGMCMLEMATSEY 227
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ Q+ Y KP F + A P
Sbjct: 228 PYSECQNAAQI-------------------------YRRVTSGVKPASFDK---VAIPEV 259
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFK 209
++E + +R + ++ L +F+
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 56/216 (25%), Positives = 82/216 (37%), Gaps = 39/216 (18%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ Q+L + + H V HR+LKP+N+L +K+ DFGLA + W
Sbjct: 116 IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFG 172
Query: 81 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
+ T Y +PE L Y +D+W+ G I LL G P F ++ Q +
Sbjct: 173 FAGTPGYLSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLY---- 222
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
+ I K F S ++ P A L+ +ML P R T
Sbjct: 223 -----QQI----------------KAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261
Query: 199 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 234
A EAL P+ + V Q +F RR
Sbjct: 262 AAEALKHPWISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 44/235 (18%)
Query: 13 DDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFG 63
D + E Y+ ++ Q GLK++H ++ H D+KP+NI+ +KI DFG
Sbjct: 137 DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA D AT + APE+ D+W+IG + LL+G F
Sbjct: 197 LATKLNPDEI----VKVTTATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPF 250
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLAL 182
G++ L+ + + + R F F + +P A
Sbjct: 251 AGED---DLETL---------QNVKRCD----------------WEFDEDAFSSVSPEAK 282
Query: 183 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITK 237
++ +L EP+ R T +AL P+ KG + + +
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 47/200 (23%), Positives = 76/200 (38%), Gaps = 24/200 (12%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV----AFNDTPTAI 76
+ + L ++H + HRDLKP+NIL N +KICDF L +
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 77 FWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133
+ Y APE+ S Y D+WS+G I LL+G P F G+
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFE 192
+ ++ K F + + + + A L+ ++L +
Sbjct: 237 DRGEACPACQNMLFESIQEGK-------------YEFPDKDWAHISCAAKDLISKLLVRD 283
Query: 193 PKDRPTAEEALADPYFKGLA 212
K R +A + L P+ +G A
Sbjct: 284 AKQRLSAAQVLQHPWVQGCA 303
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 52/194 (26%), Positives = 77/194 (39%), Gaps = 39/194 (20%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ Q+L + Y+H + HRDLKP+N+L D LKI DFGL+++ +
Sbjct: 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKT 209
Query: 81 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
T Y APE L G Y P +D+WS+G I LL G F + +
Sbjct: 210 VCGTPGYCAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------ 260
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
I F S + + A L+ +++ +PK R T
Sbjct: 261 -----RRI----------------LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT 299
Query: 199 AEEALADPYFKGLA 212
+AL P+ G A
Sbjct: 300 TFQALQHPWVTGKA 313
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 38/191 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
+ Q+L G+ Y+H N+ H DLKP+NIL +KI DFG++R +
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LR 191
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
+ + T Y APE+ + T A D+W+IG I LLT F G++ +
Sbjct: 192 EIMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETY---- 242
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
I++V + + + F + + LA ++ +L P+ RPT
Sbjct: 243 -----LNISQVN----------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPT 281
Query: 199 AEEALADPYFK 209
AE L+ + +
Sbjct: 282 AEICLSHSWLQ 292
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 34/238 (14%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + T
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTT 222
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 140
T +Y APE+ G KY + D+WS+G I LL G P F +
Sbjct: 223 PCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH-----------GL 269
Query: 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTA 199
SP R+R + F + ++ + L+ +L EP R T
Sbjct: 270 AISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316
Query: 200 EEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLK 257
E + P+ KV + P E + + +E L + ++ K
Sbjct: 317 TEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKK 374
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 49/217 (22%), Positives = 80/217 (36%), Gaps = 40/217 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWT 79
++ Q+L L+Y H N+ HRD+KP +L +K+ FG+A
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---AG 191
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
V T + APE + Y +D+W G I LL+G F G +
Sbjct: 192 GRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF--- 241
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
E I + + +++ + + A L+ RML +P +R
Sbjct: 242 ------EGIIKGK----------------YKMNPRQWSHISESAKDLVRRMLMLDPAERI 279
Query: 198 TAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 234
T EAL P+ K + + + +F RR
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 47/208 (22%), Positives = 75/208 (36%), Gaps = 37/208 (17%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWT 79
L+ + + ++Y+H V HRDLKP NIL + ++ICDFG A+ +
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLM 178
Query: 80 DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T + APE L Y A DIWS+G + +LTG F +I+
Sbjct: 179 TPCYTANFVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL--- 232
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRP 197
I + + + A L+ +ML +P R
Sbjct: 233 ------ARI----------------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL 270
Query: 198 TAEEALADPYFKGLAKVEREPSAQPVTK 225
TA L P+ ++ + +
Sbjct: 271 TAALVLRHPWIVHWDQLPQYQLNRQDAP 298
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 33/208 (15%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 63
L Q+IK L + ++L Q L GL+Y+HT + H D+K N+L ++D + +CDFG
Sbjct: 137 LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG 196
Query: 64 LARV--AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
A + + T + APE+ +DIWS C+ +L G
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCH 254
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ + + + P P + IP P+ PL
Sbjct: 255 PWTQ---YFRGPLCLKIASEPPP--------------------IREIP-----PSCAPLT 286
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFK 209
+ ++ L EP R +A E
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 43/232 (18%), Positives = 76/232 (32%), Gaps = 44/232 (18%)
Query: 13 DDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFG 63
+ + EH + ++ Q+ +GL ++H N H DLKP+NI+ +LK+ DFG
Sbjct: 243 EKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 302
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
L T + APE+ D+WS+G + LL+G F
Sbjct: 303 LTAHLDPKQS----VKVTTGTAEFAAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPF 356
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLAL 182
G+N + + + F +
Sbjct: 357 GGEN---DDETL---------RNVKSCD----------------WNMDDSAFSGISEDGK 388
Query: 183 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 234
+ ++L +P R T +AL P+ R+ + +
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 58/199 (29%), Positives = 82/199 (41%), Gaps = 36/199 (18%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFW 78
F+ Q+L GLKY+H + HRD+K N+L N LKI DFG + R+A + T F
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF- 183
Query: 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138
T Y APE+ Y A DIWS+GC E+ TGKP P + M
Sbjct: 184 ---TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM--- 235
Query: 139 LGTPSPEAIARVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLALRLLERMLAFEPKDRP 197
+ M K P IP + + A + + +P R
Sbjct: 236 -------------------FKVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRA 271
Query: 198 TAEEALADPYFKGLAKVER 216
A + L D + K +K ++
Sbjct: 272 CANDLLVDEFLKVSSKKKK 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 46/195 (23%), Positives = 77/195 (39%), Gaps = 39/195 (20%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+++Q+ L+++H+ N+ H D++P+NI+ +KI +FG AR +
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRL 162
Query: 81 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
Y APE + A D+WS+G + LL+G F + I+
Sbjct: 163 LFTAPEYYAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET---NQQII---- 212
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
E I F + F + A+ ++R+L E K R T
Sbjct: 213 -----ENIMNAE----------------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
Query: 199 AEEALADPYFKGLAK 213
A EAL P+ K +
Sbjct: 252 ASEALQHPWLKQKIE 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 49/201 (24%), Positives = 77/201 (38%), Gaps = 39/201 (19%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
F+ Q+ G++++H + H DLKP+NIL ++KI DFGLAR
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----LKV 247
Query: 81 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139
T + APE + F + D+WS+G I LL+G F G N + +
Sbjct: 248 NFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETL---- 297
Query: 140 GTPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPT 198
I R ++F + + A + ++L E R +
Sbjct: 298 -----NNILACR----------------WDLEDEEFQDISEEAKEFISKLLIKEKSWRIS 336
Query: 199 AEEALADPYFKGLAKVEREPS 219
A EAL P+ R +
Sbjct: 337 ASEALKHPWLSDHKLHSRLSA 357
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 45/236 (19%), Positives = 81/236 (34%), Gaps = 49/236 (20%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICD 61
+ + +++ L+ + YQ R ++++H + HRDLK +N+L + +K+CD
Sbjct: 122 EFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181
Query: 62 FGLARVAFNDTPTAIFWTDYVA---------TRWYRAPELCGSFFSK--YTPAIDIWSIG 110
FG A + + T YR PE+ +S DIW++G
Sbjct: 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALG 240
Query: 111 CIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 170
CI L + F + I +Y IP
Sbjct: 241 CILYLLCFRQHPFEDGAKL----------------RIVNG------KY--------SIPP 270
Query: 171 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 226
L+ ML P++R + E + + +A P+T++
Sbjct: 271 HDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 41/202 (20%), Positives = 79/202 (39%), Gaps = 33/202 (16%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
+ L+ + +F+ L++G++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--N 185
Query: 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKN 127
A+ V T + APE ++ A+D+W++G + G+ F +
Sbjct: 186 EFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 128 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 187
+ ++++++ P P+ L+ R
Sbjct: 245 I---------------MCLHSKIKSQALE-----------FP---DQPDIAEDLKDLITR 275
Query: 188 MLAFEPKDRPTAEEALADPYFK 209
ML P+ R E P+
Sbjct: 276 MLDKNPESRIVVPEIKLHPWVT 297
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 42/226 (18%)
Query: 1 ME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 56
ME L + I+++ L+ + F Q+L G+K+ H + HRD+KP+NIL +++
Sbjct: 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
LKI DFG+A+ + T T++V T Y +PE DI+SIG + E
Sbjct: 150 LKIFDFGIAKALSETSLTQ---TNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYE 204
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175
+L G+P F G + +IA + ++ P +
Sbjct: 205 MLVGEPPFNG----------------ETAVSIA----------IKHIQDSVPNVTTDVRK 238
Query: 176 NANPLALRLLERMLAFEPKDRP-TAEEALADPYFKGLAKVEREPSA 220
+ ++ R + +R T +E D L+ V E A
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDD-----LSSVLHENRA 279
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 43/226 (19%), Positives = 80/226 (35%), Gaps = 44/226 (19%)
Query: 5 LHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L+ V+ A L + ++++G+ Y+H + H+DLK KN+ + + K+ I DFG
Sbjct: 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174
Query: 64 LARVAFNDTPTAIFWTDYVATRWYR--APEL-------CGSFFSKYTPAIDIWSIGCIFA 114
L ++ + W APE+ ++ D++++G I+
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 115 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF 174
EL + F + EAI + +
Sbjct: 235 ELHAREWPFKTQP----------------AEAIIWQMGTGMKP---------NLS----- 264
Query: 175 PNANPLALR-LLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPS 219
+ +L AFE ++RPT + + + L K R S
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLS 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 42/200 (21%), Positives = 78/200 (39%), Gaps = 30/200 (15%)
Query: 5 LHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L+ + A++ + Q RG+ Y+H ++ HRDLK NI + D +KI DFG
Sbjct: 106 LYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
LA + + + + + APE + + Y+ D+++ G + EL+TG+
Sbjct: 166 LATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
+ N + + I + + P K + P +
Sbjct: 225 YSNIN---------------NRDQIIEMVGRGSLS-----------PDLSKVRSNCPKRM 258
Query: 183 -RLLERMLAFEPKDRPTAEE 201
RL+ L + +RP+
Sbjct: 259 KRLMAECLKKKRDERPSFPR 278
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 48/219 (21%), Positives = 78/219 (35%), Gaps = 55/219 (25%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+ + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 140
A E G KY + D+WS+G I LL G P F +
Sbjct: 167 --------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----------L 204
Query: 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTA 199
SP R+R + F + ++ + L+ +L EP R T
Sbjct: 205 AISPGMKTRIRMGQ-------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 251
Query: 200 EEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
E + P+ KV + P E + + +E
Sbjct: 252 TEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 1 ME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 56
ME L ++ +TP+ + + L + H + HRD+KP NI+ +A
Sbjct: 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 154
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
+K+ DFG+AR A D+ ++ T V T Y +PE D++S+GC+ E
Sbjct: 155 VKVMDFGIAR-AIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYE 211
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA--RVRNEKARRYLSSMRKKKPIPFSQK 173
+LTG+P F G SP ++A VR + PIP S +
Sbjct: 212 VLTGEPPFTGD----------------SPVSVAYQHVRED-------------PIPPSAR 242
Query: 174 FPNANPLALRLLERMLAFEPKDRP-TAEEALAD 205
+ ++ + LA P++R TA E AD
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 44/206 (21%), Positives = 73/206 (35%), Gaps = 41/206 (19%)
Query: 4 DLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNIL-----ANADC 55
DL+ + + + + G++Y+ N + HRDL+ NI NA
Sbjct: 107 DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166
Query: 56 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
K+ DFGL++ + + + +W APE G+ YT D +S I
Sbjct: 167 CAKVADFGLSQQ-SVHSVSGLLGN----FQW-MAPETIGAEEESYTEKADTYSFAMILYT 220
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175
+LTG+ F + + I +R E R IP
Sbjct: 221 ILTGEGPFDEYSYGK-------------IKFINMIREEGLR---------PTIP-----E 253
Query: 176 NANPLALRLLERMLAFEPKDRPTAEE 201
+ P ++E + +PK RP
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 60/252 (23%), Positives = 100/252 (39%), Gaps = 52/252 (20%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
++ + A+ + + + Q++ ++Y H + HRDLK +N+L +AD +KI DFG
Sbjct: 100 EVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAELLTGK 120
+ F Y APEL F KY P +D+WS+G I L++G
Sbjct: 160 FSNEFTVGGKLDAF----CGAPPYAAPEL----FQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNAN 178
F G+N+ E RV K R Y+S
Sbjct: 212 LPFDGQNL---------------KELRERVLRGKYRIPFYMS------------------ 238
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFK-GLAKVEREPSAQPVTKMEFEF-----ER 232
LL+R L P R T E+ + D + G + E +P +P + +
Sbjct: 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVG 298
Query: 233 RRITKEDVRELI 244
++E+++E +
Sbjct: 299 MGYSQEEIQESL 310
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 45/222 (20%), Positives = 78/222 (35%), Gaps = 36/222 (16%)
Query: 1 MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLK 58
M + ++ K PE +++ L Y+ V HRD+KP NIL + ++K
Sbjct: 106 MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIK 165
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE---LCGSFFSKYTPAIDIWSIGCIFAE 115
+CDFG++ + Y APE Y D+WS+G E
Sbjct: 166 LCDFGISGRLVD----DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175
L TG+ + +++T +L P + FS F
Sbjct: 222 LATGQFPYKNCKTD--FEVLTKVLQEEPP------------------LLPGHMGFSGDFQ 261
Query: 176 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217
+ ++ L + + RP + L + K +E +
Sbjct: 262 S-------FVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 7e-23
Identities = 47/246 (19%), Positives = 81/246 (32%), Gaps = 45/246 (18%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L +IK+ D F + G+ Y+H+ N+ HRDL N L + + + DF
Sbjct: 93 TLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADF 152
Query: 63 GLARVAFNDT-----------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 111
GLAR+ ++ P V ++ APE+ Y +D++S G
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN--GRSYDEKVDVFSFGI 210
Query: 112 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS 171
+ E++ P P + P
Sbjct: 211 VLCEIIGRVNADPD--------------YLPRTMDFGLNVRGFLD---------RYCP-- 245
Query: 172 QKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFKGLAK-VEREPSAQPVTKMEF 228
PN P + R +P+ RP+ + + LA + P + + + +
Sbjct: 246 ---PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFW 302
Query: 229 EFERRR 234
E RR
Sbjct: 303 ETYRRG 308
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 23/226 (10%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFG 63
L QV+K + + +++GL Y+ + HRD+KP NIL N+ ++K+CDFG
Sbjct: 118 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
++ D+ F V TR Y +PE L G + Y+ DIWS+G E+ G+
Sbjct: 178 VSGQ-LIDSMANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKP---IPFSQKFPNANP 179
P + + + + E R R M + P N P
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
Query: 180 LALR----------LLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215
L + + L P +R ++ + + K E
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-22
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 33/212 (15%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
I+ + + Q F +QL+ G+ Y+H + HRD+KP+N+L + LKI DFGLA V
Sbjct: 96 IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155
Query: 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKN 127
+ + T Y APEL ++ +D+WS G + +L G+ +
Sbjct: 156 RYNNRERLLNK-MCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQP- 211
Query: 128 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 187
++ + Y KK + +K L LL +
Sbjct: 212 ------------------------SDSCQEYSDWKEKKTYLNPWKKID---SAPLALLHK 244
Query: 188 MLAFEPKDRPTAEEALADPYF-KGLAKVEREP 218
+L P R T + D ++ K L K + P
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 42/219 (19%)
Query: 1 ME------SDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTA-NVFHRDLKPKNILAN 52
ME ++ + PE +++ L+++H+ +V HRD+KP N+L N
Sbjct: 85 MELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 53 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIG 110
A ++K+CDFG++ + + + Y APE Y+ DIWS+G
Sbjct: 145 ALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
Query: 111 CIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 170
EL + FP + + ++ PSP+ F
Sbjct: 201 ITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQL-------------------PADKF 239
Query: 171 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
S +F + + L K+RPT E + P+F
Sbjct: 240 SAEFVD-------FTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 52/210 (24%), Positives = 73/210 (34%), Gaps = 23/210 (10%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF--------HRDLKPKNILANADCK 56
L+ +K+ L + Y + GL ++HT HRDLK KNIL +
Sbjct: 122 LYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180
Query: 57 LKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPE-LCGSFFSKYTPA---IDIWSIGC 111
I D GLA +DT I V T+ Y PE L S + + D++S G
Sbjct: 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240
Query: 112 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS 171
I E+ G +QL + PS E + + K R P
Sbjct: 241 ILWEVARRCVSG-GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR--------PSFPNR 291
Query: 172 QKFPNANPLALRLLERMLAFEPKDRPTAEE 201
+L+ A P R TA
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALR 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 45/200 (22%), Positives = 77/200 (38%), Gaps = 39/200 (19%)
Query: 4 DLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLK 58
L++++ + L Y + +G+ Y+H N + HR+LK N+L + +K
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+CDFGL+R+ + ++ T + APE+ D++S G I EL T
Sbjct: 180 VCDFGLSRLKASTFLSS---KSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELAT 234
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
+ + N + +A V + R IP N N
Sbjct: 235 LQQPWGNLN---------------PAQVVAAVGFKCKR---------LEIP-----RNLN 265
Query: 179 PLALRLLERMLAFEPKDRPT 198
P ++E EP RP+
Sbjct: 266 PQVAAIIEGCWTNEPWKRPS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 49/205 (23%), Positives = 75/205 (36%), Gaps = 43/205 (20%)
Query: 4 DLHQVI---KANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCK- 56
L+ V+ + T H + Q +G+ Y+H+ + HRDLKP N+L A
Sbjct: 85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
LKICDFG A T+ + + APE+ S Y+ D++S G I E+
Sbjct: 145 LKICDFGTACDIQTHM------TNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEV 196
Query: 117 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176
+T + F I + R P+ N
Sbjct: 197 ITRRKPFDEIG--------------GPAFRIMWAVHNGTRP---------PLI-----KN 228
Query: 177 ANPLALRLLERMLAFEPKDRPTAEE 201
L+ R + +P RP+ EE
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 3/107 (2%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80
+F+ +++ L+Y+H + HRDLKP+NIL N D ++I DFG A+V ++ A +
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 191
Query: 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
+V T Y +PEL + D+W++GCI +L+ G P F N
Sbjct: 192 FVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 7e-22
Identities = 31/236 (13%), Positives = 62/236 (26%), Gaps = 54/236 (22%)
Query: 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL-----------ANADCKLKICDF 62
+ F ++L ++ +H + H D+KP N + + L + D
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
G + IF T ++ E L + ID + + +L G
Sbjct: 228 GQSIDMKLFPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTY 283
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ V+NE + ++ P +
Sbjct: 284 MK--------------------------VKNEGGECKPEGLFRRLPHL---------DMW 308
Query: 182 LRLLERMLAFEPKDRPTAEEALA---DPYFKGLAKVEREPSAQPVTKMEFEFERRR 234
ML + + L F+ + + + E +R R
Sbjct: 309 NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRSR 364
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-22
Identities = 51/232 (21%), Positives = 77/232 (33%), Gaps = 44/232 (18%)
Query: 1 ME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 56
M DL +++ L P + Q+ L H A HRD+KP+NIL +AD
Sbjct: 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF 172
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
+ DFG+A ++ T T +Y APE S T DI+++ C+ E
Sbjct: 173 AYLVDFGIASATTDEKLTQ---LGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYE 227
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175
LTG P + G + A + S P
Sbjct: 228 CLTGSPPYQGDQLS---------------VMGAHINQA-------------IPRPSTVRP 259
Query: 176 NANPLALRLLERMLAFEPKDR-PTAEEALADPYFKGLAKVEREPSAQPVTKM 226
++ R +A P+DR T + A T +
Sbjct: 260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSAA-----AHAALATADQDRATDI 306
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 8e-22
Identities = 41/220 (18%), Positives = 70/220 (31%), Gaps = 33/220 (15%)
Query: 24 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWT 79
L +L+ L YIH HR +K +IL + D K+ + + F
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP----------LF------ 123
V + +PE+ Y DI+S+G EL G L
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253
Query: 124 ----PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP--FSQKFPNA 177
+ + ++ + + ++ R + P FS F +
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH- 312
Query: 178 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217
+E+ L P RP+A L +FK + + E
Sbjct: 313 ------FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 37/223 (16%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
I+ + + Q F +QL+ G+ Y+H + HRD+KP+N+L + LKI DFGLA V
Sbjct: 96 IEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155
Query: 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPG 125
+ + T Y APEL ++ +D+WS G + +L G+ +
Sbjct: 156 RYNNRERLLNK-MCGTLPYVAPEL----LKRREFHAEPVDVWSCGIVLTAMLAGELPW-- 208
Query: 126 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 185
D E + P+ + L LL
Sbjct: 209 -----------DQPSDSCQEYSDWKEKKTYL-----------NPWK----KIDSAPLALL 242
Query: 186 ERMLAFEPKDRPTAEEALADPYF-KGLAKVEREPSAQPVTKME 227
++L P R T + D ++ K L K + P E
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSE 285
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 33/213 (15%)
Query: 1 MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLK 58
+ V DD+ PE ++ L ++ + HRD+KP NIL + +K
Sbjct: 107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEL 116
+CDFG++ + +I T R Y APE + Y D+WS+G EL
Sbjct: 167 LCDFGISGQLVD----SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
Query: 117 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176
TG+ +P N V D +T ++ P + + FS F N
Sbjct: 223 ATGRFPYPKWNSV--FDQLTQVVKGDPP----------------QLSNSEEREFSPSFIN 264
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ L + RP +E L P+
Sbjct: 265 -------FVNLCLTKDESKRPKYKELLKHPFIL 290
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 42/209 (20%), Positives = 67/209 (32%), Gaps = 49/209 (23%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT--- 79
+ QL+ GL+Y+H+ + H+D+KP N+L LKI G+A T
Sbjct: 114 YFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 80 --DYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 136
+ PE+ + ++ +DIWS G + TG F G N+
Sbjct: 174 SPAFQ------PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------- 218
Query: 137 DLLGTPSPEAIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 194
+ + P LL+ ML +EP
Sbjct: 219 -------YKLFENIGKGSYAIPGDCG------------------PPLSDLLKGMLEYEPA 253
Query: 195 DRPTAEEALADPYF-KGLAKVEREPSAQP 222
R + + +F K E P
Sbjct: 254 KRFSIRQIRQHSWFRKKHPPAEAPVPIPP 282
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 52/208 (25%), Positives = 77/208 (37%), Gaps = 48/208 (23%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNIL--------ANA 53
L++V+ + P+ + Q+ RG+ Y+H + HRDLK NIL +
Sbjct: 93 LNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151
Query: 54 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
+ LKI DFGLAR T + W APE+ + S ++ D+WS G +
Sbjct: 152 NKILKITDFGLAREWHRTTKMSAAGA----YAW-MAPEVIRA--SMFSKGSDVWSYGVLL 204
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
ELLTG+ F G + V K PIP
Sbjct: 205 WELLTGEVPFRGID---------------GLAVAYGVAMNKLA---------LPIP---- 236
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEE 201
+L+E +P RP+
Sbjct: 237 -STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 53/210 (25%), Positives = 79/210 (37%), Gaps = 23/210 (10%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF--------HRDLKPKNILANADCK 56
L + +T E GL ++H V HRDLK KNIL +
Sbjct: 127 LFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185
Query: 57 LKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPE-LCGSFFSKYTPA---IDIWSIGC 111
I D GLA + T T I V T+ Y APE L S K+ + DI+++G
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245
Query: 112 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS 171
+F E+ + G + +QL + PS E + +V E+ R IP
Sbjct: 246 VFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR--------PNIPNR 296
Query: 172 QKFPNANPLALRLLERMLAFEPKDRPTAEE 201
+ A + +++ R TA
Sbjct: 297 WQSCEALRVMAKIMRECWYANGAARLTALR 326
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 35/199 (17%), Positives = 66/199 (33%), Gaps = 42/199 (21%)
Query: 5 LHQVI--KANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKIC 60
L+ V+ N + F + RG+ ++HT + L ++++ + D +I
Sbjct: 96 LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARIS 155
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTG 119
+ + + W APE L + D+WS + EL+T
Sbjct: 156 MADVKFSFQSPGRM---YA----PAWV-APEALQKKPEDTNRRSADMWSFAVLLWELVTR 207
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+ F + + E +V E R IP P +P
Sbjct: 208 EVPFADLS---------------NMEIGMKVALEGLR---------PTIP-----PGISP 238
Query: 180 LALRLLERMLAFEPKDRPT 198
+L++ + +P RP
Sbjct: 239 HVSKLMKICMNEDPAKRPK 257
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 4e-21
Identities = 59/253 (23%), Positives = 92/253 (36%), Gaps = 47/253 (18%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DLH + + + +F+ +++ GL+++H V +RDLKP NIL + ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA P A V T Y APE+ Y + D +S+GC+ +LL G F
Sbjct: 338 LACDFSKKKPHA-----SVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPF 391
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
R K + + M + F P
Sbjct: 392 -------------------------RQHKTKDKHEIDRMTLTMAVELPDSFS---PELRS 423
Query: 184 LLERMLAFEPKDR-----PTAEEALADPYFKGL--AKVER---EPSAQPVTKM---EFEF 230
LLE +L + R A+E P+F+ L V P P F
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAF 483
Query: 231 ERRRITKEDVREL 243
+ +ED + +
Sbjct: 484 DIGSFDEEDTKGI 496
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 54/229 (23%), Positives = 87/229 (37%), Gaps = 47/229 (20%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDF 62
DL I L + F Q++ +++ H+ V HRD+K +NIL + K+ DF
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKP 121
G + +D P +TD+ TR Y PE +Y +WS+G + +++ G
Sbjct: 185 GSGAL-LHDEP----YTDFDGTRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDI 237
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
F +I+ L P ++S P
Sbjct: 238 PFERDQ-----EILEAELHFP--------------AHVS------------------PDC 260
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFK-GLAKVEREPSAQPVTKMEFE 229
L+ R LA +P RP+ EE L DP+ + V PS + +
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 50/209 (23%), Positives = 82/209 (39%), Gaps = 46/209 (22%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDF 62
DL I L E + F +Q+L +++ H V HRD+K +NIL + + +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKP 121
G + DT +TD+ TR Y PE + +Y + +WS+G + +++ G
Sbjct: 195 GSGAL-LKDTV----YTDFDGTRVYSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDI 247
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
F +I+ + + +S
Sbjct: 248 PFEHDE-----EIIRGQVFFR--------------QRVS------------------SEC 270
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFKG 210
L+ LA P DRPT EE P+ +
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 1e-20
Identities = 52/228 (22%), Positives = 80/228 (35%), Gaps = 62/228 (27%)
Query: 1 ME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 56
ME L + L +L ++L L Y+H+ + + DLKP+NI+ + +
Sbjct: 163 MEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q 219
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
LK+ D G N T ++APE+ + T A DI+++G A L
Sbjct: 220 LKLIDLGAVS-RINSFGYLY------GTPGFQAPEIVR---TGPTVATDIYTVGRTLAAL 269
Query: 117 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176
P G+ V P + + +
Sbjct: 270 TLDLPTRNGRYVDG----------LPEDDPVLKT-------------------------- 293
Query: 177 ANPLAL-RLLERMLAFEPKDRP-TAEEALADPYFKGLAKVEREPSAQP 222
+ RLL R + +P+ R TAEE A L V RE AQ
Sbjct: 294 --YDSYGRLLRRAIDPDPRQRFTTAEEMSAQ-----LTGVLREVVAQD 334
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 47/187 (25%), Positives = 72/187 (38%), Gaps = 24/187 (12%)
Query: 29 RGLKYIHTA----------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78
RGL Y+H + HRD+K KN+L + I DFGLA F +A
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDT 190
Query: 79 TDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 135
V TR Y APE+ +F ID++++G + EL + G + L
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 136 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL-RLLERMLAFEPK 194
++ PS E + V K +R P+ +A L +E + +
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKR---------PVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 195 DRPTAEE 201
R +A
Sbjct: 302 ARLSAGC 308
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 57/253 (22%), Positives = 88/253 (34%), Gaps = 49/253 (19%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICD 61
+L++ I + + +FF QLL G+ Y H+ + HRDLK +N L + +LKICD
Sbjct: 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161
Query: 62 FGLARVAFNDTP--TAIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAEL 116
FG ++ + + + V T Y APE+ +Y D+WS G +
Sbjct: 162 FGYSKSSVLHSQPKST------VGTPAYIAPEV----LLRQEYDGKIADVWSCGVTLYVM 211
Query: 117 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176
L G F + I R+ + K IP +
Sbjct: 212 LVGAYPFEDPEEPRDYR-----------KTIQRILSVKYS-----------IPDDIRIS- 248
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEALADPYF-KGLAKVEREPSAQPVTKMEFEF----- 230
P L+ R+ +P R + E +F K L S E E
Sbjct: 249 --PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSL 306
Query: 231 -ERRRITKEDVRE 242
+I E
Sbjct: 307 DTIMQIISEATIP 319
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 42/213 (19%), Positives = 86/213 (40%), Gaps = 39/213 (18%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
++ V + N F+ Q++ GL+++H N+ +RDLKP+N+L + D ++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 65 A-RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
A + T T + T + APEL +Y ++D +++G E++ + F
Sbjct: 336 AVELKAGQTKTKGY----AGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPF 389
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
+ + + + ++ + + KF P +
Sbjct: 390 RARGEKVENKELKQRV------------------------LEQAVTYPDKFS---PASKD 422
Query: 184 LLERMLAFEPKDR-----PTAEEALADPYFKGL 211
E +L +P+ R + + P F+ +
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 44/212 (20%), Positives = 73/212 (34%), Gaps = 23/212 (10%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCK 56
L+ ++ L + + GL ++H + HRDLK KNIL + +
Sbjct: 93 LYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151
Query: 57 LKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPE-LCGSFFS---KYTPAIDIWSIGC 111
I D GLA + + + + V T+ Y APE L + +DIW+ G
Sbjct: 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGL 211
Query: 112 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS 171
+ E+ G ++ + PS E + +V +R IP
Sbjct: 212 VLWEVARRMVSN-GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR--------PNIPNR 262
Query: 172 QKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203
+L++ P R TA
Sbjct: 263 WFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 58/267 (21%), Positives = 96/267 (35%), Gaps = 58/267 (21%)
Query: 9 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68
I +T + + F Q++ ++Y H + HRDLKP+N+L + + +KI DFGL+
Sbjct: 99 IVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS--- 155
Query: 69 FNDTPTAIFWTDYVATRW-----YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPL 122
I Y APE+ Y P +D+WS G + +L G+
Sbjct: 156 ------NIMTDGNFLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLP 207
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
F + + P +V + +P +P A
Sbjct: 208 FDDEFI---------------PNLFKKVNSCVYV-----------MP-----DFLSPGAQ 236
Query: 183 RLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 242
L+ RM+ +P R T +E DP+F V +P+ E + V +
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWF----NVNLPDYLRPME----EVQGSYADSRIVSK 288
Query: 243 LIYREILEYHPQMLKEFLEGSEPTGFM 269
L E + + + E L E
Sbjct: 289 LG--EAMGFSEDYIVEALRSDENNEVK 313
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 41/196 (20%), Positives = 75/196 (38%), Gaps = 34/196 (17%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77
E + F+ +L+ L Y+ + HRD+KP NIL + + I DF +A + +T
Sbjct: 115 ETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM 174
Query: 78 WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 136
T+ Y APE + Y+ A+D WS+G ELL G+ +
Sbjct: 175 ----AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY------------- 217
Query: 137 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 196
+R+ + + + + + + + + LL+++L P R
Sbjct: 218 ------------HIRSSTSSKEIVHTFETTVVTYPSAWS---QEMVSLLKKLLEPNPDQR 262
Query: 197 -PTAEEALADPYFKGL 211
+ PY +
Sbjct: 263 FSQLSDVQNFPYMNDI 278
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 7e-20
Identities = 51/198 (25%), Positives = 71/198 (35%), Gaps = 58/198 (29%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND--------TPT 74
Q+L + Y H V HRDLKP+N+L +A KI DFGL+ + + +P
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN 175
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133
Y APE+ Y P +DIWS G I LL G F ++V
Sbjct: 176 ------------YAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----- 216
Query: 134 IMTDLLGTPSPEAIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 191
P ++R YL+ LL ML
Sbjct: 217 ----------PTLFKKIRGGVFYIPEYLN------------------RSVATLLMHMLQV 248
Query: 192 EPKDRPTAEEALADPYFK 209
+P R T ++ +FK
Sbjct: 249 DPLKRATIKDIREHEWFK 266
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 50/196 (25%), Positives = 80/196 (40%), Gaps = 35/196 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
+ + L+ L+++H+ V HRD+K NIL D +K+ DFG TP
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPE 169
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLD 133
+ V T ++ APE+ Y P +DIWS+G I A E++ G+P P N + L
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLG-IMAIEMIEGEP--PYLN-ENPLR 223
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
+ + +P + P S F + L R L +
Sbjct: 224 ALYLIATNGTP------------------ELQNPEKLSAIFRD-------FLNRCLEMDV 258
Query: 194 KDRPTAEEALADPYFK 209
+ R +A+E L + K
Sbjct: 259 EKRGSAKELLQHQFLK 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 38/199 (19%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77
F+ ++ GL+ +H + +RDLKP+NIL + ++I D GLA
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345
Query: 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 137
V T Y APE+ + +YT + D W++GC+ E++ G+ F + + + +
Sbjct: 346 ----VGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
Query: 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR- 196
+ K+ P +S++F A L ++L +P +R
Sbjct: 400 ------------------------LVKEVPEEYSERFSPQ---ARSLCSQLLCKDPAERL 432
Query: 197 ----PTAEEALADPYFKGL 211
+A E P FK L
Sbjct: 433 GCRGGSAREVKEHPLFKKL 451
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 52/267 (19%), Positives = 91/267 (34%), Gaps = 59/267 (22%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL I + L + QL+ + Y+ ++ HRD+K +NI+ D +K+ DFG
Sbjct: 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS--KYT-PAIDIWSIGCIFAELLTGK 120
A +F+T + T Y APE+ Y P +++WS+G L+ +
Sbjct: 176 SAAYL---ERGKLFYT-FCGTIEYCAPEV----LMGNPYRGPELEMWSLGVTLYTLVFEE 227
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
F + P S
Sbjct: 228 NPFCE------------------------LEETVEAAI------HPPYLVS-------KE 250
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
+ L+ +L P+ R T E+ + DP+ QPV ++ +E +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVT-----------QPVNLADYTWEEVFRVNKPE 299
Query: 241 RELIYREILEYHPQMLKEFLEGSEPTG 267
++ LE + L + + E G
Sbjct: 300 SGVLSAASLEMGNRSLSDVAQAQELCG 326
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 54/202 (26%), Positives = 81/202 (40%), Gaps = 35/202 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L E +L+ L Y+H V HRD+K +IL D ++K+ DFG +
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKD 194
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLD 133
V T ++ APE+ S Y +DIWS+G I E++ G+P P + +
Sbjct: 195 VPKRKSLVGTPYWMAPEVISR--SLYATEVDIWSLG-IMVIEMVDGEP--PYFS-DSPVQ 248
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
M L +P P + K S + LERML +P
Sbjct: 249 AMKRLRDSPPP------------------KLKNSHKVSPVLRD-------FLERMLVRDP 283
Query: 194 KDRPTAEEALADPYFKGLAKVE 215
++R TA+E L P+ E
Sbjct: 284 QERATAQELLDHPFLLQTGLPE 305
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 44/216 (20%), Positives = 79/216 (36%), Gaps = 39/216 (18%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L + K + + E +F+L +++ + +H HRD+KP NIL + +++ DFG
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208
Query: 65 A-RVAFNDTPTAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAELLT 118
++ + T + V T Y +PE+ G Y P D W++G E+
Sbjct: 209 CLKLRADGTVRS--LV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
G+ F + Y + K+ +
Sbjct: 266 GQTPFYADSTA--------------------------ETYGKIVHYKEHLSLPLVDEGVP 299
Query: 179 PLALRLLERMLAFEPKDR---PTAEEALADPYFKGL 211
A ++R+L P+ R A + P+F GL
Sbjct: 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 24/217 (11%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
++ + + + L L ++L GL+Y+H HRD+K NIL D ++I
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163
Query: 61 DFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
DFG++ D +V T + APE+ Y DIWS G EL T
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELAT 222
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
G + H+ M L+ T +N+ K+ + + F
Sbjct: 223 GAAPY------HKYPPMKVLMLTL--------QNDPPSLETGVQDKEMLKKYGKSFRK-- 266
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215
++ L +P+ RPTA E L +F+ E
Sbjct: 267 -----MISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 61/267 (22%), Positives = 104/267 (38%), Gaps = 68/267 (25%)
Query: 1 ME-------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 53
ME +DL + K N L E + ++LRGL ++H V HRD+K +N+L
Sbjct: 106 MEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 164
Query: 54 DCKLKICDFGLA---------RVAFNDTPTAIFWTDYVATRWYRAPE--LCGSFF-SKYT 101
+ ++K+ DFG++ R F TP +W APE C + Y
Sbjct: 165 NAEVKLVDFGVSAQLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYD 212
Query: 102 PAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160
D+WS+G I A E+ G P P + +H + + + P+P
Sbjct: 213 FKSDLWSLG-ITAIEMAEGAP--PLCD-MHPMRALFLIPRNPAP---------------- 252
Query: 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 220
+ K +S+KF + +E L RP E+ + P+ +
Sbjct: 253 ---RLKSKKWSKKFQS-------FIESCLVKNHSQRPATEQLMKHPFIRDQPN-----ER 297
Query: 221 QPVTKMEFEFERRRITKEDVRELIYRE 247
Q +++ +R + + + E Y
Sbjct: 298 QVRIQLKDHIDRTKKKRGEKDETEYEY 324
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 43/217 (19%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L + K D L E +F+L +++ + +H + HRD+KP NIL + + +++ DFG
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221
Query: 65 A-RVAFNDTPTAIFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGK 120
++ + T + V T Y +PE+ +Y P D WS+G E+L G+
Sbjct: 222 CLKLMEDGTVQS--SV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
F +++V Y M K+ F + + +
Sbjct: 279 TPFYAESLV--------------------------ETYGKIMNHKERFQFPTQVTDVSEN 312
Query: 181 ALRLLERMLAFEPKDRPT------AEEALADPYFKGL 211
A L+ R++ R E+ P+F G+
Sbjct: 313 AKDLIRRLI----CSREHRLGQNGIEDFKKHPFFSGI 345
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 56/202 (27%), Positives = 84/202 (41%), Gaps = 35/202 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT + L L+GL+Y+H HRD+K NIL N + K+ DFG VA T T
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG---VAGQLTDT 178
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKNVVHQLD 133
+ T ++ APE+ Y DIWS+G I A E+ GKP P + +H +
Sbjct: 179 MAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLG-ITAIEMAEGKP--PYAD-IHPMR 232
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
+ + P P +KP +S F + +++ L P
Sbjct: 233 AIFMIPTNPPP------------------TFRKPELWSDNFTD-------FVKQCLVKSP 267
Query: 194 KDRPTAEEALADPYFKGLAKVE 215
+ R TA + L P+ + V
Sbjct: 268 EQRATATQLLQHPFVRSAKGVS 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77
+ F+L ++ L ++H + +RDLKP+NI+ N +K+ DFGL + + +D
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-- 178
Query: 78 WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IM 135
+ T Y APE L S + A+D WS+G + ++LTG P F G+N +D I+
Sbjct: 179 -HTFCGTIEYMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 136 TDLLGTP---SPEAIA 148
L P + EA
Sbjct: 235 KCKLNLPPYLTQEARD 250
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 51/195 (26%), Positives = 72/195 (36%), Gaps = 52/195 (26%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
Q+L G+ Y H V HRDLKP+N+L +A KI DFGL+ +
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---------NMMSDGEF 171
Query: 83 ATRW-----YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 136
Y APE+ Y P +DIWS G I LL G F +V
Sbjct: 172 LRTSCGSPNYAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------- 221
Query: 137 DLLGTPSPEAIARVRNEKAR--RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 194
P ++ + +YL+ P + LL+ ML +P
Sbjct: 222 -------PTLFKKICDGIFYTPQYLN------------------PSVISLLKHMLQVDPM 256
Query: 195 DRPTAEEALADPYFK 209
R T ++ +FK
Sbjct: 257 KRATIKDIREHEWFK 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 59/214 (27%), Positives = 80/214 (37%), Gaps = 65/214 (30%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--------- 65
L L ++L+GL Y+H+ HRD+K N+L + ++K+ DFG+A
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFP 124
R F TP FW APE+ S Y DIWS+G I A EL G+P
Sbjct: 176 RNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLG-ITAIELARGEPPH- 219
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP-----FSQKFPNANP 179
+L M L P K P +S+
Sbjct: 220 -----SELHPMKVLFLIP----------------------KNNPPTLEGNYSKPLKE--- 249
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213
+E L EP RPTA+E L + AK
Sbjct: 250 ----FVEACLNKEPSFRPTAKELLKHKFILRNAK 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 59/253 (23%), Positives = 94/253 (37%), Gaps = 70/253 (27%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-----RVAF 69
L + L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A +F
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 210
Query: 70 NDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-ELLTGKPLFPGKN 127
TP +W APE+ +Y +D+WS+G I EL KP
Sbjct: 211 VGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP------ 251
Query: 128 VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP------FSQKFPNANPLA 181
P N A L + + + P +S+ F N
Sbjct: 252 ----------------PLF-----NMNAMSALYHIAQNES-PALQSGHWSEYFRN----- 284
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVR 241
++ L P+DRPT+E L + +P T + +R + ++
Sbjct: 285 --FVDSCLQKIPQDRPTSEVLLKHRFVL---------RERPPTVIMDLIQRTKDAVRELD 333
Query: 242 ELIYREILEYHPQ 254
L YR++ + Q
Sbjct: 334 NLQYRKMKKILFQ 346
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 13/137 (9%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77
E +F+L +L L ++H+ + +RDLKP+NIL + + +K+ DFGL++ + + A
Sbjct: 126 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-- 183
Query: 78 WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DI 134
+ T Y APE + +T + D WS G + E+LTG F GK+ + I
Sbjct: 184 -YSFCGTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMI 238
Query: 135 MTDLLGTP---SPEAIA 148
+ LG P SPEA +
Sbjct: 239 LKAKLGMPQFLSPEAQS 255
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 4/118 (3%)
Query: 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73
D+ + +F+ +++ L IH+ HRD+KP N+L + LK+ DFG N
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEG 222
Query: 74 TAIFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 129
T V T Y +PE Y D WS+G E+L G F ++V
Sbjct: 223 MVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 48/214 (22%), Positives = 83/214 (38%), Gaps = 54/214 (25%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--------- 65
LT Q Q+L L ++H+ + HRDLK N+L + +++ DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-ELLTGKP 121
R +F TP +W APE+ K Y DIWS+G I E+ +P
Sbjct: 174 RDSFIGTP---YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
P ++ + ++ + + P P +S +F +
Sbjct: 221 --PHHE-LNPMRVLLKIAKSDPP------------------TLLTPSKWSVEFRD----- 254
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215
L+ L P+ RP+A + L P+ + +
Sbjct: 255 --FLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 47/194 (24%), Positives = 79/194 (40%), Gaps = 30/194 (15%)
Query: 29 RGLKYIHTANVF---------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79
RGL Y+HT HRDL +N+L D I DFGL+ +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 80 DY-----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV 128
D V T Y APE L G+ +D++++G I+ E+ LFPG++V
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 129 V-HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS-QKFPNANPLALRLLE 186
+Q+ T++ P+ E + + + + +R P + ++ A +E
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQR--------PKFPEAWKENSLAVRSLKETIE 293
Query: 187 RMLAFEPKDRPTAE 200
+ + R TA+
Sbjct: 294 DCWDQDAEARLTAQ 307
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL I++ F+ +++ GL+++H+ + +RDLK NIL + D +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163
Query: 64 LAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
+ + + + T F T Y APE+ KY ++D WS G + E+L G+
Sbjct: 164 MCKENMLGDAK-TNTF----CGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQS 216
Query: 122 LFPGKNVVHQLD-IMTDLLGTP---SPEAIA 148
F G++ I D P EA
Sbjct: 217 PFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 40/139 (28%), Positives = 73/139 (52%), Gaps = 17/139 (12%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTA 75
E +F+ +++ L+Y+H+ +V +RD+K +N++ + D +KI DFGL + ++ T
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MK 163
Query: 76 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-- 132
F T Y APE L + Y A+D W +G + E++ G+ F ++ +L
Sbjct: 164 TF----CGTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFE 215
Query: 133 DIMTDLLGTP---SPEAIA 148
I+ + + P SPEA +
Sbjct: 216 LILMEEIRFPRTLSPEAKS 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 15/138 (10%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTA 75
+F+ +++ L ++H + +RDLK N+L + + K+ DFG+ + T TA
Sbjct: 124 ARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TA 182
Query: 76 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD- 133
F T Y APE L Y PA+D W++G + E+L G F +N +
Sbjct: 183 TF----CGTPDYIAPEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235
Query: 134 IMTDLLGTP---SPEAIA 148
I+ D + P +A
Sbjct: 236 ILNDEVVYPTWLHEDATG 253
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTA 75
H F+ ++ GL ++ + + +RDLK N++ +++ +KI DFG+ + + T T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TK 179
Query: 76 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD- 133
F T Y APE + Y ++D W+ G + E+L G+ F G++
Sbjct: 180 TF----CGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 232
Query: 134 IMTDLLGTP---SPEAIA 148
IM + P S EA+A
Sbjct: 233 IMEHNVAYPKSMSKEAVA 250
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 40/202 (19%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTA 75
Q ++ +++ L+++H + +RD+K +NIL +++ + + DFGL++ VA
Sbjct: 159 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 135
F T Y AP++ S + A+D WS+G + ELLTG F
Sbjct: 219 DF----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-------- 266
Query: 136 TDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPK 194
+ ++ +S K P+ Q+ A L RLL + +PK
Sbjct: 267 ----------------EKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK----DPK 306
Query: 195 DR----PT-AEEALADPYFKGL 211
R P A+E +F+ +
Sbjct: 307 KRLGCGPRDADEIKEHLFFQKI 328
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTA 75
H F+ ++ GL ++ + + +RDLK N++ +++ +KI DFG+ + + T T
Sbjct: 442 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TK 500
Query: 76 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD- 133
F T Y APE + Y ++D W+ G + E+L G+ F G++
Sbjct: 501 TF----CGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 553
Query: 134 IMTDLLGTP---SPEAIA 148
IM + P S EA+A
Sbjct: 554 IMEHNVAYPKSMSKEAVA 571
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 8/110 (7%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77
H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++ DFG A+ T
Sbjct: 141 PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----- 195
Query: 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 127
WT T APE+ S Y A+D W++G + E+ G P F
Sbjct: 196 WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 38/138 (27%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 16 TPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
+ + +F+ +++ L Y+H+ NV +RDLK +N++ + D +KI DFGL + D T
Sbjct: 246 SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD- 133
+ T Y APE+ + Y A+D W +G + E++ G+ F ++ +
Sbjct: 306 M---KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 134 IMTDLLGTP---SPEAIA 148
I+ + + P PEA +
Sbjct: 361 ILMEEIRFPRTLGPEAKS 378
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 39/138 (28%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTA 75
+F+ ++ L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + N T T+
Sbjct: 139 PRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TS 197
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--D 133
F T Y APE+ Y +D W +G + E+L G P F +N ++ +
Sbjct: 198 TF----CGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDN 250
Query: 134 IMTDLLGTP---SPEAIA 148
I+ L + A
Sbjct: 251 ILNKPLQLKPNITNSARH 268
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 46/203 (22%), Positives = 84/203 (41%), Gaps = 39/203 (19%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTA 75
EH +F+ ++ L Y+H + +RDLK N+L +++ +K+ D+G+ + + DT T+
Sbjct: 110 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TS 168
Query: 76 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 134
F T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 169 TF----CGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD- 220
Query: 135 MTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 194
+ YL + +K I + A +L+ L +PK
Sbjct: 221 ------------------QNTEDYLFQVILEKQIRIPRSLS---VKAASVLKSFLNKDPK 259
Query: 195 DR------PTAEEALADPYFKGL 211
+R + P+F+ +
Sbjct: 260 ERLGCHPQTGFADIQGHPFFRNV 282
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 35/141 (24%), Positives = 59/141 (41%), Gaps = 20/141 (14%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ + D + ++ + Q+ +G+ Y+ + HRDL +N+L +KI DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 63 GLARVAFNDTPTAIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
GLA++ + Y A +W A E YT D+WS G EL
Sbjct: 162 GLAKLLGAEEKE------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWEL 212
Query: 117 LT-GKPLFPGKN---VVHQLD 133
+T G + G + L+
Sbjct: 213 MTFGSKPYDGIPASEISSILE 233
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 18/113 (15%)
Query: 21 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT- 79
+F+ ++ L+Y+H+ ++ +RDLKP+NIL + + +KI DFG A+ + T +T
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTL 163
Query: 80 ----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 128
DY+ APE+ + Y +ID WS G + E+L G F N
Sbjct: 164 CGTPDYI------APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 24/147 (16%)
Query: 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTA 75
EH +F+ ++ L Y+H + +RDLK N+L +++ +K+ D+G+ + + DT T+
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TS 211
Query: 76 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD- 133
F T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 212 TF----CGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
Query: 134 ---------IMTDLLGTP---SPEAIA 148
I+ + P S +A +
Sbjct: 265 NTEDYLFQVILEKQIRIPRSLSVKAAS 291
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 20/141 (14%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L++ ++ N + ++ ++Q+ G+KY+ +N HRDL +N+L KI DFG
Sbjct: 103 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 162
Query: 64 LARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
L++ D Y A +WY APE + K++ D+WS G + E
Sbjct: 163 LSKALRADENY------YKAQTHGKWPVKWY-APE--CINYYKFSSKSDVWSFGVLMWEA 213
Query: 117 LT-GKPLFPGKN---VVHQLD 133
+ G+ + G V L+
Sbjct: 214 FSYGQKPYRGMKGSEVTAMLE 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 22/130 (16%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L Q+ G+ Y+ N HRDL+ NIL + K+ DFGLAR+ ++ T
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336
Query: 75 A-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG- 125
A I WT APE + + ++T D+WS G + EL T G+ +PG
Sbjct: 337 ARQGAKFPIKWT---------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 126 --KNVVHQLD 133
+ V+ Q++
Sbjct: 386 VNREVLDQVE 395
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 36/132 (27%), Positives = 61/132 (46%), Gaps = 22/132 (16%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72
+++ + Q+ ++Y+ N HRDL +N L + +K+ DFGL+R+ DT
Sbjct: 106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
Query: 73 PTA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 124
TA I WT APE ++K++ D+W+ G + E+ T G +P
Sbjct: 166 YTAHAGAKFPIKWT---------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 214
Query: 125 GKN---VVHQLD 133
G + V L+
Sbjct: 215 GIDLSQVYELLE 226
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-15
Identities = 34/142 (23%), Positives = 62/142 (43%), Gaps = 23/142 (16%)
Query: 4 DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++++ L P Y + G+ ++ + HRDL +N L + D +K+ DF
Sbjct: 89 CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDF 148
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
G+ R +D YV++ +W APE + KY+ D+W+ G + E
Sbjct: 149 GMTRYVLDD--------QYVSSVGTKFPVKWS-APE--VFHYFKYSSKSDVWAFGILMWE 197
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
+ + GK + VV ++
Sbjct: 198 VFSLGKMPYDLYTNSEVVLKVS 219
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 22/130 (16%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
++ + Q+ ++Y+ N HR+L +N L + +K+ DFGL+R+ DT T
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 75 A-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG- 125
A I WT APE ++K++ D+W+ G + E+ T G +PG
Sbjct: 375 AHAGAKFPIKWT---------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
Query: 126 --KNVVHQLD 133
V L+
Sbjct: 424 DLSQVYELLE 433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 40/130 (30%), Positives = 61/130 (46%), Gaps = 22/130 (16%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L Q+ G+ Y+ N HRDL+ NIL + K+ DFGLAR+ ++ T
Sbjct: 360 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419
Query: 75 A-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG- 125
A I WT APE + + ++T D+WS G + EL T G+ +PG
Sbjct: 420 ARQGAKFPIKWT---------APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
Query: 126 --KNVVHQLD 133
+ V+ Q++
Sbjct: 469 VNREVLDQVE 478
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 34/142 (23%), Positives = 60/142 (42%), Gaps = 22/142 (15%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ + L P+ + Q+ +G+ Y+ + HR+L +N+L + ++++ DF
Sbjct: 100 SLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
G+A + D + +W A E F KYT D+WS G E
Sbjct: 160 GVADLLPPD-------DKQLLYSEAKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWE 209
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
L+T G + G V L+
Sbjct: 210 LMTFGAEPYAGLRLAEVPDLLE 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 35/141 (24%), Positives = 59/141 (41%), Gaps = 20/141 (14%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ + D + ++ + Q+ +G+ Y+ + HRDL +N+L +KI DF
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 63 GLARVAFNDTPTAIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
GLA++ + Y A +W A E YT D+WS G EL
Sbjct: 162 GLAKLLGAEEKE------YHAEGGKVPIKWM-ALE--SILHRIYTHQSDVWSYGVTVWEL 212
Query: 117 LT-GKPLFPGKN---VVHQLD 133
+T G + G + L+
Sbjct: 213 MTFGSKPYDGIPASEISSILE 233
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 23/142 (16%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+L ++ L + YQL L Y+ + HRD+ +N+L +++ +K+ DF
Sbjct: 101 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL+R + Y +W APE F ++T A D+W G E
Sbjct: 161 GLSRYMEDS--------TYYKASKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWE 209
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
+L G F G V+ +++
Sbjct: 210 ILMHGVKPFQGVKNNDVIGRIE 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 45/207 (21%), Positives = 77/207 (37%), Gaps = 39/207 (18%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ + + + + Q+ +G++Y+ T HRDL +NIL + ++KI DF
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL +V D Y WY APE SK++ A D+WS G + E
Sbjct: 190 GLTKVLPQDKEY------YKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYE 240
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS-MRKKKPIPFSQKF 174
L T + K+ + M + + + L + R +P
Sbjct: 241 LFT----YIEKSKSPPAEFMRMIGNDKQGQ----MIVFHLIELLKNNGRLPRP------- 285
Query: 175 PNANPLALRLLERML---AFEPKDRPT 198
P + ++ M RP+
Sbjct: 286 DGC-PDEIYMI--MTECWNNNVNQRPS 309
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 44/207 (21%), Positives = 77/207 (37%), Gaps = 39/207 (18%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ + + + + Q+ +G++Y+ T HRDL +NIL + ++KI DF
Sbjct: 99 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 158
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL +V D + WY APE SK++ A D+WS G + E
Sbjct: 159 GLTKVLPQDKEF------FKVKEPGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYE 209
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS-MRKKKPIPFSQKF 174
L T + K+ + M + + + L + R +P
Sbjct: 210 LFT----YIEKSKSPPAEFMRMIGNDKQGQ----MIVFHLIELLKNNGRLPRP------- 254
Query: 175 PNANPLALRLLERML---AFEPKDRPT 198
P + ++ M RP+
Sbjct: 255 DGC-PDEIYMI--MTECWNNNVNQRPS 278
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 38/143 (26%), Positives = 61/143 (42%), Gaps = 23/143 (16%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
LH+ + + + + L+Q+ G+KY+ N HRDL +N+L KI DF
Sbjct: 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFA 114
GL++ D Y A +WY APE F K++ D+WS G
Sbjct: 155 GLSKALGADDSY------YTARSAGKWPLKWY-APE---CINFRKFSSRSDVWSYGVTMW 204
Query: 115 ELLT-GKPLFPGKN---VVHQLD 133
E L+ G+ + V+ ++
Sbjct: 205 EALSYGQKPYKKMKGPEVMAFIE 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 34/142 (23%), Positives = 59/142 (41%), Gaps = 23/142 (16%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ E + G+ Y+ A V HRDL +N L + +K+ DF
Sbjct: 89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 148
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
G+ R +D Y ++ +W +PE FS+Y+ D+WS G + E
Sbjct: 149 GMTRFVLDD--------QYTSSTGTKFPVKWA-SPE--VFSFSRYSSKSDVWSFGVLMWE 197
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
+ + GK + ++ VV +
Sbjct: 198 VFSEGKIPYENRSNSEVVEDIS 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 43/122 (35%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------- 75
F Q+ G+ +I N HRDL+ NIL +A KI DFGLARV ++ TA
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQ 131
I WT APE F +T D+WS G + E++T G+ +PG V+
Sbjct: 349 IKWT---------APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397
Query: 132 LD 133
L+
Sbjct: 398 LE 399
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 25/143 (17%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+L ++ N + L + Q+ + + Y+ + N HRD+ +NIL + +K+ DF
Sbjct: 98 ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFA 114
GL+R ++ DY +W +PE S F ++T A D+W
Sbjct: 158 GLSRYIEDE--------DYYKASVTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMW 205
Query: 115 ELLT-GKPLFPGKN---VVHQLD 133
E+L+ GK F V+ L+
Sbjct: 206 EILSFGKQPFFWLENKDVIGVLE 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 35/143 (24%), Positives = 56/143 (39%), Gaps = 23/143 (16%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ + + Q+ G+ Y+ + HRDL +N+L +KI DF
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 165
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFA 114
GL R + YV W APE S ++ A D W G
Sbjct: 166 GLMRALPQNDDH------YVMQEHRKVPFAWC-APE---SLKTRTFSHASDTWMFGVTLW 215
Query: 115 ELLT-GKPLFPGKN---VVHQLD 133
E+ T G+ + G N ++H++D
Sbjct: 216 EMFTYGQEPWIGLNGSQILHKID 238
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 44/209 (21%), Positives = 77/209 (36%), Gaps = 44/209 (21%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L + + N + + + + Q+ +G+ Y+ + HRDL +N+L ++ ++KI DF
Sbjct: 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL + D Y WY APE SK+ A D+WS G E
Sbjct: 171 GLTKAIETDKEY------YTVKDDRDSPVFWY-APE--CLMQSKFYIASDVWSFGVTLHE 221
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS---MRKKKPIPFSQ 172
LLT + + + ++G + + + L +
Sbjct: 222 LLTY-----CDSDSSPMALFLKMIGPTHGQ----MTVTRLVNTLKEGKRLPC-------- 264
Query: 173 KFPNANPLALRLLERML---AFEPKDRPT 198
P P + L M F+P +R +
Sbjct: 265 --PPNCPDEVYQL--MRKCWEFQPSNRTS 289
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 34/126 (26%), Positives = 57/126 (45%), Gaps = 18/126 (14%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L + F + ++Y+ N HRDL +N+L + D K+ DFGL + A + T
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 75 AIF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KN 127
WT APE K++ D+WS G + E+ + G+ +P K+
Sbjct: 174 GKLPVKWT---------APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
Query: 128 VVHQLD 133
VV +++
Sbjct: 223 VVPRVE 228
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 37/142 (26%), Positives = 61/142 (42%), Gaps = 21/142 (14%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
LH+ + + + + L+Q+ G+KY+ N HR+L +N+L KI DF
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL++ D Y A +WY APE F K++ D+WS G E
Sbjct: 481 GLSKALGADDSY------YTARSAGKWPLKWY-APE--CINFRKFSSRSDVWSYGVTMWE 531
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
L+ G+ + V+ ++
Sbjct: 532 ALSYGQKPYKKMKGPEVMAFIE 553
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 19/141 (13%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ +D T L + G++Y+ HRDL +N+L +++ K+ DF
Sbjct: 136 SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 63 GLARVAFNDTPTAIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
GL+RV +D A Y T RW APE F ++ A D+WS G + E+
Sbjct: 196 GLSRVLEDDPDAA-----YTTTGGKIPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEV 247
Query: 117 LT-GKPLFPGKN---VVHQLD 133
L G+ + V+ ++
Sbjct: 248 LAYGERPYWNMTNRDVISSVE 268
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 7e-14
Identities = 36/95 (37%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 29 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TRWY 87
G+ ++H + HRD+K NIL + KI DFGLAR + T + T + T Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM--TSRIVGTTAY 201
Query: 88 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
APE L G + TP DI+S G + E++TG P
Sbjct: 202 MAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 8e-14
Identities = 41/130 (31%), Positives = 59/130 (45%), Gaps = 22/130 (16%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT Q+ G+ +I N HRDL+ NIL + KI DFGLAR+ ++ T
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165
Query: 75 A-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 126
A I WT APE + +T D+WS G + E++T G+ +PG
Sbjct: 166 AREGAKFPIKWT---------APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 127 N---VVHQLD 133
V+ L+
Sbjct: 215 TNPEVIQNLE 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 23/142 (16%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+L ++ L + YQL L Y+ + HRD+ +N+L +++ +K+ DF
Sbjct: 476 ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 535
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL+R + Y +W APE F ++T A D+W G E
Sbjct: 536 GLSRYMEDS--------TYYKASKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWE 584
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
+L G F G V+ +++
Sbjct: 585 ILMHGVKPFQGVKNNDVIGRIE 606
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+E + D LT EH + +Q+ +G++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 61 DFGLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 114 AELLT-GKPLFPGKNVVHQL 132
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 19/141 (13%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ +D T L + G+KY+ HRDL +NIL N++ K+ DF
Sbjct: 132 SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDF 191
Query: 63 GLARVAFNDTPTAIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
GL RV +D A Y RW +PE + K+T A D+WS G + E+
Sbjct: 192 GLGRVLEDDPEAA-----YTTRGGKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEV 243
Query: 117 LT-GKPLFPGKN---VVHQLD 133
++ G+ + + V+ +D
Sbjct: 244 MSYGERPYWEMSNQDVIKAVD 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 10/136 (7%)
Query: 4 DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
D ++ L + + G++Y+ + HRDL +N L LKI DF
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GK 120
G++R + A V +W APE + + +Y+ D+WS G + E + G
Sbjct: 258 GMSREEADGVYAASGGLRQVPVKWT-APE---ALNYGRYSSESDVWSFGILLWETFSLGA 313
Query: 121 PLFPGKN---VVHQLD 133
+P + ++
Sbjct: 314 SPYPNLSNQQTREFVE 329
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 47/188 (25%), Positives = 75/188 (39%), Gaps = 41/188 (21%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
+ Q+ +G++Y+ + HRDL +NIL ++ +KI DFGLA++ D YV
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------YV 185
Query: 83 AT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFPGKNVVHQLD 133
WY APE + ++ D+WS G + EL T K P + +
Sbjct: 186 VREPGQSPIFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML---A 190
D + + E+ +R + P A P + L M A
Sbjct: 243 CERD--VPALSRLLELL--EEGQR----LPA----------PPACPAEVHEL--MKLCWA 282
Query: 191 FEPKDRPT 198
P+DRP+
Sbjct: 283 PSPQDRPS 290
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 19/141 (13%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L + ++ D + L + G+KY+ N HRDL +NIL N++ K+ DF
Sbjct: 132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 63 GLARVAFNDTPTAIFWTDYVAT------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
GL+RV +D Y + RW APE + K+T A D+WS G + E+
Sbjct: 192 GLSRVLEDDP-----EATYTTSGGKIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEV 243
Query: 117 LT-GKPLFPGKN---VVHQLD 133
+T G+ + + V+ ++
Sbjct: 244 MTYGERPYWELSNHEVMKAIN 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 30/142 (21%), Positives = 55/142 (38%), Gaps = 23/142 (16%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ + + ++Y+ + HRDL +N L N +K+ DF
Sbjct: 105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 63 GLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
GL+R +D +Y ++ RW PE +SK++ DIW+ G + E
Sbjct: 165 GLSRYVLDD--------EYTSSVGSKFPVRWS-PPE--VLMYSKFSSKSDIWAFGVLMWE 213
Query: 116 LLT-GKPLFPGKN---VVHQLD 133
+ + GK + +
Sbjct: 214 IYSLGKMPYERFTNSETAEHIA 235
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 33/123 (26%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L + F + ++Y+ N HRDL +N+L + D K+ DFGL + A + T
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVH 130
+W APE K++ D+WS G + E+ + G+ +P K+VV
Sbjct: 346 GKL-----PVKWT-APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397
Query: 131 QLD 133
+++
Sbjct: 398 RVE 400
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 46/189 (24%), Positives = 67/189 (35%), Gaps = 43/189 (22%)
Query: 23 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82
F Q+ G+ Y+H + HRDL +N+L + D +KI DFGLA+ Y
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YR 192
Query: 83 AT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 135
WY APE K+ A D+WS G ELLT +
Sbjct: 193 VREDGDSPVFWY-APE--CLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKF 244
Query: 136 TDLLGTPSPEAIARVRNEKARRYLSS---MRKKKPIPFSQKFPNANPLALRLLERML--- 189
+L+G + + + L + + P+ P + L M
Sbjct: 245 LELIGIAQGQ----MTVLRLTELLERGERLPR----------PDKCPAEVYHL--MKNCW 288
Query: 190 AFEPKDRPT 198
E RPT
Sbjct: 289 ETEASFRPT 297
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 17/100 (17%)
Query: 29 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-- 86
RGL Y+HT + HRD+K NIL + + KI DFG+++ T +++T
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT------HLSTVVKG 203
Query: 87 ---YRAPELCGSFFS--KYTPAIDIWSIGCIFAELLTGKP 121
Y PE +F + T D++S G + E+L +
Sbjct: 204 TLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 26/145 (17%)
Query: 4 DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
DL Q I++ + T + F Q+ RG++Y+ HRDL +N + + +K+ DF
Sbjct: 109 DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 63 GLARVAFNDTPTAIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCI 112
GLAR I +Y + +W A E ++T D+WS G +
Sbjct: 169 GLARD--------ILDREYYSVQQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVL 217
Query: 113 FAELLT-GKPLFPGKN---VVHQLD 133
ELLT G P + + + H L
Sbjct: 218 LWELLTRGAPPYRHIDPFDLTHFLA 242
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 39/145 (26%), Positives = 63/145 (43%), Gaps = 26/145 (17%)
Query: 4 DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
DL I+ + T + F Q+ +G+KY+ + HRDL +N + + +K+ DF
Sbjct: 113 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADF 172
Query: 63 GLARVAFNDTPTAIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCI 112
GLAR ++ +Y + +W A E K+T D+WS G +
Sbjct: 173 GLARD--------MYDKEYYSVHNKTGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVL 221
Query: 113 FAELLT-GKPLFPGKN---VVHQLD 133
EL+T G P +P N + L
Sbjct: 222 LWELMTRGAPPYPDVNTFDITVYLL 246
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 37/145 (25%), Positives = 63/145 (43%), Gaps = 26/145 (17%)
Query: 4 DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
DL I+ + T + F Q+ +G+K++ + HRDL +N + + +K+ DF
Sbjct: 177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 63 GLARVAFNDTPTAIFWTDYVAT----------RWYRAPELCGSFFSKYTPAIDIWSIGCI 112
GLAR ++ ++ + +W A E K+T D+WS G +
Sbjct: 237 GLARD--------MYDKEFDSVHNKTGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVL 285
Query: 113 FAELLT-GKPLFPGKN---VVHQLD 133
EL+T G P +P N + L
Sbjct: 286 LWELMTRGAPPYPDVNTFDITVYLL 310
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 18/131 (13%)
Query: 10 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 69
AN + F Q+ +G+ ++ + N HRD+ +N+L KI DFGLAR
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 70 NDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 121
ND ++Y+ +W APE F YT D+WS G + E+ + G
Sbjct: 216 ND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
Query: 122 LFPGKNVVHQL 132
+PG V +
Sbjct: 266 PYPGILVNSKF 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 25/145 (17%), Positives = 43/145 (29%), Gaps = 25/145 (17%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL----- 57
L +K N + + QL + ++ + H ++ KNIL +
Sbjct: 98 SLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157
Query: 58 ---KICDFGLARVAFNDTPTAIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCI 112
K+ D G++ D W PE C A D WS G
Sbjct: 158 PFIKLSDPGISITVLPK--------DILQERIPWV-PPE-CIENPKNLNLATDKWSFGTT 207
Query: 113 FAELLT-GKPLFPGKN---VVHQLD 133
E+ + G + + +
Sbjct: 208 LWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 43/127 (33%), Positives = 55/127 (43%), Gaps = 20/127 (15%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD------- 194
Query: 75 AIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
I YV +W APE F YT D+WS G EL + G +PG
Sbjct: 195 -IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 126 KNVVHQL 132
V +
Sbjct: 251 MPVDSKF 257
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 25/206 (12%), Positives = 40/206 (19%), Gaps = 62/206 (30%)
Query: 1 ME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 56
E L +V + +P + L H A V P + + D
Sbjct: 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD 167
Query: 57 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 116
+ + A P DI IG L
Sbjct: 168 VVLAYPATMPDA--------------------------------NPQDDIRGIGASLYAL 195
Query: 117 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPN 176
L + P V L PI + +
Sbjct: 196 LVNRWPLPEAGVRSGLAPAERDTAGQ------------------------PIEPADIDRD 231
Query: 177 ANPLALRLLERMLAFEPKDRPTAEEA 202
+ R + + R +
Sbjct: 232 IPFQISAVAARSVQGDGGIRSASTLL 257
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 41/129 (31%), Positives = 62/129 (48%), Gaps = 20/129 (15%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD----- 197
Query: 73 PTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 123
I+ YV +W APE F YT D+WS G + E+ + G +
Sbjct: 198 ---IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 124 PGKNVVHQL 132
PG + +
Sbjct: 252 PGVKIDEEF 260
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 36/148 (24%), Positives = 63/148 (42%), Gaps = 29/148 (19%)
Query: 4 DLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 57
DLH + A+ +L + F+ + G++Y+ + N HRDL +N + D +
Sbjct: 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176
Query: 58 KICDFGLARVAFNDTPTAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSI 109
+ DFGL+R I+ DY + +W A E + YT D+W+
Sbjct: 177 CVADFGLSRK--------IYSGDYYRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAF 225
Query: 110 GCIFAELLT-GKPLFPGKN---VVHQLD 133
G E++T G+ + G + + L
Sbjct: 226 GVTMWEIMTRGQTPYAGIENAEIYNYLI 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 35/149 (23%), Positives = 57/149 (38%), Gaps = 31/149 (20%)
Query: 4 DLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 57
DLH + + + + F+ + G++Y+ N HRDL +N + D +
Sbjct: 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186
Query: 58 KICDFGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWS 108
+ DFGL++ I+ D Y +W A E S YT D+W+
Sbjct: 187 CVADFGLSKK--------IYSGDYYRQGRIAKMPVKWI-AIE---SLADRVYTSKSDVWA 234
Query: 109 IGCIFAELLT-GKPLFPGKN---VVHQLD 133
G E+ T G +PG + L
Sbjct: 235 FGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 29 RGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 85
RGL Y+H + HRD+K NIL + + + + DFGLA++ + T + T T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVRGTI 199
Query: 86 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
+ APE G K + D++ G + EL+TG+
Sbjct: 200 GHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 36/131 (27%), Positives = 56/131 (42%), Gaps = 23/131 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD------- 182
Query: 75 AIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
++ TDY RW PE + K+T D+WS G I E+ T GK +
Sbjct: 183 -VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 238
Query: 126 KN---VVHQLD 133
+ V+ +
Sbjct: 239 LSNTEVIECIT 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 30/131 (22%), Positives = 49/131 (37%), Gaps = 28/131 (21%)
Query: 10 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 69
+ ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-- 187
Query: 70 NDTPTAIFWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAELL 117
I+ TDY YR +PE +T D+WS G + E+
Sbjct: 188 ------IYETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 118 T-GKPLFPGKN 127
T + + G +
Sbjct: 235 TLAEQPYQGLS 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 34/131 (25%), Positives = 52/131 (39%), Gaps = 23/131 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L Q+ G+ Y+ + HRDL +N L +KI DFG++R
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD------- 207
Query: 75 AIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 125
I+ TDY RW PE + K+T D+WS G + E+ T GK +
Sbjct: 208 -IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263
Query: 126 KN---VVHQLD 133
+ + +
Sbjct: 264 LSNTEAIDCIT 274
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 41/130 (31%), Positives = 60/130 (46%), Gaps = 22/130 (16%)
Query: 13 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFND 71
+ LT E F YQ+ +G++++ + HRDL +N+L +KICDFGLAR + +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 72 TPTAIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLT-GKPL 122
YV +W APE S F YT D+WS G + E+ + G
Sbjct: 227 N--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 123 FPGKNVVHQL 132
+PG V
Sbjct: 275 YPGIPVDANF 284
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 42/131 (32%), Positives = 59/131 (45%), Gaps = 25/131 (19%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L+ + YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD------- 240
Query: 75 AIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLT-GK---P 121
I D Y T +W APE + F YT D+WS G + E+ T G P
Sbjct: 241 -IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 122 LFPGKNVVHQL 132
P + + L
Sbjct: 296 GVPVEELFKLL 306
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 44/145 (30%), Positives = 62/145 (42%), Gaps = 25/145 (17%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME + +T + YQL RG++Y+ + HRDL +N+L + +KI
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 61 DFGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGC 111
DFGLAR I D Y T +W APE + F YT D+WS G
Sbjct: 200 DFGLARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGV 247
Query: 112 IFAELLT-GK---PLFPGKNVVHQL 132
+ E+ T G P P + + L
Sbjct: 248 LMWEIFTLGGSPYPGIPVEELFKLL 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 44/145 (30%), Positives = 63/145 (43%), Gaps = 25/145 (17%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
ME + +T + YQL RG++Y+ + HRDL +N+L + +KI
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 61 DFGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGC 111
DFGLAR I D Y T +W APE + F YT D+WS G
Sbjct: 246 DFGLARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGV 293
Query: 112 IFAELLT-GKPLFPG---KNVVHQL 132
+ E+ T G +PG + + L
Sbjct: 294 LMWEIFTLGGSPYPGIPVEELFKLL 318
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 5e-10
Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 19/112 (16%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L P + + Q+ G++Y+ + +V H+DL +N+L +KI D GL R
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE------- 177
Query: 75 AIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
++ DY RW APE + K++ DIWS G + E+ +
Sbjct: 178 -VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 35/105 (33%), Positives = 49/105 (46%), Gaps = 21/105 (20%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT F +Q+ +G++Y+ + HRDL +NIL K+KI DFGL+R
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD------- 199
Query: 75 AIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIG 110
++ D YV +W A E S F YT D+WS G
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVWSFG 239
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 7e-10
Identities = 28/202 (13%), Positives = 49/202 (24%), Gaps = 33/202 (16%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVF-HRDLKPKNILANADCKLKICDFGLARVAFNDTP 73
+ + L+QL L + F HRDL N+L K+ + + +
Sbjct: 158 SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
Query: 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133
YT + +F ++ + LF G +Q D
Sbjct: 218 GLQV------------------SIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG-DYQFD 258
Query: 134 IMTDLLGTPSPEAIARVRNEK-------ARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 186
I L+ + + K +
Sbjct: 259 I-YRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317
Query: 187 RMLAFEPKDRPTAEEALADPYF 208
ML F +A + L
Sbjct: 318 TMLNFS-----SATDLLCQHSL 334
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 30/109 (27%), Positives = 45/109 (41%), Gaps = 29/109 (26%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L+ Q+ G+ Y+ HRDL +N L + +KI DFGL+R
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN------- 223
Query: 75 AIFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIWSIG 110
I+ DY Y+ PE S F+++YT D+W+ G
Sbjct: 224 -IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVWAYG 263
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 32/103 (31%), Positives = 43/103 (41%), Gaps = 20/103 (19%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV-- 194
Query: 75 AIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIG 110
YV RW A E +S YT D+WS G
Sbjct: 195 ------YVKKTMGRLPVRWM-AIE--SLNYSVYTTNSDVWSYG 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 33/152 (21%), Positives = 53/152 (34%), Gaps = 33/152 (21%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANA--- 53
DL ++ + + LL G +Y+ + HRD+ +N L
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178
Query: 54 DCKLKICDFGLARVAFNDTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAID 105
KI DFG+AR I+ Y +W PE +T D
Sbjct: 179 GRVAKIGDFGMARD--------IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTD 227
Query: 106 IWSIGCIFAELLT-GKPLFPGKN---VVHQLD 133
WS G + E+ + G +P K+ V+ +
Sbjct: 228 TWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 30/137 (21%), Positives = 47/137 (34%), Gaps = 26/137 (18%)
Query: 12 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVA 68
L + G +Y+ + HRD+ +N L KI DFG+AR
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD- 233
Query: 69 FNDTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-G 119
I+ Y +W PE +T D WS G + E+ + G
Sbjct: 234 -------IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLG 283
Query: 120 KPLFPGKN---VVHQLD 133
+P K+ V+ +
Sbjct: 284 YMPYPSKSNQEVLEFVT 300
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 16/46 (34%), Positives = 27/46 (58%), Gaps = 5/46 (10%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 66
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 15/44 (34%), Positives = 25/44 (56%), Gaps = 4/44 (9%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 66
++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 14/43 (32%), Positives = 23/43 (53%), Gaps = 2/43 (4%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR 66
++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 9/43 (20%), Positives = 22/43 (51%), Gaps = 2/43 (4%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKI--CDFGLAR 66
+LL L+++H H ++ +NI + + + ++ +G A
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 18/45 (40%), Positives = 26/45 (57%), Gaps = 3/45 (6%)
Query: 25 YQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 66
Q++ ++YIH+ N HRD+KP N L + I DFGLA+
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 5/46 (10%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 66
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 8e-06
Identities = 64/420 (15%), Positives = 117/420 (27%), Gaps = 158/420 (37%)
Query: 13 DDLTPEHYQFFLYQL--------LRGLKYIHTANVFHRD-----------LKPKNILANA 53
+++ +Y+F + + + YI + + D L+P L A
Sbjct: 84 EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA 143
Query: 54 DCKLK----ICDFG--------LARVAFNDT------PTAIFWTDYVATRWYRAPE---- 91
+L+ + G +A IFW + + +PE
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW---LNLKNCNSPETVLE 200
Query: 92 ----LCGSFFSKYTPAIDIWS-----IGCIFAELLTGKPLFPGKNVVHQLDIMTD----- 137
L +T D S I I AEL + L K + L ++ +
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL---RRLLKSKPYENCLLVLLNVQNAK 257
Query: 138 ----------LLGTPSPEAIARVRNEKARRYLSSMRKKKPIP-------FS-------QK 173
+L T + + + ++S + Q
Sbjct: 258 AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 174 FPNA----NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE 229
P NP L ++ + +D A D +
Sbjct: 318 LPREVLTTNPRRLSIIAESI----RDGL----ATWDNW---------------------- 347
Query: 230 FERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYG 289
+ + + + +I + L EP ++K F L
Sbjct: 348 ---KHVNCDKLTTII------------ESSLNVLEP---------AEYRKMFDRL----- 378
Query: 290 KGTTVAPPERQHASLPRP--CVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPM 347
+V PP A +P +++ D + V + L K S+ VEK P + T IP
Sbjct: 379 ---SVFPP---SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISIPS 430
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 15/44 (34%), Positives = 27/44 (61%), Gaps = 3/44 (6%)
Query: 26 QLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 66
Q++ ++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 449 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.98 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.98 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.98 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.98 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.98 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.98 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.98 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.98 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.98 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.98 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.98 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.98 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.98 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.96 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.96 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.95 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.86 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.57 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.22 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 98.98 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.44 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.95 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 95.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 94.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.88 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 91.18 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 90.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 90.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 90.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 88.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 86.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 84.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 83.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 81.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.3 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=405.36 Aligned_cols=250 Identities=50% Similarity=0.920 Sum_probs=217.5
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC-Cccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-TAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~-~~~~~~ 79 (449)
|+|+|.++|.+++.|++.+++.|++||+.||+|||++|||||||||+|||++.++.+||+|||+|+....... .....+
T Consensus 141 ~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~ 220 (398)
T 4b99_A 141 MESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 220 (398)
T ss_dssp CSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCC
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccc
Confidence 6789999999999999999999999999999999999999999999999999999999999999986543221 122346
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||++|||||++.+. ..|+.++||||+|||+|||++|++||.+.+..+++..|....|.|+.+.+..+.......++
T Consensus 221 ~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~ 299 (398)
T 4b99_A 221 EYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYI 299 (398)
T ss_dssp SSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHH
T ss_pred cceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhh
Confidence 78999999999998763 46799999999999999999999999999999999999999999999888777777777778
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHH
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKED 239 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~ 239 (449)
..+....+.++...++.+++++++||.+||.+||.+|+|++|+|+||||+.+..+..++...+ .+++.++...++.++
T Consensus 300 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~~~~~~~~~~~~~~ 377 (398)
T 4b99_A 300 QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PFDFAFDREALTRER 377 (398)
T ss_dssp HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CCCCHHHHSCCCHHH
T ss_pred hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CCCCccchhhcCHHH
Confidence 888888888888888999999999999999999999999999999999999988877776543 456778888999999
Q ss_pred HHHHHHHHHHhhCh
Q 013122 240 VRELIYREILEYHP 253 (449)
Q Consensus 240 ~~e~i~~ei~~~~p 253 (449)
+++.|++||.++|.
T Consensus 378 ~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 378 IKEAIVAEIEDFHA 391 (398)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999998875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=366.23 Aligned_cols=254 Identities=42% Similarity=0.747 Sum_probs=213.1
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC------
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT------ 74 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~------ 74 (449)
|+++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 139 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 218 (458)
T 3rp9_A 139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218 (458)
T ss_dssp CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-
T ss_pred cccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccccccccc
Confidence 57899999999888999999999999999999999999999999999999999999999999999875432111
Q ss_pred ------------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-----------CCCCCCC
Q 013122 75 ------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-----------GKPLFPG 125 (449)
Q Consensus 75 ------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-----------G~~pF~~ 125 (449)
....+.++||++|+|||++... ..|+.++||||||||+|||++ |+++|+|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g 297 (458)
T 3rp9_A 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297 (458)
T ss_dssp --------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-
T ss_pred CccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCC
Confidence 0124567899999999987442 579999999999999999998 7888988
Q ss_pred CC--------------------chhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHH
Q 013122 126 KN--------------------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 185 (449)
Q Consensus 126 ~~--------------------~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL 185 (449)
.+ ..+++..|.+++|.|..+.+..+.......++..+.......+...++..++.+++||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 377 (458)
T 3rp9_A 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLL 377 (458)
T ss_dssp -------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHH
T ss_pred CccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHH
Confidence 65 3678899999999999999999999888999988888888888889999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHHHHHHHHHHHhhChhHH
Q 013122 186 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQML 256 (449)
Q Consensus 186 ~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~ 256 (449)
.+||.+||++|||++|+|+||||+++.....++.......+.+. +...++.+++++.+++||..|||+..
T Consensus 378 ~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 447 (458)
T 3rp9_A 378 KRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEIQ 447 (458)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCTTCC
T ss_pred HHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCcccc
Confidence 99999999999999999999999999887776654433333332 33578999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=362.89 Aligned_cols=253 Identities=40% Similarity=0.720 Sum_probs=212.0
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-----
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA----- 75 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~----- 75 (449)
|+++|.++++.+..+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 112 ~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 191 (432)
T 3n9x_A 112 ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191 (432)
T ss_dssp CSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC------------
T ss_pred CCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccc
Confidence 578999999998889999999999999999999999999999999999999999999999999998764332110
Q ss_pred --------------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-----------CCCCCCCCC---
Q 013122 76 --------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-----------GKPLFPGKN--- 127 (449)
Q Consensus 76 --------------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-----------G~~pF~~~~--- 127 (449)
...+.++||++|+|||++... ..|+.++||||||||+|||++ |.++|+|.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~ 270 (432)
T 3n9x_A 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFP 270 (432)
T ss_dssp -------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC
T ss_pred cccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccc
Confidence 124678999999999987442 579999999999999999997 677777765
Q ss_pred --------------chhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 013122 128 --------------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193 (449)
Q Consensus 128 --------------~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP 193 (449)
..+++..|.+++|.|..+.+..+.......++..+....+..+...++.+++.+++||.+||.+||
T Consensus 271 ~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 350 (432)
T 3n9x_A 271 LSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNP 350 (432)
T ss_dssp ----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSST
T ss_pred cCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCc
Confidence 368899999999999999999999988899998888888888888889999999999999999999
Q ss_pred CCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHHHHHHHHHHHhhChhH
Q 013122 194 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 255 (449)
Q Consensus 194 ~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~ 255 (449)
.+|||++|+|+||||+++.....++.........|+ +...++.+++++.+++|+..|+|+.
T Consensus 351 ~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 411 (432)
T 3n9x_A 351 NKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPEL 411 (432)
T ss_dssp TTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTC
T ss_pred ccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCccc
Confidence 999999999999999999888777654332222332 2357899999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=350.56 Aligned_cols=243 Identities=44% Similarity=0.821 Sum_probs=211.3
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.++++. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .+.
T Consensus 112 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~------~~~ 184 (367)
T 1cm8_A 112 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTG 184 (367)
T ss_dssp CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS------CCS
T ss_pred CCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc------cCc
Confidence 46799999987 47999999999999999999999999999999999999999999999999999875432 245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.++|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|+.+.+..+.......++.
T Consensus 185 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 263 (367)
T 1cm8_A 185 YVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263 (367)
T ss_dssp SCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHH
T ss_pred CcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHH
Confidence 7899999999998763 578999999999999999999999999999999999999999999999999998888888888
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+...++..++.+.+||.+||..||.+|||++|+|+||||+.+.....++... .+++.++....+.+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 340 (367)
T 1cm8_A 264 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFDDVDRTLDEW 340 (367)
T ss_dssp HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC-----CCHHHH
T ss_pred hCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC---CCCCChhhhcCCHHHH
Confidence 8888777888888899999999999999999999999999999999999998887776654 3566777888999999
Q ss_pred HHHHHHHHHhhChh
Q 013122 241 RELIYREILEYHPQ 254 (449)
Q Consensus 241 ~e~i~~ei~~~~p~ 254 (449)
++.+++|++.++|+
T Consensus 341 ~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 341 KRVTYKEVLSFKPP 354 (367)
T ss_dssp HHHHHHHHHTCCC-
T ss_pred HHHHHHHHHHhccc
Confidence 99999999999876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=352.56 Aligned_cols=256 Identities=38% Similarity=0.725 Sum_probs=203.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCC--------
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-------- 72 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~-------- 72 (449)
|+++|.++++.+ .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 171 (388)
T 3oz6_A 93 METDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171 (388)
T ss_dssp CSEEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGG
T ss_pred cCcCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccc
Confidence 578999999874 79999999999999999999999999999999999999999999999999997653211
Q ss_pred ----------CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCC
Q 013122 73 ----------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142 (449)
Q Consensus 73 ----------~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 142 (449)
......+.++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|...++.|
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p 250 (388)
T 3oz6_A 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFP 250 (388)
T ss_dssp CCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 011224567899999999998763 578999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhHHHHHHHhhhccCC---CCCCCCCCC-------------CCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 143 SPEAIARVRNEKARRYLSSMRKKK---PIPFSQKFP-------------NANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 143 ~~e~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-------------~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
..+.+..+.......++..+.... ...+...++ .+++.+.+||.+||.+||.+|||++|+|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 251 SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence 999887765554444444433322 222233332 6789999999999999999999999999999
Q ss_pred cccccccccCCCCCCCccchhhHHHhhcCCHHHHHHHHHHHHHhhChhHHHhh
Q 013122 207 YFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEF 259 (449)
Q Consensus 207 ~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~e~i~~ei~~~~p~~~~~~ 259 (449)
||+.+.....++.........+. +....+.+++++.+|+++.+++++...+.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 382 (388)
T 3oz6_A 331 FVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISNK 382 (388)
T ss_dssp TTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC-
T ss_pred HHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhhc
Confidence 99999988888776554333332 23467899999999999999998876543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=351.22 Aligned_cols=244 Identities=45% Similarity=0.860 Sum_probs=205.4
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .+.
T Consensus 116 ~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~ 188 (367)
T 2fst_X 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTG 188 (367)
T ss_dssp CCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------------
T ss_pred cCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc------CCC
Confidence 46788888876 57999999999999999999999999999999999999999999999999999765332 245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|..+.+..+.......++.
T Consensus 189 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 267 (367)
T 2fst_X 189 YVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267 (367)
T ss_dssp --CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHH
T ss_pred cCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHh
Confidence 7899999999998763 578999999999999999999999999999999999999999999999999998888888888
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+...++..++.+.+||.+||.+||.+|||++|+|+||||+.+..+..++...+ +++.++...+..+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 344 (367)
T 2fst_X 268 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSLESRDLLIDEW 344 (367)
T ss_dssp TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCGGGSSCCCCHHHH
T ss_pred ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCcchhhccCCHHHH
Confidence 88777777777788899999999999999999999999999999999999988887766553 556677788999999
Q ss_pred HHHHHHHHHhhChhH
Q 013122 241 RELIYREILEYHPQM 255 (449)
Q Consensus 241 ~e~i~~ei~~~~p~~ 255 (449)
++++|+|+..++|..
T Consensus 345 ~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 345 KSLTYDEVISFVPPP 359 (367)
T ss_dssp HHHHHHHHHHCCCCC
T ss_pred HHHHHHHHHHhccCc
Confidence 999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=344.29 Aligned_cols=177 Identities=27% Similarity=0.531 Sum_probs=150.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|.+++.+. .|++.+++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....... ..+..
T Consensus 155 gg~L~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~ 230 (346)
T 4fih_A 155 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSL 230 (346)
T ss_dssp TEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCC
T ss_pred CCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC---ccccc
Confidence 46999999874 799999999999999999999999999999999999999999999999999987644322 23568
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|....
T Consensus 231 ~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---------------------- 286 (346)
T 4fih_A 231 VGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---------------------- 286 (346)
T ss_dssp CSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS----------------------
T ss_pred ccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC----------------------
Confidence 99999999999987 689999999999999999999999999887666554443211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.+....+..+++.+++||.+||..||++|||++|+|+||||+...
T Consensus 287 ------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 ------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 111223356789999999999999999999999999999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=341.11 Aligned_cols=177 Identities=29% Similarity=0.526 Sum_probs=151.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|||.++|++.+.|++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 116 gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~ 194 (311)
T 4aw0_A 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSF 194 (311)
T ss_dssp TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC-CCBCCC
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc-ccccCc
Confidence 4699999999989999999999999999999999999999999999999999999999999999876433222 234567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|...
T Consensus 195 ~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----------------------- 249 (311)
T 4aw0_A 195 VGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL----------------------- 249 (311)
T ss_dssp CSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------------------
T ss_pred ccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence 99999999999987 68999999999999999999999999988766555444321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH------HHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE------ALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~e------lL~hp~f~~~~ 212 (449)
...+ ...+++.+++||.+||+.||++|+|++| +++||||+++.
T Consensus 250 -----~~~~---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 250 -----EYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp -----CCCC---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred -----CCCC---CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 0111 2357899999999999999999999987 68999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=333.59 Aligned_cols=173 Identities=27% Similarity=0.498 Sum_probs=138.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+|+|.++|.+++.|++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 95 ~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~ 170 (275)
T 3hyh_A 95 AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKT 170 (275)
T ss_dssp CCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----ccCC
Confidence 578999999999999999999999999999999999999999999999999999999999999998654332 2356
Q ss_pred ccccccccCcccccccCCCC-CCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.+||+.|+|||++.+ ..| +.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 171 ~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~---------------------- 226 (275)
T 3hyh_A 171 SCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN---------------------- 226 (275)
T ss_dssp ----CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------------------
T ss_pred eeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----------------------
Confidence 789999999999987 454 6799999999999999999999988765544433321
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
. ... ....+++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 227 -----~-~~~---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 227 -----G-VYT---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----T-CCC---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----C-CCC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0 011 12357899999999999999999999999999999973
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=336.72 Aligned_cols=174 Identities=28% Similarity=0.448 Sum_probs=148.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|||.++|.+.+.|++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .....
T Consensus 110 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~ 186 (304)
T 3ubd_A 110 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSF 186 (304)
T ss_dssp TCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C---CCCSC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc---ccccc
Confidence 479999999998999999999999999999999999999999999999999999999999999986533222 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.+.
T Consensus 187 ~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----------------------- 241 (304)
T 3ubd_A 187 CGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA----------------------- 241 (304)
T ss_dssp CCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------------
T ss_pred ccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------------
Confidence 89999999999987 68999999999999999999999999988766555444321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~ 211 (449)
... ....+++++++||.+||+.||++||| ++|+|+||||+++
T Consensus 242 -----~~~---~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 242 -----KLG---MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp -----CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred -----CCC---CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 011 12357899999999999999999998 5899999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.60 Aligned_cols=206 Identities=28% Similarity=0.455 Sum_probs=154.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-CCEEEeecCccccccCCCCC------
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPT------ 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGlA~~~~~~~~~------ 74 (449)
+++|.++++ .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+........
T Consensus 104 g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 180 (361)
T 4f9c_A 104 HESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQ 180 (361)
T ss_dssp CCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-
T ss_pred cccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccc
Confidence 479999984 59999999999999999999999999999999999999877 78999999999764332111
Q ss_pred -------------------ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCC-CCCCchhhHHH
Q 013122 75 -------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDI 134 (449)
Q Consensus 75 -------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF-~~~~~~~~l~~ 134 (449)
....+..+||++|+|||++.+. ..|+.++||||+|||+|||++|+.|| .+.+..+++..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~ 259 (361)
T 4f9c_A 181 SEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQ 259 (361)
T ss_dssp -------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 1123456899999999999763 46899999999999999999999877 56778899999
Q ss_pred HHhhcCCCCHHHHHHHhh-----------HHHHHHHhhhcc---C---------CCCCCCCCCCCCCHHHHHHHHHhhhc
Q 013122 135 MTDLLGTPSPEAIARVRN-----------EKARRYLSSMRK---K---------KPIPFSQKFPNANPLALRLLERMLAF 191 (449)
Q Consensus 135 i~~~lg~p~~e~~~~~~~-----------~~~~~~~~~~~~---~---------~~~~~~~~~~~~s~~~~dLL~~~L~~ 191 (449)
|..++|++....+..... .........+.. . ........+..++++++|||.+||++
T Consensus 260 I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~ 339 (361)
T 4f9c_A 260 IMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDL 339 (361)
T ss_dssp HHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCS
T ss_pred HHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcC
Confidence 999988754433322110 000111111100 0 00111234567899999999999999
Q ss_pred CCCCCCCHHHHHcCcccccc
Q 013122 192 EPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 192 DP~~RpTa~elL~hp~f~~~ 211 (449)
||++|+|++|+|+||||+++
T Consensus 340 dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 340 NPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CTTTSCCHHHHHTSGGGTTC
T ss_pred ChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=345.62 Aligned_cols=177 Identities=27% Similarity=0.531 Sum_probs=151.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|.++++.. .|++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....... .....
T Consensus 232 gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~ 307 (423)
T 4fie_A 232 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSL 307 (423)
T ss_dssp TEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC---CBCCC
T ss_pred CCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc---ccccc
Confidence 46999999865 699999999999999999999999999999999999999999999999999987644322 23568
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|....
T Consensus 308 ~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~---------------------- 363 (423)
T 4fie_A 308 VGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---------------------- 363 (423)
T ss_dssp EECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------------------
T ss_pred ccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC----------------------
Confidence 99999999999987 689999999999999999999999999887665554443210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.+....+..+++.+++||.+||..||++|+|++|+|+||||+...
T Consensus 364 ------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 364 ------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 111233456899999999999999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=328.53 Aligned_cols=173 Identities=23% Similarity=0.342 Sum_probs=142.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcC-CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+|+|.++|++.+.+++..++.|+.||+.||+|||++| ||||||||+|||++. ++.+||+|||+|+..... ..
T Consensus 113 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-----~~ 187 (290)
T 3fpq_A 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FA 187 (290)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SB
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-----cc
Confidence 4799999999889999999999999999999999999 999999999999985 789999999999764332 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+....+.....
T Consensus 188 ~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~--------------------- 243 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--------------------- 243 (290)
T ss_dssp EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT---------------------
T ss_pred CCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH---------------------
Confidence 56789999999999865 699999999999999999999999987654333211110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
... .........++++++||.+||+.||++|||++|+|+||||++
T Consensus 244 -----~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 244 -----SGV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----TTC--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----cCC--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 000 011112346789999999999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.45 Aligned_cols=251 Identities=49% Similarity=0.888 Sum_probs=212.4
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 112 ~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 190 (364)
T 3qyz_A 112 METDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190 (364)
T ss_dssp CSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred cCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccc
Confidence 467899999875 6999999999999999999999999999999999999999999999999999876543333223456
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..|...+|.|..+.+..+.......+..
T Consensus 191 ~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (364)
T 3qyz_A 191 YVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269 (364)
T ss_dssp CCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred cccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence 7899999999987552 458999999999999999999999999999999999999999999999998888877778877
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+......++...++.+++.+.+||.+||+.||.+|||++|+|+||||+.+.....++.... .+.+.++...+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 347 (364)
T 3qyz_A 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKL 347 (364)
T ss_dssp TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC-----CCHHHH
T ss_pred hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcccccccCCHHHH
Confidence 77777777777778889999999999999999999999999999999999876665554433 3345566678899999
Q ss_pred HHHHHHHHHhhChhH
Q 013122 241 RELIYREILEYHPQM 255 (449)
Q Consensus 241 ~e~i~~ei~~~~p~~ 255 (449)
++++++|+..++|..
T Consensus 348 ~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 348 KELIFEETARFQPGY 362 (364)
T ss_dssp HHHHHHHTGGGCC--
T ss_pred HHHHHHHHHHhhhhc
Confidence 999999998888753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=340.08 Aligned_cols=174 Identities=25% Similarity=0.449 Sum_probs=148.0
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|||.++|..++ .+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...... ...+
T Consensus 107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---~~~~ 183 (350)
T 4b9d_A 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV---ELAR 183 (350)
T ss_dssp TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---HHHH
T ss_pred CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc---cccc
Confidence 479999997654 47999999999999999999999999999999999999999999999999998653221 1234
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|...
T Consensus 184 ~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------------------- 240 (350)
T 4b9d_A 184 ACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--------------------- 240 (350)
T ss_dssp HHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------------------
T ss_pred ccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------------------
Confidence 5789999999999988 68999999999999999999999999988766555444321
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
. +......+++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 241 ------~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 ------S---FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ------C---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ------C---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 0 11223467899999999999999999999999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.78 Aligned_cols=244 Identities=38% Similarity=0.704 Sum_probs=186.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..+.
T Consensus 149 ~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~ 222 (464)
T 3ttj_A 149 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTP 222 (464)
T ss_dssp CSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC----CC--
T ss_pred CCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc----ccCC
Confidence 56788888865 49999999999999999999999999999999999999999999999999998654332 2356
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|.|.++.+..+. .....++.
T Consensus 223 ~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~-~~~~~~~~ 299 (464)
T 3ttj_A 223 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTVRNYVE 299 (464)
T ss_dssp --CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-HHHHHHHT
T ss_pred CcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-hhhhhHhh
Confidence 789999999999988 689999999999999999999999999999999999999999999999887764 34455555
Q ss_pred hhccCCCCCCCCCCCCC------------CHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhh
Q 013122 161 SMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~------------s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~ 228 (449)
.........+...++.. ++.+++||.+||.+||++|||++|+|+||||+.+.....+... +...+++
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~-~~~~~~~ 378 (464)
T 3ttj_A 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP-PPQIYDK 378 (464)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCC-C------
T ss_pred cccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCC-CCccCCc
Confidence 44444433333333332 5679999999999999999999999999999987765443222 2233556
Q ss_pred HHHhhcCCHHHHHHHHHHHHHhhChh
Q 013122 229 EFERRRITKEDVRELIYREILEYHPQ 254 (449)
Q Consensus 229 ~~e~~~~~~e~~~e~i~~ei~~~~p~ 254 (449)
.++....+.+++++++++|+..++..
T Consensus 379 ~~~~~~~~~~~~~~~~~~e~~~~~~~ 404 (464)
T 3ttj_A 379 QLDEREHTIEEWKELIYKEVMNSEEK 404 (464)
T ss_dssp -----CCCHHHHHHHHHHHHHC----
T ss_pred chhhccCCHHHHHHHHHHHHHHhhhc
Confidence 67778889999999999999866543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=334.93 Aligned_cols=182 Identities=27% Similarity=0.385 Sum_probs=149.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCcc--cc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAI--FW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~--~~ 78 (449)
+++|.++|++.+.|++..++.|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.......... ..
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~ 213 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence 479999999988999999999999999999999999999999999999999987 599999999987644322111 12
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+....+..|..
T Consensus 214 ~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------------------- 270 (336)
T 4g3f_A 214 DYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--------------------- 270 (336)
T ss_dssp CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH---------------------
T ss_pred CccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc---------------------
Confidence 34689999999999988 6899999999999999999999999998776655544422
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH-------------HcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA-------------LADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~el-------------L~hp~f~~~~~ 213 (449)
.+.++....+.+++.+.+||.+||+.||.+|||+.|+ |+|||+..+..
T Consensus 271 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 271 -------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp -------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred -------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 1122334456789999999999999999999999997 57999987653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.09 Aligned_cols=242 Identities=43% Similarity=0.806 Sum_probs=202.8
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 129 ~~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~------~~~ 200 (371)
T 4exu_A 129 MQTDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTG 200 (371)
T ss_dssp CCEEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------------C
T ss_pred ccccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC------cCC
Confidence 45788888744 4999999999999999999999999999999999999999999999999999765332 245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+.......++.
T Consensus 201 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (371)
T 4exu_A 201 YVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 279 (371)
T ss_dssp TTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHH
T ss_pred cccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhh
Confidence 6789999999998763 578999999999999999999999999999999999999999999999888877777777777
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+...++.+++.+.+||.+||+.||.+|||++|+|+||||+.+.....+..... .+....+...++.+++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 357 (371)
T 4exu_A 280 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEW 357 (371)
T ss_dssp HSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTTSSCCCCHHHH
T ss_pred ccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcCcchhhcccchHHH
Confidence 77666666666677888999999999999999999999999999999998876655543321 2222335567889999
Q ss_pred HHHHHHHHHhhCh
Q 013122 241 RELIYREILEYHP 253 (449)
Q Consensus 241 ~e~i~~ei~~~~p 253 (449)
++.+++|+.+|+|
T Consensus 358 ~~~~~~~~~~~~~ 370 (371)
T 4exu_A 358 KQHIYKEIVNFSP 370 (371)
T ss_dssp HHHHHHHHHHCCC
T ss_pred HHHHHHHHHhccc
Confidence 9999999999876
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.89 Aligned_cols=242 Identities=43% Similarity=0.802 Sum_probs=203.4
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 111 ~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------~~~ 182 (353)
T 3coi_A 111 MQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTG 182 (353)
T ss_dssp CSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------
T ss_pred ccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC------ccc
Confidence 34667776643 4999999999999999999999999999999999999999999999999999764322 244
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+.+.+|.+..+.+..+.......++.
T Consensus 183 ~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (353)
T 3coi_A 183 YVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261 (353)
T ss_dssp -CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHH
T ss_pred cccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHH
Confidence 6789999999998763 568899999999999999999999999999999999999999999999888877777777777
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+...++.+++.+.+||.+||..||.+|||++++|+||||+.+...+.+..... .+....+...++.+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 339 (353)
T 3coi_A 262 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEW 339 (353)
T ss_dssp TSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTTTTCCCCHHHH
T ss_pred hCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccchhhccCCHHHH
Confidence 77666666677778889999999999999999999999999999999998877665544332 2344455678899999
Q ss_pred HHHHHHHHHhhCh
Q 013122 241 RELIYREILEYHP 253 (449)
Q Consensus 241 ~e~i~~ei~~~~p 253 (449)
++.|++++.+++|
T Consensus 340 ~~~~~~~~~~~~~ 352 (353)
T 3coi_A 340 KQHIYKEIVNFSP 352 (353)
T ss_dssp HHHHHHHHHTCCC
T ss_pred HHHHHHHHHhhcc
Confidence 9999999988765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=314.47 Aligned_cols=247 Identities=42% Similarity=0.835 Sum_probs=196.6
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-----
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA----- 75 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~----- 75 (449)
|+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 96 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 174 (353)
T 2b9h_A 96 MQTDLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174 (353)
T ss_dssp CSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred cCccHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccc
Confidence 467899999874 79999999999999999999999999999999999999999999999999998654322111
Q ss_pred --cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHH-HHHHHhh
Q 013122 76 --IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE-AIARVRN 152 (449)
Q Consensus 76 --~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e-~~~~~~~ 152 (449)
......+||..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...+|.+... .+..+..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (353)
T 2b9h_A 175 QQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIES 253 (353)
T ss_dssp -----CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCC
T ss_pred cccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcccccccc
Confidence 012346789999999987542 578899999999999999999999999999988888888888877532 2222333
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccc--hhhHH
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK--MEFEF 230 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~--~~~~~ 230 (449)
.....++..+.......+...++.+++.+.+||.+||..||.+|||++|+|+||||+.+.....++..+++.. +++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (353)
T 2b9h_A 254 PRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDH 333 (353)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGGC
T ss_pred chhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCcceeeecc
Confidence 3444555555444444455556788999999999999999999999999999999999887766665554443 44555
Q ss_pred HhhcCCHHHHHHHHHHHHH
Q 013122 231 ERRRITKEDVRELIYREIL 249 (449)
Q Consensus 231 e~~~~~~e~~~e~i~~ei~ 249 (449)
.+..++.+++++++++||.
T Consensus 334 ~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 334 YKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CSSCCCHHHHHHHHHHHHT
T ss_pred hhhcCCHHHHHHHHHHHhh
Confidence 6677899999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=337.67 Aligned_cols=177 Identities=28% Similarity=0.414 Sum_probs=147.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|||.++|.+.+.|++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...... ....
T Consensus 276 GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-----~~t~ 350 (689)
T 3v5w_A 276 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHAS 350 (689)
T ss_dssp SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-----CCSC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC-----CCCc
Confidence 58999999999999999999999999999999999999999999999999999999999999998764432 2457
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|||||++... ..|+.++||||||||+|||++|.+||.+.+..+....+... .
T Consensus 351 ~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--------------------~-- 407 (689)
T 3v5w_A 351 VGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------------------L-- 407 (689)
T ss_dssp CSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--------------------H--
T ss_pred cCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--------------------c--
Confidence 999999999999641 47999999999999999999999999875543322111110 0
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
.. .. .....+++++++||.+||..||.+|++ ++|+++||||+++.
T Consensus 408 --~~-~~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 408 --TM-AV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp --HC-CC---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred --CC-CC---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 00 11 122457999999999999999999998 79999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.39 Aligned_cols=178 Identities=26% Similarity=0.452 Sum_probs=130.5
Q ss_pred CCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc---
Q 013122 2 ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA--- 75 (449)
Q Consensus 2 e~dL~~~i~~~~~---Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~--- 75 (449)
+++|.+++..... ..+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.........
T Consensus 99 gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~ 178 (299)
T 4g31_A 99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178 (299)
T ss_dssp SCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-------------
T ss_pred CCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccc
Confidence 4799999998765 4556789999999999999999999999999999999999999999999998764432211
Q ss_pred ------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHH
Q 013122 76 ------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 149 (449)
Q Consensus 76 ------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~ 149 (449)
...+..+||+.|||||++.+ ..|+.++|||||||++|||++ ||.+. .+....+.......
T Consensus 179 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~------- 244 (299)
T 4g31_A 179 TPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLK------- 244 (299)
T ss_dssp -------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTC-------
T ss_pred cccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCC-------
Confidence 12245689999999999988 689999999999999999996 66432 12222222111111
Q ss_pred HhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 150 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
+...++..++.+.+||.+||+.||.+|||+.|+|+||||+++..
T Consensus 245 --------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 245 --------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp --------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred --------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 11112234567889999999999999999999999999997643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.93 Aligned_cols=242 Identities=38% Similarity=0.702 Sum_probs=178.4
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 112 ~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~ 185 (371)
T 2xrw_A 112 MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTP 185 (371)
T ss_dssp CSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------
T ss_pred CCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc----ccCC
Confidence 46789998874 59999999999999999999999999999999999999999999999999997654322 2245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...++..+.+.+|.+.++.+..+... ...++.
T Consensus 186 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~ 262 (371)
T 2xrw_A 186 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT-VRTYVE 262 (371)
T ss_dssp ----CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH-HHHHHH
T ss_pred ceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH-HHHHHh
Confidence 689999999999987 67999999999999999999999999999999999999999999998877665332 223333
Q ss_pred hhccCCCCCCCCCCCC------------CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhh
Q 013122 161 SMRKKKPIPFSQKFPN------------ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~------------~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~ 228 (449)
.........+...++. .+..+++||.+||..||.+|||++|+|+||||+.+..........+ .....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~-~~~~~ 341 (371)
T 2xrw_A 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPP-KIPDK 341 (371)
T ss_dssp SSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCC-CCCTT
T ss_pred hCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCC-CCCCh
Confidence 2222111111111111 1567899999999999999999999999999997665432211111 11223
Q ss_pred HHHhhcCCHHHHHHHHHHHHHhhC
Q 013122 229 EFERRRITKEDVRELIYREILEYH 252 (449)
Q Consensus 229 ~~e~~~~~~e~~~e~i~~ei~~~~ 252 (449)
..++...+.++++++++.++..+.
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 342 QLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp TTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred hhccccCcHHHHHHHHHHHHHHHh
Confidence 344567789999999999997754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=303.24 Aligned_cols=178 Identities=24% Similarity=0.315 Sum_probs=138.5
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+|+|.++|... ..+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+........ .....
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~ 193 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS-QQVEQ 193 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------------
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc-eeecc
Confidence 47999999765 46999999999999999999999999999999999999999999999999999865432221 12355
Q ss_pred ccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.+||+.|||||++.+. ...|+.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 194 ~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~---------------------- 251 (307)
T 3omv_A 194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG---------------------- 251 (307)
T ss_dssp CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH----------------------
T ss_pred cccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh----------------------
Confidence 6899999999998642 24689999999999999999999999988765443322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.............++++.+.+||.+||+.||++|||+.|++++
T Consensus 252 ---~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 252 ---RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ---TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ---cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111112334456789999999999999999999999988653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.58 Aligned_cols=181 Identities=23% Similarity=0.321 Sum_probs=153.2
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC--CCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+|+|+++|... +.|++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~----~~ 313 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SV 313 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS----EE
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC----ce
Confidence 47999999754 579999999999999999999999999999999999999864 789999999998765432 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|||||++.+ ..|+.++||||||||+|||++|.+||.+.+..+.+..|...-.
T Consensus 314 ~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~------------------ 373 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------------------ 373 (573)
T ss_dssp EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC------------------
T ss_pred eeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC------------------
Confidence 56789999999999988 6899999999999999999999999999887666655533211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~ 215 (449)
......+..+++.+++||.+||+.||.+|||++|+|+||||+......
T Consensus 374 ---------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 374 ---------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ---------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ---------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 111234467899999999999999999999999999999999765443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.46 Aligned_cols=244 Identities=36% Similarity=0.686 Sum_probs=191.2
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 116 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----~~ 191 (362)
T 3pg1_A 116 MRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN----KT 191 (362)
T ss_dssp CSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------------
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccc----cc
Confidence 4678999888654 699999999999999999999999999999999999999999999999999975433222 24
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..........++
T Consensus 192 ~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (362)
T 3pg1_A 192 HYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270 (362)
T ss_dssp ----CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHT
T ss_pred eecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHH
Confidence 56799999999998763 56899999999999999999999999999999999999999999998887776666666655
Q ss_pred hhhccC-CCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHH
Q 013122 160 SSMRKK-KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238 (449)
Q Consensus 160 ~~~~~~-~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e 238 (449)
...... ....+....+..++.+.+||.+||+.||.+|||+.|+|+||||+.+.......... ...+.+++...+.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 347 (362)
T 3pg1_A 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL---SERFHFDESVTDVY 347 (362)
T ss_dssp TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTC---CCCCCCCTTCCCHH
T ss_pred HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccc---ccccChhhhhhhHH
Confidence 433322 22333445567899999999999999999999999999999999886544332211 11234455677899
Q ss_pred HHHHHHHHHHHhhC
Q 013122 239 DVRELIYREILEYH 252 (449)
Q Consensus 239 ~~~e~i~~ei~~~~ 252 (449)
++++.++.|+.+++
T Consensus 348 ~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 348 DMHKIFTAEVERFN 361 (362)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHhc
Confidence 99999999998775
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.29 Aligned_cols=207 Identities=42% Similarity=0.736 Sum_probs=167.3
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 101 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 177 (311)
T 3niz_A 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR---SYT 177 (311)
T ss_dssp CSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC------
T ss_pred CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc---ccc
Confidence 4678999888765 499999999999999999999999999999999999999999999999999986543222 224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+.+..+.......... .
T Consensus 178 ~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~ 255 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK-Q 255 (311)
T ss_dssp CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH-S
T ss_pred CCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh-h
Confidence 56789999999998753 468999999999999999999999999999999999999999988877665443321110 0
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.........++....+.+++++.+||.+||++||++|||++|+|+||||+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 01111122233344567889999999999999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.18 Aligned_cols=201 Identities=36% Similarity=0.626 Sum_probs=163.1
Q ss_pred CCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 1 MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 1 me~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
|+++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 101 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----~ 176 (308)
T 3g33_A 101 VDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA----L 176 (308)
T ss_dssp CCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC----S
T ss_pred hhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc----c
Confidence 46899999998765 99999999999999999999999999999999999999999999999999976543322 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.......
T Consensus 177 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---- 250 (308)
T 3g33_A 177 TPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP---- 250 (308)
T ss_dssp GGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSC----
T ss_pred CCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhcc----
Confidence 45689999999999977 679999999999999999999999999999999999998888877665433211000
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
........+.+.....+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 00111112222333456789999999999999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.03 Aligned_cols=208 Identities=38% Similarity=0.718 Sum_probs=167.5
Q ss_pred CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc-CCCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.+.+. ....+++..++.+++||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 121 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~--- 197 (394)
T 4e7w_A 121 PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--- 197 (394)
T ss_dssp SEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---
T ss_pred CccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---
Confidence 345554443 356799999999999999999999999999999999999999 789999999999987644332
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|..+.+.........
T Consensus 198 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 198 -NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp -CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred -CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 2456889999999998763 46899999999999999999999999999999999999999999999877654321100
Q ss_pred HHHhhhccCCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCC
Q 013122 157 RYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e 217 (449)
..+......++...+ +.+++.+.+||.+||++||.+|||+.|+|+||||+++......
T Consensus 276 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 276 ---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp ---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred ---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence 011111222222222 3488999999999999999999999999999999988765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=293.05 Aligned_cols=204 Identities=39% Similarity=0.697 Sum_probs=161.4
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~ 158 (288)
T 1ob3_A 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYT 158 (288)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------
T ss_pred cCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---ccc
Confidence 457899999875 5699999999999999999999999999999999999999999999999999976543221 124
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+....+..+... ..+.
T Consensus 159 ~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PKYD 235 (288)
T ss_dssp ---CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCC
T ss_pred cccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc--cccc
Confidence 45789999999998752 46899999999999999999999999999988888888888887765544332110 0011
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.......+.++......+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 112222334445556678999999999999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.58 Aligned_cols=176 Identities=23% Similarity=0.365 Sum_probs=144.0
Q ss_pred CCcHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 2 ESDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 2 e~dL~~~i~~~~-------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
+|+|.++|+.++ .|++..+..|+.||+.||.|||+++||||||||+|||++.++.+||+|||+|+..
T Consensus 99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 178 (299)
T 4asz_A 99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 178 (299)
T ss_dssp TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHH
T ss_pred CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceec
Confidence 479999998643 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHH
Q 013122 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 69 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~ 147 (449)
...... ......+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+..+..
T Consensus 179 ~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~---------- 245 (299)
T 4asz_A 179 YSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ---------- 245 (299)
T ss_dssp TGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH----------
T ss_pred CCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----------
Confidence 433221 11234579999999999987 689999999999999999998 8999998776544433321
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.... .....+++.+.+||.+||+.||++|||+.++ ++|++.+.
T Consensus 246 -----------------~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 246 -----------------GRVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp -----------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred -----------------CCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 1111 1224578999999999999999999999999 45777654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=297.33 Aligned_cols=209 Identities=36% Similarity=0.678 Sum_probs=165.3
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 158 (324)
T 3mtl_A 82 LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYD 158 (324)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----------
T ss_pred cccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---ccc
Confidence 4678999998765 499999999999999999999999999999999999999999999999999976433221 224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..+...++.|..+.+............
T Consensus 159 ~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp ----CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred cccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 56789999999998763 46899999999999999999999999999999999999999999988777655433221111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
..............+.+++.+.+||.+||+.||.+|||++|+|+||||.++...
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 238 -NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp -CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred -ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 111111122233456789999999999999999999999999999999987644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.66 Aligned_cols=208 Identities=37% Similarity=0.680 Sum_probs=164.8
Q ss_pred CCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-CCEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGlA~~~~~~~~~~ 75 (449)
|+++|.+++. ....+++..++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 135 ~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~-- 212 (420)
T 1j1b_A 135 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-- 212 (420)
T ss_dssp CCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred ccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC--
Confidence 3456666654 35679999999999999999999999999999999999999965 5689999999987544322
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
...++||++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|.|..+.+..+....
T Consensus 213 --~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~- 288 (420)
T 1j1b_A 213 --NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY- 288 (420)
T ss_dssp --CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC-
T ss_pred --ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh-
Confidence 2456899999999998762 478999999999999999999999999999999999999999999988776542100
Q ss_pred HHHHhhhccCCCCCCCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccC
Q 013122 156 RRYLSSMRKKKPIPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 216 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~ 216 (449)
.. ..+......+|.. ..+.+++.+++||.+||.+||.+|||+.|+|+||||+.+.....
T Consensus 289 ~~--~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 289 TE--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp CC--CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred hh--hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 00 0000001111111 12457899999999999999999999999999999998876544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=290.02 Aligned_cols=206 Identities=39% Similarity=0.657 Sum_probs=161.2
Q ss_pred CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++.. ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~ 159 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYS 159 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---CCC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc---ccc
Confidence 45677777765 56799999999999999999999999999999999999999999999999999986543222 224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCC-CCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP-LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~-pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..+||..|+|||++.+. ..++.++|||||||++|+|++|.. +|.+.+..+.+..+.+.++.+..+.+....... .+
T Consensus 160 ~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~ 236 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP--DY 236 (292)
T ss_dssp SCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST--TC
T ss_pred CCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc--cc
Confidence 56789999999998762 348999999999999999997664 578888888899999988888776554432110 00
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
................+.+++.+++||.+||+.||++|||++|+|+||||+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 000000011122334456899999999999999999999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.79 Aligned_cols=202 Identities=33% Similarity=0.583 Sum_probs=163.4
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC--EEEeecCccccccCCCCCcc
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--vKL~DFGlA~~~~~~~~~~~ 76 (449)
|+++|.+++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 181 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~----- 255 (429)
T 3kvw_A 181 LSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----- 255 (429)
T ss_dssp CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----
T ss_pred cCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----
Confidence 4689999998765 4999999999999999999999999999999999999999887 999999999764332
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|.|..+.+...... .
T Consensus 256 -~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~--~ 330 (429)
T 3kvw_A 256 -VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA--K 330 (429)
T ss_dssp -CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH--H
T ss_pred -ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh--h
Confidence 245689999999999987 67999999999999999999999999999999999999999999999877654322 2
Q ss_pred HHHhhhccCCC-----------------------------CCCCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 157 RYLSSMRKKKP-----------------------------IPFSQ-KFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 157 ~~~~~~~~~~~-----------------------------~~~~~-~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
.++........ ..+.. .....++.+.+||.+||++||++|||++|+|+||
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp 410 (429)
T 3kvw_A 331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP 410 (429)
T ss_dssp HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence 22211100000 00000 0123478899999999999999999999999999
Q ss_pred cccccc
Q 013122 207 YFKGLA 212 (449)
Q Consensus 207 ~f~~~~ 212 (449)
||+...
T Consensus 411 w~~~~~ 416 (429)
T 3kvw_A 411 WLRRRL 416 (429)
T ss_dssp TTC---
T ss_pred hhccCC
Confidence 998643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.15 Aligned_cols=170 Identities=22% Similarity=0.354 Sum_probs=133.3
Q ss_pred CCcHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 2 ESDLHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 2 e~dL~~~i~~~---------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
+|+|.++|+.. ..|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+
T Consensus 127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~ 206 (329)
T 4aoj_A 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206 (329)
T ss_dssp TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccce
Confidence 47999999764 359999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHH
Q 013122 67 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 67 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e 145 (449)
........ ...+..+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.+..|..
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-------- 275 (329)
T 4aoj_A 207 DIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-------- 275 (329)
T ss_dssp --------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH--------
T ss_pred eccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 65433221 12245679999999999987 689999999999999999998 8999988776544433321
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....+++.+.+||.+||+.||++|||+.|+++
T Consensus 276 -------------------g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 276 -------------------GREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp -------------------TCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred -------------------CCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1111 112457899999999999999999999999976
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=295.10 Aligned_cols=171 Identities=22% Similarity=0.405 Sum_probs=141.3
Q ss_pred CCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~----------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+|||.++|..+ ..|++..+..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|
T Consensus 113 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGla 192 (308)
T 4gt4_A 113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 192 (308)
T ss_dssp SCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCB
T ss_pred CCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccc
Confidence 47999999753 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+........ ...+..+||+.|||||++.+ ..|+.++|||||||++|||+| |..||.+.+..+.+..+..
T Consensus 193 r~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~------- 262 (308)
T 4gt4_A 193 REVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN------- 262 (308)
T ss_dssp CGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-------
T ss_pred eeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 865433221 12345689999999999987 689999999999999999998 8999998776544433321
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
....+ ....+++.+.+||.+||+.||++|||+.|++++
T Consensus 263 --------------------~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 263 --------------------RQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp --------------------TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11111 234578999999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=301.35 Aligned_cols=172 Identities=27% Similarity=0.440 Sum_probs=140.6
Q ss_pred CCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~----------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+|+|.++|++. ..|++.++..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|
T Consensus 153 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGla 232 (353)
T 4ase_A 153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 232 (353)
T ss_dssp TEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred CCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhh
Confidence 47999999863 34899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+........ ...+..+||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+....+..+.
T Consensus 233 r~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i-------- 301 (353)
T 4ase_A 233 RDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-------- 301 (353)
T ss_dssp SCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH--------
T ss_pred hhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------
Confidence 876443322 12345689999999999987 689999999999999999998 999998876443321111
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
. ..... .....+++.+.+||.+||+.||++|||+.|+++|
T Consensus 302 ---------------~---~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 ---------------K---EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ---------------H---HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------H---cCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 0 11111 1123578999999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=294.74 Aligned_cols=208 Identities=35% Similarity=0.648 Sum_probs=163.3
Q ss_pred CCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
|+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 163 (317)
T 2pmi_A 85 MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN- 163 (317)
T ss_dssp CCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-
T ss_pred cCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-
Confidence 467899998764 3599999999999999999999999999999999999999999999999999986543221
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+++..|.+.+|.+....+..+....
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 164 --TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp --CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred --cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 12456789999999998752 468999999999999999999999999999999999999988888766554332100
Q ss_pred HHHHHhhhccCCCCCC-----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 155 ARRYLSSMRKKKPIPF-----SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.+...+....+..+ ......++..+.+||.+||+.||.+|||++|+|+||||+++...
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 241 --KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp --TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred --hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 00000000000000 01123578899999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=289.18 Aligned_cols=175 Identities=26% Similarity=0.435 Sum_probs=147.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 98 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~~ 173 (328)
T 3fe3_A 98 GGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAF 173 (328)
T ss_dssp TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC----GGGTT
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC----ccccc
Confidence 47999999988899999999999999999999999999999999999999999999999999997654332 23567
Q ss_pred cccccccCcccccccCCCC-CCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
+||++|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 174 ~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----------------------- 228 (328)
T 3fe3_A 174 CGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR----------------------- 228 (328)
T ss_dssp SSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------------------
T ss_pred cCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------------
Confidence 89999999999987 454 4789999999999999999999998775544433321
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.... ....+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 229 ---~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 229 ---GKYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ---CCCC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ---CCCC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 0111 11246899999999999999999999999999999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=289.62 Aligned_cols=206 Identities=38% Similarity=0.731 Sum_probs=157.2
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 163 (311)
T 4agu_A 87 TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD---YYDDEV 163 (311)
T ss_dssp EHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------------
T ss_pred chHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---ccCCCc
Confidence 46788888888899999999999999999999999999999999999999999999999999976543221 224567
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+...++...+......... .++...
T Consensus 164 ~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 239 (311)
T 4agu_A 164 ATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN---QYFSGV 239 (311)
T ss_dssp --GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC---GGGTTC
T ss_pred CCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc---cccccC
Confidence 99999999998653 56899999999999999999999999999999988888888887766544322111 011111
Q ss_pred ccCCC---CCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccc
Q 013122 163 RKKKP---IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215 (449)
Q Consensus 163 ~~~~~---~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~ 215 (449)
....+ .+....++.++..+.+||.+||..||.+|||++|+|+||||+++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 10000 111223467899999999999999999999999999999999876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.03 Aligned_cols=205 Identities=38% Similarity=0.741 Sum_probs=164.1
Q ss_pred CCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc-CCCCEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
|+++|.+++. .+..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 120 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-- 197 (383)
T 3eb0_A 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-- 197 (383)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--
T ss_pred CCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--
Confidence 3456666654 466799999999999999999999999999999999999998 588999999999986544332
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
....+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..|...+|.|..+.+........
T Consensus 198 --~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~ 274 (383)
T 3eb0_A 198 --SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT 274 (383)
T ss_dssp --CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-
T ss_pred --CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc
Confidence 2456789999999998763 4589999999999999999999999999999999999999999999887765432110
Q ss_pred HHHHhhhccCCCCCCCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 156 RRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
. ..........+...+ ...++.+.+||.+||+.||.+|||+.|+|+||||+.+..
T Consensus 275 ~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 275 E---VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp ----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred c---ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 0 000001111111112 347899999999999999999999999999999997754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=291.58 Aligned_cols=206 Identities=35% Similarity=0.582 Sum_probs=154.5
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc-----CCCCEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-----ADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-----~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
|+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 115 ~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~-- 192 (329)
T 3gbz_A 115 AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-- 192 (329)
T ss_dssp CSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------
T ss_pred CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--
Confidence 4679999999998999999999999999999999999999999999999995 445599999999987543221
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
.....+||..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+...++.+....+.......
T Consensus 193 -~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 269 (329)
T 3gbz_A 193 -QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP- 269 (329)
T ss_dssp --------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST-
T ss_pred -ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh-
Confidence 22456789999999998763 458999999999999999999999999999988888888888877765443321100
Q ss_pred HHHHhhhccCCCCCCCCC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 156 RRYLSSMRKKKPIPFSQK-FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.+...........+... ...+++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 270 -DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp -TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred -hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 00000000000000000 011678999999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=292.42 Aligned_cols=199 Identities=25% Similarity=0.487 Sum_probs=159.1
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-------------------------
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------------------------- 53 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~------------------------- 53 (449)
|+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 118 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (360)
T 3llt_A 118 LGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197 (360)
T ss_dssp CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEES
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccC
Confidence 4689999998765 4999999999999999999999999999999999999975
Q ss_pred CCCEEEeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHH
Q 013122 54 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 133 (449)
Q Consensus 54 ~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~ 133 (449)
++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 198 ~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 269 (360)
T 3llt_A 198 STGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269 (360)
T ss_dssp CCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 788999999999764332 245679999999999987 679999999999999999999999999999999999
Q ss_pred HHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCC-----------------CCCCHHHHHHHHHhhhcCCCCC
Q 013122 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-----------------PNANPLALRLLERMLAFEPKDR 196 (449)
Q Consensus 134 ~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~s~~~~dLL~~~L~~DP~~R 196 (449)
.+....+.++...+..........++..... ...+.... ...++.+.+||.+||+.||.+|
T Consensus 270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 347 (360)
T 3llt_A 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDEL--KLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347 (360)
T ss_dssp HHHHHTCCCCHHHHHHHTTSGGGGGEETTTT--EECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhcCCCCHHHHhhhhhccCccccCcccc--eecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence 9999988888776654332111111100000 00010000 1134778899999999999999
Q ss_pred CCHHHHHcCcccc
Q 013122 197 PTAEEALADPYFK 209 (449)
Q Consensus 197 pTa~elL~hp~f~ 209 (449)
||++|+|+||||+
T Consensus 348 pta~elL~hp~f~ 360 (360)
T 3llt_A 348 PSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHTTSGGGC
T ss_pred CCHHHHhcCcccC
Confidence 9999999999996
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.34 Aligned_cols=212 Identities=36% Similarity=0.601 Sum_probs=153.2
Q ss_pred CCCcHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE----cCCCCEEEeecCcccc
Q 013122 1 MESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLARV 67 (449)
Q Consensus 1 me~dL~~~i~~~---------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGlA~~ 67 (449)
|+++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 102 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp CSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred CCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 467888888632 149999999999999999999999999999999999999 6778999999999987
Q ss_pred ccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc---------hhhHHHHHhh
Q 013122 68 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIMTDL 138 (449)
Q Consensus 68 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~---------~~~l~~i~~~ 138 (449)
..............+||++|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+. .+++..|...
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ---------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred cCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 64432222233557899999999998763 4589999999999999999999999987654 4788889999
Q ss_pred cCCCCHHHHHHHhhHH-HHHHHhhhccCCCCC------CCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 139 LGTPSPEAIARVRNEK-ARRYLSSMRKKKPIP------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 139 lg~p~~e~~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
+|.|....|..+.... ............... +.......++.+.+||.+||.+||.+|||++|+|+||||.+.
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 9998877665543211 111111111110000 001122347789999999999999999999999999999875
Q ss_pred cc
Q 013122 212 AK 213 (449)
Q Consensus 212 ~~ 213 (449)
..
T Consensus 341 ~~ 342 (405)
T 3rgf_A 341 PL 342 (405)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.10 Aligned_cols=177 Identities=29% Similarity=0.461 Sum_probs=150.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC----CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... .
T Consensus 99 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~----~ 174 (361)
T 2yab_A 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----E 174 (361)
T ss_dssp SCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC----C
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC----c
Confidence 579999999888999999999999999999999999999999999999998877 79999999998764432 2
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..|.........
T Consensus 175 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 239 (361)
T 2yab_A 175 FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE------------- 239 (361)
T ss_dssp CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------------
T ss_pred cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-------------
Confidence 245689999999999987 67999999999999999999999999988776665555432221111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
..+..+++.+++||.+||..||.+|||++|+|+||||+..
T Consensus 240 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 240 --------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp --------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred --------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 1234578899999999999999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=295.06 Aligned_cols=175 Identities=23% Similarity=0.414 Sum_probs=145.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 108 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~---~~~~~ 184 (353)
T 3txo_A 108 GGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATF 184 (353)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCc---ccccc
Confidence 469999999988999999999999999999999999999999999999999999999999999975332221 23557
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+..|...
T Consensus 185 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------------- 239 (353)
T 3txo_A 185 CGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------------------- 239 (353)
T ss_dssp -CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------------
T ss_pred CCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence 89999999999987 57899999999999999999999999988766555444321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa------~elL~hp~f~~~~ 212 (449)
... ....+++.+.+||.+||..||.+|+++ +|+++||||+++.
T Consensus 240 -----~~~---~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 240 -----EVV---YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp -----CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred -----CCC---CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 001 113478899999999999999999999 9999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=287.05 Aligned_cols=175 Identities=26% Similarity=0.473 Sum_probs=147.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 89 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~ 165 (337)
T 1o6l_A 89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTF 165 (337)
T ss_dssp TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC---CBCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC---ccccc
Confidence 469999999888999999999999999999999999999999999999999999999999999975432221 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......|..
T Consensus 166 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------------------ 219 (337)
T 1o6l_A 166 CGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------------------ 219 (337)
T ss_dssp EECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------------
T ss_pred ccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc------------------------
Confidence 89999999999987 6799999999999999999999999987765444332211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
. ... ....+++.+.+||.+||..||.+|| +++|+++||||+++.
T Consensus 220 --~--~~~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 220 --E--EIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp --C--CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred --C--CCC---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 0 011 1235789999999999999999999 999999999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=283.82 Aligned_cols=203 Identities=32% Similarity=0.541 Sum_probs=161.6
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-------------------CCCEEE
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------------------DCKLKI 59 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-------------------~~~vKL 59 (449)
|+++|.+++..+. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||
T Consensus 99 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl 178 (339)
T 1z57_A 99 LGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178 (339)
T ss_dssp CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEE
T ss_pred CCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceE
Confidence 4689999998876 5899999999999999999999999999999999999987 667999
Q ss_pred eecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhc
Q 013122 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139 (449)
Q Consensus 60 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 139 (449)
+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...+
T Consensus 179 ~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 250 (339)
T 1z57_A 179 VDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250 (339)
T ss_dssp CCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHH
T ss_pred eeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999999764332 134679999999999987 679999999999999999999999999999888888888888
Q ss_pred CCCCHHHHHHHhhHH--------------HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 140 GTPSPEAIARVRNEK--------------ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 140 g~p~~e~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
+..+...+....... ...+....... ...+.......++.+.+||.+||..||.+|||+.|+|+|
T Consensus 251 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 888777665432110 01111110000 001111122345778999999999999999999999999
Q ss_pred ccccccc
Q 013122 206 PYFKGLA 212 (449)
Q Consensus 206 p~f~~~~ 212 (449)
|||+.+.
T Consensus 330 p~f~~~~ 336 (339)
T 1z57_A 330 PFFDLLK 336 (339)
T ss_dssp GGGGGGG
T ss_pred HHHHHHh
Confidence 9999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=288.90 Aligned_cols=208 Identities=38% Similarity=0.679 Sum_probs=165.4
Q ss_pred CCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCC
Q 013122 2 ESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 2 e~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~ 74 (449)
+++|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+|||++........
T Consensus 109 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~- 187 (360)
T 3e3p_A 109 PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP- 187 (360)
T ss_dssp SCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC-
T ss_pred cccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC-
Confidence 456655444 5667999999999999999999999 999999999999999997 89999999999986544322
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+.+.++.+..+.+..+....
T Consensus 188 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3e3p_A 188 ---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263 (360)
T ss_dssp ---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred ---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccch
Confidence 2456789999999998652 458999999999999999999999999999999999999999999988776553211
Q ss_pred HHHHHhhhccCCCCCCCCC----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCC
Q 013122 155 ARRYLSSMRKKKPIPFSQK----FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~----~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e 217 (449)
.. .........++... ....++.+.+||.+||+.||.+|||+.|+|+||||+++......
T Consensus 264 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 327 (360)
T 3e3p_A 264 TD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327 (360)
T ss_dssp CC---GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred hh---ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence 00 00111111222222 22357889999999999999999999999999999998765543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=291.23 Aligned_cols=206 Identities=38% Similarity=0.653 Sum_probs=163.8
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++..+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 94 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 170 (346)
T 1ua2_A 94 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYT 170 (346)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---CCC
T ss_pred CCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc---cCC
Confidence 4678999988764 599999999999999999999999999999999999999999999999999976543221 234
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+..+.|....... .++
T Consensus 171 ~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~ 247 (346)
T 1ua2_A 171 HQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP--DYV 247 (346)
T ss_dssp CSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST--TCC
T ss_pred cccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc--ccc
Confidence 56799999999998652 458899999999999999999999999999988888888888877665443321100 000
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
........++...+..+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 248 -TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp -CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred -cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 00001111222234567899999999999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=283.62 Aligned_cols=214 Identities=42% Similarity=0.683 Sum_probs=162.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc-CCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..............
T Consensus 104 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 182 (320)
T 2i6l_A 104 METDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182 (320)
T ss_dssp CSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCC
T ss_pred cCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccc
Confidence 45789999875 4799999999999999999999999999999999999997 567899999999986543322222234
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...+|.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+......+..+....+.... ..++
T Consensus 183 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 260 (320)
T 2i6l_A 183 EGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI-PVYI 260 (320)
T ss_dssp GGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTS-CHHH
T ss_pred cccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcC-cccc
Confidence 56789999999988652 568899999999999999999999999999888888888877777666554432210 1111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e 217 (449)
.........++....+.++..+.+||.+||+.||.+|||++|+|+||||+.+..+..+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~ 318 (320)
T 2i6l_A 261 RNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDE 318 (320)
T ss_dssp HHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC----
T ss_pred cccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCC
Confidence 1111222223344456789999999999999999999999999999999977654433
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=282.61 Aligned_cols=204 Identities=37% Similarity=0.664 Sum_probs=165.3
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 101 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~ 176 (326)
T 1blx_A 101 VDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----AL 176 (326)
T ss_dssp CSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG----GG
T ss_pred CCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC----Cc
Confidence 4679999998764 49999999999999999999999999999999999999999999999999987643221 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...++.+....+.......
T Consensus 177 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---- 250 (326)
T 1blx_A 177 TSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP---- 250 (326)
T ss_dssp CCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC----
T ss_pred cccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccc----
Confidence 45678999999999987 578999999999999999999999999999888888888887777655443211000
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
................+.++..+.+||.+||..||.+|||+.|+|+||||+++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 00011112223344556789999999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=287.96 Aligned_cols=175 Identities=21% Similarity=0.402 Sum_probs=147.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 105 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~ 181 (353)
T 2i0e_A 105 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTF 181 (353)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc---ccccc
Confidence 469999999888899999999999999999999999999999999999999999999999999975432221 23457
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..|...
T Consensus 182 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------------- 236 (353)
T 2i0e_A 182 CGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------------------- 236 (353)
T ss_dssp CSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------------
T ss_pred cCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 89999999999987 67899999999999999999999999887765444333220
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
. .. ....+++.+.+||.+||..||.+||+ ++++++||||+++.
T Consensus 237 ---~--~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 237 ---N--VA---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp ---C--CC---CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred ---C--CC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 0 11 12357899999999999999999994 79999999998753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=290.85 Aligned_cols=202 Identities=30% Similarity=0.531 Sum_probs=160.0
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccccccCCcEEEc--CCCCEEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN--ADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILl~--~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
|+++|.+++.... .+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|||+++.....
T Consensus 138 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--- 214 (382)
T 2vx3_A 138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--- 214 (382)
T ss_dssp CCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC---
T ss_pred CCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc---
Confidence 4689999998764 5999999999999999999999 57999999999999995 4778999999999876432
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|...++.++...+.... .
T Consensus 215 ---~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~ 287 (382)
T 2vx3_A 215 ---IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP--K 287 (382)
T ss_dssp ---CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT--T
T ss_pred ---cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH--H
Confidence 245689999999999987 579999999999999999999999999999999999999999998887665432 2
Q ss_pred HHHHHhhhccCCC---------CCCCC-CC------------------C-------CCCHHHHHHHHHhhhcCCCCCCCH
Q 013122 155 ARRYLSSMRKKKP---------IPFSQ-KF------------------P-------NANPLALRLLERMLAFEPKDRPTA 199 (449)
Q Consensus 155 ~~~~~~~~~~~~~---------~~~~~-~~------------------~-------~~s~~~~dLL~~~L~~DP~~RpTa 199 (449)
...++..+..... ..+.. .. . ...+.+++||.+||++||++|||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta 367 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence 2333333221100 00000 00 0 001478999999999999999999
Q ss_pred HHHHcCccccccc
Q 013122 200 EEALADPYFKGLA 212 (449)
Q Consensus 200 ~elL~hp~f~~~~ 212 (449)
+|+|+||||+...
T Consensus 368 ~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 368 YYALQHSFFKKTA 380 (382)
T ss_dssp HHHTTSGGGCC--
T ss_pred HHHhcCcccccCC
Confidence 9999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=296.37 Aligned_cols=179 Identities=27% Similarity=0.438 Sum_probs=150.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++..+..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++........ ..
T Consensus 94 gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~---~~ 170 (444)
T 3soa_A 94 GGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AW 170 (444)
T ss_dssp CCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC---BC
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc---ee
Confidence 4699999999999999999999999999999999999999999999999984 57899999999976544322 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 171 ~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--------------------- 227 (444)
T 3soa_A 171 FGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--------------------- 227 (444)
T ss_dssp CCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---------------------
T ss_pred ecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh---------------------
Confidence 45789999999999987 6799999999999999999999999988775544433322
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.........++.+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 228 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~ 275 (444)
T 3soa_A 228 ------GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275 (444)
T ss_dssp ------TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred ------CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence 111112234467899999999999999999999999999999998654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.81 Aligned_cols=175 Identities=25% Similarity=0.422 Sum_probs=148.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 102 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~ 178 (345)
T 1xjd_A 102 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTF 178 (345)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCCC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC---cccCC
Confidence 479999999888899999999999999999999999999999999999999999999999999975432221 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+....+..|..
T Consensus 179 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------------------ 232 (345)
T 1xjd_A 179 CGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------------------------ 232 (345)
T ss_dssp CSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------------
T ss_pred CCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------------------------
Confidence 89999999999987 6799999999999999999999999988776544433321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-HHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~-elL~hp~f~~~~ 212 (449)
.. . .....+++.+.+||.+||..||.+||++. ++++||||+++.
T Consensus 233 ---~~-~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 233 ---DN-P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp ---CC-C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ---CC-C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 00 0 11134789999999999999999999998 999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=282.62 Aligned_cols=172 Identities=26% Similarity=0.464 Sum_probs=147.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 90 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~------~~~~ 163 (318)
T 1fot_A 90 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTL 163 (318)
T ss_dssp SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------BCCC
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc------cccc
Confidence 4699999999889999999999999999999999999999999999999999999999999999865332 2346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+....+..|...
T Consensus 164 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------------- 218 (318)
T 1fot_A 164 CGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----------------------- 218 (318)
T ss_dssp CSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-----------------------
T ss_pred cCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 89999999999987 67999999999999999999999999887655444333210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
. .. ..+.+++.+.+||.+||..||.+|+ +++++++||||+++.
T Consensus 219 ---~--~~---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 219 ---E--LR---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp ---C--CC---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ---C--CC---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 0 11 1235789999999999999999999 999999999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=291.48 Aligned_cols=208 Identities=33% Similarity=0.559 Sum_probs=160.4
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC-Ccccc
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP-TAIFW 78 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~-~~~~~ 78 (449)
|+++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 106 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 185 (351)
T 3mi9_A 106 CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185 (351)
T ss_dssp CSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCC
T ss_pred cCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccccccccc
Confidence 456788888765 4699999999999999999999999999999999999999999999999999976542221 11223
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+...++..+....+.+..+.+..+......
T Consensus 186 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-- 262 (351)
T 3mi9_A 186 TNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY-- 262 (351)
T ss_dssp CSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG--
T ss_pred CCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhh--
Confidence 556789999999998763 46899999999999999999999999999999999999888888776655443221100
Q ss_pred HhhhccCCC--CCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKP--IPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~--~~~~~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..+..... ......+ ...++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 263 -EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp -TSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred -cccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 00000000 0000000 01367899999999999999999999999999998643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=278.39 Aligned_cols=177 Identities=25% Similarity=0.454 Sum_probs=146.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 176 (297)
T 3fxz_A 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 176 (297)
T ss_dssp TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCC
T ss_pred CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc---ccCCc
Confidence 57999999876 699999999999999999999999999999999999999999999999999876544322 22456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 177 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------------------- 231 (297)
T 3fxz_A 177 VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN----------------------- 231 (297)
T ss_dssp CSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-----------------------
T ss_pred cCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 89999999999987 67899999999999999999999999877654443322110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. +.......+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 232 --~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 232 --GT---PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp --CS---CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --CC---CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 00 01112235788999999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=282.93 Aligned_cols=204 Identities=32% Similarity=0.555 Sum_probs=160.7
Q ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE-------------------cCCCCEEE
Q 013122 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-------------------NADCKLKI 59 (449)
Q Consensus 1 me~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl-------------------~~~~~vKL 59 (449)
|+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 104 ~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl 183 (355)
T 2eu9_A 104 LGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183 (355)
T ss_dssp CCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEE
T ss_pred cCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEE
Confidence 4678888888764 69999999999999999999999999999999999999 56788999
Q ss_pred eecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhc
Q 013122 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 139 (449)
Q Consensus 60 ~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l 139 (449)
+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+...+
T Consensus 184 ~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 184 ADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp CCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 9999997643322 44679999999999987 679999999999999999999999999999888888899988
Q ss_pred CCCCHHHHHHHhhHH--------------HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 140 GTPSPEAIARVRNEK--------------ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 140 g~p~~e~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
+..+...+....... ...++...... ...........+..+.+||.+||..||.+|||+.|+|+|
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP-LKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCc-ccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 888777665432211 00111100000 000001112235678999999999999999999999999
Q ss_pred cccccccc
Q 013122 206 PYFKGLAK 213 (449)
Q Consensus 206 p~f~~~~~ 213 (449)
|||+++..
T Consensus 335 p~f~~~~~ 342 (355)
T 2eu9_A 335 PFFAGLTP 342 (355)
T ss_dssp GGGGGCCH
T ss_pred hhhcCCCh
Confidence 99998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.65 Aligned_cols=177 Identities=31% Similarity=0.475 Sum_probs=148.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC----CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 98 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---- 173 (326)
T 2y0a_A 98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---- 173 (326)
T ss_dssp SCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC----
T ss_pred CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc----
Confidence 479999999888899999999999999999999999999999999999999887 799999999987643321
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 174 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 237 (326)
T 2y0a_A 174 FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------- 237 (326)
T ss_dssp CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC--------------
T ss_pred cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC--------------
Confidence 245679999999999987 6799999999999999999999999988776555444433211111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
...+..+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 238 -------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 238 -------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 11234568899999999999999999999999999999853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=281.26 Aligned_cols=174 Identities=28% Similarity=0.481 Sum_probs=144.9
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 91 ~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~----~~~~ 166 (336)
T 3h4j_B 91 AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKT 166 (336)
T ss_dssp CCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB----TTCC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc----cccc
Confidence 468999999988899999999999999999999999999999999999999999999999999997654332 2355
Q ss_pred ccccccccCcccccccCCCC-CCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
.+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+........
T Consensus 167 ~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------------------- 218 (336)
T 3h4j_B 167 SCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------------------- 218 (336)
T ss_dssp CTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------------------------
T ss_pred ccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------------------------
Confidence 689999999999987 344 789999999999999999999998755322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
............+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 219 -----~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 219 -----KVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----CCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----HHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00111112234578999999999999999999999999999999853
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.75 Aligned_cols=171 Identities=20% Similarity=0.358 Sum_probs=147.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 125 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~------~~~~ 198 (350)
T 1rdq_E 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTL 198 (350)
T ss_dssp TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC------BCCC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC------cccc
Confidence 4799999998888999999999999999999999999999999999999999999999999999865432 1356
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..|...
T Consensus 199 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------------------- 253 (350)
T 1rdq_E 199 CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------------------- 253 (350)
T ss_dssp EECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------------
T ss_pred cCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence 89999999999987 67899999999999999999999999887655444333210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~ 211 (449)
... ....+++.+.+||.+||+.||.+||+ ++++++||||+++
T Consensus 254 -----~~~---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 254 -----KVR---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -----CCC---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -----CCC---CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 011 12357899999999999999999998 9999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.78 Aligned_cols=184 Identities=22% Similarity=0.423 Sum_probs=144.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 137 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~---~~~~~ 213 (396)
T 4dc2_A 137 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 213 (396)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCCC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC---ccccc
Confidence 469999999988999999999999999999999999999999999999999999999999999975332221 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+......... ... ......+.
T Consensus 214 ~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~--------~~~~~~i~- 275 (396)
T 4dc2_A 214 CGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTE--------DYLFQVIL- 275 (396)
T ss_dssp CBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCH--------HHHHHHHH-
T ss_pred cCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhH--------HHHHHHHh-
Confidence 89999999999988 6899999999999999999999999975432111000 000 00001111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa------~elL~hp~f~~~~ 212 (449)
.. .. .....+++.+.+||.+||+.||.+|+++ +|+++||||+++.
T Consensus 276 --~~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 276 --EK-QI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp --HC-CC---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred --cc-cc---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 11 11 1123578999999999999999999985 8999999998763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=281.54 Aligned_cols=178 Identities=26% Similarity=0.403 Sum_probs=149.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC--CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... ..
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~ 160 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NF 160 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EE
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC----cc
Confidence 369999998764 6999999999999999999999999999999999999997 7899999999998764432 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 161 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 223 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------- 223 (321)
T ss_dssp EEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---------------
T ss_pred ccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC---------------
Confidence 45679999999999987 5688999999999999999999999998776655554443221111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...++.++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 224 ------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 224 ------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 112346788999999999999999999999999999998643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=285.90 Aligned_cols=202 Identities=33% Similarity=0.640 Sum_probs=155.5
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+
T Consensus 109 ~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 185 (331)
T 4aaa_A 109 TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEV 185 (331)
T ss_dssp EHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------------CC
T ss_pred chHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc---ccCCCc
Confidence 45667777777899999999999999999999999999999999999999999999999999976543221 224567
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++...+.......... .....
T Consensus 186 ~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 261 (331)
T 4aaa_A 186 ATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP---VFAGV 261 (331)
T ss_dssp CCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG---GGTTC
T ss_pred CCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc---ccccc
Confidence 99999999998762 468899999999999999999999999999988888888888877665443321110 00000
Q ss_pred cc---CCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 163 RK---KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 163 ~~---~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.. ....+....++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 00 01111222345789999999999999999999999999999999853
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=283.27 Aligned_cols=184 Identities=22% Similarity=0.422 Sum_probs=143.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 94 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~---~~~~~ 170 (345)
T 3a8x_A 94 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 170 (345)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC---CBCCC
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC---ccccc
Confidence 469999999888899999999999999999999999999999999999999999999999999975332221 23557
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+......... .. .......+.
T Consensus 171 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------~~--------~~~~~~~i~- 232 (345)
T 3a8x_A 171 CGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NT--------EDYLFQVIL- 232 (345)
T ss_dssp CSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------C--------HHHHHHHHH-
T ss_pred CCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-------cc--------HHHHHHHHH-
Confidence 89999999999987 6789999999999999999999999965321110000 00 000001111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA------EEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa------~elL~hp~f~~~~ 212 (449)
.. ... ....++..+.+||.+||..||.+||++ +|+++||||+++.
T Consensus 233 --~~-~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 233 --EK-QIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp --HC-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred --cC-CCC---CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 11 111 123578999999999999999999995 8999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=286.68 Aligned_cols=175 Identities=27% Similarity=0.464 Sum_probs=148.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 123 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~---~~~~~ 199 (373)
T 2r5t_A 123 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTF 199 (373)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC---CCCSB
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC---ccccc
Confidence 469999999888899999999999999999999999999999999999999999999999999986433222 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+....+..|...
T Consensus 200 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------------- 254 (373)
T 2r5t_A 200 CGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------------------- 254 (373)
T ss_dssp SCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------------------
T ss_pred cCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------------------
Confidence 89999999999987 68999999999999999999999999887765544333210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa----~elL~hp~f~~~~ 212 (449)
.. ...+.++..+.+||.+||+.||.+|+++ +++++||||+++.
T Consensus 255 -----~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 255 -----PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp -----CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred -----cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 11 1224678999999999999999999986 6999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=296.16 Aligned_cols=183 Identities=24% Similarity=0.442 Sum_probs=151.3
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 158 gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~ 235 (437)
T 4aw2_A 158 GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSV 235 (437)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE--ECCS
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc--cccc
Confidence 5799999987 467999999999999999999999999999999999999999999999999999765433221 2245
Q ss_pred ccccccccCcccccc---cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~---~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.+||+.|+|||++.. ....|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 236 ~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------------ 297 (437)
T 4aw2_A 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------------------ 297 (437)
T ss_dssp CCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH------------------
T ss_pred ccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc------------------
Confidence 689999999999862 11468999999999999999999999999887766655543210
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~~~ 212 (449)
....+......+++.+++||.+||..+|++ |++++|+++||||+++.
T Consensus 298 --------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 298 --------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp --------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred --------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 011233344568999999999999998888 99999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=279.71 Aligned_cols=178 Identities=29% Similarity=0.467 Sum_probs=149.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC----CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---- 174 (321)
T 2a2a_A 99 GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---- 174 (321)
T ss_dssp SCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc----
Confidence 479999999988899999999999999999999999999999999999999887 799999999986544322
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.........
T Consensus 175 ~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------- 239 (321)
T 2a2a_A 175 FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE------------- 239 (321)
T ss_dssp CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------------
T ss_pred ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-------------
Confidence 245679999999999987 67899999999999999999999999887765555444332211111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..+...++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 240 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 240 --------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp --------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred --------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 11245688999999999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=293.01 Aligned_cols=182 Identities=25% Similarity=0.398 Sum_probs=139.0
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.++|.... .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---- 218 (400)
T 1nxk_A 143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---- 218 (400)
T ss_dssp SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------
T ss_pred CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC----
Confidence 369999998764 4999999999999999999999999999999999999998 7889999999998654322
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
.....+||+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+....... ..
T Consensus 219 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----------~~--------- 276 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----------MK--------- 276 (400)
T ss_dssp --------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-----------HH---------
T ss_pred ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-----------HH---------
Confidence 2345789999999999977 6899999999999999999999999987653221000 00
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..+. ..........+..+++.+.+||.+||..||.+|||++|+|+||||....
T Consensus 277 ~~i~---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 277 TRIR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp HHHH---HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred HHHH---cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 0000 0001111123456899999999999999999999999999999998644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=291.32 Aligned_cols=175 Identities=26% Similarity=0.487 Sum_probs=146.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 232 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~ 308 (446)
T 4ejn_A 232 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKT 308 (446)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--------CC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc---cccc
Confidence 46999999988899999999999999999999998 9999999999999999999999999999975432221 2356
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 309 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------------------- 364 (446)
T 4ejn_A 309 FCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------------------- 364 (446)
T ss_dssp SSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------------------
T ss_pred ccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC----------------------
Confidence 789999999999987 68999999999999999999999999887765444333210
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
. . .....+++.+.+||.+||+.||.+|| |++|+|+||||+++.
T Consensus 365 ----~--~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 365 ----E--I---RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp ----C--C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ----C--C---CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 0 0 11235789999999999999999999 999999999999763
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.00 Aligned_cols=184 Identities=26% Similarity=0.414 Sum_probs=146.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC----CCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+... +.+||+|||++........ .
T Consensus 100 gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~ 176 (342)
T 2qr7_A 100 GGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---L 176 (342)
T ss_dssp SCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC---C
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC---c
Confidence 46999999998899999999999999999999999999999999999998543 3499999999986544322 2
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+........
T Consensus 177 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------------------------ 230 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE------------------------ 230 (342)
T ss_dssp BCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH------------------------
T ss_pred eeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH------------------------
Confidence 245689999999999977 568899999999999999999999997643211111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.+..+...........+..+++.+.+||.+||..||++|||+.++|+||||..+...
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp HHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred HHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence 011111111111223446789999999999999999999999999999999876544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.73 Aligned_cols=178 Identities=28% Similarity=0.462 Sum_probs=147.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ..
T Consensus 112 gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~----~~ 187 (362)
T 2bdw_A 112 GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AW 187 (362)
T ss_dssp SCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC----SC
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc----cc
Confidence 469999999888899999999999999999999999999999999999998654 59999999997654332 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 188 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------- 245 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------------------- 245 (362)
T ss_dssp CCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------------
T ss_pred ccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--------------------
Confidence 45689999999999987 67999999999999999999999999887654444333221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........+..+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 246 -------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 292 (362)
T 2bdw_A 246 -------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 292 (362)
T ss_dssp -------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHH
T ss_pred -------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCc
Confidence 01111123345789999999999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=279.54 Aligned_cols=175 Identities=29% Similarity=0.471 Sum_probs=143.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 181 (327)
T 3a62_A 105 GGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTF 181 (327)
T ss_dssp TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------------CTT
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc---ccccc
Confidence 468999999888899999999999999999999999999999999999999999999999999875432221 22456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 182 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----------------------- 236 (327)
T 3a62_A 182 CGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----------------------- 236 (327)
T ss_dssp SSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----------------------
T ss_pred CCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 79999999999987 67899999999999999999999999887755444333221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
. ....+.+++.+.+||.+||..||.+|| +++|+|+||||+++.
T Consensus 237 ---~-----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 237 ---K-----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp ---C-----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred ---C-----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 0 011235789999999999999999999 899999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.95 Aligned_cols=213 Identities=20% Similarity=0.260 Sum_probs=144.9
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC----c
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT----A 75 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~----~ 75 (449)
+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... .
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 189 (389)
T 3gni_B 110 YGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189 (389)
T ss_dssp TCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBC
T ss_pred CCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccc
Confidence 37999999876 67999999999999999999999999999999999999999999999999988654322111 1
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhc--------CCCCHHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL--------GTPSPEAI 147 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~l--------g~p~~e~~ 147 (449)
......+||..|+|||++.+....|+.++|||||||++|+|++|+.||.+.+....+..+.... ..+..+..
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (389)
T 3gni_B 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269 (389)
T ss_dssp CCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------
T ss_pred cccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccc
Confidence 1123357899999999997633468999999999999999999999999877665544332110 00000000
Q ss_pred HHHhh----HHHHHHHh---hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 148 ARVRN----EKARRYLS---SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 148 ~~~~~----~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
..... ......+. ........+.......+++.+.+||.+||+.||.+|||++|+|+||||+.+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp ------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred ccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 00000 00000000 000000111122345578999999999999999999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=285.03 Aligned_cols=200 Identities=29% Similarity=0.460 Sum_probs=153.6
Q ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCC----------------------
Q 013122 1 MESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADC---------------------- 55 (449)
Q Consensus 1 me~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~---------------------- 55 (449)
|+++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 127 ~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (397)
T 1wak_A 127 LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206 (397)
T ss_dssp CCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------
T ss_pred cCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCC
Confidence 467888888765 4699999999999999999999998 999999999999999775
Q ss_pred ---------------------------CEEEeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhh
Q 013122 56 ---------------------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 108 (449)
Q Consensus 56 ---------------------------~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWS 108 (449)
.+||+|||++...... ....+||+.|+|||++.+ ..++.++||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Diws 278 (397)
T 1wak_A 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIG--SGYNTPADIWS 278 (397)
T ss_dssp ----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHT--SCCCTHHHHHH
T ss_pred CCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhcC--CCCCcHHHHHH
Confidence 7999999999765432 245679999999999987 57999999999
Q ss_pred hHHHHHhhhhCCCCCCCCC------chhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCC----C--------
Q 013122 109 IGCIFAELLTGKPLFPGKN------VVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIP----F-------- 170 (449)
Q Consensus 109 lG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~----~-------- 170 (449)
|||++|+|++|+.||.+.+ ....+..+...+|.++...+...... ..++.......... +
T Consensus 279 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (397)
T 1wak_A 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKHITKLKPWGLFEVLVE 356 (397)
T ss_dssp HHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSSCCCCCCCCHHHHHHH
T ss_pred HHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCccccccccccCCcchhHhhhh
Confidence 9999999999999998765 45667788888888877665432111 00000000000000 0
Q ss_pred -CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 171 -SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 171 -~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.......++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 357 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0001123467889999999999999999999999999973
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=284.44 Aligned_cols=188 Identities=24% Similarity=0.413 Sum_probs=127.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........ ..
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~ 166 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---PL 166 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC---cc
Confidence 469999999998999999999999999999999999999999999999998765 799999999976543322 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+...... . ....
T Consensus 167 ~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------~------------~~~~ 224 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT--------S------------AVEI 224 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC--------C------------HHHH
T ss_pred cccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc--------c------------HHHH
Confidence 45678999999999987 679999999999999999999999998754321100 0 0011
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
+..+...........+..+++.+++||.+||..||.+|||++|+|+||||++....
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 11111111111112224578999999999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-33 Score=292.36 Aligned_cols=177 Identities=33% Similarity=0.518 Sum_probs=148.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC---CCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||++....... ..
T Consensus 120 ~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~----~~ 195 (494)
T 3lij_A 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KM 195 (494)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB----CB
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc----cc
Confidence 46899999988899999999999999999999999999999999999999764 459999999998764432 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...
T Consensus 196 ~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------------------- 252 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG-------------------- 252 (494)
T ss_dssp CCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------------
T ss_pred cccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------------
Confidence 45689999999999864 6899999999999999999999999987765554443321
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........+..+++.+++||.+||+.||.+|||+.|+|+||||+...
T Consensus 253 -------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 253 -------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp -------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred -------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 11111233456889999999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=292.50 Aligned_cols=178 Identities=32% Similarity=0.518 Sum_probs=146.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc---CCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ..
T Consensus 105 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~ 180 (486)
T 3mwu_A 105 GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KM 180 (486)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC----cc
Confidence 469999998888999999999999999999999999999999999999995 45679999999997654332 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 181 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------------- 238 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK------------------- 238 (486)
T ss_dssp -CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------------
T ss_pred CCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------
Confidence 45689999999999976 58999999999999999999999999887655544433211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.......+..+++.+++||.+||..||.+|||+.++|+||||+....
T Consensus 239 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 239 --------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp --------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred --------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 11111223467899999999999999999999999999999987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.26 Aligned_cols=175 Identities=21% Similarity=0.399 Sum_probs=150.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++|...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 426 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~---~~~~~ 502 (674)
T 3pfq_A 426 GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTF 502 (674)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC---CBCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc---ccccc
Confidence 479999999988999999999999999999999999999999999999999999999999999986433222 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+..|...
T Consensus 503 ~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------------------- 557 (674)
T 3pfq_A 503 CGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------------------- 557 (674)
T ss_dssp CSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------------------
T ss_pred cCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 89999999999987 68999999999999999999999999988766555444321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA-----EEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa-----~elL~hp~f~~~~ 212 (449)
.. .....+++.+.+||.+||..||.+|+++ +|+++||||+++.
T Consensus 558 -----~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 558 -----NV---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp -----CC---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred -----CC---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 01 1123578999999999999999999997 9999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=283.22 Aligned_cols=179 Identities=26% Similarity=0.424 Sum_probs=146.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 99 gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~ 174 (384)
T 4fr4_A 99 GGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTM 174 (384)
T ss_dssp TEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC----CBCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC----ceecc
Confidence 57999999998899999999999999999999999999999999999999999999999999998654332 23567
Q ss_pred cccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+.......+.. +.
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---------------------~~ 233 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---------------------FE 233 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---------------------HH
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---------------------Hh
Confidence 899999999998642 14588999999999999999999999986543322111110 00
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-a~elL~hp~f~~~~ 212 (449)
.. . ......+++.+.+||.+||..||.+||+ ++++++||||+++.
T Consensus 234 ---~~-~---~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 234 ---TT-V---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp ---HC-C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred ---hc-c---cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 00 0 1122357899999999999999999998 99999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=267.82 Aligned_cols=183 Identities=28% Similarity=0.472 Sum_probs=150.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC---EEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++..+..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++........ .
T Consensus 89 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~----~ 164 (284)
T 3kk8_A 89 GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA----W 164 (284)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB----C
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc----c
Confidence 4689999988888999999999999999999999999999999999999987655 99999999976543322 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 165 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------------------- 222 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------------------- 222 (284)
T ss_dssp CCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------------
T ss_pred cCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc--------------------
Confidence 45679999999999987 67899999999999999999999999877654443332211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCC
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 217 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e 217 (449)
........+..+++.+.+||.+||+.||++|||++|+|+||||+........
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 223 -------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp -------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred -------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 1111122345678999999999999999999999999999999876554433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=278.17 Aligned_cols=203 Identities=29% Similarity=0.575 Sum_probs=149.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........ ...
T Consensus 117 ~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~ 189 (330)
T 3nsz_A 117 NTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNV 189 (330)
T ss_dssp CCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----CCS
T ss_pred chhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc----ccc
Confidence 367888775 399999999999999999999999999999999999999777 899999999986544332 245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCC-CCCCchhhHHHHHhhcCCCCHHHHHHHhhHH-HHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSPEAIARVRNEK-ARRY 158 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF-~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~-~~~~ 158 (449)
.+||..|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+++..+...++.+....+....... ...+
T Consensus 190 ~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 190 RVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp CCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred ccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 6799999999998763 56899999999999999999999887 4556666676666666543221111000000 0000
Q ss_pred HhhhccCCCCCCCCC-----CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQK-----FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~-----~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...........+... ...+++.+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 001111111111111 123789999999999999999999999999999999765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.13 Aligned_cols=183 Identities=22% Similarity=0.370 Sum_probs=147.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.++|.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 145 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~--~~~~ 222 (412)
T 2vd5_A 145 GGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV--RSLV 222 (412)
T ss_dssp SCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE--ECSS
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc--ccce
Confidence 579999998754 7999999999999999999999999999999999999999999999999999865433221 1234
Q ss_pred ccccccccCccccccc-----CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 81 YVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
.+||+.|+|||++... ...|+.++|||||||++|||++|+.||.+.+....+..|...-
T Consensus 223 ~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------------- 286 (412)
T 2vd5_A 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK---------------- 286 (412)
T ss_dssp CCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----------------
T ss_pred eccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------
Confidence 6899999999998621 1468899999999999999999999999887665554443210
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHHcCcccccccc
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGLAK 213 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~R---pTa~elL~hp~f~~~~~ 213 (449)
. ...+......+++.+++||.+||. +|.+| ++++|+++||||+++..
T Consensus 287 ----~------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 287 ----E------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp ----H------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred ----c------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0 001112234678999999999999 99998 59999999999997643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=279.67 Aligned_cols=205 Identities=26% Similarity=0.408 Sum_probs=154.6
Q ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEc------CCCCEEEeecCccccccCC
Q 013122 1 MESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILAN------ADCKLKICDFGLARVAFND 71 (449)
Q Consensus 1 me~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~------~~~~vKL~DFGlA~~~~~~ 71 (449)
++++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++ ..+.+||+|||++......
T Consensus 112 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~ 191 (373)
T 1q8y_A 112 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191 (373)
T ss_dssp CCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC
T ss_pred CCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC
Confidence 467899999874 3599999999999999999999998 999999999999995 3447999999999765432
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC------chhhHHHHHhhcCCCCHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN------VVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~p~~e 145 (449)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+ ....+..+...+|.++..
T Consensus 192 ------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 263 (373)
T 1q8y_A 192 ------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 263 (373)
T ss_dssp ------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHH
T ss_pred ------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHH
Confidence 244579999999999987 678999999999999999999999998754 456677788888888776
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCC-------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFS-------------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.+...... ..++............ ......+..+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 264 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 264 LLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 65543221 1121111100000000 01123457789999999999999999999999999999865
Q ss_pred ccc
Q 013122 213 KVE 215 (449)
Q Consensus 213 ~~~ 215 (449)
..+
T Consensus 342 ~~~ 344 (373)
T 1q8y_A 342 GME 344 (373)
T ss_dssp TCT
T ss_pred Ccc
Confidence 443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=291.39 Aligned_cols=168 Identities=18% Similarity=0.221 Sum_probs=137.7
Q ss_pred CCCcHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 1 MESDLHQVIKANDDLTP-------EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~-------~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
|+++|.+++.....+++ ..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 182 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--- 258 (377)
T 3byv_A 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--- 258 (377)
T ss_dssp CSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---
T ss_pred cCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---
Confidence 46899999997665665 88888999999999999999999999999999999999999999999985322
Q ss_pred CccccccccccccccCcccccccCC-----------CCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCC
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 142 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~-----------~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p 142 (449)
.....+| +.|+|||++.+ . .|+.++|||||||++|||++|+.||.+.+....+..+
T Consensus 259 ---~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~------- 325 (377)
T 3byv_A 259 ---RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI------- 325 (377)
T ss_dssp ---EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG-------
T ss_pred ---cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh-------
Confidence 2245677 99999999976 4 6899999999999999999999999765532221111
Q ss_pred CHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 143 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 143 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
......+++.+.+||.+||..||.+|||+.|+|+||||+.+.
T Consensus 326 ----------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 326 ----------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp ----------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred ----------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 112256789999999999999999999999999999998654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=276.25 Aligned_cols=171 Identities=26% Similarity=0.253 Sum_probs=136.9
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 139 ~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~----~~ 214 (311)
T 3p1a_A 139 CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA----GE 214 (311)
T ss_dssp CCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----------
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC----Cc
Confidence 4678988887654 599999999999999999999999999999999999999999999999999876543322 24
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
...||+.|+|||++.+ .++.++|||||||++|||++|..+|.+.... ..+... ..
T Consensus 215 ~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~~--~~----------------- 269 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQG--YL----------------- 269 (311)
T ss_dssp CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTTT--CC-----------------
T ss_pred ccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhcc--CC-----------------
Confidence 4569999999999875 6889999999999999999998776543221 111100 00
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.......+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 270 ----------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 ----------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 01112356889999999999999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=291.91 Aligned_cols=178 Identities=29% Similarity=0.466 Sum_probs=149.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE---cCCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ..
T Consensus 110 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~ 185 (484)
T 3nyv_A 110 GGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KM 185 (484)
T ss_dssp SCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----SH
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc----cc
Confidence 57999999998899999999999999999999999999999999999999 467889999999998764432 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 186 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------------- 243 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK------------------- 243 (484)
T ss_dssp HHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------
T ss_pred ccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 45679999999999875 68999999999999999999999999887655554443211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.......+..+++.+++||.+||+.||.+|||+.|+|+||||+....
T Consensus 244 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 244 --------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp --------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred --------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 11111223467899999999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-33 Score=278.69 Aligned_cols=178 Identities=28% Similarity=0.442 Sum_probs=137.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...... ..
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~----~~ 207 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LM 207 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc----cc
Confidence 4699999999888999999999999999999999999999999999999976 7899999999997654322 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchh-hHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 208 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~--------------------- 264 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL--------------------- 264 (349)
T ss_dssp -----CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHH---------------------
T ss_pred ccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHH---------------------
Confidence 45679999999999987 678999999999999999999999997655432 111111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..........+..++..+.+||.+||..||++|||+.|+|+||||.+..
T Consensus 265 ------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 265 ------NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ------TTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ------hCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 1111112234467889999999999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=272.92 Aligned_cols=177 Identities=30% Similarity=0.558 Sum_probs=145.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~---~~~~ 201 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSL 201 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC---BCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc---cccc
Confidence 4689998875 47999999999999999999999999999999999999999999999999998765443221 2456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 202 ~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~----------------------- 256 (321)
T 2c30_A 202 VGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----------------------- 256 (321)
T ss_dssp CSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----------------------
T ss_pred cCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------------
Confidence 89999999999987 67899999999999999999999999876654433322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. +.......+++.+.+||.+||..||++|||++++|+||||....
T Consensus 257 ----~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 257 ----PP-PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp ----SC-CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ----CC-CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 00 11111234688999999999999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=281.73 Aligned_cols=176 Identities=27% Similarity=0.398 Sum_probs=140.8
Q ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC---EEEeecCccccccCCCCCc
Q 013122 3 SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 3 ~dL~~~i~~~----~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGlA~~~~~~~~~~ 75 (449)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-- 188 (351)
T 3c0i_A 111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-- 188 (351)
T ss_dssp CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--
T ss_pred CCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--
Confidence 6888877643 25899999999999999999999999999999999999987654 99999999987644321
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+... ..+..+...
T Consensus 189 -~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~----------------- 247 (351)
T 3c0i_A 189 -VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKG----------------- 247 (351)
T ss_dssp -BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHT-----------------
T ss_pred -eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcC-----------------
Confidence 2345689999999999987 6789999999999999999999999987432 122111110
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
........+..+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 248 ----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 248 ----------KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ----------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ----------CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 0001111234578899999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=265.51 Aligned_cols=177 Identities=29% Similarity=0.424 Sum_probs=147.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE---cCCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ..
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~----~~ 165 (277)
T 3f3z_A 90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MM 165 (277)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS----CB
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc----ch
Confidence 46999999988889999999999999999999999999999999999999 778899999999997654332 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+.........
T Consensus 166 ~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 228 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE-------------- 228 (277)
T ss_dssp CCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH--------------
T ss_pred hccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc--------------
Confidence 45679999999999876 4889999999999999999999999887765554444332211111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 229 -------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp -------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred -------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 11235688999999999999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=278.94 Aligned_cols=179 Identities=27% Similarity=0.411 Sum_probs=131.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC--EEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... ...
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~----~~~ 175 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPK 175 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC----CCC
Confidence 4699999998889999999999999999999999999999999999999987765 9999999987433222 124
Q ss_pred cccccccccCcccccccCCCCCC-ccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~-~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.........+.. ..
T Consensus 176 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~-------------------~~ 234 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ-------------------RI 234 (361)
T ss_dssp -----CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH-------------------HH
T ss_pred CCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH-------------------HH
Confidence 5679999999999977 45544 48999999999999999999987654333222111 00
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
. . .... ......+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus 235 ~-~--~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 235 L-S--VKYS---IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp H-T--TCCC---CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred h-c--CCCC---CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0 0 0000 11123578999999999999999999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=286.98 Aligned_cols=184 Identities=16% Similarity=0.124 Sum_probs=139.6
Q ss_pred CCCcHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 1 MESDLHQVIKAND-DLTPEHY------QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i------~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
|+++|.+++...+ .+.+..+ ..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-- 247 (371)
T 3q60_A 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-- 247 (371)
T ss_dssp CSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--
T ss_pred CCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC--
Confidence 4589999998743 3555555 677799999999999999999999999999999999999999999865321
Q ss_pred CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.....+|+.|+|||++.+....|+.++|||||||++|+|++|+.||.+....... .+..
T Consensus 248 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-----~~~~------------ 306 (371)
T 3q60_A 248 ----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-----SWKR------------ 306 (371)
T ss_dssp ----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-----CCCB------------
T ss_pred ----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-----chhh------------
Confidence 1245677999999999753246899999999999999999999999876432110 0000
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
................+.+++.+.+||.+||+.||++|||+.++|+||||+.+.
T Consensus 307 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 307 -----PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp -----CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred -----hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 000000000111122357899999999999999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-33 Score=285.01 Aligned_cols=181 Identities=25% Similarity=0.356 Sum_probs=147.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 153 gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~ 229 (410)
T 3v8s_A 153 GGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM--VRCDTA 229 (410)
T ss_dssp TEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE--EECCSC
T ss_pred CCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc--ccccCC
Confidence 57999999875 699999999999999999999999999999999999999999999999999976543321 122467
Q ss_pred cccccccCcccccccC--CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 82 VATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
+||+.|+|||++.+.. ..|+.++|||||||++|||++|++||.+.+....+..|....
T Consensus 230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-------------------- 289 (410)
T 3v8s_A 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-------------------- 289 (410)
T ss_dssp CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------------------
T ss_pred cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--------------------
Confidence 8999999999997621 117889999999999999999999999887766555443210
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD--RPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~--RpTa~elL~hp~f~~~~ 212 (449)
.. ..+ .....+++.+++||.+||..+|.+ |++++|+++||||+++.
T Consensus 290 ~~------~~~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 290 NS------LTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HH------CCC-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred cc------ccC-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 00 001 112467899999999999999988 99999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=278.16 Aligned_cols=191 Identities=23% Similarity=0.222 Sum_probs=131.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
+|+|.++|+.. .++++.+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 163 (303)
T 3hmm_A 85 HGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence 37999999875 699999999999999999999987 999999999999999999999999999987654332
Q ss_pred Cc-cccccccccccccCcccccccC----CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 74 TA-IFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 74 ~~-~~~~~~~gt~~Y~APE~l~~~~----~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
.. ......+||+.|||||++.+.. ..|+.++|||||||++|||++|.+||........-- .......+..+.+
T Consensus 164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~~~~~~~~- 241 (303)
T 3hmm_A 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPSDPSVEEM- 241 (303)
T ss_dssp EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCSSCCHHHH-
T ss_pred ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccccchHHHH-
Confidence 21 1223468999999999987521 136779999999999999999988775433211100 0000011111111
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...+.. ......+...+ ......+.+||.+||+.||++|||+.|+++
T Consensus 242 -------~~~~~~--~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 242 -------RKVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp -------HHHHTT--SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred -------HHHHhc--ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111110 11111111111 123356889999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=283.09 Aligned_cols=178 Identities=29% Similarity=0.426 Sum_probs=147.4
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC--CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........ .
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~----~ 207 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----V 207 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC----E
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc----e
Confidence 469999998664 6999999999999999999999999999999999999974 46799999999987643321 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 208 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------------------- 265 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------------------- 265 (387)
T ss_dssp EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------------
T ss_pred eeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------------
Confidence 34579999999999987 67899999999999999999999999887765444333221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........+..+++.+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 266 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 266 -------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11111234457899999999999999999999999999999998643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=276.38 Aligned_cols=178 Identities=27% Similarity=0.497 Sum_probs=146.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........ ....
T Consensus 184 g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~----~~~~ 259 (365)
T 2y7j_A 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK----LREL 259 (365)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC----BCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc----cccC
Confidence 359999999888899999999999999999999999999999999999999999999999999876544322 2456
Q ss_pred cccccccCccccccc----CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 82 VATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
+||+.|+|||++.+. ...++.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 260 ~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------------- 325 (365)
T 2y7j_A 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS-------------- 325 (365)
T ss_dssp CSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------------
T ss_pred CCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 899999999998641 13578899999999999999999999988765544443332111111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
...+...+..+.+||.+||..||++|||++++|+||||+.
T Consensus 326 -------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 -------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp -------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1112456788999999999999999999999999999973
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.2e-33 Score=276.55 Aligned_cols=182 Identities=26% Similarity=0.399 Sum_probs=145.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... ......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~ 167 (323)
T 3tki_A 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKM 167 (323)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-CCBCSC
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc-cccCCC
Confidence 3589999988888999999999999999999999999999999999999999999999999999765332211 123456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+........ ...
T Consensus 168 ~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----------------------~~~- 223 (323)
T 3tki_A 168 CGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----------------------WKE- 223 (323)
T ss_dssp CSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH----------------------HHT-
T ss_pred ccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH----------------------Hhc-
Confidence 899999999999762 23477899999999999999999999876543221100 000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
. ......+..+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 224 --~---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 224 --K---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp --T---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred --c---cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 0 0111223457899999999999999999999999999999986543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-33 Score=270.46 Aligned_cols=174 Identities=24% Similarity=0.445 Sum_probs=137.5
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+
T Consensus 123 ~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 198 (298)
T 2zv2_A 123 GPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTV 198 (298)
T ss_dssp CBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC---EECCCC
T ss_pred CcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc---cccCCc
Confidence 45555433 34799999999999999999999999999999999999999999999999999986543321 234568
Q ss_pred ccccccCcccccccCCC-CCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 83 ATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~-~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
||+.|+|||++.+.... ++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 199 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------------------------ 254 (298)
T 2zv2_A 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS------------------------ 254 (298)
T ss_dssp SCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------------
T ss_pred CCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc------------------------
Confidence 99999999998763111 36789999999999999999999987654332221111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.. ..+ ...+.+++.+.+||.+||+.||++|||+.|+|+||||+
T Consensus 255 --~~--~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 255 --QA--LEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp --CC--CCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred --cc--CCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 00 011 12346789999999999999999999999999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-33 Score=273.74 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=138.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC---EEEeecCccccccCCCC----C
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTP----T 74 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGlA~~~~~~~~----~ 74 (449)
+++|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ .
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 3799999998888999999999999999999999999999999999999998776 99999999876432211 1
Q ss_pred ccccccccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 75 AIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
.......+||..|+|||++.+. ...++.++|||||||++|+|++|+.||.+....+..-... ....
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~------- 243 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG----EACP------- 243 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--------CCH-------
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc----ccch-------
Confidence 1112345699999999998641 0247889999999999999999999998765332100000 0000
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.........+...........+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 244 -~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 244 -ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred -hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 000011111111111111112345789999999999999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=266.57 Aligned_cols=173 Identities=26% Similarity=0.432 Sum_probs=143.1
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 94 ~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~~~ 168 (279)
T 3fdn_A 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTDLC 168 (279)
T ss_dssp EEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------------C
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-----ccccC
Confidence 6899999988889999999999999999999999999999999999999999999999999986543322 24467
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 169 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------- 223 (279)
T 3fdn_A 169 GTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE----------------------- 223 (279)
T ss_dssp CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-----------------------
T ss_pred CCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-----------------------
Confidence 8999999999987 678899999999999999999999998776544433332110
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
......+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 224 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 --------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred --------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 0112346889999999999999999999999999999987553
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=286.48 Aligned_cols=174 Identities=31% Similarity=0.466 Sum_probs=146.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 100 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~----~~~~~ 175 (476)
T 2y94_A 100 GGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTS 175 (476)
T ss_dssp SEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC----CBCCC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc----ccccc
Confidence 47999999988899999999999999999999999999999999999999999999999999998754332 23456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 176 ~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------------- 231 (476)
T 2y94_A 176 CGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG----------------------- 231 (476)
T ss_dssp CSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT-----------------------
T ss_pred CCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------------
Confidence 899999999999872 22368999999999999999999999887655444333211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
. ......+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus 232 ----~----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 232 ----I----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ----C----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ----C----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 01123468899999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=266.09 Aligned_cols=173 Identities=33% Similarity=0.494 Sum_probs=135.5
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE---cCCCCEEEeecCccccccCCCCCc
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~-- 182 (285)
T 3is5_A 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-- 182 (285)
T ss_dssp CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------
T ss_pred CcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc--
Confidence 588888854 3679999999999999999999999999999999999999 4467899999999976543321
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
.....||..|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 183 --~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------------------ 239 (285)
T 3is5_A 183 --STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------------------ 239 (285)
T ss_dssp ------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------
T ss_pred --CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------------------
Confidence 245679999999999864 688999999999999999999999988764433222111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
....+.......++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 240 ----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 240 ----------KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011122223447899999999999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.5e-33 Score=274.58 Aligned_cols=178 Identities=27% Similarity=0.425 Sum_probs=144.3
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCccc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 114 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---- 189 (327)
T 3lm5_A 114 GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---- 189 (327)
T ss_dssp EEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc----
Confidence 5788888654 56999999999999999999999999999999999999998 78999999999987543322
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 190 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------------------ 249 (327)
T 3lm5_A 190 LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN------------------ 249 (327)
T ss_dssp ----CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------------
T ss_pred cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc------------------
Confidence 244679999999999987 678999999999999999999999998877654443332211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.......+..+++.+.+||.+||+.||.+|||++++|+||||+++..
T Consensus 250 ---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 250 ---------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp ---------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ---------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 11122344568899999999999999999999999999999997654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.7e-33 Score=276.63 Aligned_cols=180 Identities=28% Similarity=0.395 Sum_probs=136.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++........ ......
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~ 169 (343)
T 3dbq_A 92 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQ 169 (343)
T ss_dssp SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc-ccCCCC
Confidence 579999999998999999999999999999999999999999999999997 678999999999765433221 122456
Q ss_pred cccccccCccccccc---------CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ...+.
T Consensus 170 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~---------------- 231 (343)
T 3dbq_A 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH---------------- 231 (343)
T ss_dssp CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHH----------------
T ss_pred cCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHH----------------
Confidence 799999999998531 146788999999999999999999999754321 11110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
..+ ..... .......+..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 232 ----~~~---~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 232 ----AII---DPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ----HHH---CTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ----HHh---cCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 011 01111 11223356789999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=277.61 Aligned_cols=182 Identities=25% Similarity=0.388 Sum_probs=144.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 143 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~ 220 (355)
T 1vzo_A 143 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDF 220 (355)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG--GGGCGG
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC--CcccCc
Confidence 369999999888899999999999999999999999999999999999999999999999999976533221 122456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+....++.++|||||||++|+|++|+.||...........+.. ....
T Consensus 221 ~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-------------------~~~~- 280 (355)
T 1vzo_A 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-------------------RILK- 280 (355)
T ss_dssp GSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH-------------------HHHH-
T ss_pred ccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH-------------------HHhc-
Confidence 89999999999975334578999999999999999999999976543322221111 0010
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
. .......++..+.+||.+||..||.+|| |++|+++||||+.+.
T Consensus 281 ---~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 281 ---S----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ---C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---c----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 0 0112345788999999999999999999 999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=280.32 Aligned_cols=177 Identities=28% Similarity=0.382 Sum_probs=147.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE--cCCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl--~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~----~ 245 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----L 245 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB----C
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc----c
Confidence 368988887654 69999999999999999999999999999999999999 5677899999999987644322 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 246 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------------ 305 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW------------------ 305 (373)
T ss_dssp CCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------------
T ss_pred ccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------------
Confidence 44579999999999976 6789999999999999999999999998876655544432110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
......+..+++.+++||.+||..||.+|||++|+|+||||++.
T Consensus 306 ---------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 306 ---------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 01122345678999999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=264.89 Aligned_cols=173 Identities=23% Similarity=0.414 Sum_probs=145.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 99 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~ 173 (284)
T 2vgo_A 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-----RRTMC 173 (284)
T ss_dssp EEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-----BCCCC
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-----ccccc
Confidence 5899999988889999999999999999999999999999999999999999999999999986653322 23467
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 174 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------------------ 227 (284)
T 2vgo_A 174 GTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------------------------ 227 (284)
T ss_dssp SCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------------------
T ss_pred CCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc------------------------
Confidence 8999999999987 67899999999999999999999999876654333222110
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.. ...+.++..+.+||.+||..||.+|||++++|+||||+....
T Consensus 228 ----~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 228 ----DL---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ----CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ----cc---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 00 112457889999999999999999999999999999986543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-32 Score=267.34 Aligned_cols=178 Identities=29% Similarity=0.457 Sum_probs=147.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE---cCCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-----~~ 164 (304)
T 2jam_A 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IM 164 (304)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-----TT
T ss_pred CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-----cc
Confidence 46999999988889999999999999999999999999999999999999 77889999999998754322 12
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 165 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------------- 222 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-------------------- 222 (304)
T ss_dssp HHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC--------------------
T ss_pred ccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 34579999999999987 67899999999999999999999999877654443333221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
...........+++.+.+||.+||..||.+|||++++|+||||++...
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 223 -------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp -------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred -------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 111112234567899999999999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=278.48 Aligned_cols=181 Identities=28% Similarity=0.399 Sum_probs=138.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++........ ......
T Consensus 139 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~ 216 (390)
T 2zmd_A 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQ 216 (390)
T ss_dssp SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----------CCS
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc-ccCCCC
Confidence 578999999998999999999999999999999999999999999999995 578999999999865433211 123456
Q ss_pred cccccccCccccccc---------CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
+||+.|+|||++.+. ...|+.++||||||||+|+|++|+.||.+.... ...+.
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~---------------- 278 (390)
T 2zmd_A 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH---------------- 278 (390)
T ss_dssp CCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHH----------------
T ss_pred CcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHH----------------
Confidence 899999999998641 135888999999999999999999999764321 11111
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..+. ...... .....+..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 279 ----~~~~---~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 279 ----AIID---PNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ----HHHC---TTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ----HHhC---ccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 1110 011111 1123478899999999999999999999999999998543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=286.46 Aligned_cols=178 Identities=32% Similarity=0.469 Sum_probs=149.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ..
T Consensus 130 gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~ 205 (504)
T 3q5i_A 130 GGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY----KL 205 (504)
T ss_dssp TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS----CB
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC----cc
Confidence 469999999888999999999999999999999999999999999999999876 69999999998664432 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....+..+........
T Consensus 206 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 267 (504)
T 3q5i_A 206 RDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD--------------- 267 (504)
T ss_dssp CCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred ccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 45689999999999875 689999999999999999999999998877665555433211111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
...+..+++.+++||.+||..||.+|||++|+|+||||+....
T Consensus 268 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 268 ------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp ------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred ------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 1123457899999999999999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=264.00 Aligned_cols=179 Identities=28% Similarity=0.478 Sum_probs=146.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC----CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++..+..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---- 167 (283)
T 3bhy_A 92 GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---- 167 (283)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc----
Confidence 479999999888899999999999999999999999999999999999998877 799999999976543321
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 168 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 231 (283)
T 3bhy_A 168 FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------------- 231 (283)
T ss_dssp ----CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--------------
T ss_pred ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--------------
Confidence 244578999999999987 6789999999999999999999999988776554443332211111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
...+...+..+.+||.+||..||.+|||+.++|+||||+.+..
T Consensus 232 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 232 -------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp -------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred -------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 1122456888999999999999999999999999999997654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=263.28 Aligned_cols=173 Identities=22% Similarity=0.333 Sum_probs=140.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEc-CCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....... .
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~-----~ 187 (290)
T 1t4h_A 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-----A 187 (290)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-----B
T ss_pred CCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc-----c
Confidence 4699999998888999999999999999999999999 99999999999998 78899999999997543322 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+....
T Consensus 188 ~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---------------------- 242 (290)
T 1t4h_A 188 KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------------------- 242 (290)
T ss_dssp EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH----------------------
T ss_pred ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH----------------------
Confidence 34579999999998875 58999999999999999999999998755433221110
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
... ..........++.+.+||.+||..||.+|||++|+|+||||++
T Consensus 243 ----~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 243 ----TSG--VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----TTT--CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----hcc--CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 000 0011122345688999999999999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=271.67 Aligned_cols=165 Identities=24% Similarity=0.385 Sum_probs=139.9
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~g 83 (449)
+|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....+|
T Consensus 116 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~----~~~~~g 191 (335)
T 3dls_A 116 DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYTFCG 191 (335)
T ss_dssp BHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC----BCEECS
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc----eeccCC
Confidence 8999999998999999999999999999999999999999999999999999999999999987644322 245679
Q ss_pred cccccCcccccccCCCC-CCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 84 TRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 84 t~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
|+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.... .
T Consensus 192 t~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------------------~ 237 (335)
T 3dls_A 192 TIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------------------V 237 (335)
T ss_dssp CGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------------------T
T ss_pred CccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------------------H
Confidence 999999999987 444 78999999999999999999999652210 0
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.. .......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 238 ~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 238 EA-----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp TT-----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred hh-----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 00 001122468899999999999999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=282.61 Aligned_cols=178 Identities=30% Similarity=0.524 Sum_probs=136.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 223 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~----~~ 298 (419)
T 3i6u_A 223 GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LM 298 (419)
T ss_dssp TCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---------
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCc----cc
Confidence 468999998888999999999999999999999999999999999999997644 59999999998654322 23
Q ss_pred ccccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHH-HHHhhcCCCCHHHHHHHhhHHHH
Q 013122 79 TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~-~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
...+||+.|+|||++.+. ...|+.++|||||||++|+|++|..||.+......+. .+...
T Consensus 299 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~------------------ 360 (419)
T 3i6u_A 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG------------------ 360 (419)
T ss_dssp ------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT------------------
T ss_pred cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC------------------
Confidence 456899999999998531 2467889999999999999999999998755432221 11111
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
........+..+++.+.+||.+||+.||.+|||++|+|+||||++
T Consensus 361 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 361 ---------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 111112223457889999999999999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=271.98 Aligned_cols=183 Identities=23% Similarity=0.393 Sum_probs=142.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++................
T Consensus 100 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 179 (311)
T 3ork_A 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179 (311)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccccccccccc
Confidence 36999999988899999999999999999999999999999999999999999999999999997654433222223446
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 180 ~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~----------------------- 234 (311)
T 3ork_A 180 IGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE----------------------- 234 (311)
T ss_dssp --CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------------------
T ss_pred CcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-----------------------
Confidence 79999999999987 67899999999999999999999999887654443222211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
...+.......+++.+.+||.+||+.||.+||++.++|.|+|++....
T Consensus 235 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 235 ----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ----CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ----CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 111112223467899999999999999999999999999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=262.86 Aligned_cols=180 Identities=29% Similarity=0.451 Sum_probs=147.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ ....
T Consensus 108 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~~~ 183 (298)
T 1phk_A 108 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREV 183 (298)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC----BCCC
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc----cccc
Confidence 369999999888899999999999999999999999999999999999999999999999999976543322 2456
Q ss_pred cccccccCcccccc----cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 82 VATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 82 ~gt~~Y~APE~l~~----~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.|+..|+|||++.+ ....++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 244 (298)
T 1phk_A 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------------------- 244 (298)
T ss_dssp CSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------------
T ss_pred cCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC-------------------
Confidence 78999999999852 1146788999999999999999999999876654433322211
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........+..++..+.+||.+||..||.+|||+.|+|+||||++..
T Consensus 245 --------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 --------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp --------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred --------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 00111122345788999999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=271.35 Aligned_cols=172 Identities=27% Similarity=0.438 Sum_probs=134.7
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC--CEEEeecCccccccCCCCC-ccccccccccccccCcc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPT-AIFWTDYVATRWYRAPE 91 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~vKL~DFGlA~~~~~~~~~-~~~~~~~~gt~~Y~APE 91 (449)
+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......... ........||+.|+|||
T Consensus 165 ~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 244 (345)
T 3hko_A 165 QREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence 46888999999999999999999999999999999998776 8999999999865332211 11234567999999999
Q ss_pred cccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCC
Q 013122 92 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFS 171 (449)
Q Consensus 92 ~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (449)
++.+....++.++|||||||++|+|++|+.||.+.+..+.+..+... ......
T Consensus 245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---------------------------~~~~~~ 297 (345)
T 3hko_A 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK---------------------------KLCFEN 297 (345)
T ss_dssp HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------------------------CCCTTS
T ss_pred hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc---------------------------ccccCC
Confidence 98653357889999999999999999999999887765544333221 111111
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 172 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 172 ~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
..+..+++.+.+||.+||..||.+|||+.++|+||||+++..
T Consensus 298 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 298 PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 223347899999999999999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=261.06 Aligned_cols=175 Identities=26% Similarity=0.456 Sum_probs=121.3
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ...
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~ 171 (278)
T 3cok_A 95 NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYT 171 (278)
T ss_dssp TEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc---cee
Confidence 35899999876 56999999999999999999999999999999999999999999999999999765432211 234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.
T Consensus 172 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------------------ 225 (278)
T 3cok_A 172 LCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------------------ 225 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC------------------------
T ss_pred ccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh------------------------
Confidence 578999999999987 578899999999999999999999998765433221110
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. .......++..+.+||.+||..||.+|||++++|+||||....
T Consensus 226 ---~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 226 ---LA----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ---SS----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ---hc----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00 0112234688999999999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=271.06 Aligned_cols=176 Identities=27% Similarity=0.445 Sum_probs=135.1
Q ss_pred CCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc---
Q 013122 2 ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA--- 75 (449)
Q Consensus 2 e~dL~~~i~~~~~---Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~--- 75 (449)
+++|.+++..... .++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 145 ~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~ 224 (332)
T 3qd2_B 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224 (332)
T ss_dssp SSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------
T ss_pred CCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc
Confidence 4699999988754 5667799999999999999999999999999999999999999999999998765432111
Q ss_pred ------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHH
Q 013122 76 ------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 149 (449)
Q Consensus 76 ------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~ 149 (449)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..++.. ....+......
T Consensus 225 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~-------- 289 (332)
T 3qd2_B 225 TPMPAYATHTGQVGTKLYMSPEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNL-------- 289 (332)
T ss_dssp -------CCCSCC-CGGGSCHHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTT--------
T ss_pred ccccccccccccCCCcCccChHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhcc--------
Confidence 12244679999999999987 6889999999999999999998765421 11111110000
Q ss_pred HhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 150 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.+...+...++.+.+||.+||+.||.+|||++|+|+||||+++
T Consensus 290 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 290 -------------------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp -------------------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred -------------------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 1111122345778999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=261.59 Aligned_cols=184 Identities=21% Similarity=0.360 Sum_probs=145.6
Q ss_pred CCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 1 MESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 1 me~dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
|++.|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ...
T Consensus 90 ~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 168 (305)
T 2wtk_C 90 CVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTC 168 (305)
T ss_dssp CSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSS-CEE
T ss_pred ccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccc-ccc
Confidence 34567787776 346999999999999999999999999999999999999999999999999999865432221 123
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||..|+|||++.+....++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--------------------- 227 (305)
T 2wtk_C 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--------------------- 227 (305)
T ss_dssp CCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---------------------
T ss_pred ccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc---------------------
Confidence 45679999999999876323347799999999999999999999987664433322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccC
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 216 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~ 216 (449)
.. ......+++.+.+||.+||..||.+|||++|+|+||||+.......
T Consensus 228 ------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 275 (305)
T 2wtk_C 228 ------GS----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275 (305)
T ss_dssp ------CC----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-C
T ss_pred ------CC----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcC
Confidence 00 0122357889999999999999999999999999999987655443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=263.44 Aligned_cols=179 Identities=24% Similarity=0.374 Sum_probs=130.6
Q ss_pred CCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~----~~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
|+++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 88 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 165 (290)
T 3fme_A 88 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-- 165 (290)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred hccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc--
Confidence 4567766665 356799999999999999999999998 999999999999999999999999999976544322
Q ss_pred cccccccccccccCcccccc--cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCch-hhHHHHHhhcCCCCHHHHHHHhh
Q 013122 76 IFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~--~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
.....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.... ..+..+
T Consensus 166 --~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------------- 226 (290)
T 3fme_A 166 --KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV----------------- 226 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH-----------------
T ss_pred --ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH-----------------
Confidence 133479999999999631 1156889999999999999999999999764321 111111
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. ... .......+++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 227 ------~~---~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 227 ------VE---EPS---PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp ------HH---SCC---CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ------hc---cCC---CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 11 110 1111235788999999999999999999999999999998543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=272.88 Aligned_cols=202 Identities=21% Similarity=0.349 Sum_probs=146.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....... ...
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~ 189 (360)
T 3eqc_A 115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANS 189 (360)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--------
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc-----ccC
Confidence 359999999988899999999999999999999996 99999999999999999999999999987543221 234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcC-CCCHHHHHHH---------
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG-TPSPEAIARV--------- 150 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg-~p~~e~~~~~--------- 150 (449)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..... ..........
T Consensus 190 ~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 190 FVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp -CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred CCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 679999999999987 6789999999999999999999999988765544332221111 1100000000
Q ss_pred -----hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 151 -----RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 151 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........+..+....... .....++..+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccCCCCcccchhhhhHHhccCCCC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 0000011111111111111 11234688999999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.3e-32 Score=270.65 Aligned_cols=174 Identities=25% Similarity=0.405 Sum_probs=141.9
Q ss_pred CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 1 me~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
|+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 136 ~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-------~ 208 (348)
T 1u5q_A 136 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------N 208 (348)
T ss_dssp CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------C
T ss_pred CCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-------C
Confidence 45788888854 557999999999999999999999999999999999999999999999999999765321 3
Q ss_pred cccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
..+||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~--------------------- 267 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------------- 267 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------------------
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---------------------
Confidence 46799999999998421 15688999999999999999999999987665443322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
...+ ......+++.+.+||.+||+.||.+|||++++|+||||..
T Consensus 268 -----~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 268 -----NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp -----SCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -----cCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0011 1112356889999999999999999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=290.48 Aligned_cols=178 Identities=28% Similarity=0.453 Sum_probs=145.7
Q ss_pred CCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 268 gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~----~~ 343 (576)
T 2acx_A 268 GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IK 343 (576)
T ss_dssp SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC----EE
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc----cc
Confidence 5799999987654 99999999999999999999999999999999999999999999999999987543321 24
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.......+. ..+
T Consensus 344 ~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--------------------~~i 401 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------------RLV 401 (576)
T ss_dssp CCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--------------------HHH
T ss_pred ccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--------------------HHh
Confidence 5689999999999987 678999999999999999999999998765322211111 111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
... +.. ....+++.+.+||.+||..||.+|| +++|+++||||+++.
T Consensus 402 ~~~----~~~---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 402 KEV----PEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp HHC----CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred hcc----ccc---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 111 111 1245789999999999999999999 899999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=268.47 Aligned_cols=175 Identities=33% Similarity=0.504 Sum_probs=146.2
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......
T Consensus 126 ~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 202 (335)
T 2owb_A 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLC 202 (335)
T ss_dssp CBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCC
T ss_pred CCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc---cccccC
Confidence 68999999888899999999999999999999999999999999999999999999999999986543222 124467
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 203 gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------------------- 255 (335)
T 2owb_A 203 GTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------------------------- 255 (335)
T ss_dssp SCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------------------------
T ss_pred CCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc-------------------------
Confidence 9999999999987 6788999999999999999999999987664433222211
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.. ......+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 256 -~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 256 -NE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -TC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -CC-----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 00 0112356889999999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.78 Aligned_cols=176 Identities=33% Similarity=0.494 Sum_probs=146.4
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......
T Consensus 100 ~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~ 176 (294)
T 2rku_A 100 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLC 176 (294)
T ss_dssp CBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc---cccccc
Confidence 68999999888899999999999999999999999999999999999999999999999999976543222 124467
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 177 ~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------------- 229 (294)
T 2rku_A 177 GTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------------------------- 229 (294)
T ss_dssp SCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------------------------
T ss_pred CCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-------------------------
Confidence 8999999999987 5788999999999999999999999987664433222111
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
. . ......+++.+.+||.+||..||++|||++++|+||||.....+
T Consensus 230 --~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 230 --N-E---YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp --T-C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred --c-c---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 0 0 01123568899999999999999999999999999999875443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-32 Score=269.30 Aligned_cols=181 Identities=25% Similarity=0.409 Sum_probs=121.9
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC---CCEEEeecCccccccCCCCCccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 111 g~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----- 185 (336)
T 3fhr_A 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----- 185 (336)
T ss_dssp EEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-----
Confidence 59999998765 59999999999999999999999999999999999999864 459999999997654322
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 186 ~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------------- 243 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-------------------- 243 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------------
T ss_pred cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--------------------
Confidence 234678999999999976 5788999999999999999999999976543222111000
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.+...........+..+++.+.+||.+||..||.+|||++|+|+||||+....
T Consensus 244 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 244 ---RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred ---hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 00000011112234567899999999999999999999999999999987543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=258.47 Aligned_cols=174 Identities=28% Similarity=0.404 Sum_probs=135.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .....
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~ 170 (276)
T 2h6d_A 95 GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTS 170 (276)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----------
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc----ceecc
Confidence 46999999988889999999999999999999999999999999999999999999999999997654322 12345
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|+..|+|||++.+. ...+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 171 ~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------------ 225 (276)
T 2h6d_A 171 CGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------------------------ 225 (276)
T ss_dssp ------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------------
T ss_pred cCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc------------------------
Confidence 789999999999762 2236799999999999999999999987654333322211
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.. ......++..+.+||.+||+.||.+|||++++|+||||+..
T Consensus 226 ---~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 226 ---GV----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ---CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ---Cc----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00 01123467899999999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=284.70 Aligned_cols=179 Identities=23% Similarity=0.393 Sum_probs=144.5
Q ss_pred CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~----~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.++|... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--- 345 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--- 345 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC---
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc---
Confidence 47999999864 36999999999999999999999999999999999999999999999999999875443221
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+.. .
T Consensus 346 ~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~-------------------~ 404 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------------------R 404 (543)
T ss_dssp BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH-------------------H
T ss_pred cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH-------------------H
Confidence 244689999999999987 6899999999999999999999999987643211111110 0
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
... . .. .....+++.+.+||.+||..||.+||+ ++++++||||+++.
T Consensus 405 i~~----~-~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 405 VLE----Q-AV---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp HHH----C-CC---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred Hhh----c-cc---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 111 0 01 112457899999999999999999996 58999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=261.88 Aligned_cols=190 Identities=25% Similarity=0.378 Sum_probs=138.7
Q ss_pred CCcHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~--------~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 176 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence 4689999874 45699999999999999999999999999999999999999999999999999876543211
Q ss_pred --CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 74 --TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 74 --~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
.........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+......+........ +.
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~-------- 246 (303)
T 2vwi_A 177 ITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-PS-------- 246 (303)
T ss_dssp -----------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC-CC--------
T ss_pred ccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC-Cc--------
Confidence 11112345799999999998642 3588999999999999999999999987665443322111000 00
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.............++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 247 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 247 ------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp ------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 00001112334567899999999999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=259.63 Aligned_cols=179 Identities=26% Similarity=0.400 Sum_probs=143.0
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++..+..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......... ......+
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~ 168 (276)
T 2yex_A 90 GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMC 168 (276)
T ss_dssp EEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-CCBCCCC
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch-hcccCCc
Confidence 588899888778999999999999999999999999999999999999999999999999999765332211 1234567
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhH-HHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
||..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..... ..+ ..
T Consensus 169 ~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----------------------~~- 223 (276)
T 2yex_A 169 GTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----------------------KE- 223 (276)
T ss_dssp SCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-----------------------HT-
T ss_pred cccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-----------------------hh-
Confidence 99999999999762 22467899999999999999999999876543211 111 00
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
. ......+..+++.+.+||.+||..||.+|||++|+++||||+...
T Consensus 224 ---~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 224 ---K--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ---T--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ---c--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 0 001112345788999999999999999999999999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=258.01 Aligned_cols=169 Identities=21% Similarity=0.261 Sum_probs=133.8
Q ss_pred CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-------------------CCEE
Q 013122 2 ESDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------------------CKLK 58 (449)
Q Consensus 2 e~dL~~~i~~~----~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-------------------~~vK 58 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+|
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k 174 (289)
T 1x8b_A 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174 (289)
T ss_dssp TCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEE
T ss_pred CCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence 35999999875 569999999999999999999999999999999999999844 4799
Q ss_pred EeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhh
Q 013122 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 138 (449)
Q Consensus 59 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~ 138 (449)
|+|||++...... ....||..|+|||++.+. ..++.++|||||||++|+|++|.+++..... ...+
T Consensus 175 l~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~--- 240 (289)
T 1x8b_A 175 IGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI--- 240 (289)
T ss_dssp ECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH---
T ss_pred EcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH---
Confidence 9999999765432 234589999999999762 3566899999999999999999987754321 1111
Q ss_pred cCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 139 lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
. .. ........+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 --------------------~----~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 --------------------R----QG---RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp --------------------H----TT---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred --------------------H----cC---CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 0 01 0112234678999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=263.76 Aligned_cols=177 Identities=23% Similarity=0.403 Sum_probs=135.9
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ ....
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 188 (326)
T 2x7f_A 112 GSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---RRNT 188 (326)
T ss_dssp EEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--------------
T ss_pred CcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc---cccc
Confidence 4899999875 4699999999999999999999999999999999999999999999999999876533221 1234
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
..||..|+|||++... ...++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 189 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 248 (326)
T 2x7f_A 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------------------- 248 (326)
T ss_dssp --CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------------
T ss_pred ccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--------------------
Confidence 5799999999998621 14688999999999999999999999977654333221111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... .......++..+.+||.+||..||.+|||++++|+||||+..
T Consensus 249 -------~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 249 -------NPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp -------SCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred -------Ccc--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 000 011234578999999999999999999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=283.20 Aligned_cols=169 Identities=18% Similarity=0.226 Sum_probs=137.6
Q ss_pred CCCcHHHHHH------h-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 1 MESDLHQVIK------A-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 1 me~dL~~~i~------~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
++++|.+++. . +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-- 264 (413)
T 3dzo_A 187 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-- 264 (413)
T ss_dssp CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--
T ss_pred hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc--
Confidence 3578888884 1 234888999999999999999999999999999999999999999999999998764332
Q ss_pred CccccccccccccccCcccccc--------cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHH
Q 013122 74 TAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~--------~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e 145 (449)
....+| +.|+|||++.+ ....|+.++|||||||++|+|++|+.||.+.+.......+
T Consensus 265 ----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~---------- 329 (413)
T 3dzo_A 265 ----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI---------- 329 (413)
T ss_dssp ----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG----------
T ss_pred ----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH----------
Confidence 245678 99999999831 1145788999999999999999999999876543221111
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
......+++.+.+||.+||..||++|||+.++|+||||+.+
T Consensus 330 -------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 330 -------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp -------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -------------------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 11223568999999999999999999999999999999854
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=266.88 Aligned_cols=178 Identities=30% Similarity=0.518 Sum_probs=141.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC---EEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....... ..
T Consensus 98 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~ 173 (322)
T 2ycf_A 98 GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LM 173 (322)
T ss_dssp TEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH----HH
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc----cc
Confidence 3589999998889999999999999999999999999999999999999987664 9999999997653321 12
Q ss_pred ccccccccccCcccccc-cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhH-HHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 79 TDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....||..|+|||++.+ ....++.++|||||||++|+|++|..||.+......+ ..+....
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 236 (322)
T 2ycf_A 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK----------------- 236 (322)
T ss_dssp HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC-----------------
T ss_pred ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc-----------------
Confidence 34578999999999742 1156889999999999999999999999865543222 1111110
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.......+..++..+.+||.+||..||.+|||++++|+||||+.
T Consensus 237 ----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 237 ----------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ----------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 00111123457889999999999999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=260.71 Aligned_cols=177 Identities=27% Similarity=0.451 Sum_probs=143.4
Q ss_pred CcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~-~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .....
T Consensus 109 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~ 185 (314)
T 3com_A 109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNTV 185 (314)
T ss_dssp EEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS---CBCCC
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc---ccCcc
Confidence 58999997 456799999999999999999999999999999999999999999999999999976543322 12446
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 186 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------------ 239 (314)
T 3com_A 186 IGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------------------------ 239 (314)
T ss_dssp CSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------------------
T ss_pred CCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc------------------------
Confidence 78999999999987 5789999999999999999999999987654322211110
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
... ........++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 240 ---~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 240 ---NPP-PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp ---SCC-CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ---CCC-cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 001 11111234678999999999999999999999999999998653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=259.41 Aligned_cols=177 Identities=32% Similarity=0.531 Sum_probs=144.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC---CCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++........ .
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~----~ 180 (287)
T 2wei_A 105 GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----M 180 (287)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS----C
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc----c
Confidence 46899999888889999999999999999999999999999999999999764 4699999999976543321 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||..|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 181 ~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 237 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-------------------- 237 (287)
T ss_dssp SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------------
T ss_pred ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 34568999999999876 5889999999999999999999999887654443332211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
........+..+++.+.+||.+||..||.+|||+.|+|+||||+++.
T Consensus 238 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 238 -------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 00011122346789999999999999999999999999999998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=265.77 Aligned_cols=167 Identities=27% Similarity=0.466 Sum_probs=139.5
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc-CCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ....
T Consensus 134 ~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~-----~~~~ 208 (320)
T 3a99_A 134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-----YTDF 208 (320)
T ss_dssp EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC-----BCCC
T ss_pred ccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc-----ccCC
Confidence 68999999888999999999999999999999999999999999999999 67899999999998764332 2446
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.||..|+|||++.+. ..++.++|||||||++|+|++|+.||.+... + ..
T Consensus 209 ~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~-----------------------~~- 257 (320)
T 3a99_A 209 DGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I-----------------------IR- 257 (320)
T ss_dssp CSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H-----------------------HH-
T ss_pred CCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------h-----------------------hc-
Confidence 799999999998762 2346789999999999999999999964221 0 00
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. ......+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus 258 --~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 258 --GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp --CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --cc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00 011245789999999999999999999999999999998653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=277.50 Aligned_cols=184 Identities=28% Similarity=0.404 Sum_probs=132.9
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-----CCCEEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-----~~~vKL~DFGlA~~~~~~~~~ 74 (449)
|+++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+++........
T Consensus 100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 4679999998765 4666778899999999999999999999999999999953 235889999999876543322
Q ss_pred ccccccccccccccCccccccc-CCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 75 AIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
.......+||+.|+|||++.+. ...++.++|||||||++|+|++ |..||...... ....+.
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~~---------------- 242 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANILL---------------- 242 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHHT----------------
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHHh----------------
Confidence 2223557899999999998642 1467789999999999999999 88998544321 111110
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..............+..+.+||.+||+.||.+|||++++|+||||..+.
T Consensus 243 -----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 243 -----------GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp -----------TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred -----------ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 0001111111122356688999999999999999999999999998654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=258.68 Aligned_cols=180 Identities=23% Similarity=0.400 Sum_probs=139.0
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 176 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ---KRDS 176 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH---C---
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc---cccc
Confidence 3578888875 45699999999999999999999999999999999999999999999999998754321110 1134
Q ss_pred ccccccccCcccccc---cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~---~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
..||..|+|||++.. ....++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 237 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------------------- 237 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------------
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc-------------------
Confidence 578999999999831 1156889999999999999999999999876654332222110
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
. . +.......++..+.+||.+||..||.+|||+.++|+||||+.+.
T Consensus 238 -------~-~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 238 -------D-P-PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp -------C-C-CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred -------C-C-cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 0 0 01111234678899999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=256.34 Aligned_cols=173 Identities=28% Similarity=0.445 Sum_probs=142.8
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......
T Consensus 105 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 180 (303)
T 3a7i_A 105 GSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFV 180 (303)
T ss_dssp EEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---CBCCCC
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc---ccCccC
Confidence 589998875 4799999999999999999999999999999999999999999999999999976543321 124567
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus 181 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------------------- 232 (303)
T 3a7i_A 181 GTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-------------------------- 232 (303)
T ss_dssp SCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--------------------------
T ss_pred CCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh--------------------------
Confidence 9999999999987 678899999999999999999999997765433221111
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.... ......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 233 -~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 233 -KNNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -HSCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -cCCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 1111 12234578899999999999999999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=258.85 Aligned_cols=181 Identities=28% Similarity=0.397 Sum_probs=135.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......... ......
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~-~~~~~~ 188 (313)
T 3cek_A 111 NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQ 188 (313)
T ss_dssp SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc-ccccCC
Confidence 578999999988999999999999999999999999999999999999996 488999999999765433221 112345
Q ss_pred cccccccCccccccc---------CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
+||..|+|||++.+. ...++.++|||||||++|+|++|..||.+..... ..+
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~----------------- 249 (313)
T 3cek_A 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKL----------------- 249 (313)
T ss_dssp -CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH-----------------
T ss_pred CCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHH-----------------
Confidence 799999999998641 1367889999999999999999999997643211 001
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...+ ...... ......+..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 250 ---~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 250 ---HAII---DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp ---HHHH---CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ---HHHH---hccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 0111 011111 11234578899999999999999999999999999998643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-31 Score=261.94 Aligned_cols=182 Identities=26% Similarity=0.422 Sum_probs=124.0
Q ss_pred CCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~-----~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
|+++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 103 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 181 (327)
T 3aln_A 103 MSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA- 181 (327)
T ss_dssp CSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred cCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc-
Confidence 35677777763 56799999999999999999999999 999999999999999999999999999976543321
Q ss_pred ccccccccccccccCccccccc--CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 75 AIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~--~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
.....||..|+|||++... ...++.++|||||||++|+|++|+.||.+.+... ..
T Consensus 182 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~------------------ 238 (327)
T 3aln_A 182 ---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQ------------------ 238 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------------
T ss_pred ---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HH------------------
Confidence 2344799999999998321 1468899999999999999999999997643210 00
Q ss_pred HHHHHHHhhhccCCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 153 EKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
+..+.......+ ......+++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 239 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 239 ------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ------HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 111111111111 122346789999999999999999999999999999998654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=258.97 Aligned_cols=178 Identities=22% Similarity=0.352 Sum_probs=131.8
Q ss_pred CCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIKAND------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~~~~------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (323)
T 3qup_A 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194 (323)
T ss_dssp TCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccccccccc
Confidence 358999986543 59999999999999999999999999999999999999999999999999997654332211
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 195 -~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~---------------- 255 (323)
T 3qup_A 195 -QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG---------------- 255 (323)
T ss_dssp -------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT----------------
T ss_pred -ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC----------------
Confidence 1233456788999999987 678999999999999999999 99999887765544333211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-------HHHHHcCccccccc
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-------AEEALADPYFKGLA 212 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-------a~elL~hp~f~~~~ 212 (449)
. .....+.+++.+.+||.+||..||.+||| +++++.|+|+....
T Consensus 256 -----------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 256 -----------N---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp -----------C---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred -----------C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 0 11223467889999999999999999999 77888899998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=257.38 Aligned_cols=181 Identities=25% Similarity=0.347 Sum_probs=139.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 95 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~ 172 (294)
T 4eqm_A 95 GPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT--QTNHV 172 (294)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc--ccCcc
Confidence 4699999999889999999999999999999999999999999999999999999999999999765432211 12346
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 173 ~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------------------------ 226 (294)
T 4eqm_A 173 LGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ------------------------ 226 (294)
T ss_dssp --CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS------------------------
T ss_pred ccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh------------------------
Confidence 79999999999987 6789999999999999999999999988765433211111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...+.......+.+++.+.+||.+||..||.+||+..+.|.+.|..-+.
T Consensus 227 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 227 --DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111111123356789999999999999999999766666777765444
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=255.40 Aligned_cols=179 Identities=14% Similarity=0.207 Sum_probs=139.8
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC-----EEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----vKL~DFGlA~~~~~~~~~ 74 (449)
++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 88 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 3689999999765 5999999999999999999999999999999999999987765 999999999876543221
Q ss_pred c----cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 75 A----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 75 ~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
. .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~------------ 233 (298)
T 1csn_A 168 QHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------------ 233 (298)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH------------
T ss_pred ccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH------------
Confidence 1 11245679999999999987 67899999999999999999999999875533222221111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ...+.....+.+++.+.+||.+||..||.+|||++++++
T Consensus 234 ~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 234 GEKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred Hhhc-----------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 0000 001112223467899999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=253.29 Aligned_cols=180 Identities=28% Similarity=0.439 Sum_probs=138.8
Q ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-CCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~---~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++........ .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---~ 179 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---C 179 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC---c
Confidence 468999998753 4679999999999999999999999999999999999987 88999999999976543221 1
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....||..|+|||++.+....++.++|||||||++|+|++|+.||.+......... .
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----------------------~ 237 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF----------------------K 237 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH----------------------H
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH----------------------h
Confidence 245678999999999865323478999999999999999999999965432211000 0
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
...... .......+++.+.+||.+||..||++|||++++|+||||+...
T Consensus 238 --~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 238 --VGMFKV----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp --HHHHCC----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred --hccccc----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 000000 1122345789999999999999999999999999999998654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=254.56 Aligned_cols=179 Identities=17% Similarity=0.223 Sum_probs=139.3
Q ss_pred CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE---cCCCCEEEeecCccccccCCCCCc-
Q 013122 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTA- 75 (449)
Q Consensus 1 me~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGlA~~~~~~~~~~- 75 (449)
++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~ 166 (296)
T 4hgt_A 87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp CCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence 46899999985 4469999999999999999999999999999999999999 788999999999998765433211
Q ss_pred ---cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 76 ---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 76 ---~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
.......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... ..
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------------~~ 232 (296)
T 4hgt_A 167 IPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI------------SE 232 (296)
T ss_dssp CCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH------------HH
T ss_pred CCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh------------hc
Confidence 11235679999999999987 67899999999999999999999999875543222111110 00
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ..+.......+++.+.+||.+||+.||++|||++++++
T Consensus 233 ~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 233 KKM-----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHH-----------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccc-----------cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 000 00111122456789999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=255.05 Aligned_cols=180 Identities=22% Similarity=0.369 Sum_probs=130.8
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++.+..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........ ..
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~ 182 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA----KD 182 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc----cc
Confidence 3445555543 45799999999999999999999995 999999999999999999999999999876543221 23
Q ss_pred cccccccccCcccccc---cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCc-hhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 80 DYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~---~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
...||..|+|||++.. ....++.++|||||||++|+|++|+.||.+... ...+..+.
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------------- 243 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL------------------- 243 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-------------------
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-------------------
Confidence 4578999999999852 114688899999999999999999999976432 11111111
Q ss_pred HHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 156 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
. ... +.......+++.+.+||.+||..||.+|||++++|+||||+.+..
T Consensus 244 ----~----~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 244 ----Q----EEP-PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp ----H----SCC-CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred ----c----cCC-CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 1 111 111122357899999999999999999999999999999987543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=258.23 Aligned_cols=167 Identities=28% Similarity=0.492 Sum_probs=138.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc-CCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....... ...
T Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-----~~~ 197 (312)
T 2iwi_A 123 AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-----YTD 197 (312)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-----BCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-----ccc
Confidence 468999999888899999999999999999999999999999999999999 78899999999998764432 245
Q ss_pred ccccccccCcccccccCCCC-CCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||..|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+... + .
T Consensus 198 ~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~-----------------------~ 246 (312)
T 2iwi_A 198 FDGTRVYSPPEWISR--HQYHALPATVWSLGILLYDMVCGDIPFERDQE------I-----------------------L 246 (312)
T ss_dssp CCSCTTTSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H-----------------------H
T ss_pred cCCcccccCceeeec--CCCCCccchHHHHHHHHHHHHHCCCCCCChHH------H-----------------------h
Confidence 679999999999876 344 4589999999999999999999964211 0 0
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.. . ......++..+.+||.+||..||++|||++|+|+||||+...
T Consensus 247 ~~---~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 247 EA---E-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HT---C-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred hh---c-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 00 0 011245788999999999999999999999999999998643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.63 Aligned_cols=191 Identities=20% Similarity=0.294 Sum_probs=141.4
Q ss_pred CcHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 3 SDLHQV------IKA--NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 3 ~dL~~~------i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 128 ~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 205 (348)
T 2pml_X 128 DSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-- 205 (348)
T ss_dssp CBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred CcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc--
Confidence 377776 555 5679999999999999999999999 99999999999999999999999999999765433
Q ss_pred CccccccccccccccCcccccccCCCCCC-ccchhhhHHHHHhhhhCCCCCCCCCc-hhhHHHHHhhcCCCCHHHHHHHh
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~-~~DIWSlG~il~eLltG~~pF~~~~~-~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
......||..|+|||++.+. ..++. ++|||||||++|+|++|..||.+... ......+.......+... .
T Consensus 206 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~-~--- 277 (348)
T 2pml_X 206 ---KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR-N--- 277 (348)
T ss_dssp ---EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS-S---
T ss_pred ---cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch-h---
Confidence 22456799999999999872 25555 89999999999999999999987765 333333322100000000 0
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.+ ...............+++.+.+||.+||..||.+|||++|+|+||||++.
T Consensus 278 -----~~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 278 -----HF---LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp -----SS---TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred -----hh---hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 00 00000000111225678999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=254.62 Aligned_cols=174 Identities=32% Similarity=0.488 Sum_probs=139.9
Q ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 3 SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 3 ~dL~~~i~~~~----~Ls~~~i~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~ 171 (279)
T 2w5a_A 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171 (279)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH
T ss_pred CCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc
Confidence 58999987532 4999999999999999999999999 99999999999999999999999999976543221
Q ss_pred CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 172 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~---------------- 230 (279)
T 2w5a_A 172 ---FAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------------- 230 (279)
T ss_dssp ---HHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------------
T ss_pred ---cccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh----------------
Confidence 1234578999999999987 5789999999999999999999999987664333222211
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.. +......++..+.+||.+||..||.+|||++|+|+|+|+.+-
T Consensus 231 -----------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 231 -----------GK---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------TC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------cc---cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 10 111223578899999999999999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=250.40 Aligned_cols=178 Identities=26% Similarity=0.425 Sum_probs=130.5
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC-------
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP------- 73 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~------- 73 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 178 (303)
T 1zy4_A 99 NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178 (303)
T ss_dssp SCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----------
T ss_pred CCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccc
Confidence 369999998654 589999999999999999999999999999999999999999999999999976532210
Q ss_pred ----CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCC-CchhhHHHHHhhcCCCCHHHHH
Q 013122 74 ----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 74 ----~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
.........||..|+|||++.+. ..++.++|||||||++|+|++ ||... +....+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~---------------- 238 (303)
T 1zy4_A 179 NLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL---------------- 238 (303)
T ss_dssp ---------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH----------------
T ss_pred cccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH----------------
Confidence 01122456789999999998762 468999999999999999998 44321 111111
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
..+...............+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 239 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 -----------KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp -----------HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred -----------HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 111111111111223456788999999999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=257.89 Aligned_cols=191 Identities=23% Similarity=0.381 Sum_probs=137.8
Q ss_pred CCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE----cCCCCEEEeecCccccccCCCCC
Q 013122 2 ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 2 e~dL~~~i~~~~~---Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
+++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~- 171 (319)
T 4euu_A 93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ- 171 (319)
T ss_dssp TCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC-
T ss_pred CCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc-
Confidence 4799999987543 9999999999999999999999999999999999998 7778899999999987644332
Q ss_pred ccccccccccccccCccccccc------CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchh-hHHHHHhhcCCCCHHHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~------~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i~~~lg~p~~e~~ 147 (449)
....+||..|+|||++... ...++.++|||||||++|+|++|+.||.+..... ....+..++...+...+
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (319)
T 4euu_A 172 ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (319)
T ss_dssp ---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCC
T ss_pred ---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccc
Confidence 2456799999999998521 1578899999999999999999999997544322 22222221111110000
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQK-------FPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
..+. . .......|... ...++..+.+||.+||+.||++|||++|+|+||
T Consensus 249 ~~~~---------~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 249 SGVQ---------K-AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp EEEE---------C-STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred hhhh---------c-ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 0000 0 00001111111 123456789999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=262.17 Aligned_cols=181 Identities=18% Similarity=0.166 Sum_probs=138.1
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc--CCCCEEEeecCccccccCCCCCc---
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARVAFNDTPTA--- 75 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~vKL~DFGlA~~~~~~~~~~--- 75 (449)
+++|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.........
T Consensus 135 g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 214 (364)
T 3op5_A 135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214 (364)
T ss_dssp EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSS
T ss_pred CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccc
Confidence 57899999876 5799999999999999999999999999999999999999 88999999999997654322111
Q ss_pred -cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 76 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 76 -~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.............. ....
T Consensus 215 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~-----------~~~~ 281 (364)
T 3op5_A 215 ADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR-----------YREN 281 (364)
T ss_dssp CCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHH-----------HHHC
T ss_pred cCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHH-----------hhhh
Confidence 11234569999999999987 579999999999999999999999998643322221111100 0000
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+.... ....+++.+.+||..||..||.+||++.++++
T Consensus 282 ~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 282 IASLMDKCF---------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHS---------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhc---------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 111111110 01356889999999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=261.11 Aligned_cols=171 Identities=27% Similarity=0.418 Sum_probs=138.8
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.++|.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 171 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 250 (370)
T 2psq_A 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250 (370)
T ss_dssp TCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSC
T ss_pred CCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCC
Confidence 469999998753 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+......... ......+|+.|+|||++.+ ..|+.++|||||||++|||++ |..||.+.........+..
T Consensus 251 ~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~------- 320 (370)
T 2psq_A 251 RDINNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE------- 320 (370)
T ss_dssp EETTCCCTTC-TTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-------
T ss_pred cccCccccee-cccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-------
Confidence 8654332211 1234467889999999987 679999999999999999999 9999988765444332211
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......++..+.+||.+||..||.+|||+.|++++
T Consensus 321 --------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 321 --------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp --------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 100 11224578899999999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=257.51 Aligned_cols=171 Identities=20% Similarity=0.309 Sum_probs=136.9
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 134 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 213 (325)
T 3kul_A 134 NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG 213 (325)
T ss_dssp TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC-
T ss_pred CCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccC
Confidence 46999999765 47999999999999999999999999999999999999999999999999999876544333222334
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 214 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--------------------- 270 (325)
T 3kul_A 214 GKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG--------------------- 270 (325)
T ss_dssp --CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---------------------
T ss_pred CCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---------------------
Confidence 456788999999977 578999999999999999999 99999877654443333221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 271 ------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 271 ------YRL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 122457889999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=254.48 Aligned_cols=174 Identities=25% Similarity=0.382 Sum_probs=132.7
Q ss_pred CCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~~---Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--- 194 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--- 194 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc---
Confidence 4699999988764 999999999999999999999999 99999999999999999999999999975433221
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 195 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~------------------- 253 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF------------------- 253 (309)
T ss_dssp -------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-------------------
T ss_pred ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------------
Confidence 1245679999999999987 6789999999999999999999999987665433322211
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc--Ccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFK 209 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~--hp~f~ 209 (449)
... .......+++.+.+||.+||..||.+|||+.++++ +++++
T Consensus 254 -------~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 254 -------KCK---RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -------SCC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -------cCC---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000 11223467899999999999999999999999987 44444
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-30 Score=248.55 Aligned_cols=176 Identities=18% Similarity=0.239 Sum_probs=138.0
Q ss_pred CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc---CCCCEEEeecCccccccCCCCCc-
Q 013122 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAFNDTPTA- 75 (449)
Q Consensus 1 me~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~vKL~DFGlA~~~~~~~~~~- 75 (449)
++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..........
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (296)
T 3uzp_A 87 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred cCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccc
Confidence 46799999984 44699999999999999999999999999999999999994 78899999999998765433211
Q ss_pred ---cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchh---hHHHHHhhcCCCCHHHHHH
Q 013122 76 ---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH---QLDIMTDLLGTPSPEAIAR 149 (449)
Q Consensus 76 ---~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~---~l~~i~~~lg~p~~e~~~~ 149 (449)
.......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+..
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 232 (296)
T 3uzp_A 167 IPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE------------ 232 (296)
T ss_dssp CCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH------------
T ss_pred cccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc------------
Confidence 01245679999999999987 678999999999999999999999998754322 2211111
Q ss_pred HhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 150 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .+.......+++.+.+||.+||+.||.+|||++++++
T Consensus 233 ---~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 233 ---KKMS-----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---HHHH-----------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---cccC-----------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0000 0011122456889999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=259.77 Aligned_cols=159 Identities=28% Similarity=0.450 Sum_probs=128.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCccccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 94 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 94 (449)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... .......||..|+|||++.
T Consensus 190 l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~ 268 (359)
T 3vhe_A 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIF 268 (359)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-EEC--CEECGGGCCHHHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc-hhccccCCCceeEChhhhc
Confidence 999999999999999999999999999999999999999999999999999765433221 1234567899999999998
Q ss_pred ccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCC
Q 013122 95 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173 (449)
Q Consensus 95 ~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (449)
+ ..++.++|||||||++|+|++ |..||.+......+..... .... ...
T Consensus 269 ~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--------------------------~~~~---~~~ 317 (359)
T 3vhe_A 269 D--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------------------EGTR---MRA 317 (359)
T ss_dssp H--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH--------------------------HTCC---CCC
T ss_pred C--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH--------------------------cCCC---CCC
Confidence 7 679999999999999999998 9999987664433221111 0011 112
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 174 FPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 174 ~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
...+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 23478899999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=257.47 Aligned_cols=171 Identities=21% Similarity=0.308 Sum_probs=137.6
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ....
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 178 (327)
T 3poz_A 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-HAEG 178 (327)
T ss_dssp TCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccc-cccC
Confidence 47899999874 469999999999999999999999999999999999999999999999999998764433221 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 179 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--------------------- 235 (327)
T 3poz_A 179 GKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------------------- 235 (327)
T ss_dssp -CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------------------
T ss_pred CCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC---------------------
Confidence 456889999999987 689999999999999999999 99999887654443322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. ....+..+..+.+||.+||+.||.+|||+.+++++
T Consensus 236 ------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 236 ------ER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ------CC---CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ------CC---CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01 11224568899999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=257.21 Aligned_cols=178 Identities=17% Similarity=0.248 Sum_probs=137.6
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC-----EEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----vKL~DFGlA~~~~~~~~~ 74 (449)
|+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 87 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 87 LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 468999999874 57999999999999999999999999999999999999998887 999999999875443221
Q ss_pred cc----ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 75 AI----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 75 ~~----~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.. .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+..+.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----------- 233 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG----------- 233 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH-----------
T ss_pred ccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH-----------
Confidence 10 1245689999999999987 678999999999999999999999998865443332222110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... . ..+........ +.+.+||.+||..||.+||+++++++
T Consensus 234 -~~~---~--------~~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 -DTK---R--------ATPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp -HHH---H--------HSCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -hhh---c--------cCCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000 0 00001111223 38999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=256.94 Aligned_cols=171 Identities=20% Similarity=0.350 Sum_probs=136.2
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 98 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~ 176 (325)
T 3kex_A 98 LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-LLYSE 176 (325)
T ss_dssp TCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC-CC---
T ss_pred CCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCccccc-ccccC
Confidence 47899999875 46999999999999999999999999999999999999999999999999999876443322 12345
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 177 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------------------- 233 (325)
T 3kex_A 177 AKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG--------------------- 233 (325)
T ss_dssp --CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---------------------
T ss_pred CCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---------------------
Confidence 568889999999987 679999999999999999999 99999876654433222210
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... .....++..+.+||.+||..||.+|||+.++++|
T Consensus 234 ------~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 ------ERL---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------CBC---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------CCC---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011 1112356678899999999999999999999885
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=259.06 Aligned_cols=179 Identities=15% Similarity=0.143 Sum_probs=136.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC--CEEEeecCccccccCCCCC----c
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPT----A 75 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~vKL~DFGlA~~~~~~~~~----~ 75 (449)
+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........ .
T Consensus 135 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 214 (345)
T 2v62_A 135 GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214 (345)
T ss_dssp EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchh
Confidence 578999999888899999999999999999999999999999999999999887 9999999999765332111 1
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchh-hHHHH-HhhcCCCCHHHHHHHhhH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIM-TDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~-~l~~i-~~~lg~p~~e~~~~~~~~ 153 (449)
.......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... ....+ .......+.
T Consensus 215 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 283 (345)
T 2v62_A 215 NPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQ--------- 283 (345)
T ss_dssp CGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTH---------
T ss_pred ccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccH---------
Confidence 11245679999999999987 578999999999999999999999996532211 11111 111000000
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+... .....+++.+.+||.+||..||.+|||++++++
T Consensus 284 ----~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 284 ----SVLKW---------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp ----HHHHH---------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----HHHhh---------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 00000 001257889999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=269.45 Aligned_cols=184 Identities=27% Similarity=0.410 Sum_probs=128.6
Q ss_pred CCCcHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-------------CCEEEe
Q 013122 1 MESDLHQVIKANDDLT-------PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-------------CKLKIC 60 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls-------~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-------------~~vKL~ 60 (449)
|+++|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 4679999998765432 33457899999999999999999999999999999754 479999
Q ss_pred ecCccccccCCCCCc-cccccccccccccCccccccc-----CCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHH
Q 013122 61 DFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 133 (449)
Q Consensus 61 DFGlA~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~ 133 (449)
|||++.......... ......+||+.|+|||++.+. ...++.++|||||||++|||++ |..||.+..... ..
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~ 249 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SN 249 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HH
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HH
Confidence 999998764432211 112356799999999998651 1468899999999999999999 999997544221 11
Q ss_pred HHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 134 ~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.+.. ....... .......+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 250 i~~~------------------------~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 250 IIRG------------------------IFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHT------------------------CCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HhcC------------------------CCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1110 0000000 00001124578999999999999999999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=249.86 Aligned_cols=168 Identities=25% Similarity=0.407 Sum_probs=128.2
Q ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~ 177 (281)
T 1mp8_A 100 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KASKG 177 (281)
T ss_dssp EEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccc--ccccC
Confidence 58999998765 6999999999999999999999999999999999999999999999999999765433211 11334
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 178 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~----------------------- 232 (281)
T 1mp8_A 178 KLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------------------- 232 (281)
T ss_dssp -CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----------------------
T ss_pred CCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-----------------------
Confidence 56788999999976 678999999999999999996 9999988766544433321
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ....+.+++.+.+||.+||..||.+|||+.++++
T Consensus 233 ----~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 233 ----GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp ----TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 1123467899999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=262.53 Aligned_cols=175 Identities=21% Similarity=0.305 Sum_probs=140.2
Q ss_pred CCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC---CEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~~-------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGlA~~~~~~ 71 (449)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 158 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~ 237 (367)
T 3l9p_A 158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237 (367)
T ss_dssp TEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHH
T ss_pred CCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccc
Confidence 469999998653 499999999999999999999999999999999999999555 4999999999754322
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+....+..+...
T Consensus 238 ~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~------------ 302 (367)
T 3l9p_A 238 GYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG------------ 302 (367)
T ss_dssp SSCT-TCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT------------
T ss_pred cccc-cCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 1111 1234568999999999977 679999999999999999998 99999887655444333221
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.. ......++..+.+||.+||+.||.+|||+.+++++.++.
T Consensus 303 ---------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 303 ---------------GR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ---------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------CC---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 111245688999999999999999999999999988764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=250.86 Aligned_cols=171 Identities=25% Similarity=0.403 Sum_probs=139.0
Q ss_pred CCcHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCE
Q 013122 2 ESDLHQVIKANDD------------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 57 (449)
Q Consensus 2 e~dL~~~i~~~~~------------------------Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 57 (449)
+++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~ 189 (314)
T 2ivs_A 110 YGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189 (314)
T ss_dssp TCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEE
T ss_pred CCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCE
Confidence 3789999987543 8999999999999999999999999999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHH
Q 013122 58 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 136 (449)
Q Consensus 58 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 136 (449)
||+|||++......... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 190 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 266 (314)
T 2ivs_A 190 KISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266 (314)
T ss_dssp EECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred EEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhh
Confidence 99999999765433221 11234467888999999977 578999999999999999999 999998876544433222
Q ss_pred hhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 137 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 137 ~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. . .......+++.+.+||.+||..||.+|||+.+++++
T Consensus 267 ~~---------------------------~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 267 TG---------------------------H---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp TT---------------------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC---------------------------C---cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 10 0 112234678999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=254.08 Aligned_cols=170 Identities=21% Similarity=0.309 Sum_probs=132.2
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ....
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~-~~~~ 178 (327)
T 3lzb_A 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-HAEG 178 (327)
T ss_dssp SCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccc-cccC
Confidence 47899999874 469999999999999999999999999999999999999999999999999998654332211 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 179 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--------------------- 235 (327)
T 3lzb_A 179 GKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------------------- 235 (327)
T ss_dssp -CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------------------
T ss_pred CCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------------------
Confidence 457889999999987 689999999999999999999 99999887655443332211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. ....+.++..+.+||.+||..||.+|||+.|+++
T Consensus 236 ------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 236 ------ER---LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------CC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 1123457889999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=257.78 Aligned_cols=171 Identities=27% Similarity=0.427 Sum_probs=139.5
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 159 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a 238 (382)
T 3tt0_A 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238 (382)
T ss_dssp TCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCC
T ss_pred CCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcc
Confidence 459999998764 4999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+......... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 239 ~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~------- 308 (382)
T 3tt0_A 239 RDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE------- 308 (382)
T ss_dssp CCSSCCCTTC-CCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-------
T ss_pred cccccccccc-cccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654332211 1234567889999999987 679999999999999999999 9999987765443332221
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......+++.+.+||.+||+.||++|||+.|++++
T Consensus 309 --------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 309 --------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp --------------------TCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 11224578899999999999999999999999884
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=248.52 Aligned_cols=170 Identities=20% Similarity=0.310 Sum_probs=137.9
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 180 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVG 180 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH--STTS
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc--cccC
Confidence 4789999987 457999999999999999999999999999999999999999999999999999765332111 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+....
T Consensus 181 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------------------- 238 (283)
T 3gen_A 181 SKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------------------- 238 (283)
T ss_dssp TTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC--------------------
T ss_pred CccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc--------------------
Confidence 456788999999987 578999999999999999998 999998776544433332211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
. .......++.+.+||.+||+.||.+|||+.++|+|
T Consensus 239 -------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 239 -------R---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------C---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------C---CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 11123457889999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=248.69 Aligned_cols=171 Identities=20% Similarity=0.293 Sum_probs=138.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++..+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................
T Consensus 101 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 180 (291)
T 1xbb_A 101 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180 (291)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccC
Confidence 36899999998889999999999999999999999999999999999999999999999999998764433322222334
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 181 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----------------------- 235 (291)
T 1xbb_A 181 KWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----------------------- 235 (291)
T ss_dssp CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------------------
T ss_pred CCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------------------
Confidence 56788999999976 578899999999999999999 9999987665433222211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 236 ----~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 ----GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 1123467899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=256.60 Aligned_cols=191 Identities=24% Similarity=0.274 Sum_probs=141.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcccccccCCcEEEcCCCCEEEeecCccccccCC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------NVFHRDLKPKNILANADCKLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~----------gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~ 71 (449)
+++|.++++.+ .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~ 184 (322)
T 3soc_A 106 KGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184 (322)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTT
T ss_pred CCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccc
Confidence 35999999875 599999999999999999999999 9999999999999999999999999999776443
Q ss_pred CCCccccccccccccccCcccccccC---CCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
... ......+||+.|+|||++.+.. ..++.++|||||||++|||++|+.||.+..............+.+....+.
T Consensus 185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 3soc_A 185 KSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263 (322)
T ss_dssp SCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred cCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence 322 1224467999999999987521 134567899999999999999999998876544433333334444443322
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. .. .......+...+. ..++.+.+||.+||+.||++|||+.|+++
T Consensus 264 ~~--------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 264 EV--------VV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HH--------HT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hh--------hh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 11 1111111111111 12456899999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=247.86 Aligned_cols=177 Identities=25% Similarity=0.340 Sum_probs=129.7
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 181 (289)
T 3og7_A 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-HQFEQ 181 (289)
T ss_dssp EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc-ccccc
Confidence 36899999654 46999999999999999999999999999999999999999999999999999754332211 12345
Q ss_pred ccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||..|+|||++... ...++.++|||||||++|+|++|+.||.+......+..+..
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------------------- 239 (289)
T 3og7_A 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG---------------------- 239 (289)
T ss_dssp --CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH----------------------
T ss_pred cCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc----------------------
Confidence 6799999999998621 15678899999999999999999999987665433322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. ......+......+++.+.+||.+||..||.+|||+.++++
T Consensus 240 -~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 240 -R--GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -H--TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -c--cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 11122233445578899999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-30 Score=246.07 Aligned_cols=170 Identities=22% Similarity=0.362 Sum_probs=137.4
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 166 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTG 166 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH--STTS
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc--cccC
Confidence 368999997654 5999999999999999999999999999999999999999999999999999765332111 1234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 167 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~--------------------- 223 (269)
T 4hcu_A 167 TKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------------------- 223 (269)
T ss_dssp TTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---------------------
T ss_pred cccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC---------------------
Confidence 456788999999987 679999999999999999999 99999877654443332211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. .......++.+.+||.+||..||.+|||+.++++|
T Consensus 224 ------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 224 ------FR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------cc---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 11123468899999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=245.81 Aligned_cols=170 Identities=21% Similarity=0.342 Sum_probs=137.4
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~ 164 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV--SSVG 164 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE--ECCS
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh--cccC
Confidence 468999998765 4999999999999999999999999999999999999999999999999999865443221 1234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 165 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---------------------- 220 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ---------------------- 220 (268)
T ss_dssp CCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----------------------
T ss_pred CCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc----------------------
Confidence 456778999999977 578899999999999999999 9999987665443322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... .......++.+.+||.+||+.||.+|||+.+++++
T Consensus 221 -----~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 221 -----GHR---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -----TCC---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----CCC---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 11123357889999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=256.29 Aligned_cols=181 Identities=11% Similarity=0.151 Sum_probs=138.6
Q ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC--CEEEeecCccccccCCCCC--
Q 013122 1 MESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTPT-- 74 (449)
Q Consensus 1 me~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~vKL~DFGlA~~~~~~~~~-- 74 (449)
|+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 140 ~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 219 (352)
T 2jii_A 140 LGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219 (352)
T ss_dssp CCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC
T ss_pred CCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccc
Confidence 467999999986 6799999999999999999999999999999999999999998 8999999999765432211
Q ss_pred --ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC-chhhHHHHHhhcCCCCHHHHHHHh
Q 013122 75 --AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 75 --~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ....+....
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~--------------- 282 (352)
T 2jii_A 220 YVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQK--------------- 282 (352)
T ss_dssp CCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHH---------------
T ss_pred ccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHH---------------
Confidence 111234579999999999987 678999999999999999999999997654 111111110
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..+...... ..........+++.+.+||.+||..||.+|||++++++
T Consensus 283 ----~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 283 ----QKFVDKPGP--FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp ----HHHHHSCCC--EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ----HhccCChhh--hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 001000000 00011112356899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=252.62 Aligned_cols=173 Identities=25% Similarity=0.388 Sum_probs=138.2
Q ss_pred CCcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEE
Q 013122 2 ESDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58 (449)
Q Consensus 2 e~dL~~~i~~~~-----------------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vK 58 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 133 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k 212 (344)
T 1rjb_A 133 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK 212 (344)
T ss_dssp TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred CCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEE
Confidence 369999998754 289999999999999999999999999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHh
Q 013122 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTD 137 (449)
Q Consensus 59 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~ 137 (449)
|+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 213 L~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 289 (344)
T 1rjb_A 213 ICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289 (344)
T ss_dssp ECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred eCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHh
Confidence 9999999865443221 12244567889999999977 678999999999999999998 9999987664333221111
Q ss_pred hcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 138 ~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
.... ......+++.+.+||.+||..||.+|||+.++++|-
T Consensus 290 --------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 290 --------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp --------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 1101 112235689999999999999999999999999853
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=245.94 Aligned_cols=170 Identities=22% Similarity=0.352 Sum_probs=135.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 96 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 173 (281)
T 3cc6_A 96 YGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY--KASV 173 (281)
T ss_dssp TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----------C
T ss_pred CCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc--cccc
Confidence 368999997654 5999999999999999999999999999999999999999999999999999765433211 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.........+...
T Consensus 174 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~--------------------- 230 (281)
T 3cc6_A 174 TRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--------------------- 230 (281)
T ss_dssp CCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---------------------
T ss_pred CCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---------------------
Confidence 457888999999976 678999999999999999998 99999876654443322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... .....+++.+.+||.+||..||.+|||+.|++++
T Consensus 231 ------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 231 ------DRL---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCC---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 011 1123468899999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=247.82 Aligned_cols=172 Identities=23% Similarity=0.318 Sum_probs=139.2
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 173 (287)
T 1u59_A 94 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173 (287)
T ss_dssp EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccc
Confidence 5899999754 459999999999999999999999999999999999999999999999999998764433222222334
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+..
T Consensus 174 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~----------------------- 228 (287)
T 1u59_A 174 KWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------------------- 228 (287)
T ss_dssp CCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-----------------------
T ss_pred cccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-----------------------
Confidence 56889999999976 578899999999999999998 9999987665433322211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
... ....+.+++.+.+||.+||..||.+|||+.+++++.
T Consensus 229 ----~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 229 ----GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ----TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ----CCc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 111 122346789999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=248.98 Aligned_cols=171 Identities=20% Similarity=0.344 Sum_probs=137.5
Q ss_pred CCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~----------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~ 71 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191 (322)
T ss_dssp TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred CCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccc
Confidence 36899998763 35799999999999999999999999999999999999999999999999999765332
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 192 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------------- 255 (322)
T 1p4o_A 192 DYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------------- 255 (322)
T ss_dssp GCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT-------------
T ss_pred ccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc-------------
Confidence 211 11234467889999999987 678999999999999999999 8999987665433322211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. .......++..+.+||.+||..||.+|||+.|+++|
T Consensus 256 --------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 --------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp --------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 112234678899999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=250.21 Aligned_cols=182 Identities=23% Similarity=0.280 Sum_probs=131.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
+++|.++++. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 90 MGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168 (301)
T ss_dssp TCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccc
Confidence 3699999965 47999999999999999999999 99999999999999999999999999999976544322
Q ss_pred Cc-cccccccccccccCcccccccCC----CCCCccchhhhHHHHHhhhhC----------CCCCCCCCchh-hHHHHHh
Q 013122 74 TA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------KPLFPGKNVVH-QLDIMTD 137 (449)
Q Consensus 74 ~~-~~~~~~~gt~~Y~APE~l~~~~~----~~s~~~DIWSlG~il~eLltG----------~~pF~~~~~~~-~l~~i~~ 137 (449)
.. ......+||+.|+|||++.+... .++.++|||||||++|||++| ..||.+..... ....+.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~- 247 (301)
T 3q4u_A 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR- 247 (301)
T ss_dssp EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHH-
T ss_pred cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhh-
Confidence 21 11234579999999999876211 344689999999999999999 77876533211 111110
Q ss_pred hcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 138 ~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
............+........++.+.+||.+||+.||.+|||+.++++
T Consensus 248 -------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 248 -------------------KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp -------------------HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -------------------HHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 111000001111100011124567999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=251.54 Aligned_cols=170 Identities=21% Similarity=0.287 Sum_probs=136.2
Q ss_pred CCcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCE
Q 013122 2 ESDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 57 (449)
Q Consensus 2 e~dL~~~i~~~------------------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 57 (449)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 134 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~ 213 (343)
T 1luf_A 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 213 (343)
T ss_dssp TCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeE
Confidence 35899999874 569999999999999999999999999999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHH
Q 013122 58 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 136 (449)
Q Consensus 58 KL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~ 136 (449)
||+|||++......... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 214 kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 290 (343)
T 1luf_A 214 KIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290 (343)
T ss_dssp EECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred EEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHh
Confidence 99999999765332211 11234568899999999987 579999999999999999999 999998766543332221
Q ss_pred hhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 137 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 137 ~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. ... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 291 ~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 291 D---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp T---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1 111 1122457889999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=242.22 Aligned_cols=163 Identities=26% Similarity=0.429 Sum_probs=124.4
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------- 171 (299)
T 3m2w_A 99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------- 171 (299)
T ss_dssp SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------
Confidence 359999998865 5999999999999999999999999999999999999998 7889999999985431
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 172 ------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------------------- 212 (299)
T 3m2w_A 172 ------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------------- 212 (299)
T ss_dssp ------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-------------------
T ss_pred ------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------------------
Confidence 1 3467899999999999999999999976543221100000
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
.+...........+..+++.+.+||.+||..||.+|||++|+|+||||+.....
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 213 ----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp ----SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred ----HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 000000000001114578999999999999999999999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=249.07 Aligned_cols=171 Identities=27% Similarity=0.456 Sum_probs=137.8
Q ss_pred CcHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 3 SDLHQVIKANDD----------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 3 ~dL~~~i~~~~~----------------Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 117 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 196 (316)
T 2xir_A 117 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196 (316)
T ss_dssp EEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred CcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCcccc
Confidence 689999987654 8999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHH
Q 013122 67 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 67 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e 145 (449)
........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+...
T Consensus 197 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---------- 263 (316)
T 2xir_A 197 DIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---------- 263 (316)
T ss_dssp CTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH----------
T ss_pred ccccCccc-eeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH----------
Confidence 65443221 12344568889999999977 678999999999999999998 99999876543322111
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
+. .... .......++.+.+||.+||+.||.+|||+.++++|
T Consensus 264 -------------~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 264 -------------LK---EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp -------------HH---HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------hc---cCcc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 0111 11223468899999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=247.14 Aligned_cols=172 Identities=28% Similarity=0.396 Sum_probs=138.1
Q ss_pred CCcHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecC
Q 013122 2 ESDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63 (449)
Q Consensus 2 e~dL~~~i~~~~------------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFG 63 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 190 (313)
T 1t46_A 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190 (313)
T ss_dssp TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred CCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccc
Confidence 358999998764 39999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCC
Q 013122 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTP 142 (449)
Q Consensus 64 lA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p 142 (449)
++......... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 191 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----- 262 (313)
T 1t46_A 191 LARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK----- 262 (313)
T ss_dssp GGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH-----
T ss_pred ccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhc-----
Confidence 99876543322 12234567889999999877 678999999999999999998 9999987664433221111
Q ss_pred CHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 143 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 143 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
. ... ......++..+.+||.+||..||.+|||+.|++++
T Consensus 263 ------------------~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 263 ------------------E---GFR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp ------------------H---TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------c---CCC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0 000 11124578899999999999999999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=242.77 Aligned_cols=171 Identities=23% Similarity=0.346 Sum_probs=135.4
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-ccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 107 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 186 (298)
T 3pls_A 107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186 (298)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSS
T ss_pred CCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCc
Confidence 57999999874 46999999999999999999999999999999999999999999999999999754332111 11123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |.++|.+.+.......+...
T Consensus 187 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-------------------- 244 (298)
T 3pls_A 187 HARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-------------------- 244 (298)
T ss_dssp CTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT--------------------
T ss_pred CCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC--------------------
Confidence 4568899999999987 678999999999999999999 55666655544333222211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. ......+++.+.+||.+||..||.+|||+.++++
T Consensus 245 -------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 245 -------RR---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CC---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 1112346789999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=250.15 Aligned_cols=170 Identities=24% Similarity=0.366 Sum_probs=130.3
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++................
T Consensus 131 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 210 (333)
T 1mqb_A 131 GALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210 (333)
T ss_dssp EEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCC
Confidence 5999999875 469999999999999999999999999999999999999999999999999998764432222112234
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+..
T Consensus 211 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~----------------------- 265 (333)
T 1mqb_A 211 KIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----------------------- 265 (333)
T ss_dssp CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----------------------
T ss_pred CccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-----------------------
Confidence 56788999999976 678999999999999999998 9999987664433322211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....+++.+.+||.+||+.||.+||++.++++
T Consensus 266 ----~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 266 ----GFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp ----TCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 112357889999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=265.16 Aligned_cols=179 Identities=16% Similarity=0.222 Sum_probs=140.2
Q ss_pred CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE---cCCCCEEEeecCccccccCCCCCc-
Q 013122 1 MESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTA- 75 (449)
Q Consensus 1 me~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGlA~~~~~~~~~~- 75 (449)
|+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.........
T Consensus 85 ~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (483)
T 3sv0_A 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (483)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccc
Confidence 46899999985 4579999999999999999999999999999999999999 578899999999998765433211
Q ss_pred ---cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 76 ---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 76 ---~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
......+||..|+|||++.+ ..++.++||||||||+|||++|+.||.+.........+..+ ..
T Consensus 165 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i------------~~ 230 (483)
T 3sv0_A 165 IPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------------SE 230 (483)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH------------HH
T ss_pred cccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH------------hh
Confidence 11235679999999999987 67999999999999999999999999886554333222211 11
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
......+ ......++..+.+||.+||..||.+||++++|++
T Consensus 231 ~~~~~~~-----------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 231 KKVATSI-----------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHSCH-----------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccH-----------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1100001 1112356789999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=246.61 Aligned_cols=187 Identities=19% Similarity=0.306 Sum_probs=134.5
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 176 (295)
T 3ugc_A 97 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176 (295)
T ss_dssp TCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------C
T ss_pred CCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccC
Confidence 469999998865 4999999999999999999999999999999999999999999999999999876443322222234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||++.+ ..++.++|||||||++|+|++|..||..... .....++........ ......
T Consensus 177 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~------~~~~~~ 243 (295)
T 3ugc_A 177 GESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQMI------VFHLIE 243 (295)
T ss_dssp TTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTHHH------HHHHHH
T ss_pred CCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccchh------HHHHHH
Confidence 567888999999987 6789999999999999999999988864321 111111211111000 011111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+...... .....+++.+.+||.+||..||.+|||+.|+++
T Consensus 244 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 244 LLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 12222211 123467899999999999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-29 Score=246.83 Aligned_cols=171 Identities=20% Similarity=0.303 Sum_probs=131.7
Q ss_pred CCcHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIK------ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~------~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (313)
T 3brb_A 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204 (313)
T ss_dssp TCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------
T ss_pred CCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccC
Confidence 369999984 33469999999999999999999999999999999999999999999999999997654332111
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 205 -~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~---------------- 265 (313)
T 3brb_A 205 -QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG---------------- 265 (313)
T ss_dssp -------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT----------------
T ss_pred -cccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC----------------
Confidence 1233457889999999987 678999999999999999999 88999877655443332211
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 266 -----------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 -----------HR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------CC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------CC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01 11224578899999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=246.25 Aligned_cols=172 Identities=21% Similarity=0.307 Sum_probs=136.6
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 183 (291)
T 1u46_A 104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183 (291)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred CCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhcc
Confidence 36899999875 46999999999999999999999999999999999999999999999999999876544332222234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+...
T Consensus 184 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------------- 240 (291)
T 1u46_A 184 RKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--------------------- 240 (291)
T ss_dssp --CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---------------------
T ss_pred CCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc---------------------
Confidence 567888999999977 568899999999999999999 99999877654433222110
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......++..+.+||.+||..||.+|||+.++++
T Consensus 241 -----~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 -----GER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -----CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCC---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001 1123457899999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=241.06 Aligned_cols=170 Identities=21% Similarity=0.286 Sum_probs=134.1
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCC-----EEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~-----vKL~DFGlA~~~~~~~~ 73 (449)
+++|.+++.... .+++..+..++.||+.||+|||++| |+||||||+|||++.++. +||+|||+++.....
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 182 (287)
T 4f0f_A 105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182 (287)
T ss_dssp TCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--
T ss_pred CCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--
Confidence 378988887654 6999999999999999999999999 999999999999988776 999999999754321
Q ss_pred CccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhH
Q 013122 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNE 153 (449)
Q Consensus 74 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~ 153 (449)
.....||..|+|||++.+....++.++|||||||++|+|++|+.||.+.+.......
T Consensus 183 ----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~------------------- 239 (287)
T 4f0f_A 183 ----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI------------------- 239 (287)
T ss_dssp ----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-------------------
T ss_pred ----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-------------------
Confidence 245679999999999854325678899999999999999999999987654322100
Q ss_pred HHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 154 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... ... .......+++.+.+||.+||+.||.+|||++++++
T Consensus 240 ---~~~~~--~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 240 ---NMIRE--EGL---RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---HHHHH--SCC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHhc--cCC---CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00000 000 11223467899999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=246.55 Aligned_cols=170 Identities=29% Similarity=0.373 Sum_probs=127.9
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......
T Consensus 119 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~ 196 (309)
T 2h34_A 119 VDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT--QLGNTV 196 (309)
T ss_dssp EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------------
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc--cccccC
Confidence 599999998888999999999999999999999999999999999999999999999999998765433211 124567
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 197 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------------------------- 248 (309)
T 2h34_A 197 GTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-------------------------- 248 (309)
T ss_dssp CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH--------------------------
T ss_pred CCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc--------------------------
Confidence 9999999999987 678899999999999999999999998755321111110
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-TAEEALA 204 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-Ta~elL~ 204 (449)
..........+.+++.+.+||.+||..||++|| |++++++
T Consensus 249 --~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 249 --QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp --SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred --cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 111112233456888999999999999999999 7888775
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=250.94 Aligned_cols=168 Identities=24% Similarity=0.355 Sum_probs=134.8
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~ 189 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcC
Confidence 469999998764 6999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 190 ~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~------- 256 (327)
T 1fvr_A 190 RGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------- 256 (327)
T ss_dssp ESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-------
T ss_pred ccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc-------
Confidence 7432211 1133456888999999976 578899999999999999998 9999987765433322211
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 257 --------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 --------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp --------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111 11223578899999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=255.29 Aligned_cols=171 Identities=23% Similarity=0.365 Sum_probs=125.8
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 130 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 209 (373)
T 2qol_A 130 NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG 209 (373)
T ss_dssp TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccC
Confidence 479999998765 6999999999999999999999999999999999999999999999999999876443222111122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+.......+...
T Consensus 210 ~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~--------------------- 266 (373)
T 2qol_A 210 GKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG--------------------- 266 (373)
T ss_dssp ----CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT---------------------
T ss_pred CCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------------------
Confidence 345778999999987 679999999999999999997 99999876654333222111
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. . .....++..+.+||.+||+.||.+|||+.++++
T Consensus 267 --~~----~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 267 --YR----L---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --EE----C---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CC----C---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 00 0 112356788999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=242.92 Aligned_cols=168 Identities=22% Similarity=0.413 Sum_probs=138.3
Q ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ....
T Consensus 94 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~ 171 (288)
T 3kfa_A 94 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--AHAG 171 (288)
T ss_dssp EEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE--EETT
T ss_pred CcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc--cccC
Confidence 69999998744 4999999999999999999999999999999999999999999999999999876443221 2234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 172 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------------------- 228 (288)
T 3kfa_A 172 AKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------------------- 228 (288)
T ss_dssp EEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---------------------
T ss_pred CccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc---------------------
Confidence 567888999999987 578999999999999999999 99999887655443332211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. ......+++.+.+||.+||..||.+|||++++++
T Consensus 229 ------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 229 ------YR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CC---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00 1122457889999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=246.08 Aligned_cols=178 Identities=22% Similarity=0.382 Sum_probs=136.8
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-----
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA----- 75 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~----- 75 (449)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 170 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence 4699999998 4579999999999999999999999999999999999999999999999999998654332211
Q ss_pred ------cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHH
Q 013122 76 ------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 149 (449)
Q Consensus 76 ------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~ 149 (449)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..+|........... .
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------~-------- 234 (310)
T 3s95_A 171 LKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------L-------- 234 (310)
T ss_dssp ---------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------B--------
T ss_pred ccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------h--------
Confidence 01124679999999999987 6889999999999999999999999875432211000 0
Q ss_pred HhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 150 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
........ ...+.+++.+.+||.+||+.||++|||+.++++ |+..+
T Consensus 235 ----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 235 ----NVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp ----CHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred ----hhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 00001110 012456778999999999999999999999987 55544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=250.18 Aligned_cols=173 Identities=23% Similarity=0.342 Sum_probs=117.9
Q ss_pred CCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCCEEEeecCccccccCCCCCc
Q 013122 1 MESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 1 me~dL~~~i~~---~~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~ 75 (449)
++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..........
T Consensus 116 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 195 (337)
T 3ll6_A 116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195 (337)
T ss_dssp CSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---
T ss_pred cCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccc
Confidence 46789888875 557999999999999999999999999 9999999999999999999999999998654332211
Q ss_pred ---------cccccccccccccCcccccc-cCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHH
Q 013122 76 ---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 76 ---------~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e 145 (449)
.......||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+.
T Consensus 196 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------------ 263 (337)
T 3ll6_A 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN------------ 263 (337)
T ss_dssp ----------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc------------
Confidence 01124568999999999831 11568889999999999999999999997543221110
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
.... .......+..+.+||.+||+.||.+|||+.|+++|-
T Consensus 264 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 264 ------------------GKYS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp --------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ------------------Cccc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 0000 011234567789999999999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=239.82 Aligned_cols=167 Identities=29% Similarity=0.425 Sum_probs=128.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccCCcEEEcC--------CCCEEEeecCccccccC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANA--------DCKLKICDFGLARVAFN 70 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILl~~--------~~~vKL~DFGlA~~~~~ 70 (449)
+++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++.....
T Consensus 90 ~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 168 (271)
T 3dtc_A 90 GGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168 (271)
T ss_dssp TEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------
T ss_pred CCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccc
Confidence 4678888864 57999999999999999999999999 899999999999986 67799999999976543
Q ss_pred CCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 71 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 71 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
... ....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 169 ~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------- 228 (271)
T 3dtc_A 169 TTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM------------- 228 (271)
T ss_dssp ------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT-------------
T ss_pred ccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc-------------
Confidence 321 34578999999999987 6789999999999999999999999987664333221110
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 229 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 -------------NKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1111 11224578899999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=240.39 Aligned_cols=170 Identities=22% Similarity=0.363 Sum_probs=136.7
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 164 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTG 164 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH--HSTTS
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc--ccccc
Confidence 36899999876 4599999999999999999999999999999999999999999999999999976532211 11233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 165 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~---------------------- 220 (267)
T 3t9t_A 165 TKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------------------- 220 (267)
T ss_dssp TTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----------------------
T ss_pred ccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc----------------------
Confidence 457788999999986 578999999999999999999 8999987665443322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... .......+..+.+||.+||..||.+|||+.+++++
T Consensus 221 -----~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 221 -----GFR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCc---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 01123467899999999999999999999999873
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=242.66 Aligned_cols=171 Identities=23% Similarity=0.344 Sum_probs=135.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-ccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 190 (298)
T 3f66_A 111 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190 (298)
T ss_dssp TCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC----
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhcccccc
Confidence 359999998644 5999999999999999999999999999999999999999999999999999765432211 11123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 191 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~-------------------- 248 (298)
T 3f66_A 191 GAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------------------- 248 (298)
T ss_dssp -CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT--------------------
T ss_pred CCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC--------------------
Confidence 4567889999999977 678999999999999999999 67788776654443322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. ......++..+.+||.+||..||.+|||+.++++
T Consensus 249 -------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 -------RR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 1112346788999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=271.64 Aligned_cols=171 Identities=20% Similarity=0.301 Sum_probs=136.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++|..+..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 46899999998899999999999999999999999999999999999999999999999999998765433222222344
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+.......+..
T Consensus 533 ~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~----------------------- 587 (635)
T 4fl3_A 533 KWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----------------------- 587 (635)
T ss_dssp --CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------------------
T ss_pred CCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------------------
Confidence 57788999999977 689999999999999999998 9999988775444333321
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....+++.+.+||.+||..||++|||++++++
T Consensus 588 ----~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 588 ----GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1111 122357899999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=243.12 Aligned_cols=186 Identities=22% Similarity=0.407 Sum_probs=139.7
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 109 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 188 (302)
T 4e5w_A 109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188 (302)
T ss_dssp TCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCC
T ss_pred CCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCC
Confidence 3599999954 456999999999999999999999999999999999999999999999999999876554332223345
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..||..|+|||++.+ ..++.++|||||||++|+|++|..|+... ...+....+...... .......
T Consensus 189 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~ 254 (302)
T 4e5w_A 189 RDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQM-------TVTRLVN 254 (302)
T ss_dssp TTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGG-------HHHHHHH
T ss_pred CCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCccccc-------CHHHHHH
Confidence 678889999999977 57889999999999999999999876422 112222222221111 1111222
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+...... ...+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 255 TLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 22222221 223467899999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=240.55 Aligned_cols=166 Identities=29% Similarity=0.410 Sum_probs=135.7
Q ss_pred CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ...
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~ 180 (284)
T 2a19_B 105 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK----RTR 180 (284)
T ss_dssp CBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC----CCC
T ss_pred CCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccccc----ccc
Confidence 5999999754 5799999999999999999999999999999999999999999999999999977644322 244
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..||..|+|||++.+ ..++.++|||||||++|+|++|..+|.... ....
T Consensus 181 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----------------------------~~~~ 229 (284)
T 2a19_B 181 SKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS-----------------------------KFFT 229 (284)
T ss_dssp CCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----------------------------HHHH
T ss_pred cCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH-----------------------------HHHH
Confidence 579999999999987 678999999999999999999987763210 0011
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.+... .....++..+.+||.+||..||.+|||+.|+++|.+.-
T Consensus 230 ~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 230 DLRDG------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHTT------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Hhhcc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 01234678899999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=247.78 Aligned_cols=171 Identities=27% Similarity=0.415 Sum_probs=137.7
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 125 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 204 (334)
T 2pvf_A 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204 (334)
T ss_dssp TCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccc
Confidence 369999998754 3899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
......... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 205 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------- 274 (334)
T 2pvf_A 205 RDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE------- 274 (334)
T ss_dssp EECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-------
T ss_pred ccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhc-------
Confidence 865433211 11233457888999999977 578899999999999999999 9999987665433322211
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......++..+.+||.+||..||.+|||+.+++++
T Consensus 275 --------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 275 --------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp --------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 11224578899999999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=248.47 Aligned_cols=175 Identities=21% Similarity=0.317 Sum_probs=138.8
Q ss_pred CCcHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~~-------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~ 71 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++......
T Consensus 117 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~ 196 (327)
T 2yfx_A 117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196 (327)
T ss_dssp TEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-
T ss_pred CCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccc
Confidence 469999998763 4999999999999999999999999999999999999995 446999999999765332
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 197 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------------- 260 (327)
T 2yfx_A 197 SYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS------------- 260 (327)
T ss_dssp ------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-------------
T ss_pred cccc-cCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc-------------
Confidence 2111 1234567899999999977 678999999999999999998 9999987665433322211
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
... ......+++.+.+||.+||..||.+|||+.++++|.|+-
T Consensus 261 --------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 261 --------------GGR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp --------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 101 112245788999999999999999999999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=242.18 Aligned_cols=169 Identities=26% Similarity=0.373 Sum_probs=137.0
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ...
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 168 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT--ARE 168 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE--CCT
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc--ccc
Confidence 479999997653 6999999999999999999999999999999999999999999999999999876433211 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+..
T Consensus 169 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--------------------- 225 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--------------------- 225 (279)
T ss_dssp TCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------------------
T ss_pred CCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc---------------------
Confidence 3456788999999976 578899999999999999999 9999987665443322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......+++.+.+||.+||..||++|||++++++
T Consensus 226 ------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 226 ------GYR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------ccC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 100 1112457889999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=260.56 Aligned_cols=169 Identities=27% Similarity=0.405 Sum_probs=136.8
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.++|.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~--~~~ 343 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT--ARE 343 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH--TTC
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee--ccC
Confidence 469999998643 6999999999999999999999999999999999999999999999999999865332111 112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.. ..++.++|||||||++|||++ |+.||.+.+..+.+..+...
T Consensus 344 ~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-------------------- 401 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------------------- 401 (454)
T ss_dssp SSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT--------------------
T ss_pred CCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 3446788999999976 679999999999999999999 99999887654443332211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...+ ....+++.+.+||.+||..||.+|||++++++
T Consensus 402 -------~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 402 -------YRMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -------CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1111 12357889999999999999999999999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=253.04 Aligned_cols=171 Identities=23% Similarity=0.350 Sum_probs=128.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-cccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~-~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ....
T Consensus 175 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~ 254 (373)
T 3c1x_A 175 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254 (373)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred CCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccC
Confidence 369999998754 58999999999999999999999999999999999999999999999999997654322111 1123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+|..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 255 ~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~--------------------- 311 (373)
T 3c1x_A 255 GAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------------------- 311 (373)
T ss_dssp ---CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT---------------------
T ss_pred CCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc---------------------
Confidence 4567889999999987 689999999999999999999 7888887665443322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......++..+.+||.+||..||.+|||+.++++
T Consensus 312 ------~~~---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 312 ------GRR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001 1112356889999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=244.33 Aligned_cols=164 Identities=18% Similarity=0.267 Sum_probs=129.6
Q ss_pred CCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC--------EEEeecCccccccCCC
Q 013122 2 ESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~~~-Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--------vKL~DFGlA~~~~~~~ 72 (449)
+++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 96 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~- 174 (289)
T 4fvq_A 96 FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK- 174 (289)
T ss_dssp TCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-
Confidence 3799999998765 999999999999999999999999999999999999998887 999999998654221
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCC-CCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
....||..|+|||++.+. ..++.++|||||||++|+|++|. ++|...+.......+
T Consensus 175 ------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~---------------- 231 (289)
T 4fvq_A 175 ------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY---------------- 231 (289)
T ss_dssp ------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----------------
T ss_pred ------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----------------
Confidence 234688899999998752 46889999999999999999954 555444332221111
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.. . .......++.+.+||.+||+.||.+|||+.++++|
T Consensus 232 --------~~---~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 --------ED---R-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp --------HT---T-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred --------hc---c-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 00 0 01112346678999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=246.79 Aligned_cols=182 Identities=25% Similarity=0.286 Sum_probs=129.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
+++|.++++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++........
T Consensus 119 ~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 197 (337)
T 3mdy_A 119 NGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197 (337)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccc
Confidence 35999999875 699999999999999999999999 999999999999999999999999999976543322
Q ss_pred Cc-cccccccccccccCcccccccCCCCCCc------cchhhhHHHHHhhhhC----------CCCCCCCCchhhHHHHH
Q 013122 74 TA-IFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAELLTG----------KPLFPGKNVVHQLDIMT 136 (449)
Q Consensus 74 ~~-~~~~~~~gt~~Y~APE~l~~~~~~~s~~------~DIWSlG~il~eLltG----------~~pF~~~~~~~~l~~i~ 136 (449)
.. ......+||..|+|||++.+ ..++.. +|||||||++|||++| ..||........
T Consensus 198 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~----- 270 (337)
T 3mdy_A 198 EVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP----- 270 (337)
T ss_dssp -----CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-----
T ss_pred cccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-----
Confidence 11 11234679999999999976 344444 8999999999999999 555544321110
Q ss_pred hhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 137 DLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 137 ~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
....+ .............+.......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 271 ------~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 271 ------SYEDM--------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp ------CHHHH--------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ------chhhh--------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00000 01110000000111001112345679999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=247.18 Aligned_cols=186 Identities=22% Similarity=0.273 Sum_probs=136.6
Q ss_pred CCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccCCcEEEcCCCCEEEeecCccccccCCCCC
Q 013122 2 ESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 2 e~dL~~~i~~~~----~Ls~~~i~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
+++|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.........
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (326)
T 3uim_A 111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190 (326)
T ss_dssp TCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc
Confidence 469999998754 399999999999999999999999 9999999999999999999999999999865433222
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC-----chhhHHHHHhhcCCCCHHHHHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-----VVHQLDIMTDLLGTPSPEAIAR 149 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~-----~~~~l~~i~~~lg~p~~e~~~~ 149 (449)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+...+....
T Consensus 191 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 260 (326)
T 3uim_A 191 --VTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK------ 260 (326)
T ss_dssp --EECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC------
T ss_pred --ccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh------
Confidence 2345569999999999976 578999999999999999999999995211 1111111111100000
Q ss_pred HhhHHHHHHHhhhccCCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 150 VRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
+........ .......+..+.+||.+||+.||.+|||+.|+++|-.-.
T Consensus 261 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 261 ------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp ------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 000000000 011112346789999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=251.18 Aligned_cols=187 Identities=21% Similarity=0.350 Sum_probs=139.9
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 189 (327)
T 3lxl_A 110 SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189 (327)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSC
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeecc
Confidence 57999999874 46999999999999999999999999999999999999999999999999999876544333223345
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..||..|+|||++.+ ..++.++|||||||++|+|++|..||........ ........ .........
T Consensus 190 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~ 255 (327)
T 3lxl_A 190 GQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCERD-------VPALSRLLE 255 (327)
T ss_dssp CCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC-----------CCHHHHHHH
T ss_pred CCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhcccccc-------cccHHHHHH
Confidence 568889999999977 5788999999999999999999999865332111 00000000 000011111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.+...... .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12222111 2235678999999999999999999999999763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=244.52 Aligned_cols=183 Identities=22% Similarity=0.317 Sum_probs=136.6
Q ss_pred CCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~---~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ...
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 192 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT-VMT 192 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-EEC
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-ccc
Confidence 4789999874 346999999999999999999999999999999999999999999999999999765432221 122
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....||..|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+...+..... ....+
T Consensus 193 ~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 260 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK---------TIEDY 260 (307)
T ss_dssp SSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC---------CHHHH
T ss_pred cccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh---------hhhhh
Confidence 34579999999999875 4788999999999999999999999876654433322221100000 00011
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
+. ..........+..+.+||.+||..||.+|||+.++++
T Consensus 261 ~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 261 ID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp SC-------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cc-------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 10 0111112234567889999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=254.16 Aligned_cols=170 Identities=22% Similarity=0.371 Sum_probs=134.8
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.++++..+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~-~~~~~ 274 (377)
T 3cbl_A 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-ASGGL 274 (377)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE-CCSSC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee-ecCCC
Confidence 479999998754 5999999999999999999999999999999999999999999999999999764332111 01112
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+..
T Consensus 275 ~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~---------------------- 330 (377)
T 3cbl_A 275 RQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---------------------- 330 (377)
T ss_dssp CEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT----------------------
T ss_pred CCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------------------
Confidence 345778999999976 578999999999999999998 9999987664333222211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+ ....+++.+.+||.+||+.||.+|||++++++
T Consensus 331 -----~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 331 -----GGRLP---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -----TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11111 12346789999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=240.59 Aligned_cols=164 Identities=20% Similarity=0.345 Sum_probs=129.8
Q ss_pred CcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 3 SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 3 ~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------~~ 173 (278)
T 1byg_A 100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DT 173 (278)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc------cC
Confidence 489999987654 8999999999999999999999999999999999999999999999999987543321 23
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 174 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~---------------------- 229 (278)
T 1byg_A 174 GKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------------------- 229 (278)
T ss_dssp --CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----------------------
T ss_pred CCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc----------------------
Confidence 357889999999977 678999999999999999998 9999987665433322211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 230 -----~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 230 -----GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -----TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 111 1123457899999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=257.13 Aligned_cols=165 Identities=20% Similarity=0.360 Sum_probs=134.9
Q ss_pred CCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~~--Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~ 344 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------D 344 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc------c
Confidence 3699999987654 7999999999999999999999999999999999999999999999999997543221 2
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+..
T Consensus 345 ~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--------------------- 401 (450)
T 1k9a_A 345 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------------------- 401 (450)
T ss_dssp --CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT---------------------
T ss_pred CCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------------------
Confidence 2356888999999987 689999999999999999998 9999987765444332221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 402 ------~~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 402 ------GYKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 122457899999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=249.52 Aligned_cols=186 Identities=22% Similarity=0.263 Sum_probs=136.1
Q ss_pred CCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~----~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ..
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 197 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT-HL 197 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC-CC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc-cc
Confidence 358888886553 4999999999999999999999999999999999999999999999999999764332211 12
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+... . ..
T Consensus 198 ~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-------------~---~~ 259 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-------------V---ES 259 (321)
T ss_dssp BCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-------------H---HH
T ss_pred ccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-------------h---hc
Confidence 244568999999999977 57899999999999999999999999875543221111000 0 00
Q ss_pred HH-hhhccCC-CCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 158 YL-SSMRKKK-PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 158 ~~-~~~~~~~-~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
.. ..+.... +.......+..+..+.+||.+||+.||++|||+.|++++-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00 0000000 0000111223456789999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=250.03 Aligned_cols=192 Identities=23% Similarity=0.285 Sum_probs=134.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcccccccCCcEEEcCCCCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~ 72 (449)
+++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~ 174 (336)
T 3g2f_A 96 NGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174 (336)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred CCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeeccccc
Confidence 46999999876 469999999999999999999999 99999999999999999999999999997654321
Q ss_pred C-----CccccccccccccccCcccccccC-----CCCCCccchhhhHHHHHhhhhCCCC-CCCCCchhhHHHHH-hhcC
Q 013122 73 P-----TAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMT-DLLG 140 (449)
Q Consensus 73 ~-----~~~~~~~~~gt~~Y~APE~l~~~~-----~~~s~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~-~~lg 140 (449)
. ........+||..|+|||++.+.. ..++.++|||||||++|||++|..| |.+.........+. ....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3g2f_A 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254 (336)
T ss_dssp CC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCS
T ss_pred ccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCC
Confidence 1 111223567999999999987521 2355789999999999999999644 55443322211111 1222
Q ss_pred CCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCC---CCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP---NANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 141 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+..+.+.. .+.. ......+...+. ..++.+.+||.+||..||++|||+.|+++
T Consensus 255 ~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 255 HPTFEDMQV--------LVSR--EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp SCCHHHHHH--------HHTT--SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CchHHHHHh--------hhcc--cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 233222211 1111 111112222222 24567999999999999999999999965
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=235.18 Aligned_cols=166 Identities=16% Similarity=0.221 Sum_probs=133.0
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcCCCCEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~------- 165 (271)
T 3kmu_A 93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------- 165 (271)
T ss_dssp TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-------
Confidence 369999999876 4899999999999999999999999 99999999999999999999999988754221
Q ss_pred cccccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 78 WTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------------- 225 (271)
T 3kmu_A 166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL------------------- 225 (271)
T ss_dssp -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH-------------------
T ss_pred -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh-------------------
Confidence 335789999999998752 12233479999999999999999999987665433222211
Q ss_pred HHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 157 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ......+++.+.+||.+||+.||.+|||++++++
T Consensus 226 -------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 226 -------EGLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0101 1223457899999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-29 Score=246.91 Aligned_cols=170 Identities=25% Similarity=0.382 Sum_probs=135.6
Q ss_pred CcHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 3 SDLHQVIKAN--------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 3 ~dL~~~i~~~--------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 135 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 214 (333)
T 2i1m_A 135 GDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214 (333)
T ss_dssp EEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCG
T ss_pred CcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECcccccccc
Confidence 5899988753 45899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHH
Q 013122 69 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 69 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~ 147 (449)
...... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+..
T Consensus 215 ~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---------- 281 (333)
T 2i1m_A 215 MNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK---------- 281 (333)
T ss_dssp GGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH----------
T ss_pred ccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh----------
Confidence 443221 12234567889999999877 678999999999999999998 9999987654333221111
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. ... .......++.+.+||.+||+.||.+|||+.++++
T Consensus 282 -------------~---~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 282 -------------D---GYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp -------------H---TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------c---CCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 000 0112346789999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-29 Score=250.29 Aligned_cols=167 Identities=14% Similarity=0.157 Sum_probs=130.8
Q ss_pred CCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-----------CCCEEEeecCcc
Q 013122 2 ESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----------DCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~-----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-----------~~~vKL~DFGlA 65 (449)
+++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 151 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a 230 (365)
T 3e7e_A 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230 (365)
T ss_dssp SCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTC
T ss_pred CCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchh
Confidence 4799999974 457999999999999999999999999999999999999998 899999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 145 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e 145 (449)
+....... .......+||..|+|||++.+ ..|+.++|||||||++|||++|+.||.........
T Consensus 231 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------------- 294 (365)
T 3e7e_A 231 IDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------------- 294 (365)
T ss_dssp EEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------------
T ss_pred hhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------------
Confidence 76432221 123456789999999999988 57999999999999999999999998543221000
Q ss_pred HHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCc
Q 013122 146 AIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 206 (449)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp 206 (449)
+.. .+. . ...++.+.+|+.+||+.+|.+|++..+.|.+.
T Consensus 295 ----------------~~~----~~~-~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 295 ----------------PEG----LFR-R-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ----------------ECS----CCT-T-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ----------------ech----hcc-c-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000 000 0 12356788999999999999997655555543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=259.01 Aligned_cols=169 Identities=21% Similarity=0.398 Sum_probs=137.6
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.++|+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~ 377 (495)
T 1opk_A 300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT--AHA 377 (495)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE--CCT
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee--ecC
Confidence 37999999874 35999999999999999999999999999999999999999999999999999875433211 123
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+...
T Consensus 378 ~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------------------- 435 (495)
T 1opk_A 378 GAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------------------- 435 (495)
T ss_dssp TCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------------------
T ss_pred CCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 3456788999999976 578999999999999999999 99999887755443322211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 436 -------~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 -------YR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CC---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 01 1122457889999999999999999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=264.82 Aligned_cols=171 Identities=22% Similarity=0.321 Sum_probs=133.6
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 419 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp TCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 468999997654 5999999999999999999999999999999999999999999999999999875433221111122
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+..
T Consensus 499 ~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---------------------- 554 (613)
T 2ozo_A 499 GKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------------------- 554 (613)
T ss_dssp ---CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT----------------------
T ss_pred CCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------------------
Confidence 345678999999976 689999999999999999998 9999988775544333221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 555 -----~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 555 -----GKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----TCCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 122457899999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=256.38 Aligned_cols=169 Identities=28% Similarity=0.377 Sum_probs=132.3
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~ 339 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQ 339 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee--ccc
Confidence 36999999753 45999999999999999999999999999999999999999999999999999865432211 112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus 340 ~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--------------------- 396 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------------- 396 (452)
T ss_dssp ---CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------------------
T ss_pred CCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------------------
Confidence 3456788999999976 679999999999999999999 9999988765444332221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ...+.+++.+.+||.+||..||++|||++++++
T Consensus 397 ------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 397 ------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 112457889999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=239.63 Aligned_cols=167 Identities=29% Similarity=0.406 Sum_probs=128.4
Q ss_pred CCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHH---CCcccccccCCcEEEcCCCC-EEEeecCccccccCCCCC
Q 013122 2 ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPT 74 (449)
Q Consensus 2 e~dL~~~i~~~~~---Ls~~~i~~i~~QIl~aL~yLHs---~gIvHrDLKP~NILl~~~~~-vKL~DFGlA~~~~~~~~~ 74 (449)
+++|.+++..... ++...+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 4699999987653 7899999999999999999999 89999999999999998886 799999999754322
Q ss_pred ccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEK 154 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~ 154 (449)
.....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~------------------- 214 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM------------------- 214 (307)
T ss_dssp --------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH-------------------
T ss_pred ---cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH-------------------
Confidence 134568999999999987 68899999999999999999999999754322110 00
Q ss_pred HHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 155 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....... .......+++.+.+||.+||..||.+|||++++++
T Consensus 215 -----~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 215 -----WAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -----HHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----HHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000111 11223467899999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=245.34 Aligned_cols=185 Identities=23% Similarity=0.333 Sum_probs=137.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++................
T Consensus 119 ~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 197 (318)
T 3lxp_A 119 LGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197 (318)
T ss_dssp TCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---C
T ss_pred CCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCC
Confidence 36999999876 59999999999999999999999999999999999999999999999999998765443322223455
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+...... ........
T Consensus 198 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~-------~~~~~~~~ 263 (318)
T 3lxp_A 198 DSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM-------TVLRLTEL 263 (318)
T ss_dssp CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH-------HHHHHHHH
T ss_pred CCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch-------hHHHHHHH
Confidence 68889999999987 57889999999999999999999998643211 111111111110 00111111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
+..... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 264 ~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 LERGER---LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcccC---CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111 1223467899999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=239.12 Aligned_cols=178 Identities=20% Similarity=0.247 Sum_probs=133.0
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCC--Ccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--TAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~--~~~~~ 78 (449)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ .....
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 191 (319)
T 2y4i_B 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL 191 (319)
T ss_dssp SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccc
Confidence 468999998765 699999999999999999999999999999999999998 67999999999875432111 11122
Q ss_pred ccccccccccCccccccc-------CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 79 TDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~-------~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
....||..|+|||++.+. ...++.++|||||||++|+|++|..||.+.........+..
T Consensus 192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------------- 257 (319)
T 2y4i_B 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT-------------- 257 (319)
T ss_dssp BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT--------------
T ss_pred ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--------------
Confidence 345689999999998642 13578899999999999999999999987664433222211
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.... ......++..+.+||.+||..||.+|||+.++++ .|+.+
T Consensus 258 -------------~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l 300 (319)
T 2y4i_B 258 -------------GMKP--NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKL 300 (319)
T ss_dssp -------------TCCC--CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC
T ss_pred -------------CCCC--CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHH
Confidence 1000 1112246778999999999999999999999987 34443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=237.46 Aligned_cols=170 Identities=24% Similarity=0.377 Sum_probs=123.2
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 117 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~ 193 (310)
T 2wqm_A 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AA 193 (310)
T ss_dssp CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------------
T ss_pred CCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc---cc
Confidence 589988874 45699999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+...... .. ...
T Consensus 194 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~---------------------~~~ 249 (310)
T 2wqm_A 194 HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL---------------------CKK 249 (310)
T ss_dssp -----CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HH---------------------HHH
T ss_pred cccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HH---------------------HHH
Confidence 34578999999999987 6789999999999999999999999976432110 00 000
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
+. ..... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 250 ~~---~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 250 IE---QCDYP--PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HH---TTCSC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hh---cccCC--CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11 11000 0112457889999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=265.69 Aligned_cols=193 Identities=26% Similarity=0.346 Sum_probs=141.1
Q ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC---EEEeecCccccccCCCCCc
Q 013122 2 ESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTA 75 (449)
Q Consensus 2 e~dL~~~i~~~~---~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGlA~~~~~~~~~~ 75 (449)
+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus 102 ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~-- 179 (676)
T 3qa8_A 102 GGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-- 179 (676)
T ss_dssp SCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC--
T ss_pred CCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccc--
Confidence 579999998755 5999999999999999999999999999999999999997765 99999999987644322
Q ss_pred cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHH
Q 013122 76 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKA 155 (449)
Q Consensus 76 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~ 155 (449)
....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+......+. ..+.....
T Consensus 180 --~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~---~~i~~~~~----------- 241 (676)
T 3qa8_A 180 --CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH---GKVREKSN----------- 241 (676)
T ss_dssp --CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSS---TTCC---------------
T ss_pred --cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhh---hhhhcccc-----------
Confidence 245689999999999987 689999999999999999999999997654321110 00000000
Q ss_pred HHHHhhhccCCCCCC-------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 156 RRYLSSMRKKKPIPF-------SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 156 ~~~~~~~~~~~~~~~-------~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
..............+ ......+++.+.+||.+||.+||++|||+.++|+||||+.+...
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 000000000001111 11223357889999999999999999999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=240.72 Aligned_cols=175 Identities=25% Similarity=0.395 Sum_probs=131.6
Q ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc---
Q 013122 3 SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA--- 75 (449)
Q Consensus 3 ~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~--- 75 (449)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 194 (317)
T 2buj_A 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194 (317)
T ss_dssp CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHH
T ss_pred CcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccc
Confidence 589998876 4679999999999999999999999999999999999999999999999999987543211110
Q ss_pred ---cccccccccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHh
Q 013122 76 ---IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVR 151 (449)
Q Consensus 76 ---~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~ 151 (449)
.......||..|+|||++.+. ...++.++|||||||++|+|++|+.||.+......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------------- 254 (317)
T 2buj_A 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-------------------- 254 (317)
T ss_dssp HHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--------------------
T ss_pred ccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--------------------
Confidence 011234679999999998652 12368899999999999999999999953110000
Q ss_pred hHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 152 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
....... .... ....+.+++.+.+||.+||..||.+|||+.+++++
T Consensus 255 --~~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 255 --SVALAVQ---NQLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp --CHHHHHH---CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --hhhHHhh---ccCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000000 0101 11124578999999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=259.53 Aligned_cols=169 Identities=28% Similarity=0.386 Sum_probs=136.3
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.++|+.. ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~ 422 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TARQ 422 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH--HTTC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce--eccc
Confidence 35999999753 4599999999999999999999999999999999999999999999999999976532111 0112
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+.+..+..
T Consensus 423 ~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~--------------------- 479 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------------- 479 (535)
T ss_dssp STTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT---------------------
T ss_pred CCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------------------
Confidence 3456788999999976 679999999999999999999 9999988765444332221
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+ ....++..+.+||.+||..||++|||++++++
T Consensus 480 ------~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 480 ------GYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp ------TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11111 12457889999999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-28 Score=238.24 Aligned_cols=187 Identities=19% Similarity=0.306 Sum_probs=138.2
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 128 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 207 (326)
T 2w1i_A 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207 (326)
T ss_dssp TCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSC
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccC
Confidence 369999998864 5999999999999999999999999999999999999999999999999999876544322112234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..++..|+|||++.+ ..++.++|||||||++|+|++|..+|.... ..+.+..+........ ......
T Consensus 208 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~~~------~~~~~~ 274 (326)
T 2w1i_A 208 GESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQMI------VFHLIE 274 (326)
T ss_dssp CSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTHHH------HHHHHH
T ss_pred CCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchhhh------HHHHHH
Confidence 467888999999977 568899999999999999999998875321 1111222222111100 001111
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.+...... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 275 ~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 LLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111 123467899999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=242.33 Aligned_cols=180 Identities=23% Similarity=0.258 Sum_probs=130.9
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
++|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++.+||+|||++.........
T Consensus 125 g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 203 (342)
T 1b6c_B 125 GSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203 (342)
T ss_dssp CBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred CcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccc
Confidence 5999999875 6999999999999999999999 899999999999999999999999999999776543321
Q ss_pred c-cccccccccccccCcccccccCC----CCCCccchhhhHHHHHhhhhC----------CCCCCCCCchh-hHHHHHhh
Q 013122 75 A-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------KPLFPGKNVVH-QLDIMTDL 138 (449)
Q Consensus 75 ~-~~~~~~~gt~~Y~APE~l~~~~~----~~s~~~DIWSlG~il~eLltG----------~~pF~~~~~~~-~l~~i~~~ 138 (449)
. .......||..|+|||++.+... .++.++|||||||++|+|++| ..||....... ....+
T Consensus 204 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~--- 280 (342)
T 1b6c_B 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM--- 280 (342)
T ss_dssp EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH---
T ss_pred cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHH---
Confidence 1 11245579999999999876211 223689999999999999999 66775543211 00000
Q ss_pred cCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 139 LGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 139 lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
...+. .......+...+ ......+.+||.+||..||.+|||+.++++|
T Consensus 281 -----------------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 281 -----------------RKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp -----------------HHHHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred -----------------HHHHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 00110 001111111111 1234578999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=259.91 Aligned_cols=169 Identities=25% Similarity=0.409 Sum_probs=135.3
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 474 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~~~~ 551 (656)
T 2j0j_A 474 LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KASK 551 (656)
T ss_dssp TCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce--eccC
Confidence 379999998765 6999999999999999999999999999999999999999999999999999865433221 1233
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+|..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+..
T Consensus 552 ~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---------------------- 607 (656)
T 2j0j_A 552 GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------------------- 607 (656)
T ss_dssp --CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH----------------------
T ss_pred CCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc----------------------
Confidence 456789999999977 689999999999999999997 9999988765444333221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 608 -----~~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 608 -----GERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1111 123467899999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-28 Score=251.82 Aligned_cols=189 Identities=23% Similarity=0.377 Sum_probs=133.5
Q ss_pred CCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEE----cCCCCEEEeecCccccccCCCCC
Q 013122 2 ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 2 e~dL~~~i~~~~~---Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGlA~~~~~~~~~ 74 (449)
+++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 93 ~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-- 170 (396)
T 4eut_A 93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-- 170 (396)
T ss_dssp TEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--
T ss_pred CCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC--
Confidence 4689999986543 9999999999999999999999999999999999998 777789999999998654332
Q ss_pred ccccccccccccccCccccccc------CCCCCCccchhhhHHHHHhhhhCCCCCCCCCch-hhHHHHHhhcCCCCHHHH
Q 013122 75 AIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAI 147 (449)
Q Consensus 75 ~~~~~~~~gt~~Y~APE~l~~~------~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~-~~l~~i~~~lg~p~~e~~ 147 (449)
.....+||..|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... .....+..+++..+...+
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~ 248 (396)
T 4eut_A 171 --QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248 (396)
T ss_dssp --GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred --ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence 22456799999999998531 024678999999999999999999999754322 122222222211111100
Q ss_pred HHHhhHHHHHHHhhhccCCCCCCCCC-------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 148 ARVRNEKARRYLSSMRKKKPIPFSQK-------FPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..+.. .......|... ...++..+.+||.+||..||++|||+.++++
T Consensus 249 ~~~~~----------~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 249 SGVQK----------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp EEEEC----------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hhhee----------ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 00000 00001111111 1224567889999999999999999999865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=239.77 Aligned_cols=167 Identities=17% Similarity=0.135 Sum_probs=123.4
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccCCcEEEcCCC--------------------CEEEee
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC--------------------KLKICD 61 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~--------------------~vKL~D 61 (449)
++|.+.+.+ ..+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|
T Consensus 147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D 225 (336)
T 2vuw_A 147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225 (336)
T ss_dssp CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence 334444433 46999999999999999999999 99999999999999999887 899999
Q ss_pred cCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHH-HHhhhhCCCCCCCCCchhhHHHHHhhcC
Q 013122 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI-FAELLTGKPLFPGKNVVHQLDIMTDLLG 140 (449)
Q Consensus 62 FGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~i-l~eLltG~~pF~~~~~~~~l~~i~~~lg 140 (449)
||+|+.... ...+||+.|+|||++.+. . +.++||||+|++ .++++.|..||.+..... .+
T Consensus 226 FG~a~~~~~--------~~~~gt~~y~aPE~~~g~--~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~---~~----- 286 (336)
T 2vuw_A 226 YTLSRLERD--------GIVVFCDVSMDEDLFTGD--G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH---YL----- 286 (336)
T ss_dssp CTTCBEEET--------TEEECCCCTTCSGGGCCC--S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH---HH-----
T ss_pred ccccEecCC--------CcEEEeecccChhhhcCC--C-ccceehhhhhCCCCcccccccCCCcchhhhh---HH-----
Confidence 999987643 235799999999999872 3 789999998777 788899998884311000 00
Q ss_pred CCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH-cCcccc
Q 013122 141 TPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL-ADPYFK 209 (449)
Q Consensus 141 ~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL-~hp~f~ 209 (449)
........ ..........++.+++.+++||.+||++| |++|+| +||||+
T Consensus 287 --------------~~~~~~~~-~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 287 --------------TDKMLKQM-TFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp --------------HHHHHHTC-CCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred --------------HHhhhhhh-ccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 00111110 11111111122346788999999999987 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=250.29 Aligned_cols=159 Identities=26% Similarity=0.353 Sum_probs=126.2
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..... ...+
T Consensus 169 ~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-------~~~~ 238 (681)
T 2pzi_A 169 QSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-------GYLY 238 (681)
T ss_dssp EECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-------SCCC
T ss_pred CcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-------CccC
Confidence 577777655 69999999999999999999999999999999999999985 8999999999765432 3457
Q ss_pred ccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhh
Q 013122 83 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSM 162 (449)
Q Consensus 83 gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~ 162 (449)
||+.|+|||++.+ .++.++|||||||++|+|++|.++|.+..... .+...
T Consensus 239 gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~~----------------- 288 (681)
T 2pzi_A 239 GTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPEDD----------------- 288 (681)
T ss_dssp CCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTTC-----------------
T ss_pred CCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc----------ccccc-----------------
Confidence 9999999999876 35889999999999999999998886532110 00000
Q ss_pred ccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 163 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 163 ~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.....++.+.+||.+||..||.+||+..++|.|+|+..+
T Consensus 289 ----------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 289 ----------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000124678899999999999999999999999988643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.5e-24 Score=210.52 Aligned_cols=144 Identities=17% Similarity=0.096 Sum_probs=112.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++++.+ ....++..++.||+.||+|||++||+||||||+|||++.++.+||+++|.
T Consensus 115 g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~----------------- 175 (286)
T 3uqc_A 115 GGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------------- 175 (286)
T ss_dssp EEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----------------
T ss_pred CCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----------------
Confidence 36899999653 56778999999999999999999999999999999999999999985542
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
++ .++.++|||||||++|+|++|+.||.+.+....+.......
T Consensus 176 ------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------------------- 218 (286)
T 3uqc_A 176 ------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT---------------------- 218 (286)
T ss_dssp ------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT----------------------
T ss_pred ------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh----------------------
Confidence 22 36789999999999999999999998876533211000000
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
...........+.+++.+.+||.+||+.||.+| |+.|+++
T Consensus 219 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 219 --AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp --TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred --ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 000111122345678999999999999999999 9999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-23 Score=221.84 Aligned_cols=110 Identities=21% Similarity=0.212 Sum_probs=80.0
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++|..++.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....... .....
T Consensus 326 G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~---~~~t~ 399 (569)
T 4azs_A 326 GRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS---WPTNL 399 (569)
T ss_dssp SEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C---CSHHH
T ss_pred CCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc---cccCc
Confidence 46999999999999875 4789999999999999999999999999999999999999999986544322 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCC
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~ 120 (449)
+||+.|+|||++.+ .+..++|+||+|+++++|+++.
T Consensus 400 vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 400 VQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHC--------------------CCCCTTH
T ss_pred eechhhccHHHhCC---CCCCcccccccccchhhhcccc
Confidence 89999999999976 4677899999999999987764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1e-16 Score=170.38 Aligned_cols=112 Identities=22% Similarity=0.347 Sum_probs=90.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc----cc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA----IF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~----~~ 77 (449)
+++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++......... ..
T Consensus 423 ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~ 492 (540)
T 3en9_A 423 GKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVF 492 (540)
T ss_dssp SEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHH
T ss_pred CCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhh
Confidence 3789988876 6799999999999999999999999999999998 99999999998764321111 01
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCC
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF 123 (449)
....+||+.|+|||++......|+..+|+|+..+-..+.+.++..|
T Consensus 493 ~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 493 KKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2356899999999999764456888899999988888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.7e-12 Score=125.01 Aligned_cols=60 Identities=20% Similarity=0.151 Sum_probs=52.0
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCccccc
Q 013122 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 94 (449)
Q Consensus 18 ~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 94 (449)
.....++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.. ..|+|||++.
T Consensus 193 ~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~~----------------~~~~a~e~l~ 252 (282)
T 1zar_A 193 ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV----------------GEEGWREILE 252 (282)
T ss_dssp SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEET----------------TSTTHHHHHH
T ss_pred hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeEC----------------CCCCHHHHHH
Confidence 34567999999999999999999999999999999 999999999998632 3367888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=2.7e-10 Score=109.18 Aligned_cols=60 Identities=22% Similarity=0.259 Sum_probs=51.4
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccCCcEEEcCCCCEEEeecCccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVA 68 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~ 68 (449)
.|.+++.. +++..+..++.||+.||.||| +.||+||||||+|||++. .++|+|||+|...
T Consensus 159 ~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 159 TLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp BHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred cHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 56665432 345678899999999999999 999999999999999998 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.44 E-value=1.1e-07 Score=96.42 Aligned_cols=50 Identities=16% Similarity=0.130 Sum_probs=44.5
Q ss_pred HHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCC----------EEEeecCcccc
Q 013122 18 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK----------LKICDFGLARV 67 (449)
Q Consensus 18 ~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~----------vKL~DFGlA~~ 67 (449)
+....++.||+.+|.+||++|||||||||.|||++.++. +.|+||+.+..
T Consensus 205 ~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 205 PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 456778999999999999999999999999999998763 89999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.75 E-value=7.3e-06 Score=79.65 Aligned_cols=79 Identities=20% Similarity=0.271 Sum_probs=48.0
Q ss_pred CcccccccCCcEEEcC--CCCEEEeecCccccccCCCCCccccccccccccc---cCcccccc---cCCC---------C
Q 013122 38 NVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY---RAPELCGS---FFSK---------Y 100 (449)
Q Consensus 38 gIvHrDLKP~NILl~~--~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y---~APE~l~~---~~~~---------~ 100 (449)
.++|+|+++.||+++. ...+.|+||+.+........ ......+ ..++.+.. .+.. .
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-------l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~ 264 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-------FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY 264 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-------HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-------HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHH
Confidence 3799999999999998 45578999999865322100 0000011 12222111 0011 1
Q ss_pred CCccchhhhHHHHHhhhhCCCCC
Q 013122 101 TPAIDIWSIGCIFAELLTGKPLF 123 (449)
Q Consensus 101 s~~~DIWSlG~il~eLltG~~pF 123 (449)
..-.+.|++|.++|.+.+|..+|
T Consensus 265 ~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 265 RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHcCCHHH
Confidence 11258999999999999998655
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0027 Score=58.90 Aligned_cols=97 Identities=18% Similarity=0.090 Sum_probs=64.0
Q ss_pred cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 4 DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 4 dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|.++|... .+|+++++|.+++|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 588888754 479999999999999999887622 2212333457899999999988774 2110
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhC
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG 119 (449)
.....+.+||... ...+.+.=|+|||+++|.-+--
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhc
Confidence 0122355888764 2455677899999999998863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00034 Score=69.30 Aligned_cols=54 Identities=19% Similarity=0.373 Sum_probs=47.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------------
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHT--------------------------------------------------------- 36 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs--------------------------------------------------------- 36 (449)
.++......++.++...|+.||+
T Consensus 135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 214 (359)
T 3dxp_A 135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD 214 (359)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence 36788889999999999999997
Q ss_pred -CCcccccccCCcEEEcCCCC--EEEeecCcccc
Q 013122 37 -ANVFHRDLKPKNILANADCK--LKICDFGLARV 67 (449)
Q Consensus 37 -~gIvHrDLKP~NILl~~~~~--vKL~DFGlA~~ 67 (449)
.+++|+|+++.|||++.++. +.|+||+.+..
T Consensus 215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0002 Score=66.75 Aligned_cols=28 Identities=25% Similarity=0.153 Sum_probs=24.7
Q ss_pred cccccccCCcEEEcCCCCEEEeecCccc
Q 013122 39 VFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 39 IvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
++|+|++|.|||++.++.+.|+||+.+.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876666799999874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00027 Score=66.55 Aligned_cols=30 Identities=23% Similarity=0.222 Sum_probs=25.1
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
..++|+|+++.|||++.+..+.|+||+.+.
T Consensus 183 ~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 183 LVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999875556799999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.0075 Score=58.40 Aligned_cols=42 Identities=19% Similarity=0.196 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHH-------------CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 25 YQLLRGLKYIHT-------------ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 25 ~QIl~aL~yLHs-------------~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++..++.+|+. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 344556666653 579999999999999888889999999763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=94.60 E-value=0.046 Score=52.78 Aligned_cols=30 Identities=40% Similarity=0.658 Sum_probs=25.3
Q ss_pred CcccccccCCcEEEcC---CCCE-EEeecCcccc
Q 013122 38 NVFHRDLKPKNILANA---DCKL-KICDFGLARV 67 (449)
Q Consensus 38 gIvHrDLKP~NILl~~---~~~v-KL~DFGlA~~ 67 (449)
.++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 5699999999999997 4554 8999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.10 E-value=0.03 Score=56.59 Aligned_cols=32 Identities=16% Similarity=0.313 Sum_probs=27.9
Q ss_pred HHCCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 35 HTANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 35 Hs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999999876 99999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.88 E-value=0.058 Score=51.91 Aligned_cols=30 Identities=33% Similarity=0.339 Sum_probs=25.6
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 368999999999999877656899999764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.63 E-value=0.12 Score=49.71 Aligned_cols=28 Identities=32% Similarity=0.292 Sum_probs=24.5
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999999 4 89999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=91.18 E-value=0.083 Score=51.26 Aligned_cols=31 Identities=26% Similarity=0.470 Sum_probs=26.8
Q ss_pred CCcccccccCCcEEEcCC----CCEEEeecCcccc
Q 013122 37 ANVFHRDLKPKNILANAD----CKLKICDFGLARV 67 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~----~~vKL~DFGlA~~ 67 (449)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6799999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=90.52 E-value=0.095 Score=48.93 Aligned_cols=28 Identities=21% Similarity=0.281 Sum_probs=24.8
Q ss_pred cccccccCCcEEEcCCCCEEEeecCccc
Q 013122 39 VFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 39 IvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 7999999999999977667799999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=90.50 E-value=0.31 Score=46.47 Aligned_cols=28 Identities=21% Similarity=0.281 Sum_probs=24.2
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++|+|+.+.||+ ..++.+.|+||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 556778999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=90.25 E-value=0.092 Score=51.35 Aligned_cols=31 Identities=13% Similarity=0.208 Sum_probs=25.9
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999999644578999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.83 E-value=0.34 Score=47.68 Aligned_cols=28 Identities=32% Similarity=0.665 Sum_probs=23.8
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
+++|+|+.+.|||++.++ +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999998654 8999998774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.67 E-value=0.22 Score=48.76 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.2
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCcccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLARV 67 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~ 67 (449)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999987653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=86.41 E-value=0.46 Score=47.15 Aligned_cols=30 Identities=27% Similarity=0.381 Sum_probs=25.4
Q ss_pred HCCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 36 TANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 36 s~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
...++|+|+.+.|||++.+ .++|+||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 3579999999999999876 48999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=84.43 E-value=0.49 Score=48.54 Aligned_cols=15 Identities=33% Similarity=0.457 Sum_probs=14.1
Q ss_pred CcccccccCCcEEEc
Q 013122 38 NVFHRDLKPKNILAN 52 (449)
Q Consensus 38 gIvHrDLKP~NILl~ 52 (449)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=83.47 E-value=0.36 Score=48.95 Aligned_cols=17 Identities=35% Similarity=0.466 Sum_probs=14.9
Q ss_pred CcccccccCCcEEEcCC
Q 013122 38 NVFHRDLKPKNILANAD 54 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~ 54 (449)
.++|+|+.+.|||++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 58999999999999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=81.78 E-value=0.59 Score=46.72 Aligned_cols=29 Identities=28% Similarity=0.418 Sum_probs=25.8
Q ss_pred CcccccccCCcEEEcCC----CCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANAD----CKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~----~~vKL~DFGlA~ 66 (449)
.++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999876 689999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 449 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-69 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-61 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-61 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-52 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-52 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-51 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-46 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-30 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-29 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-28 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-26 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-24 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-15 | |
| d1iodg_ | 44 | g.32.1.1 (G:) Coagulation factor X {Cow (Bos tauru | 0.004 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 7e-69
Identities = 122/254 (48%), Positives = 168/254 (66%), Gaps = 4/254 (1%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL++++K L+ +H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKIC
Sbjct: 93 MGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 151
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLARVA D F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNR 210
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
P+FPGK+ + QL+ + +LG+PS E + + N KAR YL S+ K +P+++ FPNA+
Sbjct: 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 270
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
AL LL++ML F P R E+ALA PY + EP A+ +F+ E + KE +
Sbjct: 271 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKL 328
Query: 241 RELIYREILEYHPQ 254
+ELI+ E + P
Sbjct: 329 KELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-61
Identities = 110/253 (43%), Positives = 152/253 (60%), Gaps = 10/253 (3%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+ I LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI
Sbjct: 104 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR T T YVATRWYRAPE+ ++ Y +DIWS+GCI AELLTG+
Sbjct: 164 DFGLAR------HTDDEMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGR 216
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LFPG + + QL ++ L+GTP E + ++ +E AR Y+ S+ + + F+ F ANPL
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML + R TA +ALA YF + EP A P + FE R + ++
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSFESRDLLIDEW 333
Query: 241 RELIYREILEYHP 253
+ L Y E++ + P
Sbjct: 334 KSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-61
Identities = 106/253 (41%), Positives = 161/253 (63%), Gaps = 11/253 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M +DL +++K ++ L + QF +YQ+L+GL+YIH A + HRDLKP N+ N DC+LKI
Sbjct: 105 MGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A ++ T YV TRWYRAPE+ ++ +YT +DIWS+GCI AE++TGK
Sbjct: 164 DFGLARQADSEM------TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGK 216
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
LF G + + QL + + GTP E + R+++++A+ Y+ + + + F+ NA+PL
Sbjct: 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL 276
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240
A+ LLE+ML + + R TA EALA PYF+ L E EP Q K + F+ T ++
Sbjct: 277 AVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFDDVDRTLDEW 333
Query: 241 RELIYREILEYHP 253
+ + Y+E+L + P
Sbjct: 334 KRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-52
Identities = 94/261 (36%), Positives = 141/261 (54%), Gaps = 22/261 (8%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
M+++L QVI+ D E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI
Sbjct: 104 MDANLCQVIQMELD--HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR A T YV TR+YRAPE+ Y +DIWS+GCI E++ K
Sbjct: 162 DFGLARTAGTSFMM----TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHK 215
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA--- 177
LFPG++ + Q + + + LGTP PE + ++ R Y+ + K + F + FP++
Sbjct: 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFP 274
Query: 178 ---------NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228
A LL +ML +P R + ++AL PY E A P +
Sbjct: 275 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD-PAEVEAPPPQIYDK 333
Query: 229 EFERRRITKEDVRELIYREIL 249
+ + R T E+ +ELIY+E++
Sbjct: 334 QLDEREHTIEEWKELIYKEVM 354
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-52
Identities = 79/241 (32%), Positives = 119/241 (49%), Gaps = 10/241 (4%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL-KI 59
+ +A L + + ++YQL R L YIH+ + HRD+KP+N+L + D + K+
Sbjct: 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 164
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
CDFG A+ P Y+ +R+YRAPEL YT +ID+WS GC+ AELL G
Sbjct: 165 CDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLG 219
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKF-PNAN 178
+P+FPG + V QL + +LGTP+ E I + + K P+++ F P
Sbjct: 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI---KAHPWTKVFRPRTP 276
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
P A+ L R+L + P R T EA A +F L + T F F + ++
Sbjct: 277 PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336
Query: 239 D 239
Sbjct: 337 P 337
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-51
Identities = 74/210 (35%), Positives = 108/210 (51%), Gaps = 10/210 (4%)
Query: 6 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65
+ + E + ++QLLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLA
Sbjct: 104 YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163
Query: 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 125
R+ T V T WYRAPE+ S Y +D+WS+GCIFAE+ KPLF G
Sbjct: 164 RIYSFQMA----LTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRG 217
Query: 126 KNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 185
+ V QL + D++G P E R + + K P + + + L LL
Sbjct: 218 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF----HSKSAQPIEKFVTDIDELGKDLL 273
Query: 186 ERMLAFEPKDRPTAEEALADPYFKGLAKVE 215
+ L F P R +A AL+ PYF+ L + +
Sbjct: 274 LKCLTFNPAKRISAYSALSHPYFQDLERCK 303
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 6e-51
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 3/208 (1%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+ T + + LL GL YIH + HRD+K N+L D LK+ DFG
Sbjct: 103 LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162
Query: 64 LAR-VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
LAR + +T+ V T WYR PEL Y P ID+W GCI AE+ T P+
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMR-KKKPIPFSQKFPNANPLA 181
G HQL +++ L G+ +PE V N + L ++ +K+ + K +P A
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFK 209
L L++++L +P R +++AL +F
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFFW 309
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-50
Identities = 72/222 (32%), Positives = 106/222 (47%), Gaps = 13/222 (5%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
+ + LTP H + ++ L+GL+Y+H + HRDLKP N+L + + LK+ DFGL
Sbjct: 87 EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 146
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124
A+ + +T V TRWYRAPEL Y +D+W++GCI AELL P P
Sbjct: 147 AKSFGSPNRA---YTHQVVTRWYRAPELL-FGARMYGVGVDMWAVGCILAELLLRVPFLP 202
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 184
G + + QL + + LGTP+ E + + + IP F A L L
Sbjct: 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT---FKSFPGIPLHHIFSAAGDDLLDL 259
Query: 185 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 226
++ + F P R TA +AL YF P P ++
Sbjct: 260 IQGLFLFNPCARITATQALKMKYFSN------RPGPTPGCQL 295
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 166 bits (421), Expect = 6e-49
Identities = 77/209 (36%), Positives = 110/209 (52%), Gaps = 6/209 (2%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+ + L + FL QLL G+ Y H V HRDLKP+N+L N + +LKI
Sbjct: 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLAR +T + T WYRAP++ KY+ IDIWS+GCIFAE++ G
Sbjct: 143 DFGLARAFGIPVRK---YTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
PLFPG + QL + +LGTP+ + V + +Y + +P+P+ +
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVT--ELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFK 209
+ LL +ML +P R TA++AL YFK
Sbjct: 257 GIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-48
Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 21/221 (9%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDF 62
L QV+K + + +++GL Y+ + + HRD+KP NIL N+ ++K+CDF
Sbjct: 90 SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
G++ + +V TR Y +PE + Y+ DIWS+G E+ G+
Sbjct: 150 GVSGQLIDSMA-----NSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNA----- 177
P + + + + E R R M + P+ +
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 178 --------NPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210
+ + + L P +R ++ + + K
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-47
Identities = 78/215 (36%), Positives = 115/215 (53%), Gaps = 8/215 (3%)
Query: 1 MESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58
+ DL + + A+ + + +L+QLL+GL + H+ V HRDLKP+N+L N + +K
Sbjct: 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 142
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ DFGLAR +T V T WYRAPE+ Y+ A+DIWS+GCIFAE++T
Sbjct: 143 LADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVT 198
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
+ LFPG + + QL + LGTP Y S K FS+ P +
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPG--VTSMPDYKPSFPKWARQDFSKVVPPLD 256
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213
LL +ML ++P R +A+ ALA P+F+ + K
Sbjct: 257 EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (401), Expect = 6e-46
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 35/210 (16%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+L + L+ + + + LL + +H N+ HRDLKP+NIL + D +K+ DFG
Sbjct: 96 ELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 155
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELC----GSFFSKYTPAIDIWSIGCIFAELLTG 119
+ + T Y APE+ Y +D+WS G I LL G
Sbjct: 156 FSCQLDPGEKL----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
P F + + L + + S ++ + +
Sbjct: 212 SPPFWHRKQMLMLRM---------------------------IMSGNYQFGSPEWDDYSD 244
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFK 209
L+ R L +P+ R TAEEALA P+F+
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 9e-46
Identities = 80/212 (37%), Positives = 106/212 (50%), Gaps = 7/212 (3%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+ N DL PE + FL+QLL+GL + H+ NV HRDLKP+N+L N + +LK+
Sbjct: 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
+FGLAR ++ V T WYR P++ Y+ +ID+WS GCIFAEL
Sbjct: 144 NFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAG 199
Query: 121 -PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
PLFPG +V QL + LLGTP+ E + K Y P N
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--KLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
LL+ +L P R +AEEAL PYF
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 158 bits (399), Expect = 3e-45
Identities = 62/218 (28%), Positives = 112/218 (51%), Gaps = 16/218 (7%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDF 62
D Q+ + LT +F++Y++L+ L Y H+ + HRD+KP N++ + + KL++ D+
Sbjct: 118 DFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW 174
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-P 121
GLA + VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P
Sbjct: 175 GLAEFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEP 229
Query: 122 LFPGKNVVHQLDIMTDLLGTPSP-EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN-- 178
F G + QL + +LGT + I + E R+ + + + + + N
Sbjct: 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH 289
Query: 179 ---PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213
P AL L+++L ++ + R TA EA+ PYF + K
Sbjct: 290 LVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-45
Identities = 46/207 (22%), Positives = 74/207 (35%), Gaps = 38/207 (18%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+++ ++ + ++ +L L Y H+ V HRD+KP+N+L + +LKI DFG
Sbjct: 92 TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFG 151
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+ A + T T Y PE+ + +D+WS+G + E L GKP F
Sbjct: 152 WSVHAPSSRR-----TTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPF 204
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
+ R + P A
Sbjct: 205 EANTYQETYKRI--------------------------SRVEFTFP-----DFVTEGARD 233
Query: 184 LLERMLAFEPKDRPTAEEALADPYFKG 210
L+ R+L P RP E L P+
Sbjct: 234 LISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-44
Identities = 60/268 (22%), Positives = 106/268 (39%), Gaps = 35/268 (13%)
Query: 4 DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLK 58
+L I+ D T + + ++Y+H+ N+ HRD+KP+N+L + LK
Sbjct: 95 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 154
Query: 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 118
+ DFG A+ + T T +Y APE+ G KY + D+WS+G I LL
Sbjct: 155 LTDFGFAKETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLC 208
Query: 119 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNAN 178
G P F + + M + +R + + ++ +
Sbjct: 209 GYPPFYSNHGLAISPGM-----------------------KTRIRMGQYEFPNPEWSEVS 245
Query: 179 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
L+ +L EP R T E + P+ KV + P ++ + ER KE
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERWEDVKE 304
Query: 239 DVRELIYREILEYHPQMLKEFLEGSEPT 266
++ + ++Y +K+ + S P
Sbjct: 305 EMTSALATMRVDYEQIKIKKIEDASNPL 332
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-44
Identities = 48/206 (23%), Positives = 78/206 (37%), Gaps = 30/206 (14%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+L I+ + + Q F +QL+ G+ Y+H + HRD+KP+N+L + LKI DFG
Sbjct: 89 ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA V F T Y APEL + +D+WS G + +L G+ +
Sbjct: 149 LATV-FRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW 206
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
+ Q K+ + + + L
Sbjct: 207 DQPSDSCQEY----------------------------SDWKEKKTYLNPWKKIDSAPLA 238
Query: 184 LLERMLAFEPKDRPTAEEALADPYFK 209
LL ++L P R T + D ++
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 9e-43
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 36/238 (15%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKIC 60
+L I T ++Q+L +KY+H + HRDLKP+N+L + D K+ I
Sbjct: 93 ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGL+++ + + T Y APE+ Y+ A+D WSIG I LL G
Sbjct: 153 DFGLSKMEDPGSVL----STACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGY 206
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
P F +N + + K + S + + +
Sbjct: 207 PPFYDENDAKLFE---------------------------QILKAEYEFDSPYWDDISDS 239
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
A + ++ +P+ R T E+AL P+ G +++ +++ F + + +
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 1e-42
Identities = 50/246 (20%), Positives = 87/246 (35%), Gaps = 38/246 (15%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
S + L + L+GL Y+H+ N+ HRD+K NIL + +K+ DF
Sbjct: 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
G A + +V T ++ APE + +Y +D+WS+G EL KP
Sbjct: 160 GSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
N + L + + + P S +
Sbjct: 213 PLFNMNAMSALYHI--------------------------AQNESPALQSGHWS---EYF 243
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVR 241
++ L P+DRPT+E L + TK E + ++
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR-ELDNLQYRKMK 302
Query: 242 ELIYRE 247
+++++E
Sbjct: 303 KILFQE 308
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-42
Identities = 45/211 (21%), Positives = 70/211 (33%), Gaps = 35/211 (16%)
Query: 4 DLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+ V+ + LT Q Q L L Y+H + HRDLK NIL D +K+ DF
Sbjct: 95 AVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADF 154
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFAELLTG 119
G++ ++ T ++ APE+ SK Y D+WS+G E+
Sbjct: 155 GVSAKNTRTIQR---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 211
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+P N + L K P + +
Sbjct: 212 EPPHHELNPMRVLL----------------------------KIAKSEPPTLAQPSRWSS 243
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKG 210
L++ L R T + L P+
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-41
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 38/238 (15%)
Query: 4 DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKIC 60
D+ + I + +L +++Q+ L+++H+ N+ H D++P+NI+ +KI
Sbjct: 87 DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
+FG AR + +T Y APE+ + A D+WS+G + LL+G
Sbjct: 147 EFGQARQLKPGDNFRLLFT----APEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGI 200
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
F + ++ ++ + + F +
Sbjct: 201 NPFLAETNQQIIE---------------------------NIMNAEYTFDEEAFKEISIE 233
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 238
A+ ++R+L E K R TA EAL P+ K K+ER + T + I K+
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQ--KIERVSTKVIRTLKHRRYYHTLIKKD 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-41
Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 33/209 (15%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+ + + + L+ L+++H+ V HRD+K NIL D +K+
Sbjct: 99 LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFG + + V T ++ APE+ Y P +DIWS+G + E++ G+
Sbjct: 159 DFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGE 213
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
P + +N + L + P Q + +
Sbjct: 214 PPYLNENPLRALY----------------------------LIATNGTPELQNPEKLSAI 245
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFK 209
L R L + + R +A+E L + K
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-40
Identities = 53/208 (25%), Positives = 77/208 (37%), Gaps = 40/208 (19%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKI 59
+ + K L E + QL LK H V HRDLKP N+ + +K+
Sbjct: 96 ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFGLAR+ +DT A +V T +Y +PE Y DIWS+GC+ EL
Sbjct: 156 GDFGLARILNHDTSFA---KAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCAL 210
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
P F + +R+ K ++
Sbjct: 211 MPPFTAFSQKELAG---------------------------KIREGKFRRIPYRYS---D 240
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPY 207
++ RML + RP+ EE L +P
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 9e-40
Identities = 42/209 (20%), Positives = 79/209 (37%), Gaps = 39/209 (18%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNIL-ANADCKLKIC 60
L +K + + + + Q+L+GL+++HT + HRDLK NI +KI
Sbjct: 98 TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
D GLA + A+ + T + APE+ + KY ++D+++ G E+ T +
Sbjct: 158 DLGLATLKRASFAKAV-----IGTPEFMAPEM---YEEKYDESVDVYAFGMCMLEMATSE 209
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
+ Q+ Y KP F + P
Sbjct: 210 YPYSECQNAAQI-------------------------YRRVTSGVKPASFDKVAI---PE 241
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFK 209
++E + +R + ++ L +F+
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 143 bits (361), Expect = 2e-39
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 36/210 (17%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKIC 60
+L I A D ++ ++ Q GLK++H ++ H D+KP+NI+ +KI
Sbjct: 112 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 171
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLA D AT + APE+ D+W+IG + LL+G
Sbjct: 172 DFGLATKLNPDEIV----KVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGL 225
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
F G++ + L ++++ F + +P
Sbjct: 226 SPFAGEDDLETLQ---------------------------NVKRCDWEFDEDAFSSVSPE 258
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKG 210
A ++ +L EP+ R T +AL P+ KG
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (359), Expect = 4e-39
Identities = 44/222 (19%), Positives = 78/222 (35%), Gaps = 36/222 (16%)
Query: 4 DLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKIC 60
+L + + ++ ++ + ++ Q+ +GL ++H N H DLKP+NI+ +LK+
Sbjct: 109 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLI 168
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGL T + APE+ D+WS+G + LL+G
Sbjct: 169 DFGLTAHLDPKQSV----KVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
F G+N L + A F +
Sbjct: 223 SPFGGENDDETLRNVKSCDWNMDDSA---------------------------FSGISED 255
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 222
+ ++L +P R T +AL P+ R+
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 297
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-39
Identities = 45/203 (22%), Positives = 75/203 (36%), Gaps = 28/203 (13%)
Query: 4 DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L+ + + Q +G+ Y+H ++ HRDLK NI + D +KI DF
Sbjct: 89 SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDF 148
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 121
GLA V + + F + + APE + + Y+ D+++ G + EL+TG+
Sbjct: 149 GLATVKSRWSGSHQF-EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ N Q+ M R S+ N
Sbjct: 208 PYSNINNRDQIIFMV-------------------------GRGYLSPDLSKVRSNCPKAM 242
Query: 182 LRLLERMLAFEPKDRPTAEEALA 204
RL+ L + +RP + LA
Sbjct: 243 KRLMAECLKKKRDERPLFPQILA 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-38
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 40/214 (18%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+L + I+ +F+ +++ L+Y+H + HRDLKP+NIL N D ++I DFG
Sbjct: 94 ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 153
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
A+V ++ A +V T Y +PEL + D+W++GCI +L+ G P F
Sbjct: 154 TAKVLSPESKQA-RANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPF 210
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
N + K F +KF P A
Sbjct: 211 RAGNEYLIFQKI----------------------------IKLEYDFPEKFF---PKARD 239
Query: 184 LLERMLAFEPKDRPTAEEA------LADPYFKGL 211
L+E++L + R EE A P+F+ +
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-37
Identities = 44/209 (21%), Positives = 79/209 (37%), Gaps = 37/209 (17%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DL I++ F+ +++ GL+++H+ + +RDLK NIL + D +KI DFG
Sbjct: 89 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 148
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+ + + T Y APE+ KY ++D WS G + E+L G+ F
Sbjct: 149 MCKENMLGDAK---TNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPF 203
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
G++ + + + + A
Sbjct: 204 HGQDEEELFHSI----------------------------RMDNPFYPRWLE---KEAKD 232
Query: 184 LLERMLAFEPKDRPTAE-EALADPYFKGL 211
LL ++ EP+ R + P F+ +
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-35
Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 44/212 (20%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKI 59
DL I L E + F +Q+L +++ H V HRD+K +NIL + + +LK+
Sbjct: 93 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 152
Query: 60 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 119
DFG + + +TD+ TR Y PE + + + +WS+G + +++ G
Sbjct: 153 IDFGSGALLKDT-----VYTDFDGTRVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCG 206
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
F + + + F Q+
Sbjct: 207 DIPFEHDEEI----------------------------------IRGQVFFRQRVS---S 229
Query: 180 LALRLLERMLAFEPKDRPTAEEALADPYFKGL 211
L+ LA P DRPT EE P+ + +
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-34
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 41/212 (19%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L + T E +F+ +++ L+Y+H+ +V +RD+K +N++ + D +KI DFGL
Sbjct: 92 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL 151
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124
+ +D T + T Y APE+ + Y A+D W +G + E++ G+ F
Sbjct: 152 CKEGISDGATMKTF---CGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFY 206
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 184
++ +++ + I F + P A L
Sbjct: 207 NQDHERLFELI----------------------------LMEEIRFPRTLS---PEAKSL 235
Query: 185 LERMLAFEPKDRP-----TAEEALADPYFKGL 211
L +L +PK R A+E + +F +
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 8e-34
Identities = 55/210 (26%), Positives = 82/210 (39%), Gaps = 37/210 (17%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKIC 60
L + + LT E FL Q+L G+ Y+H+ + H DLKP+NI+ ++KI
Sbjct: 100 LFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGLA + T + APE+ D+WSIG I LL+G
Sbjct: 160 DFGLAHKIDFGNEF----KNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGA 213
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
F G L ++ + E F N + L
Sbjct: 214 SPFLGDTKQETLANVSAVNYEFEDE---------------------------YFSNTSAL 246
Query: 181 ALRLLERMLAFEPKDRPTAEEALADPYFKG 210
A + R+L +PK R T +++L P+ K
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-33
Identities = 44/216 (20%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+L + + T Q ++ +++ L+++H + +RD+K +NIL +++ + +
Sbjct: 112 NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 171
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFGL++ F T + + + G S + A+D WS+G + ELLTG
Sbjct: 172 DFGLSK-EFVADETERAYDFCGTIEYMAPDIVRGG-DSGHDKAVDWWSLGVLMYELLTGA 229
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
F + ++ + P P P + L
Sbjct: 230 SPFTVDGEKNSQAEISRRILKSEP----------------------PYP-----QEMSAL 262
Query: 181 ALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211
A L++R+L +PK R A+E +F+ +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-33
Identities = 49/213 (23%), Positives = 77/213 (36%), Gaps = 23/213 (10%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADC 55
L + +T E GL ++H + HRDLK KNIL +
Sbjct: 87 SLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145
Query: 56 KLKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIG 110
I D GLA + T T I V T+ Y APE+ + + DI+++G
Sbjct: 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205
Query: 111 CIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPF 170
+F E+ + G + +QL + PS E + +V E+ R IP
Sbjct: 206 LVFWEIARRCSIG-GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR--------PNIPN 256
Query: 171 SQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 203
+ A + +++ R TA
Sbjct: 257 RWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (315), Expect = 8e-33
Identities = 51/213 (23%), Positives = 80/213 (37%), Gaps = 39/213 (18%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
DLH + + + +F+ +++ GL+++H V +RDLKP NIL + ++I D G
Sbjct: 93 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
LA P A T Y APE+ Y + D +S+GC+ +LL G F
Sbjct: 153 LACDFSKKKPHASVG-----THGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPF 206
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
+ +I M + F P
Sbjct: 207 RQHKTKDKHEID-------------------------RMTLTMAVELPDSFS---PELRS 238
Query: 184 LLERMLAFEPKDRPT-----AEEALADPYFKGL 211
LLE +L + R A+E P+F+ L
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (310), Expect = 3e-32
Identities = 53/242 (21%), Positives = 88/242 (36%), Gaps = 32/242 (13%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD----- 54
+ + + + QLL GL Y+H + H D+KP+N+L
Sbjct: 108 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167
Query: 55 -CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
++KI D G A +T+ + TR YR+PE+ + + DIWS C+
Sbjct: 168 LIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLI 219
Query: 114 AELLTGKPLFPGKNV------VHQLDIMTDLLGTPSPEAIARVRNEK----ARRYLSSMR 163
EL+TG LF + + +LLG + + + +R L ++
Sbjct: 220 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 279
Query: 164 KKKPIPFSQKF-------PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 216
K K P + L ML +P+ R A + P+ K +E
Sbjct: 280 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEE 339
Query: 217 EP 218
Sbjct: 340 IR 341
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 5e-32
Identities = 54/222 (24%), Positives = 77/222 (34%), Gaps = 42/222 (18%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+ L Q+ G+ Y+ N HRDL+ NIL + K+ DFG
Sbjct: 99 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 158
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 122
LAR+ ++ TA + APE ++T D+WS G + EL T G+
Sbjct: 159 LARLIEDNEYTAR--QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVP 214
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
+PG LD + P P P
Sbjct: 215 YPGMVNREVLDQVERGYRMPCP------------------------------PECPESLH 244
Query: 183 RLLERMLAFEPKDRPTAEEALA--DPYFKGLAKVEREPSAQP 222
L+ + EP++RPT E A + YF EP QP
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST-----EPQYQP 281
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (303), Expect = 6e-32
Identities = 48/203 (23%), Positives = 82/203 (40%), Gaps = 30/203 (14%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L ++ +TP+ + + L + H + HRD+KP NI+ +A +K+ DFG
Sbjct: 97 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 123
+AR + + + T Y +PE D++S+GC+ E+LTG+P F
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPF 214
Query: 124 PGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 183
G + V ++ PIP S + +
Sbjct: 215 TGDSPVSVAY---------------------------QHVREDPIPPSARHEGLSADLDA 247
Query: 184 LLERMLAFEPKDRP-TAEEALAD 205
++ + LA P++R TA E AD
Sbjct: 248 VVLKALAKNPENRYQTAAEMRAD 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (298), Expect = 7e-31
Identities = 54/269 (20%), Positives = 105/269 (39%), Gaps = 57/269 (21%)
Query: 5 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 64
L +++ + +F+ ++ L+Y+H+ ++ +RDLKP+NIL + + +KI DFG
Sbjct: 91 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150
Query: 65 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 124
A+ + T Y APE+ + Y +ID WS G + E+L G F
Sbjct: 151 AKYVPDV------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFY 202
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 184
N + + + + + P P N L
Sbjct: 203 DSNTMKTYEKI--------------------------LNAELRFP-----PFFNEDVKDL 231
Query: 185 LERMLAFEPKDR-----PTAEEALADPYFKG------LAKVEREPSAQPVTKMEF---EF 230
L R++ + R E+ P+FK L++ P P+ + + +F
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF 291
Query: 231 ERRRITKEDVRELIYREILEYHPQMLKEF 259
+ + +ED+ + E + + + ++F
Sbjct: 292 D--KYPEEDINYGVQGE--DPYADLFRDF 316
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-30
Identities = 39/212 (18%), Positives = 76/212 (35%), Gaps = 36/212 (16%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
L++ ++ N + ++ ++Q+ G+KY+ +N HRDL +N+L KI DFG
Sbjct: 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFG 152
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 122
L++ D T + APE K++ D+WS G + E + G+
Sbjct: 153 LSKALRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKP 210
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
+ G + + K + + P
Sbjct: 211 YRGMKGSEVTAM---------------------------LEKGERMGCPAGCP---REMY 240
Query: 183 RLLERMLAFEPKDRPTAEE---ALADPYFKGL 211
L+ ++ ++RP L + Y+ +
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-30
Identities = 47/217 (21%), Positives = 79/217 (36%), Gaps = 37/217 (17%)
Query: 4 DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
LH+ + +++ + L+Q+ G+KY+ N HRDL +N+L KI DF
Sbjct: 94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 121
GL++ D + + APE K++ D+WS G E L+ G+
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQK 211
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ PE +A + K+ P P P
Sbjct: 212 PYKKMK---------------GPEVMAFIEQ----------GKRMECP-----PECPPEL 241
Query: 182 LRLLERMLAFEPKDRPTAEE---ALADPYFKGLAKVE 215
L+ ++ +DRP + Y+ +KVE
Sbjct: 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-30
Identities = 42/191 (21%), Positives = 73/191 (38%), Gaps = 33/191 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
LT E F YQ+ +G++++ + HRDL +N+L +KICDFGLAR +D+
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-N 219
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 133
+ + + APE F YT D+WS G + E+ + G +PG V
Sbjct: 220 YVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
+ ++ + +++ AF+
Sbjct: 278 KL--------------------------IQNGFKMDQPFYAT---EEIYIIMQSCWAFDS 308
Query: 194 KDRPTAEEALA 204
+ RP+ +
Sbjct: 309 RKRPSFPNLTS 319
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-29
Identities = 37/203 (18%), Positives = 69/203 (33%), Gaps = 41/203 (20%)
Query: 4 DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 61
L +++ L + F + ++Y+ N HRDL +N+L + D K+ D
Sbjct: 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 146
Query: 62 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 120
FGL + A + T + APE K++ D+WS G + E+ + G+
Sbjct: 147 FGLTKEASSTQDTGKL------PVKWTAPEAL--REKKFSTKSDVWSFGILLWEIYSFGR 198
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
+P + + + RV K P P
Sbjct: 199 VPYPRIPL---------------KDVVPRVEKGY----------KMDAP-----DGCPPA 228
Query: 181 ALRLLERMLAFEPKDRPTAEEAL 203
+++ + RP+ +
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 3e-29
Identities = 33/217 (15%), Positives = 60/217 (27%), Gaps = 35/217 (16%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKI 59
S + + + Q++ ++YIH+ N HRD+KP N L + I
Sbjct: 88 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYI 147
Query: 60 CDFGLARVAFNDTPTAIFW----TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 115
DFGLA+ + + T Y + + + D+ S+G +
Sbjct: 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH--LGIEQSRRDDLESLGYVLMY 205
Query: 116 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFP 175
G + G + Y KK P
Sbjct: 206 FNLGSLPWQGLKAATKRQK-----------------------YERISEKKMSTPIEVLCK 242
Query: 176 NANPLALRLLERMLAFEPKDRPTAE---EALADPYFK 209
L + D+P + + + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (287), Expect = 4e-29
Identities = 38/215 (17%), Positives = 76/215 (35%), Gaps = 44/215 (20%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
++ ++ + H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 120
DFG A+ T T APE+ S Y A+D W++G + E+ G
Sbjct: 184 DFGFAKRVKGRTWTLCGTP------EALAPEIILS--KGYNKAVDWWALGVLIYEMAAGY 235
Query: 121 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 180
P F + + + + K P + +
Sbjct: 236 PPFFADQPIQIYEKI--------------------------VSGKVRFP-----SHFSSD 264
Query: 181 ALRLLERMLAFEPKDR-----PTAEEALADPYFKG 210
LL +L + R + +F
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 112 bits (282), Expect = 6e-29
Identities = 27/208 (12%), Positives = 58/208 (27%), Gaps = 34/208 (16%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----L 57
S + + + Q+L ++ IH ++ +RD+KP N L +
Sbjct: 86 SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 145
Query: 58 KICDFGLARVAFNDTPTAIFW----TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 113
+ DFG+ + + + T Y + + + D+ ++G +F
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH--LGREQSRRDDLEALGHVF 203
Query: 114 AELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQK 173
L G + G + R+ KK+ P +
Sbjct: 204 MYFLRGSLPWQGLKAATNK------------QKYERI-----------GEKKQSTPLREL 240
Query: 174 FPNANPLALRLLERMLAFEPKDRPTAEE 201
+ + P +
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-28
Identities = 35/204 (17%), Positives = 69/204 (33%), Gaps = 35/204 (17%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L+ + + + + ++Y+ + HRDL +N L N +K+ DF
Sbjct: 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 144
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 121
GL+R +D T+ + PE+ SK++ DIW+ G + E+ + GK
Sbjct: 145 GLSRYVLDDEYTS--SVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKM 200
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ + + L P A+
Sbjct: 201 PYERFTNSETAEHIAQGLRLYRPH------------------------------LASEKV 230
Query: 182 LRLLERMLAFEPKDRPTAEEALAD 205
++ + +RPT + L++
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 2e-28
Identities = 41/202 (20%), Positives = 70/202 (34%), Gaps = 32/202 (15%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
S L ++ K + Q+ G+ Y+ + HRDL +N+L +KI DF
Sbjct: 96 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 121
GL R + + + APE + ++ A D W G E+ T G+
Sbjct: 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQE 213
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ G N + + ++ E R P P +
Sbjct: 214 PWIGLNGS---------------QILHKIDKEGERL---------PRP-----EDCPQDI 244
Query: 182 LRLLERMLAFEPKDRPTAEEAL 203
++ + A +P+DRPT
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALR 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (274), Expect = 1e-27
Identities = 35/204 (17%), Positives = 64/204 (31%), Gaps = 34/204 (16%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+ + L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-G 119
DFGL+R ++ D + RW + + +YT D+W+ G + E+ + G
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYG 239
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+ G + +R + + P
Sbjct: 240 LQPYYGMAHEEVIY---------------------------YVRDGNILACPENCP---L 269
Query: 180 LALRLLERMLAFEPKDRPTAEEAL 203
L+ + P DRP+
Sbjct: 270 ELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-27
Identities = 40/202 (19%), Positives = 75/202 (37%), Gaps = 31/202 (15%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+ + + + + + L + G+KY+ N HRDL +NIL N++ K+ DF
Sbjct: 95 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 154
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 122
GL+RV +D + + APE K+T A D+WS G + E++T
Sbjct: 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGER 212
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
+ H++ + ++ +P P
Sbjct: 213 PYWELSNHEV--------------------------MKAINDGFRLPTPMDCP---SAIY 243
Query: 183 RLLERMLAFEPKDRPTAEEALA 204
+L+ + E RP + ++
Sbjct: 244 QLMMQCWQQERARRPKFADIVS 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (268), Expect = 7e-27
Identities = 40/191 (20%), Positives = 68/191 (35%), Gaps = 35/191 (18%)
Query: 16 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT--P 73
T L + G+KY+ N HRDL +NIL N++ K+ DFGL+R +DT P
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 74 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 132
T + AP + K+T A D+WS G + E+++ G+ + +
Sbjct: 186 TYTSALGGKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 133 DIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 192
+ + P P + +L+ +
Sbjct: 244 NAIEQDYRLPPPM------------------------------DCPSALHQLMLDCWQKD 273
Query: 193 PKDRPTAEEAL 203
RP + +
Sbjct: 274 RNHRPKFGQIV 284
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 7e-27
Identities = 47/253 (18%), Positives = 85/253 (33%), Gaps = 49/253 (19%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L V + D++ ++ + Q+ +G+ Y+ + HRDL +N+L +KI DF
Sbjct: 96 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDF 155
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 121
GLA++ + A E YT D+WS G EL+T G
Sbjct: 156 GLAKL-LGAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSK 212
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ G I+ P P P
Sbjct: 213 PYDGIPASEISSILEKGERLPQP------------------------------PICTIDV 242
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE----------FE 231
++ + + RP E + + +K+ R+P V + + F
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIE-----FSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297
Query: 232 RRRITKEDVRELI 244
R + +ED+ +++
Sbjct: 298 RALMDEEDMDDVV 310
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-26
Identities = 42/206 (20%), Positives = 72/206 (34%), Gaps = 34/206 (16%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+E + + L+ + YQ+ RG++Y+ + HRDL +N+L D +KI
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-G 119
DFGLAR + + +W L YT D+WS G + E+ T G
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLG 234
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+PG V + +++ + N
Sbjct: 235 GSPYPGVPVEELFKL---------------------------LKEGHRMDKPSNCTNE-- 265
Query: 180 LALRLLERMLAFEPKDRPTAEEALAD 205
++ P RPT ++ + D
Sbjct: 266 -LYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-26
Identities = 39/202 (19%), Positives = 71/202 (35%), Gaps = 36/202 (17%)
Query: 4 DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
L ++ L + G+ Y+ A V HRDL +N L + +K+ DF
Sbjct: 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 145
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 121
G+ R +D T T + +PE+ FS+Y+ D+WS G + E+ + GK
Sbjct: 146 GMTRFVLDDQYT--SSTGTKFPVKWASPEVF--SFSRYSSKSDVWSFGVLMWEVFSEGKI 201
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
+ ++ ++ ++ P A+
Sbjct: 202 PYENRSNSEVVEDISTGFRLYKPR------------------------------LASTHV 231
Query: 182 LRLLERMLAFEPKDRPTAEEAL 203
+++ P+DRP L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-26
Identities = 39/191 (20%), Positives = 63/191 (32%), Gaps = 37/191 (19%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 133
T + A E S YT D+WS G + E+++ G + G +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
+ P N + L+ + +P
Sbjct: 238 KLPQGYRLEKPL------------------------------NCDDEVYDLMRQCWREKP 267
Query: 194 KDRPTAEEALA 204
+RP+ + L
Sbjct: 268 YERPSFAQILV 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-26
Identities = 44/206 (21%), Positives = 73/206 (35%), Gaps = 37/206 (17%)
Query: 6 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65
+ LT Q+ G+ +I N HRDL+ NIL + KI DFGLA
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
Query: 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 124
R+ ++ TA + APE + +T D+WS G + E++T G+ +P
Sbjct: 157 RLIEDNEYTA--REGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 125 GKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 184
G + + + + P +L
Sbjct: 213 GMTNPEVIQN---------------------------LERGYRMVRPDNCP---EELYQL 242
Query: 185 LERMLAFEPKDRPTAEEALA--DPYF 208
+ P+DRPT + + + +F
Sbjct: 243 MRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (262), Expect = 3e-26
Identities = 39/201 (19%), Positives = 73/201 (36%), Gaps = 35/201 (17%)
Query: 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63
+ +++ + Q+ ++Y+ N HRDL +N L + +K+ DFG
Sbjct: 101 LDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 160
Query: 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 122
L+R+ DT TA + APE +K++ D+W+ G + E+ T G
Sbjct: 161 LSRLMTGDTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 123 FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 182
+PG ++ +++ K + + P
Sbjct: 217 YPGIDLSQVYELL---------------------------EKDYRMERPEGCP---EKVY 246
Query: 183 RLLERMLAFEPKDRPTAEEAL 203
L+ + P DRP+ E
Sbjct: 247 ELMRACWQWNPSDRPSFAEIH 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-26
Identities = 45/194 (23%), Positives = 74/194 (38%), Gaps = 33/194 (17%)
Query: 11 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 70
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 71 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVV 129
D P + D + APE YT D+WS G + E+ + +PG +
Sbjct: 187 D-PDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 130 HQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 189
+ +++ + P + +
Sbjct: 244 EEF--------------------------CRRLKEGTRMRAPDYTT---PEMYQTMLDCW 274
Query: 190 AFEPKDRPTAEEAL 203
EP RPT E +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-25
Identities = 37/193 (19%), Positives = 74/193 (38%), Gaps = 34/193 (17%)
Query: 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDT 72
+ T + F Q+ +G+K++ + HRDL +N + + +K+ DFGLAR + +
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 131
+ T + A E + K+T D+WS G + EL+T G P +P N
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243
Query: 132 LDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 191
+ + + + + P+ ++ +
Sbjct: 244 TV---------------------------YLLQGRRLLQPEYCPDP---LYEVMLKCWHP 273
Query: 192 EPKDRPTAEEALA 204
+ + RP+ E ++
Sbjct: 274 KAEMRPSFSELVS 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 7e-25
Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 40/220 (18%)
Query: 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 62
+ L + YQL L Y+ + HRD+ +N+L +++ +K+ DF
Sbjct: 93 ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 152
Query: 63 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 121
GL+R + T + + APE ++T A D+W G E+L G
Sbjct: 153 GLSRYMEDSTYYKA--SKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVK 208
Query: 122 LFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 181
F G + + I R+ N ++ P+P PN P
Sbjct: 209 PFQGVK---------------NNDVIGRIEN----------GERLPMP-----PNCPPTL 238
Query: 182 LRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 221
L+ + A++P RP E A L+ + E AQ
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ-----LSTILEEEKAQ 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 3e-24
Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 33/190 (17%)
Query: 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 74
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR ND+
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 75 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 133
+ + +W + YT D+WS G EL + G +PG V +
Sbjct: 202 VVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 134 IMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 193
M +++ + + P +++ +P
Sbjct: 259 KM--------------------------IKEGFRMLSPEHAP---AEMYDIMKTCWDADP 289
Query: 194 KDRPTAEEAL 203
RPT ++ +
Sbjct: 290 LKRPTFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 8e-23
Identities = 35/216 (16%), Positives = 67/216 (31%), Gaps = 40/216 (18%)
Query: 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 60
+ ++ G+ Y++ HRDL +N + D +KI
Sbjct: 116 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175
Query: 61 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG- 119
DFG+ R +T + + +PE +T D+WS G + E+ T
Sbjct: 176 DFGMTRD-IYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLA 232
Query: 120 KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANP 179
+ + G + L + + + P
Sbjct: 233 EQPYQGLSNEQVLRF---------------------------VMEGGLLDKPDNCP---D 262
Query: 180 LALRLLERMLAFEPKDRPTAEEALA------DPYFK 209
+ L+ + PK RP+ E ++ +P F+
Sbjct: 263 MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.6 bits (172), Expect = 7e-15
Identities = 16/93 (17%), Positives = 29/93 (31%), Gaps = 11/93 (11%)
Query: 19 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78
+ L +L + + + H DL N+L ++ + I DF + + I
Sbjct: 104 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILE 162
Query: 79 TD-YVATRWYRAPELCGSFFSKYTPAIDIWSIG 110
D ++ Y DI S
Sbjct: 163 RDVRNIITYFS---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 449 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.98 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.98 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.18 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 90.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 89.17 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 84.49 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=352.45 Aligned_cols=242 Identities=44% Similarity=0.825 Sum_probs=205.2
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|+.+|..+++. ..|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .+.
T Consensus 105 ~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~------~~~ 177 (346)
T d1cm8a_ 105 MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTG 177 (346)
T ss_dssp CSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS------CCS
T ss_pred ccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc------ccc
Confidence 35678887765 47999999999999999999999999999999999999999999999999999875432 255
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+....+..+....+.++.+.+..........+..
T Consensus 178 ~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (346)
T d1cm8a_ 178 YVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256 (346)
T ss_dssp SCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHH
T ss_pred ccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhc
Confidence 7899999999998763 467899999999999999999999999999999999999999999999988887777777777
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.........+...++.+++.+++||.+||..||.+|||++|+|+||||+.+...+.++..+ +++..++....+.+++
T Consensus 257 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~e~ 333 (346)
T d1cm8a_ 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFDDVDRTLDEW 333 (346)
T ss_dssp HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC-----CCHHHH
T ss_pred cCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCCCchhhhhcCHHHH
Confidence 7777777778888889999999999999999999999999999999999988777666543 4455666667889999
Q ss_pred HHHHHHHHHhhCh
Q 013122 241 RELIYREILEYHP 253 (449)
Q Consensus 241 ~e~i~~ei~~~~p 253 (449)
++++++|+++++|
T Consensus 334 k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 334 KRVTYKEVLSFKP 346 (346)
T ss_dssp HHHHHHHHHTCCC
T ss_pred HHHHHHHhhcCCC
Confidence 9999999999886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=348.14 Aligned_cols=251 Identities=49% Similarity=0.882 Sum_probs=209.0
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++||++++..+ .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|...............
T Consensus 93 ~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 171 (345)
T d1pmea_ 93 MGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171 (345)
T ss_dssp CCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCC
T ss_pred cCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecc
Confidence 468999999875 7999999999999999999999999999999999999999999999999999876544333333456
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||+.|+|||++... ..|+.++||||+||++|+|++|+.||.+.+..++...+...++.+..+...............
T Consensus 172 ~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T d1pmea_ 172 YVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250 (345)
T ss_dssp CCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred ccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccc
Confidence 7899999999998553 568899999999999999999999999999999999999999999888776666556666666
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
........++...++.+++.+++||.+||+.||.+|||++|+|+||||+.......++.... .+.++.+...+..+++
T Consensus 251 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 328 (345)
T d1pmea_ 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKL 328 (345)
T ss_dssp TSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CC--------CCHHHH
T ss_pred cCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccC--ccCCChhhhhCCHHHH
Confidence 66666666777778899999999999999999999999999999999998877666554433 3345566778899999
Q ss_pred HHHHHHHHHhhChhH
Q 013122 241 RELIYREILEYHPQM 255 (449)
Q Consensus 241 ~e~i~~ei~~~~p~~ 255 (449)
++++++|...++|+-
T Consensus 329 ~~l~~~e~~~~~~~~ 343 (345)
T d1pmea_ 329 KELIFEETARFQPGY 343 (345)
T ss_dssp HHHHHHHSGGGSTTT
T ss_pred HHHHHHHHHhcCCCC
Confidence 999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=342.85 Aligned_cols=243 Identities=46% Similarity=0.861 Sum_probs=208.8
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++++|.+++..+ .|++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 105 ~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~------~~~~ 177 (348)
T d2gfsa1 105 MGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD------EMTG 177 (348)
T ss_dssp CSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG------GGSS
T ss_pred cCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc------cccc
Confidence 368999999654 799999999999999999999999999999999999999999999999999865432 2245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
..||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....+.+..+............+..
T Consensus 178 ~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (348)
T d2gfsa1 178 YVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256 (348)
T ss_dssp SCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHT
T ss_pred ccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhh
Confidence 6899999999987763 457899999999999999999999999999999999999999999988887777766677776
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhhHHHhhcCCHHHH
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDV 240 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~ 240 (449)
.+.......+...+..+++.+++||.+||..||.+|||++|+|+||||+.+..+..++...+ ++.+++....+.+++
T Consensus 257 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 333 (348)
T d2gfsa1 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSFESRDLLIDEW 333 (348)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCC---CCCGGGGCCCCHHHH
T ss_pred hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCC---CCCcccchhcCHHHH
Confidence 66666666666677889999999999999999999999999999999999988877776554 345677889999999
Q ss_pred HHHHHHHHHhhChh
Q 013122 241 RELIYREILEYHPQ 254 (449)
Q Consensus 241 ~e~i~~ei~~~~p~ 254 (449)
++++++|+.++.|.
T Consensus 334 k~~~~~e~~~~~p~ 347 (348)
T d2gfsa1 334 KSLTYDEVISFVPP 347 (348)
T ss_dssp HHHHHHHHHTCCCC
T ss_pred HHHHHHHhhccCCC
Confidence 99999999998763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=329.36 Aligned_cols=205 Identities=36% Similarity=0.601 Sum_probs=163.3
Q ss_pred CCcHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQ-VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~-~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
++++.. ++..+..+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ....
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~---~~~~ 159 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYTH 159 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---CCCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc---cccc
Confidence 334444 444455799999999999999999999999999999999999999999999999999976544322 2245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.+||++|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+++..|.+.+|.|..+.+....... ...
T Consensus 160 ~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~---~~~ 235 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP---DYV 235 (299)
T ss_dssp SCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST---TCC
T ss_pred eecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc---hhh
Confidence 6899999999998652 568999999999999999999999999999999999999999988876543321110 000
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
........++...++.+++.+++||.+||+.||++||||+|+|+||||++...
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 11111222333445678999999999999999999999999999999986543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=319.93 Aligned_cols=171 Identities=26% Similarity=0.438 Sum_probs=147.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++|.....+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... ....
T Consensus 90 ~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-----~~~~ 164 (263)
T d2j4za1 90 LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTTL 164 (263)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-----CEET
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-----cccc
Confidence 47999999998899999999999999999999999999999999999999999999999999997654332 2456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 165 ~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----------------------- 219 (263)
T d2j4za1 165 CGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------------------- 219 (263)
T ss_dssp TEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------------------
T ss_pred CCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence 89999999999988 67999999999999999999999999887765554433221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
... ....+++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 220 -----~~~---~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -----EFT---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CCC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 011 12347899999999999999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=320.47 Aligned_cols=202 Identities=38% Similarity=0.674 Sum_probs=164.1
Q ss_pred CCcHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~--~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
++++..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~----~~~ 173 (305)
T d1blxa_ 98 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALT 173 (305)
T ss_dssp SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG----GGC
T ss_pred cCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc----cCC
Confidence 444444443 33469999999999999999999999999999999999999999999999999987543322 235
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+..+++..|...+|.+....+....... .
T Consensus 174 ~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----~ 247 (305)
T d1blxa_ 174 SVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP----R 247 (305)
T ss_dssp CCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC----G
T ss_pred CcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch----h
Confidence 6789999999999987 689999999999999999999999999999999999999999988776543221100 0
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
.........+.......+++.+++||.+||++||++|||++|+|+||||+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 111122233344556678999999999999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=321.32 Aligned_cols=178 Identities=26% Similarity=0.408 Sum_probs=145.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++|..+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ...+..
T Consensus 87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~-~~~~~~ 165 (271)
T d1nvra_ 87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKM 165 (271)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE-CCBCCC
T ss_pred CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc-ccccce
Confidence 3699999998889999999999999999999999999999999999999999999999999999876433221 223567
Q ss_pred cccccccCcccccccCCC-CCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~-~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
+||+.|+|||++.+ .. ++.++|||||||++|||++|++||.+.+..........
T Consensus 166 ~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~----------------------- 220 (271)
T d1nvra_ 166 CGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----------------------- 220 (271)
T ss_dssp CSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH-----------------------
T ss_pred eeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------------
Confidence 89999999999976 44 46789999999999999999999987654332211110
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
. .......+..+++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 221 ---~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 ---E--KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---T--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---c--CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 01112223467899999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=318.57 Aligned_cols=175 Identities=26% Similarity=0.460 Sum_probs=147.1
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.++ .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .....
T Consensus 101 gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~ 176 (293)
T d1yhwa1 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 176 (293)
T ss_dssp TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCC
T ss_pred CCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc---ccccc
Confidence 47999988775 699999999999999999999999999999999999999999999999999987644322 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 177 ~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~----------------------- 231 (293)
T d1yhwa1 177 VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN----------------------- 231 (293)
T ss_dssp CSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-----------------------
T ss_pred ccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence 89999999999987 68999999999999999999999999887765544333210
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
. .+.......+++.+++||.+||+.||.+|||++|+|+||||+.
T Consensus 232 ---~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 232 ---G--TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ---C--SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---C--CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 0111223457899999999999999999999999999999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=324.71 Aligned_cols=239 Identities=38% Similarity=0.696 Sum_probs=178.8
Q ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 1 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 1 me~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
|.++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..+.
T Consensus 104 ~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~----~~~~ 177 (355)
T d2b1pa1 104 MDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTP 177 (355)
T ss_dssp CSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred cchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc----cccc
Confidence 4567777764 469999999999999999999999999999999999999999999999999987654432 2356
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...++..+...++.+..+.+...... ...+..
T Consensus 178 ~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~ 254 (355)
T d2b1pa1 178 YVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRNYVE 254 (355)
T ss_dssp ---CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH-HHHHHH
T ss_pred ccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh-HHHHhh
Confidence 689999999999987 68999999999999999999999999999999999999999999988887765432 233333
Q ss_pred hhccCCCCCCCCCC------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccccCCCCCCCccchhh
Q 013122 161 SMRKKKPIPFSQKF------------PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEF 228 (449)
Q Consensus 161 ~~~~~~~~~~~~~~------------~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~~e~~~~~~~~~~~ 228 (449)
.........+...+ ...++.+++||.+||.+||++||||+|+|+||||+.......+....+ ...+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~-~~~~~ 333 (355)
T d2b1pa1 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP-QIYDK 333 (355)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC------
T ss_pred cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCC-CCCCc
Confidence 32222211111111 123577899999999999999999999999999998765443333222 34556
Q ss_pred HHHhhcCCHHHHHHHHHHHHH
Q 013122 229 EFERRRITKEDVRELIYREIL 249 (449)
Q Consensus 229 ~~e~~~~~~e~~~e~i~~ei~ 249 (449)
+++++..+.++|+++|++|++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 334 QLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp --CCCCCCHHHHHHHHHHHHH
T ss_pred chhhhhcCHHHHHHHHHHHhc
Confidence 777889999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=320.38 Aligned_cols=174 Identities=26% Similarity=0.477 Sum_probs=149.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.+++.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....... .....
T Consensus 89 gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~---~~~~~ 165 (337)
T d1o6la_ 89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTF 165 (337)
T ss_dssp TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC---CBCCC
T ss_pred CCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc---ccccc
Confidence 479999999999999999999999999999999999999999999999999999999999999986543322 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......+..
T Consensus 166 ~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~------------------------ 219 (337)
T d1o6la_ 166 CGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------------------ 219 (337)
T ss_dssp EECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------------
T ss_pred eeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc------------------------
Confidence 89999999999988 6899999999999999999999999998876554433321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
. ... ....+++.+++||.+||+.||.+|+ +++|+++||||+++
T Consensus 220 ---~-~~~---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 220 ---E-EIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ---C-CCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---C-CCC---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 0 111 1245789999999999999999999 49999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-40 Score=324.26 Aligned_cols=202 Identities=22% Similarity=0.375 Sum_probs=145.5
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+...... .+.
T Consensus 88 gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-----~~~ 162 (322)
T d1s9ja_ 88 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANS 162 (322)
T ss_dssp TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-----C--
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-----ccc
Confidence 36999999998899999999999999999999997 599999999999999999999999999998654322 245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhh-HHHHHhhcCCCCHHHHHHHhh-------
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIARVRN------- 152 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~-l~~i~~~lg~p~~e~~~~~~~------- 152 (449)
.+||++|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+.... ...+....|.+..........
T Consensus 163 ~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp -CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred ccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 789999999999988 6899999999999999999999999988664432 222222233221111000000
Q ss_pred -------HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 153 -------EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 153 -------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.........+....+... .....+.++++||.+||++||.+|||++|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000011111111111111 1123688999999999999999999999999999998643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-39 Score=317.82 Aligned_cols=177 Identities=29% Similarity=0.462 Sum_probs=138.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc---CCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.++|..++.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+...... ..
T Consensus 91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~----~~ 166 (307)
T d1a06a_ 91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VL 166 (307)
T ss_dssp SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------
T ss_pred CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC----ee
Confidence 479999999998999999999999999999999999999999999999995 47889999999998654332 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......|..
T Consensus 167 ~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------------------- 223 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--------------------- 223 (307)
T ss_dssp ------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT---------------------
T ss_pred eeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 45789999999999987 6899999999999999999999999988776554433322
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
..........+.+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 224 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 224 ------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11111223446789999999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-39 Score=310.71 Aligned_cols=171 Identities=23% Similarity=0.364 Sum_probs=141.7
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccCCcEEEcC-CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~-~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.++..+++..++.|+.||+.||+|||++| |+||||||+|||++. ++.+||+|||+|+..... ..
T Consensus 96 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-----~~ 170 (270)
T d1t4ha_ 96 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-----FA 170 (270)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----SB
T ss_pred CCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-----cc
Confidence 4699999999889999999999999999999999999 999999999999974 789999999999764332 12
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhH-HHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l-~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
...+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+ ..+..
T Consensus 171 ~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-------------------- 227 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-------------------- 227 (270)
T ss_dssp EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--------------------
T ss_pred CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--------------------
Confidence 45689999999999875 6999999999999999999999999876543322 11111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
.. .........++++.+||.+||+.||++|||++|+|+||||+
T Consensus 228 -------~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 228 -------GV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -------TC--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -------CC--CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 00 01112234688999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=316.10 Aligned_cols=177 Identities=28% Similarity=0.502 Sum_probs=146.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ......
T Consensus 92 gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~-~~~~~~ 170 (288)
T d1uu3a_ 92 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSF 170 (288)
T ss_dssp TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----------C
T ss_pred CCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc-cccccc
Confidence 3699999999999999999999999999999999999999999999999999999999999999876433221 123456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 171 ~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------------------------ 224 (288)
T d1uu3a_ 171 VGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------------------------ 224 (288)
T ss_dssp CCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT------------------------
T ss_pred cCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc------------------------
Confidence 89999999999987 6899999999999999999999999998776555443321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH------HHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE------ALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~e------lL~hp~f~~~~ 212 (449)
. ... ....+++.+++||.+||+.||++|||++| +++||||+++.
T Consensus 225 ---~-~~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 225 ---L-EYD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp ---T-CCC---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---C-CCC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 0 111 12357899999999999999999999987 68899998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-38 Score=320.03 Aligned_cols=171 Identities=21% Similarity=0.363 Sum_probs=148.6
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.+++.+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||+|+..... ....
T Consensus 125 ~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~------~~~~ 198 (350)
T d1rdqe_ 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTL 198 (350)
T ss_dssp TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC------BCCC
T ss_pred ccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc------cccc
Confidence 5799999999889999999999999999999999999999999999999999999999999999876432 2456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 199 ~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------------------- 253 (350)
T d1rdqe_ 199 CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----------------------- 253 (350)
T ss_dssp EECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------------------
T ss_pred cCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-----------------------
Confidence 89999999999988 68999999999999999999999999987765554443221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
. ......+++.+.+||.+||..||.+|+ |++++|+||||+++
T Consensus 254 ----~----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 254 ----K----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ----C----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ----C----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 0 111245789999999999999999995 99999999999865
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-39 Score=314.46 Aligned_cols=208 Identities=38% Similarity=0.645 Sum_probs=164.6
Q ss_pred CCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccc
Q 013122 1 MESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 1 me~dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
|++++.+++.. ...|++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~---~~ 159 (298)
T d1gz8a_ 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TY 159 (298)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB---CT
T ss_pred cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc---cc
Confidence 35666666654 34699999999999999999999999999999999999999999999999999987644332 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+..+++..+....+.+....+...... ..+
T Consensus 160 ~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~ 236 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--PDY 236 (298)
T ss_dssp TCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTC
T ss_pred eeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc--ccc
Confidence 556899999999998763 45688999999999999999999999999998998888888888776554432211 011
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 214 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~ 214 (449)
...........+...++.+++.+++||.+||+.||++|||++|+|+||||+++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 11111112222233456788999999999999999999999999999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-39 Score=312.01 Aligned_cols=201 Identities=38% Similarity=0.659 Sum_probs=161.4
Q ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccc
Q 013122 4 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 83 (449)
Q Consensus 4 dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~g 83 (449)
.|..+...++.|++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++........ .....++
T Consensus 86 ~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~ 162 (286)
T d1ob3a_ 86 LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYTHEIV 162 (286)
T ss_dssp HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------C
T ss_pred hHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc---ccceecc
Confidence 4455556677899999999999999999999999999999999999999999999999999987643322 1245578
Q ss_pred cccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhc
Q 013122 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMR 163 (449)
Q Consensus 84 t~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~ 163 (449)
++.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+..+++..+...+|.+....+...... ..+.....
T Consensus 163 ~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~ 239 (286)
T d1ob3a_ 163 TLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PKYDPNFT 239 (286)
T ss_dssp CCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTTCC
T ss_pred cchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh--hhcccccc
Confidence 9999999998763 56789999999999999999999999999999999999998888876655433211 11112222
Q ss_pred cCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 164 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 164 ~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.....++....+.+++.+.+||.+||++||++|||++|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 33344556667788999999999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-39 Score=313.84 Aligned_cols=178 Identities=24% Similarity=0.326 Sum_probs=145.4
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++.+ ...|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....... .....
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---~~~~~ 169 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---QRRDS 169 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH---HHHTC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc---ccccc
Confidence 4689998765 4569999999999999999999999999999999999999999999999999987543221 12245
Q ss_pred ccccccccCccccccc---CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 81 YVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
.+||+.|+|||++... ...|+.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~------------------- 230 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------------------- 230 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-------------------
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 7899999999998431 146889999999999999999999999987766554433221
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
. .+.......+++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 231 --------~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 231 --------E-PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------C-CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------C-CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0 1111223457899999999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-38 Score=319.16 Aligned_cols=177 Identities=27% Similarity=0.395 Sum_probs=147.8
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.++|.++..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... ....
T Consensus 91 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-----~~~~ 165 (364)
T d1omwa3 91 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHAS 165 (364)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-----CCSC
T ss_pred CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-----cccc
Confidence 48999999999899999999999999999999999999999999999999999999999999998654432 2456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++... ..|+.++|||||||++|||++|+.||.+.+.......+...
T Consensus 166 ~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~----------------------- 221 (364)
T d1omwa3 166 VGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------------------- 221 (364)
T ss_dssp CSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-----------------------
T ss_pred ccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------------
Confidence 899999999998642 56899999999999999999999999876644332211111
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpT-----a~elL~hp~f~~~~ 212 (449)
.... ......+++.+++||.+||+.||++||| |+|+|+||||+++.
T Consensus 222 --~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 222 --LTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp --SSCC---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred --ccCC---CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 0111 1223467999999999999999999999 79999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=318.25 Aligned_cols=206 Identities=37% Similarity=0.661 Sum_probs=165.4
Q ss_pred CCcHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i----~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+++|.+.+ .....|++.+++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---- 177 (350)
T d1q5ka_ 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---- 177 (350)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS----
T ss_pred CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc----
Confidence 44444443 4566799999999999999999999999999999999999999875 89999999998764433
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
.....+||..|+|||++.+. ..|+.++||||+||++|||++|++||.+.+..+++..|.+.+|.+..+.+.........
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 23457899999999988653 57899999999999999999999999999999999999999999998887655332111
Q ss_pred HHHhhhccCCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccc
Q 013122 157 RYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215 (449)
Q Consensus 157 ~~~~~~~~~~~~~~-~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~ 215 (449)
. ........++ ....+..++.+.+||.+||.+||++|||+.|+|+||||+.+....
T Consensus 257 ~---~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 257 F---KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp C---CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred c---cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 1 0111111122 123456899999999999999999999999999999999886543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-38 Score=319.54 Aligned_cols=181 Identities=23% Similarity=0.334 Sum_probs=150.8
Q ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC--CCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~-~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.++|.. .+.|++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+....... .
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~----~ 182 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----V 182 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC----E
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc----c
Confidence 4799999964 457999999999999999999999999999999999999964 57899999999987644322 2
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+..+.+..|...-..
T Consensus 183 ~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------------- 243 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN----------------- 243 (350)
T ss_dssp EEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----------------
T ss_pred ceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 45789999999999987 68899999999999999999999999988776665554332111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 215 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~~~ 215 (449)
.....++.+++.+++||.+||+.||++|||++|+|+||||+......
T Consensus 244 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 244 ----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp ----------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred ----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 11223356789999999999999999999999999999998765443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-38 Score=308.85 Aligned_cols=177 Identities=31% Similarity=0.475 Sum_probs=149.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC----CEEEeecCccccccCCCCCccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIF 77 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGlA~~~~~~~~~~~~ 77 (449)
+++|.++|..++.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|........
T Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---- 172 (293)
T d1jksa_ 97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---- 172 (293)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB----
T ss_pred CccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc----
Confidence 479999999988999999999999999999999999999999999999998876 499999999987643322
Q ss_pred cccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 78 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 78 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..|...-....
T Consensus 173 ~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 236 (293)
T d1jksa_ 173 FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------- 236 (293)
T ss_dssp CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--------------
T ss_pred ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--------------
Confidence 245689999999999987 6799999999999999999999999998887666555543211111
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
...++.+++.+++||.+||+.||.+|||++|+|+||||+..
T Consensus 237 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 237 -------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp -------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred -------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11234678999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=307.58 Aligned_cols=172 Identities=33% Similarity=0.502 Sum_probs=134.4
Q ss_pred CCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cccccccCCcEEEcCCCCEEEeecCccccccCCC
Q 013122 2 ESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDT 72 (449)
Q Consensus 2 e~dL~~~i~~----~~~Ls~~~i~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~ 72 (449)
+++|.+++.+ +..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 168 (269)
T d2java1 89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168 (269)
T ss_dssp TEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred CCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence 4699998864 457999999999999999999999976 9999999999999999999999999998764432
Q ss_pred CCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 73 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 73 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+....|..
T Consensus 169 ~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~--------------- 228 (269)
T d2java1 169 S---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--------------- 228 (269)
T ss_dssp ----------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---------------
T ss_pred C---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc---------------
Confidence 2 2356789999999999987 6899999999999999999999999988775544333321
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 208 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f 208 (449)
.. +......+++.+.+||.+||+.||.+|||++|+|+|||+
T Consensus 229 ------------~~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 ------------GK---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------TC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------CC---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 11 112234578999999999999999999999999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-38 Score=310.37 Aligned_cols=171 Identities=26% Similarity=0.471 Sum_probs=148.3
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 88 gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~------~~~~ 161 (316)
T d1fota_ 88 GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTL 161 (316)
T ss_dssp SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC------BCCC
T ss_pred CccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc------cccc
Confidence 4689999999999999999999999999999999999999999999999999999999999999876432 2456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 162 ~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----------------------- 216 (316)
T d1fota_ 162 CGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----------------------- 216 (316)
T ss_dssp CSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-----------------------
T ss_pred cCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-----------------------
Confidence 89999999999987 67999999999999999999999999987765554433220
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~ 211 (449)
. . ...+.+++.+.+||.+||..||.+|+ |++++|+||||+++
T Consensus 217 ---~--~---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 217 ---E--L---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ---C--C---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ---C--C---CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 0 0 11245789999999999999999996 99999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-38 Score=317.51 Aligned_cols=178 Identities=29% Similarity=0.422 Sum_probs=150.9
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEc--CCCCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.+++.... .|++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|....... ..
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~ 185 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IV 185 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CE
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC----ce
Confidence 479999887655 699999999999999999999999999999999999998 57889999999998765432 23
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|....
T Consensus 186 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------------- 244 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD------------------- 244 (352)
T ss_dssp EEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC-------------------
T ss_pred eeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------------
Confidence 45689999999999987 689999999999999999999999999888766655443311
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
.......++.+++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 245 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 245 --------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp --------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 1112334567899999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-38 Score=311.19 Aligned_cols=172 Identities=26% Similarity=0.396 Sum_probs=143.2
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 82 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~ 82 (449)
++|..++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ...+
T Consensus 100 g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-------~~~~ 172 (309)
T d1u5ra_ 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFV 172 (309)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------CCCC
T ss_pred CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------Cccc
Confidence 567777778888999999999999999999999999999999999999999999999999999764322 3468
Q ss_pred ccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 83 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 83 gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
||+.|+|||++.+. ...|+.++|||||||++|||++|..||.+.+..+.+..+..
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~------------------------ 228 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------------------ 228 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------------------
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------------------------
Confidence 99999999998652 24689999999999999999999999988765544333221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
...+ ......+++.+.+||.+||+.||.+|||++|+|+||||..
T Consensus 229 --~~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 229 --NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --SCCC---CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --CCCC---CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 1111 1112357899999999999999999999999999999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-38 Score=304.85 Aligned_cols=179 Identities=29% Similarity=0.454 Sum_probs=150.2
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++||.++|+.++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .+..
T Consensus 94 ~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~----~~~~ 169 (277)
T d1phka_ 94 KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREV 169 (277)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC----BCCC
T ss_pred CchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCc----eeee
Confidence 469999999999999999999999999999999999999999999999999999999999999987644322 2557
Q ss_pred cccccccCccccccc----CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 82 VATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
+||..|+|||++.+. ...++.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 170 ~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~------------------- 230 (277)
T d1phka_ 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------------------- 230 (277)
T ss_dssp CSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------------------
T ss_pred eccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 899999999998531 235788999999999999999999999988765554433221
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
.........+++++.+++||.+||+.||.+|||++|+|+||||+..
T Consensus 231 --------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 --------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp --------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred --------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111222345789999999999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-38 Score=309.74 Aligned_cols=174 Identities=26% Similarity=0.445 Sum_probs=149.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|.++|..+..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..+..
T Consensus 87 ~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~---~~~~~ 163 (320)
T d1xjda_ 87 GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTF 163 (320)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCCC
T ss_pred CCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc---ccccc
Confidence 469999999999999999999999999999999999999999999999999999999999999986543322 23557
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 164 ~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------------------------ 217 (320)
T d1xjda_ 164 CGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------------------------ 217 (320)
T ss_dssp CSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------------------
T ss_pred CCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc------------------------
Confidence 89999999999988 6899999999999999999999999998876555443321
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-HHHcCcccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EALADPYFKGL 211 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~-elL~hp~f~~~ 211 (449)
..+ .....+++.+.+||.+||..||.+|||+. ++++||||+++
T Consensus 218 ---~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 218 ---DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp ---CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ---CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 111 11235789999999999999999999996 89999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-38 Score=313.81 Aligned_cols=180 Identities=27% Similarity=0.461 Sum_probs=143.3
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCcc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 76 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~~ 76 (449)
+|||.++|.+.+ .|++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.......
T Consensus 93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~--- 169 (335)
T d2ozaa1 93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--- 169 (335)
T ss_dssp SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---
T ss_pred CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCc---
Confidence 469999998753 6999999999999999999999999999999999999986 45799999999987654332
Q ss_pred ccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHH
Q 013122 77 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKAR 156 (449)
Q Consensus 77 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~ 156 (449)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+....
T Consensus 170 -~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i----------------- 229 (335)
T d2ozaa1 170 -LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----------------- 229 (335)
T ss_dssp -CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-----------------
T ss_pred -cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-----------------
Confidence 255789999999999987 679999999999999999999999998876544433222111
Q ss_pred HHHhhhccCCCCCC-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 013122 157 RYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 211 (449)
Q Consensus 157 ~~~~~~~~~~~~~~-~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~ 211 (449)
... ...+ ...+..+++.+.+||.+||+.||++|||+.|+|+||||...
T Consensus 230 ------~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 230 ------RMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ------CSC-SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ------hcC-CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000 0111 11123578999999999999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-38 Score=302.57 Aligned_cols=167 Identities=27% Similarity=0.468 Sum_probs=139.4
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC-CCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++..+..+++++++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ..+..
T Consensus 95 ~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-----~~~~~ 169 (273)
T d1xwsa_ 95 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDF 169 (273)
T ss_dssp EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-----CBCCC
T ss_pred chHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-----ccccc
Confidence 5888999988899999999999999999999999999999999999999854 78999999999765432 23567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +. .
T Consensus 170 ~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~-----------------------~- 218 (273)
T d1xwsa_ 170 DGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II-----------------------R- 218 (273)
T ss_dssp CSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH-----------------------H-
T ss_pred ccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hh-----------------------h-
Confidence 899999999998762 3346789999999999999999999975321 10 0
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
. .. .....+++++++||.+||+.||++|||++|+|+||||+++.
T Consensus 219 --~--~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 219 --G--QV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp --C--CC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --c--cc---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0 00 11245789999999999999999999999999999998653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-38 Score=307.98 Aligned_cols=207 Identities=33% Similarity=0.576 Sum_probs=156.3
Q ss_pred CCcHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCC-ccccc
Q 013122 2 ESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWT 79 (449)
Q Consensus 2 e~dL~~~i~-~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~-~~~~~ 79 (449)
++++...+. ....+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++......... .....
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 179 (318)
T d3blha1 100 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179 (318)
T ss_dssp CEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCC
T ss_pred CCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccccccccc
Confidence 344554443 4457999999999999999999999999999999999999999999999999999765432211 11224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..+||++|+|||++.+. ..|+.++||||+||++|||++|+.||.+.+....+..+.+.++.+..+.+...........+
T Consensus 180 ~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T d3blha1 180 NRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 258 (318)
T ss_dssp SCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC------
T ss_pred ceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhh
Confidence 46899999999998763 56899999999999999999999999999999999999999988877655444332222221
Q ss_pred hhhccCCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 160 SSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
...... .......+ ...++.+++||.+||++||++|||++|+|+||||+.
T Consensus 259 ~~~~~~-~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 259 ELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp -CCSSC-CBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cccccc-cccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 111110 00000000 114678999999999999999999999999999984
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-37 Score=303.45 Aligned_cols=176 Identities=26% Similarity=0.411 Sum_probs=148.2
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCC--CCEEEeecCccccccCCCCCcccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFW 78 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~vKL~DFGlA~~~~~~~~~~~~~ 78 (449)
+++|.++|..++ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ..
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----~~ 160 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NF 160 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC----cc
Confidence 369999998765 69999999999999999999999999999999999999854 479999999998754332 22
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...++|+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..|...-...+
T Consensus 161 ~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 223 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------- 223 (321)
T ss_dssp EEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---------------
T ss_pred cccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 45679999999999987 6789999999999999999999999998887666555543221111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
...++.+++.+++||.+||..||.+|||++|+|+||||+.
T Consensus 224 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 224 ------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1223467899999999999999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-36 Score=295.92 Aligned_cols=205 Identities=38% Similarity=0.614 Sum_probs=161.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|..++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.++........ ....
T Consensus 85 ~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~---~~~~ 161 (292)
T d1unla_ 85 QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAE 161 (292)
T ss_dssp EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---CCSC
T ss_pred ccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---ceee
Confidence 3577888888889999999999999999999999999999999999999999999999999999876443322 2445
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCC-CCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.++..|+|||++.+. ..++.++||||+||++|||++|+.| |.+.+..+++..+....+.+....+....... .+..
T Consensus 162 ~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 238 (292)
T d1unla_ 162 VVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP--DYKP 238 (292)
T ss_dssp CSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST--TCCC
T ss_pred ccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc--cccc
Confidence 678899999998763 4578999999999999999998866 67777788888888888877665443321100 0000
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
..............+..++.+.+||.+||+.||++||||+|+|+||||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0000111233445567899999999999999999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-36 Score=299.75 Aligned_cols=202 Identities=28% Similarity=0.554 Sum_probs=149.7
Q ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCC-CEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.++ .+.|++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....... ....
T Consensus 117 ~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~----~~~~ 189 (328)
T d3bqca1 117 TDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----YNVR 189 (328)
T ss_dssp CBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC----CCSC
T ss_pred CcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc----cccc
Confidence 455544 34699999999999999999999999999999999999998765 599999999987644332 2557
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCC-CchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~-~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
++|+.|+|||++.+. ..|+.++||||+||++|+|++|+.||... +..++...+...+|.+....+...........+.
T Consensus 190 ~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 268 (328)
T d3bqca1 190 VASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268 (328)
T ss_dssp CSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred ccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence 899999999998763 46899999999999999999999988654 4556677777777755443332211100000011
Q ss_pred hhc-cCCCCCC-----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 013122 161 SMR-KKKPIPF-----SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 212 (449)
Q Consensus 161 ~~~-~~~~~~~-----~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~ 212 (449)
... ......+ ......+++++++||.+||.+||++|||++|+|+||||+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 111 1111111 112234789999999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-36 Score=290.71 Aligned_cols=177 Identities=25% Similarity=0.324 Sum_probs=138.1
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.++|... ..+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+........ ......
T Consensus 88 g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~ 166 (276)
T d1uwha_ 88 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-HQFEQL 166 (276)
T ss_dssp EEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------------C
T ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc-cccccc
Confidence 7999999765 46999999999999999999999999999999999999999999999999999765432221 123456
Q ss_pred cccccccCccccccc-CCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~---------------------- 224 (276)
T d1uwha_ 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---------------------- 224 (276)
T ss_dssp CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH----------------------
T ss_pred ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc----------------------
Confidence 899999999998642 135899999999999999999999999887654443222110
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
............++++.+.+||.+||..||.+|||+.|++++
T Consensus 225 ---~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 ---GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ---TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112233445688999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=292.59 Aligned_cols=176 Identities=20% Similarity=0.317 Sum_probs=142.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+|+|.+++..+..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 46999999999999999999999999999999999999999999999999999999999999998765443333233456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.||+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+..
T Consensus 171 ~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~----------------------- 225 (277)
T d1xbba_ 171 KWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----------------------- 225 (277)
T ss_dssp CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------------------
T ss_pred CCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-----------------------
Confidence 78999999999987 678999999999999999997 8999988765443332211
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH---cCcccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL---ADPYFK 209 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL---~hp~f~ 209 (449)
.... .....+++.+.+||.+||+.||++|||+++++ +|+|+.
T Consensus 226 ----~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 ----GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ----TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1111 12245789999999999999999999999984 565554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-35 Score=293.18 Aligned_cols=172 Identities=26% Similarity=0.402 Sum_probs=140.5
Q ss_pred CCcHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEE
Q 013122 2 ESDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLK 58 (449)
Q Consensus 2 e~dL~~~i~~~~-----------------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vK 58 (449)
+|+|.++|+.+. .|++..++.|+.||+.||+|||++|||||||||+|||++.++.+|
T Consensus 125 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~K 204 (325)
T d1rjba_ 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK 204 (325)
T ss_dssp TCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEE
T ss_pred CCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEE
Confidence 479999998653 489999999999999999999999999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHh
Q 013122 59 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTD 137 (449)
Q Consensus 59 L~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~ 137 (449)
|+|||+|+........ .......||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+....+..+..
T Consensus 205 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~ 281 (325)
T d1rjba_ 205 ICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281 (325)
T ss_dssp ECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred EeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999875543322 12345678999999999987 689999999999999999997 8999988765544332211
Q ss_pred hcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 138 LLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 138 ~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
..... .....+++.+.+||.+||+.||++|||++||++|
T Consensus 282 --------------------------~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 282 --------------------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp --------------------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------cCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11111 1224578999999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=292.62 Aligned_cols=182 Identities=25% Similarity=0.394 Sum_probs=147.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .....
T Consensus 113 ~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~--~~~~~ 190 (322)
T d1vzoa_ 113 GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE--RAYDF 190 (322)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG--GGCGG
T ss_pred ccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccc--ccccc
Confidence 4799999999999999999999999999999999999999999999999999999999999999765433222 23456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
.|++.|++||.+.+....++.++|||||||+||+|++|+.||.+.+.......+... ..
T Consensus 191 ~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-------------------~~-- 249 (322)
T d1vzoa_ 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-------------------IL-- 249 (322)
T ss_dssp GSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-------------------HH--
T ss_pred ccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-------------------cc--
Confidence 899999999999764346788999999999999999999999887765554433221 00
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGLA 212 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~Rp-----Ta~elL~hp~f~~~~ 212 (449)
... ......+++.+.+||.+||..||.+|+ |++|+|+||||+++.
T Consensus 250 -~~~-----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 250 -KSE-----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -HCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -cCC-----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 000 112245799999999999999999999 589999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-35 Score=287.11 Aligned_cols=179 Identities=24% Similarity=0.427 Sum_probs=137.9
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
+++|.+++...+.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||.+................
T Consensus 95 g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 174 (277)
T d1o6ya_ 95 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174 (277)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC------------
T ss_pred CCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccc
Confidence 36899999998899999999999999999999999999999999999999999999999999987654443333344567
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSS 161 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~ 161 (449)
+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus 175 ~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~------------------------- 227 (277)
T d1o6ya_ 175 IGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV------------------------- 227 (277)
T ss_dssp ----TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------------------------
T ss_pred cCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH-------------------------
Confidence 89999999999987 689999999999999999999999998877554432221
Q ss_pred hccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 013122 162 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 209 (449)
Q Consensus 162 ~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~ 209 (449)
...+.+.....+.+++.+.+||.+||+.||.+||+..+.|.|+|++
T Consensus 228 --~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 228 --REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --HCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --hcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1222333445567899999999999999999999544444567664
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=288.47 Aligned_cols=178 Identities=22% Similarity=0.339 Sum_probs=145.7
Q ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccc
Q 013122 3 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 81 (449)
Q Consensus 3 ~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~ 81 (449)
++|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...............
T Consensus 93 g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 172 (285)
T d1u59a_ 93 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172 (285)
T ss_dssp EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccccccccc
Confidence 6999998654 569999999999999999999999999999999999999999999999999998765544333333456
Q ss_pred cccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHh
Q 013122 82 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLS 160 (449)
Q Consensus 82 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~ 160 (449)
.||+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+.+..|..
T Consensus 173 ~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~----------------------- 227 (285)
T d1u59a_ 173 KWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------------------- 227 (285)
T ss_dssp CCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-----------------------
T ss_pred ccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------------------
Confidence 78999999999977 679999999999999999998 8999988765444333321
Q ss_pred hhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH---HcCccccccc
Q 013122 161 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA---LADPYFKGLA 212 (449)
Q Consensus 161 ~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~el---L~hp~f~~~~ 212 (449)
.... ...+.+++.+.+||.+||+.||++|||+.++ |+|+|+.-..
T Consensus 228 ----~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 228 ----GKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp ----TCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ----CCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 1111 1234678999999999999999999999887 6688875433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-35 Score=287.55 Aligned_cols=172 Identities=26% Similarity=0.410 Sum_probs=133.4
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+++|.++|+... .|++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|
T Consensus 102 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla 181 (299)
T d1ywna1 102 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 181 (299)
T ss_dssp TCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC----
T ss_pred CCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcch
Confidence 479999997542 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhC-CCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+....+..+..
T Consensus 182 ~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~------- 251 (299)
T d1ywna1 182 RDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK------- 251 (299)
T ss_dssp --CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH-------
T ss_pred hhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------
Confidence 865433222 22345689999999999987 6899999999999999999986 578877654433221111
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
..... .....+++.+.+||.+||+.||++|||++|+++|
T Consensus 252 -------------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 -------------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp -------------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------cCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11111 1224578999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-34 Score=283.18 Aligned_cols=172 Identities=24% Similarity=0.361 Sum_probs=129.6
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcc--cc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI--FW 78 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~--~~ 78 (449)
+++|.+++.... .+++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......... ..
T Consensus 111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 190 (299)
T d1jpaa_ 111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190 (299)
T ss_dssp TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------------
T ss_pred CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeec
Confidence 468999888754 699999999999999999999999999999999999999999999999999987644322211 11
Q ss_pred ccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 79 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 79 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
....||+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+.+..+..
T Consensus 191 ~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-------------------- 248 (299)
T d1jpaa_ 191 LGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------------------- 248 (299)
T ss_dssp -----CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--------------------
T ss_pred ccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------------------
Confidence 23467899999999987 689999999999999999998 8999988776544433321
Q ss_pred HHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 158 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
....+ ....+++.+.+||.+||+.||++|||+.|++++
T Consensus 249 -------~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 249 -------DYRLP---PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------TCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------CCCCC---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11111 124578999999999999999999999999863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-34 Score=277.50 Aligned_cols=170 Identities=22% Similarity=0.380 Sum_probs=128.3
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
.++|.+++... ..++++.+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~--~~~ 161 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STG 161 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee--ecc
Confidence 47999998765 458999999999999999999999999999999999999999999999999998764433221 234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||..|+|||++.+ ..|+.++|||||||++|||++ |.++|.+.+..+.+..+...
T Consensus 162 ~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~--------------------- 218 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------------------- 218 (263)
T ss_dssp ---CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT---------------------
T ss_pred eecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc---------------------
Confidence 578999999999987 689999999999999999999 56777666554443333211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... .....+++.+.+||.+||+.||++|||++|+|+|
T Consensus 219 ------~~~---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 219 ------FRL---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ------CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCC---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 111 1113467899999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-35 Score=282.92 Aligned_cols=175 Identities=25% Similarity=0.380 Sum_probs=140.1
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|+|.+++.... .+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........ ...
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~--~~~ 168 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT--ARE 168 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE--CCT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc--ccc
Confidence 478888776443 5999999999999999999999999999999999999999999999999999876443221 224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhC-CCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...||..|+|||++.+ ..|+.++|||||||++|||+|| .++|.+.+..+.+..+..
T Consensus 169 ~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~--------------------- 225 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--------------------- 225 (272)
T ss_dssp TCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------------------
T ss_pred ccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------------------
Confidence 5678999999999986 6799999999999999999995 566665554433332211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc--Cccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~--hp~f~~ 210 (449)
.... .....+++.+.+||.+||+.||++|||++++++ |+||..
T Consensus 226 ------~~~~---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 226 ------GYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------cCCC---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1111 112457889999999999999999999999998 788863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-34 Score=282.16 Aligned_cols=171 Identities=21% Similarity=0.320 Sum_probs=137.6
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+ ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ .....
T Consensus 94 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 172 (317)
T d1xkka_ 94 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEG 172 (317)
T ss_dssp TCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-------
T ss_pred CCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccccc-ccccc
Confidence 57888887765 46999999999999999999999999999999999999999999999999999876543322 12234
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||..|+|||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 173 ~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------------------- 229 (317)
T d1xkka_ 173 GKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------------------- 229 (317)
T ss_dssp --CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------------------
T ss_pred cccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------------------
Confidence 568999999999987 689999999999999999998 78999887655443333211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ...+.+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 230 ------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 ------ERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 111 1224578899999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-34 Score=276.93 Aligned_cols=173 Identities=22% Similarity=0.392 Sum_probs=136.9
Q ss_pred CCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~--~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
.|+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........ ...
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~--~~~ 174 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--AHA 174 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE--EET
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce--eec
Confidence 37899999764 46999999999999999999999999999999999999999999999999999876443322 223
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCC-CCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~p-F~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...|+..|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.....+.+.
T Consensus 175 ~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~---------------------- 230 (287)
T d1opja_ 175 GAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------------- 230 (287)
T ss_dssp TEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----------------------
T ss_pred cccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh----------------------
Confidence 4568899999999987 6899999999999999999996655 54444332222211
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 210 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~ 210 (449)
.... ......+++.+.+||.+||+.||++|||++|+++ +|+.
T Consensus 231 -----~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~ 272 (287)
T d1opja_ 231 -----KDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFET 272 (287)
T ss_dssp -----TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred -----cCCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence 1111 1123457899999999999999999999999975 4543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-34 Score=275.88 Aligned_cols=170 Identities=25% Similarity=0.393 Sum_probs=130.0
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........ ..+.
T Consensus 91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~--~~~~ 168 (273)
T d1mp8a_ 91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KASK 168 (273)
T ss_dssp TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------
T ss_pred CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce--eccc
Confidence 36888887654 46999999999999999999999999999999999999999999999999999865433221 1244
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 169 ~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~---------------------- 224 (273)
T d1mp8a_ 169 GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------------------- 224 (273)
T ss_dssp --CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT----------------------
T ss_pred eecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------------
Confidence 568999999999987 689999999999999999997 8999988776555443322
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ....+++++.+.+||.+||+.||++|||++|+++|
T Consensus 225 -----~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 225 -----GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 12335688999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=274.50 Aligned_cols=171 Identities=23% Similarity=0.356 Sum_probs=126.8
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 172 (283)
T d1mqba_ 93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172 (283)
T ss_dssp TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred cCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEecc
Confidence 35677777655 46999999999999999999999999999999999999999999999999999876543332222344
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCC-CCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||..|+|||++.+ ..|+.++|||||||++|||++|. ++|.+.+..+.+..+..
T Consensus 173 ~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---------------------- 228 (283)
T d1mqba_ 173 GKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---------------------- 228 (283)
T ss_dssp -CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT----------------------
T ss_pred CCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc----------------------
Confidence 568999999999987 68999999999999999999965 55554443333222211
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+ ....++..+.+||.+||+.||++|||+.|+++
T Consensus 229 -----~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 -----GFRLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -----TCCCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----cCCCC---CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 11111 22357789999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=270.62 Aligned_cols=170 Identities=19% Similarity=0.300 Sum_probs=139.7
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+|+|.+++... ..+++..+..|+.||++||+|||++||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~ 160 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVG 160 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC--CCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce--eecc
Confidence 36788886654 46999999999999999999999999999999999999999999999999999765443222 2245
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..||..|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 161 ~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~--------------------- 217 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------------------- 217 (258)
T ss_dssp SCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT---------------------
T ss_pred cCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC---------------------
Confidence 678999999999987 689999999999999999998 89999887765444333221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
.... .....++.+.+||.+||+.||++|||++++|+|
T Consensus 218 ------~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 218 ------LRLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ------CCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------CCCC---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1111 123567899999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-33 Score=273.95 Aligned_cols=176 Identities=27% Similarity=0.377 Sum_probs=135.6
Q ss_pred CCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~--~~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+|+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~~ 172 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQ 172 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce--eec
Confidence 3678888764 346999999999999999999999999999999999999999999999999999865433221 224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhC-CCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...||+.|+|||++.. ..++.++|||||||++|||++| .++|.+....+.+..+..
T Consensus 173 ~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~--------------------- 229 (285)
T d1fmka3 173 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------------- 229 (285)
T ss_dssp ---CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------------------
T ss_pred cccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------------------
Confidence 4678999999999987 6899999999999999999995 455665554444333321
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc--Ccccccc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFKGL 211 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~--hp~f~~~ 211 (449)
.... ...+.+++.+.+||.+||+.||++|||++++++ ++||...
T Consensus 230 ------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 230 ------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------cCCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1111 123467899999999999999999999999988 8888764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.1e-33 Score=271.62 Aligned_cols=172 Identities=21% Similarity=0.307 Sum_probs=138.2
Q ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCcccccc
Q 013122 2 ESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 80 (449)
Q Consensus 2 e~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~ 80 (449)
+++|.+++..+ ..|++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 94 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~ 173 (273)
T d1u46a_ 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173 (273)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC---
T ss_pred CcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCc
Confidence 46778776654 46999999999999999999999999999999999999999999999999999876554443333345
Q ss_pred ccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHH
Q 013122 81 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYL 159 (449)
Q Consensus 81 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~ 159 (449)
..|+..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+.+..+.+.
T Consensus 174 ~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~--------------------- 230 (273)
T d1u46a_ 174 RKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--------------------- 230 (273)
T ss_dssp --CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS---------------------
T ss_pred cccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC---------------------
Confidence 668889999999987 679999999999999999998 89999988766554443221
Q ss_pred hhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 160 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......+++.+.+||.+||+.||++|||+.|+++
T Consensus 231 -----~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 231 -----GER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -----CCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCC---CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1223467899999999999999999999999963
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=4.7e-33 Score=277.97 Aligned_cols=193 Identities=26% Similarity=0.392 Sum_probs=144.6
Q ss_pred hCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccCCcEEEcCCC------CEEEeecCccccccCCCCCccccccccc
Q 013122 11 ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC------KLKICDFGLARVAFNDTPTAIFWTDYVA 83 (449)
Q Consensus 11 ~~~~Ls~~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~------~vKL~DFGlA~~~~~~~~~~~~~~~~~g 83 (449)
....+++..++.++.||+.||.|||+ .||+||||||+|||++.++ .+||+|||.+....... ...+|
T Consensus 118 ~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~------~~~~g 191 (362)
T d1q8ya_ 118 EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY------TNSIQ 191 (362)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC------CSCCS
T ss_pred cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc------ccccc
Confidence 44579999999999999999999998 8999999999999998765 39999999987643322 45679
Q ss_pred cccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC------chhhHHHHHhhcCCCCHHHHHHHhhHHHHH
Q 013122 84 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN------VVHQLDIMTDLLGTPSPEAIARVRNEKARR 157 (449)
Q Consensus 84 t~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~------~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~ 157 (449)
|+.|+|||++.+ ..|+.++||||+||++++|++|+.||.+.+ ..+.+..+...+|.++.+.+...... ..
T Consensus 192 t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~ 267 (362)
T d1q8ya_ 192 TREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYT--RT 267 (362)
T ss_dssp CGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTH--HH
T ss_pred cccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccccc--cc
Confidence 999999999987 689999999999999999999999997543 23456667788888877765443221 11
Q ss_pred HHhhhccCCCCCCC-------------CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 013122 158 YLSSMRKKKPIPFS-------------QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 213 (449)
Q Consensus 158 ~~~~~~~~~~~~~~-------------~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~hp~f~~~~~ 213 (449)
++............ ......++.+++||.+||.+||.+||||+|+|+||||++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 268 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp HBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred ccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence 11111000000000 011234678999999999999999999999999999996543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.4e-32 Score=268.90 Aligned_cols=170 Identities=26% Similarity=0.425 Sum_probs=139.5
Q ss_pred CCcHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~~----------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+|+|.++|.... .|++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 103 ~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~ 182 (299)
T d1fgka_ 103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182 (299)
T ss_dssp TCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCC
T ss_pred CCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhh
Confidence 478999997553 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+......... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++ |.+||.+.+.......+.
T Consensus 183 ~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~-------- 251 (299)
T d1fgka_ 183 RDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-------- 251 (299)
T ss_dssp CCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH--------
T ss_pred cccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH--------
Confidence 8765443322 2345678999999999987 689999999999999999998 789998766543332221
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..... .....+++.+.+||.+||+.||++|||+.|+|+
T Consensus 252 -------------------~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 -------------------EGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp -------------------TTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------cCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 11111 122457899999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=8e-33 Score=270.86 Aligned_cols=158 Identities=21% Similarity=0.261 Sum_probs=128.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCcccc
Q 013122 14 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 93 (449)
Q Consensus 14 ~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l 93 (449)
.|++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+........ ...+...||+.|+|||++
T Consensus 136 ~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 214 (301)
T d1lufa_ 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESI 214 (301)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHH
T ss_pred CCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHH
Confidence 3899999999999999999999999999999999999999999999999999865433221 123456788999999999
Q ss_pred cccCCCCCCccchhhhHHHHHhhhhCC-CCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHHHhhhccCCCCCCCC
Q 013122 94 GSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRYLSSMRKKKPIPFSQ 172 (449)
Q Consensus 94 ~~~~~~~s~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (449)
.+ ..|+.++|||||||++|||++|. +||.+.+..+.+..+.+ ... ..
T Consensus 215 ~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~---------------------------~~~---~~ 262 (301)
T d1lufa_ 215 FY--NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD---------------------------GNI---LA 262 (301)
T ss_dssp HH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---------------------------TCC---CC
T ss_pred cc--CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHc---------------------------CCC---CC
Confidence 87 68999999999999999999985 78887766544433321 111 12
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 173 KFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 173 ~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
....+++.+.+||.+||+.||++|||+.|+++
T Consensus 263 ~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 263 CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 23467899999999999999999999999965
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.2e-32 Score=268.78 Aligned_cols=184 Identities=17% Similarity=0.226 Sum_probs=138.0
Q ss_pred CCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC---CCCEEEeecCccccccCCCCCc-
Q 013122 1 MESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTA- 75 (449)
Q Consensus 1 me~dL~~~i~~~-~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGlA~~~~~~~~~~- 75 (449)
|+++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.........
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 467887777654 46999999999999999999999999999999999999864 4569999999998765432211
Q ss_pred ---cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhh
Q 013122 76 ---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRN 152 (449)
Q Consensus 76 ---~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~ 152 (449)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.... .
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~------------~ 230 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------------E 230 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH------------H
T ss_pred eeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh------------c
Confidence 12245689999999999988 679999999999999999999999998765443332221100 0
Q ss_pred HHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH---HHcCcccc
Q 013122 153 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADPYFK 209 (449)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~e---lL~hp~f~ 209 (449)
. ....+......++++++.+||.+||..||.+||++++ +|+|+|.+
T Consensus 231 ~-----------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 K-----------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp H-----------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred c-----------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0 0001112234567899999999999999999999874 56777654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-32 Score=268.70 Aligned_cols=168 Identities=23% Similarity=0.340 Sum_probs=136.3
Q ss_pred CCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCcc
Q 013122 2 ESDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 65 (449)
Q Consensus 2 e~dL~~~i~~~----------------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA 65 (449)
+|+|.++|..+ ..|++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a 174 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccc
Confidence 47999999765 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCC-CCCCCCCchhhHHHHHhhcCCCCH
Q 013122 66 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSP 144 (449)
Q Consensus 66 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~-~pF~~~~~~~~l~~i~~~lg~p~~ 144 (449)
+....... .....||..|+|||.+.+ ..|+.++|||||||++|||++|. +||.+.+..+.+..+.+
T Consensus 175 ~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~------- 241 (309)
T d1fvra_ 175 RGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------- 241 (309)
T ss_dssp ESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-------
T ss_pred cccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-------
Confidence 76443222 134568999999999987 68999999999999999999965 67877765444333221
Q ss_pred HHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 145 EAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 145 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
... ......+++.+.+||.+||+.||++|||++|+|+|
T Consensus 242 --------------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 --------------------GYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp --------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------cCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 11234578999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.9e-32 Score=262.09 Aligned_cols=165 Identities=19% Similarity=0.348 Sum_probs=131.3
Q ss_pred CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccc
Q 013122 2 ESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~--~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~ 79 (449)
+++|.++|..+. .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~------~ 158 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------D 158 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC------c
Confidence 578999997654 49999999999999999999999999999999999999999999999999997654322 3
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...+|..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 159 ~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~--------------------- 215 (262)
T d1byga_ 159 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------------------- 215 (262)
T ss_dssp ---CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---------------------
T ss_pred cccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---------------------
Confidence 4568899999999987 689999999999999999998 7888887665544333311
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... .....+++.+.+||.+||..||.+|||+.++++
T Consensus 216 ------~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 216 ------GYKM---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp ------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCC---CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1111 223457899999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.4e-31 Score=263.36 Aligned_cols=171 Identities=28% Similarity=0.414 Sum_probs=138.6
Q ss_pred CCcHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecC
Q 013122 2 ESDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 63 (449)
Q Consensus 2 e~dL~~~i~~~~------------------~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFG 63 (449)
+++|.++|+... .+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 111 ~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG 190 (311)
T d1t46a_ 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190 (311)
T ss_dssp TEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCG
T ss_pred CCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccc
Confidence 368888887653 59999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhh-CCCCCCCCCchhhHHHHHhhcCCC
Q 013122 64 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTP 142 (449)
Q Consensus 64 lA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLlt-G~~pF~~~~~~~~l~~i~~~lg~p 142 (449)
+++........ ...+..+||+.|+|||++.+ ..++.++|||||||++|||++ |.++|.+.+....+..+..
T Consensus 191 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~----- 262 (311)
T d1t46a_ 191 LARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK----- 262 (311)
T ss_dssp GGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH-----
T ss_pred hheeccCCCcc-eEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----
Confidence 99876543322 23355789999999999987 689999999999999999998 6777877665544332221
Q ss_pred CHHHHHHHhhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 143 SPEAIARVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 143 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
. .... .....+++.+.+||.+||+.||++|||++++|+
T Consensus 263 ------------------~---~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 263 ------------------E---GFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp ------------------H---TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------c---CCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 0011 112346889999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=263.61 Aligned_cols=170 Identities=21% Similarity=0.327 Sum_probs=138.1
Q ss_pred CCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCC
Q 013122 2 ESDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 71 (449)
Q Consensus 2 e~dL~~~i~~~----------~~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~ 71 (449)
+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 107 ~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~ 186 (308)
T d1p4oa_ 107 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186 (308)
T ss_dssp TCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred CCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCC
Confidence 47888888643 24789999999999999999999999999999999999999999999999999865443
Q ss_pred CCCccccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhC-CCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 72 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 72 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG-~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
.. .......+||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+.+
T Consensus 187 ~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~------------- 250 (308)
T d1p4oa_ 187 DY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------------- 250 (308)
T ss_dssp GC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT-------------
T ss_pred cc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------------
Confidence 22 122344578999999999987 6899999999999999999998 588887766554433321
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
... ......+++.+.+||.+||+.||.+|||++++++
T Consensus 251 --------------~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 251 --------------GGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp --------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1122457889999999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=4.5e-31 Score=257.47 Aligned_cols=179 Identities=14% Similarity=0.205 Sum_probs=139.3
Q ss_pred CCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcC-----CCCEEEeecCccccccCCCCC
Q 013122 1 MESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLARVAFNDTPT 74 (449)
Q Consensus 1 me~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-----~~~vKL~DFGlA~~~~~~~~~ 74 (449)
++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+........
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 83 LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred cCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 5789999998765 6999999999999999999999999999999999999975 567999999999875433221
Q ss_pred c----cccccccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHHHH
Q 013122 75 A----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 150 (449)
Q Consensus 75 ~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~~~ 150 (449)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+
T Consensus 163 ~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i------------ 228 (293)
T d1csna_ 163 QHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------------ 228 (293)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH------------
T ss_pred cceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH------------
Confidence 1 12345689999999999987 68999999999999999999999999876554333222111
Q ss_pred hhHHHHHHHhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 151 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
.... ...+.....+++++++.+|+..|+..+|++||+.+.+.+
T Consensus 229 ~~~~-----------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 229 GEKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred Hhcc-----------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0000 001112233567889999999999999999999887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.7e-31 Score=258.19 Aligned_cols=172 Identities=20% Similarity=0.279 Sum_probs=134.3
Q ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCc-cccc
Q 013122 2 ESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWT 79 (449)
Q Consensus 2 e~dL~~~i~~~~-~Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~-~~~~ 79 (449)
+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......... ....
T Consensus 113 ~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~ 192 (311)
T d1r0pa_ 113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192 (311)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTT
T ss_pred cCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecc
Confidence 378999888654 48889999999999999999999999999999999999999999999999998754432221 1224
Q ss_pred cccccccccCcccccccCCCCCCccchhhhHHHHHhhhhCCCCCCCCC-chhhHHHHHhhcCCCCHHHHHHHhhHHHHHH
Q 013122 80 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIARVRNEKARRY 158 (449)
Q Consensus 80 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~il~eLltG~~pF~~~~-~~~~l~~i~~~lg~p~~e~~~~~~~~~~~~~ 158 (449)
...||..|+|||.+.. ..++.++|||||||++|||++|..||.... ..+....+.
T Consensus 193 ~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~---------------------- 248 (311)
T d1r0pa_ 193 GAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---------------------- 248 (311)
T ss_dssp CSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH----------------------
T ss_pred cccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH----------------------
Confidence 4678999999999987 689999999999999999999776665432 222211111
Q ss_pred HhhhccCCCCCCCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 013122 159 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 205 (449)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~s~~~~dLL~~~L~~DP~~RpTa~elL~h 205 (449)
..... .....+++.+.+||.+||+.||++|||+.|+++|
T Consensus 249 -----~g~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 249 -----QGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----cCCCC---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11111 1224568899999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3e-31 Score=260.07 Aligned_cols=191 Identities=22% Similarity=0.223 Sum_probs=132.4
Q ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcccccccCCcEEEcCCCCEEEeecCccccccCCCC
Q 013122 2 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 73 (449)
Q Consensus 2 e~dL~~~i~~~~~Ls~~~i~~i~~QIl~aL~yLHs--------~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~ 73 (449)
.++|.++|+++ .++++.+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~ 163 (303)
T d1vjya_ 85 HGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence 46999999886 69999999999999999999996 5999999999999999999999999999987654332
Q ss_pred Cc-cccccccccccccCcccccccCC----CCCCccchhhhHHHHHhhhhCCCCCCCCCchhhHHHHHhhcCCCCHHHHH
Q 013122 74 TA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 148 (449)
Q Consensus 74 ~~-~~~~~~~gt~~Y~APE~l~~~~~----~~s~~~DIWSlG~il~eLltG~~pF~~~~~~~~l~~i~~~lg~p~~e~~~ 148 (449)
.. ......+||+.|+|||++.+... .++.++|||||||++|||++|..||......... ........+..+.+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 242 (303)
T d1vjya_ 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVPSDPSVEEMR 242 (303)
T ss_dssp EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSCSSCCHHHHH
T ss_pred ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhcccccchHHHHH
Confidence 21 12345789999999999875211 2567899999999999999999887543321110 000011112221111
Q ss_pred HHhhHHHHHHHhhhccCCCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 013122 149 RVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALA 204 (449)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLL~~~L~~DP~~RpTa~elL~ 204 (449)
..+.. ......+.... ......+.+|+.+||+.||++|||+.|+++
T Consensus 243 --------~~~~~--~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 243 --------KVVCE--QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp --------HHHTT--SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred --------HHHhc--cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11110 01111111111 122345889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.35 E-value=3.3e-14 Score=128.08 Aligned_cols=90 Identities=18% Similarity=0.115 Sum_probs=62.8
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccccccCCcEEEcCCCCEEEeecCccccccCCCCCccccccccccccccCccccc
Q 013122 15 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 94 (449)
Q Consensus 15 Ls~~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGlA~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 94 (449)
++...+..++.||+.+|+|||++||+||||||+|||++.+ .++|+|||+|.......... .....+.. -.+.+.
T Consensus 100 l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~-~l~rd~~~----~~~~f~ 173 (191)
T d1zara2 100 VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE-ILERDVRN----IITYFS 173 (191)
T ss_dssp CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH-HHHHHHHH----HHHHHH
T ss_pred hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHH-HHHHHHHH----HHHHHc
Confidence 6667788999999999999999999999999999999965 49999999997653222110 00000000 001121
Q ss_pred ccCCCCCCccchhhhHHHH
Q 013122 95 SFFSKYTPAIDIWSIGCIF 113 (449)
Q Consensus 95 ~~~~~~s~~~DIWSlG~il 113 (449)
..|+.++|+||+.--+
T Consensus 174 ---r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 174 ---RTYRTEKDINSAIDRI 189 (191)
T ss_dssp ---HHHCCCCCHHHHHHHH
T ss_pred ---CCCCCcccHHHHHHHH
Confidence 4678899999975433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.88 E-value=0.013 Score=54.32 Aligned_cols=30 Identities=33% Similarity=0.339 Sum_probs=26.6
Q ss_pred CCcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 37 ANVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 37 ~gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.||||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.18 E-value=0.058 Score=50.24 Aligned_cols=27 Identities=30% Similarity=0.229 Sum_probs=22.5
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
++||+|+.+.|||++. + ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 6899999999999974 3 4589999764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=90.19 E-value=0.05 Score=48.34 Aligned_cols=29 Identities=24% Similarity=0.243 Sum_probs=24.9
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEEeeccCcceeecCCceEEEeechhcc
Confidence 38999999999999976666799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=89.17 E-value=0.057 Score=47.69 Aligned_cols=29 Identities=24% Similarity=0.123 Sum_probs=25.1
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 38999999999999987667899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=84.49 E-value=0.19 Score=47.94 Aligned_cols=28 Identities=29% Similarity=0.351 Sum_probs=24.6
Q ss_pred CcccccccCCcEEEcCCCCEEEeecCccc
Q 013122 38 NVFHRDLKPKNILANADCKLKICDFGLAR 66 (449)
Q Consensus 38 gIvHrDLKP~NILl~~~~~vKL~DFGlA~ 66 (449)
.++|+|+.+.|||++.+. ++|+||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 589999999999998764 8999998774
|